{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "80829310",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "from dotenv import load_dotenv\n",
    "\n",
    "from langchain_community.document_loaders import PyPDFLoader, PyMuPDFLoader\n",
    "from langchain_community.document_loaders import DirectoryLoader\n",
    "from langchain_community.document_loaders import TextLoader\n",
    "\n",
    "from langchain_tavily import TavilySearch\n",
    "from langchain_text_splitters import RecursiveCharacterTextSplitter\n",
    "from tqdm import tqdm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "659ca9fe",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 4/4 [00:09<00:00,  2.35s/it]\n"
     ]
    }
   ],
   "source": [
    "all_pdf_documents = []\n",
    "dir_loader=DirectoryLoader(\n",
    "    \"../data/pdfs\",\n",
    "    glob=\"**/*.pdf\", \n",
    "    loader_cls= PyMuPDFLoader, \n",
    "    use_multithreading=True,\n",
    "    show_progress=True\n",
    "\n",
    ")\n",
    "\n",
    "all_processed_docs = []\n",
    "\n",
    "pdf_documents=dir_loader.lazy_load()\n",
    "\n",
    "for doc in dir_loader.lazy_load():   \n",
    "    doc.metadata[\"source_type\"] = \"Authorotative\"\n",
    "    doc.metadata[\"priority\"] = \"1\"\n",
    "    all_pdf_documents.append(doc)\n",
    "\n",
    " \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "fc2e1a08",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Search Successful!\n",
      "{'query': 'current 2025 health alerts', 'follow_up_questions': None, 'answer': None, 'images': [], 'results': [{'url': 'https://www.cdc.gov/respiratory-viruses/data/index.html', 'title': 'Respiratory Illnesses Data Channel', 'content': 'Due to the Christmas holiday, the weekly respiratory virus data and summaries will not be updated on Friday, December 26, 2025. Data updates will resume on Tuesday, December 30, 2025.\\n\\n## What to know\\n\\nRI Alert Graphic Low\\n\\n## Your community snapshot\\n\\n### Keep in mind\\n\\n## Weekly national summary\\n\\n## Season Outlook [...] CDC continues to expect that the fall and winter respiratory disease season in the United States will likely have a similar number of combined peak hospitalizations due to COVID-19, influenza, and RSV compared to last season. Read more: 2025-2026 Respiratory Disease Season Outlook - December Update | CDC\\n\\n## Protect yourself and your community\\n\\n### Looking for guidance?\\n\\n## Continue exploring these data [...] Wastewater (sewage) data specific to SARS-CoV-2, the virus that causes COVID-19, are displayed at the national, regional, and state levels. These data can provide an early signal of changes in infection levels.\\n\\n### COVID-19 Variants\\n\\nCOVID-19 variants and genomic surveillance data are displayed for the nation.\\n\\n### Nursing Homes\\n\\nNursing home data on vaccinations, cases, and hospitalizations for COVID-19, flu, and RSV are displayed at the national and state levels.\\n\\n### Hospital Bed Occupancy', 'score': 0.5126688, 'raw_content': None}, {'url': 'https://www.cdc.gov/respiratory-viruses/data/illnesses-going-around.html', 'title': 'Other Respiratory Illnesses Going Around | Respiratory Illnesses | CDC', 'content': 'Due to the Christmas holiday, the weekly respiratory virus data and summaries will not be updated on Friday, December 26, 2025. Data updates will resume on Tuesday, December 30, 2025.\\n\\n## About\\n\\nhospital icon\\n\\n## Summary\\n\\n### Are you looking for data on COVID-19, flu, or RSV?\\n\\n## Other Viruses and Bacteria that Cause Respiratory Illness [...] | Laryngitis and tracheitis or supraglottitis | J04.X | Acute laryngitis and tracheitis |\\n| Other lower respiratory disease | J22 | Unspecified acute lower respiratory tract infection |\\n| Pneumonia | J09.X1 | Influenza due to identified novel influenza A virus with pneumonia |\\n| J10.0X | Influenza due to other identified influenza virus with pneumonia |\\n| J11.0X | Influenza due to unidentified influenza virus with pneumonia |\\n| J12.X | Viral pneumonia, not elsewhere classified | [...] | J13 | Pneumonia due to Streptococcus pneumoniae |\\n| J14 | Pneumonia due to Hemophilus influenzae |\\n| J15.X | Bacterial pneumonia, not elsewhere classified |\\n| J16.X | Pneumonia due to other infectious organisms, not elsewhere classified |\\n| J17 | Pneumonia in diseases classified elsewhere |\\n| J18.X | Pneumonia, unspecified organism |\\n| J85.1 | Abscess of lung with pneumonia |\\n| Respiratory distress or failure | J80 | Acute Respiratory Distress Syndrome |\\n| J96.0 | Acute respiratory failure |', 'score': 0.4199102, 'raw_content': None}, {'url': 'https://www.cdc.gov/han/php/about/index.html', 'title': 'Health Alert Network (HAN)', 'content': '## Latest Messages from the Health Alert Network\\n\\nThe Centers for Disease Control and Prevention (CDC) protects people’s\\nhealth and safety by preventing\\nand controlling diseases and injuries; enhances health decisions by\\nproviding credible information on\\ncritical health issues; and promotes healthy living through strong\\npartnerships with local, national\\nand international organizations.\\n\\nU.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES\\n\\nHAN message types\\n\\n### [...] Health Alert: Conveys the highest level of importance about a public health incident.  \\nHealth Advisory: Provides important information about a public health incident.  \\nHealth Update: Provides updated information about a public health incident.\\n\\n### Sign Up for HAN Email Updates\\n\\nYou can sign up to receive HAN Update Alerts when a new HAN is added to the system by using the following steps:\\n\\nOnce you complete these steps, you will receive HAN alerts by email when new HANs are distributed. [...] CDC’s Health Alert Network (HAN) is CDC’s primary method of sharing cleared information about urgent public health incidents with public information officers; federal, state, territorial, tribal, and local public health practitioners; clinicians; and public health laboratories.\\n\\nHealth Alert Network badge\\n\\n## Overview', 'score': 0.28933704, 'raw_content': None}], 'response_time': 7.09, 'request_id': '2734fd10-733d-4c62-af67-cda6e34de5c6'}\n"
     ]
    }
   ],
   "source": [
    "load_dotenv()\n",
    "os.getenv('TAVILY_API_KEY')\n",
    "\n",
    "# Instantiate using the new name\n",
    "web_search_tool = TavilySearch(\n",
    "    max_results=3, \n",
    "    search_depth=\"advanced\", \n",
    "    include_domains=[\"who.int\", \"cdc.gov\", \"mayoclinic.org\"] \n",
    ")\n",
    "\n",
    "\n",
    "try:\n",
    "    results = web_search_tool.invoke({\"query\": \"current 2025 health alerts\"})\n",
    "    print(\"Search Successful!\")\n",
    "    print(results)\n",
    "except Exception as e:\n",
    "    print(f\"Error: {e}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "28a11bb9",
   "metadata": {},
   "outputs": [],
   "source": [
    "def split_documents(pdf_documents,chunk_size=1000,chunk_overlap=200):\n",
    "\n",
    "    text_splitter = RecursiveCharacterTextSplitter(\n",
    "        chunk_size=chunk_size,\n",
    "        chunk_overlap=chunk_overlap,\n",
    "        length_function=len,\n",
    "        separators=[\"\\n\\n\", \"\\n\", \" \", \"\"]\n",
    "    )\n",
    "    split_docs = text_splitter.split_documents(pdf_documents)\n",
    "    #print(f\"Split {len(pdf_documents)} documents into {len(split_docs)} chunks\")\n",
    "    \n",
    "    # Show example of a chunk\n",
    "    if split_docs:\n",
    "        print(f\"\\nExample chunk:\")\n",
    "        print(f\"Content: {split_docs[0].page_content[:200]}...\")\n",
    "        print(f\"Metadata: {split_docs[0].metadata}\")\n",
    "    \n",
    "    return split_docs\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "b164ea04",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Example chunk:\n",
      "Content: i \n",
      " \n",
      "National Health \n",
      "Mission (NHM) \n",
      "Manual for District- Level Functionaries \n",
      " \n",
      "2017...\n",
      "Metadata: {'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 0, 'source_type': 'Authorotative', 'priority': '1'}\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 0, 'source_type': 'Authorotative', 'priority': '1'}, page_content='i \\n \\nNational Health \\nMission (NHM) \\nManual for District- Level Functionaries \\n \\n2017'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ii \\n \\nPREFACE \\n \\n \\nThe purpose of this Development Manual for National Health Mission (NHM) is to create an \\nenabling mechanism for improved implementation of the Centrally Sponsored Scheme \\n(CSS) at the cutting edge, leading to enhanced outcomes in nature and extent. \\nAccordingly, it would act as a guide for implementation by the District Collector and key \\nDistrict-level functionaries, enable quick learning about the Scheme, implementation \\nmodalities, roles and responsibilities of the various functionaries as well as stakeholders. \\n \\nThis Manual is prepared with inputs from a combination of sources, such as review of \\nscheme guidelines and circulars issued by the Ministry of Health & Family Welfare, the \\nnodal Ministry for administration of the scheme, interaction with nodal officers from \\nMinistry of Health & Family Welfare; Government of India (GoI), National Health Systems \\nResource Centre (NHSRC), District and Sub district level authorities and discussions with'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Ministry of Health & Family Welfare; Government of India (GoI), National Health Systems \\nResource Centre (NHSRC), District and Sub district level authorities and discussions with \\nthe key personnel involved in the implementation of the Scheme. \\n \\nFor greater direction, the guidelines cited must be referred to along with the scheme \\nwebsite (www.nhm.gov.in) for guidance and clarifications on implementation from time to \\ntime.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3 \\n \\n \\n \\nCONTENTS \\n \\n        \\n1. National Health Mission (NHM) ........................................................................................... 4 \\n1.1 National Health Mission (NHM): About the Scheme ................................................... 4 \\n2. National Rural Health Mission (NRHM)  ............................................................................. 4 \\n2.1 Objectives, Goals and Key Strategies  of the NRHM ................................................... 4 \\n2.2 Components .................................................................................................................. 5 \\n2.3 Convergence ............................................................................................................... 15 \\n2.4 Institutional Framework ................................................................................................ 17'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2.4 Institutional Framework ................................................................................................ 17 \\n2.5 Untied Funds ................................................................................................................. 21 \\n2.6 Fund Flow Management ................................................................................................ 22 \\n2.7 District Health Action Plans (DHAP)/City Health Action Plan .................................... 23 \\n2.8 Best Practices/ State Innovations................................................................................... 27 \\n3. Roles and Responsibilities of Key District Level Functionaries ................................ 29 \\n3.1 Chair of District Health Society (DHS) (District Collector/ Magistrate) .................. 29 \\n3.2 Village/  Block/City  /  District/Ward Level Officers- Programme Management'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3.1 Chair of District Health Society (DHS) (District Collector/ Magistrate) .................. 29 \\n3.2 Village/  Block/City  /  District/Ward Level Officers- Programme Management \\nUnit (PMU) ................................................................................................................. 31 \\n3.3 Block/City   / District Level Officers- Community Process Unit ............................... 35 \\n4. Accountability, Monitoring, and Reporting ................................................................... 39 \\n4.1 Accountability Framework  ........................................................................................... 39 \\n4.2 Monitoring & Evaluation Activities .............................................................................. 40 \\n5.  National Urban Health Mission (NUHM) ......................................................................... 40'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='5.  National Urban Health Mission (NUHM) ......................................................................... 40 \\n5.1 About the Scheme ......................................................................................................... 42 \\n5.2 Goals, Objectives and Strategies of NUHM .................................................................. 43 \\n5.3 Institutional Framework: Resource Planning in NUHM ............................................... 43 \\n5.4 Convergence  ................................................................................................................. 44 \\n5.5 Roles and Responsibilities of District Health Society in Urban Areas (NUHM) ......... 45 \\nNHM- IMPLEMENTATION MONITORING PROFORMA (YEARLY REVIEW SHEET \\nwith MONTHLY REPORT FORMAT)  [For District Level Functionaries \\nbased on the District Action Plan (DAP)] ................................................... 46'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='with MONTHLY REPORT FORMAT)  [For District Level Functionaries \\nbased on the District Action Plan (DAP)] ................................................... 46 \\nABBREVIATIONS ........................................................................................................ 51 \\nENDNOTES & REFERENCES ..................................................................................... 53'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='4 \\n \\n \\n \\n1. National Health Mission (NHM) \\n1.1 \\nNational Health Mission (NHM): About the Scheme1 \\n \\nNational Rural Health Mission (NRHM) was launched in April 12, 2005 to address the \\nhealth needs of the underserved rural population especially women, children and \\nvulnerable sections of the society and to provide affordable, accessible and quality \\nhealthcare. \\n \\nThe National Urban Health Mission, (NUHM) was launched in May 2013 and was \\nsubsumed with NRHM as a sub-Mission of the overarching National Health Mission. \\n(NHM). Many unique practices were encouraged like innovations in healthcare \\ndelivery practices, flexible financing to the states with strengthened monitoring and \\nevaluation component for better health outcomes and health indicators of the \\nstates.  \\nThe vision 2  of the NHM is the “Attainment of Universal Access to Equitable, \\nAffordable and Quality health care services, accountable and responsive to people’s'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='states.  \\nThe vision 2  of the NHM is the “Attainment of Universal Access to Equitable, \\nAffordable and Quality health care services, accountable and responsive to people’s \\nneeds, with effective inter-sectoral convergent action to address the wider social \\ndeterminants of health”.     \\nNHM focuses on  decentralized health planning, service delivery, creating \\nknowledge hubs within district hospitals, strengthening secondary level care at \\ndistrict hospitals,  expanding outreach services, improving community processes and \\nbehavior change communication, human resources development, public health \\nmanagement, and health management information systems.   NHM particularly \\nfocuses on equity: prioritizing the health of tribal populations, those in LWE and \\nurban poor. A key outcome of NHM is to reduce Out of Pocket expenditures.   Health \\noutcomes, output and process indicators are monitored through large scale surveys'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='urban poor. A key outcome of NHM is to reduce Out of Pocket expenditures.   Health \\noutcomes, output and process indicators are monitored through large scale surveys \\nconducted periodically with evaluations, use of HMIS data, and periodic reviews \\ndone. \\nThe main aim is to create a fully functional, decentralized and community owned \\nsystem with greater inter- sectoral coordination so that wider social determinant \\nfactors affecting health of people like water, sanitation, nutrition, gender and \\neducation are also equally addressed.  \\n \\n2. National Rural Health Mission (NRHM) \\n \\n2.1 \\nObjectives3, Goals4 and Key Strategies 5 of the NRHM \\nMajor Strategies were incorporated for improving outreach of health services to \\npublic for greater synergy; decentralized planning and innovation in service \\ndelivery. The summary* of objectives, goals and strategies are in Table 1:  \\n \\nTable 1: Objectives, Goals & Strategies of NRHM \\nObjectives \\nGoals \\nStrategic Changes'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='5 \\n \\n1. Reduction in Infant Mortality \\nRate (IMR) and Maternal \\nMortality Rate (MMR  \\n2. Population stabilization, \\ngender and demographic \\nbalance \\n1. Reduce IMR to 25/ 1000 live births \\n2. . Prevention and reduction of anaemia \\nin women aged 15- 49 years \\n3. Reduce Total Fertility Rate (TFR) to 2.1 \\n4. Reduce MMR to 1/ 1000 live births \\n1. Strengthening infrastructure at all levels  \\n2. Quality Monitoring of facilities as per Indian Public Health \\nStandards ( IPHS) Standard \\n3. Decentralised planning with autonomy for local action  \\n4. Institutional Mechanisms at all levels with autonomy \\n5. Induction of management specialist into Programme \\nmanagement Units \\n6. Centralized technical support unit- National Health \\nResource Centre and State Health Resource Centre(NHSRC \\nand SHSRC) \\n3. Achieve Universal access to \\npublic health services like \\nwomen’s health, child health, \\nwater, sanitation & hygiene, \\nimmunization, and nutrition. \\n4. Promotion of healthy life \\nstyles'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3. Achieve Universal access to \\npublic health services like \\nwomen’s health, child health, \\nwater, sanitation & hygiene, \\nimmunization, and nutrition. \\n4. Promotion of healthy life \\nstyles \\n1. Reduce household out –of-pocket \\nexpenditure on total health care \\nexpenditure \\n1. Decentralised planning with autonomy for local action  \\n2. Inter sector District Health Plan includes drinking water, \\nsanitation, hygiene, nutrition \\nCapacity- Building of Panchayati Raj institutions \\n3. Developing capacities for preventive health care at all \\nlevels \\n5. Prevention and control of \\ncommunicable and non- \\ncommunicable diseases, \\nincluding locally endemic \\ndiseases  \\n \\n1. Prevent and reduce mortality and \\nmorbidity from communicable, non- \\ncommunicable, injuries and emergency \\ndiseases \\n2. Reduce annual incidence and mortality \\nfrom Tuberculosis by half \\n3. Reduce prevalence of Leprosy to \\n<1/10000 population and incidence to \\nzero in all districts \\n4. Annual Malaria incidence to be <1/1000'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='from Tuberculosis by half \\n3. Reduce prevalence of Leprosy to \\n<1/10000 population and incidence to \\nzero in all districts \\n4. Annual Malaria incidence to be <1/1000 \\nLess than 1 per cent microfilaria \\nprevalence in all districts \\n5. Kala- Azar Elimination by 2015, <1case \\nper 10000 population in all blocks \\n1. Integrating vertical Health and Family Welfare programmes \\n2. Developing capacities for preventive health care at all \\nlevels \\n3. Reorienting Medical Education to Rural Health Issues \\n6. Access to integrated \\ncomprehensive primary \\nhealthcare  \\n7. Revitalization of local health \\ntraditions and mainstream \\nAYUSH  \\n1. Reduce household out –of-pocket \\nexpenditure on total health care \\nexpenditure \\n1. Promote ASHA healthcare service delivery  \\n2. Health Plan for each village through VHNSC \\n3. Untied funds with flexi pools of funds \\n4. Effective and visible risk pooling and social health \\ninsurance \\n 5. Promoting non-profit sector and PPP for achieving goals in \\nunderserved areas'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3. Untied funds with flexi pools of funds \\n4. Effective and visible risk pooling and social health \\ninsurance \\n 5. Promoting non-profit sector and PPP for achieving goals in \\nunderserved areas \\n6. Mainstreaming AYUSH and local health traditions \\n*Many Strategic Changes and programme components are overlapping to achieve Goals and Objectives. For convenience they are put in one category \\n \\n2.2 \\nComponents  \\n \\n \\n \\nComponents of NHM\\nPublic Health Planning \\nand Financing\\nHuman Resource \\nStrengthening\\nHealth System \\nStrengthening\\nReproductive, \\nMaternal, New Born, \\nChild Health and \\nAdolescent (RMNCH+ \\nA) Services\\nNational Disease \\nControl Programmes \\n(NDCPs)\\nCommunity Processes'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='6 \\n \\n \\nFigure 1: Components of National Health Mission  \\n \\n2.2.1 Public Health Planning and Financing:  \\n \\n\\uf0b7 \\nMapping of facilities and differential planning for districts/cities/blocks as per their \\nhealth indicators \\n\\uf0b7 \\nPlanning for full spectrum of health services \\n\\uf0b7 \\nEmphasis on quality assurance in delivery points \\n\\uf0b7 \\nStrengthening of Management with full time Mission Director, Director Finance and \\nProgramme Management support at all levels.  \\n\\uf0b7 \\nDeveloping a separate and trained Public health cadre of professionals including \\ndoctors and nurses \\n \\n \\n2.2.2 Human Resource Strengthening in Health; Deployment and Development \\n \\n\\uf0b7 \\nHR gaps met based on case load. Engagement of medical specialists, Medical \\nprofessionals and nurses on contract based on need.  \\n\\uf0b7 \\nHR accountability: Performance- based incentives and for working in difficult areas. \\n\\uf0b7 \\nAdditional incentives to health professionals to serve in rural and remote areas \\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7 \\nHR accountability: Performance- based incentives and for working in difficult areas. \\n\\uf0b7 \\nAdditional incentives to health professionals to serve in rural and remote areas \\n\\uf0b7 \\nSpeedy recruitment to fill up vacancy, preferable decentralized.  \\n\\uf0b7 \\nAmendments in medical college norms to increase availability of doctors  \\n\\uf0b7 \\nCapacity building and training of staff at all levels. \\n \\n2.2.3 Health Systems Strengthening  \\n \\nFunds are provided for up gradation of existing and construction of new infrastructure. \\nHigh focus States spend up to 33 per cent and other States up to 25 per cent of their funds \\non infrastructure. Relevant Guidelines in Table 2: \\n \\nTable 2: Guidelines for health facilities based on population norms6  \\nHealth facility level \\nPopulation Covered in \\nPlain areas \\nDifficult/ tribal & hilly \\nareas \\nStaff \\nRequirement \\nSub centre \\n1 per 5,000 population \\n1 per 3,000 population \\n3 \\nPrimary Health Centre (PHC) \\n1 per 30,000 population \\n1 per 20,000 population \\n15'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Difficult/ tribal & hilly \\nareas \\nStaff \\nRequirement \\nSub centre \\n1 per 5,000 population \\n1 per 3,000 population \\n3 \\nPrimary Health Centre (PHC) \\n1 per 30,000 population \\n1 per 20,000 population \\n15 \\nCommunity Health Centre (CHC) \\n1 per 1,20,000 population \\n1 per 80,000 population \\n25 \\nDistrict Hospital \\n100 beds per 1,00,000 \\npopulation \\n \\n60-70 \\n \\nFacility type and time taken to reach by walk7 \\nFacility Type \\nTime taken for walking to facility from any \\nhabitation \\nSub centre( in hilly and desert states) \\nWithin 30 min'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='7 \\n \\nPHC \\nWithin 30 min  \\nCHC \\nWith 2 hrs \\nHowever, to ensure easy access, facilities can be created/ upgraded based on the ‘time to care’ approach. \\n \\nThe various sub- components of Health Systems Strengthening are as follows: \\n \\n1. Construction of new buildings and renovation of existing ones.  \\n \\nBudget provisions available for construction, maintenance, carpentry, electrical, \\nplumbing, sanitation, water provision etc. to fulfill the infrastructural gaps based of IPHS \\n(Indian Public Health Standards) and existing structure.   \\n \\n2. Improving Sanitation & Hygiene in Public facilities: Kayakalp 8 \\n \\nKayakalp initiative is a new initiative launched in 2015 under NHM, to inculcate the \\npractice of hygiene, sanitation, effective waste management and infection control in \\npublic health facilities. It also includes recognition with Certificate of Commendation and \\nCash Awards of such public healthcare facilities that show extraordinary performance and \\ncompliance to protocols.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Cash Awards of such public healthcare facilities that show extraordinary performance and \\ncompliance to protocols. \\n \\n \\n \\n \\nTable 3: Incentives under Kayakalp initiative  \\nFacility Type \\n \\nRanked Awards \\nCertificate of Commendation \\nDH \\n1st 50 lakh,  2nd 20 lakh \\nRs 3 lakh \\nCHC & SDH \\n1st 15 lakh, 2nd 10 lakh \\nRs 1 lakh \\nPHC \\n2 lakh \\nRs 50,000 \\n \\n3. Social Protection: Reducing Out of pocket expense:  \\n \\n \\n \\nA. Drugs: Free Drugs Service Initiatives9 \\nSOCIAL \\nPROTECTION\\nFree Drugs \\nService \\nInitiatives\\nFree \\nDiagnostics \\nService \\nInitiative\\nFree Diet\\nFree \\nPatient \\nTransport \\nService'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7 \\nProvisions for sup\\n(EDL), free of cost\\n\\uf0b7 \\nCentrally procure\\nStandard Treatme\\n\\uf0b7 \\nProvision of local p\\n \\n \\nDrugs & Logistic Suppo\\n \\n Drug Procurement Sys\\nare very crucial for su\\n \\nB. Diagnostics: Free D\\n \\nUnder this programme\\nprovided to patients f\\nGuidelines on Free Dia\\n \\nC. Diet: Free good qu\\n \\nIt is available to all in\\n \\nD. Transport: Emerg\\nNational Ambulanc\\n \\nThese services are off\\nassured transport serv\\n(JSY) and Janani Sishu\\nMany of these models \\nmodel, approximately\\neach ambulance has a\\ntechnicians, with two \\n \\nEquipments: Biomedi\\n The comprehensive pr\\n108 Ambu\\nis an Emergency respon\\nambulances work to \\naccidents to the near\\nhospital. It also provides\\nreferral to another d\\nPregnant women obtain\\nfrom their home to h\\ninstitutional d\\n8 \\nply of essential drugs as per the defined E\\nt, to lower the out- of- pocket expenses of t\\nment of drugs for various programmes as\\nnt Guidelines (STG).  \\npurchase of drugs and supplies at lower leve\\nort: Procurement and Supply Chain Managem'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='t, to lower the out- of- pocket expenses of t\\nment of drugs for various programmes as\\nnt Guidelines (STG).  \\npurchase of drugs and supplies at lower leve\\nort: Procurement and Supply Chain Managem\\nstem for public health facilities and E-procur\\nupply of essential drugs for JSSK and other p\\nDiagnostics Service Initiative11 \\ne, free diagnostics services (radiological & la\\nfree of charge, as per the level of the facilit\\nagnostics Service Initiative. \\nuality Diet  \\npatients including pregnant women. \\ngency Response System (ERS)/ Patient T\\nce Services (NAS)12 \\nfered on cashless basis and are the pillars fo\\nvices to the patients as entitled by Janani Su\\nu Suraksha Karyakram (JSSK)13.  \\nhave dedicated call centers attached to the\\ny one ambulance is positioned for one lakh p\\na staff of three drivers and three paramedica\\nsupervisors for every 15 vehicles. \\nical Equipment Management and Maintena\\nrogram includes detailed guidelines on the c\\nAmbulance Services\\nulance\\nnse system. These'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='supervisors for every 15 vehicles. \\nical Equipment Management and Maintena\\nrogram includes detailed guidelines on the c\\nAmbulance Services\\nulance\\nnse system. These \\nbring victims of \\nrest government \\ns services in case of \\ndistrict hospital. \\nn the pickup facility \\nealth Center for \\ndelivery.\\n102 Ambu\\nis a basic patient transpo\\nambulances are located\\nhospitals and post- deli\\nfacility is provided to a\\nchildren and mothers fro\\ntheir homes. It also w\\ncritically ill neonatal pat\\nto the hosp\\nEssential Drugs List \\nthe patients.  \\ns per the EDL and \\nels, if need arises. \\nment Systems10  \\nrement systems \\nrogrammes. \\naboratory) are \\nty. (Refer \\nTransport Service/ \\nor providing free \\nuraksha Yojana \\n \\nem. In Dial 108 \\npopulation, and \\nal emergency \\nance Programme14 \\ncomprehensive \\nlance \\nort system. These \\nd in government \\nivery, drop- back \\nall the registered \\nom the hospital to \\nworks to bring \\ntients from home \\npital.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 8, 'source_type': 'Authorotative', 'priority': '1'}, page_content='9 \\n \\nmedical equipment management and maintenance in a Public Private Partnership \\nmode, its components, structure for partnerships and inventory mapping. \\n \\n Blood Services: NHM supports activities to meet annual requirements of blood \\nthrough district government by supplementing Human Resources, equipment and \\nother requirements like e- blood banking, voluntary blood donation and functional \\nlinkages of blood storage centres with blood banks. \\n \\n \\n4. Outreach Services: Mobile Medical Units15.  \\n \\nVehicles are used to improve outreach services and bring healthcare to the \\ndoorstep of especially in difficult terrain and remote areas. It may carry medical \\nand paramedical personnel, drugs, supplies and laboratory and diagnostics \\nequipment. The number of vehicles varies from State to State.  \\n \\n \\n2.2.4 Reproductive, Maternal, New Born, Child Health and Adolescent (RMNCH+ \\nA) Services \\n \\nThis programme was launched in 2013 to address increasing maternal and child'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 8, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2.2.4 Reproductive, Maternal, New Born, Child Health and Adolescent (RMNCH+ \\nA) Services \\n \\nThis programme was launched in 2013 to address increasing maternal and child \\nhealth mortality, associated causes and to bring in improvement in access and \\nutilisation of health care services by the vulnerable population. The sub- \\ncomponents of this Scheme are as follows:  \\n \\nA. Reducing Maternal Mortality Rate: Maternal Health \\n \\n1. Incentivization: Janani Suraksha Yojana (JSY)16 \\n \\nThis scheme is for strengthening Maternal and Child Health Services wherein \\nincentives are paid to all the pregnant women of both urban and rural areas for \\ndeliveries in public institutions. Incentives are given to all patients irrespective of \\ntheir BPL status, so as to facilitate public institutional deliveries.  \\n \\n \\nTable 4 a: Incentives for Institutional Deliveries under Janani Suraksha Yojana (JSY) \\n \\nState \\nIncentives for Institutional Deliveries under JSY \\nRural Areas \\nUrban Areas \\nPregnant Women'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 8, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Table 4 a: Incentives for Institutional Deliveries under Janani Suraksha Yojana (JSY) \\n \\nState \\nIncentives for Institutional Deliveries under JSY \\nRural Areas \\nUrban Areas \\nPregnant Women  \\n(Rs.) \\nASHA (Rs.) \\nPregnant \\nWomen \\n(Rs.) \\nASHA \\n(Rs.)'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 9, 'source_type': 'Authorotative', 'priority': '1'}, page_content='10 \\n \\nHigh performing States \\n700 \\n600 \\n600 \\n400 \\nLow performing States \\n1,400 \\nSame as above \\n1,000 \\nSame as \\nabove \\nIncentives for Home \\nDeliveries \\n500 \\n- \\n500 \\n- \\n \\n2. Free Patient Entitlements: Janani Sishu Suraksha Karyakram (JSSK)17 \\n \\nJSSK scheme ensures cashless delivery and C- section for pregnant women and \\nmanagement of sick neonates up to one year to prevent incurring high out- of- \\npocket expenses and exploitation by unwarranted people. \\n \\nTable 4 b: Patient Entitlements under JSSK \\n \\nPregnant women \\nSick newborns till 30 days after birth. \\n\\uf0b7 \\nFree and cashless delivery \\n\\uf0b7 \\nFree C- Section \\n\\uf0b7 \\nFree drugs and consumables \\n\\uf0b7 \\nFree diagnostics \\n\\uf0b7 \\nFree diet during stay in the health institutions \\n\\uf0b7 \\nFree provision of blood \\n\\uf0b7 \\nExemption from user charges \\n\\uf0b7 \\nFree transport from home to health institutions \\n\\uf0b7 \\nFree transport between facilities in case of referral \\n\\uf0b7 \\nFree drop back from Institutions to home after 48 \\nhours stay \\n\\uf0b7 \\nFree treatment \\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 9, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7 \\nFree transport from home to health institutions \\n\\uf0b7 \\nFree transport between facilities in case of referral \\n\\uf0b7 \\nFree drop back from Institutions to home after 48 \\nhours stay \\n\\uf0b7 \\nFree treatment \\n\\uf0b7 \\nFree drugs and consumables \\n\\uf0b7 \\nFree diagnostics \\n\\uf0b7 \\nFree provision of blood \\n\\uf0b7 \\nExemption from user charges \\n\\uf0b7 \\nFree Transport from Home to Health Institutions \\n\\uf0b7 \\nFree Transport between facilities in case of \\nreferral \\n\\uf0b7 \\nFree drop Back from Institutions to home \\nUnit Price per case allocations to the hospital are Drugs & Consumable for Normal Deliveries- Rs.350/-, Drugs & Consumable for C-\\nsections- Rs.1, 600/-, Diagnostic- Rs.200/-, Blood Transfusion- Rs.300/-, Transport (Referral transport inter facility) - Rs.250/. A separate \\naccount for this budget is maintained by the institutions. (Refer Guidelines on JSSK) \\n \\n3. Strengthening infrastructure: Maternal and Child Health (MCH)18 Services \\n \\nUnder NHM, 100/50/30 bedded MCH wings are established to improve quality of'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 9, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"3. Strengthening infrastructure: Maternal and Child Health (MCH)18 Services \\n \\nUnder NHM, 100/50/30 bedded MCH wings are established to improve quality of \\ncare if the bed occupancy is more than 70 per cent. Such wings can be established \\nin District Hospitals/ District Women's Hospitals/ Sub- District Hospitals/CHC- First \\nReferral Units (FRUs) to overcome the constraints of increasing caseloads and \\ninstitutional deliveries at these facilities. (Refer: Maternal and Newborn Health \\nTool Kit, Nov 2013; MoHFW, GoI) \\n \\n4. Reorienting Medical Education: Skill Labs19  \\n \\nSkills Labs are established for competency based training and skill enhancement of \\nhealthcare providers for RMNCH+A services, both in- service and pre- service \\ntraining. Thus reorient existing personnel and train students of ANM, GNM and \\nmidwifery courses.  \\n \\n5. Capacity Building: Dakshata Programme20\"),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 10, 'source_type': 'Authorotative', 'priority': '1'}, page_content='11 \\n \\n \\nIt is the capacity building programme for service providers in labor room best \\npractices during labor, delivery and post- partum. \\n \\n6. Promotive Health : Mothers Absolute Affection (MAA)21  \\n \\nIt is a new initiative Programme for Promotion of Breast Feeding.  \\n \\n7. Improves access and Coverage: Safe Abortion Services \\n \\nMedical Termination of Pregnancy (MTP) services are provided in FRUs, functional \\n24x7. \\n \\n8. Improving access by PPP mode: Pradhan Mantri Surakshit Matritva Abhiyan(PMSMA)22 \\n \\n Under the PMSMA, on the 9th of every month, pregnant ladies are given free health \\ncheck- up including blood pressure, sugar level, Hemoglobin test, Blood test etc. \\nand the required treatment in all government medical facilities. Private sector \\ngynecologists are encouraged to voluntarily participate and provide antenatal \\ncheckup (ANC) services in these public health facilities. \\n \\n9. NGOs Involvement: Gender Based Violence'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 10, 'source_type': 'Authorotative', 'priority': '1'}, page_content='gynecologists are encouraged to voluntarily participate and provide antenatal \\ncheckup (ANC) services in these public health facilities. \\n \\n9. NGOs Involvement: Gender Based Violence \\n \\nASHAs and clinical service providers are sensitized and trained to identify, counsel \\nand refer such cases to higher centres, with the support of Non- Governmental \\nOrganisations (NGOs) and women support groups. \\n \\n10. Monitoring and accountability of services: Maternal Death Review \\n \\nThe purpose of both Facility- Based Maternal Death Review (FBMDR) and \\nCommunity- Based Maternal Death Review (CBMDR) is to identify the causes of \\nmaternal deaths and the gaps in service delivery in order to take corrective action. \\n \\nB. Reducing Infant Mortality and Child Mortality Rate: New Born and Child \\nHealth  \\n \\n1. New born Care Services Programme \\n \\nTable 5: Programmes under New- born Care Services Programme23  \\nNewborn care services \\nLocation \\nServices \\nNew Born Care Corner \\nAll Delivery points'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 10, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Health  \\n \\n1. New born Care Services Programme \\n \\nTable 5: Programmes under New- born Care Services Programme23  \\nNewborn care services \\nLocation \\nServices \\nNew Born Care Corner \\nAll Delivery points \\nEssential newborn care including \\nresuscitation, Zero day immunization \\nNew Born Stabilization \\nUnits (NBSU) \\nCHCs/FRUs \\nStabilization and referral of sick newborns.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 11, 'source_type': 'Authorotative', 'priority': '1'}, page_content='12 \\n \\nSpecial New born Care \\nUnits (SNCUs) \\nDHs and tertiary care \\nhospitals \\nManagement of sick new-borns \\n \\n2. Universal Immunization Programme (UIP)24 & Mission Indra dhanush \\n \\nUnder the routine immunization, children are given vaccines for the prevention of \\nseven life- threatening diseases (Tetanus, Tuberculosis, Diphtheria, Pertussis, \\nMeasles, Polio and Hepatitis-B). Vitamin A dosages are also given with Measles. \\nTetanus Toxoid is provided to the pregnant women. These vaccinations are being \\norganized by immunization sessions in all the hospitals, health centers, sub centers \\nand anganwadi centers, during special vaccination weeks. Cold chain logistics are \\nprovided at all facilities. Surveillance of vaccine preventable diseases is integrated \\nwith Integrated Disease Surveillance Programme (IDSP). Name- based monitoring of \\nboth mother and children for vaccination are done through Mother and Child \\nTracking System (MCTS).'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 11, 'source_type': 'Authorotative', 'priority': '1'}, page_content='with Integrated Disease Surveillance Programme (IDSP). Name- based monitoring of \\nboth mother and children for vaccination are done through Mother and Child \\nTracking System (MCTS). \\n \\n \\n Mission Indradhanush: To strengthen and invigorate the Universal Immunization \\nProgramme    (UIP) and achieve full immunization coverage for all children at a \\nrapid pace, the Government of India (GoI) launched Mission Indradhanush in \\nDecember 2014.25  \\n \\n \\n Mission Indradhanush ensures that all children under the age of two years and \\npregnant women are fully immunized with all available vaccines. (Ref: Operational \\nGuidelines for UIP and Operational Guidelines for Mission Indradhanush) \\n \\n3. Rashtriya Bal Swasthya Karyakram (RBSK)26 \\n \\nThe Purpose of RBSK is to improve the overall quality of life of children, 0- 18 \\nyears, through early detection & intervention of 4Ds i.e. Defect at birth, Diseases, \\nDeficiencies, Developmental delays and disabilities. These will cover 38 identified'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 11, 'source_type': 'Authorotative', 'priority': '1'}, page_content='years, through early detection & intervention of 4Ds i.e. Defect at birth, Diseases, \\nDeficiencies, Developmental delays and disabilities. These will cover 38 identified \\nhealth conditions through dedicated mobile health teams in every block in schools \\nand Anganwadi centers. District Early Intervention Center (DEIC) is the setup for \\nfurther screening, management support and referral to higher center. \\n \\n4. Integrated Management of Common Childhood Illnesses(IMNCI) \\n \\nFacilities for prevention, early detection and management of diarrhea, Pneumonia \\nand Malaria \\n \\n5. Nutritional Rehabilitation Centers (NRCs) \\n \\nNRCs are set up in the health facilities, especially at DHs and FRUs for inpatient \\nmanagement of severely malnourished children, with counseling of mothers for \\nproper feeding and regular follow up on discharge. \\n \\n6. Monitoring: Child Death Review'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 12, 'source_type': 'Authorotative', 'priority': '1'}, page_content='13 \\n \\nReporting and reviewing of child death under 5 years is a priority area. \\n \\nC. Adolescent Health Programme  \\n \\n1. Rashtriya Kishor Swasthya Karyakram (RKSK) 27 \\n \\nAdolescent Friendly Health Services (AFHS) are present in district health facilities \\nto provide counseling on sexual and reproductive health including menstrual \\nhygiene, substance abuse, violence including domestic violence, mental health, \\ninjuries, non- communicable diseases and provide iron and folic acid tablets, \\ncondoms, pregnancy kits and Oral Contraceptive Pills (OCPs) through dedicated \\ntrained counselors. \\n \\nD. Reducing Fertility Rate: Family Planning Services 28 \\n \\n \\nFor the purpose of encouraging family planning in the district, all PHCs, CHCs and \\nDH services provide temporary and permanent family planning methods including \\nmale and female sterilization surgeries, Intrauterine Contraceptive Device (IUCD), \\nPost- Partum Intrauterine Contraceptive Device (PPIUCD), Oral Contraceptive Pills'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 12, 'source_type': 'Authorotative', 'priority': '1'}, page_content='male and female sterilization surgeries, Intrauterine Contraceptive Device (IUCD), \\nPost- Partum Intrauterine Contraceptive Device (PPIUCD), Oral Contraceptive Pills \\n(OCPs), Emergency Contraceptive Pills (ECPs), condoms and counseling services. In \\naddition, outreach sterilization services are conducted in remote areas. A month \\nlong (in two phases June 27- July 10 and July 11- July 24) national campaign on \\nWorld Population Day per year, is done in all the states/ Districts. AYUSH Doctors \\nare also trained in IUCD insertions. NSV Day (Non Scalpel Vasectomy Day) is \\nconducted on the 21st of each month.  \\n \\nNational family planning indemnity scheme (NFPIS) insures and indemnifies \\ninstitutions against litigations in case of deaths, complications and sterilization \\nfailures. \\n \\n \\nE. Declining Sex Ratio \\n \\nUnder this program, Government has been implementing the Pre- Conception and \\nPre- Natal Diagnostic Techniques (PCPNDT) Act 1994, to control the falling child sex'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 12, 'source_type': 'Authorotative', 'priority': '1'}, page_content='E. Declining Sex Ratio \\n \\nUnder this program, Government has been implementing the Pre- Conception and \\nPre- Natal Diagnostic Techniques (PCPNDT) Act 1994, to control the falling child sex \\nratio and to prevent female foeticide. Registered ultrasound centres have to ensure \\nthat sex determination of foetus is not done under any circumstances. There is a \\nprovision of punitive action during the execution or after receiving the complaint of \\nfoetal testing. \\n \\n2.2.5 Preventing Communicable and Non Communicable Diseases: National Disease \\nControl Programmes29   \\n \\n \\nA summary of the programmes are given below in the table. \\n \\nTable 1: Summary of Non- Communicable and Communicable Disease Programmes \\nS. No. \\nProgramme Name \\nKey Functions \\nNon- Communicable Disease Programmes'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 13, 'source_type': 'Authorotative', 'priority': '1'}, page_content='14 \\n \\nS. No. \\nProgramme Name \\nKey Functions \\n1.  National Program for Prevention and \\nControl of Diabetes, CVD and Stroke \\n(NPCDCS) \\nSpecialized management of Diabetes, CVD, Stroke \\nand Cancer. \\n2.  National program for Prevention and \\nControl of Blindness (NPCB) \\nProviding screening for detection and management \\nof diabetic retinopathy, refractory defects and \\nglaucoma. \\n3.  National Program for Prevention and \\nControl of Deafness (NPPCD)  \\nPrevention of avoidable hearing loss and early \\ndetection & treatment of ear problems. \\n4.  National Mental Health Program \\n(NMHP) \\nProviding services for early detection & treatment \\nof mental illness in the community  \\n5.  National Oral Health Program (NOHP) \\nPromotive and preventive oral health care at \\nPrimary and secondary level. \\n6.  National Program for Health Care of \\nthe Elderly (NPHCE) \\nSpecialized accessible healthcare for elderly. \\n7.  National Iodine Deficiency Disease \\nControl Program (NIDDCP)'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 13, 'source_type': 'Authorotative', 'priority': '1'}, page_content='6.  National Program for Health Care of \\nthe Elderly (NPHCE) \\nSpecialized accessible healthcare for elderly. \\n7.  National Iodine Deficiency Disease \\nControl Program (NIDDCP) \\nTo check iodine deficiency related health \\nProblems. \\n8.  National Tobacco Control Program \\n(NTCP) \\nTo spread awareness and better implementation \\nof tobacco control. \\nCommunicable Disease Programmes \\n1.  \\nNational Vector Borne Disease \\nControl Programme (NVBDCP) \\nPrevention and control of vector borne diseases \\nlike malaria, Japanese encephalitis, dengue, \\nchicken guinea, Kala-azar, Lymphatic filariasis. \\n2.  \\nRevised National Tuberculosis \\nControl Program (RNTCP) \\nPrevention, Control & Treatment of Tuberculosis. \\n3.  \\nNational Leprosy Eradication \\nProgram (NLEP) \\nDiagnosis and treatment (Multi-Drug Treatment- \\nMDT) of leprosy patients. \\n4.  \\nIntegrated Disease Surveillance \\nProgram (IDSP) \\nPrevention and Control of outbreaks \\n \\n \\nNCD screening at Population Level'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 13, 'source_type': 'Authorotative', 'priority': '1'}, page_content='MDT) of leprosy patients. \\n4.  \\nIntegrated Disease Surveillance \\nProgram (IDSP) \\nPrevention and Control of outbreaks \\n \\n \\nNCD screening at Population Level \\n \\nThis is a new initiative. In March 2017, GOI has initiated a programme in Population \\nlevel screening of risk factors of NCDs (Diabetes, Hypertension, Common Cancers- \\nOral, Breast, and Cervical) by the ASHAs and Auxiliary Nurse Midwife (ANMs).30 \\n \\n \\n2.2.6 Community Processes 31 : Institutionalizing Community- Led Action for \\nHealth32'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 14, 'source_type': 'Authorotative', 'priority': '1'}, page_content='15 \\n \\n  \\n \\nA summary of Community- Led Activities under NRHM is given below: \\nTable 2: Summary of Community- Led Activities under NRHM \\n IEC Activities: Comprehensive communication strategy adopted with a strong \\nbehavior change communication (BCC) component in the IEC strategy; \\ndissemination in villages and lowest levels. There is participation of non \\ngovernment agencies and professional and specialized agencies, visible mass media \\nefforts in massive health communication efforts. There is a substantial portion of \\nthe interpersonal BCC effort is through local ground level workers including ASHA \\nand ANMs, and community level structures equipped with communication kits, \\ninteracting on a one to one basis with families.  \\n \\n \\n2.3 \\nConvergence \\n \\n2.3.1 Convergence with Private Institutions and NGOs \\n \\nA. PPP Mode: National Dialysis Programme33 \\n \\nThis Programme enables for providing free dialysis services in District Hospitals on'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 14, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2.3.1 Convergence with Private Institutions and NGOs \\n \\nA. PPP Mode: National Dialysis Programme33 \\n \\nThis Programme enables for providing free dialysis services in District Hospitals on \\nPublic Private Partnership (PPP) Mode. The service provider provides medical and \\ntechnical staff, dialysis machine and Reverse Osmosis (RO) Plant infrastructure \\nwhile government provides Drugs, Water and Electricity and pays for the dialysis \\ncosts. \\n \\n \\nS. \\nNo. \\nCommunity Led \\nActivities \\nFunctions \\n1. \\nVillage Health \\nSanitation & \\nNutrition \\nCommittee \\n(VHSNC) \\n\\uf0b7 \\nFormed at each village level within the framework of Gram Sabha. \\n\\uf0b7 \\nSubcommittee or a standing committee of the Gram Panchayat. \\n\\uf0b7 \\nRepresentation of disadvantaged sections including women. \\n\\uf0b7 \\nActs as a platform for convergence of all departments at village level. \\nIt is also functions as a Planning and monitoring committee at the \\nvillage level.  \\n2. \\nASHA \\n\\uf0b7 \\nInterface between the community and the public health system. \\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 14, 'source_type': 'Authorotative', 'priority': '1'}, page_content='It is also functions as a Planning and monitoring committee at the \\nvillage level.  \\n2. \\nASHA \\n\\uf0b7 \\nInterface between the community and the public health system. \\n\\uf0b7 \\nThey are female health activists at household level.  \\n\\uf0b7 \\nInvolved in educating and mobilizing communities particularly \\nmarginalized communities.  \\n\\uf0b7 \\nFunctions include home visits, attending the Village Health and \\nNutrition Day (VHND), visits to the health facility, holding village level \\nmeetings and maintaining records.  \\n\\uf0b7 \\nIn rural areas, one ASHA worker per village and in urban areas, one \\nASHA per 1000-2500 population.  \\n3. \\nAnganwadi \\nWorkers \\n\\uf0b7 \\nUnder the ICDS programme Involved with ASHAs and ANM( Triple A \\nteam) in convening the Village Health & Nutrition Days and VHSNCs.  \\n4. \\nJan Sunwai or \\nJan Samvad \\n\\uf0b7 \\nPublic Dialogues/Public Hearings - taking direct feedback taken from \\nthe Community members  \\n\\uf0b7 \\nGrievance Redressal mechanism'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 15, 'source_type': 'Authorotative', 'priority': '1'}, page_content='16 \\n \\n \\n \\n \\nB. Role of Civil Society and Grant in aid to NGOs: Mechanisms for consultation with \\ncivil society are developed. The civil society members are made part of \\ncommunity processes. Involvement of NGOs in training, evaluations and filling \\nservice delivery gaps to achieve the goals. Up to 5%34 of the NHM budget (of \\nresource envelope of state) is used to support NGOs for a range of activities i.e. \\nto provide implementation support, undertake service delivery in remote areas, \\ncommunity monitoring, capacity building, for innovations in community \\nprocesses, implementation research, impact assessments and research.  \\n \\n \\n2.3.2 Inter and intra sectoral Coordination: Convergence with Other Departments3536  \\n \\nA. Revitalization of local traditions: Mainstreaming of AYUSH \\nThis includes co- location of AYUSH services at public health facilities including \\nplacing an AYUSH doctor at PHCs to strengthen Out- Patient (OP) services and'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 15, 'source_type': 'Authorotative', 'priority': '1'}, page_content='This includes co- location of AYUSH services at public health facilities including \\nplacing an AYUSH doctor at PHCs to strengthen Out- Patient (OP) services and \\nsetting up of separate AYUSH units/clinics at CHCs and District Hospitals. AYUSH \\ndoctors are trained and involved in Skilled Birth Attendant (SBA), IUCD insertion \\netc. and in preventive, screening and referral services under National Disease \\nControl Programmes such as NPCDCS. \\n \\nB. Integration with other programmes of Ministry of Health & Family Welfare \\n[MoHFW] \\n MoHFW has large number of National Disease Control Programmes (Communicable \\nand Non communicable) like RNTCP, IDSP, NVBDCP etc. All are brought under \\ntogether in District/City/Village Plan so that preventive, promotive and curative \\naspects are well integrated at all levels and there is efficient and effective \\nutilization of manpower and financial allocations under common District Health \\nSociety and availability of services at one point( UPHC).'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 15, 'source_type': 'Authorotative', 'priority': '1'}, page_content='utilization of manpower and financial allocations under common District Health \\nSociety and availability of services at one point( UPHC).  \\n \\nC. With National Aids Control Organization (NACO):  \\nNHM provides support to NACO programme implementation at district and sub- \\ndistrict levels. NACO provides counselors at CHCs and PHCs and testing kits as a \\npart of NACP-III. Additional training is provided to existing medical officers and \\nPara healthcare workers at lower levels on HIV/AIDS, condom promotion and \\nInformation Education and Communication (IEC) activities for better outreach.  \\n \\nD. Swachh Swasth Sarvtra:  \\nJoint initiative with Ministry of Drinking water and Sanitation (MDWS), is to \\ncomplement initiatives of Kayakalp and Swachh Bharat to make India free of Open \\nDefecation and have safe drinking water.37 Convergence at the level of Panchayati \\nRaj Institutions (PRIs), a common VHSNC, and common ASHA workers looks into the \\nall these aspects.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 15, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Defecation and have safe drinking water.37 Convergence at the level of Panchayati \\nRaj Institutions (PRIs), a common VHSNC, and common ASHA workers looks into the \\nall these aspects.  \\n \\nE. Ministry Of Women And Child Development \\nAnganwadi Centre is a major activity centre for health services in addition to ICDS \\nactivities. AWW and MAS to work as a team for promoting health and nutrition \\nrelated activities \\n \\nF. Convergence with the Education department and programmes such as SABLA for \\npreventing early age at marriage for girls.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 16, 'source_type': 'Authorotative', 'priority': '1'}, page_content='At Ministry level, inter\\nreporting to Empower\\nat the level of Mission\\nMinistries is also done \\n \\n2.4 Institutional Framewo\\n \\nA. National Level Implem\\nAt National Level, the\\nof Union Minister o\\nDepartment of Healt\\nThere is an Empow\\nDepartment of Health\\nbefore approval by \\nstructure of NHM is giv\\n \\n \\nMinist\\nFamil\\nMiss\\nProgram Divisions\\nSta\\nS\\nDist\\nSociety\\nS\\n17 \\nrdepartmental Committee with Mission Dire\\nred Programme Committee (EPC), is develop\\nn Steering Group (MSG) with representation o\\nfor Review and Monitoring.  \\nork \\nmentation  \\nere is a Mission Steering Group (MSG) unde\\nof Health & Family Welfare and Conve\\nh & Family Welfare. MSG provides policy \\nwered Programme Committee (EPC) head\\nh & Family Welfare, which scrutinizes all \\nMSG. 38  A diagrammatic representation o\\nven below: \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\ntry of Health & \\nly Welfare, GoI\\nsion Director\\ns\\nFMG headed by \\nDirector (Finance)\\nate Health \\nSociety\\nrict Health \\ny/City Health \\nSociety\\nctor as Chairman, \\nped. Convergence'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 16, 'source_type': 'Authorotative', 'priority': '1'}, page_content='try of Health & \\nly Welfare, GoI\\nsion Director\\ns\\nFMG headed by \\nDirector (Finance)\\nate Health \\nSociety\\nrict Health \\ny/City Health \\nSociety\\nctor as Chairman, \\nped. Convergence \\nof all concerned \\ner the chairmanship \\nener as Secretary, \\ndirection to NHM. \\nded by Secretary, \\nfinancial proposals \\nof the Governance \\nNational Institute of \\nHealth & Family \\nWelfare (NIHFW) , \\nApex Body for \\nTraining and Skill \\nDevelopment \\nprogrammes \\nNational Health \\nSystems Resource \\nCentre (NHSRC), Apex \\nBody for Technical \\nSupport Development \\nprogrammes \\nNational Programme \\nManagement Unit \\n(NPMU) for \\nprogramme \\nmanagement and \\nactivities for policy \\nsupport programmes \\nNational ASHA \\nMentoring Group \\n \\n \\n \\n \\n \\nDistrict Hospital, \\nGeneral Hospital, Sub- \\nDistrict Hospital, Rogi'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 17, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Figure 2: G\\n \\nB. State Level Implemen\\n \\nThere is a State Healt\\nthe Mission Director. I\\nState Health Resource\\n \\nC. District Level Implem\\n  \\nAt District Level, the \\nHealth Mission (CHM) \\nCollector. Societies fo\\nin DHS.  \\n \\nDistrict Health Societ\\nMission in every Distri\\nits activities. It has a \\nthe Chairperson and C\\n(CEO). It also has an E\\n(DDC)/CMO (if no DDC\\nas the CEO and Conve\\nprogrammes in the dis\\n \\nCommunity \\nHealth Centres \\n(CHCs)/ Primary \\nHealth Centres \\n(PHCs)\\nRogi Kalyan Samiti \\n(RKS)\\n18 \\n \\n \\n \\n \\nGovernance Structure of National Health Missio\\nntation  \\nth Mission with the State level Health Societ\\nIt is further supported by State Programme M\\ne Centre and State Institute of Health & Fam\\nmentation \\nmission operates under the District Health M\\nwith District Health Society (DHS) headed b\\nor various National and State Health Program\\nty (DHS): Like State Health Mission, there is\\nct and under it functions a District Health S\\nGoverning Body with District Collector/Distr'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 17, 'source_type': 'Authorotative', 'priority': '1'}, page_content='or various National and State Health Program\\nty (DHS): Like State Health Mission, there is\\nct and under it functions a District Health S\\nGoverning Body with District Collector/Distr\\nChief Medical Officer (CMO) as the Chief Exe\\nExecutive Committee with Deputy District Co\\nC) as the Chairperson and District Programm\\nener. DHS is responsible for planning and ma\\nstrict.39 \\nSub- Centres\\nVillage Health, \\nSanitation and \\nNutrition \\nCommittees \\n(VHSNC)\\nKalyan Samiti (RKS) \\n \\nRogi Kalyan Samiti \\n(RKS) \\n \\n \\n \\n \\non (NHM)  \\ny (SHS), headed by \\nManagement Unit, \\nmily Welfare.  \\nMission (DHM)/City \\ny District \\nmmes are merged \\ns a District Health \\nociety to support \\nrict Magistrate as \\necutive Officer \\nollector \\ne Manager (DPM) \\nnaging all NHM'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 18, 'source_type': 'Authorotative', 'priority': '1'}, page_content='District Programme Ma\\nCentre and District Ed\\nstate and national cou\\nEach District Hospita\\nKnowledge Centre (D\\ntertiary care provisio\\nclinical site training f\\nmanagement and an\\ncentres below it via te\\n \\nA diagrammatic repre\\nFigure 3: Orga\\n \\nD. Block and Below Leve\\n  \\nImplementation of pro\\nAccounts Officer disbu\\nVHCs under his jurisdi\\n \\nA diagrammatic repre\\n \\nDistrict \\nProgramme \\nManager\\nDistrict \\nAccount \\nManager \\nDAM\\n19 \\nanagement Unit (DPMU), District Public Hea\\nducation and Training Centre perform simila\\nunterparts.  \\nal’s role is strengthened to create Dist\\nHKC)40.  This includes secondary care prov\\nn, referral support, centre for skill based i\\nfor nursing, paramedical and public health \\nalysis for district planning, knowledge su\\nelemedicine etc.  \\nesentation of the structure at District level is\\nanisational Structure of National Health Missio\\nDistrict Level \\nel Implementation \\nogramme and utilization of funds starts at B\\nurses the funds to Block Level PHCs, CHCs, S'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 18, 'source_type': 'Authorotative', 'priority': '1'}, page_content='anisational Structure of National Health Missio\\nDistrict Level \\nel Implementation \\nogramme and utilization of funds starts at B\\nurses the funds to Block Level PHCs, CHCs, S\\niction and monitors its utilization.  \\nesentation of the structure at Block level is g\\nDistrict \\nCollector\\nChief \\nMedical \\nOfficer\\nNodal \\nOfficer \\nNRHM\\nDistrict \\nQuality \\nAssurance \\nofficer \\n(DQAC)\\nDistrict \\nEarly \\nIntervention \\nCentre \\n(DEIC) \\nManager\\nDistrict \\nCommunity \\nProcess \\nManager \\n(DCPM)\\nDistrict ASHA, \\nDistrict ASHA \\ntraining team\\nNodal \\nOfficer \\nNUHM\\nalth Resource \\nr functions as their \\ntrict Hospital and \\nvision, considerable \\nin service training, \\nprofessionals, data \\nupport for clinical \\ns given below:  \\n \\nn (NHM) at  \\nBlock level. Block \\nSub- centres, and \\ngiven below:  \\nDistrict \\nUrban \\nHealth \\nCoordinator'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 19, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Figure 4: Orga\\n At Village level, there\\n20 ASHAs) supported \\nCommittee (VHSNC). V\\nat village level. \\n \\nHospital Developme\\n \\nA HDS is constituted a\\nare separate legal e\\nRegistration Act of the\\n \\nEach RKS has three fu\\nand Monitoring Comm\\ndonors, NGOs, Local \\n(MLA) etc.41 \\n \\n \\nThe heads of the Com\\nbelow:  \\n \\n \\nTable 8: Comm\\nLevel of Facility \\nDistrict Level \\nCh\\nMe\\nSu\\nho\\nSub District Hospital \\nCh\\nMa\\nOf\\nMe\\nOf\\nFor remaining facility levels and co\\n \\nThe Governing Body h\\nThe Executive Comm\\nDepartment (IPD) an\\nBlock\\nProgram\\ne \\nManage\\nock\\nAccoun\\nManag\\n(NRHM\\n20 \\n \\nanisational Structure of National Health Missio\\nBlock Level \\n \\ne is PHC Medical Officer in Charge and ASHA\\nby ANM; AWW and Village Health Sanita\\nVHSNC acts as a platform for convergence \\nent Society (HDS)/ Rogi Kalyan Samiti (R\\nat facility level i.e. PHC, CHC, AH, DH quart\\nentities and are registered under the re\\ne State.  \\nunctional committees- Governing Body, Exe\\nmittee. It has representation of PRIs, eminen'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 19, 'source_type': 'Authorotative', 'priority': '1'}, page_content='at facility level i.e. PHC, CHC, AH, DH quart\\nentities and are registered under the re\\ne State.  \\nunctional committees- Governing Body, Exe\\nmittee. It has representation of PRIs, eminen\\nMember of Parliament (MP)/Member of Le\\nmittees for a district and sub- district hospi\\nmittees at district and sub- district levels  \\nGoverning Body \\nExecutive \\nhairperson: D M \\nember Secretary : Chief Medical \\nperintendent (C.M.S) of the \\nospital \\nChairman: \\nMember Se\\nOfficer of t\\nhairperson: Sub Divisional \\nagistrate/Block Development \\nfficer(BDO) \\nember Secretary: Senior Medical \\nfficer of the hospital \\nChairperso\\nhospitals \\nMember Se\\nof hospital \\nomposition details ((Refer Guidelines for RKS in Public Healt\\nhas full control and authority over the affa\\nmittee reviews Out- Patient Department \\nd Outreach performance of the hospitals \\nBlock \\nMedical \\nOfficer\\nSecond \\nMedical \\nOfficer\\nk \\nmm\\ner/Bl\\nk \\nnts \\nger \\nM)\\nBlock Urban \\nAccounts \\nAssistant\\nMCTS \\nOperator\\nBlo\\nComm\\ny Pro\\nMana\\n \\nn (NHM) at'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 19, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Block \\nMedical \\nOfficer\\nSecond \\nMedical \\nOfficer\\nk \\nmm\\ner/Bl\\nk \\nnts \\nger \\nM)\\nBlock Urban \\nAccounts \\nAssistant\\nMCTS \\nOperator\\nBlo\\nComm\\ny Pro\\nMana\\n \\nn (NHM) at  \\nA Facilitators (1 per \\nation and Nutrition \\nof all departments \\nRKS)  \\nter Hospitals.  They \\nespective Societies \\necutive Committee \\nnt citizens, leading \\negislative Assembly \\nitals are mentioned \\nCommittee \\nC.M.S of the hospital \\necretary: Senior Medical \\nthe hospital  \\nn: Officer In charge of \\necretary: Medical Officer \\n \\nth Facilities, 2015).  \\nairs of the facility. \\n(OPD), In- Patient \\nevery month and \\nck \\nmunit\\nocess \\nager'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 20, 'source_type': 'Authorotative', 'priority': '1'}, page_content='21 \\n \\ntargets for next month and takes up remedial measures for observations of \\nMonitoring Committee. Monitoring Committee collects patient feedback from \\nhospital wards and sends a monthly report to District Collector and Chairperson, \\nZilla Parishad.  \\nHDS meets at least once a quarter or more frequently, if required. A quorum of at \\nleast one third of members should be maintained. The members are re- nominated \\nafter every three years.  \\n \\n2.5 Untied Funds \\n \\nNHM brought redesigning of health systems with an aim to provide the field units \\nmore functional, administrative and financial resources with suitable autonomy. \\nThis was undertaken to fill gaps due to unavailability of funds and inflexibility of \\nfund usage in traditional systems for local innovative and facility specific need \\nbased activity at block and down levels. Following are the funds which are given by \\nNHM to each facility per annum, depending upon the type of facility.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 20, 'source_type': 'Authorotative', 'priority': '1'}, page_content='based activity at block and down levels. Following are the funds which are given by \\nNHM to each facility per annum, depending upon the type of facility.  \\n \\nTable 9: Funds given under NHM to each facility per annum42  \\nType of facility \\nRKS \\nGrants/each \\nfacility/annum \\n(Rs.) \\nAnnual Maintenance \\nGrants (for physical \\ninfrastructure) /each \\nfacility/ annum (Rs.) \\nUntied Funds/each \\nfacility/annum (Rs.) \\nDistrict Hospital \\n5 lakh \\n \\n \\nSDH \\n1 lakh \\n \\n \\nCHC/UGPHC/Area \\nHospital (AH) \\n1 lakh \\n1 lakh \\n50,000 \\nPHC \\n1 lakh \\n50,000 \\n25,000 \\nSub- centre \\n- \\n10,000 (Selected Sub \\ncentre) \\n10,000/ 20,000 (varies \\nfrom Sub-  centre to \\nsub- centre) \\n \\nFunds are received from NHM in the Bank account of the concerned HDS and are \\nutilized with prior approval of council members of HDS except for emergencies \\nwhere they are vetted by the council members after spending. HDS is also \\nempowered to utilize hospital funds from registration charges, collections and'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 20, 'source_type': 'Authorotative', 'priority': '1'}, page_content='where they are vetted by the council members after spending. HDS is also \\nempowered to utilize hospital funds from registration charges, collections and \\ndonations etc. This fund is used for maintenance and improvement of physical \\ninfrastructure mainly, incentives to ASHAs but not for paying salaries, purchase of \\nany vehicle, drugs, consumables etc. Please refer to Guidelines43 for utilization of \\nuntied funds, Annual Maintenance Grant and RKS (HDS) for further details.  \\nIn case of emergency/ exigency, the designated person can sanction the specified \\namount and later get it ratified in the next RKS meeting. The amount which can be \\nspent in emergency varies from State to State.  \\nAll bank- related operations including signing of cheque are done by joint \\nsignatories i.e. following authorized members of respective RKS of the facility: \\n \\nTable 30: Authorised signatories at various levels  \\nS. \\nNo.  \\nLevel \\nApproved Signatories \\n\\uf0b7 \\n \\nDH \\nCDMO/CHMO/CMO  & Senior most Medical Officer'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 20, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Table 30: Authorised signatories at various levels  \\nS. \\nNo.  \\nLevel \\nApproved Signatories \\n\\uf0b7 \\n \\nDH \\nCDMO/CHMO/CMO  & Senior most Medical Officer \\n\\uf0b7 \\n \\nSDH \\nSDMO & Senior most Medical Officer \\n\\uf0b7 \\n \\nBlock PHC/CHC/AH \\nMedical Officer (In charge) & Senior most Medical \\nOfficer/AYUSH Doctor/BPO/Pharmacist in that order \\ndecided by the Governing Body \\n\\uf0b7 \\n \\nPHC \\nBlock Medical Officer (In charge) & MO (In charge)/AYUSH \\ndoctor/Pharmacist who is Member Secretary cum treasurer \\nof respective RKS,  in that order'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 21, 'source_type': 'Authorotative', 'priority': '1'}, page_content='22 \\n \\n\\uf0b7 \\n \\nVHNSC \\nGram Pradhan & ANM \\n \\n2.6 Fund Flow Management \\n \\nStates are strengthened to carry out health reforms with additional resources and \\nappropriate flexibility as per local needs. Planning and implementation are decentralized \\nto the States (State Health Mission developing State Health Action Plan) to Districts \\n(Districts Health Mission developing District Health Action Plan) to Block Health Action Plan \\nwhich are community- owned and as per local needs, keeping in view the implementation \\nguidelines of various programmes.   \\nFunds in NHM are pooled under “Mission Flexi Pool”. It is divided into five components \\nunder which funds are utilized for respective programmes, as follows:  \\n \\n \\nFigure 5: Mission Flexi Pool Components \\n \\nThere is a separate financial envelope tied to Part A to D with flexibility provided to all \\nStates to allocate finds across various strategies as per local needs and broad national'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 21, 'source_type': 'Authorotative', 'priority': '1'}, page_content='There is a separate financial envelope tied to Part A to D with flexibility provided to all \\nStates to allocate finds across various strategies as per local needs and broad national \\npriorities. The number of components under Flexi pool varies from State to State.   \\nAt least 70 % of funds of State under Part A- NRHM –RMNCH flexible pool is allocated to the \\ndistricts, with high priority districts allocation are at least 30 % more per capita than non \\npriority districts.44  \\nThe NHM funding between the Centre and States is in the ratio of 60:40 (for all states \\nexcept NE and 3 Himalayan States), 60 from Central government and 40 from State.45  \\nStates have to work towards increase of at least 10 % in expenditure every year. 46 \\nMaximum funds have to be spent at lower levels i.e. at least 70% at Block and below, 20 % \\nDistrict level and 10 % at State Level.47 For implementation and supervision of the scheme,'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 21, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Maximum funds have to be spent at lower levels i.e. at least 70% at Block and below, 20 % \\nDistrict level and 10 % at State Level.47 For implementation and supervision of the scheme, \\nDecentralized planning and funds dispersion from Top to Bottom is done. There is periodic \\nreporting at each level through their supervisory units to GOI. The fund flow mechanism is \\nas follows:  \\n \\nMission \\nFlexipool \\nPart A\\nNRHM/ RMNCH+A( \\ninlcuding \\nImmunization) \\nFlexipool\\nPart B \\nNUHM Flexipool\\nPart C\\nFlexible Pool for \\nCommunicable \\nDiseases \\nPart D\\nFlexible Pool for \\nNon Communicable \\nDiseases\\nPart E \\nInfrastructure \\nMaintainence'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 22, 'source_type': 'Authorotative', 'priority': '1'}, page_content='23 \\n \\n \\n \\n \\n \\nFunds from \\nGOI \\n \\n \\n \\nDirection of \\nFlow of Funds  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nState Treasury \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nRegular \\nfinancial \\nand \\nPhysical \\nprogress \\nreports -\\nFMR - UC, \\nAudit \\nReport \\nSHS- Group A/c \\nof NHM at \\nState \\n \\n4 Categories of \\nFlexi pool at \\nState level \\n \\nState level \\nExpenses \\n \\n \\n \\n \\n \\n \\n \\nDHS- Group \\nA/C of NHM at \\nDistrict \\n \\n \\n4 Categories of \\nFlexi pool at \\nDistrict level \\n \\nDistrict level \\nExpenses \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nBlock Level \\nCHC/PHC- (A \\nsingle Bank A/c \\nfor NHM Funds \\n \\nFacility level \\nRespective RKS \\n \\n \\nFacility level \\nExpenses \\n \\n \\n \\nFigure 6: Direction of Flow of Funds in NHM  \\n \\n2.7 District Health Action Plans (DHAP)48/City Health Action Plan49 \\n \\nINTEGRATION: DHAP is prepared by District Programme Management Unit (DPMU) based on \\nBlock Health Action Plans (BHAP). BHAP are prepared by Block Programme Management \\nUnits based on the facility level plans and village level plans. It is prepared after reviewing'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 22, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Block Health Action Plans (BHAP). BHAP are prepared by Block Programme Management \\nUnits based on the facility level plans and village level plans. It is prepared after reviewing \\nthe targets, both physical and financial achievement in last PIP and after a consultation \\nworkshop/review meeting with the relevant stakeholders of lower levels. It depicts the \\nresources requirements and budget required for various activities at various district and \\nsub districts levels.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 23, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Figure 7\\n \\nFigure 7b2: P\\n \\n \\n \\nGaps in \\nDistrict \\nHealth \\nInfrastru-\\ncture \\n24 \\n7a1: District Health Action Plan (DHAP) Prepara\\nre Preparation Data Collection by District Plan\\nConverge \\nwith \\nongoing \\nschemes \\nand \\nprograms \\nBlock \\nHealth \\nAction \\nation \\n \\nnning Team  \\n \\nDistrict \\nHealth \\nAction \\nPlan \\n(DHAP)'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 24, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Figure 7 c: Decentrali\\n(*) = The\\n \\nPROCESS OF DHAP Preparati\\n \\nFigure 8 shows the process an\\npreparation.  \\n\\uf0b7 \\nUp to 10 % of district\\ndistricts as per their lo\\n\\uf0b7 \\nThe district/city heal\\nare more difficult to \\nimprove access to serv\\n\\uf0b7 \\nDistricts should prepa\\nin account funds avail\\n\\uf0b7 \\nDHAP also integrate \\nChild Development, S\\nPoverty Alleviation, R\\n \\nFigure 8: Process of Distric\\nD\\nCommunity\\n(CHCs)/ P\\nCentr\\nGrama\\n25 \\nized and Bottoms Up Approach50 *: Preparatio\\nand Block Level Health Action Plan \\ne number of Units in each level will vary from State To State. \\nion:  \\nnd Figure 9 shows the tentative timelines of\\nt allocation is earmarked for schemes to be\\nocal needs.   \\nth action plan will clearly prioritize intra d\\nreach, or have lower baseline indicators a\\nvices. \\nare also prepare facility plans for high volum\\nlable from untied grant. 5152.  \\nthe common goals of related department\\nSchool Education, Water and Sanitation, H\\nRural Development, Urban Development, and'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 24, 'source_type': 'Authorotative', 'priority': '1'}, page_content='lable from untied grant. 5152.  \\nthe common goals of related department\\nSchool Education, Water and Sanitation, H\\nRural Development, Urban Development, and\\nct Health Plan (DHAP) preparation \\n• State Programme\\nAction Plan review meeting betwee\\nDistrict Officers before submission \\nState may approve/ disapprove the\\ntargets\\nState\\n•District Health Action Plan \\nAction Plan review meeting be\\nand Block officers before subm\\nlevel. District may approve/di\\nBlock targets\\nDistrict\\n•Block Health Action P\\nInputs from Gram Panc\\nCHC\\nBlock\\ny Health Centres \\nPrimary Health \\nres (PHCs)\\na Panchayat \\n \\nn of State, District \\nf DHAP \\ne developed by the \\ndistrict areas which \\nand devise plans to \\nme facilities, taking \\nts like Women and \\nHousing and Urban \\nd Environment.  \\nen State and \\nto next level. \\ne district \\netween District \\nmission to next \\nisapprove the \\nPlan\\nchayat, PHC,'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 25, 'source_type': 'Authorotative', 'priority': '1'}, page_content='26 \\n \\n \\n \\n \\n \\nMission Director sets \\nup formal planning \\nteams at State, and \\ndistrict/City levels\\nAllocation of Funds by \\nthe State to the \\nDistricts\\nGuidelines for \\nDistrict/City \\ndisseminated\\nOne day workshop held for \\nthe district planning team \\nto explain the key \\nguidelines, criteria and \\nprocess for approval of \\ndistrict plan and \\ntimeframe\\nStates provides \\ndetailed formats to \\ndistrict for preparing \\ntheir respective plans, \\nfor easy consolidation \\nin State PIP\\nData Collection  by \\nDistrict Planning Teams \\nSetting up of realistic \\nTargets and goals for \\nindicators of service \\ndelivery, outputs  for \\ndistrict, lower levels \\nincluding facilities\\nOrganization of District \\nlevel workshop with \\nstakeholders\\nDHAP approved by the \\nGoverning Body of the \\nDistrict Health Society \\n(DHS) for submission to \\nState\\nBudgeting done for \\nappropriate provisions, \\nincentives, \\nentitlements and staff \\ncompensation\\nData Analysis and \\nidentification of core \\nissues,in the District'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 25, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(DHS) for submission to \\nState\\nBudgeting done for \\nappropriate provisions, \\nincentives, \\nentitlements and staff \\ncompensation\\nData Analysis and \\nidentification of core \\nissues,in the District \\nand lower levels. \\nOutcome definition \\nand identification of \\npriority key areas for \\nnext three years\\nDraft Preparation of \\nDHAP \\nState Programme \\nImplmentation Plan \\napproved , final \\napproval i.e. Records of \\nProceedings(RoP) are \\nsent to Districts.\\nBased on the approved \\nplan, funds are \\nreleased by the State \\nHealth Society (SHS).'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 26, 'source_type': 'Authorotative', 'priority': '1'}, page_content='27 \\n \\n \\nFigure 93: Tentative timelines and Process for preparation and finalization of PIP at the \\ndistrict/ state/ national level \\n \\n \\n2.8 Best Practices/ State Innovations53 \\n \\nNHM encourages innovations by the States and the Districts to meet the local needs. Some \\nof the innovations are given in Table 15 below:  \\n \\nTable 15: Best Practices/State Innovations \\nS \\nNo.  \\nName of the Best \\nPractice \\nName of the \\nState \\nDetails \\n1 Infection Control by \\nSwachhata Mission \\nAudit \\nGujarat \\nSwachhata Mission monitoring and reporting online data entry \\nPortal \\n2 Kangaroo Care \\nUP \\nInnovative and comfortable Health systems for New born care \\ndeveloped to reduce IMR \\n3 Overcoming vaccine \\nhesitancy in Measles \\nRubella campaign  \\nKarnataka \\nInnovative communication channels used- Awareness \\ncampaigns in schools, using Radio Channels as partners for \\nspreading awareness \\n4 DAMAN –Improving \\naccess to malaria \\ncontrol services at \\nOdisha'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 26, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Innovative communication channels used- Awareness \\ncampaigns in schools, using Radio Channels as partners for \\nspreading awareness \\n4 DAMAN –Improving \\naccess to malaria \\ncontrol services at \\nOdisha \\nImproved Access for the Inaccessible people, vector control \\ninterventions, diagnosis and treatment with the help of ASHA \\nworkers and others \\nIntimation of resource \\nenvelope to \\nDistricts/otheragencies \\nby State - by October\\nFinalized Village Health \\nPlan for upcoming FY \\nsubmitted to the Block \\nby October end\\nConsolidation of Village \\nHealth Plans, First draft \\nBlock submitted to \\nDistrict Health Mission-\\nDecember mid\\nConsolidation of  Block \\nHealth Plans, District \\nHealth Plan submitted \\nto State - December end\\nConsolidation of District \\nPlans, First draft State \\nPIP submitted to \\nMOH&FW, GOI- January \\nMid\\nApproved Records of \\nProceedings(RoPs) sent \\nto States after Mission \\nDirector’s approval -\\nMarch-April\\nRecords of \\nProceedings(RoPs) sent  \\nto Districts by States-\\nJuly'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 26, 'source_type': 'Authorotative', 'priority': '1'}, page_content='MOH&FW, GOI- January \\nMid\\nApproved Records of \\nProceedings(RoPs) sent \\nto States after Mission \\nDirector’s approval -\\nMarch-April\\nRecords of \\nProceedings(RoPs) sent  \\nto Districts by States-\\nJuly\\nGuidlelines for fund \\nUtilization sent by \\nDistrict to Blocks-\\nAugust/September\\nGuidlelines for fund \\nUtilization sent by from \\nBlocks to lower levels \\nfor Implementation and \\nfund utilization - varies \\neach year'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 27, 'source_type': 'Authorotative', 'priority': '1'}, page_content='28 \\n \\ncommunity level  \\n5 Core Dash Board \\nIntegrated Hospital \\nSanitation Monitoring \\nSystem  \\nAndhra \\nPradesh \\nNew Scientific Sanitation Policy-2015 for better \\nimplementation of sanitation in government hospitals with \\nHospital Sanitation Monitoring Application (HSMS) for scientific \\ndaily Monitoring mechanism and decentralized services  \\nPlease refer for more details of the Best Practices/Innovations by the State from \\nNational Health Care Innovation Portal.54 \\n \\n \\n***'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 28, 'source_type': 'Authorotative', 'priority': '1'}, page_content='29 \\n \\n3. Roles \\nand \\nResponsibilities \\nof \\nKey \\nDistrict \\nLevel \\nFunctionaries \\n \\n3.1 Chair of District Health Society (DHS) (District Collector/ Magistrate) \\n \\nDistrict Collector/ District Magistrate, the Chair of District Health Society is envisaged to \\nplay a crucial role at the district level to bring in convergence, both amongst the scheme \\ncomponents and other external resources. \\n \\nTable 11: Roles and Responsibilities of District Collector/ Magistrate \\nRole \\nResponsibilities \\n \\n \\nPLANNING \\n \\n \\n \\nDistrict Health Action Plan( DHAP) \\n\\uf0b7 Facilitate conduct of data collection by planning teams followed by data \\nanalysis as inputs for district health action plan \\n\\uf0b7 Ensure that the district health action plan is based on identified health \\nneeds, block/village plans, and available resources \\nManpower/Resources \\n\\uf0b7 Ensures recruitment of individual/institutional experts to strengthen the \\ntechnical / management capacity of the District Health Administration.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 28, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Manpower/Resources \\n\\uf0b7 Ensures recruitment of individual/institutional experts to strengthen the \\ntechnical / management capacity of the District Health Administration. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nIMPLEMENTATION \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nApprovals \\nFinalize and approve DHAP and submit to State Nodal Department/SHS  for \\nintegration into PIP \\nApprove district health packages- specific entitlement & incentives for \\nnational health programmes based on district specific requirements e.g. JSY, \\nJSSK & family planning etc. \\nApprove and oversee receivable, management and accounting for the funds \\nreceived from the Govt. (including State health Society) for implementation of \\nNHM in the district as the Chairman of DHS. \\nMobilize financial and non-financial resources for implementing/ \\nsupplementing the health and family welfare activities in the district. \\nIntegration & Convergence \\n\\uf0b7 \\nSteer inter departmental coordination for multi-sectoral intervention'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 28, 'source_type': 'Authorotative', 'priority': '1'}, page_content='supplementing the health and family welfare activities in the district. \\nIntegration & Convergence \\n\\uf0b7 \\nSteer inter departmental coordination for multi-sectoral intervention \\nrequired for implementation of DHAP such as nutrition, water and \\nsanitation, education, etc. \\n\\uf0b7 Act as the nodal officer for district health society & all stake holders– line \\ndepartments, PRI and NGOs- to participate in various health and family \\nwelfare programs and projects in the district. \\nTarget achievement  \\n\\uf0b7 Guides the district health officials in strengthening of all the district health \\nfacilities for preventive, promotive, curative and rehabilitative health \\nservices as well as for the district Health knowledge centre, to achieve the \\ndefined goals and targets programme wise. \\n\\uf0b7 Recommends corrective measures to ensure that the programme objectives \\nare achieved and services delivered in an effective as well as efficient \\nmanner. \\nCapacity Building'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 28, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7 Recommends corrective measures to ensure that the programme objectives \\nare achieved and services delivered in an effective as well as efficient \\nmanner. \\nCapacity Building \\n\\uf0b7 Ensures capacity building at all levels in the district, are done as planned. \\nGrievance Redressal'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 29, 'source_type': 'Authorotative', 'priority': '1'}, page_content='30 \\n \\nRole \\nResponsibilities \\n\\uf0b7 Institute a formal grievance redressal mechanism for both patients and staff \\nin the district in a time bound manner. \\nFund Management \\n\\uf0b7 Ensure that the DHS & RKS at District level maintains an exclusive account \\nfor receipt and expenditure at the district level   \\n\\uf0b7 Allocate Funds to DHS & RKS as per approved DHAP.  \\n\\uf0b7 Ensure mechanisms for proper utilization of funds and transparent \\n\\uf0b7 Ensure expenditure statements and Utilization Certificates (UCs) to State \\nNodal Department timely. \\nMONITORING& \\nREPORTING \\n \\n \\n \\n\\uf0b7 District Collector is the overall monitoring authority for the district \\nReports Review /HMIS review/evaluation  \\n\\uf0b7 Monthly review the progress vis a vis the targets in NRHM Dashboards55/ \\nHMIS/indicators at the district level.  \\n\\uf0b7 Ensure that physical and financial progress of all the components are \\nreported in the respective HMIS  \\n\\uf0b7 Support external evaluation agencies in their monitoring activities and'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 29, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7 Ensure that physical and financial progress of all the components are \\nreported in the respective HMIS  \\n\\uf0b7 Support external evaluation agencies in their monitoring activities and \\nreview reports of the external evaluation agencies. \\nCommittees/Meetings \\n\\uf0b7 Assists District /City Level Vigilance and Monitoring Committee for strict \\nadherence to prudent fiscal norms, inter-sectoral convergence, community \\nparticipation and monitoring. \\n\\uf0b7 Regular monitoring and transparent functioning of hospital management \\nsocieties/RKS in the district as a Chairperson of Governing body. \\n\\uf0b7 Conducts review meetings quarterly for ensuring the progress of \\nimplementation of the District Health Action Plan and National Health \\nProgrammes under NHM and provide guidance. \\n\\uf0b7 Convene the meetings of District Health Mission and District Health \\nSocieties on monthly basis or as per State bylaws. \\n\\uf0b7 Ensures, monitors and supports the implementation of National Quality'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 29, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7 Convene the meetings of District Health Mission and District Health \\nSocieties on monthly basis or as per State bylaws. \\n\\uf0b7 Ensures, monitors and supports the implementation of National Quality \\nAssurance standards with District Quality Assurance Officer and coordinate \\nwith the State \\nField Visits \\n\\uf0b7 Undertake regular visits to the health facilities in rural/urban/city areas \\nand ensure the availability of human resource at various levels. \\n \\nFunctions of the Chief Medical Officer (CMO)/Chief District Medical Officer \\n(CDMO)/CMHO/Civil Surgeon assists DM in his above functions i.e. planning, implementing \\nand monitoring activities of the NRHM programme.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 30, 'source_type': 'Authorotative', 'priority': '1'}, page_content='31 \\n \\n3.2 Village/  Block/City  /  District/Ward Level Officers- Programme \\nManagement Unit (PMU) \\n \\nTable 42: Roles and Responsibilities of Village/  Block/City  / District/Ward level \\nOfficers- Programme Management Unit (PMU)  \\nDeliverable/ Officer Responsible* \\nVillage Level \\nBlock/City Level \\nDistrict/Ward Level \\nASHA  \\nBlock Programme Manager (BPM) \\nDistrict Programme Manager \\n(DPM) \\nPLANNING \\nHealth Action Plan/PIP \\nPreparation \\n \\n\\uf0b7 Village Health Committee \\n(Gram Sabha Pradhan along \\nwith the Multipurpose Workers \\n(MPW) and ASHA etc.), provide \\ninformation on intervention \\nrequirements and village level \\ngaps for village level health \\nplans as per local needs. This is \\ndone by doing house to house \\nsurvey, from village health \\nregisters and from village \\nhealth camps. 56 \\n \\n \\n \\n\\uf0b7 Block Health Monitoring and \\nPlanning Committee and PHC \\nHealth Monitoring and Planning \\nCommittees contribute to \\ndevelopment of the Block Health \\nPlan, based on an assessment of'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 30, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7 Block Health Monitoring and \\nPlanning Committee and PHC \\nHealth Monitoring and Planning \\nCommittees contribute to \\ndevelopment of the Block Health \\nPlan, based on an assessment of \\nthe situation and priorities for \\nthe Block. This is done by PHC \\nand CHC records, Discussions \\nwith and interviews of the CHC \\nRKS members, Report of Public \\ndialogue (Jan Samvad), quarterly \\nfeedback from village and PHC \\nHealth Committees, Periodic \\nassessment of the existing \\nstructural and functional \\ndeficiencies. There is a PHC \\nHealth Monitoring and Planning \\nCommittee at PHC level.57  \\n\\uf0b7 BPM coordinate with \\nstakeholders and consolidate \\nVillage level health Plans for \\npreparation of Block Level \\nHealth Action Plan (BHAP). \\n \\n \\n\\uf0b7 District Health Monitoring and \\nPlanning Committee contribute \\nto development of the District \\nHealth Plan, based on an \\nassessment of the situation and \\npriorities for the district. This \\nis done from Report from the \\nPHC Health committees  Report'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 30, 'source_type': 'Authorotative', 'priority': '1'}, page_content='to development of the District \\nHealth Plan, based on an \\nassessment of the situation and \\npriorities for the district. This \\nis done from Report from the \\nPHC Health committees  Report \\nof the District Mission \\ncommittee  Public Dialogue \\n(Jan Samvad)58 \\n\\uf0b7 DPM Coordinate with \\nstakeholders and lower levels \\nfor preparation of District \\nHealth Action Plan (DHAP) and \\napproval by District Health \\nSociety (DHS). \\n\\uf0b7 Brief, consult and assist Chief \\nMedical Officer (CMO) in human \\nand financial resources \\nplanning and management \\nrelated activities. \\n\\uf0b7 Coordinate with respective \\nmonitoring division and \\nconduct field- level studies to \\nidentify gaps for ascertaining \\nintervention requirements and \\ndistrict action plan scope.  \\n\\uf0b7 Support Block Programme \\nManagers in preparation of the \\nblock action plans in line with \\nthe district plans. \\nIMPLEMENTATION \\nCOORDINATION/LAISIONING \\n \\n\\uf0b7 ASHA is First portal of call for \\nany health related demands \\nespecially for marginalized and'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 30, 'source_type': 'Authorotative', 'priority': '1'}, page_content='block action plans in line with \\nthe district plans. \\nIMPLEMENTATION \\nCOORDINATION/LAISIONING \\n \\n\\uf0b7 ASHA is First portal of call for \\nany health related demands \\nespecially for marginalized and \\nin difficult access areas. 59 \\n \\n\\uf0b7 \\nCOUNSELLING \\no \\nCounseling women on birth \\npreparedness, importance of \\nbreast \\nfeeding \\nand \\n \\n \\n\\uf0b7 Coordinate implementation of \\nactivities according to BHAP. \\n\\uf0b7 Provide periodic feedback to \\nMedical Officer in- Charge and \\nDistrict Programme Manager on \\nquality of services and status of \\nimplementation of programme \\nactivities. \\n\\uf0b7 Communicate to lower levels \\n \\n \\n\\uf0b7 Coordinate implementation of \\nactivities in district according \\nto DHAP and provides logistics \\nsupport to staff in the field for \\nimplementation. \\n\\uf0b7 Support Block Programme \\nManagers in development of \\nBHAPs for all NRHM \\ninterventions.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 31, 'source_type': 'Authorotative', 'priority': '1'}, page_content='32 \\n \\nDeliverable/ Officer Responsible* \\nVillage Level \\nBlock/City Level \\nDistrict/Ward Level \\nASHA  \\nBlock Programme Manager (BPM) \\nDistrict Programme Manager \\n(DPM) \\ncomplementary \\nfeeding, \\nimmunization, contraception \\nand prevention of common \\ninfections \\nincluding \\nReproductive Tract Infection \\n(RTI)/Sexually \\nTransmitted \\nInfection (STI) and care of \\nyoung child.  \\n \\n\\uf0b7 \\nMOBILIZATION \\nMake house visits and Creating \\nawareness \\nand \\nprovide \\ninformation to the community  \\no on determinants of health \\nsuch \\nas \\nnutrition, \\nbasic \\nsanitation \\n& \\nhygienic \\npractice, healthy living and \\nworking conditions, \\no Information on existing health \\nservices and need for timely \\nutilization \\nof \\nhealth \\nand \\nfamily welfare services \\nMobilizing the community and \\nfacilitating in accessing \\nhealth and related services \\navailable at village level. \\n \\n\\uf0b7 \\nCOMMUNITY LEVEL \\nCURATIVE CARE \\no \\nProviding medical care for \\nminor ailments at the \\ngrassroots for fever, \\ndiarrhea, first aid, sick'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 31, 'source_type': 'Authorotative', 'priority': '1'}, page_content='health and related services \\navailable at village level. \\n \\n\\uf0b7 \\nCOMMUNITY LEVEL \\nCURATIVE CARE \\no \\nProviding medical care for \\nminor ailments at the \\ngrassroots for fever, \\ndiarrhea, first aid, sick \\nchildren, DOTS for \\nTuberculosis etc. and act as \\ndepot holder with provisions \\nlike ORS, Iron and Folic Acid \\ntablets, delivery kits.  \\n \\n\\uf0b7 \\nESCORT SERVICES \\no \\nShe will escort pregnant \\nwomen/children to nearest \\nhealth facility- \\nPHC/CHC/FRU.  \\no \\nShe will inform Sub-\\nCenters/Primary health \\nCenter about the birth and \\ndeaths and any outbreaks in \\ntheir village. \\no \\nParticipate in Block level \\nASHA Day \\nunder jurisdiction of the Block \\nfor the implementation of BHAP. \\n\\uf0b7 Support district and state level \\nvisit to augment local level \\ncoordination. \\n\\uf0b7 Planning and monitoring Village \\nHealth and Nutrition Day (VHND). \\n\\uf0b7 Coordination of meetings of RKS \\nand monitor implementation of \\ndecisions taken. \\n\\uf0b7 Locate and coordinate with local \\nfield level implementation \\norganizations (NGOs,'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 31, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7 Coordination of meetings of RKS \\nand monitor implementation of \\ndecisions taken. \\n\\uf0b7 Locate and coordinate with local \\nfield level implementation \\norganizations (NGOs, \\ncommunication implementation \\nagencies, RKS, village health and \\nsanitation committee) and \\nprovide logistic support for \\nimplementation.  \\n\\uf0b7 CAPACITY BUILDING: Developed \\ncapacity building plans for \\nASHAs, NGOs, RKS and VHSCs. \\n \\n \\n\\uf0b7 Assist CMO in coordinating \\nDistrict Health Society \\nmeetings.  \\n\\uf0b7 Provide periodic feedback to \\nChief Medical Officer and \\nRegional Monitoring Division on \\nquality of services and status of \\nimplementation of programme \\nactivities. \\n\\uf0b7 Coordinate and liaison with \\nother consultants at \\nState/District/Block levels for \\nimplementation of NRHM \\nprogramme.  \\n\\uf0b7 Assist CMO in managing human \\nresource including posting, \\ntransfer, performance \\nmonitoring, training etc.  \\n\\uf0b7 Provide support to technical \\nconsultants at State and field \\nlevels during their field visits'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 32, 'source_type': 'Authorotative', 'priority': '1'}, page_content='33 \\n \\nDeliverable/ Officer Responsible* \\nVillage Level \\nBlock/City Level \\nDistrict/Ward Level \\nASHA  \\nBlock Programme Manager (BPM) \\nDistrict Programme Manager \\n(DPM) \\nCONVERGENCE  \\n \\n\\uf0b7 Works with women health \\ngroups, NGOS, VHSNC, ANMs, \\nGram Panchayats and \\nAnganwadi workers for \\nimplementation of activities at \\nthe village level. This is done \\nby attending Village Health and \\nNutrition Day (VHND) and as a \\nmember of VHSNC convenes \\nVillage level meeting.  \\n\\uf0b7 She promotes construction of \\nhousehold Toilets under Total \\nsanitation Campaign \\n \\n \\n \\n \\n\\uf0b7 Liaison with Block level \\nstakeholders to disseminate \\ninformation and mobilize support \\nfor program activities in the \\nBlock. \\n\\uf0b7 Coordinate implementation with \\nother development departments \\nin the block. \\n \\n \\n \\n\\uf0b7 Coordinate for smooth \\nimplementation with other \\ndevelopment departments in \\nthe district and give inputs for \\nplanning convergence \\nactivities. \\n\\uf0b7 Coordinate with development \\npartners (aid agencies, UNICEF,'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 32, 'source_type': 'Authorotative', 'priority': '1'}, page_content='implementation with other \\ndevelopment departments in \\nthe district and give inputs for \\nplanning convergence \\nactivities. \\n\\uf0b7 Coordinate with development \\npartners (aid agencies, UNICEF, \\nWHO etc. & other NGOs) in the \\nfield and ensure convergence \\nof programme activities. \\nMONITORING \\nFINANCIAL MANAGEMENT & \\nAUDIT60 \\n \\n\\uf0b7 \\nMaintain records and \\nreporting of activities and \\nstatistics as defined at village \\nlevel. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n\\uf0b7 Ensure appropriate receipt and \\ndisbursement of funds in \\naccordance with BHAP. \\n\\uf0b7 Processing of transfer of funds to \\nVHSCs and SCs. \\n\\uf0b7 Ensure appropriate utilization of \\nfunds by implementing partners \\nin coordination with data cum \\naccount officer and district \\naccount manager \\n\\uf0b7 Facilitate all audits of the block \\nlevel units. \\n\\uf0b7 Monitoring of physical and \\nfinancial progress in accordance \\nwith the BHAP with Block \\nAccountant under the guidance \\nof BMO. \\n\\uf0b7 Ensure submission of utilization \\ncertificates for all funds released'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 32, 'source_type': 'Authorotative', 'priority': '1'}, page_content='financial progress in accordance \\nwith the BHAP with Block \\nAccountant under the guidance \\nof BMO. \\n\\uf0b7 Ensure submission of utilization \\ncertificates for all funds released \\nto BPMUs and also to CHCs in \\ntheir blocks. \\n \\n \\n \\n \\n\\uf0b7 Ensure provision of timely and \\n \\n \\n \\n\\uf0b7 Ensure appropriate receipt and \\ndisbursement of funds in \\naccordance with DHAP. \\n\\uf0b7 Assist CMO in financial matters \\ncontrol and logistics \\nmanagement \\n\\uf0b7 Monitor funds received from \\nState from Part A, B and C of \\nNRHM as per the \\nimplementation plan and \\nutilization of blocks/ district \\nlevel and request for next \\ntranche of funds in time. \\n\\uf0b7 Ensure appropriate utilization \\nof funds by implementing \\npartners in coordination with \\nDistrict Accounts Manager. \\n\\uf0b7 Obtain timely statement of \\nexpenditures and utilization \\nreports from different levels in \\nrequisite formats and \\nsubmission to SPMU. \\n \\n \\n \\n\\uf0b7 Preparation and Analysis61 of \\nmonthly and quarterly \\nmonitoring reports of the \\nDistricts and take corrective \\naction.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 33, 'source_type': 'Authorotative', 'priority': '1'}, page_content='34 \\n \\nDeliverable/ Officer Responsible* \\nVillage Level \\nBlock/City Level \\nDistrict/Ward Level \\nASHA  \\nBlock Programme Manager (BPM) \\nDistrict Programme Manager \\n(DPM) \\n \\n \\n \\n \\n \\n \\n \\nPERFORMANCE INDICATORS & \\nPROGRESS MEASUREMENT \\n\\uf0b7 Ensure timely submission of \\ndata as per defined indicators.  \\n \\naccurate monthly reporting in \\nthe requisite formats to district \\nlevel Level. \\n\\uf0b7 Regular Field visits for Physical \\nverification.  \\n \\n\\uf0b7 Regular Field visits for \\nPhysical verification.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 34, 'source_type': 'Authorotative', 'priority': '1'}, page_content='35 \\n \\n3.3 Block/City   / District Level Officers- Community Process Unit  \\n \\nTable 13: Roles and Responsibilities of Block/City   / District level officers-  \\nCommunity Processes Unit \\n(Please note that Village level officials and their roles in Community Processes are same as Programme \\nManagement Unit.) \\nDeliverable/Officer Responsible* \\nBlock/City Level \\nDistrict Level \\nBlock Community Process Manager/Block \\nCommunity Mobilizer \\nDistrict Community Process Manager/ \\nCommunity Mobilizer/ District ASHA \\nProgramme Coordinator \\nPLANNING \\nHEALTH ACTION PLAN/PIP \\n \\n\\uf0b7 Works with VHSNCs in completion of all the \\nvillage health plans and contribute in \\npreparing the community processes section of \\nthe block/ district health action plan and \\nfunds planning; \\n \\n \\n \\n \\n \\n\\uf0b7 Support Block Programme Managers in \\ndeveloping localized communication and \\nimplementation plans. \\n\\uf0b7 Facilitate compilation of communication plan \\nand funds plan, of the Block health action'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 34, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7 Support Block Programme Managers in \\ndeveloping localized communication and \\nimplementation plans. \\n\\uf0b7 Facilitate compilation of communication plan \\nand funds plan, of the Block health action \\nplans and preparation of communication plan \\nat the District level (as a part of DHAP), with \\nBlock Programme Managers.  \\nIMPLEMENTATION \\nCOORDINATION & LAISIOING \\n \\n\\uf0b7 Coordinates with district level functionaries, \\nBPMU and Block Medical Officer/ In- Charge \\nto \\nensure \\nefficient \\nimplementation \\nof \\ncommunity process.  \\n\\uf0b7 Facilitating \\nregular \\nconduction \\nof \\nRKS \\nmeetings and helping block officials in \\npreparation of RKS expenditure plans based \\non the identification of the specific facility \\nrequirements. \\n\\uf0b7 Replenish ASHA kits, supplies etc.  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n\\uf0b7 Liaise with district level stakeholders to \\ndisseminate information and mobilize support \\nfor programme activities. \\n\\uf0b7 Develop TOR for selection of implementing \\nagency and taking approval from SPMU/DHS \\nthrough CMO.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 34, 'source_type': 'Authorotative', 'priority': '1'}, page_content='disseminate information and mobilize support \\nfor programme activities. \\n\\uf0b7 Develop TOR for selection of implementing \\nagency and taking approval from SPMU/DHS \\nthrough CMO. \\n\\uf0b7 Follow up with Block Programme Managers on \\nworking of RKS  \\n\\uf0b7 Conduct and oversee community mobilization \\nand awareness campaigns for all programmes \\nin the District.  \\n\\uf0b7 Ensure operationalization of all Delivery \\npoints \\nfor \\ninstitutional \\ndeliveries \\nand \\nentitlements and incentives to ASHA for JSY, \\nJSSK etc.  \\n\\uf0b7 Ensure ASHA uniforms and functional ASHA \\nRest Rooms, Replenish ASHA kits, logistics \\nsupport, drugs and consumables  \\n \\n \\n \\n\\uf0b7 \\nEnsure Database updation and selection of \\nASHA and ASHA facilitators as per norm.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 35, 'source_type': 'Authorotative', 'priority': '1'}, page_content='36 \\n \\nDeliverable/Officer Responsible* \\nBlock/City Level \\nDistrict Level \\nBlock Community Process Manager/Block \\nCommunity Mobilizer \\nDistrict Community Process Manager/ \\nCommunity Mobilizer/ District ASHA \\nProgramme Coordinator \\n \\n \\nDATABASE OF FUNCTIONARIES \\n \\n\\uf0b7 \\nReports and maintains a facilitator wise data \\nbase for the profile of every ASHA, training \\nstatus \\nand \\ndropouts; \\nASHA \\nselection, \\npayments \\nto \\nASHA, \\nregular \\nsupply \\ndistribution and replenishment of ASHA Kits \\n\\uf0b7 \\nSupports \\nthe \\nformation \\nand \\nimproved \\nfunctioning \\nof \\nVHSNCs \\nand \\nmaintains \\ndatabase of VHSNCs for their training, \\nfunctionality, expenditure and back logs; \\nCONVERGENCE \\n \\n\\uf0b7 Establishes smooth working relationships \\nwith block level functionaries of other \\ngovernment departments such as; WCD, \\nWater and Sanitation and Rural Development \\nto avoid/ solve issues related to field level in \\ncoordination or conflicts if present. \\n \\nCAPACITY BUILDING & HANDHOLDING'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 35, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Water and Sanitation and Rural Development \\nto avoid/ solve issues related to field level in \\ncoordination or conflicts if present. \\n \\nCAPACITY BUILDING & HANDHOLDING \\n \\n\\uf0b7 Evaluation of skills and knowledge of ASHA \\nand ASHA facilitators after the trainings. \\n\\uf0b7 Support for improving HMIS/MCTS data \\nquality through supportive supervision and \\nonsite mentoring ANM and ASHA; \\n\\uf0b7 Supporting orientation of field staff/ASHAs \\nwith Community Based Monitoring tools, \\nimplementation, organization of Jan \\nSamwaad and overall support to the \\nprogramme \\n \\n \\n \\n \\n \\n \\n \\n \\n\\uf0b7 Develop communication network inter and \\nintradepartmental \\nwith \\nDistrict \\nLevel \\nfunctionaries & with community resources for \\noptimal implementation of the programme \\nand coordination.  \\n \\n \\n \\n\\uf0b7 Coordinate with State ASHA and Community \\nProcess Resource Centre & DHS to ensure \\ntraining calendar, organize and supervise \\ntrainings for ASHA, ASHA facilitators and \\nVHNCS members.  \\n\\uf0b7 Supervision and monitoring of the ASHA'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 35, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Process Resource Centre & DHS to ensure \\ntraining calendar, organize and supervise \\ntrainings for ASHA, ASHA facilitators and \\nVHNCS members.  \\n\\uf0b7 Supervision and monitoring of the ASHA \\nsupport mechanisms with the support of \\nNGOs.  \\n \\nMONITORING \\nCOMMUNITY MONITORING \\n \\n\\uf0b7 Facilitating \\nCommunity \\nparticipation \\nactivities, \\nNGOs \\ninvolvement, \\nVHSNC \\nformation, its regular meeting, and utilization \\nof untied funds in the block.   \\n \\nPERFORMANCE INDICATORS & PROGRESS \\nMEASUREMENT \\n \\n \\n \\n\\uf0b7 Facilitating \\nCommunity \\nparticipation \\nactivities, \\nNGOs \\ninvolvement, \\nVHSNC \\nformation, \\nits \\nregular \\nmeeting, \\nand \\nutilization of untied funds in the district.   \\n \\n \\n \\n \\n\\uf0b7 Document \\nfield \\nlevel \\ninnovations, \\nachievements \\nand \\nchallenges \\nin'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 36, 'source_type': 'Authorotative', 'priority': '1'}, page_content='37 \\n \\nDeliverable/Officer Responsible* \\nBlock/City Level \\nDistrict Level \\nBlock Community Process Manager/Block \\nCommunity Mobilizer \\nDistrict Community Process Manager/ \\nCommunity Mobilizer/ District ASHA \\nProgramme Coordinator \\n\\uf0b7 Undertakes monthly block level compilation \\nof performance indicators according to the \\nformats submitted by ASHA Facilitators, to \\nassess functionality of ASHA on key tasks. \\n\\uf0b7 Further, identifies the poor performing \\nASHAs, assess the causes of low performance \\nand devise strategies for improvement; \\n\\uf0b7 Support in identification and selection of best \\nASHAs for felicitation at ASHA Sammelan and \\noverall support in ensuring their participation \\nin the Sammelan; \\n\\uf0b7 Helping the ASHA Facilitators and block \\nofficials in identifying and narrating best \\nASHA \\nstories \\nbased \\non \\nexceptional \\nperformance. \\n \\n \\n \\n \\n \\n \\n \\nREVIEW MEETINGS \\n\\uf0b7 Participating in district review meetings with \\ncomplete and updated status of various \\nCommunity Process programmes being'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 36, 'source_type': 'Authorotative', 'priority': '1'}, page_content='based \\non \\nexceptional \\nperformance. \\n \\n \\n \\n \\n \\n \\n \\nREVIEW MEETINGS \\n\\uf0b7 Participating in district review meetings with \\ncomplete and updated status of various \\nCommunity Process programmes being \\nimplemented in the concerned block; \\n\\uf0b7 Organizing block review meetings every \\nmonth on a fixed day, in coordination with \\nBlock Medical Officer In-charge (BMOIC) and \\nBlock Programmer Manager for facilitating: \\no Periodic refresher trainings, capacity \\nbuilding, updating information and \\nsharing new guidelines; \\no Review and assessment of performance \\nof ASHAs along with trouble shooting; \\no Replenishment of ASHA drugs/ \\nequipment kits; \\no Verifying records and release of \\npayments; \\n\\uf0b7 Provides supportive supervision and \\ncontinuous monitoring through – monthly \\nmeeting of the ASHA facilitators at block \\nheadquarters and field visits to assess \\nfunctionality and handholding ASHA \\nFacilitators and ASHAs;  \\n\\uf0b7 Review and assess the functionality of \\nimplementation of programme.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 36, 'source_type': 'Authorotative', 'priority': '1'}, page_content='headquarters and field visits to assess \\nfunctionality and handholding ASHA \\nFacilitators and ASHAs;  \\n\\uf0b7 Review and assess the functionality of \\nimplementation of programme. \\n\\uf0b7 Furnish district news for inclusion in ASHA \\nnewsletter and distribution of ASHA Bullet to \\nstakeholders, district and state levels. \\n\\uf0b7 Ensure data collection and reporting systems \\nfrom grass root levels, in HMIS and monthly \\nreview.  \\n\\uf0b7 Ensure timely reporting of Maternal Deaths, \\nChild Deaths and Births.  \\n\\uf0b7 Ensure completion of monitoring progress \\nperformance reports, field visit reports \\n(Random & Planned) in the requisite format \\non a monthly basis. \\n\\uf0b7 Seek feedback of district level activities from \\nmonitoring division as compared to other \\ndistrict. \\n\\uf0b7 Undertake monitoring of interventions \\nimplementation agencies, including GOs, in \\nline with their implementation plans. \\n \\n \\n\\uf0b7 Responsible for coordination and monitoring \\nof community led activities in the District-'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 36, 'source_type': 'Authorotative', 'priority': '1'}, page_content='implementation agencies, including GOs, in \\nline with their implementation plans. \\n \\n \\n\\uf0b7 Responsible for coordination and monitoring \\nof community led activities in the District- \\nASHAs, VHSNC, and Village Health & Nutrition \\nDays etc.  \\n\\uf0b7 Conducts Block wise review and ensures full \\nand timely payment of all ANMs.  \\n\\uf0b7 Monitors and reviews ASHA performance of its \\nfunctions, ASHA meetings and VHND sessions \\nas per schedule.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 37, 'source_type': 'Authorotative', 'priority': '1'}, page_content='38 \\n \\nDeliverable/Officer Responsible* \\nBlock/City Level \\nDistrict Level \\nBlock Community Process Manager/Block \\nCommunity Mobilizer \\nDistrict Community Process Manager/ \\nCommunity Mobilizer/ District ASHA \\nProgramme Coordinator \\nVHSNCS in terms of regular meetings, fund \\nutilization etc. \\n\\uf0b7 Supporting micro planning, quality activities, \\nmonitoring and reporting of Sub-Centre level \\nAAA forum meetings in the selected districts. \\n \\nRegular Field visits \\n \\n\\uf0b7 For Physical Verification and supervision.  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\no \\nEnsuring operationalization of delivery \\npoints District wise review of operation \\nand status, HMIS review.  \\no \\nField visits to facilities for physical \\nverification and supervision visits and \\nmonitor quality of intervention \\nimplementations- IFA tablets, home \\nbased care etc.  \\no \\nEnsure adoption and implementation of \\nlocalized communication interventions, \\nidentify gaps and take corrective action'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 37, 'source_type': 'Authorotative', 'priority': '1'}, page_content='implementations- IFA tablets, home \\nbased care etc.  \\no \\nEnsure adoption and implementation of \\nlocalized communication interventions, \\nidentify gaps and take corrective action \\n \\n\\uf0b7 Designations included in the table are indicative and generic in nature. States may \\nhave different administrative structures for implementation'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 38, 'source_type': 'Authorotative', 'priority': '1'}, page_content='39 \\n \\n \\n \\n \\n \\n \\n \\n4. Accountability, Monitoring62, and Reporting \\n \\n4.1 Accountability Framework 63 \\n \\nAccountability frameworks are developed at all levels for making executives \\naccountable for the services provided and for better review of the progress of the \\nprogramme.  \\n \\n1. REVIEW MEETINGS: The Governing Body and Executive Committees of the DHS \\nhold regular review meetings (at least annually and thrice a year respectively). \\nThe DHS (Chairperson and Member Secretary) is also answerable to Legislature and \\nParliament. RKS at the facility level also plays a similar role.  \\n \\n2. AUDITS: NRHM is subjected to Comptroller and Audit General (CAG) audit as well \\nas audit by Charted Accountants, down to district and block levels. All districts \\nhave a system of periodic concurrent audit and an annual audit.  All audit reports \\nhave to be presented and reviewed in the Governing Body Meeting of District \\nHealth Society under the Chairmanship of District Collector.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 38, 'source_type': 'Authorotative', 'priority': '1'}, page_content='have to be presented and reviewed in the Governing Body Meeting of District \\nHealth Society under the Chairmanship of District Collector. \\n \\n3.  Community monitoring of facilities supported by NGOs:  \\n \\n\\uf0b7 \\nCommunity monitoring itself brings in accountability.  \\n\\uf0b7 \\nHealth Monitoring and Planning Committee at PHC, Block and District levels \\nensure community monitoring activities and use these inputs for developing \\nHealth Action Plans and PIP.  \\n\\uf0b7 \\nPeriodic Jan Sanwad or Jan Sunwai where direct feedback is provided by the \\ncommunity/beneficiaries. \\n\\uf0b7 \\nSpecial Rapporteurs are appointed by the mission to carry out field visits and \\nevaluate the progress of programme. Mentoring group of ASHA and Regional \\nResource Centres are also involved. Sample household and facility surveys are \\ndone by external research organizations/NGOs. \\n\\uf0b7 \\nPublic health surveys by district /Block level Mission Teams/ research and \\nresource institutions at PHC, CHC and District levels to verify whether patients'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 38, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7 \\nPublic health surveys by district /Block level Mission Teams/ research and \\nresource institutions at PHC, CHC and District levels to verify whether patients \\nare receiving their entitlements.  \\n\\uf0b7 \\nDisplay of Citizens Charter with rights of the citizens, User Charges and Agreed \\nEntitlements and service guarantees, at prominent locations in the facilities.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 39, 'source_type': 'Authorotative', 'priority': '1'}, page_content='40 \\n \\n4. DISHA District Development Coordination and Monitoring Committee (DISHA) / \\nDistrict Level Vigilance & Monitoring Committee (DLVMC)64  \\n \\nThe DISHA /DLVMC is constituted to monitor the progress of implementation of \\nNational Health Mission (both NRHM & NUHM) under the overall Framework of \\nImplementation. This committee is chaired by MP of Lok Sabha in each District. \\nThe committee is mandated to review the inter-sectoral convergence, community \\nmonitoring mechanisms, management information system etc.65 \\n \\n4.2 Monitoring66 & Evaluation Activities \\n \\nThere is a multi fold approach for monitoring. This includes  \\ni. \\nLarge scale population surveys \\nii. \\nEvaluation studies or research on implementation \\niii. \\nHMIS data \\niv. \\nField visits by officials.  \\n \\n1. Periodic Population Health Surveys and Demographic information \\nPeriodic Sample Registration Surveys (SRS), Death statistics, National Sample Survey'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 39, 'source_type': 'Authorotative', 'priority': '1'}, page_content='HMIS data \\niv. \\nField visits by officials.  \\n \\n1. Periodic Population Health Surveys and Demographic information \\nPeriodic Sample Registration Surveys (SRS), Death statistics, National Sample Survey \\nOrganization (NSSO) data on cost of care and morbidity, District Level Household \\nsurvey (DLHS) and National Family Health Survey (NFHS) is done to give insights into \\nthe functioning of NRHM.   \\n \\n2. Evaluation studies or research on implementation67 \\nExpert groups from multiple organizations are involved for conducting independent \\nevaluation of all components of NRHM.  Evaluation of the programme implementation \\nin districts is done by Regional Evaluation Teams and reports are available in public \\ndomain.  \\n \\n3. Strengthening Data Capturing: Health Management Information systems (HMIS)68:  \\nData is regularly uploaded from all levels, facility wise and programme wise and is \\nmonitored by the District Teams. \\nHealth Management Information System (HMIS) Reports: HMIS is a web based'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 39, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Data is regularly uploaded from all levels, facility wise and programme wise and is \\nmonitored by the District Teams. \\nHealth Management Information System (HMIS) Reports: HMIS is a web based \\nmonitoring system to capture information from the primary levels and is consolidated \\nat State Level on a monthly basis. This is used to monitor performance of health \\nprogrammes at facility and district level and thus helps in timely corrective action. \\n \\nThe information from HMIS and other sources like National Family Health Survey \\n(NFHS), District Level Household Survey (DLHS), Census, SRS and performance \\nstatistics, is compiled into the NHM Health Statistics Information Portal.69  \\n \\nData Analysis is done based on the data uploaded and further used for development of \\nScorecards/Grading of CHC/Dashboards of performance based on key performance \\nindicators for Grading of Districts all over the country. 70 Process and Outcome'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 39, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Scorecards/Grading of CHC/Dashboards of performance based on key performance \\nindicators for Grading of Districts all over the country. 70 Process and Outcome \\n(Mortality and Morbidity rates) indicators for diseases and Output indicators for \\nprogrammes, are measured and monitored regularly. Suitable corrective actions are'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 40, 'source_type': 'Authorotative', 'priority': '1'}, page_content='41 \\n \\ntaken for facilities with low scores and reward/recognition for high performing \\nfacilities. Achievement of goals of Universal health care i.e. out of pocket expenditure \\nby patients, percentage of access/coverage of people for specific services, assured \\nservices access and availability on a cashless basis is also monitored. This is an \\nimportant monitoring tool used by District level Programme Managers.  \\nState and District wise analysis reports are published and are available in the public \\ndomain. 71 \\n \\n4. Access of services to disadvantaged communities of various geographical areas is \\nmonitored by surveys and MCTS reporting system. Mother and Child Tracking System \\n(MCTS)72 is a web- based application to monitor Maternal and Infant Mortality, by \\nfacilitating tracking of Case specific pregnant women (both ANC and PNC), child births \\nand immunization of children up to five years of age. It is a tool which sends regular'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 40, 'source_type': 'Authorotative', 'priority': '1'}, page_content='facilitating tracking of Case specific pregnant women (both ANC and PNC), child births \\nand immunization of children up to five years of age. It is a tool which sends regular \\nalerts to the service providers as well as beneficiaries about the services, to ensure \\nthe continuity of services. \\n \\n5. Field Visits/Appraisal Visits: by public health experts. Reports of Common Review \\nMission (CRM) annually, integrated monitoring teams of the Ministry, the Regional \\nDirectors, and the Population Resource Centers (PRC) are some of the important ones. \\nThere are regular monitoring visits from the Programme Management Units from \\nStates, Districts and Block to respective lower levels under their jurisdiction.  \\n \\n6. Training Information Management System( TMIS)73: It is an online database from \\ndistrict level and above, which captures details of trainings( Guidelines, manuals, \\ncourse content, real time trainings, nominations, registrations, post training'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 40, 'source_type': 'Authorotative', 'priority': '1'}, page_content='district level and above, which captures details of trainings( Guidelines, manuals, \\ncourse content, real time trainings, nominations, registrations, post training \\nevaluations, deployment of staff etc). This is used for monitoring of in-service trainings \\nof health professionals in India on a single mouse click.  \\n \\n7. Quality Monitoring  \\n \\na. Quality Assurance in Public Health Facilities74 \\n \\nGoI has rolled out the “National Quality Assurance Standards (NQAS) Guidelines” in \\n2013. These guidelines define a ‘road map’ for implementing and improving quality \\nstandards of Public Health Facilities. Each healthcare facility has in- house Quality \\nManagement System and Ranking of the facilities is done based on performance \\nagainst predefined standards. There is a State Level and District Level Quality \\nAssurance Cell (State Quality Assurance Committee (SQAC) & District Quality \\nAssurance Committee (DQAC)) coordinating these activities. \\n \\nb. Mera Aspataal75'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 40, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Assurance Cell (State Quality Assurance Committee (SQAC) & District Quality \\nAssurance Committee (DQAC)) coordinating these activities. \\n \\nb. Mera Aspataal75 \\n \\nGOI recently initiated an ICT- based Patient Satisfaction System (PSS) i.e. “Mera \\nAspataal/ My Hospital”. This to empower the patients to express their views on the \\nhealth services delivered in a public facility and empanelled private hospitals.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 41, 'source_type': 'Authorotative', 'priority': '1'}, page_content='5. Nati\\n \\n5.1 About the Scheme 76 \\n \\n As a response to stagnation a\\nthe NUHM was launched in 20\\nnew skills and capacities for \\nhealth needs and innovating \\ncomprehensive primary healt\\nwith social determinants that\\nvulnerable population in urba\\nhaving robust upward and dow\\nbelow gives a population base\\n \\nFigure 10: Popu\\n \\nNUHM strategies are designed\\nstreet children, rickshaw pull\\nmigrants.   NUHM also empha\\nsectors for urban health-care\\ndeterminants of health like-a\\noccupational safety, road saf\\nstress.  \\n \\nMahila Arogya Samiti80: is a C\\ncovering 50-100 household\\nbehaviour change promotio\\nfacilitating community risk\\nimprove access to healthca\\nUrban Community \\nHealth Centre\\nUrban Primary Heal\\nCentre\\nMahila Arogy\\n \\n42 \\nional Urban Health Mission (NUHM\\nand even worsening of key health indicators\\n013.   Urban health issues77 are distinct and \\nanalyzing complex urban scenario, assessing\\nnovel context-specific solutions.   The NUHM\\nthcare services to the urban poor and enable'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 41, 'source_type': 'Authorotative', 'priority': '1'}, page_content='013.   Urban health issues77 are distinct and \\nanalyzing complex urban scenario, assessing\\nnovel context-specific solutions.   The NUHM\\nthcare services to the urban poor and enable\\nt have a direct bearing on the health of mar\\nan areas. Urban health facilities under NUHM\\nwnward linkages to address urban specific n\\ned structure of urban service delivery mode\\nulation based service delivery model under NU\\nd to target populations79 such as the homele\\nlers, construction workers, sex workers and \\nasises building partnerships with for profit &\\ne delivery.  NUHM focus goes beyond health \\nair pollution, solid waste management, wate\\nfety, housing, vector control, reduction of vi\\nCommunity group of 5-20 women from a\\n’s i.e. 250-500 population. They are invo\\non and communication on Health and Hy\\nk pooling programmes in their coverage a\\nare at household level.  ASHA may provid\\nlth \\nya Samiti \\nM) \\ns in urban areas, \\nunique, requiring \\ng differential \\nM aims to provide \\ne convergence \\nrginalized and'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 41, 'source_type': 'Authorotative', 'priority': '1'}, page_content='are at household level.  ASHA may provid\\nlth \\nya Samiti \\nM) \\ns in urban areas, \\nunique, requiring \\ng differential \\nM aims to provide \\ne convergence \\nrginalized and \\nM are envisaged as \\nneeds. The figure \\nel under NUHM: \\n \\nHM78 \\ness, rag pickers, \\ntemporary \\n& not-for-profit \\nto cover wider \\ner quality, \\niolence and urban \\na slum area, \\nolved in \\nygiene and \\narea. This is to \\nde leadership to'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 42, 'source_type': 'Authorotative', 'priority': '1'}, page_content='43 \\n \\nMAS. Each MAS has an elected Chairperson/Secretary and another representative \\nlike Treasurer. NUHM gives an annual grant to MAS of Rs 5000 every year.81 \\n \\n \\n5.2 Goals, Objectives and Strategies of NUHM82 \\n \\n \\nTable 14: Goals, Objectives and Strategies of NUHM \\nGoals \\nObjectives \\nStrategies \\n1.Identify marginalized and \\nvulnerable pockets and \\nimprove the status of health \\ncare delivery services to \\ncover entire urban \\npopulation \\n \\n \\n \\n \\n \\n \\n1. Operationalizing program \\nmanagement units at State, District \\nand city level  \\n2. Mapping of vulnerable population & \\nhealth facilities \\n3. Setting up urban health facilities \\n(Urban Primary Health Centres- \\nUPHCs, Urban Community Health \\nCentres- UCHC) as per the population \\nnorms* \\n4. Developing a network of \\ncommunity healthcare workers \\n(ASHAs and Mahila Arogya Samities - \\nMAS) \\n1.  Mapping of vulnerable population in the urban area \\n2.  GIS mapping of city to mark location of major landmarks, slum and'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 42, 'source_type': 'Authorotative', 'priority': '1'}, page_content='community healthcare workers \\n(ASHAs and Mahila Arogya Samities - \\nMAS) \\n1.  Mapping of vulnerable population in the urban area \\n2.  GIS mapping of city to mark location of major landmarks, slum and \\nvulnerable pockets, government and private health facilities with their \\ncatchment areas \\n3. Constituting Urban Primary Health Centres (UPHCs) and Urban \\nCommunity Health Centres (UCHCs) as per the population norms and in \\nproximity to slums \\n4. Providing adequate HR, infrastructure and resources to the facilities \\n5. Establishing UPHCs as centres for assured comprehensive primary \\nhealth care services (clinical, diagnostic, Non Communicable Diseases \\nand outreach) and multi-directional referral units \\n6. Mobilizing community to UPHCs with the help of ASHAs and MAS \\n7. Forming referral linkages of UPHCs with UCHCs, DH, Nutrition \\nRehabilitation Centres (NRCs), Mental health clinics, de-addiction \\ncentres, palliative care hospices, homeless shelters and domestic'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 42, 'source_type': 'Authorotative', 'priority': '1'}, page_content='7. Forming referral linkages of UPHCs with UCHCs, DH, Nutrition \\nRehabilitation Centres (NRCs), Mental health clinics, de-addiction \\ncentres, palliative care hospices, homeless shelters and domestic \\nviolence help centres etc.    \\n8. Conducting regular outreach services (UHNDs & Special outreach \\nsessions) in remote vulnerable areas \\n \\n2.Link urban health with \\nother social determinants of \\nhealth like clean drinking \\nwater, sanitation, pollution, \\nsolid waste management, \\nnutrition, education etc. \\n5. Convergence83 with Urban Local \\nBodies (ULBs) and other Ministries at \\nState and ward level. \\n9. Convergence of NUHM with all National Health Programmes \\n \\n10. Ensuring regular convergence84 meeting of officials from MoHFW \\nwith officials from other Ministries like Ministry of Urban Development, \\nMinistry of Women and Child Development, Ministry of Housing and \\nUrban Poverty Alleviation, Department of AYUSH etc. \\n \\n5.3 Institutional Framework85: Resource Planning in NUHM'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 42, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Ministry of Women and Child Development, Ministry of Housing and \\nUrban Poverty Alleviation, Department of AYUSH etc. \\n \\n5.3 Institutional Framework85: Resource Planning in NUHM \\n \\nThe National Urban Health Mission leverage on the institutional structures of the NRHM at the National, \\nState and District level for operationalisation of the NUHM. However in order to provide dedicated \\nfocus to issues relating to Urban Health the institutional mechanism under the NRHM at various levels \\nare strengthened for NUHM implementation.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 43, 'source_type': 'Authorotative', 'priority': '1'}, page_content='44 \\n \\n \\n1. State Level: There is a separate Urban Health Cell for NUHM at State level, reporting to State \\nMission Director.  \\n \\n2. District Level: At the District level the States may either decide to constitute a separate \\nDistrict Urban Health Missions/ District Urban Health Societies or use the existing structure of \\nthe District Health Society / Mission under NRHM with additional stakeholder members. \\n  \\nAt the district level, the management of NUHM activities may be coordinated by a District level         \\nUrban Health Committee headed by the District Magistrate/ Additional District Magistrate/Sub Division \\nMagistrate based on whether the district is a district headquarters or a sub-division headquarter. This \\nwould help ensure better coordination with municipal departments like sanitation, water, waste \\nmanagement, especially in times of response to disease outbreaks/epidemics in the district.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 43, 'source_type': 'Authorotative', 'priority': '1'}, page_content='would help ensure better coordination with municipal departments like sanitation, water, waste \\nmanagement, especially in times of response to disease outbreaks/epidemics in the district.  \\n \\nFurther for enhancing the Program Management, a District Program Management Unit (DPMU) may be \\nestablished. The staff at the District PMU level may be as proposed below:  \\n \\n(i) \\nUrban Health Data Manager/Coordinators.  \\n(ii) \\nUrban Health Accounts Manager  \\n(iii) \\nConsultant (Epidemiologist)  \\n \\nThe National Urban Health Mission would promote participation of the urban local bodies in the \\nplanning and management of the urban health programmes. \\n \\nComponents, Fund management, Fund flow and Monitoring and Accountability of NUHM are on the \\nsame lines as NRHM and thus refer Section 2 of this document for details.  \\n \\n5.4 Convergence 86 \\n \\nFollowing areas of Convergence are present in NUHM. Some other areas of Convergence are \\nalready mentioned in Section 2.3.2 of this document.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 43, 'source_type': 'Authorotative', 'priority': '1'}, page_content='5.4 Convergence 86 \\n \\nFollowing areas of Convergence are present in NUHM. Some other areas of Convergence are \\nalready mentioned in Section 2.3.2 of this document.  \\n \\nA. Ministry of Urban Development and Ministry of Housing and Urban Poverty Alleviation: \\nConvergence with Jawaharlal Nehru National Urban Renewal Mission (JnNURM): Basic \\nServices to the Urban Poor (BSUP), which is a sub mission of JnNURM mandates the provision \\nof health services to the urban poor via a seven point charter, namely security of land \\ntenure, affordable shelter, water, sanitation, education, health and social security.  \\n \\nB. Convergence with Rajiv Awas Yojana (RAY): GIS based physical mapping of the slums and \\nthe spatial representation of the socio-economic profile of slums (Slum MIS) is being \\nundertaken under RAY. This will also be useful for development of city health plans.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 44, 'source_type': 'Authorotative', 'priority': '1'}, page_content='45 \\n \\n \\nC. Convergence with Swarn Jayanti Shahri Rozgar Yojana (SJSRY): The community level \\nstructures under NUHM can be strengthened by effectively aligning them with the SJSRY \\nstructures. \\n \\nD. Ministry Of Human Resource Development; Convergence with School Health Programme \\nfor Medical Examination of children and health education activities.  \\n \\n5.5 Roles and Responsibilities of District Health Society in Urban Areas (NUHM) \\n \\nDistrict Urban Health Coordinator will assist the District Magistrate (DM) and Chief Medical \\nOfficer (CMO) in implementation of these roles and responsibilities: \\n \\nTable 15: Roles and Responsibilities of District Health Society in Urban Areas \\nRole \\nResponsibilities \\n \\n \\nPLANNING \\n \\n\\uf0b7 \\nEnsure that the program management units in state, district and cities \\nare in place and stationed with adequate & qualified HR, infrastructure \\nand resources \\n\\uf0b7 \\nFacilitate vulnerability assessment and GIS mapping of the districts \\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 44, 'source_type': 'Authorotative', 'priority': '1'}, page_content='are in place and stationed with adequate & qualified HR, infrastructure \\nand resources \\n\\uf0b7 \\nFacilitate vulnerability assessment and GIS mapping of the districts \\n\\uf0b7 \\nEnsure that the session sites chosen for outreach are located in remote \\nareas away from urban health facilities, to expand benefits to \\nextremely marginalized population \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nIMPLEMENTATION \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nCOORDINATION & LAISIOING:  \\n \\n\\uf0b7 \\nOrganize population based screenings for NCDs. \\n\\uf0b7 \\nFacilitate UPHCs to develop strong referral linkages with centres of \\nurban specific needs like Nutritional Rehabilitation centres, mental \\nclinics, de-addiction centres, homeless shelters, palliative care centres \\nand domestic violence shelters etc. \\n\\uf0b7 \\nFacilitate land allotment for identified UPHCs or support the rented \\nUPHCs in rationalizing the rent costs \\n\\uf0b7 \\nFacilitate increased coverage through allotment of community halls for \\nconducting special outreach sessions \\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 44, 'source_type': 'Authorotative', 'priority': '1'}, page_content='UPHCs in rationalizing the rent costs \\n\\uf0b7 \\nFacilitate increased coverage through allotment of community halls for \\nconducting special outreach sessions \\n\\uf0b7 \\nDDeveloping un-used open spaces into clean and green belts/ gardens \\nfor public \\n\\uf0b7 \\nEnable Vector control by ensuring adequate supply of anti-larval sprays \\nand pesticides \\n\\uf0b7 \\nFacilitate districts to design innovative projects for improving health\\nand living standards in urban vulnerable areas \\nREVIEW MEETINGS:  \\n\\uf0b7 \\nFacilitate meetings of urban frontline workers from NUHM (ANMs, ASHAs \\nand MAS) with ground level workers of other programs like Self Help \\nGroups (SHGs) from National Urban Livelihood Mission (NULM) and \\nSwacchagrahis from Swachh Bharat Abhiyaan (SBM) etc.  \\n\\uf0b7 \\nChair( by DM) regular convergence meeting of health officials with ULBs \\nand related departments and ministries'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 45, 'source_type': 'Authorotative', 'priority': '1'}, page_content='46 \\n \\nRole \\nResponsibilities \\n \\nCAPACITY BUILDING/PPP Model \\n\\uf0b7 \\nExplore the possibilities of PPP models with private providers and \\npartnerships with NGOs and academic institutions to fill the gaps in \\nservice deliveries if any. \\nMONITORING \\n \\n \\n \\n\\uf0b7 \\nEnsure \\nUPHCs \\nare \\nproviding \\npatient \\nfriendly, \\nhigh \\nquality \\ncomprehensive primary health care services. \\n\\uf0b7 \\nEnsure the formation of RKS in urban health facilities and regularly \\nmonitor fund utilization \\n\\uf0b7 \\nEnsure maintenance of proper channel of waste collection from source \\n(Household/ commercial establishments) to solid waste management \\nplant, which will avoid development of waste dumping grounds in \\ncommunity areas and open spaces \\n\\uf0b7 \\nRegular check on air, water, land and noise pollution and make \\nregulations to charge penalties from people/institutions violating them \\n\\uf0b7 \\nRegularly check the condition of drinking water pipelines and sewerage \\npipelines for any leakage/ damages'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 45, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7 \\nRegularly check the condition of drinking water pipelines and sewerage \\npipelines for any leakage/ damages \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nNHM- IMPLEMENTATION MONITORING PROFORMA (YEARLY REVIEW SHEET with \\nMONTHLY REPORT FORMAT)  \\n[For District Level Functionaries based on the District Action Plan (DAP)] \\n \\nBelow are Yearly Review Sheet format and Programme wise monthly monitoring formats of \\nKey Performance Indicators used at District Level.  Financial Monitoring Report (FMR)87 is \\nuploaded on HMIS by the district regularly \\nExpenditure reports, Utilization Certificate and MIS are also submitted to the State level \\nregularly.'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 46, 'source_type': 'Authorotative', 'priority': '1'}, page_content='47 \\n \\nSummary Yearly Review Sheet Format for Districts (From Data Analysis reports of HMIS) 88 \\n \\nState …………..-District………..Year………………. \\n1 \\n Proportion of ANC registration against Estimated pregnancy: % - …………………….Total reported: …………… \\n2 \\nProportion of ANC registration in first trimester against reported ANC registration: ………………...% - Total reported: ………………… \\n3 \\nProportion of 3 ANC Check up against reported ANC registration: ……………. % - Total reported: ………………………. \\n4 \\nProportion of Deliveries (Home + Pub + Pvt) against Estimated Deliveries : …………………..% Total reported :……………. , Home Deliveries : …………..., Institution\\nDeliveries (Pub) : ……….. Institutional Deliveries (Pvt): …………….. \\n5 \\nProportion of Institutional Deliveries (Pub + Pvt) against Estimated Deliveries …% - Total reported : …………………. \\n6 \\nProportion of C-Section Deliveries ( pub + Pvt) against total Institutional Deliveries(Pub + Pvt) : ……………..% -  Reported C-Section Deliveries :…………...; in pu'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 46, 'source_type': 'Authorotative', 'priority': '1'}, page_content='6 \\nProportion of C-Section Deliveries ( pub + Pvt) against total Institutional Deliveries(Pub + Pvt) : ……………..% -  Reported C-Section Deliveries :…………...; in pu\\nfacility : ………... and in private facility : ………… \\n7 \\nPercentage Newborn visited within 24 hours of Home deliveries: ……….. -Total Visited: ……….. Total Home Deliveries: ………………. \\n8 \\n Percentage PNC Visits within 48 hrs of delivery against total deliveries is……………. %   \\n9 \\nSex Ratio at Birth: …... Male Live Births: ……………. and Female Live Births: ………………… \\n10 \\nPercentage Newborn weighed less than 2.5 kg against total live births : …………... %  \\n11 \\nMeasles (………………...) given is less than BCG (…………….) by  ……………..% \\n12 \\nPercentage fully immunised infants (0 to 11 months) against Estimated live births: ……………...% Total fully immunised infants (BCG, 3 doses of OPV, DPT & \\nMeasles) : …………………… \\n13 \\n Total sterilisations reported : ………………. ; Male sterilisation :……………….%  ( ……………number ) ; Female sterilisation :……………….%  ( ……………number ) \\n14'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 46, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Measles) : …………………… \\n13 \\n Total sterilisations reported : ………………. ; Male sterilisation :……………….%  ( ……………number ) ; Female sterilisation :……………….%  ( ……………number ) \\n14 \\nTotal IUD Inserted ( Pub + Pvt): ………………………….. \\n15 \\nDeaths due to sterilisations - Male: ……….; Female: ………… \\n16 \\n Total OPD reported = ……………... which is …………….. OPD per 1000 population; Total IPD reported = ………………...which is ……………. IPD per 1000 population\\n17 \\nInfant deaths = …... Under 5 deaths = …... Maternal Deaths = ………………. and Deaths due to other causes = ……………….. \\n \\nMonthly Status of OPD, IPD and Bed Occupancy rate \\nName of the Health Facility /Block \\nwise( depending on number of the \\nunits) \\nOPD Status \\nIPD Status \\nBed Occupancy Rate, BOR: (Total Patient bed days \\n*100/Functional beds*days in month \\nNo. Of OPD \\nMonth Last \\nYear \\nNo. of OPD same \\nmonth Current \\nYear \\nNo. Of \\nIPD \\nMonth \\nLast \\nYear \\nNo. of IPD same \\nmonth Current Year \\nMonth  \\nLast Year \\nSame Month Current Year \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 47, 'source_type': 'Authorotative', 'priority': '1'}, page_content='48 \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\n \\nMonthly Status of Janani Surakhsha yojna Scheme \\n \\n \\n \\nFacility /Block wise( depending on number \\nof the units) \\nNumber of estimated deliveries/year \\nTotal number of institutional deliveries in\\nGovernment facilities till this month \\nNumber of deliveries in registered private  \\ninstitutions till this month \\nNumber of deliveries in non registered \\nprivate  institutions till this month \\nTotal number of institutional deliveries \\n(column3+4+5) \\nPercentage Target achieved (6/2) \\nNo. of patients paid Rs 1400 incentive \\n(Rural) \\nNo. of patients paid Rs 1000 incentive \\n(Urban) \\n% of Patients paid incentives( 8+9/3) \\nNo. of ASHA who had to be paid incentives \\nNo. of ASHA who were paid incentives \\nNo. of Total home deliveries beneficiaries\\nNo. of  beneficiaries out of column 10 who \\nhave been paid\\nNo. of estimated Maternal Mortality in this\\nmonth \\nActual reported number of Maternal\\nMortality Cases \\nNo. of cases audited by the CMO herself \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n9'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 47, 'source_type': 'Authorotative', 'priority': '1'}, page_content='have been paid\\nNo. of estimated Maternal Mortality in this\\nmonth \\nActual reported number of Maternal\\nMortality Cases \\nNo. of cases audited by the CMO herself \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n9 \\n10 \\n# \\n12 \\n13 \\n14 \\n15 \\n16 \\n17 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n \\n \\n \\n \\n \\nMonthly Status of Routine Immunization  \\nDistrict:  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nMonth:  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nMonthly Status of Janani Shishu Suraksha Yojna Scheme \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nSno./Name \\nof Block \\nNo. of \\ndeliveries \\nconducted \\nin Block \\nlevels and \\nabove \\nfacilities \\nNo. of \\nbeneficiaries \\nwho have \\nstayed for 48 \\nhours \\nNo. of \\nbeneficiaries \\nwho have \\nreceived \\nfree diet \\nNo. of \\nbeneficiaries who \\nhave received drop \\nback facility \\nTotal \\nnumber of \\npregnant \\nladies who \\nhave come \\nto any \\ngovernment \\nfacilities \\nNo. of pregnant \\nladies who have \\nreceived free \\nconsultation \\nNo. of pregnant \\nladies who have \\nreceived free drugs \\n& Diagnostic services \\nAverage \\npercentage \\nof all \\nservices'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 47, 'source_type': 'Authorotative', 'priority': '1'}, page_content='facilities \\nNo. of pregnant \\nladies who have \\nreceived free \\nconsultation \\nNo. of pregnant \\nladies who have \\nreceived free drugs \\n& Diagnostic services \\nAverage \\npercentage \\nof all \\nservices \\nprovided \\nunder JSSK \\n \\nMonth \\nCumulative \\ntill now\\nMonth \\nCumulative \\ntill now \\nPercentage \\n%(5/3)\\nMonth \\nCumulative \\ntill now \\nMonth \\nCumulative \\ntill now \\nPercentage \\n%(11/3) \\nMonth \\nCumulative \\ntill now \\nMonth \\nCumulative \\ntill now \\nPercentage \\n%(16/14) \\nMonth \\nCumulative \\ntill now \\nPercentage \\n%(19/14) \\n(6+9+1+2+17\\n+20)/5 \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n10 \\n11 \\n12 \\n13 \\n14 \\n1\\n5 \\n16 \\n17 \\n18 \\n19 \\n20\\n21'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 48, 'source_type': 'Authorotative', 'priority': '1'}, page_content='49 \\n \\nS. No./Name of \\nBlock/Facility \\nTarget \\nchildren \\nin \\nCurrent \\nFinancial \\nyear \\nChildren \\nregistered \\non MCTS \\nportal in \\nCurrent \\nFinancial \\nyear \\nPercentage of \\nChildren \\nregistered on \\nMCTS portal in \\nCurrent \\nFinancial year \\n(Percentage:3/2) \\nTarget for \\nfully \\nimmunized \\nchildren \\n(0-12 \\nmonths) \\non MCTS \\nportal last \\nFinancial \\nyear \\nTotal \\nnumber of \\nfully \\nimmunized \\nchildren(0-\\n12 \\nmonths) \\non MCTS \\nportal last \\nFinancial \\nyear \\nPercentage \\nof fully \\nimmunized \\nchildren (0-\\n12 months) \\non MCTS \\nportal last \\nFinancial \\nyear : \\n(Percentage \\n: 6/5) \\n(cumulative) \\nPercentage \\nof fully \\nimmunized \\nchildren on \\nHMIS portal \\n(0-12 \\nmonths) \\n(cumulative) \\nDistrict level \\nimmunization \\ntask force \\nmeetings held till \\ndate \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n9 \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\n \\n \\nRevised National Tuberculosis Control Program Monthly Monitoring Format \\nS. No. \\n Description \\nTarget \\n  \\nAchieved \\nPercentage \\n1- \\nTotal  Chest symptomatic patients'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 48, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Revised National Tuberculosis Control Program Monthly Monitoring Format \\nS. No. \\n Description \\nTarget \\n  \\nAchieved \\nPercentage \\n1- \\nTotal  Chest symptomatic patients \\nreferred from OPD \\n More than 2% \\n  \\n  \\n2- \\nTotal New Adult OPD   \\n  \\n3- \\nTotal Cases \\n 256/Lac \\n  \\n  \\n4- \\nTotal Patient detected per Lac \\n  \\n5- \\nNew sputum positive patients \\n 95/Lac \\n  \\n  \\n6- \\nNew sputum positive patients per Lac per \\nyear \\n  \\n7- \\nConversion rate (NSP) - % \\n 90% \\n  \\n  \\n8- \\nCure rate (NSP) - % \\n 85% \\n  \\n  \\n9- \\nDefault Rate NSP (%)  \\nLess than 3% \\n  \\n  \\n10- \\nDeath Rate NSP (%)   \\nLess than 4% \\n  \\n  \\n* Dummy data entered in the above table for better understanding \\n \\nPre Conception, Pre Natal Diagnostic Technique Act (PCPNDT) \\n  Sno.  \\nAs per census \\n2011 \\nTotal Centres registered \\nunder PCPNDT Act \\nTotal number of centres \\nsuspended \\nNo. of Inspections \\ndone by competent \\nauthority \\nTotal number \\nof inspection \\ndone by \\nDecoy \\nAction taken by inspector \\nAdvisor'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 48, 'source_type': 'Authorotative', 'priority': '1'}, page_content='under PCPNDT Act \\nTotal number of centres \\nsuspended \\nNo. of Inspections \\ndone by competent \\nauthority \\nTotal number \\nof inspection \\ndone by \\nDecoy \\nAction taken by inspector \\nAdvisor \\ncommittee \\nmeetings held \\nComments'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 49, 'source_type': 'Authorotative', 'priority': '1'}, page_content='50 \\n \\nSex ratio in the district \\nSex ratio between 0-6 years \\nIn this Month \\nTill month end \\nPercentage(7/4) \\nIn this Month \\nTill month end \\nTotal number of unregistered clinics caught \\nTotal number of clinics closed \\nTotal number of appeals received by competent \\nauthority \\nTotal Number of clinic suspended \\nTotal number meetings held in a month \\nTotal number of meetings held till month end \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n9 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\n16 \\n17 \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nMonthly MCH tracking by MCTS System \\nS.no \\nIndicators for Name based Tracking of Pregnant Mothers and \\nChildren \\nNumb\\ners  \\n(duri\\nng \\nmont\\nh) \\nCumulative \\nnumber  \\ntill this \\nmonth \\nAnnual Target \\n1 \\nTotal Number of Women registered for ANC  \\n  \\n  \\n  \\n2 \\nTotal Deliveries (sum of 2.1 to 2.3) \\n  \\n  \\n  \\n2.1 \\nTotal deliveries at Home \\n  \\n  \\n  \\n2.2 \\nTotal deliveries at Public Institutions  \\n  \\n  \\n  \\n2.3 \\nTotal deliveries at Private Institutions \\n  \\n  \\n  \\n3 \\nTotal Women given PNC Check-up'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 49, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2.1 \\nTotal deliveries at Home \\n  \\n  \\n  \\n2.2 \\nTotal deliveries at Public Institutions  \\n  \\n  \\n  \\n2.3 \\nTotal deliveries at Private Institutions \\n  \\n  \\n  \\n3 \\nTotal Women given PNC Check-up \\n  \\n  \\n  \\n4 \\nTotal Live Births (4.1 + 4.2) \\n  \\n  \\n  \\n4.1 \\nMale \\n  \\n  \\n  \\n4.2 \\nFemale \\n  \\n  \\n  \\n5 \\nTotal number of Children given BCG \\n  \\n  \\n  \\n6 \\nTotal number of Children given Measles'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 50, 'source_type': 'Authorotative', 'priority': '1'}, page_content='51 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nABBREVIATIONS \\n \\n \\n \\nAMG \\nAnnual Maintenance Grant \\nIMR \\nInfant Mortality Rate'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 51, 'source_type': 'Authorotative', 'priority': '1'}, page_content='52 \\n \\nANM \\nAuxiliary Nurse Midwife  \\nJSY \\nJanani Suraksha Yojana  \\nASHA \\nAccredited Social Health \\nActivist  \\nMIS \\nManagement Information System  \\nATR \\nAction Taken Report  \\nMO \\nMedical Officer  \\nAWW \\nAngan Wadi Worker  \\nMoHFW \\nMinistry of Health and Family \\nWelfare \\nBAM \\nBlock Accounts Manager  \\nMOIC \\nMedical Officer In Charge  \\nBCHC \\nBlock Community Health \\nCentre \\nMMR \\nMaternal Mortality Rate  \\nBEE \\nBlock Extension Educator  \\nMPW (M) \\nMultipurpose Worker (Male)  \\n \\nBMO \\nBlock Medical Officer \\nMSW \\nMaster in Social Work  \\nBPHC \\nBlock Primary Healthcare \\nCentre \\nNA \\nNot applicable  \\nBPM \\nBlock Programme Manager  \\nNDCP \\nNational Disease Control Programme  \\nBRS \\nBank Reconciliation \\nStatement  \\nNPCC \\nNational Programme Coordination \\nCommittee  \\nCA \\nChartered Accountant  \\nNRHM \\nNational Rural Health Mission  \\nCDMO \\nChief District Medical \\nOfficer  \\nPHC \\nPrimary Health Centre  \\nCEO \\nChief Executive Officer  \\nRCH \\nReproductive and Child Health  \\nCHC \\nCommunity Health Centre  \\nRKS'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 51, 'source_type': 'Authorotative', 'priority': '1'}, page_content='CDMO \\nChief District Medical \\nOfficer  \\nPHC \\nPrimary Health Centre  \\nCEO \\nChief Executive Officer  \\nRCH \\nReproductive and Child Health  \\nCHC \\nCommunity Health Centre  \\nRKS \\nRogi Kalyan Samiti  \\nCMO \\nChief Medical Officer  \\nRoP \\nRecord of Proceedings  \\nCM&HO Chief Medical & Health \\nOfficer \\nSAM \\nState Accounts Manager  \\nDA \\nData Assistant  \\nSFM \\nState Finance Manager  \\nDAM \\nDistrict Accounts Manager  \\nSFP \\nStatement of Fund Position  \\nDHAP \\nDistrict Health Action Plan  \\nSHS \\nState Health Society  \\nDHS \\nDistrict Health Society  \\nSPMU \\nState Programme Management Unit  \\nDPM \\nDistrict Programme \\nManager  \\nSPIP \\nState Project Implementation Plan  \\nDPMU \\nDistrict Programme \\nManagement  \\nSoE \\nStatement of Expenditure  \\nFMG \\nFinancial Management \\nGroup \\nSC \\nSub- Centres'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 52, 'source_type': 'Authorotative', 'priority': '1'}, page_content='53 \\n \\n \\nENDNOTES & REFERENCES \\n \\n                                                          \\n1  Mission \\nDocument, \\nNRHM \\nGuidelines. \\nAvailable \\nat \\nhttp://nhm.gov.in/images/pdf/guidelines/nrhm-guidelines/mission_document.pdf \\n2\\n Chapter \\n2, \\nNHM \\nFramework \\nfor \\nImplementation;        \\nhttp://nhm.gov.in/images/pdf/NHM/NHM_Framework_for_Implementation__08-01-2014_.pdf 2012-\\n2017. \\n3  Section II, http://nhm.gov.in/images/pdf/about-nrhm/nrhm-framework-implementation/nrhm-\\nframework-latest.pdf \\n4  http://nhm.gov.in/images/pdf/NHM/NHM_Framework_for_Implementation__08-01-2014_.pdf \\n5  Section II, http://nhm.gov.in/images/pdf/about-nrhm/nrhm-framework-implementation/nrhm-\\nframework-latest.pdf \\n6  Part \\n1, \\nTable \\n1, \\nRural \\nHealth \\nStatistics, \\n2014-2015, \\nhttp://wcd.nic.in/sites/default/files/RHS_1.pdf   \\n7\\n  \\n \\nRefer \\nSection \\n2.4.2. \\n2.4.3. \\nRural \\nHealth \\nStatistics, \\n2014-2015, \\nhttp://wcd.nic.in/sites/default/files/RHS_1.pdf \\n8  Refer: \\nguidelines \\nfor \\nKayakalp \\nProgramme,'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 52, 'source_type': 'Authorotative', 'priority': '1'}, page_content='7\\n  \\n \\nRefer \\nSection \\n2.4.2. \\n2.4.3. \\nRural \\nHealth \\nStatistics, \\n2014-2015, \\nhttp://wcd.nic.in/sites/default/files/RHS_1.pdf \\n8  Refer: \\nguidelines \\nfor \\nKayakalp \\nProgramme, \\nhttp://nhm.gov.in/images/pdf/in-\\nfocus/Revised_Kayakalp_Guidelines.pdf \\n9  Refer \\nGuidelines \\non \\nFree \\nDrugs \\nService \\nInitiative, \\nhttp://nhsrcindia.org/recruitment/Free%20Diagnostics%20Service%20Initiative.pdf \\nFMR \\nFinancial Monitoring Report  ToR \\nTerms of Reference  \\nGOI \\nGovernment of India  \\nUF \\nUntied Fund \\nGFR \\nGeneral Financial Rule  \\nUC \\nUtilization Certificate  \\nIDHAP \\nIntegrated District Health \\nAction Plan  \\nVHSC \\nVillage Health Sanitation Committee'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 53, 'source_type': 'Authorotative', 'priority': '1'}, page_content='54 \\n \\n                                                                                                                                                                                    \\n10  Available \\nfrom \\nhttps://mpphscl.in/Files/PDF/b731acad-eded-43b6-b286-\\n99aea308b1fb_0_Free_Drugs_Service_Intitiative.pdf \\n11   Refer \\nGuidelines \\non \\nFree \\nDiagnostics \\nService \\nInitiative, \\nhttp://nhsrcindia.org/recruitment/Free%20Diagnostics%20Service%20Initiative.pdf \\n12  Available from http://nhm.gov.in/nrhm-components/health-systems-strengthening/emri-\\npatient-transport-service.html \\n13 Available from http://nhm.gov.in/nrhm-components/health-systems-strengthening/emri-patient-  \\ntransport-service.html \\n14 Refer: Guidelines on Biomedical Equipment Management and Maintenance Programme, 2015, \\nhttp://nhsrcindia.org/recruitment/Biomedical%20Equipment%20Revised%20(10-02-2015).pdf \\n15  Refer: \\nOperational \\nGuidelines \\nfor \\nMMU \\nUnit, \\nJune \\n2015,'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 53, 'source_type': 'Authorotative', 'priority': '1'}, page_content='http://nhsrcindia.org/recruitment/Biomedical%20Equipment%20Revised%20(10-02-2015).pdf \\n15  Refer: \\nOperational \\nGuidelines \\nfor \\nMMU \\nUnit, \\nJune \\n2015, \\nhttp://nhm.gov.in/images/pdf/programmes/mmu/Mobile_Medical_Units.pdf \\n16  Refer: \\nGuidelines \\non \\nJSY, \\nhttp://nhm.gov.in/images/pdf/programmes/jsy/guidelines/jsy_guidelines_2006.pdf \\n17  Refer Guidelines on JSSK, \\nhttp://nhm.gov.in/images/pdf/programmes/jssk/guidelines/guidelines_for_jssk.pdf \\n18\\n Refer: \\nMaternal \\nand \\nNewborn \\nHealth \\nTool \\nKit, \\nNov \\n2013; \\nMoHFW, \\nGoI, \\nhttp://164.100.130.11:8091/rch/MNH%20Toolkit_23_11_2013.pdf \\n19  http://164.100.130.11:8091/training/SkillsLab_OperationalGuidelines.pdf \\n20  Refer http://nhm.gov.in/nrhm-components/rmnch-a/maternal-health/dakshata.html \\n21    Refer Operational Guidelines on Programme for Promotion of Breast Feeding ; \\nhttp://nhm.gov.in/MAA/Operational_Guidelines.pdf \\n22  Available \\nfrom \\nhttps://pmsma.nhp.gov.in/wp-'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 53, 'source_type': 'Authorotative', 'priority': '1'}, page_content='21    Refer Operational Guidelines on Programme for Promotion of Breast Feeding ; \\nhttp://nhm.gov.in/MAA/Operational_Guidelines.pdf \\n22  Available \\nfrom \\nhttps://pmsma.nhp.gov.in/wp-\\ncontent/uploads/2016/09/Pradhan_Mantri_Surakshit_Matritva_Abhiyan-2.pdf \\n23  Refer: Facility Based Newborn Care Operational Guide- 2011 http://nhm.gov.in/nrhm-\\ncomponents/rmnch-a/child-health-immunization/child-health/schemes.html \\n24  Refer http://www.missionindradhanush.in/about.html \\n25 Refer http://www.missionindradhanush.in/about.html \\n26  Refer Operational Guidelines RBSK, February 2013 and Operational Guidelines DEIC, May 2014, \\nhttp://nhm.gov.in/images/pdf/programmes/RBSK/Operational_Guidelines/Operational%20Guid\\nelines_RBSK.pdf \\n27  Ref: Rashtriya Kishor Swasthya Karyakram (RKSK)-operational framework, Jan 2014; MoHFW, \\nGoI, http://rmncha.in/wp-content/uploads/guidelines_img/1475125418.pdf \\n28   Refer \\nFamily \\nPlanning \\nGuidelines, \\nhttp://nhm.gov.in/nhm/nrhm/guidelines/nrhm-'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 53, 'source_type': 'Authorotative', 'priority': '1'}, page_content='GoI, http://rmncha.in/wp-content/uploads/guidelines_img/1475125418.pdf \\n28   Refer \\nFamily \\nPlanning \\nGuidelines, \\nhttp://nhm.gov.in/nhm/nrhm/guidelines/nrhm-\\nguidelines/family-planning-guidelines.html \\n29  http://nhm.gov.in/nrhm-components/national-disease-control-programmes-ndcps \\n30  Refer Guidelines on NCDS, June 2016. Available from http://nhm.gov.in/images/pdf/NHM/NHM-\\nGuidelines/Operational_Guidelines_NCDs.pdf \\n31  Section \\nIV, \\nPoint \\nC, \\nAvailable \\nfrom \\nhttp://nhm.gov.in/images/pdf/about-nrhm/nrhm-\\nframework-implementation/nrhm-framework-latest.pdf \\n32 Refer Guidelines for Community Processes 2013, http//nhsrcindia.org/ \\n33  Refer \\nguidelines \\non \\nNational \\nDialysis \\nProgramme, \\nApril \\n2016, \\nhttp://nhm.gov.in/images/pdf/NHM/NHM-\\nGuidelines/Operational_Guidelines_for_Dialysis_Programme.pdf \\n34\\n Table \\nA, \\nPage \\n47, \\nNHM \\nframework \\nfor \\nImplementation; \\nhttp://nhm.gov.in/images/pdf/NHM/NHM_Framework_for_Implementation__08-01-2014_.pdf'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 53, 'source_type': 'Authorotative', 'priority': '1'}, page_content='34\\n Table \\nA, \\nPage \\n47, \\nNHM \\nframework \\nfor \\nImplementation; \\nhttp://nhm.gov.in/images/pdf/NHM/NHM_Framework_for_Implementation__08-01-2014_.pdf \\n35  Section IV, Point M & N, http://nhm.gov.in/images/pdf/about-nrhm/nrhm-framework-\\nimplementation/nrhm-framework-latest.pdf \\n36\\n Section \\n5.5 \\n.4.7, \\nNHM \\nframework \\nfor \\nImplementation; \\nhttp://nhm.gov.in/images/pdf/NHM/NHM_Framework_for_Implementation__08-01-2014_.pdf'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 54, 'source_type': 'Authorotative', 'priority': '1'}, page_content='55 \\n \\n                                                                                                                                                                                    \\n37  Refer Operational guidelines Swachh Swasth Sarvatra http://nhm.gov.in/images/pdf/in-\\nfocus/Swachh_Swasth_Sarvtra_Guidelines.pdf \\n38  Section I & VI point 92; Available from http://nhm.gov.in/images/pdf/about-nrhm/nrhm \\nframework-implementation/nrhm-framework-latest.pdf, \\nChapter \\n3, \\nNHM \\nframework \\nfor \\nImplementation; \\nhttp://nhm.gov.in/images/pdf/NHM/NHM_Framework_for_Implementation__08-\\n01-2014_.pdf \\n39  Chapter \\n3; \\nNHM \\nFramework \\nfor \\nimplementation, \\nhttp://nhm.gov.in/images/pdf/NHM/NHM_Framework_for_Implementation__08-01-2014_.pdf \\n40\\n Chapter \\n5.3, \\nNHM \\nFramework \\nfor \\nimplementation, \\nhttp://nhm.gov.in/images/pdf/NHM/NHM_Framework_for_Implementation__08-01-2014_.pdf \\n41\\n  \\nSection \\n5.3; \\nAvailable \\nfrom \\nhttp://nhm.gov.in/nhm/nrhm/guidelines/nrhm-'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 54, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Framework \\nfor \\nimplementation, \\nhttp://nhm.gov.in/images/pdf/NHM/NHM_Framework_for_Implementation__08-01-2014_.pdf \\n41\\n  \\nSection \\n5.3; \\nAvailable \\nfrom \\nhttp://nhm.gov.in/nhm/nrhm/guidelines/nrhm-\\nguidelines/constitution-of-rogi-kalyan-samities.html \\n42 Source: http://www.pbnrhm.org/docs/untied_funds.pdf \\n43 Source: http://www.pbnrhm.org/docs/untied_funds.pdf \\n44 Refer Section 2.08, Operating Manual for Preparation and Monitoring of State Programme \\nImplementation Plan (PIP), October 2013; \\nhttp://nhm.gov.in/images/pdf/NHM/PIP_Guidelines%20_2016-17_draft_17th_Nov.pdf \\n45 Refer communicated vide letter no. 7 (139)/2015-NRHM I dated 16th November 2015 \\n46    Section IV, point B, Available from http://nhm.gov.in/images/pdf/about-nrhm/nrhm-\\nframework-implementation/nrhm-framework-latest.pdf \\n47\\n  \\nCapacity \\nBuilding, \\nAvailable \\nfrom \\nhttp://nhm.gov.in/images/pdf/guidelines/nrhm-\\nguidelines/distt_health_action_plan.pdf'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 54, 'source_type': 'Authorotative', 'priority': '1'}, page_content='framework-implementation/nrhm-framework-latest.pdf \\n47\\n  \\nCapacity \\nBuilding, \\nAvailable \\nfrom \\nhttp://nhm.gov.in/images/pdf/guidelines/nrhm-\\nguidelines/distt_health_action_plan.pdf \\n48  Refer Section 4.02, Operating Manual for Preparation and Monitoring of State Programme \\nImplementation Plan (PIP), October 2013; \\nhttp://nhm.gov.in/images/pdf/NHM/PIP_Guidelines%20_2016-17_draft_17th_Nov.pdf \\n49 Chapter 5.1, http://nhm.gov.in/images/pdf/NHM/NHM_Framework_for_Implementation__08-01-\\n2014_.pdf \\n50  Section \\nVI, \\nPoint \\n85, \\nhttp://nhm.gov.in/images/pdf/about-nrhm/nrhm-framework-\\nimplementation/nrhm-framework-latest.pdf \\n51  Refer Section 4.02, Operating Manual for Preparation and Monitoring of State Programme \\nImplementation \\nPlan \\n(PIP), \\nOctober \\n2013; \\nhttp://nhm.gov.in/images/pdf/NHM/PIP_Guidelines%20_2016-17_draft_17th_Nov.pdf \\n52 Refer Section XI, Point 4, Mission Document, NRHM Guidelines. Available at \\nhttp://nhm.gov.in/images/pdf/guidelines/nrhm-guidelines/mission_document.pdf'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 54, 'source_type': 'Authorotative', 'priority': '1'}, page_content='52 Refer Section XI, Point 4, Mission Document, NRHM Guidelines. Available at \\nhttp://nhm.gov.in/images/pdf/guidelines/nrhm-guidelines/mission_document.pdf \\n53  *Refer National HealthCare Innovation Portal;  http://www.nhinp.org/index.php/best-\\npractices/best-practices-2017-indore# \\n54  Refer \\nNational \\nHealthCare \\nInnovation \\nPortal; \\n \\nhttp://www.nhinp.org/index.php/best-\\npractices/best-practices-2017-indore# \\n55   Refer https://nrhm-mis.nic.in/hmisreports/analyticalreports.aspx \\n56 Refer Section XI, Point 1 & 2, Mission Document, NRHM Guidelines. Available at \\nhttp://nhm.gov.in/images/pdf/guidelines/nrhm-guidelines/mission_document.pdf \\n57  Refer Section XI, Point 3, Mission Document, NRHM Guidelines. Available at \\nhttp://nhm.gov.in/images/pdf/guidelines/nrhm-guidelines/mission_document.pdf \\n58 Refer Section XI, Point 4, Mission Document, NRHM Guidelines. Available at \\nhttp://nhm.gov.in/images/pdf/guidelines/nrhm-guidelines/mission_document.pdf'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 54, 'source_type': 'Authorotative', 'priority': '1'}, page_content='58 Refer Section XI, Point 4, Mission Document, NRHM Guidelines. Available at \\nhttp://nhm.gov.in/images/pdf/guidelines/nrhm-guidelines/mission_document.pdf \\n59 Refer Guidelines for Community Processes 2013, http//nhsrcindia.org/ \\n60 http://pipnrhm-\\nmohfw.nic.in/index_files/high_focus_ne/nagaland/Chapter%206%20Financial%20Management.pdf \\n61         Refer https://nrhm-mis.nic.in/hmisreports/analyticalreports.aspx'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 55, 'source_type': 'Authorotative', 'priority': '1'}, page_content='56 \\n \\n                                                                                                                                                                                    \\n62  Reference Section XI, http://nhm.gov.in/images/pdf/about-nrhm/nrhm-framework-\\nimplementation/nrhm-framework-latest.pdf \\n63\\n Refer \\nSection \\n5.14, \\nNHM \\nFramework \\nfor \\nImplementation \\nhttp://nhm.gov.in/images/pdf/NHM/NHM_Framework_for_Implementation__08-01-2014_.pdf \\n64 Refer DISHA Guidelines; \\nhttp://rural.nic.in/netrural/rural/sites/downloads/Monitoring/Disha_Guidelines_English.PDF  \\n65  Refer http://nhm.gov.in/monitoring/district-level-vigilance-monitoring-committee.html \\n66\\n Refer \\nChapter \\n7, \\nNHM \\nFramework \\nfor \\nImplementation \\nhttp://nhm.gov.in/images/pdf/NHM/NHM_Framework_for_Implementation__08-01-2014_.pdf \\n67\\n (Refer \\nhttps://nrhm-mis.nic.in/Pages/HMIS-\\nPeriodicReport.aspx?RootFolder=%2FPart%20B%20Demographic%20and%20Vital%20Indicators%2FHighl'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 55, 'source_type': 'Authorotative', 'priority': '1'}, page_content='67\\n (Refer \\nhttps://nrhm-mis.nic.in/Pages/HMIS-\\nPeriodicReport.aspx?RootFolder=%2FPart%20B%20Demographic%20and%20Vital%20Indicators%2FHighl\\nights%20on%20Evaluation%20Report%20of%20RETs&FolderCTID=0x012000F14E657A4E28DE48BA36CCA\\nF7331E92D&View={FC6CFF2C-3E22-4926-9E71-52C06FABE639} \\n68  Refer: https://HMIS-PeriodicReport.aspxps://nrhm-mis.nic.in/Page \\n69 Refer https://nrhm-mis.nic.in/SitePages/Home.aspx \\n70 Refer https://nrhm-mis.nic.in/hmisreports/analyticalreports.aspx \\n71 Refer https://nrhm-mis.nic.in/hmisreports/analyticalreports.aspx,    \\nhttp://nhsrcindia.org/index.php?option=com_content&view=article&id=184&Itemid=681) \\n72 Refer http://apps.nic.in/apps/government/mother-and-child-tracking-system-mcts ,  \\nhttps://nrhm-mis.nic.in/SitePages/ManE_MCHTrackingSystem.aspx_ \\n73  Refer http://117.239.178.8/tmis/Home/Status.aspx \\n74  Refer Operational Guidelines for Quality Assurance in Public Health Facilities, 2013,'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 55, 'source_type': 'Authorotative', 'priority': '1'}, page_content='73  Refer http://117.239.178.8/tmis/Home/Status.aspx \\n74  Refer Operational Guidelines for Quality Assurance in Public Health Facilities, 2013, \\nhttp://nhm.gov.in/nrhm-components/rmnch-a/maternal-health/guidelines.html \\n75  https://www.nhp.gov.in/mobile-mera-aspataal \\n76\\n Section \\n1, \\nImplementation \\nFramework \\nfor \\nNUHM, \\nhttp://nhm.gov.in/images/pdf/NUHM/Implementation_Framework_NUHM.pdf \\n77\\n Section \\n3, \\nImplementation \\nFramework \\nfor \\nNUHM, \\n, \\nhttp://nhm.gov.in/images/pdf/NUHM/Implementation_Framework_NUHM.pdf \\n \\n78\\n Section \\n1, \\nImplementation \\nFramework \\nfor \\nNUHM, \\n, \\nhttp://nhm.gov.in/images/pdf/NUHM/Implementation_Framework_NUHM.pdf \\n79\\n Section \\n4; \\nImplementation \\nFramework \\nfor \\nNUHM, \\nhttp://nhm.gov.in/images/pdf/NUHM/Implementation_Framework_NUHM.pdf \\n80\\n Section \\n5.2.2; \\nImplementation \\nFramework \\nfor \\nNUHM, \\nhttp://nhm.gov.in/images/pdf/NUHM/Implementation_Framework_NUHM.pdf \\n81\\n Section \\n1.18 \\nImplementation \\nFramework \\nfor \\nNUHM'),\n",
       " Document(metadata={'producer': 'Foxit PhantomPDF Printer Version 6.0.4.1129', 'creator': '', 'creationdate': '2017-09-25T12:36:34+05:30', 'source': '../data/pdfs/National Health Mission.pdf', 'file_path': '../data/pdfs/National Health Mission.pdf', 'total_pages': 56, 'format': 'PDF 1.7', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2017-09-25T12:36:44+05:30', 'trapped': '', 'modDate': \"D:20170925123644+05'30'\", 'creationDate': \"D:20170925123634+05'30'\", 'page': 55, 'source_type': 'Authorotative', 'priority': '1'}, page_content='80\\n Section \\n5.2.2; \\nImplementation \\nFramework \\nfor \\nNUHM, \\nhttp://nhm.gov.in/images/pdf/NUHM/Implementation_Framework_NUHM.pdf \\n81\\n Section \\n1.18 \\nImplementation \\nFramework \\nfor \\nNUHM \\nhttp://nhm.gov.in/images/pdf/NUHM/Implementation_Framework_NUHM.pdf \\n82\\n Section \\n5, \\nImplementation \\nFramework \\nfor \\nNUHM \\nhttp://nhm.gov.in/images/pdf/NUHM/Implementation_Framework_NUHM.pdf \\n83\\n Section \\n6, \\nImplementation \\nFramework \\nfor \\nNUHM \\nhttp://nhm.gov.in/images/pdf/NUHM/Implementation_Framework_NUHM.pdf \\n84\\n Section \\n6, \\nImplementation \\nFramework \\nfor \\nNUHM \\nhttp://nhm.gov.in/images/pdf/NUHM/Implementation_Framework_NUHM.pdf \\n85 Section 5.14, http://nhm.gov.in/images/pdf/NUHM/Implementation_Framework_NUHM.pdf \\n86 Chapter 6, http://nhm.gov.in/images/pdf/NUHM/Implementation_Framework_NUHM.pdf \\n87 Refer https://nrhm-mis.nic.in/Part%20A%20HMIS/Financial%20Management%20Report%) \\n88 Refer https://nrhm-mis.nic.in/hmisreports/analyticalreports.aspx'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Table of Contents\\n1\\nFront    ................................................................................................................................................................................................................\\n1\\nCover    .......................................................................................................................................................................................................\\n2\\nFront Matter    ...........................................................................................................................................................................................\\n53\\n1 - Nutritional Disorders    ...............................................................................................................................................................\\n53'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content='53\\n1 - Nutritional Disorders    ...............................................................................................................................................................\\n53\\nChapter 1. Nutrition: General Considerations    .....................................................................................................................\\n59\\nChapter 2. Undernutrition    .............................................................................................................................................................\\n69\\nChapter 3. Nutritional Support    ...................................................................................................................................................\\n76\\nChapter 4. Vitamin Deficiency, Dependency & Toxicity    ..................................................................................................\\n99'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content='76\\nChapter 4. Vitamin Deficiency, Dependency & Toxicity    ..................................................................................................\\n99\\nChapter 5. Mineral Deficiency & Toxicity    ..............................................................................................................................\\n108\\nChapter 6. Obesity & the Metabolic Syndrome    ...............................................................................................................\\n120\\n2 - Gastrointestinal Disorders    ..............................................................................................................................................\\n120\\nChapter 7. Approach to the Patient With Upper GI Complaints    ...............................................................................\\n132\\nChapter 8. Approach to the Patient With Lower GI Complaints    ...............................................................................\\n143'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content='132\\nChapter 8. Approach to the Patient With Lower GI Complaints    ...............................................................................\\n143\\nChapter 9. Diagnostic & Therapeutic GI Procedures    ....................................................................................................\\n150\\nChapter 10. GI Bleeding    ............................................................................................................................................................\\n158\\nChapter 11. Acute Abdomen & Surgical Gastroenterology    .........................................................................................\\n172\\nChapter 12. Esophageal & Swallowing Disorders    ..........................................................................................................\\n183\\nChapter 13. Gastritis & Peptic Ulcer Disease    ..................................................................................................................\\n196'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content='183\\nChapter 13. Gastritis & Peptic Ulcer Disease    ..................................................................................................................\\n196\\nChapter 14. Bezoars & Foreign Bodies    ..............................................................................................................................\\n199\\nChapter 15. Pancreatitis    ............................................................................................................................................................\\n206\\nChapter 16. Gastroenteritis    ......................................................................................................................................................\\n213\\nChapter 17. Malabsorption Syndromes    ..............................................................................................................................\\n225'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content='213\\nChapter 17. Malabsorption Syndromes    ..............................................................................................................................\\n225\\nChapter 18. Irritable Bowel Syndrome    ................................................................................................................................\\n229\\nChapter 19. Inflammatory Bowel Disease    .........................................................................................................................\\n241\\nChapter 20. Diverticular Disease    ...........................................................................................................................................\\n246\\nChapter 21. Anorectal Disorders    ............................................................................................................................................\\n254'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content='246\\nChapter 21. Anorectal Disorders    ............................................................................................................................................\\n254\\nChapter 22. Tumors of the GI Tract    ......................................................................................................................................\\n275\\n3 - Hepatic & Biliary Disorders    ............................................................................................................................................\\n275\\nChapter 23. Approach to the Patient With Liver Disease    ...........................................................................................\\n294\\nChapter 24. Testing for Hepatic & Biliary Disorders    ......................................................................................................\\n305'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content='294\\nChapter 24. Testing for Hepatic & Biliary Disorders    ......................................................................................................\\n305\\nChapter 25. Drugs & the Liver    ................................................................................................................................................\\n308\\nChapter 26. Alcoholic Liver Disease    ....................................................................................................................................\\n314\\nChapter 27. Fibrosis & Cirrhosis    ............................................................................................................................................\\n322\\nChapter 28. Hepatitis    ..................................................................................................................................................................\\n333'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content='322\\nChapter 28. Hepatitis    ..................................................................................................................................................................\\n333\\nChapter 29. Vascular Disorders of the Liver    .....................................................................................................................\\n341\\nChapter 30. Liver Masses & Granulomas    ..........................................................................................................................\\n348\\nChapter 31. Gallbladder & Bile Duct Disorders    ...............................................................................................................\\n362\\n4 - Musculoskeletal & Connective Tissue Disorders    .........................................................................................\\n362\\nChapter 32. Approach to the Patient With Joint Disease    ............................................................................................\\n373'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content='362\\nChapter 32. Approach to the Patient With Joint Disease    ............................................................................................\\n373\\nChapter 33. Autoimmune Rheumatic Disorders    ..............................................................................................................\\n391\\nChapter 34. Vasculitis    .................................................................................................................................................................\\n416\\nChapter 35. Joint Disorders    .....................................................................................................................................................\\n435\\nChapter 36. Crystal-Induced Arthritides    ..............................................................................................................................\\n443'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"435\\nChapter 36. Crystal-Induced Arthritides    ..............................................................................................................................\\n443\\nChapter 37. Osteoporosis    .........................................................................................................................................................\\n448\\nChapter 38. Paget's Disease of Bone    ..................................................................................................................................\\n451\\nChapter 39. Osteonecrosis    .......................................................................................................................................................\\n455\\nChapter 40. Infections of Joints & Bones    ...........................................................................................................................\\n463\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content='455\\nChapter 40. Infections of Joints & Bones    ...........................................................................................................................\\n463\\nChapter 41. Bursa, Muscle & Tendon Disorders    .............................................................................................................\\n470\\nChapter 42. Neck & Back Pain    ...............................................................................................................................................\\n481\\nChapter 43. Hand Disorders    ....................................................................................................................................................'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='491\\nChapter 44. Foot & Ankle Disorders    .....................................................................................................................................\\n502\\nChapter 45. Tumors of Bones & Joints    ...............................................................................................................................\\n510\\n5 - Ear, Nose, Throat & Dental Disorders    ..................................................................................................................\\n510\\nChapter 46. Approach to the Patient With Ear Problems    ...........................................................................................\\n523\\nChapter 47. Hearing Loss    .........................................................................................................................................................\\n535'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='523\\nChapter 47. Hearing Loss    .........................................................................................................................................................\\n535\\nChapter 48. Inner Ear Disorders    ............................................................................................................................................\\n542\\nChapter 49. Middle Ear & Tympanic Membrane Disorders    ........................................................................................\\n550\\nChapter 50. External Ear Disorders    .....................................................................................................................................\\n554\\nChapter 51. Approach to the Patient With Nasal & Pharyngeal Symptoms    .......................................................\\n567\\nChapter 52. Oral & Pharyngeal Disorders    .........................................................................................................................\\n578'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='567\\nChapter 52. Oral & Pharyngeal Disorders    .........................................................................................................................\\n578\\nChapter 53. Nose & Paranasal Sinus Disorders    .............................................................................................................\\n584\\nChapter 54. Laryngeal Disorders    ...........................................................................................................................................\\n590\\nChapter 55. Tumors of the Head & Neck    ...........................................................................................................................\\n600\\nChapter 56. Approach to Dental & Oral Symptoms    .......................................................................................................\\n619'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='600\\nChapter 56. Approach to Dental & Oral Symptoms    .......................................................................................................\\n619\\nChapter 57. Common Dental Disorders    .............................................................................................................................\\n629\\nChapter 58. Dental Emergencies    ..........................................................................................................................................\\n635\\nChapter 59. Temporomandibular Disorders    ......................................................................................................................\\n641\\n6 - Eye Disorders    ............................................................................................................................................................................\\n641'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='6 - Eye Disorders    ............................................................................................................................................................................\\n641\\nChapter 60. Approach to the Ophthalmologic Patient    ..................................................................................................\\n669\\nChapter 61. Refractive Error    ...................................................................................................................................................\\n674\\nChapter 62. Eyelid & Lacrimal Disorders    ...........................................................................................................................\\n680\\nChapter 63. Conjunctival & Scleral Disorders    .................................................................................................................\\n690'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='680\\nChapter 63. Conjunctival & Scleral Disorders    .................................................................................................................\\n690\\nChapter 64. Corneal Disorders    ...............................................................................................................................................\\n703\\nChapter 65. Glaucoma    ...............................................................................................................................................................\\n710\\nChapter 66. Cataract    ...................................................................................................................................................................\\n713\\nChapter 67. Uveitis    ......................................................................................................................................................................\\n719'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='713\\nChapter 67. Uveitis    ......................................................................................................................................................................\\n719\\nChapter 68. Retinal Disorders    .................................................................................................................................................\\n731\\nChapter 69. Optic Nerve Disorders    ......................................................................................................................................\\n737\\nChapter 70. Orbital Diseases    ..................................................................................................................................................\\n742\\n7 - Dermatologic Disorders    ....................................................................................................................................................\\n742'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='742\\n7 - Dermatologic Disorders    ....................................................................................................................................................\\n742\\nChapter 71. Approach to the Dermatologic Patient    .......................................................................................................\\n755\\nChapter 72. Principles of Topical Dermatologic Therapy    ............................................................................................\\n760\\nChapter 73. Acne & Related Disorders    ...............................................................................................................................\\n766\\nChapter 74. Bullous Diseases    .................................................................................................................................................\\n771'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='766\\nChapter 74. Bullous Diseases    .................................................................................................................................................\\n771\\nChapter 75. Cornification Disorders    .....................................................................................................................................\\n775\\nChapter 76. Dermatitis    ...............................................................................................................................................................\\n786\\nChapter 77. Reactions to Sunlight    ........................................................................................................................................\\n791\\nChapter 78. Psoriasis & Scaling Diseases    ........................................................................................................................\\n799'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='791\\nChapter 78. Psoriasis & Scaling Diseases    ........................................................................................................................\\n799\\nChapter 79. Hypersensitivity & Inflammatory Disorders    .............................................................................................\\n808\\nChapter 80. Sweating Disorders    ............................................................................................................................................\\n811\\nChapter 81. Bacterial Skin Infections    ...................................................................................................................................\\n822\\nChapter 82. Fungal Skin Infections    ......................................................................................................................................\\n831'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='822\\nChapter 82. Fungal Skin Infections    ......................................................................................................................................\\n831\\nChapter 83. Parasitic Skin Infections    ...................................................................................................................................\\n836\\nChapter 84. Viral Skin Diseases    ............................................................................................................................................\\n841\\nChapter 85. Pigmentation Disorders    ....................................................................................................................................\\n846\\nChapter 86. Hair Disorders    .......................................................................................................................................................\\n855'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='846\\nChapter 86. Hair Disorders    .......................................................................................................................................................\\n855\\nChapter 87. Nail Disorders    .......................................................................................................................................................\\n861\\nChapter 88. Pressure Ulcers    ...................................................................................................................................................\\n867\\nChapter 89. Benign Tumors    .....................................................................................................................................................\\n874\\nChapter 90. Cancers of the Skin    ............................................................................................................................................\\n882'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='874\\nChapter 90. Cancers of the Skin    ............................................................................................................................................\\n882\\n8 - Endocrine & Metabolic Disorders    .............................................................................................................................\\n882\\nChapter 91. Principles of Endocrinology    ............................................................................................................................\\n887\\nChapter 92. Pituitary Disorders    ..............................................................................................................................................\\n901\\nChapter 93. Thyroid Disorders    ................................................................................................................................................'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='921\\nChapter 94. Adrenal Disorders    ................................................................................................................................................\\n936\\nChapter 95. Polyglandular Deficiency Syndromes    ........................................................................................................\\n939\\nChapter 96. Porphyrias    ..............................................................................................................................................................\\n949\\nChapter 97. Fluid & Electrolyte Metabolism    .....................................................................................................................\\n987\\nChapter 98. Acid-Base Regulation & Disorders    ..............................................................................................................\\n1001\\nChapter 99. Diabetes Mellitus & Disorders of Carbohydrate Metabolism    ........................................................\\n1024'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1001\\nChapter 99. Diabetes Mellitus & Disorders of Carbohydrate Metabolism    ........................................................\\n1024\\nChapter 100. Lipid Disorders    ................................................................................................................................................\\n1034\\nChapter 101. Amyloidosis    ......................................................................................................................................................\\n1037\\nChapter 102. Carcinoid Tumors    ..........................................................................................................................................\\n1040\\nChapter 103. Multiple Endocrine Neoplasia Syndromes    .........................................................................................\\n1046'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1040\\nChapter 103. Multiple Endocrine Neoplasia Syndromes    .........................................................................................\\n1046\\n9 - Hematology & Oncology    ...............................................................................................................................................\\n1046\\nChapter 104. Approach to the Patient With Anemia    ..................................................................................................\\n1050\\nChapter 105. Anemias Caused by Deficient Erythropoiesis    ...................................................................................\\n1061\\nChapter 106. Anemias Caused by Hemolysis    ...............................................................................................................\\n1078\\nChapter 107. Neutropenia & Lymphocytopenia    ...........................................................................................................\\n1086'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1078\\nChapter 107. Neutropenia & Lymphocytopenia    ...........................................................................................................\\n1086\\nChapter 108. Thrombocytopenia & Platelet Dysfunction    .........................................................................................\\n1097\\nChapter 109. Hemostasis    ......................................................................................................................................................\\n1104\\nChapter 110. Thrombotic Disorders    ...................................................................................................................................\\n1107\\nChapter 111. Coagulation Disorders    ..................................................................................................................................\\n1113\\nChapter 112. Bleeding Due to Abnormal Blood Vessels    ...........................................................................................\\n1116'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1113\\nChapter 112. Bleeding Due to Abnormal Blood Vessels    ...........................................................................................\\n1116\\nChapter 113. Spleen Disorders    ............................................................................................................................................\\n1120\\nChapter 114. Eosinophilic Disorders    .................................................................................................................................\\n1126\\nChapter 115. Histiocytic Syndromes    .................................................................................................................................\\n1131\\nChapter 116. Myeloproliferative Disorders    .....................................................................................................................\\n1141'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1131\\nChapter 116. Myeloproliferative Disorders    .....................................................................................................................\\n1141\\nChapter 117. Leukemias    .........................................................................................................................................................\\n1154\\nChapter 118. Lymphomas    ......................................................................................................................................................\\n1164\\nChapter 119. Plasma Cell Disorders    .................................................................................................................................\\n1172\\nChapter 120. Iron Overload    ...................................................................................................................................................\\n1177'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1172\\nChapter 120. Iron Overload    ...................................................................................................................................................\\n1177\\nChapter 121. Transfusion Medicine    ...................................................................................................................................\\n1186\\nChapter 122. Overview of Cancer    ......................................................................................................................................\\n1198\\nChapter 123. Tumor Immunology    .......................................................................................................................................\\n1204\\nChapter 124. Principles of Cancer Therapy    ...................................................................................................................\\n1215'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1204\\nChapter 124. Principles of Cancer Therapy    ...................................................................................................................\\n1215\\n10 - Immunology; Allergic Disorders    ...........................................................................................................................\\n1215\\nChapter 125. Biology of the Immune System    ...............................................................................................................\\n1227\\nChapter 126. Immunodeficiency Disorders    ....................................................................................................................\\n1243\\nChapter 127. Allergic & Other Hypersensitivity Disorders    .......................................................................................\\n1263\\nChapter 128. Transplantation    ...............................................................................................................................................\\n1281'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1263\\nChapter 128. Transplantation    ...............................................................................................................................................\\n1281\\n11 - Infectious Diseases    ........................................................................................................................................................\\n1281\\nChapter 129. Biology of Infectious Disease    ...................................................................................................................\\n1300\\nChapter 130. Laboratory Diagnosis of Infectious Disease    ......................................................................................\\n1306\\nChapter 131. Immunization    ...................................................................................................................................................\\n1313'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1306\\nChapter 131. Immunization    ...................................................................................................................................................\\n1313\\nChapter 132. Bacteria & Antibacterial Drugs    .................................................................................................................\\n1353\\nChapter 133. Gram-Positive Cocci    ....................................................................................................................................\\n1366\\nChapter 134. Gram-Positive Bacilli    ...................................................................................................................................\\n1376\\nChapter 135. Gram-Negative Bacilli    .................................................................................................................................\\n1405'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1376\\nChapter 135. Gram-Negative Bacilli    .................................................................................................................................\\n1405\\nChapter 136. Spirochetes    ......................................................................................................................................................\\n1413\\nChapter 137. Neisseriaceae    .................................................................................................................................................\\n1419\\nChapter 138. Chlamydia & Mycoplasmas    ......................................................................................................................\\n1421\\nChapter 139. Rickettsiae & Related Organisms    ..........................................................................................................\\n1431'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1421\\nChapter 139. Rickettsiae & Related Organisms    ..........................................................................................................\\n1431\\nChapter 140. Anaerobic Bacteria    ........................................................................................................................................\\n1450\\nChapter 141. Mycobacteria    ...................................................................................................................................................\\n1470\\nChapter 142. Fungi    ...................................................................................................................................................................\\n1493\\nChapter 143. Approach to Parasitic Infections    .............................................................................................................\\n1496'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1493\\nChapter 143. Approach to Parasitic Infections    .............................................................................................................\\n1496\\nChapter 144. Nematodes (Roundworms)    .......................................................................................................................'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1513\\nChapter 145. Trematodes (Flukes)    ....................................................................................................................................\\n1520\\nChapter 146. Cestodes (Tapeworms)    ...............................................................................................................................\\n1527\\nChapter 147. Intestinal Protozoa    ........................................................................................................................................\\n1536\\nChapter 148. Extraintestinal Protozoa    .............................................................................................................................\\n1555\\nChapter 149. Viruses    ...............................................................................................................................................................\\n1559'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1555\\nChapter 149. Viruses    ...............................................................................................................................................................\\n1559\\nChapter 150. Respiratory Viruses    ......................................................................................................................................\\n1571\\nChapter 151. Herpesviruses    .................................................................................................................................................\\n1584\\nChapter 152. Enteroviruses    ..................................................................................................................................................\\n1590\\nChapter 153. Arboviridae, Arenaviridae & Filoviridae    ...............................................................................................\\n1601'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1590\\nChapter 153. Arboviridae, Arenaviridae & Filoviridae    ...............................................................................................\\n1601\\nChapter 154. Human Immunodeficiency Virus    .............................................................................................................\\n1615\\nChapter 155. Other Viruses    ..................................................................................................................................................\\n1627\\nChapter 156. Sexually Transmitted Diseases    ...............................................................................................................\\n1647\\n12 - Psychiatric Disorders    ....................................................................................................................................................\\n1647\\nChapter 157. Approach to the Patient With Mental Symptoms    ............................................................................\\n1656'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1647\\nChapter 157. Approach to the Patient With Mental Symptoms    ............................................................................\\n1656\\nChapter 158. Anxiety Disorders    ..........................................................................................................................................\\n1665\\nChapter 159. Dissociative Disorders    .................................................................................................................................\\n1672\\nChapter 160. Drug Use & Dependence    ...........................................................................................................................\\n1706\\nChapter 161. Eating Disorders    ............................................................................................................................................\\n1712'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1706\\nChapter 161. Eating Disorders    ............................................................................................................................................\\n1712\\nChapter 162. Mood Disorders    ..............................................................................................................................................\\n1726\\nChapter 163. Personality Disorders    ...................................................................................................................................\\n1730\\nChapter 164. Schizophrenia & Related Disorders    ......................................................................................................\\n1740\\nChapter 165. Sexuality & Sexual Disorders    ..................................................................................................................\\n1748'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1740\\nChapter 165. Sexuality & Sexual Disorders    ..................................................................................................................\\n1748\\nChapter 166. Somatoform & Factitious Disorders    ......................................................................................................\\n1755\\nChapter 167. Suicidal Behavior    ..........................................................................................................................................\\n1759\\n13 - Neurologic Disorders    ....................................................................................................................................................\\n1759\\nChapter 168. Approach to the Neurologic Patient    .......................................................................................................\\n1779'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1759\\nChapter 168. Approach to the Neurologic Patient    .......................................................................................................\\n1779\\nChapter 169. Neurotransmission    ........................................................................................................................................\\n1783\\nChapter 170. Autonomic Nervous System    .....................................................................................................................\\n1790\\nChapter 171. Pain    .....................................................................................................................................................................\\n1803\\nChapter 172. Function & Dysfunction of the Cerebral Lobes    .................................................................................\\n1812'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1803\\nChapter 172. Function & Dysfunction of the Cerebral Lobes    .................................................................................\\n1812\\nChapter 173. Stroke    .................................................................................................................................................................\\n1825\\nChapter 174. Coma & Impaired Consciousness    ..........................................................................................................\\n1836\\nChapter 175. Delirium & Dementia    ...................................................................................................................................\\n1857\\nChapter 176. Seizure Disorders    ..........................................................................................................................................\\n1867'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1857\\nChapter 176. Seizure Disorders    ..........................................................................................................................................\\n1867\\nChapter 177. Sleep & Wakefulness Disorders    .............................................................................................................\\n1880\\nChapter 178. Headache    ..........................................................................................................................................................\\n1891\\nChapter 179. Brain Infections    ..............................................................................................................................................\\n1902\\nChapter 180. Meningitis    ..........................................................................................................................................................\\n1913'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1902\\nChapter 180. Meningitis    ..........................................................................................................................................................\\n1913\\nChapter 181. Neuro-Ophthalmologic & Cranial Nerve Disorders    ........................................................................\\n1923\\nChapter 182. Craniocervical Junction Abnormalities    .................................................................................................\\n1926\\nChapter 183. Movement & Cerebellar Disorders    ........................................................................................................\\n1943\\nChapter 184. Demyelinating Disorders    ............................................................................................................................\\n1949\\nChapter 185. Peripheral Nervous System & Motor Unit Disorders    .....................................................................\\n1973'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1949\\nChapter 185. Peripheral Nervous System & Motor Unit Disorders    .....................................................................\\n1973\\nChapter 186. Spinal Cord Disorders    .................................................................................................................................\\n1983\\nChapter 187. Intracranial & Spinal Tumors    ....................................................................................................................\\n1994\\n14 - Pulmonary Disorders    ....................................................................................................................................................\\n1994\\nChapter 188. Approach to the Patient With Pulmonary Symptoms    ....................................................................\\n2016\\nChapter 189. Tests of Pulmonary Function    ....................................................................................................................\\n2024'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2016\\nChapter 189. Tests of Pulmonary Function    ....................................................................................................................\\n2024\\nChapter 190. Diagnostic & Therapeutic Pulmonary Procedures    ..........................................................................\\n2035\\nChapter 191. Asthma    ...............................................................................................................................................................\\n2048\\nChapter 192. Chronic Obstructive Pulmonary Disease    ............................................................................................\\n2063\\nChapter 193. Sleep Apnea    ....................................................................................................................................................\\n2070'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2063\\nChapter 193. Sleep Apnea    ....................................................................................................................................................\\n2070\\nChapter 194. Pulmonary Embolism    ..................................................................................................................................\\n2079\\nChapter 195. Acute Bronchitis    .............................................................................................................................................'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2081\\nChapter 196. Pneumonia    .......................................................................................................................................................\\n2094\\nChapter 197. Lung Abscess    ..................................................................................................................................................\\n2097\\nChapter 198. Bronchiectasis    ................................................................................................................................................\\n2101\\nChapter 199. Interstitial Lung Diseases    ...........................................................................................................................\\n2122\\nChapter 200. Sarcoidosis    .......................................................................................................................................................\\n2127'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2122\\nChapter 200. Sarcoidosis    .......................................................................................................................................................\\n2127\\nChapter 201. Environmental Pulmonary Diseases    .....................................................................................................\\n2145\\nChapter 202. Pulmonary Hypertension    ............................................................................................................................\\n2150\\nChapter 203. Diffuse Alveolar Hemorrhage & Pulmonary-Renal Syndromes    ................................................\\n2156\\nChapter 204. Mediastinal & Pleural Disorders    ..............................................................................................................\\n2166\\nChapter 205. Tumors of the Lungs    ....................................................................................................................................\\n2176'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2166\\nChapter 205. Tumors of the Lungs    ....................................................................................................................................\\n2176\\n15 - Cardiovascular Disorders    .........................................................................................................................................\\n2176\\nChapter 206. Approach to the Cardiac Patient    .............................................................................................................\\n2204\\nChapter 207. Cardiovascular Tests & Procedures    ......................................................................................................\\n2221\\nChapter 208. Arterial Hypertension    ...................................................................................................................................\\n2234'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2221\\nChapter 208. Arterial Hypertension    ...................................................................................................................................\\n2234\\nChapter 209. Arteriosclerosis    ...............................................................................................................................................\\n2242\\nChapter 210. Coronary Artery Disease    ............................................................................................................................\\n2268\\nChapter 211. Heart Failure    ....................................................................................................................................................\\n2285\\nChapter 212. Cardiomyopathies    .........................................................................................................................................\\n2293'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2285\\nChapter 212. Cardiomyopathies    .........................................................................................................................................\\n2293\\nChapter 213. Arrhythmias & Conduction Disorders    ....................................................................................................\\n2318\\nChapter 214. Valvular Disorders    .........................................................................................................................................\\n2336\\nChapter 215. Endocarditis    .....................................................................................................................................................\\n2343\\nChapter 216. Pericarditis    .......................................................................................................................................................\\n2349'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2343\\nChapter 216. Pericarditis    .......................................................................................................................................................\\n2349\\nChapter 217. Diseases of the Aorta & Its Branches    ...................................................................................................\\n2360\\nChapter 218. Peripheral Arterial Disorders    ....................................................................................................................\\n2370\\nChapter 219. Peripheral Venous & Lymphatic Disorders    .........................................................................................\\n2383\\nChapter 220. Sports & the Heart    ........................................................................................................................................\\n2387'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2383\\nChapter 220. Sports & the Heart    ........................................................................................................................................\\n2387\\nChapter 221. Cardiac Tumors    ..............................................................................................................................................\\n2391\\n16 - Critical Care Medicine    .................................................................................................................................................\\n2391\\nChapter 222. Approach to the Critically Ill Patient    ......................................................................................................\\n2401\\nChapter 223. Cardiac Arrest    .................................................................................................................................................\\n2411'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2401\\nChapter 223. Cardiac Arrest    .................................................................................................................................................\\n2411\\nChapter 224. Respiratory Arrest    ..........................................................................................................................................\\n2422\\nChapter 225. Respiratory Failure & Mechanical Ventilation    ...................................................................................\\n2436\\nChapter 226. Shock & Fluid Resuscitation    .....................................................................................................................\\n2444\\nChapter 227. Sepsis & Septic Shock    ................................................................................................................................\\n2448'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2444\\nChapter 227. Sepsis & Septic Shock    ................................................................................................................................\\n2448\\n17 - Genitourinary Disorders    .............................................................................................................................................\\n2448\\nChapter 228. Approach to the Genitourinary Patient    .................................................................................................\\n2484\\nChapter 229. Male Reproductive Endocrinology    .........................................................................................................\\n2495\\nChapter 230. Voiding Disorders    ..........................................................................................................................................\\n2506'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2495\\nChapter 230. Voiding Disorders    ..........................................................................................................................................\\n2506\\nChapter 231. Obstructive Uropathy    ...................................................................................................................................\\n2510\\nChapter 232. Urinary Calculi    ................................................................................................................................................\\n2514\\nChapter 233. Urinary Tract Infections    ...............................................................................................................................\\n2525\\nChapter 234. Cystic Kidney Disease    ................................................................................................................................\\n2531'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2525\\nChapter 234. Cystic Kidney Disease    ................................................................................................................................\\n2531\\nChapter 235. Glomerular Disorders    ..................................................................................................................................\\n2558\\nChapter 236. Tubulointerstitial Diseases    .........................................................................................................................\\n2571\\nChapter 237. Renal Transport Abnormalities    ................................................................................................................\\n2580\\nChapter 238. Renovascular Disorders    .............................................................................................................................\\n2589'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2580\\nChapter 238. Renovascular Disorders    .............................................................................................................................\\n2589\\nChapter 239. Renal Failure    ...................................................................................................................................................\\n2600\\nChapter 240. Renal Replacement Therapy    ...................................................................................................................\\n2606\\nChapter 241. Penile & Scrotal Disorders    ........................................................................................................................\\n2612\\nChapter 242. Benign Prostate Disease    ............................................................................................................................\\n2618'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2612\\nChapter 242. Benign Prostate Disease    ............................................................................................................................\\n2618\\nChapter 243. Genitourinary Cancer    ..................................................................................................................................\\n2632\\n18 - Gynecology & Obstetrics    ...........................................................................................................................................\\n2632\\nChapter 244. Approach to the Gynecologic Patient    ...................................................................................................\\n2646\\nChapter 245. Female Reproductive Endocrinology    ...................................................................................................'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2649\\nChapter 246. Menstrual Abnormalities    .............................................................................................................................\\n2665\\nChapter 247. Menopause    .......................................................................................................................................................\\n2668\\nChapter 248. Sexual Dysfunction in Women    ................................................................................................................\\n2678\\nChapter 249. Pelvic Relaxation Syndromes    ..................................................................................................................\\n2681\\nChapter 250. Benign Gynecologic Lesions    ....................................................................................................................\\n2688'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2681\\nChapter 250. Benign Gynecologic Lesions    ....................................................................................................................\\n2688\\nChapter 251. Uterine Fibroids    ..............................................................................................................................................\\n2691\\nChapter 252. Endometriosis    .................................................................................................................................................\\n2694\\nChapter 253. Vaginitis & Pelvic Inflammatory Disease    ............................................................................................\\n2702\\nChapter 254. Medical Examination of the Rape Victim    ............................................................................................\\n2706'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2702\\nChapter 254. Medical Examination of the Rape Victim    ............................................................................................\\n2706\\nChapter 255. Breast Disorders    ............................................................................................................................................\\n2721\\nChapter 256. Gynecologic Tumors    ....................................................................................................................................\\n2738\\nChapter 257. Family Planning    .............................................................................................................................................\\n2747\\nChapter 258. Infertility    .............................................................................................................................................................\\n2755'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2747\\nChapter 258. Infertility    .............................................................................................................................................................\\n2755\\nChapter 259. Prenatal Genetic Counseling & Evaluation    ........................................................................................\\n2763\\nChapter 260. Conception & Prenatal Development    ...................................................................................................\\n2764\\nChapter 261. Approach to the Pregnant Woman & Prenatal Care    ......................................................................\\n2781\\nChapter 262. Normal Pregnancy, Labor & Delivery    ...................................................................................................\\n2793\\nChapter 263. Pregnancy Complicated by Disease    .....................................................................................................\\n2812'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2793\\nChapter 263. Pregnancy Complicated by Disease    .....................................................................................................\\n2812\\nChapter 264. High-Risk Pregnancy    ...................................................................................................................................\\n2817\\nChapter 265. Abnormalities of Pregnancy    ......................................................................................................................\\n2842\\nChapter 266. Abnormalities & Complications of Labor & Delivery    ......................................................................\\n2854\\nChapter 267. Postpartum Care    ...........................................................................................................................................\\n2862'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2854\\nChapter 267. Postpartum Care    ...........................................................................................................................................\\n2862\\n19 - Pediatrics    ................................................................................................................................................................................\\n2862\\nChapter 268. Approach to the Care of Normal Infants & Children    .......................................................................\\n2898\\nChapter 269. Approach to the Care of Adolescents    ...................................................................................................\\n2901\\nChapter 270. Caring for Sick Children & Their Families    ..........................................................................................\\n2904\\nChapter 271. Physical Growth & Development    ............................................................................................................\\n2908'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2904\\nChapter 271. Physical Growth & Development    ............................................................................................................\\n2908\\nChapter 272. Principles of Drug Treatment in Children    ............................................................................................\\n2912\\nChapter 273. Perinatal Physiology    ....................................................................................................................................\\n2916\\nChapter 274. Perinatal Problems    .......................................................................................................................................\\n2929\\nChapter 275. Perinatal Hematologic Disorders    ............................................................................................................\\n2936\\nChapter 276. Metabolic, Electrolyte & Toxic Disorders in Neonates    ...................................................................\\n2950'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2936\\nChapter 276. Metabolic, Electrolyte & Toxic Disorders in Neonates    ...................................................................\\n2950\\nChapter 277. Gastrointestinal Disorders in Neonates & Infants    ...........................................................................\\n2958\\nChapter 278. Dehydration & Fluid Therapy    ...................................................................................................................\\n2962\\nChapter 279. Infections in Neonates    .................................................................................................................................\\n2990\\nChapter 280. Miscellaneous Infections in Infants & Children    ................................................................................\\n2996\\nChapter 281. Human Immunodeficiency Virus Infection in Infants & Children    ..............................................\\n3005'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2996\\nChapter 281. Human Immunodeficiency Virus Infection in Infants & Children    ..............................................\\n3005\\nChapter 282. Rheumatic Fever    ...........................................................................................................................................\\n3010\\nChapter 283. Respiratory Disorders in Neonates, Infants & Young Children    ..................................................\\n3031\\nChapter 284. Cystic Fibrosis    ................................................................................................................................................\\n3038\\nChapter 285. Endocrine Disorders in Children    .............................................................................................................\\n3051\\nChapter 286. Neurologic Disorders in Children    ............................................................................................................\\n3060'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3051\\nChapter 286. Neurologic Disorders in Children    ............................................................................................................\\n3060\\nChapter 287. Neurocutaneous Syndromes    ....................................................................................................................\\n3065\\nChapter 288. Bone & Connective Tissue Disorders in Children    ...........................................................................\\n3078\\nChapter 289. Eye Defects & Conditions in Children    ..................................................................................................\\n3083\\nChapter 290. Incontinence in Children    .............................................................................................................................\\n3089\\nChapter 291. Miscellaneous Disorders in Infants & Children    .................................................................................\\n3101'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3089\\nChapter 291. Miscellaneous Disorders in Infants & Children    .................................................................................\\n3101\\nChapter 292. Pediatric Cancers    ..........................................................................................................................................\\n3110\\nChapter 293. Congenital Cardiovascular Anomalies    ..................................................................................................\\n3135\\nChapter 294. Congenital Craniofacial & Musculoskeletal Abnormalities    ..........................................................\\n3143\\nChapter 295. Congenital Gastrointestinal Anomalies    ................................................................................................\\n3151\\nChapter 296. Congenital Renal & Genitourinary Anomalies    ..................................................................................\\n3160'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3151\\nChapter 296. Congenital Renal & Genitourinary Anomalies    ..................................................................................\\n3160\\nChapter 297. Congenital Renal Transport Abnormalities    .........................................................................................\\n3165\\nChapter 298. Congenital Neurologic Anomalies    ..........................................................................................................'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3172\\nChapter 299. Chromosomal Anomalies    ...........................................................................................................................\\n3182\\nChapter 300. Inherited Muscular Disorders    ...................................................................................................................\\n3187\\nChapter 301. Inherited Disorders of Metabolism    .........................................................................................................\\n3209\\nChapter 302. Hereditary Periodic Fever Syndromes    .................................................................................................\\n3214\\nChapter 303. Behavioral Concerns & Problems in Children    ..................................................................................\\n3222\\nChapter 304. Learning & Developmental Disorders    ..................................................................................................\\n3237'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3222\\nChapter 304. Learning & Developmental Disorders    ..................................................................................................\\n3237\\nChapter 305. Mental Disorders in Children & Adolescents    .....................................................................................\\n3255\\nChapter 306. Child Maltreatment    .......................................................................................................................................\\n3262\\n20 - Geriatrics    ................................................................................................................................................................................\\n3262\\nChapter 307. Approach to the Geriatric Patient    ...........................................................................................................\\n3280'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3262\\nChapter 307. Approach to the Geriatric Patient    ...........................................................................................................\\n3280\\nChapter 308. Drug Therapy in the Elderly    ......................................................................................................................\\n3290\\nChapter 309. Prevention of Disease & Disability in the Elderly    ............................................................................\\n3295\\nChapter 310. Quality of Life & Therapeutic Objectives    ............................................................................................\\n3297\\nChapter 311. Provision of Care    ...........................................................................................................................................\\n3312\\nChapter 312. Gait Disorders in the Elderly    ....................................................................................................................\\n3318'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3312\\nChapter 312. Gait Disorders in the Elderly    ....................................................................................................................\\n3318\\nChapter 313. Falls in the Elderly    ........................................................................................................................................\\n3322\\nChapter 314. Social Issues in the Elderly    .......................................................................................................................\\n3333\\nChapter 315. The Older Driver    ............................................................................................................................................\\n3339\\nChapter 316. Funding Health Care for the Elderly    .....................................................................................................\\n3348'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3339\\nChapter 316. Funding Health Care for the Elderly    .....................................................................................................\\n3348\\n21 - Clinical Pharmacology    .................................................................................................................................................\\n3348\\nChapter 317. Concepts in Pharmacotherapy    ................................................................................................................\\n3354\\nChapter 318. Pharmacokinetics    ..........................................................................................................................................\\n3362\\nChapter 319. Pharmacodynamics    ......................................................................................................................................\\n3365'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3362\\nChapter 319. Pharmacodynamics    ......................................................................................................................................\\n3365\\nChapter 320. Adverse Drug Reactions    .............................................................................................................................\\n3367\\n22 - Injuries; Poisoning    ...........................................................................................................................................................\\n3367\\nChapter 321. Approach to the Trauma Patient    .............................................................................................................\\n3371\\nChapter 322. Lacerations    .......................................................................................................................................................\\n3379'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3371\\nChapter 322. Lacerations    .......................................................................................................................................................\\n3379\\nChapter 323. Fractures, Dislocations & Sprains    ..........................................................................................................\\n3395\\nChapter 324. Traumatic Brain Injury    .................................................................................................................................\\n3404\\nChapter 325. Spinal Trauma    ................................................................................................................................................\\n3409\\nChapter 326. Facial Trauma    .................................................................................................................................................\\n3413'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3409\\nChapter 326. Facial Trauma    .................................................................................................................................................\\n3413\\nChapter 327. Eye Injuries    ......................................................................................................................................................\\n3418\\nChapter 328. Genitourinary Tract Trauma    ......................................................................................................................\\n3423\\nChapter 329. Burns    ...................................................................................................................................................................\\n3430\\nChapter 330. Electrical & Lightning Injuries    ..................................................................................................................\\n3435'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3430\\nChapter 330. Electrical & Lightning Injuries    ..................................................................................................................\\n3435\\nChapter 331. Radiation Exposure & Contamination    ..................................................................................................\\n3445\\nChapter 332. Heat Illness    ......................................................................................................................................................\\n3455\\nChapter 333. Cold Injury    ........................................................................................................................................................\\n3460\\nChapter 334. Altitude Sickness    ...........................................................................................................................................\\n3464'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3460\\nChapter 334. Altitude Sickness    ...........................................................................................................................................\\n3464\\nChapter 335. Motion Sickness    .............................................................................................................................................\\n3467\\nChapter 336. Drowning    ...........................................................................................................................................................\\n3471\\nChapter 337. Injury During Diving or Work in Compressed Air    .............................................................................\\n3483\\nChapter 338. Exercise & Sports Injury    .............................................................................................................................\\n3504'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3483\\nChapter 338. Exercise & Sports Injury    .............................................................................................................................\\n3504\\nChapter 339. Bites & Stings    ..................................................................................................................................................\\n3524\\nChapter 340. Poisoning    ..........................................................................................................................................................\\n3547\\n23 - Special Subjects    ...............................................................................................................................................................\\n3547\\nChapter 341. General Principles of Medical Genetics    ..............................................................................................\\n3557'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3547\\nChapter 341. General Principles of Medical Genetics    ..............................................................................................\\n3557\\nChapter 342. Clinical Decision Making    ............................................................................................................................\\n3573\\nChapter 343. Principles of Radiologic Imaging    ............................................................................................................\\n3584\\nChapter 344. Complementary & Alternative Medicine    ..............................................................................................\\n3594\\nChapter 345. Dietary Supplements    ...................................................................................................................................\\n3605\\nChapter 346. Smoking Cessation    .......................................................................................................................................\\n3610'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3605\\nChapter 346. Smoking Cessation    .......................................................................................................................................\\n3610\\nChapter 347. Medical Aspects of Travel    ..........................................................................................................................\\n3615\\nChapter 348. Syndromes of Uncertain Origin    ...............................................................................................................'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 8, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3619\\nChapter 349. Care of the Surgical Patient    .....................................................................................................................\\n3625\\nChapter 350. Rehabilitation    ..................................................................................................................................................\\n3640\\nChapter 351. Medicolegal Issues    .......................................................................................................................................\\n3647\\nChapter 352. Financial Issues in Health Care    ..............................................................................................................\\n3655\\nChapter 353. The Dying Patient    ..........................................................................................................................................\\n3664'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 8, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3655\\nChapter 353. The Dying Patient    ..........................................................................................................................................\\n3664\\nAppendixes    .......................................................................................................................................................................................\\n3664\\nI: Ready Reference Guides    ...................................................................................................................................................\\n3667\\nII: Normal Laboratory Values    ................................................................................................................................................\\n3668\\nIII: Trade Names of Some Commonly Used Drugs    ....................................................................................................\\n3695'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 8, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3668\\nIII: Trade Names of Some Commonly Used Drugs    ....................................................................................................\\n3695\\nIndex    ......................................................................................................................................................................................................\\n3695\\nNote    .................................................................................................................................................................................................\\n3696\\nA    ........................................................................................................................................................................................................\\n3738\\nB    ........................................................................................................................................................................................................'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 8, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3758\\nC    .......................................................................................................................................................................................................\\n3798\\nD    .......................................................................................................................................................................................................\\n3819\\nE    ........................................................................................................................................................................................................\\n3838\\nF    ........................................................................................................................................................................................................\\n3852'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 8, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3852\\nG    .......................................................................................................................................................................................................\\n3866\\nH    .......................................................................................................................................................................................................\\n3894\\nI    .........................................................................................................................................................................................................\\n3909\\nJ    ........................................................................................................................................................................................................\\n3911'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 8, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3911\\nK    ........................................................................................................................................................................................................\\n3916\\nL    ........................................................................................................................................................................................................\\n3932\\nM    .......................................................................................................................................................................................................\\n3954\\nN    .......................................................................................................................................................................................................\\n3968'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 8, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3968\\nO    .......................................................................................................................................................................................................\\n3977\\nP    ........................................................................................................................................................................................................\\n4017\\nQ    .......................................................................................................................................................................................................\\n4018\\nR    .......................................................................................................................................................................................................\\n4032'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 8, 'source_type': 'Authorotative', 'priority': '1'}, page_content='4032\\nS    ........................................................................................................................................................................................................\\n4061\\nT    ........................................................................................................................................................................................................\\n4081\\nU    .......................................................................................................................................................................................................\\n4087\\nV    ........................................................................................................................................................................................................\\n4098'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 8, 'source_type': 'Authorotative', 'priority': '1'}, page_content='4098\\nW    ......................................................................................................................................................................................................\\n4102\\nX    ........................................................................................................................................................................................................\\n4103\\nY    ........................................................................................................................................................................................................\\n4104\\nZ    ........................................................................................................................................................................................................'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 9, 'source_type': 'Authorotative', 'priority': '1'}, page_content='The Merck Manual of Diagnosis & Therapy, 19th Edition\\nCover\\n1'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 10, 'source_type': 'Authorotative', 'priority': '1'}, page_content='THE MERCK MANUAL OF DIAGNOSIS AND THERAPY - 19th Ed. (2011)\\nFront Matter\\nTitle Page\\nThe Merck Manual Of Diagnosis and Therapy, Nineteenth Edition\\nRobert S. Porter MD, Editor-in-Chief\\nJustin L. Kaplan MD, Senior Assistant Editor\\nEditorial Board\\nRichard K. Albert MD\\nMarjorie A. Bowman MD, MPA\\nGlenn D. Braunstein MD\\nSidney Cohen MD\\nLinda Emanuel PhD\\nJan Fawcett MD\\nEugene P. Frenkel MD\\nSusan L. Hendrix DO\\nMichael Jacewicz MD\\nMatthew E. Levison MD\\nJames Jeffrey Malatack MD\\nBrian F. Mandell MD, PhD\\nGerald L. Mandell MD\\nJudith S. Palfrey MD\\nAlbert A. Rundio Jr., PhD\\nDavid A. Spain MD\\nPaul H. Tanser MD\\nMichael R. Wasserman MD\\nMerck Sharp & Dohme Corp., A Subsidiary of Merck & Co., Inc.\\nWhitehouse Station, NJ\\n2011\\nCopyright Page\\nEditorial and Production Staff\\nExecutive Editor: Keryn A.G. Lane\\nSenior Staff Writers : Susan T. Schindler\\n                                  Susan C. Short\\nStaff Editor : Michelle A. Steigerwald\\nSenior Operations Manager : Diane C. Zenker'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 10, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Senior Staff Writers : Susan T. Schindler\\n                                  Susan C. Short\\nStaff Editor : Michelle A. Steigerwald\\nSenior Operations Manager : Diane C. Zenker\\nSenior Project Manager : Diane Cosner Gartenmayer\\nManager, Electronic Publications: Michael A. DeFerrari\\nExecutive Assistant: Jean Perry\\nDesigner: Alisha Webber\\nIllustrators: Christopher C. Butts\\n                    Michael Reingold\\nIndexers: Keryn A.G. Lane\\n                Susan Thomas, PhD\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n2'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 11, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Publisher: Gary Zelko\\nAdvertising and Promotions Supervisor : Pamela J. Barnes-Paul\\nSubsidiary Rights Coordinator : Jeanne Nilsen\\nSystems Administrator : Leta S. Bracy\\nManufacturing books in the USA ensures compliance with strict environmental laws and eliminates the\\nneed for international freight shipping, a major contributor to global air pollution. Printing on recycled\\npaper helps minimize consumption of trees, water, and fossil fuels. The 19th Edition of The Merck\\nManual uses paper with 10% post-consumer waste. According to Environmental Defense's Paper\\nCalculator, the following environmental benefits were achieved:\\nTrees Saved: 609 • Air Emissions Eliminated: 57,930 pounds • Water Saved: 279,000 gallons • Solid\\nWaste Eliminated: 16,939 pounds\\n  \\n \\n \\n \\n \\nPlanet Friendly Publishing\\n√ Made in the United States\\n√ Printed on Recycled Paper Text: 10%\\nLearn more: www.greenedition.org\\n \\nLibrary of Congress Catalog Card Number   1-31760\\nISBN (13 digit) 978-0-911910-19-3\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 11, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"√ Made in the United States\\n√ Printed on Recycled Paper Text: 10%\\nLearn more: www.greenedition.org\\n \\nLibrary of Congress Catalog Card Number   1-31760\\nISBN (13 digit) 978-0-911910-19-3\\nISBN (10 digit) 0-911910-19-0\\nISSN 0076-6526\\nCopyright © 2011 by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co, Inc.\\nAll rights reserved. No part of this book may be reproduced or used in any form or by any means,\\nelectronic or mechanical, including photocopying, or by any information storage and retrieval system,\\nwithout permission in writing from the Publisher. Inquiries should be addressed to The Merck Manuals\\nDepartment, P.O. Box 4, Merck & Co., Inc., West Point, PA 19486.\\nPrinted in the USA.\\nForeign Language Editions of The Merck Manual\\nArabic—Larike Publications Services, Cyprus\\nChinese—People's Medical Publishing House, Beijing\\nCroatian—Placebo, Split\\nCzech—Egem, Prague\\nFrench—Editions d'Apres, Paris\\nGerman—Elsevier, Ltd., Munich\\nGreek—Medical & Scientific Publishing, Athens\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 11, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Croatian—Placebo, Split\\nCzech—Egem, Prague\\nFrench—Editions d'Apres, Paris\\nGerman—Elsevier, Ltd., Munich\\nGreek—Medical & Scientific Publishing, Athens\\nHungarian—Melania, Budapest\\nItalian—Springer-Verlag Italia Srl (Medicom), Milan\\nJapanese—Nikkei Business Publications, Tokyo\\nKorean—Hanwoori Publishing Co., Seoul\\nPolish—Elsevier, Ltd, Wroclaw\\nPortuguese—Editora Roca Ltda, Sao Paolo\\nRomanian—All Publishers, Bucharest\\nRussian—Geotar-Media Publishing Group, Moscow\\nSpanish—Elsevier Espana, S.A., Madrid\\nTurkish—Yuce, Istanbul\\nOther Merck Books\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n3\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 12, 'source_type': 'Authorotative', 'priority': '1'}, page_content='The MERCK Manual\\n1st Edition - 1899\\n2nd Edition - 1901\\n3rd Edition - 1905\\n4th Edition - 1911\\n5th Edition - 1923\\n6th Edition - 1934\\n7th Edition - 1940\\n8th Edition - 1950\\n9th Edition - 1956\\n10th Edition - 1961\\n11th Edition - 1966\\n12th Edition - 1972\\n13th Edition - 1977\\n14th Edition - 1982\\n15th Edition - 1987\\n16th Edition - 1992\\n17th Edition - 1999\\n18th Edition - 2006\\n19th Edition - 2011\\nTHE MERCK INDEX\\nFirst Edition, 1889\\nTHE MERCK VETERINARY MANUAL\\nFirst Edition, 1955\\nTHE MERCK MANUAL OF GERIATRICS\\nFirst Edition, 1990\\nTHE MERCK MANUAL OF MEDICAL INFORMATION—HOME EDITION\\nFirst Edition, 1997\\nTHE MERCK MANUAL OF HEALTH & AGING\\nFirst Edition, 2004\\nTHE MERCK/MERIAL MANUAL FOR PET HEALTH\\nFirst Edition, 2007\\nTHE MERCK MANUAL OF PATIENT SYMPTOMS\\nFirst Edition, 2008\\nMerck books are published on a nonprofit basis as a service to the scientific community and the public.\\nPreface\\nAt the beginning of the 2nd decade of the 21st century, the amount of information available to health care'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 12, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Preface\\nAt the beginning of the 2nd decade of the 21st century, the amount of information available to health care\\npractitioners is immense. Medical websites and journals send daily messages announcing results of the\\nlatest studies. Within minutes, subspecialty data heretofore found only in university libraries can be\\nunearthed, along with a vast array of information from academics, commercial organizations, advocacy\\ngroups, the government, and seemingly anyone with a computer and an internet connection.\\nWhat is the role of a general reference work such as The Merck Manual when seemingly the entire body\\nof medical knowledge is at one's fingertips electronically? With such a vast body of knowledge available,\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n4\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 13, 'source_type': 'Authorotative', 'priority': '1'}, page_content='finding a good starting place can be difficult. The Manual has always been intended as the first stop on\\nthe road to understanding for readers encountering a topic for the first time or for the first time in a long\\ntime. After digesting a Merck Manual topic, readers will be well prepared to understand and evaluate the\\nwealth of more detailed information available elsewhere.\\nAs it has for over 110 years, The Merck Manual focuses on discussions of specific disorders, organized\\nby organ system or medical specialty. In its structured introductions to medical disorders, The Manual\\nprovides health care practitioners and students with straightforward, practical explanations of \"what to do\"\\nto diagnose and treat those conditions. We discuss when to suspect a disease, the proper sequence of\\nevaluation, and the first-line options for treatment along with selected alternatives. In addition, we provide\\nenough background information on etiology and pathophysiology to ensure comprehension of the'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 13, 'source_type': 'Authorotative', 'priority': '1'}, page_content='enough background information on etiology and pathophysiology to ensure comprehension of the\\nmanagement recommendations.\\nThe Manual continues to enhance its accessibility. In addition to having introductory \"nut-shells\" at the\\nbeginning of each disease discussion, we have included bulleted lists in the text whenever possible,\\nincluding at the beginning of diagnosis and treatment discussions.\\nIn the interest of brevity, The Merck Manual has never cited references to the medical literature.\\nNonetheless, readers can be assured that our hundreds of contributors and dozens of peer reviewers are\\npresenting the best current recommendations, soundly based on available evidence.\\nAlthough the printed Merck Manual has long since grown too big to be carried in a lab coat, it has\\nreturned to the pocket as content on many different handheld electronic devices. In addition, The Merck\\nManual continues to be available to all readers free of charge at www.merckmanuals.com. Although our'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 13, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Manual continues to be available to all readers free of charge at www.merckmanuals.com. Although our\\nelectronic versions have a currency that a printed product cannot, the book still provides a better in-depth\\nreading experience along with a tactile satisfaction and ease of perusal not possessed by electronic\\ndevices. Undoubtedly this will change as technology advances, but whatever the platform, we will\\ncontinue to strive to keep The Merck Manual as useful as ever.\\nWe thank the numerous contributors who have worked diligently with us to craft this edition, and we hope\\nyou will find it worthy of continued and frequent use. As always, suggestions for improvements will be\\nwarmly welcomed and carefully considered.\\nRobert S. Porter, MD\\nEditor-in-Chief\\nCommitted to Providing Medical Information: Merck and The Merck Manuals\\nIn 1899, the American drug manufacturer Merck & Co. first published a small book titled Merck's Manual\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 13, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Editor-in-Chief\\nCommitted to Providing Medical Information: Merck and The Merck Manuals\\nIn 1899, the American drug manufacturer Merck & Co. first published a small book titled Merck\\'s Manual\\nof the Materia Medica. It was meant as an aid to physicians and pharmacists, reminding doctors that\\n\"Memory is treacherous.\" Compact in size, easy to use, and comprehensive, The Merck Manual (as it\\nwas later known) became a favorite of those involved in medical care and others in need of a medical\\nreference. Even Albert Schweitzer carried a copy to Africa in 1913, and Admiral Byrd carried a copy to the\\nSouth Pole in 1929.\\nBy the 1980s, the book had become the world\\'s largest selling medical text and was translated into more\\nthan a dozen languages. While the name of the parent company has changed somewhat over the years,\\nthe book\\'s name has remained constant, known officially as The Merck Manual of Diagnosis and\\nTherapy but usually referred to as The Merck Manual and sometimes \"The Merck.\"'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 13, 'source_type': 'Authorotative', 'priority': '1'}, page_content='the book\\'s name has remained constant, known officially as The Merck Manual of Diagnosis and\\nTherapy but usually referred to as The Merck Manual and sometimes \"The Merck.\"\\nIn 1990, the editors of The Merck Manual introduced The Merck Manual of Geriatrics . This new book\\nquickly became the best-selling textbook of geriatric medicine, providing specific and comprehensive\\ninformation on the care of older people. The 3rd edition was published in five languages.\\nIn 1997, The Merck Manual of Medical Information-Home Edition  was published. In this revolutionary\\nbook, the editors translated the complex medical information in The Merck Manual into plain language,\\nproducing a book meant for all those people interested in medical care who did not have a medical\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n5'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 14, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"degree. The book received critical acclaim and sold over 2 million copies. The Second Home Edition was\\nreleased in 2003. Merck's commitment to providing comprehensive, understandable medical information\\nto all people continued with The Merck Manual Home Health Handbook, published in 2009.\\nThe Merck Manual of Health & Aging , published in 2004, continued Merck's commitment to education\\nand geriatric care, providing information on aging and the care of older people in words understandable\\nby the lay public.\\nIn 2008, The Merck Manual of Patient Symptoms  was introduced to complement The Merck Manual\\nand was intended to help newcomers to clinical diagnosis approach patients who present with certain\\ncommon symptoms.\\nAs part of its commitment to ensuring that all who need and want medical information can get it, Merck\\nprovides the content of these Merck Manuals on the web for free (www.merckmanuals.com). Registration\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 14, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"provides the content of these Merck Manuals on the web for free (www.merckmanuals.com). Registration\\nis not required, and use is unlimited. The web publications are continuously updated to ensure that the\\ninformation is as up-to-date as possible.\\nMerck also supports the community of chemists and others with the need to know about chemical\\ncompounds with The Merck Index. First published in 1889, this publication actually predates The Merck\\nManual and is the most widely used text of its kind. The Merck Veterinary Manual  was first published in\\n1955. It provides information on the health care of animals and is the preeminent text in its field.\\nMerck & Co., Inc., is one of the world's largest pharmaceutical companies. Merck is committed to\\nproviding excellent medical information and, as part of that effort, continues to proudly provide all of The\\nMerck Manuals as a service to the community.\\nContents\\nGuide for Readers…viii\\nAbbreviations…ix\\nEditors and Editorial Board…xi\\nConsultants…xiii\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 14, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Merck Manuals as a service to the community.\\nContents\\nGuide for Readers…viii\\nAbbreviations…ix\\nEditors and Editorial Board…xi\\nConsultants…xiii\\nContributors…xv\\n1 Nutritional Disorders… 1\\n2 Gastrointestinal Disorders… 67\\n3 Hepatic and Biliary Disorders… 203\\n4 Musculoskeletal and Connective Tissue Disorders… 281\\n5 Ear, Nose, Throat, and Dental Disorders… 411\\n6 Eye Disorders… 535\\n7 Dermatologic Disorders… 629\\n8 Endocrine and Metabolic Disorders… 755\\n9 Hematology and Oncology… 915\\n10 Immunology; Allergic Disorders… 1077\\n11 Infectious Diseases… 1143\\n12 Psychiatric Disorders… 1483\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n6'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 15, 'source_type': 'Authorotative', 'priority': '1'}, page_content='13 Neurologic Disorders… 1583\\n14 Pulmonary Disorders… 1823\\n15 Cardiovascular Disorders… 2015\\n16 Critical Care Medicine… 2243\\n17 Genitourinary Disorders… 2303\\n18 Gynecology and Obstetrics… 2479\\n19 Pediatrics… 2691\\n20 Geriatrics… 3069\\n21 Clinical Pharmacology… 3165\\n22 Injuries; Poisoning… 3187\\n23 Special Subjects… 3371\\nAppendixes… 3489\\nReady Reference Guides…3489\\nNormal Laboratory Values…3491\\nTrade Names of Some Commonly Used Drugs…3505\\nIndex…3521\\nGuide For Readers\\nThe Contents (p. vii) shows the pages on which readers can find the Editors and Editorial Board\\nmembers, consultants, additional reviewers, and contributors, as well as titles of sections, appendixes,\\nand the index. Thumb tabs with appropriate abbreviations and section numbers mark each section and\\nthe index.\\nEach Section begins with its own table of contents, listing chapters and topics in that section. Chapters\\nare numbered serially from the beginning to the end of the book.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 15, 'source_type': 'Authorotative', 'priority': '1'}, page_content='the index.\\nEach Section begins with its own table of contents, listing chapters and topics in that section. Chapters\\nare numbered serially from the beginning to the end of the book.\\nThe Index is highly detailed and contains many cross-entries. In addition, readers will find many cross-\\nreferences throughout the text to specific pages where additional or related information can be found.\\nRunning heads carry the section number and title on left-hand pages and the chapter number and title\\non right-hand pages.\\nAbbreviations and symbols, used throughout the text as essential space savers, are listed on pages ix\\nand x. Other abbreviations in the text are expanded at first mention in the chapter or topic.\\nTables and figures are referenced in the index but are not listed in a separate table of contents. An\\ninsert of color plates contains photographs of many eye, ear, endocrine, skin, and gynecologic disorders\\nas well as infectious diseases.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 15, 'source_type': 'Authorotative', 'priority': '1'}, page_content='insert of color plates contains photographs of many eye, ear, endocrine, skin, and gynecologic disorders\\nas well as infectious diseases.\\nLaboratory values in the book are given in conventional units. In most cases, SI units follow in\\nparentheses. Appendix II contains several tables listing normal laboratory values for many tests\\nconducted on blood, plasma, serum, urine, CSF, and stool.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n7'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 16, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Drugs are designated in the text by generic (nonproprietary) names. In Appendix III, many of the drugs\\nmentioned in the book are listed alphabetically, with each generic name followed by one or more trade\\nnames.\\nSection 23, Special Subjects, has discussions on clinical decision making, radiologic imaging,\\ncomplementary and alternative medicine, dietary supplements, genetics, smoking cessation,\\nrehabilitation, care of the surgical patient, financial issues in health care, and care of the dying patient,\\namong others.\\nImportant: The authors, reviewers, and editors of this book have made extensive efforts to ensure that\\ntreatments, drugs, and dosage regimens are accurate and conform to the standards accepted at the time\\nof publication. However, constant changes in information resulting from continuing research and clinical\\nexperience, reasonable differences in opinions among authorities, unique aspects of individual clinical'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 16, 'source_type': 'Authorotative', 'priority': '1'}, page_content='experience, reasonable differences in opinions among authorities, unique aspects of individual clinical\\nsituations, and the possibility of human error in preparing such an extensive text require that the reader\\nexercise individual judgment when making a clinical decision and, if necessary, consult and compare\\ninformation from other sources. In particular, the reader is advised to check the product information\\nprovided by the manufacturer of a drug product before prescribing or administering it, especially if the\\ndrug is unfamiliar or is used infrequently.\\nNote: Readers can find up-to-date information, additional tables and figures, as well as multimedia\\nenhancements at www.merckmanuals.com. Visit the web site frequently for new enhancements and the\\nlatest information on clinical developments.\\nAbbreviations\\nThe following abbreviations are used throughout the text; other abbreviations are expanded at first\\nmention in the chapter or subchapter.\\nABG\\narterial blood gas\\nACE'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 16, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Abbreviations\\nThe following abbreviations are used throughout the text; other abbreviations are expanded at first\\nmention in the chapter or subchapter.\\nABG\\narterial blood gas\\nACE\\nangiotensin converting enzyme\\nACTH\\nadrenocorticotropic hormone\\nADH\\nantidiuretic hormone\\nAIDS\\nacquired immunodeficiency syndrome\\nALT\\nalanine transaminase (formerly SGPT)\\nAST\\naspartate transaminase (formerly SGOT)\\nATP\\nadenosine triphosphate\\nBCG\\nbacille Calmette-Guerin\\nbid\\n2 times a day (only in dosages)\\nBMR\\nbasal metabolic rate\\nBP\\nblood pressure\\nBSA\\nbody surface area\\nBUN\\nblood urea nitrogen\\nC\\nCelsius; centigrade\\nCa\\ncalcium\\ncAMP\\ncyclic adenosine monophosphate\\nCBC\\ncomplete blood count\\ncGy\\ncentigray\\nCi\\ncurie\\nCK\\ncreatine kinase\\nCK-MB\\ncreatine kinase of muscle band\\nCl\\nchloride; chlorine\\ncm\\ncentimeter\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n8'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 17, 'source_type': 'Authorotative', 'priority': '1'}, page_content='CNS\\ncentral nervous system\\nCO2\\ncarbon dioxide\\nCOPD\\nchronic obstructive pulmonary disease\\nCPR\\ncardiopulmonary resuscitation\\nCSF\\ncerebrospinal fluid\\nCT\\ncomputed tomography\\ncu\\ncubic\\nD & C\\ndilation and curettage\\ndL\\ndeciliter (= 100 mL)\\nDNA\\ndeoxyribonucleic acid\\nDTP\\ndiphtheria-tetanus-pertussis (toxoids/vaccine)\\nD/W or D dextrose\\nECF\\nextracellular fluid\\nECG\\nelectrocardiogram, electrocardiography\\nEEG\\nelectroencephalogram, electroencephalography\\nENT\\near, nose, and throat\\nERCP\\nendoscopic retrograde cholangiopancreatography\\nESR\\nerythrocyte sedimentation rate\\nF\\nFahrenheit\\nFDA\\nUS Food and Drug Administration\\nft\\nfoot; feet (measure)\\nFUO\\nfever of unknown origin\\ng\\ngram\\nGFR\\nglomerular filtration rate\\nGI\\ngastrointestinal\\nG6PD\\nglucose-6-phosphate dehydrogenase\\nGU\\ngenitourinary\\nGy\\ngray\\nh\\nhour\\nHb\\nhemoglobin\\nHCl\\nhydrochloric acid; hydrochloride\\nHCO3\\nbicarbonate\\nHct\\nhematocrit\\nHg\\nmercury\\nHIV\\nhuman immunodeficiency virus\\nHLA\\nhuman leukocyte antigen\\nHMG-CoA hydroxymethyl glutaryl coenzyme A\\nHz'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 17, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Hb\\nhemoglobin\\nHCl\\nhydrochloric acid; hydrochloride\\nHCO3\\nbicarbonate\\nHct\\nhematocrit\\nHg\\nmercury\\nHIV\\nhuman immunodeficiency virus\\nHLA\\nhuman leukocyte antigen\\nHMG-CoA hydroxymethyl glutaryl coenzyme A\\nHz\\nhertz (cycles/second)\\nICF\\nintracellular fluid\\nICU\\nintensive care unit\\nIgA, etc\\nimmunoglobulin A, etc\\nIL-1, etc\\ninterleukin-1, etc\\nIM\\nintramuscular(ly)\\nINR\\ninternational normalized ratio\\nIU\\ninternational unit\\nIV\\nintravenous(ly)\\nIVU\\nintravenous urography\\nK\\npotassium\\nkcal\\nkilocalorie (food calorie)\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n9'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 18, 'source_type': 'Authorotative', 'priority': '1'}, page_content='kg\\nkilogram\\nL\\nliter\\nlb\\npound\\nLDH\\nlactic dehydrogenase\\nM\\nmolar\\nm\\nmeter\\nMAOI\\nmonoamine oxidase inhibitor\\nMCH\\nmean corpuscular hemoglobin\\nMCHC\\nmean corpuscular hemoglobin concentration\\nmCi\\nmillicurie\\nMCV\\nmean corpuscular volume\\nmEq\\nmilliequivalent\\nMg\\nmagnesium\\nmg\\nmilligram\\nMI\\nmyocardial infarction\\nMIC\\nminimum inhibitory concentration\\nmin\\nminute\\nmIU\\nmilli-international unit\\nmL\\nmilliliter\\nmm\\nmillimeter\\nmmol\\nmillimole\\nmo\\nmonth\\nmOsm\\nmilliosmole\\nMRI\\nmagnetic resonance imaging\\nN\\nnitrogen; normal (strength of solution)\\nNa\\nsodium\\nNaCl\\nsodium chloride\\nng\\nnanogram (= millimicrogram)\\nNGT\\nnasogastric tube\\nnm\\nnanometer (= millimicron)\\nnmol\\nnanomole\\nnpo\\nnothing by mouth\\nNSAID\\nnonsteroidal anti-inflammatory drug\\nO2\\noxygen\\nOTC\\nover-the-counter (pharmaceuticals)\\noz\\nounce\\nP\\nphosphorus\\nPACO2\\nalveolar carbon dioxide partial pressure\\nPaCO2\\narterial carbon dioxide partial pressure\\nPAO2\\nalveolar oxygen partial pressure\\nPaO2\\narterial oxygen partial pressure\\nPCO2\\ncarbon dioxide partial pressure (or tension)\\nPCR'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 18, 'source_type': 'Authorotative', 'priority': '1'}, page_content='PaCO2\\narterial carbon dioxide partial pressure\\nPAO2\\nalveolar oxygen partial pressure\\nPaO2\\narterial oxygen partial pressure\\nPCO2\\ncarbon dioxide partial pressure (or tension)\\nPCR\\npolymerase chain reaction\\nPET\\npositron emission tomography\\npg\\npicogram (= micromicrogram)\\npH\\nhydrogen ion concentration\\nPMN\\npolymorphonuclear leukocyte\\npo\\norally\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n10'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 19, 'source_type': 'Authorotative', 'priority': '1'}, page_content='PO2\\noxygen partial pressure (or tension)\\nPPD\\npurified protein derivative (tubercullin)\\nppm\\nparts per million\\nprn\\nas needed\\nPT\\nprothrombin time\\nPTT\\npartial thromboplastin time\\nq\\nevery (only in dosages)\\nqid\\n4 times a day (only in dosages)\\nRA\\nrheumatoid arthritis\\nRBC\\nred blood cell\\nRNA\\nribonucleic acid\\nSaO2\\narterial oxygen saturation\\nsc\\nsubcutaneous\\nsec\\nsecond\\nSI\\nInternational System of Units\\nSIDS\\nsudden infant death syndrome\\nSLE\\nsystemic lupus erythematosus\\nsp\\nspecies (when referring to the singular) [eg, Clostridium sp]\\nspp\\nspecies (when referring to the plural) [eg, Nocardia and Myocardia spp]\\nsp gr\\nspecific gravity\\nsq\\nsquare\\nSSRI\\nselective serotonin reuptake inhibitor\\nTB\\ntuberculosis\\ntid\\n3 times a day (only in dosages)\\nTNF\\ntumor necrosis factor\\nTPN\\ntotal parenteral nutrition\\nTSH\\nthyroid-stimulating hormone\\nURI\\nupper respiratory infection\\nUTI\\nurinary tract infection\\nvs\\nversus\\nWBC\\nwhite blood cell\\nWHO\\nWorld Health Organization\\nwk\\nweek\\nwt\\nweight\\nyr\\nyear\\nμ\\nmicro-; micron\\nμCi\\nmicrocurie\\nμg'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 19, 'source_type': 'Authorotative', 'priority': '1'}, page_content='URI\\nupper respiratory infection\\nUTI\\nurinary tract infection\\nvs\\nversus\\nWBC\\nwhite blood cell\\nWHO\\nWorld Health Organization\\nwk\\nweek\\nwt\\nweight\\nyr\\nyear\\nμ\\nmicro-; micron\\nμCi\\nmicrocurie\\nμg\\nmicrogram\\nμL\\nmicroliter\\nμm\\nmicrometer (= micron)\\nμmol\\nmicromole\\nμOsm\\nmicro-osmole\\nmμ\\nmillimicron\\nEditors\\nEditor-in-Chief\\nROBERT S. PORTER, MD\\nMerck & Co., Inc, and Clinical Assistant Professor, Department of Emergency Medicine, Jefferson\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n11'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 20, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Medical College\\nSenior Assistant Editor\\nJUSTIN L. KAPLAN, MD\\nMerck & Co., Inc, and Clinical Associate Professor, Department of Emergency Medicine, Jefferson\\nMedical College\\nEditorial Board\\nRICHARD K. ALBERT, MD\\nProfessor, Department of Medicine, University\\nof Colorado Health Sciences Center; Chief of\\nMedicine, Denver Health Medical Center\\nMARJORIE A. BOWMAN, MD, MPA\\nProfessor and Founding Chair of Family\\nPractice and Community Health, University of\\nPennsylvania School of Medicine\\nGLENN D. BRAUNSTEIN, MD\\nProfessor of Medicine, David Geffen School\\nof Medicine at University of California, Los\\nAngeles; Chairman, Department of Medicine,\\nCedars-Sinai Medical Center\\nSIDNEY COHEN, MD\\nProfessor of Medicine and Director, Research\\nPrograms, Thomas Jefferson University School\\nof Medicine\\nLINDA EMANUEL, PhD\\nProfessor of Medicine, Northwestern University,\\nFeinberg School of Medicine, Buehler Center\\non Aging\\nJAN FAWCETT, MD\\nProfessor of Psychiatry, University of New\\nMexico School of Medicine'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 20, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Professor of Medicine, Northwestern University,\\nFeinberg School of Medicine, Buehler Center\\non Aging\\nJAN FAWCETT, MD\\nProfessor of Psychiatry, University of New\\nMexico School of Medicine\\nEUGENE P. FRENKEL, MD\\nProfessor of Internal Medicine and Radiology,\\nPatsy R. and Raymond D. Nasher Distinguished\\nChair in Cancer Research, Elaine Dewey\\nSammons Distinguished Chair in Cancer\\nResearch in honor of Eugene P. Frenkel, MD,\\nA. Kenneth Pye Professorship in Cancer\\nResearch, Harold C. Simmons Comprehensive\\nCancer Center, The University of Texas\\nSouthwestern Medical Center at Dallas\\nSUSAN L. HENDRIX, DO\\nClinical Professor, Department of Obstetrics\\nand Gynecology, Michigan State University\\nSchool of Osteopathic Medicine, and a partner\\nin Hutzel Women's Hospital at the Detroit\\nMedical Center\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n12\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 21, 'source_type': 'Authorotative', 'priority': '1'}, page_content='MICHAEL JACEWICZ, MD\\nProfessor of Neurology, University of\\nTennessee Health Science Center; Assistant\\nChief of Neurology, VA Medical Center,\\nMemphis\\nMATTHEW E. LEVISON, MD\\nAdjunct Professor of Medicine, Drexel\\nUniversity College of Medicine; Professor,\\nSchool of Public Health, Drexel University\\nJAMES JEFFREY MALATACK, MD\\nProfessor of Pediatrics, Thomas Jefferson\\nUniversity School of Medicine; Division Chief\\nof Diagnostic Referral Service and Medical\\nLiver Transplantation, Alfred I. duPont\\nHospital for Children\\nBRIAN F. MANDELL, MD, PhD\\nProfessor and Vice Chairman of Medicine,\\nDepartment of Rheumatic and Immunologic\\nDiseases, Center for Vasculitis Care and\\nResearch, Cleveland Clinic Lerner College of\\nMedicine at Case Western Reserve University\\nGERALD L. MANDELL, MD\\nProfessor of Medicine (Emeritus), Owen R.\\nCheatham Professor of the Sciences\\n(Emeritus), Chief of Infectious Diseases\\n(Emeritus), University of Virginia Health\\nSystem\\nJUDITH S. PALFREY, MD'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 21, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Professor of Medicine (Emeritus), Owen R.\\nCheatham Professor of the Sciences\\n(Emeritus), Chief of Infectious Diseases\\n(Emeritus), University of Virginia Health\\nSystem\\nJUDITH S. PALFREY, MD\\nT. Berry Brazelton Professor of Pediatrics,\\nHarvard Medical School\\nALBERT A. RUNDIO, Jr., PhD\\nAssociate Professor of Nursing, The Richard\\nStockton College of New Jersey; Nurse\\nPractitioner, Lighthouse at Mays Landing\\nDAVID A. SPAIN, MD\\nProfessor of Surgery and Chief of Trauma/\\nSurgical Critical Care, Stanford University\\nPAUL H. TANSER, MD\\nProfessor of Medicine (Emeritus), McMaster\\nUniversity; Medical Cardiologist, North Shore\\nand Waitakere Hospitals, Auckland\\nMICHAEL R. WASSERMAN, MD\\nCo-founder, Senior Care of Colorado, PC\\nConsultants\\nNOEL A. ARMENAKAS, MD\\nClinical Associate Professor, Department\\nof Urology, Weill Cornell Medical School;\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n13'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 22, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Attending Physician, Lenox Hill Hospital\\nand New York Presbyterian Hospital\\nGenitourinary (Urologic) Disorders\\nINA CALLIGARO, PharmD\\nAssistant Dean for Education and Associate\\nProfessor of Pharmacy Practice, Temple\\nUniversity School of Pharmacy\\nPediatric Pharmaceutical Preparations and\\nDosages\\nMICHAEL F. CELLUCCI, MD\\nAttending Physician, Department of Pediatrics,\\nDiagnostic Referral Division, Alfred I. duPont\\nHospital for Children; Clinical Instructor,\\nJefferson Medical College\\nPediatrics\\nROBERT B. COHEN, DMD\\nClinical Associate Professor of Dentistry\\nand Practice Coordinator, Tufts University\\nSchool of Dental Medicine\\nDental Disorders\\nDEBORAH M. CONSOLINI, MD\\nAssistant Professor of Pediatrics, Jefferson\\nMedical College; Staff Physician, Diagnostic\\nReferral Division, Alfred I. duPont Hospital\\nfor Children\\nPediatrics\\nJ. CARLTON GARTNER, Jr., MD\\nProfessor of Pediatrics, Jefferson Medical\\nCollege; Pediatrician-in-Chief, Alfred I. duPont\\nHospital for Children\\nPediatrics\\nSIDNEY N. KLAUS, MD'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 22, 'source_type': 'Authorotative', 'priority': '1'}, page_content='for Children\\nPediatrics\\nJ. CARLTON GARTNER, Jr., MD\\nProfessor of Pediatrics, Jefferson Medical\\nCollege; Pediatrician-in-Chief, Alfred I. duPont\\nHospital for Children\\nPediatrics\\nSIDNEY N. KLAUS, MD\\nProfessor of Medicine, Section of Dermatology,\\nDartmouth Medical School; Chief of\\nDermatology, White River Junction, Vermont\\nVA Medical Center\\nDermatologic Disorders\\nCHRISTOPHER P. RAAB, MD\\nClinical Instructor, Thomas Jefferson University;\\nStaff Physician, Pediatrics Department,\\nDiagnostic Referral Division, Alfred I. duPont\\nHospital for Children\\nPediatrics\\nMELVIN I. ROAT, MD\\nClinical Associate Professor, Wills Eye Institute,\\nDepartment of Ophthalmology, Jefferson\\nMedical College, Thomas Jefferson University\\nEye Disorders\\nJAMES R. ROBERTS, MD\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n14'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 23, 'source_type': 'Authorotative', 'priority': '1'}, page_content=',\\nProfessor and Vice Chairman, Department\\nof Emergency Medicine, Drexel University\\nCollege of Medicine; Chair, Department of\\nEmergency Medicine and Director, Division\\nof Toxicology, Mercy Catholic Medical Center\\nInjuries and Poisoning\\nROBERT J. RUBEN, MD\\nDistinguished University Professor, Department\\nof Otorhinolaryngology-Head & Neck Surgery,\\nAlbert Einstein College of Medicine and\\nMontefiore Medical Center\\nEar, Nose, and Throat Disorders\\nSTEWART SHANKEL, MD\\nClinical Professor of Medicine and Director of\\nClinical Instruction, University of California,\\nRiverside\\nGenitourinary (Nephrotic) Disorders\\nEVA M. VIVIAN, PharmD\\nClinical Associate Professor, University of\\nWisconsin School of Pharmacy\\nAdult Pharmaceutical Preparations and\\nDosages\\nReviewers for Selected Chapters\\nWilliam E. Brant, MD\\nArthur Coverdale, MD\\nAlbert T. Derivan, MD\\nRobert A. Dobie, MD\\nNorton J. Greenberger, MD\\nJohn E. Greenlee, MD\\nMary L. Hardy, MD\\nRandall Hughes, MD\\nDiane Kraft, MS, RD, LDN\\nDouglas Lanska, MD, MS, MSPH'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 23, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Albert T. Derivan, MD\\nRobert A. Dobie, MD\\nNorton J. Greenberger, MD\\nJohn E. Greenlee, MD\\nMary L. Hardy, MD\\nRandall Hughes, MD\\nDiane Kraft, MS, RD, LDN\\nDouglas Lanska, MD, MS, MSPH\\nEdwin M. Leidholdt, Jr., PhD\\nMichael C. Levin, MD\\nS. Gene McNeeley, MD\\nColonel David F. Murchison, DDS, MMS\\nDavid S. Rootman, MD\\nMichael B. Steinberg, MD, MPH\\nJames Wayne Warnica, MD\\nAcknowledgments\\nWe thank Barbara P. Homeier, MD, Noelle Rotondo, DO, and Oren Traub, MD, PhD, for their editorial\\nassistance. We also thank Paul Fennessy and the team at Nesbitt Graphics for their assistance in\\nproducing this book.\\nWe thank the following people and institutions for allowing us to publish their photographs in the color\\nplates: Piet van Hasselt, MD (Plate 1); Bechara Ghorayeb, MD (Plate 2); Robert Machemer via the\\nOnline Journal of Ophthalmology (ONJOPH)  (Plates 3, 5, 10, 11 [bottom], 23, and 25 [bottom]);\\nOphthalmic Clinic of the Health Center of the University of Erlangen-Nurnberg via ONJOPH (Plates 4'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 23, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Online Journal of Ophthalmology (ONJOPH)  (Plates 3, 5, 10, 11 [bottom], 23, and 25 [bottom]);\\nOphthalmic Clinic of the Health Center of the University of Erlangen-Nurnberg via ONJOPH (Plates 4\\nand 17 [bottom]); A. Viestenz via ONJOPH (Plate 6); Jonathan J. Dutton via ONJOPH (Plate 7);\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n15'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 24, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Professor J. Wollensak via ONJOPH (Plates 8, 9, 15, 16, 17 [top], and 18); Dr. Brooks McCuen via\\nONJOPH (Plate 11 [top]); Jonathan J. Dutton via ONJOPH (Plate 12); University of California at San\\nDiego via ONJOPH (Plate 13); Professor H.J. Meyer via ONJOPH (Plate 14); Dr. James Garrity (Plate\\n19); World Health Organization via ONJOPH (Plate 20); C. Newman (Plate 21) and B. Biller (Plate 22)\\nfrom Atlas of Clinical Endocrinology: Neuroendocrinology and Pituitary Disease ; Thomas Habif, MD\\n(Plates 24, 26-30, 32-37, 38 [top], 39-47, 49, 51-55, and 60); Prof. Dr. K.W. Ruprecht and Dr. Med. B.\\nKaesmann-Kellner via ONJOPH (Plate 25 [top]); Allen W. Mathies, MD, via the Public Health Image\\nLibrary of the Centers for Disease Control and Prevention (CDC) (Plate 31); Dennis D. Juranek, MD, via\\nthe Public Health Image Library of the CDC (Plate 38 [bottom]) and via www.doctorfungus.com (Plates\\n48 and 50); S. Deitcher from Atlas of Clinical Hematology  (Plate 56); E. Joe and N. Soter from Current'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 24, 'source_type': 'Authorotative', 'priority': '1'}, page_content='48 and 50); S. Deitcher from Atlas of Clinical Hematology  (Plate 56); E. Joe and N. Soter from Current\\nDermatologic Diagnosis and Treatment (Plate 57); Public Health Image Library of the CDC (Plates 58,\\n64-67, and 70); Drs. S.E. Thompson and J. Pledger via the Public Health Image Library of the CDC\\n(Plate 59); Noel Armenakas, MD (Plate 61); Dr. Susan Lindsley via the Public Health Image Library of the\\nCDC (Plate 62); Joe Miller and Dr. Cornelio Arevalo via the Public Health Image Library of the CDC\\n(Plate 63); M.S. Klempner from Atlas of Infectious Diseases: External Manifestations of Systemic\\nInfections (Plate 68); R. Kaufman and D. Brown from Atlas of Clinical Gynecology: Gynecologic\\nPathology (Plate 69); J.D. Sobel from Atlas of Infectious Diseases: Fungal Infections  (Plate 71); A.\\nOster and R. Rosa from Atlas of Ophthalmology  (Plate 72); I. Scott, R. Warman, and T. Murray from\\nAtlas of Ophthalmology  (Plate 73); J. Burns and M. Glode from Atlas of Infectious Diseases: Pediatric'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 24, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Atlas of Ophthalmology  (Plate 73); J. Burns and M. Glode from Atlas of Infectious Diseases: Pediatric\\nInfectious Diseases (Plate 74); Steven E. Wolf, MD (Plates 75 and 76).\\nContributors\\nBOLA ADAMOLEKUN, MD\\nDirector of Epilepsy, Department of Neurology,\\nUniversity of Tennessee Health Science Center\\nSeizure Disorders\\nNEIL B. ALEXANDER, MD\\nProfessor, Department of Internal Medicine,\\nDivision of Geriatric Medicine, University of\\nMichigan; Associate Professor for Research;\\nDirector, VA Ann Arbor Health Care System,\\nGeriatrics Research, Education and Clinical\\nCenter\\nFalls in the Elderly\\nROY D. ALTMAN, MD\\nProfessor of Medicine, Division of\\nRheumatology and Immunology, University\\nof California, Los Angeles\\nJoint Disorders; Paget's Disease of Bone\\nBRADLEY D. ANAWALT, MD\\nAssociate Professor of Medicine, University\\nof Washington; Associate Chief of Medicine,\\nVA Puget Sound\\nMale Reproductive Endocrinology\\nMARY ANN ANDERSON, PhD, RN\\nAssociate Professor, University of Illinois at\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 24, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of Washington; Associate Chief of Medicine,\\nVA Puget Sound\\nMale Reproductive Endocrinology\\nMARY ANN ANDERSON, PhD, RN\\nAssociate Professor, University of Illinois at\\nChicago, College of Nursing, Quad Cities\\nRegional Program\\nProvision of Care\\nGERALD L. ANDRIOLE, MD\\nProfessor and Chief of Urologic Surgery,\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n16'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 25, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Barnes-Jewish Hospital, Washington\\nUniversity School of Medicine\\nBenign Prostate Disease\\nPARSWA ANSARI, MD\\nAssistant Program Director, Department of\\nSurgery, Lenox Hill Hospital, New York\\nGI Bleeding; Acute Abdomen and Surgical\\nGastroenterology; Anorectal Disorders\\nBRIAN R. APATOFF, MD, PhD\\nAssociate Professor of Neurology and\\nNeuroscience, Weill Cornell Medical College;\\nClinical Attending of Neurology, New York\\nPresbyterian Hospital\\nDemyelinating Disorders\\nNOEL A. ARMENAKAS, MD\\nClinical Associate Professor, Department of\\nUrology, Weill Cornell Medical College;\\nAttending Physician, Lenox Hill Hospital and\\nNew York Presbyterian Hospital\\nGenitourinary Tract Trauma\\nJ. MALCOLM O. ARNOLD, MD\\nProfessor of Medicine, Physiology and\\nPharmacology, University of Western Ontario;\\nCardiologist, University Hospital, London\\nHealth Sciences Center\\nHeart Failure; Cardiomyopathies\\nALEXANDER AUCHUS, MD\\nProfessor and McCarty Chair of Neurology,\\nUniversity of Mississippi Medical Center'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 25, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Health Sciences Center\\nHeart Failure; Cardiomyopathies\\nALEXANDER AUCHUS, MD\\nProfessor and McCarty Chair of Neurology,\\nUniversity of Mississippi Medical Center\\nDelirium and Dementia; Function and\\nDysfunction of the Cerebral Lobes\\nGEORGE L. BAKRIS, MD\\nProfessor of Medicine and Director,\\nHypertensive Diseases Unit, University\\nof Chicago-Pritzker School of Medicine\\nArterial Hypertension\\nDAVID H. BARAD, MD, MS\\nAssociate Clinical Professor, Albert Einstein\\nCollege of Medicine\\nApproach to the Gynecologic Patient\\nPEGGY P. BARCO, MS, OTR/L\\nProgram in Occupational Therapy,\\nWashington University Medical School;\\nDriving Connections, The Rehabilitation\\nInstitute of Saint Louis\\nThe Older Driver\\nROBERT A. BARISH, MD, MBA\\nProfessor of Emergency Medicine, Chancellor,\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n17'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 26, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Louisiana State University Health Sciences\\nCenter at Shreveport\\nBites and Stings\\nJOHN G. BARTLETT, MD\\nProfessor of Medicine, Johns Hopkins\\nUniversity School of Medicine\\nAcute Bronchitis; Pneumonia; Lung Abscess\\nROSEMARY BASSON, MD\\nClinical Professor, Department of Psychiatry,\\nUniversity of British Columbia and Vancouver\\nHospital\\nSexual Dysfunction in Women\\nBYRON E. BATTEIGER, MD\\nProfessor of Medicine and Microbiology and\\nImmunology, Division of Infectious Diseases,\\nIndiana University School of Medicine\\nChlamydia and Mycoplasmas\\nLEE B. BEERMAN, MD\\nProfessor of Pediatrics, Division of Pediatric\\nCardiology, Children's Hospital of Pittsburgh\\nof UPMC, University of Pittsburgh School of\\nMedicine\\nCongenital Cardiovascular Anomalies\\nJ. BRAD BELLOTTE, MD\\nDirector of Complex Spine Surgery and\\nDirector of Neurotrauma, Department of\\nNeurosurgery, Allegheny General Hospital,\\nPittsburgh\\nSpinal Trauma\\nJOSHUA O. BENDITT, MD\\nProfessor of Medicine, Division of Pulmonary\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 26, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Director of Neurotrauma, Department of\\nNeurosurgery, Allegheny General Hospital,\\nPittsburgh\\nSpinal Trauma\\nJOSHUA O. BENDITT, MD\\nProfessor of Medicine, Division of Pulmonary\\nand Critical Care, University of Washington\\nSchool of Medicine; Director of Respiratory\\nCare Medicine, University of Washington\\nMedical Center\\nBronchiectasis\\nJAMES R. BERENSON, MD\\nMedical and Scientific Director, Institute for\\nMyeloma and Bone Cancer Research, West\\nHollywood\\nPlasma Cell Disorders\\nBARBARA J. BERKMAN, DSW, PhD\\nHelen Rehr/Ruth Fitzdale Professor, Columbia\\nUniversity School of Social Work; Principal\\nInvestigator and National Director, Hartford\\nGeriatric Social Work Faculty Scholars Program\\nSocial Issues in the Elderly\\nCHESTON M. BERLIN, Jr., MD\\nUniversity Professor of Pediatrics and\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n18'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 27, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Professor of Pharmacology, Penn State\\nUniversity College of Medicine\\nPrinciples of Drug Treatment in Children\\nJESSICA R. BERMAN, MD\\nAssistant Professor of Medicine, Weill Cornell\\nMedical College; Assistant Attending Physician,\\nHospital for Special Surgery\\nApproach to the Patient With Joint Disease\\nRICHARD W. BESDINE, MD\\nProfessor of Medicine, Greer Professor of\\nGeriatric Medicine, and Director, Division of\\nGeriatrics (Medicine) and of the Center for\\nGerontology and Healthcare Research, The\\nWarren Alpert Medical School of Brown\\nUniversity\\nApproach to the Geriatric Patient; Quality of\\nLife and Therapeutic Objectives\\nADIL E. BHARUCHA, MBBS, MD\\nProfessor of Medicine, Division of\\nGastroenterology and Hepatology, Mayo\\nClinic College of Medicine\\nApproach to the Patient With Lower GI\\nComplaints; Irritable Bowel Syndrome\\nALBERT W. BIGLAN, MD\\nAdjunct Associate Professor of Ophthalmology,\\nUniversity of Pittsburgh School of Medicine;\\nStaff Physician, Children's Hospital of Pittsburgh\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 27, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Complaints; Irritable Bowel Syndrome\\nALBERT W. BIGLAN, MD\\nAdjunct Associate Professor of Ophthalmology,\\nUniversity of Pittsburgh School of Medicine;\\nStaff Physician, Children's Hospital of Pittsburgh\\nEye Defects and Conditions in Children\\nJOSEPH J. BIUNDO, MD\\nClinical Professor of Medicine, Tulane Medical\\nCenter\\nBursa, Muscle, and Tendon Disorders\\nSEAN C. BLACKWELL, MD\\nAssistant Professor, Department of Obstetrics,\\nGynecology, and Reproductive Sciences, The\\nUniversity of Texas Health Sciences Center at\\nHouston\\nPregnancy Complicated by Disease\\nRUSSELL BLAIR, MD\\nFellow, Section of Pulmonary, Critical Care,\\nAllergy and Immunologic Diseases, Wake\\nForest University Baptist Medical Center\\nAsthma\\nCHARLES D. BORTLE, EdD\\nDirector of Logistics and Field Operations,\\nDepartment of Emergency Medicine, Albert\\nEinstein Medical Center\\nRespiratory Arrest\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n19\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 28, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ANN S. BOTASH, MD\\nProfessor of Pediatrics, State University of\\nNew York, Upstate Medical University\\nChild Maltreatment\\nALFRED A. BOVE, MD, PhD\\nChief of Cardiology, Cardiology Section,\\nTemple University School of Medicine\\nInjury During Diving or Work in Compressed\\nAir\\nTHOMAS G. BOYCE, MD, MPH\\nAssociate Professor of Pediatrics and Consultant\\nin Pediatric Infectious Diseases and Immunology,\\nMayo Clinic College of Medicine\\nGastroenteritis\\nPETER C. BRAZY, MD\\nProfessor of Medicine, University of Wisconsin-\\nMadison\\nRenal Transport Abnormalities; Congenital\\nRenal Transport Abnormalities\\nJEREMY S. BREIT, MD\\nFellow, Section of Pulmonary, Critical Care,\\nAllergy and Immunologic Diseases, Wake Forest\\nUniversity Baptist Medical Center\\nAsthma\\nCHRISTIAN M. BRIERY, MD\\nDirector of Maternal-Fetal Medicine, Willis-\\nKnighton Medical Center, Shreveport\\nHigh-Risk Pregnancy\\nGEORGE R. BROWN, MD\\nProfessor and Associate Chairman, Department\\nof Psychiatry, East Tennessee State University;'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 28, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Knighton Medical Center, Shreveport\\nHigh-Risk Pregnancy\\nGEORGE R. BROWN, MD\\nProfessor and Associate Chairman, Department\\nof Psychiatry, East Tennessee State University;\\nChief of Psychiatry, James H. Quillen VA\\nMedical Center\\nSexuality and Sexual Disorders\\nHAYWOOD L. BROWN, MD\\nRoy T. Parker Professor and Chair, Department\\nof Obstetrics and Gynecology, Duke\\nUniversity Medical Center\\nNormal Pregnancy, Labor, and Delivery\\nROBERT G. BRZYSKI, MD, PhD\\nAssociate Professor of Obstetrics and\\nGynecology, The University of Texas\\nHealth Science Center at San Antonio\\nFemale Reproductive Endocrinology\\nREBECCA H. BUCKLEY, MD\\nJ. Buren Sidbury Professor of Pediatrics and\\nProfessor of Immunology, Duke University\\nSchool of Medicine\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n20'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 29, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Immunodeficiency Disorders\\nLARRY M. BUSH, MD\\nAssociate Clinical Professor of Medicine,\\nUniversity of Miami-Miller School of Medicine/\\nFlorida Atlantic University; Chief, Division of\\nInfectious Diseases, JFK Medical Center\\nGram-Positive Bacilli; Gram-Positive Cocci\\nJERROLD T. BUSHBERG, PhD,\\nDABMP\\nClinical Professor of Radiology and Radiation\\nOncology, School of Medicine, University of\\nCalifornia, Davis\\nRadiation Exposure and Contamination\\nJUAN R. BUSTILLO, MD\\nAssociate Professor of Psychiatry and\\nNeurosciences, University of New Mexico\\nSchizophrenia and Related Disorders\\nDAVID B. CARR, MD\\nAssociate Professor of Internal Medicine and\\nNeurology, Washington University School of\\nMedicine-Older Adult Health Center\\nThe Older Driver\\nMARY T. CASERTA, MD\\nAssociate Professor of Pediatrics, Division of\\nInfectious Diseases, University of Rochester\\nSchool of Medicine; Attending Physician,\\nGolisano Children's Hospital at Strong,\\nUniversity of Rochester Medical Center\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 29, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Infectious Diseases, University of Rochester\\nSchool of Medicine; Attending Physician,\\nGolisano Children's Hospital at Strong,\\nUniversity of Rochester Medical Center\\nEnteroviruses; Other Viruses; Infections in\\nNeonates\\nBRUCE A. CHABNER, MD\\nProfessor of Medicine, Harvard Medical School;\\nClinical Director, Massachusetts General\\nHospital Cancer Center\\nOverview of Cancer; Principles of Cancer\\nTherapy\\nFREDY CHAPARRO-ROJAS, MD\\nInternal Medicine Resident, University of\\nMiami-Miller School of Medicine/Florida\\nAtlantic University at JFK Medical Center\\nGram-Positive Cocci\\nIAN M. CHAPMAN, MBBS, PhD\\nAssociate Professor of Endocrinology,\\nUniversity of Adelaide, Department of\\nMedicine, Royal Adelaide Hospital\\nPituitary Disorders\\nRACHEL L. CHAPMAN, MD\\nAssociate Professor of Pediatrics, Division of\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n21\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 30, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Neonatal-Perinatal Medicine, University of\\nMichigan, C.S. Mott Children's Hospital\\nApproach to the Care of Normal Infants and\\nChildren; Perinatal Physiology; Caring for\\nSick Children and Their Families\\nWILLIAM J. COCHRAN, MD\\nVice Chairman, Department of Pediatrics,\\nGeisinger Clinic, Danville, PA\\nGastrointestinal Disorders in Neonates and\\nInfants; Congenital Gastrointestinal Anomalies\\nALAN S. COHEN, MD\\nDistinguished Professor of Medicine (Emeritus),\\nConrad Wessolhoeft Professor of Medicine,\\nBoston University School of Medicine; Editor-\\nin-Chief, Amyloid: The Journal of Protein\\nFolding Disorders\\nAmyloidosis\\nROBERT B. COHEN, DMD\\nClinical Associate Professor of Dentistry and\\nPractice Coordinator, Tufts University School\\nof Dental Medicine\\nApproach to Dental and Oral Symptoms\\nSIDNEY COHEN, MD\\nProfessor of Medicine and Director, Research\\nPrograms, Thomas Jefferson University\\nSchool of Medicine\\nGastritis and Peptic Ulcer Disease; Bezoars\\nand Foreign Bodies; Hepatitis\\nKATHRYN COLBY, MD, PhD\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 30, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Professor of Medicine and Director, Research\\nPrograms, Thomas Jefferson University\\nSchool of Medicine\\nGastritis and Peptic Ulcer Disease; Bezoars\\nand Foreign Bodies; Hepatitis\\nKATHRYN COLBY, MD, PhD\\nAssistant Professor of Ophthalmology, Harvard\\nMedical School; Director, Clinical Research\\nCenter, Massachusetts Eye and Ear Infirmary\\nApproach to the Ophthalmologic Patient;\\nCataract; Eye Injuries\\nDANIEL W. COLLISON, MD\\nAssociate Professor of Medicine and Surgery,\\nSection of Dermatology, Dartmouth Medical\\nSchool\\nSweating Disorders; Benign Tumors; Pressure\\nUlcers\\nEVE R. COLSON, MD\\nAssociate Professor of Pediatrics, Yale\\nUniversity School of Medicine; Director, Well\\nNewborn Nursery, Yale-New Haven Children's\\nHospital\\nApproach to the Care of Normal Infants and\\nChildren; Perinatal Physiology; Caring for\\nSick Children and Their Families\\nMARY ANN COOPER, MD\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n22\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 31, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Professor, Department of Emergency\\nMedicine, University of Illinois at Chicago\\nElectrical and Lightning Injuries\\nWILLIAM CORYELL, MD\\nGeorge Winokur Professor of Psychiatry,\\nUniversity of Iowa\\nMood Disorders\\nBRYAN D. COWAN, MD\\nProfessor and Chairman, Department of\\nObstetrics and Gynecology, University of\\nMississippi Medical Center\\nUterine Fibroids\\nJILL P. CRANDALL, MD\\nAssociate Professor of Clinical Medicine,\\nAlbert Einstein College of Medicine\\nDiabetes Mellitus and Disorders of\\nCarbohydrate Metabolism\\nRICARDO CRUCIANI, MD, PhD\\nClinical Assistant and Professor, Department\\nof Neurology and Anesthesiology, Albert\\nEinstein College of Medicine; Director,\\nResearch Division, Department of Pain\\nMedicine and Palliative Care, Beth Israel\\nMedical Center\\nNeurotransmission\\nBURKE A. CUNHA, MD\\nProfessor of Medicine, State University of\\nNew York School of Medicine, Stony Brook;\\nChief, Infectious Disease Division, Winthrop-\\nUniversity Hospital, Mineola\\nGram-Negative Bacilli; Spirochetes'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 31, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Professor of Medicine, State University of\\nNew York School of Medicine, Stony Brook;\\nChief, Infectious Disease Division, Winthrop-\\nUniversity Hospital, Mineola\\nGram-Negative Bacilli; Spirochetes\\nEMMETT T. CUNNINGHAM, Jr., MD,\\nPhD, MPH\\nProfessor of Ophthalmology, Stanford\\nUniversity; Director, The Uveitis Service,\\nCalifornia Pacific Medical Center and Clinic\\nUveitis\\nDREW C. CUTLER, MD\\nAssociate Professor of Pediatrics, Loma Linda\\nUniversity School of Medicine\\nCystic Kidney Disease\\nRALPH E. CUTLER, MD (Deceased)\\nProfessor of Medicine (Emeritus), Loma Linda\\nUniversity School of Medicine; Consultant in\\nNephrology, Loma Linda VA Medical Center\\nObstructive Uropathy; Urinary Tract Infections\\nPATRICIA A. DALY, MD\\nVisiting Assistant Professor of Medicine,\\nUniversity of Virginia; Clinical Endocrinologist,\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n23'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 32, 'source_type': 'Authorotative', 'priority': '1'}, page_content='y\\ng\\n;\\ng\\n,\\nFront Royal Internal Medicine, VA\\nMultiple Endocrine Neoplasia Syndromes\\nDANIEL F. DANZL, MD\\nProfessor and Chair of Emergency Medicine,\\nUniversity of Louisville School of Medicine\\nCold Injury\\nNORMAN L. DEAN, MD\\nFellow (Emeritus), American College of Chest\\nPhysicians; Lifetime Fellow, American College\\nof Physicians\\nDrowning\\nALAN H. DeCHERNEY, MD\\nBranch Chief, Reproductive Biology and\\nMedicine, National Institute of Child Health\\nand Human Development, National Institutes\\nof Health\\nEndometriosis\\nPETER J. DELVES, PhD\\nReader in Immunology, Department of\\nImmunology and Molecular Pathology,\\nDivision of Infection and Immunity, University\\nCollege London\\nBiology of the Immune System; Allergic and\\nOther Hypersensitivity Disorders\\nARA DerMARDEROSIAN, PhD\\nProfessor of Pharmacognosy and Medicinal\\nChemistry, Roth Chair of Natural Products,\\nScientific Director, Complementary and\\nAlternative Medicine Institute, University of\\nthe Sciences in Philadelphia\\nDietary Supplements'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 32, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chemistry, Roth Chair of Natural Products,\\nScientific Director, Complementary and\\nAlternative Medicine Institute, University of\\nthe Sciences in Philadelphia\\nDietary Supplements\\nDEEPINDER K. DHALIWAL, MD\\nAssociate Professor, Department of\\nOphthalmology, University of Pittsburgh\\nSchool of Medicine; Director of Cornea/\\nExternal Disease and Director of Refractive\\nSurgery, University of Pittsburgh Medical\\nCenter Eye Center; Medical Director,\\nUniversity of Pittsburgh Medical Center Laser\\nCenter; Director and Founder, Center for\\nIntegrative Eye Care, University of Pittsburgh\\nRefractive Error\\nA. DAMIAN DHAR, MD, JD\\nPrivate Practice, North Atlanta Dermatology\\nBacterial Skin Infections; Fungal Skin Infections\\nMICHAEL C. DiMARINO, MD\\nClinical Assistant Professor of Medicine,\\nDivision of Gastroenterology and Hepatology,\\nDepartment of Medicine, Thomas Jefferson\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n24'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 33, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"University\\nEsophageal and Swallowing Disorders;\\nDiverticular Disease\\nJAMES G.H. DINULOS, MD\\nAssistant Professor of Medicine and Pediatrics\\n(Medicine), Dartmouth Medical School\\nParasitic Skin Infections; Viral Skin Diseases;\\nCornification Disorders\\nCAROLINE CARNEY DOEBBELING,\\nMD, MSc\\nChief Executive Officer, Cetan Health\\nConsultants LLC; Associate Professor of\\nInternal Medicine and Psychiatry, Indiana\\nUniversity School of Medicine; Research\\nScientist, Regenstrief Institute\\nApproach to the Patient With Mental Symptoms\\nKARL DOGHRAMJI, MD\\nProfessor of Psychiatry and Human Behavior\\nand Medical Director, Jefferson Sleep\\nDisorders Center, Thomas Jefferson University\\nSleep and Wakefulness Disorders\\nDANIEL A. DOYLE, MD\\nAssociate Professor of Pediatrics, Thomas\\nJefferson University; Division of Endocrinology,\\nA.I. duPont Children's Hospital\\nPhysical Growth and Development\\nANTONETTE T. DULAY, MD\\nAssistant Professor, Division of Maternal-\\nFetal Medicine, Department of Obstetrics,\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 33, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"A.I. duPont Children's Hospital\\nPhysical Growth and Development\\nANTONETTE T. DULAY, MD\\nAssistant Professor, Division of Maternal-\\nFetal Medicine, Department of Obstetrics,\\nGynecology, and Reproductive Sciences,\\nYale University School of Medicine\\nAbnormalities of Pregnancy\\nJEFFREY S. DUNGAN, MD\\nAssociate Professor, Department of Obstetrics\\nand Gynecology, Northwestern University,\\nFeinberg School of Medicine\\nPrenatal Genetic Counseling and Evaluation\\nSOUMITRA R. EACHEMPATI, MD\\nAssociate Professor of Surgery and Public\\nHealth, Weill Cornell Medical College\\nApproach to the Critically Ill Patient\\nMEGAN A. ECONOMIDIS, MD\\nAssociate Director, Fellowship in Family\\nPlanning, Department of Obstetrics and\\nGynecology, Keck School of Medicine,\\nUniversity of Southern California\\nFamily Planning\\nDAVID EIDELBERG, MD\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n25\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 34, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Susan and Leonard Feinstein Professor of\\nNeurology and Neurosurgery, New York\\nUniversity School of Medicine; Director,\\nCenter for Neurosciences, The Feinstein\\nInstitute for Medical Research, North Shore-\\nLong Island Jewish Health System\\nMovement and Cerebellar Disorders\\nSHERMAN ELIAS, MD\\nJohn J. Sciarra Professor and Chair,\\nDepartment of Obstetrics and Gynecology,\\nNorthwestern University, Feinberg School\\nof Medicine; Chairman, Obstetrics and\\nGynecology, Prentice Women's Hospital of\\nNorthwestern Memorial Hospital\\nPrenatal Genetic Counseling and Evaluation\\nNORAH C. FEENY, PhD\\nAssociate Professor, Department of Psychology,\\nCase Western Reserve University\\nMedical Examination of the Rape Victim\\nMICHAEL C. FIORE, MD\\nProfessor of Medicine, University of\\nWisconsin School of Medicine and Public\\nHealth; Director, University of Wisconsin\\nCenter for Tobacco Research and Intervention\\nSmoking Cessation\\nCHIN-TO FONG, MD\\nAssociate Professor of Pediatrics and Medicine,\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 34, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Health; Director, University of Wisconsin\\nCenter for Tobacco Research and Intervention\\nSmoking Cessation\\nCHIN-TO FONG, MD\\nAssociate Professor of Pediatrics and Medicine,\\nBiochemistry & Biophysics, Medical Humanities\\nand Dentistry; Chief, Division of Genetics,\\nDepartment of Pediatrics and Medicine;\\nUniversity of Rochester School of Medicine\\nand Dentistry\\nInherited Disorders of Metabolism\\nSTEVEN D. FREEDMAN, MD, PhD\\nAssociate Professor of Medicine, Harvard\\nMedical School; Director, The Pancreas\\nCenter, Beth Israel Deaconess Medical Center\\nPancreatitis\\nEMIL J FREIREICH, MD\\nProfessor, Department of Leukemia, and\\nDirector, Adult Leukemia Research Programs,\\nThe University of Texas MD Anderson Cancer\\nCenter\\nLeukemias\\nEUGENE P. FRENKEL, MD\\nProfessor of Internal Medicine and Radiology,\\nPatsy R. and Raymond D. Nasher Distinguished\\nChair in Cancer Research; Elaine Dewey\\nSammons Distinguished Chair in Cancer\\nResearch in honor of Eugene P. Frenkel, MD;\\nand A. Kenneth Pye Professorship in Cancer'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 34, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chair in Cancer Research; Elaine Dewey\\nSammons Distinguished Chair in Cancer\\nResearch in honor of Eugene P. Frenkel, MD;\\nand A. Kenneth Pye Professorship in Cancer\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n26'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 35, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Research, Harold C. Simmons Comprehensive\\nCancer Center, The University of Texas\\nSouthwestern Medical Center at Dallas\\nIron Overload\\nMARVIN P. FRIED, MD\\nProfessor and Chairman, Department of\\nOtorhinolaryngology-Head & Neck Surgery,\\nAlbert Einstein College of Medicine and\\nMontefiore Medical Center\\nApproach to the Patient With Nasal and\\nPharyngeal Symptoms; Nose and Paranasal\\nSinus Disorders\\nMITCHELL H. FRIEDLAENDER, MD\\nAdjunct Professor, The Scripps Research\\nInstitute; Head, Division of Ophthalmology,\\nScripps Clinic\\nConjunctival and Scleral Disorders\\nDMITRY GABRILOVICH, MD, PhD\\nRobert Rothman Endowed Chair in Cancer\\nResearch, Head, Section of Dendritic Cell\\nBiology, H. Lee Moffitt Cancer Center and\\nResearch Institute; Professor of Oncologic\\nSciences and Molecular Medicine, University\\nof South Florida\\nTumor Immunology\\nSUNIR J. GARG, MD\\nAssistant Professor of Ophthalmology, Thomas\\nJefferson University; Assistant Surgeon, The\\nRetina Service of Wills Eye Institute\\nRetinal Disorders'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 35, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of South Florida\\nTumor Immunology\\nSUNIR J. GARG, MD\\nAssistant Professor of Ophthalmology, Thomas\\nJefferson University; Assistant Surgeon, The\\nRetina Service of Wills Eye Institute\\nRetinal Disorders\\nJAMES GARRITY, MD\\nWhitney and Betty MacMillan Professor of\\nOphthalmology, Mayo Clinic\\nEyelid and Lacrimal Disorders; Optic Nerve\\nDisorders; Orbital Diseases\\nBRIAN K. GEHLBACH, MD\\nAssistant Professor of Medicine, Section of\\nPulmonary and Critical Medicine, University\\nof Chicago\\nRespiratory Failure and Mechanical Ventilation\\nJAMES N. GEORGE, MD\\nGeorge Lynn Cross Research Professor,\\nDepartment of Medicine, College of Medicine\\nand Department of Biostatistics and\\nEpidemiology, College of Public Health,\\nThe University of Oklahoma Health Sciences\\nCenter\\nThrombocytopenia and Platelet Dysfunction;\\nBleeding Due to Abnormal Blood Vessels\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n27'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 36, 'source_type': 'Authorotative', 'priority': '1'}, page_content='DAVID M. GERSHENSON, MD\\nProfessor and Chairman, Department of\\nGynecologic Oncology and J. Taylor Wharton,\\nMD, Distinguished Chair in Gynecologic\\nOncology, The University of Texas MD\\nAnderson Cancer Center\\nGynecologic Tumors\\nELIAS A. GIRALDO, MD\\nAssistant Professor and Senior Associate\\nConsultant, Department of Neurology, Mayo\\nClinic\\nStroke\\nANNE CAROL GOLDBERG, MD\\nAssociate Professor of Medicine, Washington\\nUniversity School of Medicine\\nLipid Disorders\\nSTEPHEN E. GOLDFINGER, MD\\nProfessor of Medicine, Harvard Medical\\nSchool; Physician, Massachusetts General\\nHospital\\nHereditary Periodic Fever Syndromes\\nM. JAY GOODKIND, MD\\nAssociate Professor (Emeritus) of Clinical\\nMedicine, University of Pennsylvania School\\nof Medicine; Chief of Cardiology (Retired),\\nMercer Medical Center\\nCardiac Tumors\\nCARMEN E. GOTA, MD\\nStaff Physician, Department of Rheumatology,\\nCleveland Clinic Foundation\\nVasculitis\\nNORTON J. GREENBERGER, MD\\nClinical Professor of Medicine, Harvard'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 36, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Cardiac Tumors\\nCARMEN E. GOTA, MD\\nStaff Physician, Department of Rheumatology,\\nCleveland Clinic Foundation\\nVasculitis\\nNORTON J. GREENBERGER, MD\\nClinical Professor of Medicine, Harvard\\nMedical School; Senior Physician, Brigham\\nand Women's Hospital\\nApproach to the Patient With Upper GI\\nComplaints; Diagnostic and Therapeutic GI\\nProcedures\\nJOHN H. GREIST, MD\\nClinical Professor of Psychiatry, University\\nof Wisconsin; Distinguished Senior Scientist,\\nMadison Institute of Medicine\\nAnxiety Disorders\\nASHLEY B. GROSSMAN, MD\\nProfessor of Neuroendocrinology, St.\\nBartholomew's Hospital and The London\\nSchool of Medicine\\nAdrenal Disorders\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n28\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 37, 'source_type': 'Authorotative', 'priority': '1'}, page_content='JOHN G. GUNDERSON, MD\\nProfessor of Psychiatry, Harvard Medical\\nSchool; Director, Psychosocial and Personality\\nResearch, Borderline Personality Disorder\\nCenter, McLean Hospital\\nPersonality Disorders\\nRULA A. HAJJ-ALI, MD\\nStaff Physician, Center of Vasculitis Care\\nand Research, Department of Rheumatic and\\nImmunologic Disease, Cleveland Clinic\\nFoundation\\nAutoimmune Rheumatic Disorders\\nJESSE B. HALL, MD\\nProfessor of Medicine, Department of\\nAnesthesia and Critical Care and Section\\nChief, Pulmonary and Critical Care Medicine,\\nUniversity of Chicago\\nRespiratory Failure and Mechanical Ventilation\\nJUDITH G. HALL, MD\\nProfessor Emeritus of Pediatrics and Medical\\nGenetics, University of British Columbia\\nGeneral Principles of Medical Genetics\\nJOHN W. HALLETT, Jr., MD\\nClinical Professor of Surgery, Medical\\nUniversity of South Carolina; Medical Director\\nand Vascular Surgeon, Roper St. Francis Heart\\nand Vascular Center\\nDiseases of the Aorta and Its Branches;\\nPeripheral Arterial Disorders'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 37, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"University of South Carolina; Medical Director\\nand Vascular Surgeon, Roper St. Francis Heart\\nand Vascular Center\\nDiseases of the Aorta and Its Branches;\\nPeripheral Arterial Disorders\\nKEVIN C. HAZEN, PhD\\nProfessor of Pathology and Microbiology\\nand Director of Clinical Microbiology and\\nMolecular Diagnostics-Infectious Disease,\\nUniversity of Virginia Health System\\nLaboratory Diagnosis of Infectious Disease\\nR. PHILLIPS HEINE, MD\\nAssociate Professor, Division of Maternal-\\nFetal Medicine, Department of Obstetrics and\\nGynecology, Duke University Medical Center\\nApproach to the Pregnant Woman and Prenatal\\nCare\\nMELISSA R. HELD, MD\\nAssistant Professor of Pediatrics, University of\\nConnecticut School of Medicine; Director,\\nInpatient Pediatrics Clerkship, Connecticut\\nChildren's Medical Center\\nApproach to the Care of Normal Infants and\\nChildren\\nSUSAN L. HENDRIX, DO\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n29\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 38, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Clinical Professor, Department of Obstetrics and\\nGynecology, Michigan State University School\\nof Osteopathic Medicine, and a partner in Hutzel\\nWomen's Hospital at the Detroit Medical Center\\nMenopause\\nSTEVEN K. HERRINE, MD\\nProfessor of Medicine, Division of\\nGastroenterology and Hepatology, Thomas\\nJefferson University; Assistant Dean for\\nAcademic Affairs, Jefferson Medical College\\nApproach to the Patient With Liver Disease;\\nDrugs and the Liver; Liver Masses and\\nGranulomas\\nJEROME M. HERSHMAN, MD\\nDistinguished Professor of Medicine, David\\nGeffen School of Medicine, University of\\nCalifornia, Los Angeles; Associate Chief,\\nEndocrinology and Diabetes Division, West\\nLos Angeles VA Medical Center\\nThyroid Disorders\\nMARTIN HERTL, MD, PhD\\nAssistant Professor of Surgery, Harvard\\nMedical School; Surgical Director, Liver\\nTransplantation Program, Massachusetts\\nGeneral Hospital\\nTransplantation\\nROBERT M. A. HIRSCHFELD, MD\\nHarry K. Davis Professor, Titus H. Harris\\nChair, Department of Psychiatry and\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 38, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Transplantation Program, Massachusetts\\nGeneral Hospital\\nTransplantation\\nROBERT M. A. HIRSCHFELD, MD\\nHarry K. Davis Professor, Titus H. Harris\\nChair, Department of Psychiatry and\\nBehavioral Sciences, The University of Texas\\nMedical Branch at Galveston\\nSuicidal Behavior\\nBRIAN D. HOIT, MD\\nProfessor of Medicine and Physiology and\\nBiophysics, Case Western Reserve University;\\nDirector of Echocardiography, University\\nHospitals of Cleveland\\nPericarditis\\nWAUN KI HONG, MD\\nAmerican Cancer Society Professor and\\nSamsung Distinguished University Chair in\\nCancer Medicine; Professor of Medicine,\\nDepartment of Thoracic/Head and Neck\\nMedical Oncology, and Head, Division of\\nCancer Medicine, The University of Texas\\nMD Anderson Cancer Center\\nTumors of the Lungs\\nDANIEL A. HUSSAR, PhD\\nRemington Professor of Pharmacy, Philadelphia\\nCollege of Pharmacy, University of the Sciences\\nin Philadelphia\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n30'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 39, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Concepts in Pharmacotherapy\\nMICHAEL JACEWICZ, MD\\nProfessor of Neurology, University of\\nTennessee Health Science Center; Assistant\\nChief of Neurology, VA Medical Center,\\nMemphis\\nApproach to the Neurologic Patient;\\nNeuro-Ophthalmologic and Cranial Nerve\\nDisorders; Meningitis; Brain Infections\\nHARRY S. JACOB, MD\\nProfessor of Medicine, University of\\nMinnesota Medical School; Editor-in-Chief,\\nHematology/Oncology Today\\nSpleen Disorders\\nJON A. JACOBSON, MD\\nAssociate Professor of Radiology, University\\nof Michigan\\nPrinciples of Radiologic Imaging\\nNAVIN JAIPAUL, MD, MHS\\nAssistant Professor of Medicine, Loma Linda\\nUniversity School of Medicine; Staff\\nNephrologist, VA Loma Linda Healthcare\\nSystem\\nTubulointerstitial Diseases\\nJAMES W. JEFFERSON, MD\\nClinical Professor of Psychiatry, University of\\nWisconsin; Distinguished Senior Scientist,\\nMadison Institute of Medicine\\nAnxiety Disorders\\nJANI R. JENSEN, MD\\nFellow, Reproductive Endocrinology and\\nInfertility, The University of Texas Health'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 39, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Wisconsin; Distinguished Senior Scientist,\\nMadison Institute of Medicine\\nAnxiety Disorders\\nJANI R. JENSEN, MD\\nFellow, Reproductive Endocrinology and\\nInfertility, The University of Texas Health\\nScience Center at San Antonio\\nFemale Reproductive Endocrinology\\nLARRY E. JOHNSON, MD, PhD\\nAssociate Professor of Geriatrics and\\nFamily and Preventive Medicine, University\\nof Arkansas for Medical Sciences; Attending\\nPhysician, Central Arkansas Veterans\\nHealthcare System\\nVitamin Deficiency, Dependency, and Toxicity;\\nMineral Deficiency and Toxicity\\nROBERT G. JOHNSON, MD\\nC. Rollins Hanlon Professor and Chair,\\nDepartment of Surgery, Saint Louis University\\nSchool of Medicine\\nCare of the Surgical Patient\\nBRIAN D. JOHNSTON\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n31'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 40, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Fitness Clinician and Educator with the\\nInternational Association of Resistance\\nTrainers, Ontario\\nExercise and Sports Injury\\nHUGH F. JOHNSTON, MD\\nClinical Associate Professor, Department of\\nPsychiatry and Office of Continuing Medical\\nEducation, University of Wisconsin Medical\\nSchool; Medical Director, Bureau of Mental\\nHealth and Substance Abuse\\nMental Disorders in Children and Adolescents\\nTHOMAS V. JONES, MD, MPH\\nDirector, Inflammatory Diseases, Specialty\\nCare Business Unit, Pfizer\\nMotion Sickness\\nNICHOLAS JOSPE, MD\\nProfessor of Pediatrics, University of\\nRochester School of Medicine and Dentistry\\nMetabolic, Electrolyte, and Toxic Disorders in\\nNeonates; Endocrine Disorders in Children\\nMICHAEL J. JOYCE, MD\\nAssociate Clinical Professor, Orthopaedic\\nSurgery, Case Western Reserve University;\\nOrthopaedic Surgeon, Cleveland Clinic\\nTumors of Bones and Joints\\nJAMES O. JUDGE, MD\\nAssociate Clinical Professor of Medicine,\\nUniversity of Connecticut School of Medicine;'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 40, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Orthopaedic Surgeon, Cleveland Clinic\\nTumors of Bones and Joints\\nJAMES O. JUDGE, MD\\nAssociate Clinical Professor of Medicine,\\nUniversity of Connecticut School of Medicine;\\nMedical Director, Evercare Connecticut\\nGait Disorders in the Elderly\\nANAND D. KANTAK, MD\\nClinical Associate Professor of Pediatrics,\\nNortheastern Ohio Universities Colleges of\\nMedicine and Pharmacology, Rootstown;\\nDirector, Division of Neonatology, Akron\\nChildren's Hospital\\nRespiratory Disorders in Neonates, Infants,\\nand Young Children\\nDANIEL B. KAPLAN, MSW\\nDoctoral Student, Columbia University School\\nof Social Work; Program Evaluator, Hartford\\nFaculty Scholars Program\\nSocial Issues in the Elderly\\nKENNETH M. KAYE, MD\\nAssistant Professor, Division of Infectious\\nDiseases, Department of Medicine, Brigham and\\nWomen's Hospital, Harvard Medical School\\nViruses; Herpesviruses; Arboviridae,\\nArenaviridae, and Filoviridae\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n32\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 41, 'source_type': 'Authorotative', 'priority': '1'}, page_content='JAMES W. KENDIG, MD (Deceased)\\nProfessor of Pediatrics, Penn State University\\nCollege of Medicine\\nPerinatal Problems\\nTALMADGE E. KING, Jr., MD\\nChief, Department of Medicine; Julius R.\\nKrevans Distinguished Professorship in\\nInternal Medicine, University of California,\\nSan Francisco\\nInterstitial Lung Diseases\\nJAMES P. KNOCHEL, MD\\nClinical Professor of Internal Medicine, The\\nUniversity of Texas Southwestern Medical\\nCenter at Dallas; Past Chairman, Department\\nof Internal Medicine, Presbyterian Hospital of\\nDallas\\nHeat Illness\\nKAREN BIRCKELBAW KOPACEK, RPh\\nClinical Assistant Professor and Clinical\\nPharmacist, Division of Pharmacy Practice,\\nUniversity of Wisconsin School of Pharmacy\\nPharmacokinetics\\nDAVID N. KORONES, MD\\nAssociate Professor of Pediatrics, Oncology,\\nand Neurology, University of Rochester\\nMedical Center\\nPediatric Cancers\\nJULES Y.T. LAM, MD\\nAssociate Professor of Medicine, University\\nof Montreal; Cardiologist, Montreal Heart\\nInstitute\\nArteriosclerosis\\nLEWIS LANDSBERG, MD'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 41, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Medical Center\\nPediatric Cancers\\nJULES Y.T. LAM, MD\\nAssociate Professor of Medicine, University\\nof Montreal; Cardiologist, Montreal Heart\\nInstitute\\nArteriosclerosis\\nLEWIS LANDSBERG, MD\\nIrving S. Cutter Professor of Medicine and\\nDean (Emeritus), Northwestern University\\nMultiple Endocrine Neoplasia Syndromes\\nNOAH LECHTZIN, MD, MHS\\nAssistant Professor, Department of Medicine,\\nDivision of Pulmonary and Critical Care\\nMedicine, Johns Hopkins University School of\\nMedicine\\nApproach to the Patient With Pulmonary\\nSymptoms; Diagnostic and Therapeutic\\nPulmonary Procedures\\nMATHEW H.M. LEE, MD\\nHoward A. Rusk Professor of Rehabilitation\\nMedicine and Chairman, Department of\\nRehabilitation Medicine, New York University\\nSchool of Medicine\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n33'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 42, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Rehabilitation\\nJOSEPH R. LENTINO, MD, PhD\\nProfessor of Medicine, Loyola University\\nStritch School of Medicine; Chief, Infectious\\nDiseases, Hines VA Hospital\\nAnaerobic Bacteria\\nWENDY S. LEVINBOOK, MD\\nAssistant Professor of Dermatology,\\nUniversity of Connecticut Health Center\\nHair Disorders\\nMATTHEW E. LEVISON, MD\\nAdjunct Professor of Medicine, Drexel\\nUniversity College of Medicine; Professor,\\nSchool of Public Health, Drexel University\\nBacteria and Antibacterial Drugs\\nRICHARD LEVITAN, MD\\nAssociate Professor of Emergency Medicine,\\nThomas Jefferson University Hospitals;\\nPresident, Airway Cam Tech, Inc.\\nRespiratory Arrest\\nSHARON LEVY, MD, MPH\\nAssistant Professor of Pediatrics, Harvard\\nMedical School; Center for Adolescent\\nSubstance Abuse Research, Children's\\nHospital, Boston\\nApproach to the Care of Adolescents\\nJAMES L. LEWIS, III, MD\\nNephrology Associates, P.C. of Birmingham\\nFluid and Electrolyte Metabolism; Acid-Base\\nRegulation and Disorders\\nALAN E. LICHTIN, MD\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 42, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Approach to the Care of Adolescents\\nJAMES L. LEWIS, III, MD\\nNephrology Associates, P.C. of Birmingham\\nFluid and Electrolyte Metabolism; Acid-Base\\nRegulation and Disorders\\nALAN E. LICHTIN, MD\\nAssociate Professor, Department of Medicine,\\nCleveland Clinic Lerner College of Medicine\\nof Case Western Reserve; Staff Physician,\\nHematologic Oncology and Blood Disorders,\\nCleveland Clinic\\nApproach to the Patient With Anemia; Anemias\\nCaused by Deficient Erythropoiesis; Anemias\\nCaused by Hemolysis\\nPAUL LAWRENCE LIEBERT, MD\\nPrivate Practice, Tomah Memorial Hospital,\\nTomah, WI\\nExercise and Sports Injury\\nRICHARD W. LIGHT, MD\\nProfessor of Medicine, Division of Allergy,\\nPulmonary, and Critical Care Medicine,\\nVanderbilt University Medical Center\\nMediastinal and Pleural Disorders\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n34'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 43, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"GREGORY S. LIPTAK, MD, MPH\\nProfessor of Pediatrics, and Director, Center\\nfor Development, Behavior, and Genetics,\\nUpstate Medical University\\nCongenital Craniofacial and Musculoskeletal\\nAbnormalities; Congenital Neurologic Anomalies;\\nChromosomal Anomalies\\nJEFFREY M. LIPTON, MD, PhD\\nChief, Hematology/Oncology, Schneider\\nChildren's Hospital; Professor of Pediatrics,\\nAlbert Einstein College of Medicine\\nHistiocytic Syndromes\\nELLIOT M. LIVSTONE, MD\\nAttending Physician, Sarasota Memorial\\nHospital, Sarasota, FL\\nTumors of the GI Tract\\nPHILIP LOW, MD\\nRobert D. and Patricia E. Kern Professor of\\nNeurology, Mayo Clinic College of Medicine\\nAutonomic Nervous System\\nPAUL D. LUI, MD\\nAssociate Professor of Urology, Loma Linda\\nUniversity School of Medicine\\nVoiding Disorders; Penile and Scrotal\\nDisorders\\nJOANNE LYNN, MD, MA, MS\\nClinical Improvement Expert, Colorado\\nFoundation for Medical Care\\nThe Dying Patient\\nROBERT J. MacNEAL, MD\\nAssistant Professor, Department of General\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 43, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Disorders\\nJOANNE LYNN, MD, MA, MS\\nClinical Improvement Expert, Colorado\\nFoundation for Medical Care\\nThe Dying Patient\\nROBERT J. MacNEAL, MD\\nAssistant Professor, Department of General\\nInternal Medicine and Section of Dermatology,\\nDartmouth Hitchcock Medical Center\\nApproach to the Dermatologic Patient;\\nReactions to Sunlight\\nMARCELLA A. MADERA, MD\\nInstructor, Department of Neurosurgery, Johns\\nHopkins University School of Medicine\\nTraumatic Brain Injury\\nKENNETH MAIESE, MD\\nProfessor and Chair, Department of Neurology\\nand Neurosciences, University of Dentistry and\\nMedicine of New Jersey\\nComa and Impaired Consciousness\\nJAMES F. MARKMANN, MD, PhD\\nProfessor of Surgery, Harvard Medical School;\\nClinical Director, Division of Transplantation,\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n35'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 44, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Massachusetts General Hospital\\nTransplantation\\nJOHN T. McBRIDE, MD\\nProfessor of Pediatrics, Northeastern Ohio\\nUniversities Colleges of Medicine and\\nPharmacology, Rootstown; Vice-Chair,\\nDepartment of Pediatrics, Akron Children's\\nHospital\\nRespiratory Disorders in Neonates, Infants,\\nand Young Children\\nMARGARET C. McBRIDE, MD\\nProfessor of Pediatrics (Neurology),\\nNortheastern Ohio Universities Colleges of\\nMedicine and Pharmacology, Rootstown;\\nDirector, Neurodevelopmental Center,\\nAkron Children's Hospital\\nNeurologic Disorders in Children;\\nNeurocutaneous Syndromes\\nDANIEL J. McCARTY, MD\\nWill and Cava Ross Professor of Medicine\\n(Emeritus), Medical College of Wisconsin\\nCrystal-Induced Arthritides\\nJ. ALLEN McCUTCHAN, MD, MSc\\nProfessor of Medicine, Division of Infectious\\nDiseases, School of Medicine, University of\\nCalifornia at San Diego\\nHuman Immunodeficiency Virus; Sexually\\nTransmitted Diseases\\nDOUGLAS L. McGEE, DO\\nDirector, Emergency Medicine Residency\\nProgram, Albert Einstein Medical Center;\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 44, 'source_type': 'Authorotative', 'priority': '1'}, page_content='California at San Diego\\nHuman Immunodeficiency Virus; Sexually\\nTransmitted Diseases\\nDOUGLAS L. McGEE, DO\\nDirector, Emergency Medicine Residency\\nProgram, Albert Einstein Medical Center;\\nChief Academic Officer, Albert Einstein\\nHealthcare Network\\nClinical Decision Making\\nDANIEL E. McGINLEY-SMITH, MD\\nPrivate Practice, New England Dermatology,\\nLebanon, NH; Staff Dermatologist, New London\\nHospital\\nPigmentation Disorders\\nROBERT S. McKELVIE, MD, PhD, MSc\\nProfessor of Medicine, McMaster University;\\nMedical Director, Cardiac Health and\\nRehabilitation Center\\nSports and the Heart\\nKAREN McKOY, MD, MPH\\nAssistant Professor in Clinical Dermatology,\\nHarvard Medical School; Senior Staff, Group\\nPractice, Department of Dermatology, Lahey\\nClinic Medical Center\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n36'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 45, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Acne and Related Disorders; Dermatitis;\\nPrinciples of Topical Dermatologic Therapy\\nJAMES I. McMILLAN, MD\\nAssociate Professor of Medicine, Loma Linda\\nUniversity; Chief of Nephrology, VA Loma\\nLinda Healthcare System\\nRenal Failure; Renal Replacement Therapy;\\nGlomerular Disorders\\nS. GENE McNEELEY, MD\\nChief of Gynecology, Hutzel Women's\\nHospital; Clinical Professor, Michigan State\\nUniversity, College of Osteopathic Medicine,\\nHutzel Women's Health Specialists\\nBenign Gynecologic Lesions; Pelvic Relaxation\\nSyndromes\\nNOSHIR R. MEHTA, DMD, MDS, MS\\nProfessor and Chairman of General Dentistry;\\nAssistant Dean, International Relations; and\\nDirector, Craniofacial Pain Center, Tufts\\nUniversity School of Dental Medicine\\nTemporomandibular Disorders\\nDANIEL R. MISHELL, Jr., MD\\nThe Lyle G. McNeile Professor, Department\\nof Obstetrics and Gynecology, Keck School of\\nMedicine, University of Southern California;\\nChief Physician, Women's and Children's\\nHospital, Los Angeles County and University\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 45, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"of Obstetrics and Gynecology, Keck School of\\nMedicine, University of Southern California;\\nChief Physician, Women's and Children's\\nHospital, Los Angeles County and University\\nof Southern California Medical Center\\nFamily Planning\\nL. BRENT MITCHELL, MD\\nProfessor and Head, Department of Cardiac\\nSciences, University of Calgary; Director,\\nLibin Cardiovascular Institute of Alberta,\\nCalgary Health Region and University of\\nCalgary\\nArrhythmias and Conduction Disorders\\nRICHARD T. MIYAMOTO, MD\\nArilla Spence DeVault Professor and\\nChairman, Department of Otolaryngology-\\nHead & Neck Surgery, Indiana University\\nSchool of Medicine\\nMiddle Ear and Tympanic Membrane Disorders\\nJOEL L. MOAKE, MD\\nSenior Research Scientist, Rice University;\\nProfessor of Medicine (Emeritus), Baylor\\nCollege of Medicine\\nHemostasis; Coagulation Disorders;\\nThrombotic Disorders\\nJULIE S. MOLDENHAUER, MD\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n37\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 46, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Attending Physician, The Center for Fetal\\nDiagnosis and Treatment, The Children's\\nHospital of Philadelphia\\nAbnormalities and Complications of Labor and\\nDelivery; Postpartum Care\\nJOHN E. MORLEY, MB, BCh\\nDammert Professor of Gerontology and\\nDirector, Division of Geriatric Medicine, Saint\\nLouis University Medical Center; Director,\\nGeriatric Research, Education and Clinical\\nCenter, St. Louis VA Medical Center\\nUndernutrition; Principles of Endocrinology\\nANGELA CAFIERO MORONEY,\\nPharmD\\nSenior Clinical Science Manager and Global\\nPharmaceutical Research and Development,\\nAbbott Laboratories\\nPharmacodynamics\\nALEX MOROZ, MD\\nAssistant Professor, Department of\\nRehabilitation Medicine, New York\\nUniversity School of Medicine; Director of\\nMusculoskeletal Rehabilitation Unit and\\nDirector of Residency Training and Medical\\nEducation, Rusk Institute of Rehabilitation\\nMedicine\\nRehabilitation\\nJOHN MORRISON, MD\\nProfessor of Obstetrics/Gynecology and\\nPediatrics, University of Mississippi Medical\\nCenter\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 46, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Education, Rusk Institute of Rehabilitation\\nMedicine\\nRehabilitation\\nJOHN MORRISON, MD\\nProfessor of Obstetrics/Gynecology and\\nPediatrics, University of Mississippi Medical\\nCenter\\nHigh-Risk Pregnancy\\nSAM P. MOST, MD\\nChief, Division of Facial Plastic and\\nReconstructive Surgery, Stanford University\\nFacial Trauma\\nDAVID F. MURCHISON, DDS, MMS\\nColonel, United States Air Force; Director, Air\\nForce Dental Operations, United States Air Force\\nDental Service, Lackland-Kelly Air Force Base\\nDental Emergencies\\nCARLENE A. MUTO, MD, MS\\nAssistant Professor, Epidemiology and\\nMedicine, Division of Infectious Diseases,\\nUniversity of Pittsburgh School of Medicine;\\nMedical Director of Infection Control, Donald\\nD. Wolff, Jr. Center for Quality Improvement\\nand Innovation, University of Pittsburgh\\nMedical Center Health System\\nNeisseriaceae\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n38'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 47, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"RAJ K. NARAYAN, MD\\nFrank H. Mayfield Professor and Chairman,\\nThe Neuroscience Institute, Department of\\nNeurosurgery, University of Cincinnati\\nCollege of Medicine and Mayfield Clinic\\nTraumatic Brain Injury\\nEDWARD A. NARDELL, MD\\nAssociate Professor, Harvard Medical School,\\nHarvard School of Public Health, Brigham and\\nWomen's Hospital\\nMycobacteria\\nVICTOR J. NAVARRO, MD\\nProfessor of Medicine, Pharmacology and\\nExperimental Therapeutics and Medical\\nDirector, Hepatology and Liver Transplantation\\nProgram, Jefferson Medical College, Thomas\\nJefferson University\\nDrugs and the Liver\\nJOHN H. NEWMAN, MD\\nElsa S. Hanigan Professor of Pulmonary\\nMedicine, Vanderbilt University School of\\nMedicine\\nPulmonary Embolism; Pulmonary Hypertension\\nLEE S. NEWMAN, MD, MA\\nProfessor, Department of Environmental and\\nOccupational Health, Colorado School of\\nPublic Health and Department of Medicine,\\nUniversity of Colorado at Denver\\nEnvironmental Pulmonary Diseases;\\nSarcoidosis\\nJENNIFER R. NIEBYL, MD\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 47, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Occupational Health, Colorado School of\\nPublic Health and Department of Medicine,\\nUniversity of Colorado at Denver\\nEnvironmental Pulmonary Diseases;\\nSarcoidosis\\nJENNIFER R. NIEBYL, MD\\nProfessor, Department of Obstetrics and\\nGynecology, University of Iowa Carver\\nCollege of Medicine\\nConception and Prenatal Development\\nMARY LYNN R. NIERODZIK, MD\\nAssistant Professor, New York University\\nSchool of Medicine; Chief, Hematology/\\nOncology, Bellevue Hospital Center\\nEosinophilic Disorders\\nJAMES M. O'BRIEN, Jr., MD, MSc\\nAssociate Professor, Center for Critical Care,\\nDivision of Pulmonary, Allergy, Critical Care\\nand Sleep Medicine, The Ohio State University\\nMedical Center\\nTests of Pulmonary Function\\nPATRICK G. O'CONNOR, MD, MPH\\nProfessor of Medicine; Chief, Section of\\nGeneral Internal Medicine, Yale University\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n39\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 48, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"School of Medicine\\nDrug Use and Dependence\\nGERALD F. O'MALLEY, DO\\nClinical Research Director, Thomas Jefferson\\nUniversity\\nPoisoning\\nJOHN S. OGHALAI, MD\\nAssistant Professor of Otology, Neurotology,\\nand Skull Base Surgery, Baylor College of\\nMedicine; Director, The Hearing Center at\\nTexas Children's Hospital\\nInner Ear Disorders\\nJAMES T. PACALA, MD, MS\\nAssociate Professor and Distinguished\\nUniversity Teaching Professor, Family\\nPractice and Community Health, University\\nof Minnesota Medical School\\nPrevention of Disease and Disability in the\\nElderly\\nSTEVEN A. PAGET, MD\\nProfessor of Medicine and Physician in Chief,\\nDivision of Rheumatology, Hospital for\\nSpecial Surgery and Weill Cornell Medical\\nCollege\\nApproach to the Patient With Joint Disease\\nELIZABETH J. PALUMBO, MD\\nPrivate Practice, The Pediatric Group, Fairfax,\\nVA\\nMiscellaneous Disorders in Infants and\\nChildren\\nDAVID A. PAUL, MD\\nProfessor of Pediatrics, Jefferson Medical\\nCollege, Thomas Jefferson University;\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 48, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Private Practice, The Pediatric Group, Fairfax,\\nVA\\nMiscellaneous Disorders in Infants and\\nChildren\\nDAVID A. PAUL, MD\\nProfessor of Pediatrics, Jefferson Medical\\nCollege, Thomas Jefferson University;\\nAttending Neonatologist, Christiana Care\\nHealth System\\nPerinatal Hematologic Disorders\\nRICHARD D. PEARSON, MD\\nProfessor of Medicine and Pathology,\\nAssociate Dean for Student Affairs, University\\nof Virginia School of Medicine\\nApproach to Parasitic Infections; Nematodes;\\nTrematodes; Cestodes; Intestinal Protozoa;\\nExtraintestinal Protozoa\\nLAWRENCE L. PELLETIER, Jr., MD\\nProfessor, Internal Medicine, University of\\nKansas School of Medicine; Staff Physician,\\nRobert J. Dole VA Medical and Regional\\nOffice Center, Wichita\\nEndocarditis\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n40'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 49, 'source_type': 'Authorotative', 'priority': '1'}, page_content='MARIA T. PEREZ, MD\\nAssociate Pathologist, Department of\\nPathology and Laboratory Medicine,\\nWellington Regional Medical Center,\\nWest Palm Beach\\nGram-Positive Bacilli; Gram-Positive Cocci\\nFRANK PESSLER, MD, PhD\\nPediatric Rheumatologist, Klinik und\\nPoliklinic fur Kinder und Jugendmedizin,\\nMedizinische Fakultat Carl-Gustav-Carus,\\nTechnische Universitat Dresden, Germany\\nRheumatic Fever; Bone and Connective\\nTissue Disorders in Children\\nSTEPHEN P. PETERS, MD, PhD\\nProfessor of Medicine and Pediatrics and\\nAssociate Director, Center for Human\\nGenomics, Wake Forest University Health\\nSciences\\nAsthma\\nWILLIAM A. PETRI, Jr., MD, PhD\\nWade Hampton Frost Professor of\\nEpidemiology and Chief, Division of\\nInfectious Diseases and International Health,\\nUniversity of Virginia School of Medicine\\nRickettsiae and Related Organisms\\nKATHARINE A. PHILLIPS, MD\\nProfessor of Psychiatry and Human Behavior,\\nButler Hospital and The Warren Alpert\\nMedical School of Brown University\\nSomatoform and Factitious Disorders'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 49, 'source_type': 'Authorotative', 'priority': '1'}, page_content='KATHARINE A. PHILLIPS, MD\\nProfessor of Psychiatry and Human Behavior,\\nButler Hospital and The Warren Alpert\\nMedical School of Brown University\\nSomatoform and Factitious Disorders\\nJoANN V. PINKERTON, MD\\nProfessor of Obstetrics and Gynecology\\nand Director, Midlife Health, University of\\nVirginia Health System\\nMenstrual Abnormalities\\nRUSSELL K. PORTENOY, MD\\nProfessor of Neurology and Anesthesiology,\\nAlbert Einstein College of Medicine;\\nChairman, Department of Pain Medicine and\\nPalliative Care, Beth Israel Medical Center\\nPain\\nCAROL S. PORTLOCK, MD\\nProfessor of Clinical Medicine, Weill Cornell\\nMedical College; Attending Physician,\\nLymphoma Service, Memorial Sloan-Kettering\\nCancer Center\\nLymphomas\\nMICHAEL POURFAR, MD\\nAssistant Professor, Department of Medicine,\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n41'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 50, 'source_type': 'Authorotative', 'priority': '1'}, page_content='New York University School of Medicine\\nMovement and Cerebellar Disorders\\nJOSEF T. PRCHAL, MD\\nProfessor of Medicine, Division of Hematology,\\nUniversity of Utah; George E. Wahlen VA\\nMedical Center\\nMyeloproliferative Disorders\\nGLENN M. PREMINGER, MD\\nProfessor of Urologic Surgery and Director,\\nComprehensive Kidney Stone Center, Duke\\nUniversity Medical Center\\nUrinary Calculi\\nSALLY PULLMAN-MOOAR, MD\\nClinical Associate Professor, Department\\nof Medicine, Division of Rheumatology,\\nUniversity of Pennsylvania; Chief, Department\\nof Rheumatology, Philadelphia VA Medical\\nCenter\\nNeck and Back Pain\\nRONALD RABINOWITZ, MD\\nProfessor of Urology and Pediatrics,\\nUniversity of Rochester School of Medicine and\\nDentistry; Chief of Pediatric Urology, Strong\\nMemorial and Rochester General Hospitals\\nCongenital Renal and Genitourinary Anomalies\\nLAWRENCE G. RAISZ, MD (Deceased)\\nBoard of Trustees Distinguished Professor\\nof Medicine and Director, UConn Center for\\nOsteoporosis, University of Connecticut\\nHealth Center'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 50, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"LAWRENCE G. RAISZ, MD (Deceased)\\nBoard of Trustees Distinguished Professor\\nof Medicine and Director, UConn Center for\\nOsteoporosis, University of Connecticut\\nHealth Center\\nOsteoporosis\\nPEDRO T. RAMIREZ, MD\\nAssistant Professor, Gynecologic Oncology\\nDepartment, The University of Texas MD\\nAnderson Cancer Center\\nGynecologic Tumors\\nLEONARD RAPPAPORT, MD, MS\\nMary Demig Scott Professor of Pediatrics,\\nHarvard Medical School; Chief, Division of\\nDevelopmental Medicine, Children's Hospital\\nIncontinence in Children\\nROBERT W. REBAR, MD\\nExecutive Director, American Society for\\nReproductive Medicine; Volunteer Clinical\\nProfessor, Department of Obstetrics and\\nGynecology, University of Alabama\\nInfertility\\nWINGFIELD E. REHMUS, MD, MPH\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n42\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 51, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Clinical Assistant Professor, University of\\nBritish Columbia\\nHypersensitivity and Inflammatory Disorders;\\nNail Disorders\\nDOUGLAS J. RHEE, MD\\nAssistant Professor, Massachusetts Eye and\\nEar Infirmary, Harvard Medical School\\nGlaucoma\\nMELVIN I. ROAT, MD\\nClinical Associate Professor, Wills Eye Institute,\\nDepartment of Ophthalmology, Jefferson\\nMedical College, Thomas Jefferson University\\nCorneal Disorders\\nJAMES R. ROBERTS, MD\\nProfessor and Vice Chairman, Department\\nof Emergency Medicine, Drexel University\\nCollege of Medicine; Chair, Department of\\nEmergency Medicine and Director, Division\\nof Toxicology, Mercy Catholic Medical Center\\nFractures, Dislocations, and Sprains; Heat\\nIllness\\nKENNETH B. ROBERTS, MD\\nProfessor of Pediatrics, University of North\\nCarolina School of Medicine; Director,\\nPediatric Teaching Program, Moses Cone\\nHealth System, Greensboro\\nDehydration and Fluid Therapy\\nBERYL J. ROSENSTEIN, MD\\nProfessor of Pediatrics, Johns Hopkins\\nUniversity School of Medicine\\nCystic Fibrosis'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 51, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Health System, Greensboro\\nDehydration and Fluid Therapy\\nBERYL J. ROSENSTEIN, MD\\nProfessor of Pediatrics, Johns Hopkins\\nUniversity School of Medicine\\nCystic Fibrosis\\nSTEVEN ROSENZWEIG, MD\\nClinical Associate Professor, Drexel\\nUniversity College of Medicine\\nComplementary and Alternative Medicine\\nNOELLE ROTONDO, DO\\nClinical Assistant Professor of Emergency\\nMedicine, Penn State Hershey Medical Center;\\nAdjunct Clinical Professor of Emergency\\nMedicine, Drexel University College of\\nMedicine\\nApproach to the Trauma Patient\\nROBERT J. RUBEN, MD\\nDistinguished University Professor,\\nDepartment of Otorhinolaryngology-Head &\\nNeck Surgery, Albert Einstein College of\\nMedicine and Montefiore Medical Center\\nHearing Loss\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n43'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 52, 'source_type': 'Authorotative', 'priority': '1'}, page_content='FRED H. RUBIN, MD\\nProfessor of Medicine, University of\\nPittsburgh, School of Medicine; Chair,\\nDepartment of Medicine, University of\\nPittsburgh Medical Center Presbyterian\\nShadyside Hospital, Shadyside Campus\\nImmunization\\nMICHAEL RUBIN, MD\\nProfessor of Clinical Neurology,\\nWeill Cornell Medical College; Director,\\nNeuromuscular Service and EMG Laboratory,\\nNew York Presbyterian Hospital-Cornell\\nMedical Center\\nCraniocervical Junction Abnormalities;\\nInherited Muscular Disorders; Spinal Cord\\nDisorders; Peripheral Nervous System and\\nMotor Unit Disorders\\nATENODORO R. RUIZ, Jr., MD\\nSenior Attending Physician, Department of\\nMedicine-Gastroenterology, Kaiser Permanente,\\nSanta Clara\\nMalabsorption Syndromes\\nJ. MARK RUSCIN, PharmD\\nProfessor, Department of Pharmacy Practice,\\nSouthern Illinois University Edwardsville School\\nof Pharmacy\\nDrug Therapy in the Elderly\\nJULIE E. RUSSAK, MD\\nMelanoma Fellow, Rigel Dermatology\\n(Private Practice Associated With New York\\nUniversity Medical Center)\\nBullous Diseases'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 52, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of Pharmacy\\nDrug Therapy in the Elderly\\nJULIE E. RUSSAK, MD\\nMelanoma Fellow, Rigel Dermatology\\n(Private Practice Associated With New York\\nUniversity Medical Center)\\nBullous Diseases\\nPAUL S. RUSSELL, MD\\nJohn Homans Distinguished Professor of\\nSurgery, Harvard Medical School; Senior\\nSurgeon, Massachusetts General Hospital\\nTransplantation\\nCHARLES SABATINO, JD\\nAdjunct Professor, Georgetown University\\nLaw Center; Director, Commission on Law\\nand Aging, American Bar Association\\nMedicolegal Issues\\nDAVID B. SACHAR, MD\\nClinical Professor of Medicine, Mount Sinai\\nSchool of Medicine; Director (Emeritus),\\nDr. Henry D. Janowitz Division of\\nGastroenterology, The Mount Sinai Hospital\\nInflammatory Bowel Disease\\nSEYED-ALI SADJADI, MD\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n44'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 53, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Associate Professor of Medicine, Loma Linda\\nUniversity School of Medicine\\nApproach to the Genitourinary Patient;\\nRenovascular Disorders\\nSCOTT SAMUELSON, MD\\nInstructor of Medicine, Hematology Division,\\nUniversity of Utah; Attending Physician, Utah\\nCancer Specialists\\nMyeloproliferative Disorders\\nCHRISTOPHER SANFORD, MD, MPH,\\nDTM&H\\nClinical Assistant Professor, Department of\\nFamily Medicine; Co-Director, Travel Clinic,\\nHall Health Center, University of Washington\\nMedical Aspects of Travel\\nRAVINDRA SARODE, MD\\nProfessor of Pathology and Director,\\nTransfusion Medicine and Hemostasis\\nLaboratory, The University of Texas\\nSouthwestern Medical Center at Dallas\\nTransfusion Medicine\\nCLARENCE T. SASAKI, MD\\nThe Charles W. Oshe Professor of Surgery\\nand Chief of Otolaryngology, Yale School\\nof Medicine; Director, Head and Neck\\nTumor Board, Yale Comprehensive Cancer\\nCenter\\nLaryngeal Disorders, Oral and Pharyngeal\\nDisorders\\nPETER C. SCHALOCK, MD\\nInstructor in Dermatology, Harvard Medical'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 53, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of Medicine; Director, Head and Neck\\nTumor Board, Yale Comprehensive Cancer\\nCenter\\nLaryngeal Disorders, Oral and Pharyngeal\\nDisorders\\nPETER C. SCHALOCK, MD\\nInstructor in Dermatology, Harvard Medical\\nSchool; Assistant in Dermatology,\\nMassachusetts General Hospital\\nPsoriasis and Scaling Diseases\\nSTEVEN SCHMITT, MD\\nHead, Section of Bone and Joint Infections,\\nDepartment of Infectious Disease, Cleveland\\nClinic\\nInfections of Joints and Bones\\nMARVIN I. SCHWARZ, MD\\nThe James C. Campbell Professor of\\nPulmonary Medicine, Division of Pulmonary\\nSciences and Critical Care Medicine,\\nUniversity of Colorado Denver\\nDiffuser Alveolar Hemorrhage and Pulmonary-\\nRenal Syndromes\\nELDON A. SHAFFER, MD\\nProfessor of Medicine, Faculty of Medicine,\\nUniversity of Calgary\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n45'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 54, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Testing for Hepatic and Biliary Disorders;\\nAlcoholic Liver Disease; Fibrosis and Cirrhosis;\\nVascular Disorders of the Liver; Gallbladder\\nand Bile Duct Disorders\\nSTEWART SHANKEL, MD\\nClinical Professor of Medicine and Director\\nof Clinical Instruction, University of California,\\nRiverside\\nUrinary Tract Infections\\nWILLIAM R. SHAPIRO, MD\\nProfessor of Clinical Neurology, University\\nof Arizona College of Medicine, Tucson;\\nChief, Neuro-oncology, Barrow Neurological\\nInstitute\\nIntracranial and Spinal Tumors\\nMICHAEL J. SHEA, MD\\nProfessor of Internal Medicine, Section Head,\\nCardiovascular Medicine Outpatient Services\\nand Clinical Evaluation, University of\\nMichigan Health Systems\\nCardiovascular Tests and Procedures\\nDAVID D. SHERRY, MD\\nProfessor of Pediatrics, University of\\nPennsylvania; Director, Clinical\\nRheumatology, The Children's Hospital of\\nPhiladelphia\\nRheumatic Fever; Bone and Connective Tissue\\nDisorders in Children\\nSTEPHEN D. SILBERSTEIN, MD\\nProfessor of Neurology, Headache Center,\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 54, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Rheumatology, The Children's Hospital of\\nPhiladelphia\\nRheumatic Fever; Bone and Connective Tissue\\nDisorders in Children\\nSTEPHEN D. SILBERSTEIN, MD\\nProfessor of Neurology, Headache Center,\\nThomas Jefferson University\\nHeadache\\nDAPHNE SIMEON, MD\\nAssociate Professor, Department of\\nPsychiatry, Mount Sinai School of Medicine\\nDissociative Disorders\\nADAM J. SINGER, MD\\nProfessor and Vice Chairman for Research,\\nDepartment of Emergency Medicine, Stony\\nBrook University and Medical Center\\nLacerations\\nASHISH C. SINHA, MD, PhD\\nAssistant Professor, Anesthesiology and\\nCritical Care, University of Pennsylvania\\nSchool of Medicine\\nObesity and the Metabolic Syndrome\\n(Bariatric Surgery portion)\\nRICHARD V. SMITH, MD\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n46\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 55, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Vice Chair, Department of Otolaryngology-\\nHead & Neck Surgery, Albert Einstein College\\nof Medicine; Director, Head & Neck Service,\\nMontefiore Medical Center\\nTumors of the Head and Neck\\nNORMAN SOHN, MD\\nClinical Assistant Professor of Surgery, New\\nYork University School of Medicine;\\nAttending Surgeon, Lenox Hill Hospital\\nAnorectal Disorders\\nDAVID E. SOPER, MD\\nProfessor and Vice Chairman for Clinical\\nAffairs, Department of Obstetrics and\\nGynecology, Medical University of South\\nCarolina\\nVaginitis and Pelvic Inflammatory Disease\\nDAVID R. STEINBERG, MD\\nAssociate Professor, Department of\\nOrthopaedic Surgery and Director, Hand &\\nUpper Extremity Fellowship, Department\\nof Orthopaedic Surgery, University of\\nPennsylvania\\nHand Disorders\\nMARVIN E. STEINBERG, MD\\nProfessor (Emeritus) of Orthopaedic Surgery,\\nUniversity of Pennsylvania School of\\nMedicine\\nOsteonecrosis\\nKINGMAN P. STROHL, MD\\nProfessor of Medicine and Oncology,\\nDepartment of Medicine, Division of'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 55, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Professor (Emeritus) of Orthopaedic Surgery,\\nUniversity of Pennsylvania School of\\nMedicine\\nOsteonecrosis\\nKINGMAN P. STROHL, MD\\nProfessor of Medicine and Oncology,\\nDepartment of Medicine, Division of\\nPulmonary, Critical Care and Sleep Medicine,\\nCase Medical Center; Director, Center for\\nSleep Disorders Research, Case Western\\nReserve University\\nSleep Apnea\\nALBERT J. STUNKARD, MD\\nProfessor of Psychiatry, University of\\nPennsylvania School of Medicine\\nEating Disorders\\nALAN M. SUGAR, MD\\nProfessor of Medicine (Emeritus), Boston\\nUniversity School of Medicine; Medical\\nDirector, Infectious Disease Clinical Services\\nand HIV/AIDS Program, Cape Cod Healthcare\\nFungi\\nSTEPHEN BRIAN SULKES, MD\\nProfessor of Pediatrics, Division of\\nNeurodevelopmental and Behavioral\\nPediatrics, Golisano Children's Hospital at\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n47\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 56, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Strong, University of Rochester School of\\nMedicine and Dentistry\\nLearning and Developmental Disorders;\\nBehavioral Concerns and Problems in Children\\nGEETA K. SWAMY, MD\\nAssociate Professor, Division of Maternal-\\nFetal Medicine, Department of Obstetrics and\\nGynecology, Duke University Medical Center\\nApproach to the Pregnant Woman and Prenatal\\nCare\\nDAVID A. SWANSON, MD\\nClinical Professor, Department of Urology,\\nThe University of Texas MD Anderson Cancer\\nCenter\\nGenitourinary Cancer\\nPAUL H. TANSER, MD\\nProfessor of Medicine (Emeritus), McMaster\\nUniversity; Medical Cardiologist, North Shore\\nand Waitakere Hospitals, Auckland\\nApproach to the Cardiac Patient; Valvular\\nDisorders\\nSYED H. TARIQ, MD\\nFellow, Division of Gastroenterology and\\nHepatology, Saint Louis University School\\nof Medicine\\nPolyglandular Deficiency Syndromes\\nJOAN B. TARLOFF, PhD\\nProfessor, Department of Pharmaceutical\\nSciences, University of the Sciences in\\nPhiladelphia\\nAdverse Drug Reactions\\nMARY TERRITO, MD'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 56, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Polyglandular Deficiency Syndromes\\nJOAN B. TARLOFF, PhD\\nProfessor, Department of Pharmaceutical\\nSciences, University of the Sciences in\\nPhiladelphia\\nAdverse Drug Reactions\\nMARY TERRITO, MD\\nProfessor of Medicine, Director of\\nHematopoietic Stem Cell Transplantation,\\nUniversity of California, Los Angeles\\nNeutropenia and Lymphocytopenia\\nDAVID R. THOMAS, MD\\nProfessor of Medicine, Division of Geriatric\\nMedicine, Saint Louis University Health\\nSciences Center\\nNutritional Support\\nELIZABETH CHABNER THOMPSON,\\nMD, MPH\\nPrivate Practice, New York Group for Plastic\\nSurgery\\nOverview of Cancer; Principles of Cancer\\nTherapy\\nSTIG THUNELL, MD, PhD\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n48'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 57, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Professor, Karolinska Institute; Senior\\nConsultant, Porphyria Center Sweden,\\nKarolinska University Hospital Huddinge,\\nStockholm\\nPorphyrias\\nSHELLY D. TIMMONS, MD, PhD\\nAssistant Professor and Chief of Neurotrauma\\nDivision, Department of Neurosurgery,\\nUniversity of Tennessee; Private Practice,\\nSemmes-Murphey Neurologic & Spine Institute\\nTraumatic Brain Injury\\nCOURTNEY M. TOWNSEND, Jr., MD\\nProfessor and John Woods Harris Distinguished\\nChairman, Department of Surgery, The\\nUniversity of Texas Medical Branch at\\nGalveston\\nCarcinoid Tumors\\nAMAL TRIVEDI, MD, MPH\\nAssistant Professor of Community Health,\\nThe Warren Alpert Medical School of\\nBrown University; Investigator, REAP On\\nOutcomes and Quality in Chronic Disease\\nand Rehabilitation, Providence VA Medical\\nCenter\\nFunding Health Care for the Elderly; Financial\\nIssues in Health Care\\nANNE S. TSAO, MD\\nAssistant Professor, Department of Thoracic/\\nHead & Neck Oncology, Division of Cancer\\nMedicine, The University of Texas MD\\nAnderson Cancer Center'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 57, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Issues in Health Care\\nANNE S. TSAO, MD\\nAssistant Professor, Department of Thoracic/\\nHead & Neck Oncology, Division of Cancer\\nMedicine, The University of Texas MD\\nAnderson Cancer Center\\nTumors of the Lungs\\nDEBARA L. TUCCI, MD\\nAssociate Professor of Surgery, Division of\\nOtolaryngology-Head and Neck Surgery, Duke\\nUniversity Medical Center\\nApproach to the Patient With Ear Problems\\nALLAN R. TUNKEL, MD, PhD\\nChair, Department of Medicine, Monmouth\\nMedical Center; Professor of Medicine,\\nDrexel University College of Medicine\\nBiology of Infectious Disease\\nRONALD B. TURNER, MD\\nProfessor of Pediatrics, University of Virginia\\nSchool of Medicine\\nRespiratory Viruses\\nALEXANDER G.G. TURPIE, MD\\nProfessor of Medicine, McMaster University\\nand Hamilton Health Sciences General Hospital\\nPeripheral Venous and Lymphatic Disorders\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n49'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 58, 'source_type': 'Authorotative', 'priority': '1'}, page_content='p\\ny p\\nJAMES T. UBERTALLI, DMD\\nAssistant Clinical Professor, Tufts University\\nSchool of Dental Medicine; Private Practice,\\nHingham, MA\\nCommon Dental Disorders\\nVICTOR G. VOGEL, MD, MHS\\nNational Vice President for Research, American\\nCancer Society\\nBreast Disorders\\nAARON E. WALFISH, MD\\nClinical Assistant Attending, Division of\\nDigestive Diseases, Beth Israel Medical\\nCenter; Clinical Instructor, Mount Sinai\\nMedical Center\\nInflammatory Bowel Disease\\nJAMES WAYNE WARNICA, MD\\nProfessor of Medicine, Department of Cardiac\\nScience, University of Calgary; Director,\\nCardiac Intensive Care Unit, Foothills Medical\\nCenter\\nCoronary Artery Disease\\nMAX HARRY WEIL, MD, PhD, ScD\\n(Hon)\\nDistinguished Professor and Founding\\nPresident, Weil Institute of Critical Care\\nMedicine; Research Professor of Surgery,\\nKeck School of Medicine, The University of\\nSouthern California, Los Angeles\\nCardiac Arrest; Shock and Fluid Resuscitation;\\nSepsis and Septic Shock\\nGEOFFREY A. WEINBERG, MD'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 58, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Keck School of Medicine, The University of\\nSouthern California, Los Angeles\\nCardiac Arrest; Shock and Fluid Resuscitation;\\nSepsis and Septic Shock\\nGEOFFREY A. WEINBERG, MD\\nProfessor of Pediatrics, University of\\nRochester School of Medicine and Dentistry;\\nDirector, Pediatric HIV Program, Golisano\\nChildren's Hospital at Strong, University of\\nRochester Medical Center\\nMiscellaneous Infections in Infants and\\nChildren; Human Immunodeficiency Virus\\nInfection in Infants and Children\\nLAURA WEISSMAN, MD\\nAssistant Professor in Medicine and Instructor\\nin Pediatrics, Harvard Medical School\\nIncontinence in Children\\nGREGORY L. WELLS, MD\\nResident in Dermatology, Dartmouth Medical\\nSchool and Dartmouth-Hitchcock Medical\\nCenter\\nCancers of the Skin\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n50\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 59, 'source_type': 'Authorotative', 'priority': '1'}, page_content='JOHN B. WEST, MD, PhD, DSc\\nProfessor of Medicine and Physiology,\\nUniversity of California, San Diego\\nAltitude Sickness\\nKENDRICK ALAN WHITNEY, DPM\\nAssistant Professor, Department of Medicine\\nand Orthopedics, Temple University School of\\nPodiatric Medicine\\nFoot and Ankle Disorders\\nFRANK H. WIANS, Jr., PhD\\nProfessor of Pathology (Retired), Department\\nof Pathology, The University of Texas\\nSouthwestern Medical Center at Dallas\\nNormal Laboratory Values\\nJAMES E. WILBERGER, MD\\nProfessor and Chairman, Department of\\nNeurosurgery, Allegheny General Hospital,\\nPittsburgh; Vice Dean, Drexel University\\nCollege of Medicine\\nSpinal Trauma\\nMARGARET-MARY G. WILSON, MD\\nMedical Director, Health Services, United\\nHealthcare, Maryland Heights\\nNutrition: General Considerations; Syndromes\\nof Uncertain Origin\\nG. TERENCE WILSON, PhD\\nOscar K. Buros Professor of Psychology,\\nGraduate School of Applied and Professional\\nPsychology, Rutgers University\\nEating Disorders\\nROBERT A. WISE, MD'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 59, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of Uncertain Origin\\nG. TERENCE WILSON, PhD\\nOscar K. Buros Professor of Psychology,\\nGraduate School of Applied and Professional\\nPsychology, Rutgers University\\nEating Disorders\\nROBERT A. WISE, MD\\nProfessor of Medicine, Pulmonary and\\nCritical Care, Johns Hopkins University\\nSchool of Medicine\\nChronic Obstructive Pulmonary Disease\\nGARY WITTERT, MB, Bch, MD\\nProfessor and Head, Department of Medicine,\\nRoyal Adelaide Hospital\\nObesity and the Metabolic Syndrome\\nSTEVEN E. WOLF, MD\\nBetty and Bob Kelso Distinguished Chair in\\nBurns and Trauma, Vice Chair for Research,\\nand Professor, Department of Surgery, The\\nUniversity of Texas Health Science Center at\\nSan Antonio; Chief, Clinical Research, United\\nStates Army Institute of Surgical Research\\nBurns\\nEIJI YANAGISAWA, MD\\nClinical Professor of Otolaryngology, Yale\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n51'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 60, 'source_type': 'Authorotative', 'priority': '1'}, page_content='y g\\ngy,\\nUniversity School of Medicine\\nExternal Ear Disorders\\nHEIDI YEH, MD\\nInstructor in Surgery, Harvard Medical\\nSchool; Assistant in Surgery, Massachusetts\\nGeneral Hospital\\nTransplantation\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nFront Matter\\n52'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 61, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1 - Nutritional Disorders\\nChapter 1. Nutrition: General Considerations\\nIntroduction\\nNutrition is the science of food and its relationship to health. Nutrients are chemicals in foods that are\\nused by the body for growth, maintenance, and energy. Nutrients that cannot be synthesized by the body\\nand thus must be derived from the diet are considered essential. They include vitamins, minerals, some\\namino acids, and some fatty acids. Nutrients that the body can synthesize from other compounds,\\nalthough they may also be derived from the diet, are considered nonessential. Macronutrients are\\nrequired by the body in relatively large amounts; micronutrients are needed in minute amounts.\\nLack of nutrients can result in deficiency syndromes (eg, kwashiorkor, pellagra) or other disorders (see p.\\n9). Excess intake of macronutrients can lead to obesity (see p. 56) and related disorders; excess intake of\\nmicro-nutrients can be toxic. Also, the balance of various types of nutrients, such as how much'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 61, 'source_type': 'Authorotative', 'priority': '1'}, page_content='micro-nutrients can be toxic. Also, the balance of various types of nutrients, such as how much\\nusaturated vs saturated fat is consumed, can influence the development of disorders.\\nMacronutrients\\nMacronutrients constitute the bulk of the diet and supply energy and many essential nutrients.\\nCarbohydrates, proteins (including essential amino acids), fats (including essential fatty acids),\\nmacrominerals, and water are macronutrients. Carbohydrates, fats, and proteins are interchangeable as\\nsources of energy; fats yield 9 kcal/g (37.8 kJ/g); proteins and carbohydrates yield 4 kcal/g (16.8 kJ/g).\\nCarbohydrates: Dietary carbohydrates are broken down into glucose and other monosaccharides.\\nCarbohydrates increase blood glucose levels, supplying energy. Simple carbohydrates are composed of\\nsmall molecules, generally monosaccharides or disaccharides, which increase blood glucose levels\\nrapidly. Complex carbohydrates are composed of larger molecules, which are broken down into'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 61, 'source_type': 'Authorotative', 'priority': '1'}, page_content='small molecules, generally monosaccharides or disaccharides, which increase blood glucose levels\\nrapidly. Complex carbohydrates are composed of larger molecules, which are broken down into\\nmonosaccharides. Complex carbohydrates increase blood glucose levels more slowly but for a longer\\ntime. Glucose and sucrose are simple carbohydrates; starches and fiber are complex carbohydrates.\\nThe glycemic index measures how rapidly consumption of a carbohydrate increases plasma glucose\\nlevels. Values range from 1 (the slowest increase) to 100 (the fastest increase, equivalent to pure glucose\\n—see\\nTable 1-1). However, the actual rate of increase also depends on what foods are consumed with the\\ncarbohydrate.\\nCarbohydrates with a high glycemic index may increase plasma glucose to high levels rapidly. It is\\nhypothesized that, as a result, insulin levels increase, inducing hypoglycemia and hunger, which tends to'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 61, 'source_type': 'Authorotative', 'priority': '1'}, page_content='hypothesized that, as a result, insulin levels increase, inducing hypoglycemia and hunger, which tends to\\nlead to consumption of excess calories and weight gain. Carbohydrates with a low glycemic index\\nincrease plasma glucose levels slowly, resulting in lower postprandial insulin levels and less hunger,\\nwhich probably makes consumption of excess calories less likely. These effects are predicted to result in\\na more favorable lipid profile and a decreased risk of obesity, diabetes mellitus, and complications of\\ndiabetes if present.\\nProteins: Dietary proteins are broken down into peptides and amino acids. Proteins are required for\\ntissue maintenance, replacement, function, and growth. However, if the body is not getting enough\\ncalories from dietary sources or tissue stores (particularly of fat), protein may be used for energy.\\nAs the body uses dietary protein for tissue production, there is a net gain of protein (positive nitrogen\\nbalance). During catabolic'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 61, 'source_type': 'Authorotative', 'priority': '1'}, page_content='As the body uses dietary protein for tissue production, there is a net gain of protein (positive nitrogen\\nbalance). During catabolic\\n[Table 1-1. Glycemic Index of Some Foods]\\nstates (eg, starvation, infections, burns), more protein may be used (because body tissues are broken\\ndown) than is absorbed, resulting in a net loss of protein (negative nitrogen balance). Nitrogen balance is\\nbest determined by subtracting the amount of nitrogen excreted in urine and feces from the amount of\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 1. Nutrition: General Considerations\\n53'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 62, 'source_type': 'Authorotative', 'priority': '1'}, page_content='nitrogen consumed.\\nOf the 20 amino acids, 9 are essential amino acids (EAAs); they cannot be synthesized and must be\\nobtained from the diet. All people require 8 EAAs; infants also require histidine.\\nThe weight-adjusted requirement for dietary protein correlates with growth rate, which decreases from\\ninfancy until adulthood. The daily dietary protein requirement decreases from 2.2 g/kg in 3-mo-old infants\\nto 1.2 g/kg in 5-yr-old children and to 0.8 g/kg in adults. Protein requirements correspond to EAA\\nrequirements (see\\nTable 1-2). Adults trying to increase muscle mass need very little extra protein beyond the requirements in\\nthe table.\\nThe amino acid composition of protein varies widely. Biological value (BV) reflects the similarity in amino\\nacid composition of protein to that of animal tissues; thus, BV indicates what percentage of a dietary\\nprotein provides EAAs for the body. A perfect match is egg protein, with a value of 100. Animal proteins in'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 62, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"protein provides EAAs for the body. A perfect match is egg protein, with a value of 100. Animal proteins in\\nmilk and meat have a high BV (~90); proteins in cereal and vegetables have a lower BV (~40), and some\\nderived proteins (eg, gelatin) have a BV of 0. The extent to which dietary proteins supply each other's\\nmissing amino acids (complementarity) determines the overall BV of the diet. The recommended daily\\nallowances (RDA) for protein assumes that the average mixed diet has a BV of 70.\\nFats: Fats are broken down into fatty acids and glycerol. Fats are required for tissue growth and hormone\\nproduction. Saturated fatty acids, common in animal fats, tend to be solid at room temperature. Except for\\npalm and coconut oils, fats derived from plants tend to be liquid at room temperature; these fats contain\\nhigh levels of monounsaturated fatty acids or polyunsaturated fatty acids (PUFAs).\\nPartial hydrogenation of unsaturated fatty acids (as occurs during food manufacturing) produces trans\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 62, 'source_type': 'Authorotative', 'priority': '1'}, page_content='high levels of monounsaturated fatty acids or polyunsaturated fatty acids (PUFAs).\\nPartial hydrogenation of unsaturated fatty acids (as occurs during food manufacturing) produces trans\\nfatty acids, which are solid or semisolid at room temperature. In the US, the main dietary source of trans\\nfatty acids is partially hydrogenated vegetable oils, used in manufacturing certain foods (eg, cookies,\\ncrackers, chips) to prolong shelf-life. Trans fatty acids may elevate LDL cholesterol and lower HDL; they\\nmay also independently increase the risk of coronary artery disease.\\nEssential fatty acids (EFAs) are linoleic acid, an ω-6 (n-6) fatty acid, and linolenic acid, an ω-3 (n-3) fatty\\nacid. Other ω-6 acids (eg, arachidonic acid) and other ω-3 fatty acids (eg, eicosapentaenoic acid,\\ndocosahexaenoic acid) are required by the body but can be synthesized from EFAs.\\nEFAs (see also p. 19) are needed for the formation of various eicosanoids (biologically active lipids),'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 62, 'source_type': 'Authorotative', 'priority': '1'}, page_content='docosahexaenoic acid) are required by the body but can be synthesized from EFAs.\\nEFAs (see also p. 19) are needed for the formation of various eicosanoids (biologically active lipids),\\nincluding prostaglandins, thromboxanes, prostacyclins, and leukotrienes. Consumption of ω-3 fatty acids\\nmay decrease the risk of coronary artery disease.\\n[Table 1-2. Essential Amino Acid Requirements in mg/kg Body Weight]\\nRequirements for EFAs vary by age. Adults require amounts of linoleic acid equal to at least 2% of total\\ncaloric needs and linolenic acid equal to at least 0.5%. Vegetable oils provide linoleic acid and linolenic\\nacid. Oils made from safflower, sunflower, corn, soya, primrose, pumpkin, and wheat germ provide large\\namounts of linoleic acid. Marine fish oils and oils made from flax-seeds, pumpkin, soy, and canola provide\\nlarge amounts of linolenic acid. Marine fish oils also provide some other ω-3 fatty acids in large amounts.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 62, 'source_type': 'Authorotative', 'priority': '1'}, page_content='large amounts of linolenic acid. Marine fish oils also provide some other ω-3 fatty acids in large amounts.\\nMacrominerals: Na, Cl, K, Ca, P, and Mg are required in relatively large amounts per day (see\\nTables 1-3,\\n1-4, and\\n5-2).\\nWater: Water is considered a macronutrient because it is required in amounts of 1 mL/kcal (0.24 mL/kJ)\\nof energy expended, or about 2500 mL/day. Needs vary with fever, physical activity, and changes in\\nclimate and humidity.\\n[Table 1-3. Macrominerals]\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 1. Nutrition: General Considerations\\n54'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 63, 'source_type': 'Authorotative', 'priority': '1'}, page_content='[Table 1-4. Recommended Dietary Reference Intakes* for Some Macronutrients, Food and Nutrition\\nBoard, Institute of Medicine of the National Academies]\\nMicronutrients\\nVitamins and minerals required in minute amounts (trace minerals) are micronutrients (see Chs. 4 and 5).\\nWater-soluble vitamins are vitamin C (ascorbic acid) and 8 members of the vitamin B complex: biotin,\\nfolate, niacin, pantothenic acid, riboflavin (vitamin B2), thiamin (vitamin B1), vitamin B6 (pyridoxine), and\\nvitamin B12 (cobalamin).\\nFat-soluble vitamins are vitamins A (retinol), D (cholecalciferol and ergocalciferol), E (α-tocopherol), and\\nK (phylloquinone and menaquinone).\\nOnly vitamins A, E, and B12 are stored to any significant extent in the body; the other vitamins must be\\nconsumed regularly to maintain tissue health.\\nEssential trace minerals include chromium, copper, iodine, iron, manganese, molybdenum, selenium,\\nand zinc. Except for chromium, each of these is incorporated into enzymes or hormones required in'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 63, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Essential trace minerals include chromium, copper, iodine, iron, manganese, molybdenum, selenium,\\nand zinc. Except for chromium, each of these is incorporated into enzymes or hormones required in\\nmetabolism. Except for deficiencies of iron and zinc, micromineral deficiencies are uncommon in\\ndeveloped countries (see Ch. 5).\\nOther minerals (eg, aluminum, arsenic, boron, cobalt, fluoride, nickel, silicon, vanadium) have not been\\nproved essential for people. Fluoride, although not essential, helps prevent tooth decay by forming a\\ncompound with Ca (CaF2), which stabilizes the mineral matrix in teeth.\\nAll trace minerals are toxic at high levels, and some (arsenic, nickel, and chromium) may cause cancer.\\nOther Dietary Substances\\nThe daily human diet typically contains as many as 100,000 chemicals (eg, coffee contains 1000). Of\\nthese, only 300 are nutrients, only some of which are essential. However, many nonnutrients in foods are'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 63, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"these, only 300 are nutrients, only some of which are essential. However, many nonnutrients in foods are\\nuseful. For example, food additives (eg, preservatives, emulsifiers, antioxidants, stabilizers) improve the\\nproduction and stability of foods. Trace components (eg, spices, flavors, odors, colors, phytochemicals,\\nmany other natural products) improve appearance and taste.\\nFiber: Fiber occurs in various forms (eg, cellulose, hemicellulose, pectin, gums). It increases GI motility,\\nprevents constipation, and helps control diverticular disease. Fiber is thought to accelerate the elimination\\nof cancer-causing substances produced by bacteria in the large intestine. Epidemiologic evidence\\nsuggests an association between colon cancer and low fiber intake and a beneficial effect of fiber in\\npatients with functional bowel disorders, Crohn's disease, obesity, and hemorrhoids. Soluble fiber\\n(present in fruits, vegetables, oats, barley, and legumes) reduces the postprandial increase in blood\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 63, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(present in fruits, vegetables, oats, barley, and legumes) reduces the postprandial increase in blood\\nglucose and insulin and can reduce cholesterol levels.\\nThe typical Western diet is low in fiber (about 12 g/day) because of a high intake of highly refined wheat\\nflour and a low intake of fruits and vegetables. Increasing fiber intake to about 30 g/day by consuming\\nmore vegetables, fruits, and high-fiber cereals and grains is generally recommended. However, very high\\nfiber intake may reduce absorption of certain minerals.\\nNutritional Requirements\\nGood nutrition aims to achieve and maintain a desirable body composition and high potential for physical\\nand mental work. Balancing energy intake with energy expenditure is necessary for a desirable body\\nweight. Energy expenditure depends on age, sex, weight (see Table 1-4), and metabolic and physical\\nactivity. If energy intake exceeds expenditure, weight is gained. Taking in about 100 calories/day more'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 63, 'source_type': 'Authorotative', 'priority': '1'}, page_content='activity. If energy intake exceeds expenditure, weight is gained. Taking in about 100 calories/day more\\nthan needed results in a weight gain of about 4 to 5 kg in a year. If energy intake is less than expenditure,\\nweight is lost.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 1. Nutrition: General Considerations\\n55'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 64, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Daily dietary requirements for essential nutrients also depend on age, sex, weight, and metabolic and\\nphysical activity. Every 5 yr, the Food and Nutrition Board of the National Academy of Sciences/National\\nResearch Council and the US Department of Agriculture (USDA) issues the dietary reference intakes\\n(DRIs) for protein, energy, and some vitamins and minerals (see Tables 1-4,\\n4-1, and 5-2). For vitamins and minerals about which less is known, safe and adequate daily dietary\\nintakes are estimated.\\nPregnant women (see p. 2608) and infants (see p. 2703) have special nutritional needs.\\nThe USDA publishes the Food Guide Pyramid, which specifies the number of recommended daily\\nservings of various food groups. The recommendations are individualized based on age, sex, and\\nphysical activity (see\\nTable 1-5). Generally, the recommended intake decreases with aging because physical activity tends to\\ndecrease, resulting in less energy expended. The new Food Guide Pyramid emphasizes the following:'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 64, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Table 1-5). Generally, the recommended intake decreases with aging because physical activity tends to\\ndecrease, resulting in less energy expended. The new Food Guide Pyramid emphasizes the following:\\n• Increasing consumption of whole grains\\n• Increasing consumption of vegetables and fruits\\n• Substituting fat-free or low-fat milk products (or equivalents) for whole-fat milk products\\n• Reducing consumption of saturated fats and trans fatty acids\\n• Exercising regularly\\nAdequate fluid intake is also important.\\nFats should constitute ≤ 30% of total calories, and saturated and trans fatty acids should constitute <\\n10%. Excess intake of saturated fats contributes to atherosclerosis. Substituting polyunsaturated fatty\\nacids for saturated fats can decrease the risk of atherosclerosis. Routine use of nutritional supplements is\\nnot necessary or beneficial; some supplements can be harmful. For example, excess vitamin A can lead to\\nhypervitaminosis A, with headaches, osteoporosis, and rash.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 64, 'source_type': 'Authorotative', 'priority': '1'}, page_content='not necessary or beneficial; some supplements can be harmful. For example, excess vitamin A can lead to\\nhypervitaminosis A, with headaches, osteoporosis, and rash.\\nNutrition in Clinical Medicine\\nNutritional deficiencies can often worsen health outcomes (whether a disorder is present or not), and\\nsome disorders (eg, malabsorption) can cause nutritional deficiencies. Also, many patients (eg, elderly\\npatients during acute hospitalization) have unsuspected nutritional deficiencies that require treatment.\\nMany medical centers have multi-disciplinary nutrition support teams of physicians, nurses, dietitians, and\\npharmacists to help the clinician prevent, diagnose, and treat occult nutritional deficiencies.\\nOvernutrition may contribute to chronic disorders, such as cancer, hypertension, obesity, diabetes\\nmellitus, and coronary artery disease. Dietary restrictions are necessary in many hereditary metabolic\\ndisorders (eg, galactosemia, phenylketonuria).\\nEvaluation of Nutritional Status'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 64, 'source_type': 'Authorotative', 'priority': '1'}, page_content='mellitus, and coronary artery disease. Dietary restrictions are necessary in many hereditary metabolic\\ndisorders (eg, galactosemia, phenylketonuria).\\nEvaluation of Nutritional Status\\nIndications for nutritional evaluation include undesirable body weight or body composition, suspicion of\\nspecific deficiencies or toxicities\\n[Table 1-5. Recommended Dietary Intake for 40-yr-Olds with Moderate Physical Activity*]\\nof essential nutrients, and, in infants and children, insufficient growth or development. Nutritional status\\nshould be evaluated routinely as part of the clinical examination for infants and children, the elderly,\\npeople taking several drugs, people with psychiatric disorders, and people with systemic disorders that\\nlast longer than several days.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 1. Nutrition: General Considerations\\n56'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 65, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Evaluating general nutritional status includes history, physical examination, and sometimes tests. If\\nundernutrition is suspected, laboratory tests (eg, albumin levels) and skin tests for delayed\\nhypersensitivity may be done (see p.\\n13). Body composition analysis (eg, skinfold measurements, bioelectrical impedance analysis) is used to\\nestimate percentage of body fat and to evaluate obesity (see p. 58).\\nHistory includes questions about dietary intake, weight change, and risk factors for nutritional deficiencies\\nand a focused review of systems (see\\nTable 2-1 on p. 11). A dietitian can obtain a more detailed dietary history. It usually includes a list of foods\\neaten within the previous 24 h and a food questionnaire. A food diary may be used to record all foods\\neaten. The weighed ad libitum diet, in which the patient weighs and writes down all foods consumed, is\\nthe most accurate record.\\nA complete physical examination, including measurement of height and weight and distribution of body'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 65, 'source_type': 'Authorotative', 'priority': '1'}, page_content='the most accurate record.\\nA complete physical examination, including measurement of height and weight and distribution of body\\nfat, should be done. Body mass index (BMI)—weight(kg)/height(m)2, which adjusts weight for height (see\\nTable 6-2 on p. 59), is more accurate than height and weight tables. There are standards for growth and\\nweight gain in infants, children, and adolescents (see p. 2756).\\nDistribution of body fat is important. Disproportionate truncal obesity (ie, waist/hip ratio > 0.8) is\\nassociated with cardiovascular and cerebrovascular disorders, hypertension, and diabetes mellitus more\\noften than fat located elsewhere. Measuring waist circumference in patients with a BMI of < 35 helps\\ndetermine whether they have truncal obesity and helps predict risk of diabetes, hypertension,\\nhypercholesterolemia, and cardiovascular disorders. Risk is increased if waist circumference is > 102 cm\\n(> 40 in) in men or > 88 cm (> 35 in) in women.\\nNutrient-Drug Interactions'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 65, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"hypercholesterolemia, and cardiovascular disorders. Risk is increased if waist circumference is > 102 cm\\n(> 40 in) in men or > 88 cm (> 35 in) in women.\\nNutrient-Drug Interactions\\nNutrition can affect the body's response to drugs; conversely, drugs can affect the body's nutrition.\\nFoods can enhance, delay, or decrease drug absorption. Foods impair absorption of many antibiotics.\\nThey can alter metabolism of drugs; eg, high-protein diets can accelerate metabolism of certain drugs by\\nstimulating cytochrome P-450. Eating grapefruit can inhibit cytochrome P-450 34A, slowing metabolism of\\nsome drugs (eg, amiodarone, carbamazepine, cyclosporine, certain Ca channel blockers). Diets that alter\\nthe bacterial flora may markedly affect the overall metabolism of certain drugs. Some foods affect the\\nbody's response to drugs. For example, tyramine, a component of cheese and a potent vasoconstrictor,\\ncan cause hypertensive crisis in some patients who take monoamine oxidase inhibitors and eat cheese.\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 65, 'source_type': 'Authorotative', 'priority': '1'}, page_content='can cause hypertensive crisis in some patients who take monoamine oxidase inhibitors and eat cheese.\\nNutritional deficiencies can affect drug absorption and metabolism. Severe energy and protein\\ndeficiencies reduce enzyme tissue concentrations and may impair the response to drugs by reducing\\nabsorption or protein binding and causing liver dysfunction. Changes in the GI tract can impair absorption\\nand affect the response to a drug. Deficiency of Ca, Mg, or zinc may impair drug metabolism. Vitamin C\\ndeficiency decreases activity of drug-metabolizing enzymes, especially in the elderly.\\nMany drugs affect appetite, food absorption, and tissue metabolism (see\\nTable 1-6). Some drugs (eg, metoclopramide) increase GI motility, decreasing food absorption. Other\\ndrugs (eg, opioids, anticholinergics) decrease GI motility. Some drugs are better tolerated if taken with\\nfood.\\nCertain drugs affect mineral metabolism. For example, diuretics, especially thiazides, and corticosteroids'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 65, 'source_type': 'Authorotative', 'priority': '1'}, page_content='food.\\nCertain drugs affect mineral metabolism. For example, diuretics, especially thiazides, and corticosteroids\\ncan deplete body K, increasing susceptibility to digoxin-induced cardiac arrhythmias. Repeated use of\\nlaxatives may deplete K. Cortisol, desoxycorticosterone, and aldosterone cause marked Na and water\\nretention, at least temporarily; retention is much less with prednisone, prednisolone, and some other\\ncorticosteroid analogs. Sulfonylureas and lithium can impair the uptake or release of iodine by the thyroid.\\nOral contraceptives can lower blood zinc levels and increase copper levels. Certain antibiotics (eg,\\ntetracyclines) reduce iron absorption, as can certain foods (eg, vegetables, tea, bran).\\nCertain drugs affect vitamin absorption or metabolism. Ethanol impairs thiamin utilization, and isoniazid\\ninterferes with niacin and pyridoxine metabolism. Ethanol and oral contraceptives inhibit folate (folic acid)\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 65, 'source_type': 'Authorotative', 'priority': '1'}, page_content='interferes with niacin and pyridoxine metabolism. Ethanol and oral contraceptives inhibit folate (folic acid)\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 1. Nutrition: General Considerations\\n57'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 66, 'source_type': 'Authorotative', 'priority': '1'}, page_content='absorption. Most patients receiving phenytoin, phenobarbital, primidone, or phenothiazines develop folate\\ndeficiency, probably because hepatic microsomal drug-metabolizing enzymes are affected. Folate\\nsupplements may\\n[Table 1-6. Effects of Some Drugs on Nutrition]\\nmake phenytoin less effective. Anticonvulsants can cause vitamin D deficiency. Malabsorption of vitamin\\nB12 can occur with use of aminosalicylic acid, slow-release K iodide, colchicine, trifluoperazine, ethanol,\\nand oral contraceptives. Oral contraceptives with a high progestin dose can cause depression, probably\\nbecause of metabolically induced tryptophan deficiency.\\nFood Additives and Contaminants\\nAdditives: Chemicals are often combined with foods to facilitate their processing and preservation or to\\nenhance their desirability. Only amounts of additives shown to be safe by laboratory tests are permitted in\\ncommercially prepared foods.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 66, 'source_type': 'Authorotative', 'priority': '1'}, page_content='enhance their desirability. Only amounts of additives shown to be safe by laboratory tests are permitted in\\ncommercially prepared foods.\\nWeighing the benefits of additives (eg, reduced waste, increased variety of available foods, protection\\nagainst food-borne illness) against the risks is often complex. For example, nitrite, which is used in cured\\nmeats, inhibits the growth of Clostridium botulinum and improves flavor. However, nitrite converts to\\nnitrosamines, which are carcinogens in animals. On the other hand, the amount of nitrite added to cured\\nmeat is small compared with the amount from naturally occurring food nitrates converted to nitrite by the\\nsalivary glands. Dietary vitamin C can reduce nitrite formation in the GI tract. Rarely, some additives (eg,\\nsulfites) cause food hypersensitivity (allergy) reactions. Most of these reactions are caused by ordinary\\nfoods (see p. 1118).\\nContaminants: Sometimes limited amounts of contaminants are allowed in foods because the'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 66, 'source_type': 'Authorotative', 'priority': '1'}, page_content='foods (see p. 1118).\\nContaminants: Sometimes limited amounts of contaminants are allowed in foods because the\\ncontaminants cannot be completely eliminated without damaging the foods. Common contaminants are\\npesticides, heavy metals (lead, cadmium, mercury), nitrates (in green leafy vegetables), aflatoxins (in nuts\\nand milk), growth-promoting hormones (in dairy products and meat), animal hairs and feces, and insect\\nparts.\\nFDA-estimated safe levels are levels that have not caused illness or adverse effects in people. However,\\ndemonstrating a causal relationship between extremely low level exposures and adverse effects is\\ndifficult; long-term adverse effects, although unlikely, are still possible. Safe levels are often determined\\nby consensus rather than by hard evidence.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 1. Nutrition: General Considerations\\n58'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 67, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chapter 2. Undernutrition\\nIntroduction\\nUndernutrition is a form of malnutrition. (Malnutrition also includes overnutrition—see Ch. 6).\\nUndernutrition can result from inadequate ingestion of nutrients, malabsorption, impaired\\nmetabolism, loss of nutrients due to diarrhea, or increased nutritional requirements (as occurs\\nin cancer or infection). Undernutrition progresses in stages; each stage usually takes\\nconsiderable time to develop. First, nutrient levels in blood and tissues change, followed by\\nintracellular changes in biochemical functions and structure. Ultimately, symptoms and signs\\nappear.\\nRisk Factors\\nUndernutrition is associated with many disorders and circumstances, including poverty and social\\ndeprivation. Risk is also greater at certain times (ie, during infancy, early childhood, adolescence,\\npregnancy, breastfeeding, and old age).\\nInfancy and childhood: Infants and children are particularly susceptible to undernutrition because of'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 67, 'source_type': 'Authorotative', 'priority': '1'}, page_content='pregnancy, breastfeeding, and old age).\\nInfancy and childhood: Infants and children are particularly susceptible to undernutrition because of\\ntheir high demand for energy and essential nutrients. Because vitamin K does not readily cross the\\nplacenta, neonates may be deficient, so all are given a single injection of vitamin K within 1 h of birth to\\nprevent hemorrhagic disease of the newborn, a life-threatening disorder (see pp. 46 and\\n2783). Infants fed only breast milk, which is typically low in vitamin D, are given supplemental vitamin D;\\nthey can develop vitamin B12 deficiency if the mother is a vegan. Inadequately fed infants and children\\nare at risk of protein-energy undernutrition (PEU—previously called protein-energy malnutrition) and\\ndeficiencies of iron, folate (folic acid), vitamins A and C, copper, and zinc. During adolescence, nutritional\\nrequirements increase because the growth rate accelerates. Anorexia nervosa (see p. 1535) may affect\\nadolescent girls in particular.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 67, 'source_type': 'Authorotative', 'priority': '1'}, page_content='requirements increase because the growth rate accelerates. Anorexia nervosa (see p. 1535) may affect\\nadolescent girls in particular.\\nPregnancy and breastfeeding: Requirements for nutrients increase during pregnancy and\\nbreastfeeding. Aberrations of diet, including pica (consumption of nonnutritive substances, such as clay\\nand charcoal), may occur during pregnancy. Anemia due to iron deficiency is common, as is anemia due\\nto folate deficiency, especially among women who have taken oral contraceptives. Vitamin D deficiency is\\ncommon during late pregnancy, predisposing the child to decreased bone mass.\\nOld age: Aging—even when disease or dietary deficiency is absent—leads to sarcopenia (progressive\\nloss of lean body mass), starting after age 40 and eventually amounting to a muscle loss of about 10 kg\\n(22 lb) in men and 5 kg (11 lb) in women. Undernutrition contributes to sarcopenia, and sarcopenia'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 67, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"(22 lb) in men and 5 kg (11 lb) in women. Undernutrition contributes to sarcopenia, and sarcopenia\\naccounts for many of the complications of undernutrition (eg, decreased nitrogen balance, increased\\nsusceptibility to infections). Causes of sarcopenia include the following:\\n• Decreased physical activity\\n• Decreased food intake\\n• Increased levels of cytokines (particularly interleukin-6)\\n• Decreased levels of growth hormone and mechano growth factor (insulin-like growth factor-3)\\n• In men, decreasing androgen levels\\nAging decreases basal metabolic rate (due mainly to decreased fat-free mass), total body weight, height,\\nand skeletal mass; aging increases mean body fat (as a percentage of body weight) to about 30% (from\\n20%) in men and to 40% (from 27%) in women.\\nFrom age 20 to 80, food intake decreases, especially in men. Anorexia due to aging itself has many\\ncauses, including reduced adaptive relaxation of the stomach's fundus, increased release and activity of\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 67, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"causes, including reduced adaptive relaxation of the stomach's fundus, increased release and activity of\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 2. Undernutrition\\n59\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 68, 'source_type': 'Authorotative', 'priority': '1'}, page_content='cholecystokinin (which produces satiation), and increased leptin (an anorectic hormone produced by fat\\ncells). Diminished taste and smell can decrease eating pleasure but usually decrease food intake only\\nslightly. Anorexia may have other causes (eg, loneliness, inability to shop or prepare meals, dementia,\\nsome chronic disorders, use of certain drugs). Depression is a common cause. Occasionally, anorexia\\nnervosa (sometimes called anorexia tardive in the elderly), paranoia, or mania interferes with eating.\\nDental problems limit the ability to chew and subsequently to digest foods. Swallowing difficulties (eg, due\\nto strokes, other neurologic disorders, esophageal candidiasis, or xerostomia) are common. Poverty or\\nfunctional impairment limits access to nutrients.\\nThe institutionalized elderly are at particular risk of PEU. They are often confused and may be unable to\\nexpress hunger or preferences for foods. They may be physically unable to feed themselves. Chewing or'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 68, 'source_type': 'Authorotative', 'priority': '1'}, page_content='express hunger or preferences for foods. They may be physically unable to feed themselves. Chewing or\\nswallowing may be very slow, making it tedious for another person to feed them enough food.\\nIn the elderly, particularly the institutionalized elderly, inadequate intake and often decreased absorption\\nor synthesis of vitamin D, increased demand for vitamin D, and inadequate exposure to sunshine\\ncontribute to osteomalacia (see p. 41).\\nDisorders and medical procedures: Diabetes, some chronic disorders that affect the GI tract, intestinal\\nresection, and certain other GI surgical procedures tend to impair absorption of fat-soluble vitamins,\\nvitamin B12, Ca, and iron. Gluten enteropathy, pancreatic insufficiency, or other disorders can result in\\nmalabsorption. Decreased absorption possibly contributes to iron deficiency and osteoporosis. Liver\\ndisorders impair storage of vitamins A and B12 and interfere with metabolism of protein and energy'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 68, 'source_type': 'Authorotative', 'priority': '1'}, page_content='malabsorption. Decreased absorption possibly contributes to iron deficiency and osteoporosis. Liver\\ndisorders impair storage of vitamins A and B12 and interfere with metabolism of protein and energy\\nsources. Renal insufficiency predisposes to protein, iron, and vitamin D deficiencies. Anorexia causes\\nsome patients with cancer or depression and many with AIDS to consume inadequate amounts of food.\\nInfections, trauma, hyperthyroidism, extensive burns, and prolonged fever increase metabolic demands.\\nAny condition that increases cytokines may be accompanied by muscle loss, lipolysis, low albumin levels,\\nand anorexia.\\nVegetarian diets: Iron deficiency can occur in ovo-lacto vegetarians (although such a diet can be\\ncompatible with good health). Vegans may develop vitamin B12 deficiency unless they consume yeast\\nextracts or Asian-style fermented foods. Their intake of Ca, iron, and zinc also tends to be low. A fruit-only'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 68, 'source_type': 'Authorotative', 'priority': '1'}, page_content='extracts or Asian-style fermented foods. Their intake of Ca, iron, and zinc also tends to be low. A fruit-only\\ndiet is not recommended because it is deficient in protein, Na, and many micronutrients.\\nFad diets: Some fad diets result in vitamin, mineral, and protein deficiencies; cardiac, renal, and\\nmetabolic disorders; and sometimes death. Very low calorie diets (< 400 kcal/day) cannot sustain health\\nfor long.\\nDrugs and nutritional supplements: Many drugs (eg, appetite suppressants, digoxin) decrease\\nappetite; others impair nutrient absorption or metabolism. Some drugs (eg, stimulants) have catabolic\\neffects. Certain drugs can impair absorption of many nutrients; eg, anticonvulsants can impair absorption\\nof vitamins.\\nAlcohol or drug dependency: Patients with alcohol or drug dependency may neglect their nutritional\\nneeds. Absorption and metabolism of nutrients may also be impaired. IV drug addicts typically become\\nundernourished, as do\\n['),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 68, 'source_type': 'Authorotative', 'priority': '1'}, page_content='needs. Absorption and metabolism of nutrients may also be impaired. IV drug addicts typically become\\nundernourished, as do\\n[\\nTable 2-1. Symptoms and Signs of Nutritional Deficiency]\\nalcoholics who consume ≥ 1 quart of hard liquor/day. Alcoholism can cause deficiencies of Mg, zinc, and\\ncertain vitamins, including thiamin.\\nSymptoms and Signs\\nSymptoms vary depending on the cause and type of undernutrition (see p. 15 and Chs. 4 and 5).\\nEvaluation\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 2. Undernutrition\\n60'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 69, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Diagnosis is based on results of medical and diet histories, physical examination, body composition\\nanalysis (see p. 58), and selected laboratory tests.\\nHistory: History should include questions about dietary intake (see\\nFig. 2-1), recent changes in weight, and risk factors for undernutrition, including drug and alcohol use.\\nUnintentional loss of ≥ 10% of usual body weight during a 3-mo period indicates a high probability of\\nundernutrition. Social history should include questions about whether money is available for food and\\nwhether the patient can shop and cook.\\nReview of systems should focus on symptoms of nutritional deficiencies (see Table 2-1). For example,\\nimpaired night vision may indicate vitamin A deficiency.\\nPhysical examination: Physical examination should include measurement of height and weight,\\ninspection of body fat distribution, and anthropometric measurements of lean body mass. Body mass\\nindex (BMI = weight(kg)/height(m)2) adjusts weight for height (see'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 69, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"inspection of body fat distribution, and anthropometric measurements of lean body mass. Body mass\\nindex (BMI = weight(kg)/height(m)2) adjusts weight for height (see\\nTable 6-2 on p. 59). If weight is < 80% of what is predicted for the patient's height or if BMI is ≤ 18,\\nundernutrition should be suspected. Although these findings are useful in diagnosing undernutrition and\\nare acceptably sensitive, they lack specificity.\\n[Fig. 2-1. Mini nutritional assessment.]\\nThe mid upper arm muscle area estimates lean body mass. This area is derived from the triceps skinfold\\nthickness (TSF) and mid upper arm circumference. Both are measured at the same site, with the patient's\\nright arm in a relaxed position. The average mid upper arm circumference is about 32 ± 5 cm for men and\\n28 ± 6 cm for women. The formula for calculating the mid upper arm muscle area in cm2 is as follows:\\nThis formula corrects the upper arm area for fat and bone. Average values for the mid upper arm muscle\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 69, 'source_type': 'Authorotative', 'priority': '1'}, page_content='This formula corrects the upper arm area for fat and bone. Average values for the mid upper arm muscle\\narea are 54 ± 11 cm2 for men and 30 ± 7 cm2 for women. A value < 75% of this standard (depending on\\nage) indicates depletion of lean body mass (see\\nTable 2-2). This measurement may be affected by physical activity, genetic factors, and age-related\\nmuscle loss.\\nPhysical examination should focus on signs of specific nutritional deficiencies. Signs of PEU (eg, edema,\\nmuscle wasting, skin changes) should be sought. Examination should also focus on signs of conditions\\nthat could predispose to nutritional deficiencies, such as dental problems. Mental status should be\\nassessed, because depression and cognitive impairment can lead to weight loss.\\nThe widely used Subjective Global Assessment (SGA) uses information from the patient history (eg,\\nweight loss, change in intake, GI symptoms), physical examination findings (eg, loss of muscle and'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 69, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"The widely used Subjective Global Assessment (SGA) uses information from the patient history (eg,\\nweight loss, change in intake, GI symptoms), physical examination findings (eg, loss of muscle and\\nsubcutaneous fat, edema, ascites), and the clinician's judgment of the patient's nutritional status. The\\nMini Nutritional Assessment (MNA) has been validated and is widely used, especially for elderly patients\\n(see Fig. 2-1). The Simplified Nutrition Assessment Questionnaire (SNAQ), a simple, validated method of\\npredicting future weight loss, may be used (see\\nFig. 2-2).\\nTesting: The extent of laboratory testing needed is unclear and may depend on the patient's\\ncircumstances. If the cause is obvious and correctable (eg, a wilderness survival situation), testing is\\nprobably of little benefit. Other patients may require more detailed evaluation.\\nSerum albumin measurement is the laboratory test most often used. Decreases in albumin and other\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 69, 'source_type': 'Authorotative', 'priority': '1'}, page_content='probably of little benefit. Other patients may require more detailed evaluation.\\nSerum albumin measurement is the laboratory test most often used. Decreases in albumin and other\\nproteins (eg, prealbumin [transthyretin], transferrin, retinol-binding protein) may indicate protein deficiency\\nor PEU. As undernutrition progresses, albumin decreases slowly; prealbumin, transferrin, and retinol-\\nbinding protein decrease rapidly. Albumin measurement is inexpensive and predicts morbidity and\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 2. Undernutrition\\n61'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 70, 'source_type': 'Authorotative', 'priority': '1'}, page_content='mortality better than measurement of the other proteins. However, the correlation of albumin with\\nmorbidity and mortality may be related to nonnutritional as well as nutritional factors. Inflammation\\nproduces cytokines that cause albumin and other nutritional protein markers to extravasate, decreasing\\nserum levels. Because prealbumin, transferrin, and retinol-binding protein decrease more rapidly during\\nstarvation than does albumin, their measurements are sometimes used to diagnose or assess the severity\\nof acute starvation. However, whether they are more sensitive or specific than albumin is unclear.\\nTotal lymphocyte count, which often decreases as undernutrition progresses, may be determined.\\nUndernutrition causes a marked decline in CD4+ T lymphocytes, so this count may not be useful in\\npatients who have AIDS.\\nSkin tests using antigens can detect impaired cell-mediated immunity in PEU and in some other disorders\\nof undernutrition (see p.\\n1098).'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 70, 'source_type': 'Authorotative', 'priority': '1'}, page_content='patients who have AIDS.\\nSkin tests using antigens can detect impaired cell-mediated immunity in PEU and in some other disorders\\nof undernutrition (see p.\\n1098).\\nOther laboratory tests, such as measuring vitamin and mineral levels, are used selectively to diagnose\\nspecific deficiencies.\\n[Table 2-2. Mid Upper Arm Muscle Area in Adults]\\n[Figure 2-2. Simplified Nutrition Assessment Questionnaire (SNAQ).]\\nProtein-Energy Undernutrition\\nProtein-energy undernutrition (PEU), previously called protein-energy malnutrition, is an energy\\ndeficit due to chronic deficiency of all macronutrients. It commonly includes deficiencies of\\nmany micronutrients. PEU can be sudden and total (starvation) or gradual. Severity ranges from\\nsubclinical deficiencies to obvious wasting (with edema, hair loss, and skin atrophy) to\\nstarvation. Multiple organ systems are often impaired. Diagnosis usually involves laboratory\\ntesting, including serum albumin. Treatment consists of correcting fluid and electrolyte deficits'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 70, 'source_type': 'Authorotative', 'priority': '1'}, page_content='starvation. Multiple organ systems are often impaired. Diagnosis usually involves laboratory\\ntesting, including serum albumin. Treatment consists of correcting fluid and electrolyte deficits\\nwith IV solutions, then gradually replenishing nutrients, orally if possible.\\nIn developed countries, PEU is common among the institutionalized elderly (although often not suspected)\\nand among patients with disorders that decrease appetite or impair nutrient digestion, absorption, or\\nmetabolism. In developing countries, PEU affects children who do not consume enough calories or\\nprotein.\\nClassification and Etiology\\nPEU is graded as mild, moderate, or severe. Grade is determined by calculating weight as a percentage\\nof expected weight for length or height using international standards (normal, 90 to 110%; mild PEU, 85 to\\n90%; moderate, 75 to 85%; severe, <75%).\\nPEU may be primary or secondary. Primary PEU is caused by inadequate nutrient intake. Secondary PEU'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 70, 'source_type': 'Authorotative', 'priority': '1'}, page_content='90%; moderate, 75 to 85%; severe, <75%).\\nPEU may be primary or secondary. Primary PEU is caused by inadequate nutrient intake. Secondary PEU\\nresults from disorders or drugs that interfere with nutrient use.\\nPrimary PEU: Worldwide, primary PEU occurs mostly in children and the elderly who lack access to\\nnutrients, although a common cause in the elderly is depression. PEU can also result from fasting or\\nanorexia nervosa. Child or elder abuse may be a cause.\\nIn children, chronic primary PEU has 2 common forms: marasmus and kwashiorkor. The form depends on\\nthe balance of nonprotein and protein sources of energy. Starvation is an acute severe form of primary\\nPEU.\\nMarasmus (also called the dry form of PEU) causes weight loss and depletion of fat and muscle. In\\ndeveloping countries, marasmus is the most common form of PEU in children.\\nKwashiorkor (also called the wet, swollen, or edematous form) is associated with premature abandonment\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 70, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Kwashiorkor (also called the wet, swollen, or edematous form) is associated with premature abandonment\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 2. Undernutrition\\n62'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 71, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of breastfeeding, which typically occurs when a younger sibling is born, displacing the older child from the\\nbreast. So children with kwashiorkor tend to be older than those with marasmus. Kwashiorkor may also\\nresult from an acute illness, often gastroenteritis or another infection (probably secondary to cytokine\\nrelease), in a child who already has PEU. A diet that is more deficient in protein than energy may be more\\nlikely to cause kwashiorkor than marasmus. Less common than marasmus, kwashiorkor tends to be\\nconfined to specific parts of the world, such as rural Africa, the Caribbean, and the Pacific islands. In\\nthese areas, staple foods (eg, yams, cassavas, sweet potatoes, green bananas) are low in protein and\\nhigh in carbohydrates. In kwashiorkor, cell membranes leak, causing extravasation of intravascular fluid\\nand protein, resulting in peripheral edema.\\nStarvation is a complete lack of nutrients. It occasionally occurs when food is available (as in fasting or'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 71, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"and protein, resulting in peripheral edema.\\nStarvation is a complete lack of nutrients. It occasionally occurs when food is available (as in fasting or\\nanorexia nervosa) but usually occurs because food is unavailable (eg, during famine or wilderness\\nexposure).\\nSecondary PEU: This type most commonly results from the following:\\n• Disorders that affect GI function: These disorders can interfere with digestion (eg, pancreatic\\ninsufficiency), absorption (eg, enteritis, enteropathy), or lymphatic transport of nutrients (eg,\\nretroperitoneal fibrosis, Milroy's disease).\\n• Wasting disorders: In wasting disorders (eg, AIDS, cancer) and renal failure, catabolism causes cytokine\\nexcess, resulting in undernutrition via anorexia and cachexia (wasting of muscle and fat). End-stage\\nheart failure can cause cardiac cachexia, a severe form of undernutrition; mortality rate is particularly\\nhigh. Factors contributing to cardiac cachexia may include passive hepatic congestion (causing\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 71, 'source_type': 'Authorotative', 'priority': '1'}, page_content='high. Factors contributing to cardiac cachexia may include passive hepatic congestion (causing\\nanorexia), edema of the intestinal tract (impairing absorption), and, in advanced disease, increased O2\\nrequirement due to anaerobic metabolism. Wasting disorders can decrease appetite or impair\\nmetabolism of nutrients.\\n• Conditions that increase metabolic demands: These conditions include infections, hyperthyroidism,\\npheochromocytoma, other endocrine disorders, burns, trauma, surgery, and other critical illnesses.\\nPathophysiology\\nThe initial metabolic response is decreased metabolic rate. To supply energy, the body first breaks down\\nadipose tissue. However, later when these tissues are depleted, the body may use protein for energy,\\nresulting in a negative nitrogen balance. Visceral organs and muscle are broken down and decrease in\\nweight. Loss of organ weight is greatest in the liver and intestine, intermediate in the heart and kidneys,\\nand least in the nervous system.\\nSymptoms and Signs'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 71, 'source_type': 'Authorotative', 'priority': '1'}, page_content='weight. Loss of organ weight is greatest in the liver and intestine, intermediate in the heart and kidneys,\\nand least in the nervous system.\\nSymptoms and Signs\\nSymptoms of moderate PEU can be constitutional or involve specific organ systems. Apathy and irritability\\nare common. The patient is weak, and work capacity decreases. Cognition and sometimes\\nconsciousness are impaired. Temporary lactose deficiency and achlorhydria develop. Diarrhea is common\\nand can be aggravated by deficiency of intestinal disaccharidases, especially lactase (see p. 157).\\nGonadal tissues atrophy. PEU can cause amenorrhea in women and loss of libido in men and women.\\nWasting of fat and muscle is common in all forms of PEU. In adult volunteers who fasted for 30 to 40\\ndays, weight loss was marked (25% of initial weight). If starvation is more prolonged, weight loss may\\nreach 50% in adults and possibly more in children.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 71, 'source_type': 'Authorotative', 'priority': '1'}, page_content='days, weight loss was marked (25% of initial weight). If starvation is more prolonged, weight loss may\\nreach 50% in adults and possibly more in children.\\nIn adults, cachexia is most obvious in areas where prominent fat depots normally exist. Muscles shrink\\nand bones protrude. The skin becomes thin, dry, inelastic, pale, and cold. The hair is dry and falls out\\neasily, becoming sparse. Wound healing is impaired. In elderly patients, risk of hip fractures and pressure\\n(decubitus) ulcers increases.\\nWith acute or chronic severe PEU, heart size and cardiac output decrease; pulse slows\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 2. Undernutrition\\n63'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 72, 'source_type': 'Authorotative', 'priority': '1'}, page_content='[\\nTable 2-3. Values Commonly Used to Grade the Severity of Protein-Energy Undernutrition]\\nand BP falls. Respiratory rate and vital capacity decrease. Body temperature falls, sometimes contributing\\nto death. Edema, anemia, jaundice, and petechiae can develop. Liver, kidney, or heart failure may occur.\\nCell-mediated immunity is impaired, increasing susceptibility to infections. Bacterial infections (eg,\\npneumonia, gastroenteritis, otitis media, UTIs, sepsis) are common in both forms of PEU. Infections result\\nin release of cytokines, which cause anorexia, worsen muscle wasting, and cause a marked decrease in\\nserum albumin levels.\\nMarasmus in infants causes hunger, weight loss, growth retardation, and wasting of subcutaneous fat\\nand muscle. Ribs and facial bones appear prominent. Loose, thin skin hangs in folds.\\nKwashiorkor is characterized by peripheral and periorbital edema. The abdomen protrudes because'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 72, 'source_type': 'Authorotative', 'priority': '1'}, page_content='and muscle. Ribs and facial bones appear prominent. Loose, thin skin hangs in folds.\\nKwashiorkor is characterized by peripheral and periorbital edema. The abdomen protrudes because\\nabdominal muscles are weakened, the intestine is distended, the liver enlarges, and ascites is present.\\nThe skin is dry, thin, and wrinkled; it can become hyperpigmented and fissured and later hypopigmented,\\nfriable, and atrophic. Skin in different areas of the body may be affected at different times. The hair can\\nbecome thin, reddish brown, or gray. Scalp hair falls out easily, eventually becoming sparse, but eyelash\\nhair may grow excessively. Alternating episodes of undernutrition and adequate nutrition may cause the\\nhair to have a dramatic \"striped flag\" appearance. Affected children may be apathetic but become irritable\\nwhen held.\\nTotal starvation is fatal in 8 to 12 wk. Thus, certain symptoms of PEU do not have time to develop.\\nDiagnosis\\n• Diagnosis usually based on history'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 72, 'source_type': 'Authorotative', 'priority': '1'}, page_content='when held.\\nTotal starvation is fatal in 8 to 12 wk. Thus, certain symptoms of PEU do not have time to develop.\\nDiagnosis\\n• Diagnosis usually based on history\\n• To determine severity: BMI, serum albumin, total lymphocyte count, CD4+ count, serum transferrin\\n• To diagnose complications and consequences: CBC, electrolytes, BUN, glucose, Ca, Mg, phosphate\\nDiagnosis can be based on history when dietary intake is markedly inadequate. The cause of inadequate\\nintake, particularly in children, needs to be identified. In children and adolescents, child abuse and\\nanorexia nervosa should be considered.\\nPhysical examination findings can usually confirm the diagnosis. Laboratory tests are required if dietary\\nhistory does not clearly indicate inadequate caloric intake. Measurement of serum albumin, total\\nlymphocyte count, CD4+ T lymphocytes, transferrin, and response to skin antigens may help determine'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 72, 'source_type': 'Authorotative', 'priority': '1'}, page_content='history does not clearly indicate inadequate caloric intake. Measurement of serum albumin, total\\nlymphocyte count, CD4+ T lymphocytes, transferrin, and response to skin antigens may help determine\\nthe severity of PEU (see Table 2-3) or confirm the diagnosis in borderline cases. Many other test results\\nmay be abnormal: eg, decreased levels of hormones, vitamins, lipids, cholesterol, prealbumin, insulin\\ngrowth factor-1, fibronectin, and retinol-binding protein. Urinary creatine and methylhistidine levels can be\\nused to gauge the degree of muscle wasting. Because protein catabolism slows, urinary urea level also\\ndecreases. These findings rarely affect treatment.\\nLaboratory tests are required to identify causes of suspected secondary PEU. C-reactive protein or\\nsoluble interleukin-2 receptor should be measured when the cause of undernutrition is unclear; these\\nmeasurements can help determine whether there is cytokine excess. Thyroid function tests may also be\\ndone.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 72, 'source_type': 'Authorotative', 'priority': '1'}, page_content='measurements can help determine whether there is cytokine excess. Thyroid function tests may also be\\ndone.\\nOther laboratory tests can detect associated abnormalities that may require treatment. Serum\\nelectrolytes, BUN, glucose, and possibly levels of Ca, Mg, and phosphate should be measured. Levels of\\nserum glucose, electrolytes (especially K, occasionally Na), phosphate, Ca, and Mg are usually low. BUN\\nis often low unless renal failure is present. Metabolic acidosis may be present. CBC is usually obtained;\\nnormocytic anemia (usually due to protein deficiency) or microcytic anemia (due to simultaneous iron\\ndeficiency) is usually present.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 2. Undernutrition\\n64'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 73, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Stool cultures should be obtained and checked for ova and parasites if diarrhea is severe or does not\\nresolve with treatment. Sometimes urinalysis, urine culture, blood cultures, tuberculin testing, and a chest\\nx-ray are used to diagnose occult infections because people with PEU may have a muted response to\\ninfections.\\nPrognosis\\nChildren: In children, mortality varies from 5 to 40%. Mortality rates are lower in children with mild PEU\\nand those given intensive care. Death in the first days of treatment is usually due to electrolyte deficits,\\nsepsis, hypothermia, or heart failure. Impaired consciousness, jaundice, petechiae, hyponatremia, and\\npersistent diarrhea are ominous signs. Resolution of apathy, edema, and anorexia is a favorable sign.\\nRecovery is more rapid in kwashiorkor than in marasmus.\\nLong-term effects of PEU in children are not fully documented. Some children develop chronic'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 73, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Recovery is more rapid in kwashiorkor than in marasmus.\\nLong-term effects of PEU in children are not fully documented. Some children develop chronic\\nmalabsorption and pancreatic insufficiency. In very young children, mild intellectual disability may develop\\nand persist until at least school age. Permanent cognitive impairment may occur, depending on the\\nduration, severity, and age at onset of PEU.\\nAdults: In adults, PEU can result in morbidity and mortality (eg, progressive weight loss increases\\nmortality rate for elderly patients in nursing homes). In elderly patients, PEU increases the risk of\\nmorbidity and mortality due to surgery, infections, or other disorders. Except when organ failure occurs,\\ntreatment is uniformly successful.\\nTreatment\\n• Usually, oral feeding\\n• Possibly avoidance of lactose (eg, if persistent diarrhea suggests lactose intolerance)\\n• Supportive care (eg, environmental changes, assistance with feeding, orexigenic drugs)\\n• For children, feeding delayed 24 to 48 h'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 73, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"• Supportive care (eg, environmental changes, assistance with feeding, orexigenic drugs)\\n• For children, feeding delayed 24 to 48 h\\nWorldwide, the most important preventive strategy is to reduce poverty and improve nutritional education\\nand public health measures.\\nMild or moderate PEU, including brief starvation, can be treated by providing a balanced diet, preferably\\norally. Liquid oral food supplements (usually lactose-free) can be used when solid food cannot be\\nadequately ingested. Diarrhea often complicates oral feeding because starvation makes the GI tract more\\nlikely to move bacteria into Peyer's patches, facilitating infectious diarrhea. If diarrhea persists\\n(suggesting lactose intolerance), yogurt-based rather than milk-based formulas are given because people\\nwith lactose intolerance can tolerate yogurt. Patients should also be given a multivitamin supplement.\\nSevere PEU or prolonged starvation requires treatment in a hospital with a controlled diet. The first\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 73, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Severe PEU or prolonged starvation requires treatment in a hospital with a controlled diet. The first\\npriority is to correct fluid and electrolyte abnormalities (see Ch. 97) and treat infections. Next is to supply\\nmacronutrients orally or, if necessary (eg, when swallowing is difficult), through a feeding tube, a\\nnasogastric tube (usually), or a gastrostomy tube. Parenteral nutrition is indicated if malabsorption is\\nsevere (see p. 23).\\nOther treatments may be needed to correct specific deficiencies, which may become evident as weight\\nincreases. To avoid deficiencies, patients should take micronutrients at about twice the recommended\\ndaily allowance (RDA) until recovery is complete.\\nChildren: Underlying disorders should be treated. For children with diarrhea, feeding may be delayed 24\\nto 48 h to avoid making the diarrhea worse; during this interval, children require oral or IV rehydration.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 73, 'source_type': 'Authorotative', 'priority': '1'}, page_content='to 48 h to avoid making the diarrhea worse; during this interval, children require oral or IV rehydration.\\nFeedings are given often (6 to 12 times/day) but, to avoid overwhelming the limited intestinal absorptive\\ncapacity, are limited to small amounts (< 100 mL). During the first week, milk-based formulas with\\nsupplements added are usually given in progressively increasing amounts; after a week, the full amounts\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 2. Undernutrition\\n65'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 74, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"of 175 kcal/kg and 4 g of protein/kg can be given. Twice the RDA of micronutrients should be given,\\nusing commercial multivitamin supplements. After 4 wk, the formula can be replaced with whole milk plus\\ncod liver oil and solid foods, including eggs, fruit, meats, and yeast.\\nEnergy distribution among macronutrients should be about 16% protein, 50% fat, and 34% carbohydrate.\\nAn example is a combination of powdered cow's skimmed milk (110 g), sucrose (100 g), vegetable oil (70\\ng), and water (900 mL). Many other formulas (eg, whole [full-fat] fresh milk plus corn oil and maltodextrin)\\ncan be used. Milk powders used in formulas are diluted with water.\\nUsually, supplements should be added to formulas:\\n• Mg 0.4 mEq/kg/day IM is given for 7 days.\\n• B-complex vitamins at twice the RDA are given parenterally for the first 3 days, usually with vitamin A,\\nphosphorus, zinc, manganese, copper, iodine, fluoride, molybdenum, and selenium.\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 74, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• B-complex vitamins at twice the RDA are given parenterally for the first 3 days, usually with vitamin A,\\nphosphorus, zinc, manganese, copper, iodine, fluoride, molybdenum, and selenium.\\n• Because absorption of oral iron is poor in children with PEU, oral or IM iron supplementation may be\\nnecessary.\\nParents are taught about nutritional requirements.\\nAdults: Underlying disorders should be treated. For example, if AIDS or cancer results in excess cytokine\\nproduction, megestrol acetate or medroxyprogesterone may improve food intake. However, because\\nthese drugs dramatically decrease testosterone in men (possibly causing muscle loss), testosterone\\nshould be replaced. Because these drugs can cause adrenal insufficiency, they should be used only\\nshort-term (< 3 mo).\\nIn patients with functional limitations, home delivery of meals and feeding assistance are key.\\nAn orexigenic drug, such as the cannabis extract dronabinol, should be given to patients with anorexia'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 74, 'source_type': 'Authorotative', 'priority': '1'}, page_content='In patients with functional limitations, home delivery of meals and feeding assistance are key.\\nAn orexigenic drug, such as the cannabis extract dronabinol, should be given to patients with anorexia\\nwhen no cause is obvious or to patients at the end of life when anorexia impairs quality of life. An\\nanabolic steroid (eg, enanthate, nandrolone, testosterone) or growth hormone can benefit patients with\\ncachexia due to renal failure and possibly elderly patients (eg, by increasing lean body mass or possibly\\nby improving function).\\nCorrection of PEU in adults generally resembles that in children; feedings are often limited to small\\namounts. However, for most adults, feeding does not need to be delayed. A commercial formula for oral\\nfeeding can be used. Daily nutrient supply should be given at a rate of 60 kcal/kg and 1.2 to 2 g of\\nprotein/kg. If liquid oral supplements are used with solid food, they should be given at least 1 h before'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 74, 'source_type': 'Authorotative', 'priority': '1'}, page_content='protein/kg. If liquid oral supplements are used with solid food, they should be given at least 1 h before\\nmeals so that the amount of food eaten at the meal is not reduced.\\nTreatment of institutionalized elderly patients with PEU requires multiple interventions:\\n• Environmental measures (eg, making the dining area more attractive)\\n• Feeding assistance\\n• Changes in diet (eg, use of food enhancers and caloric supplements between meals)\\n• Treatment of depression and other underlying disorders\\n• Use of orexigenics, anabolic steroids, or both\\nThe long-term use of gastrostomy tube feeding is essential for patients with severe dysphagia; its use in\\npatients with dementia is controversial. Increasing evidence supports the avoidance of unpalatable\\ntherapeutic diets (eg, low salt, diabetic, low cholesterol) in institutionalized patients because these diets\\ndecrease food intake and may cause severe PEU.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 2. Undernutrition\\n66'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 75, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Complications of treatment: Treatment of PEU can cause complications (refeeding syndrome),\\nincluding fluid overload, electrolyte deficits, hyperglycemia, cardiac arrhythmias, and diarrhea. Diarrhea is\\nusually mild and resolves; however, diarrhea in patients with severe PEU occasionally causes severe\\ndehydration or death. Causes of diarrhea (eg, sorbitol used in elixir tube feedings, Clostridium difficile if\\nthe patient has received an antibiotic) may be correctable. Osmotic diarrhea due to excess calories is rare\\nin adults and should be considered only when other causes have been excluded.\\nBecause PEU can impair cardiac and renal function, hydration can cause intravascular volume overload.\\nTreatment decreases extra-cellular K and Mg. Depletion of K or Mg may cause arrhythmias.\\nCarbohydrate metabolism that occurs during treatment stimulates insulin release, which drives phosphate\\ninto cells. Hypophosphatemia can cause muscle weakness, paresthesias, seizures, coma, and'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 75, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Carbohydrate metabolism that occurs during treatment stimulates insulin release, which drives phosphate\\ninto cells. Hypophosphatemia can cause muscle weakness, paresthesias, seizures, coma, and\\narrhythmias. Because phosphate levels can change rapidly during parenteral feeding, levels should be\\nmeasured regularly.\\nDuring treatment, endogenous insulin may become ineffective, leading to hyperglycemia. Dehydration\\nand hyperosmolarity can result. Fatal ventricular arrhythmias can develop, possibly caused by a\\nprolonged QT interval.\\nCarnitine Deficiency\\nCarnitine deficiency results from inadequate intake of or inability to metabolize the amino acid\\ncarnitine. It can cause a heterogeneous group of disorders. Muscle metabolism is impaired,\\ncausing myopathy, hypoglycemia, or cardiomyopathy. Infants typically present with\\nhypoglycemic, hypoketotic encephalopathy. Most often, treatment consists of dietary L-\\ncarnitine.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 75, 'source_type': 'Authorotative', 'priority': '1'}, page_content='causing myopathy, hypoglycemia, or cardiomyopathy. Infants typically present with\\nhypoglycemic, hypoketotic encephalopathy. Most often, treatment consists of dietary L-\\ncarnitine.\\nThe amino acid carnitine is required for the transport of long-chain fatty acyl coenzyme A (CoA) esters\\ninto myocyte mitochondria, where they are oxidized for energy. Carnitine is obtained from foods,\\nparticularly animal-based foods, and via endogenous synthesis.\\nCauses of carnitine deficiency include the following:\\n• Inadequate intake (eg, due to fad diets, lack of access, or long-term TPN)\\n• Inability to metabolize carnitine due to enzyme deficiencies (eg, carnitine palmitoyltransferase deficiency,\\nmethylmalonicaciduria, propionicacidemia, isovalericacidemia)\\n• Decreased endogenous synthesis of carnitine due to a severe liver disorder\\n• Excess loss of carnitine due to diarrhea, diuresis, or hemodialysis\\n• A hereditary disorder in which carnitine leaks from renal tubules'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 75, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Excess loss of carnitine due to diarrhea, diuresis, or hemodialysis\\n• A hereditary disorder in which carnitine leaks from renal tubules\\n• Increased requirements for carnitine when ketosis is present or demand for fat oxidation is high (eg,\\nduring a critical illness such as sepsis or major burns; after major surgery of the GI tract)\\n• Decreased muscle carnitine levels due to mitochondrial impairment (eg, due to use of zidovudine)\\n• Use of valproate\\nThe deficiency may be generalized (systemic) or may affect mainly muscle (myopathic).\\nSymptoms and Signs\\nSymptoms and the age at which symptoms appear depend on the cause. Carnitine deficiency may cause\\nmuscle necrosis, myoglobinuria, lipid-storage myopathy, hypoglycemia, fatty liver, and hyperammonemia\\nwith muscle aches, fatigue, confusion, and cardiomyopathy.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 2. Undernutrition\\n67'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 76, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Diagnosis\\nIn neonates, carnitine palmitoyltransferase deficiency is diagnosed using mass spectrometry to screen\\nblood. Prenatal diagnosis may be possible using amniotic villous cells. In adults, the definitive diagnosis is\\nbased on acylcarnitine levels in serum, urine, and tissues (muscle and liver for systemic deficiency;\\nmuscle only for myopathic deficiency).\\nTreatment\\n• Avoidance of fasting and strenuous exercise\\n• Dietary interventions, based on cause\\nCarnitine deficiency due to inadequate dietary intake, increased requirements, excess losses, decreased\\nsynthesis, or (sometimes) enzyme deficiencies can be treated by giving L-carnitine 25 mg/kg po q 6 h.\\nAll patients must avoid fasting and strenuous exercise. Consuming uncooked cornstarch at bedtime\\nprevents early morning hypoglycemia. Some patients require supplementation with medium-chain\\ntriglycerides and essential fatty acids (eg, linoleic acid, linolenic acid). Patients with a fatty acid oxidation'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 76, 'source_type': 'Authorotative', 'priority': '1'}, page_content='triglycerides and essential fatty acids (eg, linoleic acid, linolenic acid). Patients with a fatty acid oxidation\\ndisorder require a high-carbohydrate, low-fat diet.\\nEssential Fatty Acid Deficiency\\nEssential fatty acid (EFA) deficiency is rare, occurring most often in infants fed diets deficient in\\nEFAs. Signs include scaly dermatitis, alopecia, thrombocytopenia, and, in children, growth\\nretardation. Diagnosis is clinical. Dietary replenishment of EFAs reverses the deficiency.\\nThe EFAs linoleic and linolenic acid are substrates for the endogenous synthesis of other fatty acids that\\nare needed for many physiologic processes, including maintaining the integrity of skin and cell\\nmembranes and synthesizing prostaglandins and leukotrienes. For example, eicosapentaenoic acid and\\ndocosahexaenoic acid, synthesized from EFAs, are important components of the brain and retina.\\nFor EFA deficiency to develop, dietary intake must be very low. Even small amounts of EFAs can prevent'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 76, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"docosahexaenoic acid, synthesized from EFAs, are important components of the brain and retina.\\nFor EFA deficiency to develop, dietary intake must be very low. Even small amounts of EFAs can prevent\\nEFA deficiency. Cow's milk has only about 25% of the linoleic acid in human milk, but when ingested in\\nnormal amounts, it has enough linoleic acid to prevent EFA deficiency. Total fat intake of people in many\\ndeveloping countries may be very low, but the fat is often vegetable based, with large amounts of linoleic\\nacid and enough linolenic acid to prevent EFA deficiency.\\nBabies fed a formula low in linoleic acid, such as a skim-milk formula, can develop EFA deficiency. EFA\\ndeficiency used to result from long-term TPN if fat was not included. But now, most TPN solutions include\\nfat emulsions to prevent EFA deficiency. In patients with fat malabsorption or increased metabolic needs\\n(eg, because of surgery, multiple trauma, or burns), laboratory evidence of EFA deficiency may be\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 76, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(eg, because of surgery, multiple trauma, or burns), laboratory evidence of EFA deficiency may be\\npresent without clinical signs.\\nDermatitis due to EFA deficiency is generalized and scaly; in infants, it can resemble congenital\\nichthyosis. The dermatitis increases water loss from the skin.\\nDiagnosis is usually clinical; however, laboratory assays are now available in large research centers.\\nTreatment consists of dietary EFAs, reversing the deficiency.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 2. Undernutrition\\n68'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 77, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chapter 3. Nutritional Support\\nIntroduction\\nMany undernourished patients need nutritional support, which aims to increase lean body mass. Oral\\nfeeding can be difficult for some patients with anorexia or with eating or absorption problems. Behavioral\\nmeasures that sometimes enhance oral intake include the following:\\n• Encouraging patients to eat\\n• Heating or seasoning foods\\n• Providing favorite or strongly flavored foods\\n• Encouraging patients to eat small portions\\n• Scheduling around meals\\n• Assisting patients with feeding\\nIf behavioral measures are ineffective, nutritional support—oral, enteral tube, or parenteral nutrition—is\\nindicated, except sometimes for dying or severely demented patients (see p. 25).\\nPredicting Nutritional Requirements\\nNutritional requirements are predicted so that interventions can be planned. Requirements can be\\nestimated by formulas or measured by indirect calorimetry. Indirect calorimetry requires use of a metabolic'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 77, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"estimated by formulas or measured by indirect calorimetry. Indirect calorimetry requires use of a metabolic\\ncart (a closed rebreathing system that determines energy expenditure based on total CO2 production),\\nwhich requires special expertise and is not always available. Thus, total energy expenditure (TEE) and\\nprotein requirements usually are estimated.\\nEnergy expenditure: TEE varies based on the patient's weight, activity level, and degree of metabolic\\nstress (metabolic demands); TEE ranges from 25 kcal/kg/day for people who are sedentary and not under\\nstress to about 40 kcal/kg/day for people who are critically ill. TEE equals the sum of\\n• Resting metabolic rate (RMR, or resting energy expenditure rate), which is normally about 70% of TEE\\n• Energy dissipated by metabolism of food (10% of TEE)\\n• Energy expended during physical activity (20% of TEE)\\nUndernutrition can decrease RMR up to 20%. Conditions that increase metabolic stress (eg, critical\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 77, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Energy expended during physical activity (20% of TEE)\\nUndernutrition can decrease RMR up to 20%. Conditions that increase metabolic stress (eg, critical\\nillness, infection, inflammation, trauma, surgery) can increase RMR but rarely by > 50%.\\nThe Mifflin-St. Jeor equation estimates RMR more precisely and with fewer errors than the commonly\\nused Harris-Benedict equation, usually providing results that are within 20% of those measured by\\nindirect calorimetry. The Mifflin-St. Jeor equation estimates RMR as follows:\\nMen: kcal / day = 66 + (13.7 × wt[kg]) + (5 × height[cm]) - (6.8 × age)\\nWomen: kcal / day = 665 + (9.6 × wt[kg]) + (1.8 × height[cm]) - (4.7 × age)\\nTEE can be estimated by adding about 10% (for sedentary people) to about 40% (for people who are\\ncritically ill) to RMR.\\nProtein requirements: For healthy people, protein requirements are estimated at 0.8 g/kg/day.\\nHowever, for patients with metabolic stress or kidney failure and for elderly patients, requirements may be'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 77, 'source_type': 'Authorotative', 'priority': '1'}, page_content='However, for patients with metabolic stress or kidney failure and for elderly patients, requirements may be\\nhigher (see\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 3. Nutritional Support\\n69'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 78, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Table 3-1).\\nAssessing Response to Nutritional Support\\nThere is no gold standard to assess response. Clinicians commonly use indicators of lean body mass\\nsuch as the following:\\n• Body mass index (BMI)\\n• Body composition analysis\\n• Body fat distribution (see pp.\\n11 and 58)\\nNitrogen balance, response to skin antigens, muscle strength measurement, and indirect calorimetry can\\nalso be used.\\n[Table 3-1. Estimated Adult Daily Protein Requirement]\\nNitrogen balance, which reflects the balance between protein needs and supplies, is the difference\\nbetween amount of nitrogen ingested and amount lost. A positive balance (ie, more ingested than lost)\\nimplies adequate intake. Precise measurement is impractical, but estimates help assess response to\\nnutritional support. Nitrogen intake is estimated from protein intake: nitrogen (g) equals protein (g)/6.25.\\nEstimated nitrogen losses consist of urinary nitrogen losses (estimated by measuring urea nitrogen'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 78, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Estimated nitrogen losses consist of urinary nitrogen losses (estimated by measuring urea nitrogen\\ncontent of an accurately obtained 24-h urine collection) plus stool losses (estimated at 1 g/day if stool is\\nproduced; negligible if stool is not produced) plus insensible and other unmeasured losses (estimated at\\n3 g).\\nResponse to skin antigens, a measure of delayed hypersensitivity, often increases to normal as\\nundernourished patients respond to nutritional support. However, other factors can affect response to\\nskin antigens.\\nMuscle strength indirectly reflects increases in lean body mass. It can be measured quantitatively, by\\nhand-grip dynamometry, or electrophysiologically (typically by stimulating the ulnar nerve with an\\nelectrode).\\nLevels of acute-phase reactant serum proteins (particularly short-lived proteins such as prealbumin\\n[transthyretin], retinol-binding protein, and transferrin) sometimes correlate with improved nutritional'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 78, 'source_type': 'Authorotative', 'priority': '1'}, page_content='[transthyretin], retinol-binding protein, and transferrin) sometimes correlate with improved nutritional\\nstatus, but these levels correlate better with inflammatory conditions.\\nEnteral Tube Nutrition\\nEnteral tube nutrition is indicated for patients who have a functioning GI tract but cannot ingest enough\\nnutrients orally because they are unable or unwilling to take oral feedings. Compared with parenteral\\nnutrition, enteral nutrition has the following advantages:\\n• Better preservation of the structure and function of the GI tract\\n• Lower cost\\n• Probably fewer complications, particularly infections\\nSpecific indications for enteral nutrition include the following:\\n• Prolonged anorexia\\n• Severe protein-energy undernutrition\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 3. Nutritional Support\\n70'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 79, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"• Coma or depressed sensorium\\n• Liver failure\\n• Inability to take oral feedings due to head or neck trauma or neurologic disorders\\n• Critical illnesses (eg, burns) causing metabolic stress\\nOther indications may include bowel preparation for surgery in seriously ill or undernourished patients,\\nclosure of enterocutaneous fistulas, and small-bowel adaptation after massive intestinal resection or in\\ndisorders that may cause malabsorption (eg, Crohn's disease).\\nProcedure: If tube feeding is needed for ≤ 4 to 6 wk, a small-caliber, soft nasogastric or nasoenteric (eg,\\nnasoduodenal) tube made of silicone or polyurethane is usually used. If a nasal injury or deformity makes\\nnasal placement difficult, an orogastric or other oroenteric tube can be placed.\\nTube feeding for > 4 to 6 wk usually requires a gastrostomy or jejunostomy tube, placed endoscopically,\\nsurgically, or radiologically. Choice depends on physician capabilities and patient preference.\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 79, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Tube feeding for > 4 to 6 wk usually requires a gastrostomy or jejunostomy tube, placed endoscopically,\\nsurgically, or radiologically. Choice depends on physician capabilities and patient preference.\\nJejunostomy tubes are useful for patients with contraindications to gastrostomy (eg, gastrectomy, bowel\\nobstruction proximal to the jejunum). However, these tubes do not pose less risk of tracheobronchial\\naspiration than gastrostomy tubes, as is often thought. Jejunostomy tubes are easily dislodged and are\\nusually used only for inpatients.\\nFeeding tubes are surgically placed if endoscopic and radiologic placement is unavailable, technically\\nimpossible, or unsafe (eg, because of overlying bowel). Open or laparoscopic techniques can be used.\\nFormulas: Liquid formulas commonly used include feeding modules and polymeric or other specialized\\nformulas.\\nFeeding modules are commercially available products that contain a single nutrient, such as proteins,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 79, 'source_type': 'Authorotative', 'priority': '1'}, page_content='formulas.\\nFeeding modules are commercially available products that contain a single nutrient, such as proteins,\\nfats, or carbohydrates. Feeding modules may be used individually to treat a specific deficiency or\\ncombined with other formulas to completely satisfy nutritional requirements.\\nPolymeric formulas (including blenderized food and milk-based or lactose-free commercial formulas)\\nare commercially available and generally provide a complete, balanced diet. For oral or tube feedings,\\nthey are usually preferred to feeding modules. In hospitalized patients, lactose-free formulas are the most\\ncommonly used polymeric formulas. However, milk-based formulas tend to taste better than lactose-free\\nformulas. Patients with lactose intolerance may be able to tolerate milk-based formulas given slowly by\\ncontinuous infusion.\\nSpecialized formulas include hydrolyzed protein or sometimes amino acid formulas, which are used for'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 79, 'source_type': 'Authorotative', 'priority': '1'}, page_content='continuous infusion.\\nSpecialized formulas include hydrolyzed protein or sometimes amino acid formulas, which are used for\\npatients who have difficulty digesting complex proteins. However, these formulas are expensive and\\nusually unnecessary. Most patients with pancreatic insufficiency, if given enzymes, and most patients with\\nmalabsorption can digest complex proteins. Other specialized formulas (eg, calorie- and protein-dense\\nformulas for patients whose fluids are restricted, fiber-enriched formulas for constipated patients) may be\\nhelpful.\\nAdministration: Patients should be sitting upright at 30 to 45° during tube feeding and for 1 to 2 h\\nafterward to minimize incidence of nosocomial aspiration pneumonia and to allow gravity to help propel\\nthe food. Tube feedings are given in boluses several times a day or by continuous infusion. Bolus feeding\\nis more physiologic and may be preferred for patients with diabetes. Continuous infusion is necessary if\\nboluses cause nausea.\\n['),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 79, 'source_type': 'Authorotative', 'priority': '1'}, page_content='is more physiologic and may be preferred for patients with diabetes. Continuous infusion is necessary if\\nboluses cause nausea.\\n[\\nTable 3-2. Complications of Enteral Tube Nutrition]\\nFor bolus feeding, total daily volume is divided into 4 to 6 separate feedings, which are injected through\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 3. Nutritional Support\\n71'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 80, 'source_type': 'Authorotative', 'priority': '1'}, page_content='the tube with a syringe or infused by gravity from an elevated bag. After feedings, the tube is flushed with\\nwater to prevent clogging.\\nNasogastric or nasoduodenal tube feeding often causes diarrhea initially; thus, feedings are usually\\nstarted with small amounts of dilute preparations and increased as tolerated. Most formulas contain 0.5,\\n1, or 2 kcal/mL. Formulas with higher caloric concentration (less water per calorie) may cause decreased\\ngastric emptying and thus higher gastric residuals than when more dilute formulas with the same number\\nof calories are used. Initially, a 1-kcal/mL commercially prepared solution may be given undiluted at 50\\nmL/h or, if patients have not been fed for a while, at 25 mL/h. Usually, these solutions do not supply\\nenough water, particularly if vomiting, diarrhea, sweating, or fever has increased water loss. Extra water\\nis supplied as boluses via the feeding tube or IV. After a few days, the rate or concentration can be'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 80, 'source_type': 'Authorotative', 'priority': '1'}, page_content='is supplied as boluses via the feeding tube or IV. After a few days, the rate or concentration can be\\nincreased as needed to meet caloric and water needs.\\nJejunostomy tube feeding requires greater dilution and smaller volumes. Feeding usually begins at a\\nconcentration of ≤ 0.5 kcal/mL and a rate of 25 mL/h. After a few days, concentrations and volumes can\\nbe increased to eventually meet caloric and water needs. Usually, the maximum that can be tolerated is\\n0.8 kcal/mL at 125 mL/h, providing 2400 kcal/day.\\nComplications: Complications are common and can be serious (see Table 3-2).\\nTotal Parenteral Nutrition\\nParenteral nutrition is by definition given IV.\\nPartial parenteral nutrition supplies only part of daily nutritional requirements, supplementing oral\\nintake. Many hospitalized patients are given dextrose or amino acid solutions by this method.\\nTotal parenteral nutrition (TPN) supplies all daily nutritional requirements. TPN can be used in the'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 80, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"intake. Many hospitalized patients are given dextrose or amino acid solutions by this method.\\nTotal parenteral nutrition (TPN) supplies all daily nutritional requirements. TPN can be used in the\\nhospital or at home. Because TPN solutions are concentrated and can cause thrombosis of peripheral\\nveins, a central venous catheter is usually required.\\nParenteral nutrition should not be used routinely in patients with an intact GI tract. Compared with enteral\\nnutrition, it causes more complications, does not preserve GI tract structure and function as well, and is\\nmore expensive.\\nIndications: TPN may be the only feasible option for patients who do not have a functioning GI tract or\\nwho have disorders requiring complete bowel rest, such as the following:\\n• Some stages of Crohn's disease or ulcerative colitis\\n• Bowel obstruction\\n• Certain pediatric GI disorders (eg, congenital GI anomalies, prolonged diarrhea regardless of its cause)\\n• Short bowel syndrome due to surgery\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 80, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Bowel obstruction\\n• Certain pediatric GI disorders (eg, congenital GI anomalies, prolonged diarrhea regardless of its cause)\\n• Short bowel syndrome due to surgery\\nNutritional content: TPN requires water (30 to 40 mL/kg/day), energy (30 to 60 kcal/kg/day, depending\\non energy expenditure), amino acids (1 to 2.0 g/kg/day, depending on the degree of catabolism), essential\\nfatty acids, vitamins, and minerals (see\\nTable 3-3). Children who need TPN may have different fluid requirements and need more energy (up to\\n120 kcal/kg/day) and amino acids (up to 2.5 or 3.5 g/kg/day).\\nBasic TPN solutions are prepared using sterile techniques, usually in liter batches according to standard\\nformulas. Normally, 2 L/day of the standard solution is needed. Solutions may be modified based on\\nlaboratory results, underlying disorders, hypermetabolism, or other factors.\\nMost calories are supplied as carbohydrate. Typically, about 4 to 5 mg/kg/day of dextrose is given.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 80, 'source_type': 'Authorotative', 'priority': '1'}, page_content='laboratory results, underlying disorders, hypermetabolism, or other factors.\\nMost calories are supplied as carbohydrate. Typically, about 4 to 5 mg/kg/day of dextrose is given.\\nStandard solutions contain up to about 25% dextrose, but the amount and concentration depend on other\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 3. Nutritional Support\\n72'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 81, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"factors, such as metabolic needs and the proportion of caloric needs that are supplied by lipids.\\nCommercially available lipid emulsions are often added to supply essential fatty acids and triglycerides;\\n20 to 30% of total calories are usually supplied as lipids. However, withholding lipids and their calories\\nmay help obese patients mobilize endogenous fat stores, increasing insulin sensitivity.\\nSolutions: Many solutions are commonly used. Electrolytes can be added to meet the patient's needs.\\nSolutions vary depending on other disorders present and patient age, as for the following:\\n• For renal insufficiency not being treated with dialysis or for liver failure: Reduced protein content and a\\nhigh percentage of essential amino acids\\n• For heart or kidney failure: Limited volume (liquid) intake\\n• For respiratory failure: A lipid emulsion that provides most of nonprotein calories to minimize CO2\\nproduction by carbohydrate metabolism\\n• For neonates: Lower dextrose concentrations (17 to 18%)\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 81, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• For respiratory failure: A lipid emulsion that provides most of nonprotein calories to minimize CO2\\nproduction by carbohydrate metabolism\\n• For neonates: Lower dextrose concentrations (17 to 18%)\\nBeginning TPN administration: Because the central venous catheter needs to remain in place for a\\nlong time, strict sterile technique must be used during insertion and maintenance. The TPN line should\\nnot be used for any other purpose. External tubing should be changed every 24 h with the first bag of the\\nday. In-line filters have not been shown to decrease complications. Dressings should be kept sterile and\\nare usually changed every 48 h using strict sterile techniques. If TPN is given outside the hospital,\\npatients must be taught to recognize symptoms of infection, and qualified home nursing must be\\narranged.\\nThe solution is started slowly at 50% of the calculated requirements, using 5% dextrose to make up the'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 81, 'source_type': 'Authorotative', 'priority': '1'}, page_content='arranged.\\nThe solution is started slowly at 50% of the calculated requirements, using 5% dextrose to make up the\\nbalance of fluid requirements. Energy and nitrogen should be given simultaneously. The amount of\\nregular insulin given (added directly to the TPN solution) depends on the plasma glucose level; if the\\nlevel is normal and the final solution contains 25% dextrose, the usual starting dose is 5 to 10 units of\\nregular insulin/L of TPN fluid.\\nMonitoring: Progress should be followed on a flowchart. An interdisciplinary nutrition team, if available,\\nshould monitor patients. Weight, CBC, electrolytes, and BUN should be monitored often (eg, daily for\\ninpatients). Plasma glucose should be monitored every 6 h until patients and glucose levels become\\nstable. Fluid intake and output should be monitored continuously. When patients become stable, blood\\ntests can be done much less often.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 81, 'source_type': 'Authorotative', 'priority': '1'}, page_content='stable. Fluid intake and output should be monitored continuously. When patients become stable, blood\\ntests can be done much less often.\\nLiver function tests should be done. Plasma proteins (eg, serum albumin, possibly transthyretin or retinol-\\nbinding protein), PT, plasma and urine osmolality, and Ca, Mg, and phosphate should be measured\\ntwice/wk. Changes in transthyretin and retinol-binding protein reflect overall clinical status rather than\\nnutritional status alone. If possible, blood tests should not be done during glucose infusion. Full nutritional\\nassessment (including BMI calculation and anthropometric measurements—see pp. 11 and 58) should be\\nrepeated at 2-wk intervals.\\nComplications: About 5 to 10% of patients have complications related to central venous access.\\n[Table 3-3. Basic Adult Daily Requirements for Total Parenteral Nutrition]\\nCatheter-related sepsis occurs in about ≥ 50% of patients. Glucose abnormalities (hyperglycemia or'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 81, 'source_type': 'Authorotative', 'priority': '1'}, page_content='[Table 3-3. Basic Adult Daily Requirements for Total Parenteral Nutrition]\\nCatheter-related sepsis occurs in about ≥ 50% of patients. Glucose abnormalities (hyperglycemia or\\nhypoglycemia) or liver dysfunction occurs in > 90% of patients.\\nGlucose abnormalities are common. Hyperglycemia can be avoided by monitoring plasma glucose\\noften, adjusting the insulin dose in the TPN solution and giving subcutaneous insulin as needed.\\nHypoglycemia can be precipitated by suddenly stopping constant concentrated dextrose infusions.\\nTreatment depends on the degree of hypoglycemia. Short-term hypoglycemia may be reversed with 50%\\ndextrose IV; more prolonged hypoglycemia may require infusion of 5 or 10% dextrose for 24 h before\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 3. Nutritional Support\\n73'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 82, 'source_type': 'Authorotative', 'priority': '1'}, page_content='resuming TPN via the central venous catheter.\\nHepatic complications include liver dysfunction, painful hepatomegaly, and hyperammonemia. They can\\ndevelop at any age but are most common among infants, particularly premature ones (whose liver is\\nimmature).\\n• Liver dysfunction may be transient, evidenced by increased transaminases, bilirubin, and alkaline\\nphosphatase; it commonly occurs when TPN is started. Delayed or persistent elevations may result\\nfrom excess amino acids. Pathogenesis is unknown, but cholestasis and inflammation may contribute.\\nProgressive fibrosis occasionally develops. Reducing protein delivery may help.\\n• Painful hepatomegaly suggests fat accumulation; carbohydrate delivery should be reduced.\\n• Hyperammonemia can develop in infants, causing lethargy, twitching, and generalized seizures. Arginine\\nsupplementation at 0.5 to 1.0 mmol/kg/day can correct it.\\nIf infants develop any hepatic complication, limiting amino acids to 1.0 g/kg/day may be necessary.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 82, 'source_type': 'Authorotative', 'priority': '1'}, page_content='supplementation at 0.5 to 1.0 mmol/kg/day can correct it.\\nIf infants develop any hepatic complication, limiting amino acids to 1.0 g/kg/day may be necessary.\\nAbnormalities of serum electrolytes and minerals should be corrected by modifying subsequent\\ninfusions or, if correction is urgently required, by beginning appropriate peripheral vein infusions. Vitamin\\nand mineral deficiencies are rare when solutions are given correctly. Elevated BUN may reflect\\ndehydration, which can be corrected by giving free water as 5% dextrose via a peripheral vein.\\nVolume overload (suggested by > 1 kg/day weight gain) may occur when patients have high daily\\nenergy requirements and thus require large fluid volumes.\\nMetabolic bone disease, or bone demineralization (osteoporosis or osteomalacia), develops in some\\npatients given TPN for > 3 mo. The mechanism is unknown. Advanced disease can cause severe\\nperiarticular, lower-extremity, and back pain. Temporarily or permanently stopping TPN is the only known'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 82, 'source_type': 'Authorotative', 'priority': '1'}, page_content='patients given TPN for > 3 mo. The mechanism is unknown. Advanced disease can cause severe\\nperiarticular, lower-extremity, and back pain. Temporarily or permanently stopping TPN is the only known\\ntreatment.\\nAdverse reactions to lipid emulsions (eg, dyspnea, cutaneous allergic reactions, nausea, headache,\\nback pain, sweating, dizziness) are uncommon but may occur early, particularly if lipids are given at > 1.0\\nkcal/kg/h. Temporary hyperlipidemia may occur, particularly in patients with kidney or liver failure;\\ntreatment is usually not required. Delayed adverse reactions to lipid emulsions include hepatomegaly, mild\\nelevation of liver enzymes, splenomegaly, thrombocytopenia, leukopenia, and, especially in premature\\ninfants with respiratory distress syndrome, pulmonary function abnormalities. Temporarily or permanently\\nslowing or stopping lipid emulsion infusion may prevent or minimize these adverse reactions.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 82, 'source_type': 'Authorotative', 'priority': '1'}, page_content='infants with respiratory distress syndrome, pulmonary function abnormalities. Temporarily or permanently\\nslowing or stopping lipid emulsion infusion may prevent or minimize these adverse reactions.\\nGallbladder complications include cholelithiasis, gallbladder sludge, and cholecystitis. These\\ncomplications can be caused or worsened by prolonged gallbladder stasis. Stimulating contraction by\\nproviding about 20 to 30% of calories as fat and stopping glucose infusion several hours a day is helpful.\\nOral or enteral intake also helps. Treatment with metronidazole, ursodeoxycholic acid, phenobarbital, or\\ncholecystokinin helps some patients with cholestasis.\\nNutritional Support for Dying or Severely Demented Patients\\nAnorexia or loss of appetite is common among dying patients (see p. 3485). Behavioral measures (eg,\\nusing flexible feeding schedules, feeding slowly, giving small portions or favorite or strongly flavored'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 82, 'source_type': 'Authorotative', 'priority': '1'}, page_content='using flexible feeding schedules, feeding slowly, giving small portions or favorite or strongly flavored\\nfoods) can often increase oral intake. A small amount of a favorite alcoholic drink, given 30 min before\\nmeals, may also help. Certain antidepressants, megestrol acetate, and dronabinol may stimulate appetite.\\nMetoclopramide enhances gastric emptying, but it may take 1 to 2 wk to reach peak effectiveness.\\nAdvanced dementia eventually leads to inability to eat; sometimes affected patients are given tube\\nfeedings. However, there is no convincing evidence that tube feedings prolong life, provide comfort,\\nimprove function, or prevent complications (eg, aspiration, pressure ulcers).\\nTube feedings and parenteral nutrition cause discomfort and are usually not indicated for patients who\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 3. Nutritional Support\\n74'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 83, 'source_type': 'Authorotative', 'priority': '1'}, page_content='are dying or too demented to eat. Forgoing nutritional support may be difficult for family members to\\naccept, but they should understand that patients are usually more comfortable eating and drinking as they\\nchoose. Sips of water and easy-to-swallow foods may be useful. Supportive care, including good oral\\nhygiene (eg, brushing the teeth, moistening the oral cavity with swabs and ice chips as needed, applying\\nlip salve), can physically and psychologically comfort the patients and the family members who provide\\nthe care.\\nCounseling may help family members who are dealing with anxieties about whether to use invasive\\nnutritional support.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 3. Nutritional Support\\n75'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 84, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chapter 4. Vitamin Deficiency, Dependency, and Toxicity\\nIntroduction\\nVitamins may be fat soluble (vitamins A, D, E, and K) or water soluble (B vitamins and vitamin C). The B\\nvitamins include biotin, folate, niacin, pantothenic acid, riboflavin (B2), thiamin (B1), B6 (eg, pyridoxine),\\nand B12 (cobalamins). For dietary requirements, sources, functions, effects of deficiencies and toxicities,\\nblood levels, and usual therapeutic dosages for vitamins, see\\nTables 4-1 and\\n4-2.\\nDietary requirements for vitamins (and other nutrients) are expressed as daily recommended intake (DRI).\\nThere are 3 types of DRI:\\n• Recommended daily allowance (RDA): RDAs are set to meet the needs of 97 to 98% of healthy\\npeople.\\n• Adequate intake (AI): When data to calculate an RDA are insufficient, AIs are based on observed or\\nexperimentally determined estimates of nutrient intake by healthy people.\\n• Tolerable upper intake level (UL): ULs are the largest amount of a nutrient that most adults can'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 84, 'source_type': 'Authorotative', 'priority': '1'}, page_content='experimentally determined estimates of nutrient intake by healthy people.\\n• Tolerable upper intake level (UL): ULs are the largest amount of a nutrient that most adults can\\ningest daily without risk of adverse health effects.\\nIn developed countries, vitamin deficiencies result mainly from poverty, food faddism, drugs (see p. 7 and\\nTable 4-3), alcoholism, or prolonged and inadequately supplemented parenteral feeding. Mild vitamin\\ndeficiency is common among frail and institutionalized elderly people who have protein-energy\\nundernutrition. In developing countries, deficiencies can result from lack of access to nutrients.\\nDeficiencies of water-soluble vitamins (except vitamin B12) may develop after weeks to months of\\nundernutrition. Deficiencies of fat-soluble vitamins and of vitamin B12 take > 1 yr to develop because the\\nbody stores them in relatively large amounts. Intake of vitamins sufficient to prevent classic vitamin'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 84, 'source_type': 'Authorotative', 'priority': '1'}, page_content='body stores them in relatively large amounts. Intake of vitamins sufficient to prevent classic vitamin\\ndeficiencies (like scurvy or beriberi) may not be adequate for optimum health. This area remains one of\\ncontroversy and active research.\\nVitamin dependency results from a genetic defect involving metabolism of a vitamin. In some cases,\\nvitamin doses as high as 1000 times the DRI improve function of the altered metabolic pathway. Vitamin\\ntoxicity (hypervitaminosis) usually results from taking megadoses of vitamin A, D, C, B6, or niacin.\\nBecause many people eat irregularly, foods alone may provide suboptimal amounts of some vitamins. In\\nthese cases, the risk of certain cancers or other disorders may be increased. Because of this risk, routine\\ndaily multivitamin supplements are sometimes recommended.\\nBiotin and Pantothenic Acid\\nBiotin acts as a coenzyme for carboxylation reactions essential to fat and carbohydrate metabolism.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 84, 'source_type': 'Authorotative', 'priority': '1'}, page_content='daily multivitamin supplements are sometimes recommended.\\nBiotin and Pantothenic Acid\\nBiotin acts as a coenzyme for carboxylation reactions essential to fat and carbohydrate metabolism.\\nAdequate intake for adults is 30 μg/day. Pantothenic acid is widely distributed in foods; it is an essential\\ncomponent of coenzyme A. Adults probably require about 5 mg/day. A beneficial role for pantothenic acid\\nsupplementation in lipid metabolism, RA, or athletic performance remains unproved. Isolated deficiency of\\nbiotin or pantothenic acid virtually never occurs.\\nFolate\\nFolate (folic acid) is now added to enriched grain foods in the US. Folate is also plentiful in various plant\\nfoods and meats, but its bioavailability is greater when it is in supplements\\n[Table 4-1. Recommended Daily Intakes for Vitamins]\\nor enriched foods than when it occurs naturally in food.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n76'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 85, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Folates are involved in RBC maturation and synthesis of purines and pyrimidines. They are required for\\ndevelopment of the fetal nervous system. Absorption occurs in the duodenum and upper jejunum.\\nEnterohepatic circulation of folate occurs. Folate supplements\\n[Table 4-2. Sources, Functions, and Effects of Vitamins]\\ndo not protect against coronary artery disease or stroke (by lowering homocysteine levels); their role in\\nreducing the risk of various cancers is unclear. The upper limit for folate intake is 1000 μg; higher doses\\n(up to 5 mg) are recommended for women who have had a baby with a neural tube defect. Folate is\\nessentially nontoxic.\\nFolate Deficiency\\nFolate deficiency is common. It may result from inadequate intake, malabsorption, or use of various drugs.\\nDeficiency causes megaloblastic anemia (indistinguishable from that due to vitamin B12 deficiency).\\nMaternal deficiency increases the risk of neural tube birth defects. Diagnosis requires laboratory testing'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 85, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Maternal deficiency increases the risk of neural tube birth defects. Diagnosis requires laboratory testing\\nto confirm. Measurement of neutrophil hypersegmentation is sensitive and readily available. Treatment\\nwith oral folate is usually successful.\\nEtiology and Pathophysiology\\nThe most common causes are inadequate intake (usually in patients with undernutrition or alcoholism),\\nincreased demand (eg, due to pregnancy or breastfeeding), and impaired absorption (eg, in tropical\\nsprue, due to certain drugs). Deficiency can also result from inadequate bioavailability and increased\\nexcretion (see\\nTable 4-4).\\nProlonged cooking destroys folate, predisposing to inadequate intake. Intake is sometimes barely\\nadequate (eg, in alcoholics). Liver stores provide only a several-month supply.\\nAlcohol interferes with folate absorption, metabolism, renal excretion, and enterohepatic reabsorption, as\\nwell as intake. 5-Fluorouracil, metformin, methotrexate, phenobarbital, phenytoin, sulfasalazine,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 85, 'source_type': 'Authorotative', 'priority': '1'}, page_content='well as intake. 5-Fluorouracil, metformin, methotrexate, phenobarbital, phenytoin, sulfasalazine,\\ntriamterene, and trimethoprim impair folate metabolism.\\nIn the US, many dietary staples (eg, cereals, grain products) are routinely enriched with folate, tending to\\nreduce risk of deficiency.\\n[Table 4-3. Potential Vitamin-Drug Interactions]\\nSymptoms and Signs\\nFolate deficiency may cause glossitis, diarrhea, depression, and confusion. Anemia may develop\\ninsidiously and, because of compensatory mechanisms, be more severe than symptoms suggest.\\nFolate deficiency during pregnancy increases the risk of fetal neural tube defects and perhaps other brain\\ndefects (see p. 2992).\\nDiagnosis\\n• CBC and serum vitamin B12 and folate levels\\nCBC may indicate megaloblastic anemia indistinguishable from that of vitamin B12 deficiency. If serum\\nfolate is < 3 μg/L or ng/mL (< 7 nmol/L), deficiency is likely. Serum folate reflects folate status unless'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 85, 'source_type': 'Authorotative', 'priority': '1'}, page_content='folate is < 3 μg/L or ng/mL (< 7 nmol/L), deficiency is likely. Serum folate reflects folate status unless\\nintake has recently increased or decreased. If intake has changed, erythrocyte (RBC) folate level better\\nreflects tissue stores. A level of < 140 μg/L or ng/mL (< 305 nmol/L) indicates inadequate status. Also, an\\nincrease in the homocysteine level suggests tissue folate deficiency (but the level is also affected by\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n77'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 86, 'source_type': 'Authorotative', 'priority': '1'}, page_content='vitamin B12 and vitamin B6 levels, renal insufficiency, and genetic factors). A normal methylmalonic acid\\n(MMA) level may differentiate folate deficiency from vitamin B12 deficiency because MMA levels rise in\\nvitamin B12 deficiency but not in folate deficiency.\\nTreatment\\n• Supplemental oral folate\\nFolate 400 to 1000 μg po once/day replenishes tissues and is usually successful even if deficiency has\\nresulted from malabsorption. The normal requirement is 400 μg/day.\\n[Table 4-4. Causes of Folate Deficiency]\\n(CAUTION: In patients with megaloblastic anemia, vitamin B12 deficiency must be ruled out before\\ntreating with folate. If vitamin B12 deficiency is present, folate supplementation can alleviate the\\nanemia but does not reverse and may even worsen neurologic deficits.) For pregnant women, the\\nrecommended daily allowance (RDA) is 600 μg/day. For women who have had a fetus or infant with a\\nneural tube defect, the recommended dose is 1000 to 5000 μg/day.\\nNiacin'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 86, 'source_type': 'Authorotative', 'priority': '1'}, page_content='recommended daily allowance (RDA) is 600 μg/day. For women who have had a fetus or infant with a\\nneural tube defect, the recommended dose is 1000 to 5000 μg/day.\\nNiacin\\nNiacin (nicotinic acid, nicotinamide) derivatives include nicotinamide adenine dinucleotide (NAD) and\\nnicotinamide adenine dinucleotide phosphate (NADP), which are coenzymes in oxidation-reduction\\nreactions. They are vital in cell metabolism. Because dietary tryptophan can be metabolized to niacin,\\nfoods rich in tryptophan (eg, dairy products) can compensate for inadequate dietary niacin.\\nNiacin Deficiency\\nDietary niacin deficiency (causing pellagra) is uncommon in developed countries. Clinical\\nmanifestations include the \"three Ds\": localized pigmented rash (dermatitis); gastroenteritis\\n(diarrhea); and widespread neurologic deficits, including cognitive decline (dementia).\\nDiagnosis is usually clinical, and dietary supplementation (oral or, if needed, IM) is usually\\nsuccessful.\\nEtiology'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 86, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Diagnosis is usually clinical, and dietary supplementation (oral or, if needed, IM) is usually\\nsuccessful.\\nEtiology\\nPrimary deficiency results from extremely inadequate intake of both niacin and tryptophan, which usually\\noccurs in areas where maize (Indian corn) constitutes a substantial part of the diet. Bound niacin, found in\\nmaize, is not assimilated in the GI tract unless it has been previously treated with alkali, as when tortillas\\nare prepared. Corn protein is also deficient in tryptophan. The high incidence of pellagra in India among\\npeople who eat millet with a high leucine content has led to the hypothesis that amino acid imbalance may\\ncontribute to deficiency. Deficiencies of protein and many B vitamins commonly accompany primary niacin\\ndeficiency.\\nSecondary deficiency may be due to diarrhea, cirrhosis, or alcoholism. Pellagra also may occur in\\ncarcinoid syndrome (tryptophan is diverted to form 5-hydroxytryptophan and serotonin) and in Hartnup'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 86, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Secondary deficiency may be due to diarrhea, cirrhosis, or alcoholism. Pellagra also may occur in\\ncarcinoid syndrome (tryptophan is diverted to form 5-hydroxytryptophan and serotonin) and in Hartnup\\ndisease (absorption of tryptophan by the intestine and kidneys is defective).\\nSymptoms and Signs\\nPellagra is characterized by skin, mucous membrane, CNS, and GI symptoms. Advanced pellagra can\\ncause a symmetric photosensitive rash, stomatitis, glossitis, diarrhea, and mental aberrations. Symptoms\\nmay appear alone or in combination.\\nSkin symptoms include several types of lesions, which are usually bilaterally symmetric. The distribution\\nof lesions—at pressure points or sun-exposed skin—is more pathognomonic than the form of the lesions.\\nLesions can develop in a glovelike distribution on the hands (pellagrous glove) or in a boot-shaped\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n78'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 87, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"distribution on the feet and legs (pellagrous boot). Sunlight causes Casal's necklace and butterfly-shaped\\nlesions on the face.\\nMucous membrane symptoms affect primarily the mouth but may also affect the vagina and urethra.\\nGlossitis and stomatitis characterize acute deficiency. As the deficiency progresses, the tongue and oral\\nmucous membranes become reddened, followed by pain in the mouth, increased salivation, and edema of\\nthe tongue. Ulcerations may appear, especially under the tongue, on the mucosa of the lower lip, and\\nopposite the molar teeth.\\nGI symptoms early in the deficiency include burning in the pharynx and esophagus and abdominal\\ndiscomfort and distention. Constipation is common. Later, nausea, vomiting, and diarrhea may occur.\\nDiarrhea is often bloody because of bowel hyperemia and ulceration.\\nCNS symptoms include psychosis, encephalopathy (characterized by impaired consciousness), and\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 87, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Diarrhea is often bloody because of bowel hyperemia and ulceration.\\nCNS symptoms include psychosis, encephalopathy (characterized by impaired consciousness), and\\ncognitive decline (dementia). Psychosis is characterized by memory impairment, disorientation, confusion,\\nand confabulation; the predominant symptom may be excitement, depression, mania, delirium, or\\nparanoia.\\nDiagnosis\\n• Clinical evaluation\\nDiagnosis is clinical and may be straightforward when skin and mouth lesions, diarrhea, delirium, and\\ndementia occur simultaneously. More often, the presentation is not so specific. Differentiating the CNS\\nchanges from those in thiamin deficiency is difficult. A history of a diet lacking niacin and tryptophan may\\nhelp establish the diagnosis. A favorable response to treatment with niacin can usually confirm it. If\\navailable, laboratory testing can help confirm the diagnosis, particularly when the diagnosis is otherwise'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 87, 'source_type': 'Authorotative', 'priority': '1'}, page_content='available, laboratory testing can help confirm the diagnosis, particularly when the diagnosis is otherwise\\nunclear. Urinary excretion of N1-methylnicotinamide (NMN) is decreased; < 0.8 mg/day (< 5.8 μmol/day)\\nsuggests a niacin deficiency.\\nTreatment\\n• Nicotinamide and other nutrients\\nBecause multiple deficiencies are common, a balanced diet, including other B vitamins (particularly\\nriboflavin and pyridoxine), is needed. Nicotinamide is usually used to treat deficiency, because\\nnicotinamide, unlike nicotinic acid (the most common form of niacin), does not cause flushing, itching,\\nburning, or tingling sensations. Nicotinamide is given in doses ranging from 40 to 250 mg/day po in\\ndivided doses 3 to 4 times a day.\\nNiacin Toxicity\\nNiacin (nicotinic acid) in large amounts is sometimes used to lower low-density lipoprotein\\n(LDL) cholesterol and triglyceride levels and to increase high-density lipoprotein (HDL)\\ncholesterol levels. Symptoms may include flushing and, rarely, hepatotoxicity.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 87, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(LDL) cholesterol and triglyceride levels and to increase high-density lipoprotein (HDL)\\ncholesterol levels. Symptoms may include flushing and, rarely, hepatotoxicity.\\nImmediate- and sustained-release preparations of niacin (but not nicotinamide) may improve lipid levels.\\nFlushing, which is prostaglandin-mediated, is more common with immediate-release preparations. It may\\nbe more intense after alcohol ingestion, aerobic activity, sun exposure, and consumption of spicy foods.\\nFlushing is minimized if niacin is taken after meals or if aspirin (325 mg) is taken 30 to 45 min before\\nniacin. The chance of severe flushing can be reduced by starting immediate-release niacin at a low dose\\n(eg, 50 mg tid) and increasing it very slowly. At intermediate doses (1000 mg/day), triglyceride levels\\ndecrease 15 to 20%, and HDL cholesterol levels increase 15 to 30%. Reductions in LDL cholesterol are\\nmodest (< 10%). Higher doses of niacin (3000 mg/day) reduce LDL cholesterol 15 to 20% but may cause'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 87, 'source_type': 'Authorotative', 'priority': '1'}, page_content='modest (< 10%). Higher doses of niacin (3000 mg/day) reduce LDL cholesterol 15 to 20% but may cause\\njaundice, abdominal discomfort, blurred vision, worsening of hyperglycemia, and precipitation of\\npreexisting gout. People with a liver disorder probably should not take high-dose niacin.\\nHepatotoxicity may be more common with some sustained-release preparations. Some authorities\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n79'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 88, 'source_type': 'Authorotative', 'priority': '1'}, page_content='recommend checking levels of uric acid, serum glucose, and plasma transaminases every 6 to 8 wk until\\nthe dose of niacin has been stabilized.\\nRiboflavin\\nRiboflavin (vitamin B2) is involved in carbohydrate metabolism as an essential coenzyme in many\\noxidation-reduction reactions. Riboflavin is essentially nontoxic.\\nRiboflavin Deficiency\\nRiboflavin deficiency usually occurs with other B-vitamin deficiencies. Symptoms and signs\\ninclude sore throat, lesions of the lips and mucosa of the mouth, glossitis, conjunctivitis,\\nseborrheic dermatitis, and normochromicnormocytic anemia. Diagnosis is usually clinical.\\nTreatment consists of oral or, if needed, IM riboflavin.\\nPrimary riboflavin deficiency results from inadequate intake of fortified cereals, milk, and other animal\\nproducts. The most common causes of secondary deficiency are chronic diarrhea, malabsorption\\nsyndromes, liver disorders, hemodialysis, peritoneal dialysis, long-term use of barbiturates, and chronic\\nalcoholism.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 88, 'source_type': 'Authorotative', 'priority': '1'}, page_content='syndromes, liver disorders, hemodialysis, peritoneal dialysis, long-term use of barbiturates, and chronic\\nalcoholism.\\nSymptoms and Signs\\nThe most common signs are pallor and maceration of the mucosa at the angles of the mouth (angular\\nstomatitis) and vermilion surfaces of the lips (cheilosis), eventually replaced by superficial linear fissures.\\nThe fissures can become infected with Candida albicans, causing grayish white lesions (perleche). The\\ntongue may appear magenta. Seborrheic dermatitis develops, usually affecting the nasolabial folds, ears,\\neyelids, and scrotum or labia majora. These areas become red, scaly, and greasy.\\nRarely, neovascularization and keratitis of the cornea occur, causing lacrimation and photophobia.\\nDiagnosis\\nThe lesions characteristic of riboflavin deficiency are nonspecific. Riboflavin deficiency should be\\nsuspected if characteristic signs develop in a patient with other B vitamin deficiencies. Diagnosis can be'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 88, 'source_type': 'Authorotative', 'priority': '1'}, page_content='suspected if characteristic signs develop in a patient with other B vitamin deficiencies. Diagnosis can be\\nconfirmed by a therapeutic trial or laboratory testing, usually by measuring urinary excretion of riboflavin.\\nTreatment\\nRiboflavin 5 to 10 mg/day po is given until recovery. Other water-soluble vitamins should also be given.\\nThiamin\\nThiamin (vitamin B1) is widely available in the diet. Thiamin is involved in carbohydrate, fat, amino acid,\\nglucose, and alcohol metabolism. Thiamin is essentially nontoxic.\\nThiamin Deficiency\\nThiamin deficiency (causing beriberi) is most common among people subsisting on white rice\\nor highly refined carbohydrates in developing countries and among alcoholics. Symptoms\\ninclude diffuse polyneuropathy, high-output heart failure, and Wernicke-Korsakoff syndrome.\\nThiamin is given to help diagnose and treat the deficiency.\\nEtiology\\nPrimary thiamin deficiency is caused by inadequate intake of thiamin. It is commonly due to a diet of'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 88, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Thiamin is given to help diagnose and treat the deficiency.\\nEtiology\\nPrimary thiamin deficiency is caused by inadequate intake of thiamin. It is commonly due to a diet of\\nhighly refined carbohydrates (eg, polished rice, white flour, white sugar). It also develops when intake of\\nother nutrients is inadequate; it often occurs with other B vitamin deficiencies.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n80'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 89, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Secondary thiamin deficiency is caused by increased demand (eg, due to hyperthyroidism, pregnancy,\\nbreastfeeding, strenuous exercise, or fever), impaired absorption (eg, due to prolonged diarrhea), or\\nimpaired metabolism (eg, due to hepatic insufficiency). In alcoholics, many mechanisms contribute to\\nthiamin deficiency; they include decreased intake, impaired absorption and use, increased demand, and\\npossibly an apoenzyme defect.\\nPathophysiology\\nDeficiency causes degeneration of peripheral nerves, thalamus, mammillary bodies, and cerebellum.\\nCerebral blood flow is markedly reduced, and vascular resistance is increased.\\nThe heart may become dilated; muscle fibers become swollen, fragmented, and vacuolized, with\\ninterstitial spaces dilated by fluid. Vasodilation occurs and can result in edema in the feet and legs.\\nArteriovenous shunting of blood increases. Eventually, high-output heart failure may occur.\\nSymptoms and Signs'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 89, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Arteriovenous shunting of blood increases. Eventually, high-output heart failure may occur.\\nSymptoms and Signs\\nEarly symptoms are nonspecific: fatigue, irritability, poor memory, sleep disturbances, precordial pain,\\nanorexia, and abdominal discomfort.\\nDry beriberi refers to peripheral neurologic deficits due to thiamin deficiency. These deficits are bilateral\\nand roughly symmetric, occurring in a stocking-glove distribution. They affect predominantly the lower\\nextremities, beginning with paresthesias in the toes, burning in the feet (particularly severe at night),\\nmuscle cramps in the calves, pains in the legs, and plantar dysesthesias. Calf muscle tenderness,\\ndifficulty rising from a squatting position, and decreased vibratory sensation in the toes are early signs.\\nMuscle wasting occurs. Continued deficiency worsens polyneuropathy, which can eventually affect the\\narms.\\nWernicke-Korsakoff syndrome, which combines Wernicke's encephalopathy (see p. 1522) and\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 89, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Muscle wasting occurs. Continued deficiency worsens polyneuropathy, which can eventually affect the\\narms.\\nWernicke-Korsakoff syndrome, which combines Wernicke's encephalopathy (see p. 1522) and\\nKorsakoff's psychosis (see p. 1523), occurs in some alcoholics who do not consume foods fortified with\\nthiamin. Wernicke's encephalopathy consists of psychomotor slowing or apathy, nystagmus, ataxia,\\nophthalmoplegia, impaired consciousness, and, if untreated, coma and death. It probably results from\\nsevere acute deficiency superimposed on chronic deficiency. Korsakoff's psychosis consists of mental\\nconfusion, dysphonia, and confabulation with impaired memory of recent events. It probably results from\\nchronic deficiency and may develop after repeated episodes of Wernicke's encephalopathy.\\nCardiovascular (wet) beriberi is myocardial disease due to thiamin deficiency. The first effects are\\nvasodilation, tachycardia, a wide pulse pressure, sweating, warm skin, and lactic acidosis. Later, heart\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 89, 'source_type': 'Authorotative', 'priority': '1'}, page_content='vasodilation, tachycardia, a wide pulse pressure, sweating, warm skin, and lactic acidosis. Later, heart\\nfailure develops, causing orthopnea and pulmonary and peripheral edema. Vasodilation can continue,\\nsometimes resulting in shock.\\nInfantile beriberi occurs in infants (usually by age 3 to 4 wk) who are breastfed by thiamin-deficient\\nmothers. Heart failure (which may occur suddenly), aphonia, and absent deep tendon reflexes are\\ncharacteristic.\\nBecause thiamin is necessary for glucose metabolism, glucose infusions may precipitate or worsen\\nsymptoms of deficiency in thiamin-deficient people.\\nDiagnosis\\n• Favorable response to thiamin\\nDiagnosis is usually based on a favorable response to treatment with thiamin in a patient with symptoms\\nor signs of deficiency. Similar bilateral lower-extremity polyneuropathies due to other disorders (eg,\\ndiabetes, alcoholism, vitamin B12 deficiency, heavy metal poisoning) do not respond to thiamin. Single-'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 89, 'source_type': 'Authorotative', 'priority': '1'}, page_content='diabetes, alcoholism, vitamin B12 deficiency, heavy metal poisoning) do not respond to thiamin. Single-\\nnerve neuritides (mononeuropathies—eg, sciatica) and multiple mononeuropathies (mononeuritis\\nmultiplex) are unlikely to result from thiamin deficiency.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n81'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 90, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Electrolytes, including Mg, should be measured to exclude other causes. For confirmation in equivocal\\ncases, erythrocyte transketolase activity and 24-h urinary thiamin excretion may be measured.\\nDiagnosis of cardiovascular beriberi can be difficult if other disorders that cause heart failure are present.\\nA therapeutic trial of thiamin can help.\\nTreatment\\n• Supplemental thiamin, with dose based on clinical manifestations\\nEnsuring that dietary supplies of thiamin are adequate is important regardless of symptoms. Because IV\\nglucose can worsen thiamin deficiency, alcoholics and others at risk of thiamin deficiency should receive\\nIV thiamin 100 mg before receiving IV glucose solutions.\\nFor mild polyneuropathy, thiamin 10 to 20 mg po once/day is given for 2 wk. For moderate or advanced\\nneuropathy, the dose is 20 to 30 mg/day; it should be continued for several weeks after symptoms\\ndisappear. For edema and congestion due to cardiovascular beriberi, thiamin 100 mg IV once/day is given'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 90, 'source_type': 'Authorotative', 'priority': '1'}, page_content='disappear. For edema and congestion due to cardiovascular beriberi, thiamin 100 mg IV once/day is given\\nfor several days. Heart failure is also treated.\\nFor Wernicke-Korsakoff syndrome, thiamin 50 to 100 mg IM or IV bid must usually be given for several\\ndays, followed by 10 to 20 mg once/day until a therapeutic response is obtained. Anaphylactic reactions\\nto IV thiamin are rare. Symptoms of ophthalmoplegia may resolve in a day; improvement in patients with\\nKorsakoff psychosis may take 1 to 3 mo. Recovery from neurologic deficits is often incomplete in\\nWernicke-Korsakoff syndrome and in other forms of thiamin deficiency.\\nBecause thiamin deficiency often occurs with other B vitamin deficiencies, multiple water-soluble vitamins\\nare usually given for several weeks. Patients should continue to consume a nutritious diet, supplying 1 to\\n2 times the daily recommended intake of vitamins; all alcohol intake should stop.\\nVitamin A'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 90, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"are usually given for several weeks. Patients should continue to consume a nutritious diet, supplying 1 to\\n2 times the daily recommended intake of vitamins; all alcohol intake should stop.\\nVitamin A\\nVitamin A (retinol) is required for the formation of rhodopsin, a photoreceptor pigment in the retina. Vitamin\\nA helps maintain epithelial tissues. Normally, the liver stores 80 to 90% of the body's vitamin A. To use\\nvitamin A, the body releases it into the circulation bound to prealbumin (transthyretin) and retinol-binding\\nprotein. β-Carotene and other provitamin carotenoids, contained in green leafy and yellow vegetables\\nand deep- or bright-colored fruits, are converted to vitamin A. Carotenoids are absorbed better from\\nvegetables when they are cooked or homogenized and served with some fats or oils.\\nRetinol activity equivalents (RAE) were developed because provitamin A carotenoids have less vitamin A\\nactivity than preformed vitamin A; 1 μg retinol = 3.33 IU.\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 90, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Retinol activity equivalents (RAE) were developed because provitamin A carotenoids have less vitamin A\\nactivity than preformed vitamin A; 1 μg retinol = 3.33 IU.\\nSynthetic vitamin analogs (retinoids) are being used increasingly in dermatology. The possible protective\\nrole of β-carotene, retinol, and retinoids against some epithelial cancers is under study. However, risk of\\ncertain cancers may be increased after β-carotene supplementation.\\nVitamin A Deficiency\\nVitamin A deficiency can result from inadequate intake, fat malabsorption, or liver disorders.\\nDeficiency impairs immunity and hematopoiesis and causes rashes and typical ocular effects\\n(eg, xerophthalmia, night blindness). Diagnosis is based on typical ocular findings and low\\nvitamin A levels. Treatment consists of vitamin A given orally or, if symptoms are severe or\\nmalabsorption is the cause, parenterally.\\nEtiology\\nPrimary vitamin A deficiency is usually caused by prolonged dietary deprivation. It is endemic in areas'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 90, 'source_type': 'Authorotative', 'priority': '1'}, page_content='malabsorption is the cause, parenterally.\\nEtiology\\nPrimary vitamin A deficiency is usually caused by prolonged dietary deprivation. It is endemic in areas\\nsuch as southern and eastern Asia, where rice, devoid of β-carotene, is the staple food. Xerophthalmia\\ndue to primary deficiency is a common cause of blindness among young children in developing countries.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n82'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 91, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Secondary vitamin A deficiency may be due to decreased bioavailability of provitamin A carotenoids or to\\ninterference with absorption, storage, or transport of vitamin A. Interference with absorption or storage is\\nlikely in sprue, cystic fibrosis, pancreatic insufficiency, duodenal bypass, chronic diarrhea, bile duct\\nobstruction, giardiasis, and cirrhosis. Vitamin A deficiency is common in prolonged protein-energy\\nundernutrition not only because the diet is deficient but also because vitamin A storage and transport is\\ndefective. In children with complicated measles, vitamin A can shorten the duration of the disorder and\\nreduce the severity of symptoms and risk of death.\\nSymptoms and Signs\\nImpaired dark adaptation of the eyes, which can lead to night blindness, is an early symptom.\\nXerophthalmia (which is nearly pathognomonic) results from keratinization of the eyes. It involves drying\\n(xerosis) and thickening of the conjunctivae and corneas. Superficial foamy patches composed of'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 91, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"(xerosis) and thickening of the conjunctivae and corneas. Superficial foamy patches composed of\\nepithelial debris and secretions on the exposed bulbar conjunctiva (Bitot's spots) develop. In advanced\\ndeficiency, the cornea becomes hazy and can develop erosions, which can lead to its destruction\\n(keratomalacia).\\nKeratinization of the skin and of the mucous membranes in the respiratory, GI, and urinary tracts can\\noccur. Drying, scaling, and follicular thickening of the skin and respiratory infections can result. Immunity\\nis generally impaired.\\nThe younger the patient, the more severe are the effects of vitamin A deficiency. Growth retardation and\\ninfections are common among children. Mortality rate can exceed 50% in children with severe vitamin A\\ndeficiency.\\nDiagnosis\\n• Serum retinol levels, clinical evaluation, and response to vitamin A\\nOcular findings suggest the diagnosis. Dark adaptation can be impaired in other disorders (eg, zinc\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 91, 'source_type': 'Authorotative', 'priority': '1'}, page_content='deficiency.\\nDiagnosis\\n• Serum retinol levels, clinical evaluation, and response to vitamin A\\nOcular findings suggest the diagnosis. Dark adaptation can be impaired in other disorders (eg, zinc\\ndeficiency, retinitis pigmentosa, severe refractive errors, cataracts, diabetic retinopathy). If dark\\nadaptation is impaired, rod scotometry and electroretinography are done to determine whether vitamin A\\ndeficiency is the cause.\\nSerum levels of retinol are measured. Normal range is 28 to 86 μg/dL (1 to 3 μmol/L). However, levels\\ndecrease only after the deficiency is advanced because the liver contains large stores of vitamin A. Also,\\ndecreased levels may result from acute infection, which causes retinol-binding protein and transthyretin\\n(also called prealbumin) levels to decrease transiently. A therapeutic trial of vitamin A may help confirm\\nthe diagnosis.\\nPrevention\\nThe diet should include dark green leafy vegetables, deep- or bright-colored fruits (eg, papayas,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 91, 'source_type': 'Authorotative', 'priority': '1'}, page_content='the diagnosis.\\nPrevention\\nThe diet should include dark green leafy vegetables, deep- or bright-colored fruits (eg, papayas,\\noranges), carrots, and yellow vegetables (eg, squash, pumpkin). Vitamin A-fortified milk and cereals, liver,\\negg yolks, and fish liver oils are helpful. Carotenoids are absorbed better when consumed with some\\ndietary fat. If milk allergy is suspected in infants, they should be given adequate vitamin A in formula\\nfeedings. In developing countries, prophylactic supplements of vitamin A palmitate in oil 60,000 RAE\\n(200,000 IU) po every 6 mo are advised for all children between 1 and 5 yr of age; infants < 6 mo can be\\ngiven a one-time dose of 15,000 RAE (50,000 IU), and those aged 6 to 12 mo can be given a one-time\\ndose of 30,000 RAE (100,000 IU).\\nTreatment\\n• Vitamin A palmitate\\nDietary deficiency is traditionally treated with vitamin A palmitate in oil 60,000 IU po once/day for 2 days,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 91, 'source_type': 'Authorotative', 'priority': '1'}, page_content='dose of 30,000 RAE (100,000 IU).\\nTreatment\\n• Vitamin A palmitate\\nDietary deficiency is traditionally treated with vitamin A palmitate in oil 60,000 IU po once/day for 2 days,\\nfollowed by 4500 IU po once/day. If vomiting or malabsorption is present or xerophthalmia is probable, a\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n83'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 92, 'source_type': 'Authorotative', 'priority': '1'}, page_content='dose of 50,000 IU for infants < 6 mo, 100,000 IU for infants 6 to 12 mo, or 200,000 IU for children > 12 mo\\nand adults should be given for 2 days, with a third dose at least 2 wk later. The same doses are\\nrecommended for infants and children with complicated measles. Infants born of HIV-positive mothers\\nshould receive 50,000 IU (15,000 RAE) within 48 h of birth. Prolonged daily administration of large doses,\\nespecially to infants, must be avoided because toxicity may result.\\nFor pregnant or breastfeeding women, prophylactic or therapeutic doses should not exceed 10,000 IU\\n(3000 RAE)/day to avoid possible damage to the fetus or infant.\\nVitamin A Toxicity\\nVitamin A toxicity can be acute (usually due to accidental ingestion by children) or chronic. Both\\ntypes usually cause headache and increased intracranial pressure. Acute toxicity also causes\\nnausea and vomiting. Chronic toxicity also causes changes in skin, hair, and nails; abnormal'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 92, 'source_type': 'Authorotative', 'priority': '1'}, page_content='types usually cause headache and increased intracranial pressure. Acute toxicity also causes\\nnausea and vomiting. Chronic toxicity also causes changes in skin, hair, and nails; abnormal\\nliver test results; and, in a fetus, birth defects. Diagnosis is usually clinical. Unless birth defects\\nare present, adjusting the dose almost always leads to complete recovery.\\nAcute vitamin A toxicity in children may result from taking large doses (> 100,000 RAE [> 300,000 IU]),\\nusually accidentally. In adults, acute toxicity has occurred when arctic explorers ingested polar bear or\\nseal livers, which contain several million units of vitamin A.\\nChronic toxicity in older children and adults usually develops after doses of > 30,000 RAE (> 100,000\\nIU)/day have been taken for months. Megavitamin therapy is a possible cause, as are massive daily\\ndoses (50,000 to 120,000 RAE [150,000 to 350,000 IU]) of vitamin A or its metabolites, which are'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 92, 'source_type': 'Authorotative', 'priority': '1'}, page_content='IU)/day have been taken for months. Megavitamin therapy is a possible cause, as are massive daily\\ndoses (50,000 to 120,000 RAE [150,000 to 350,000 IU]) of vitamin A or its metabolites, which are\\nsometimes given for nodular acne or other skin disorders. Adults who consume > 1500 RAE (> 4500\\nIU)/day of vitamin A may develop osteoporosis. Infants who are given excessive doses (6,000 to 20,000\\nRAE [18,000 to 60,000 IU]/day) of water-miscible vitamin A may develop toxicity within a few weeks. Birth\\ndefects occur in children of women receiving isotretinoin (which is related to vitamin A) for acne treatment\\nduring pregnancy.\\nAlthough carotene is converted to vitamin A in the body, excessive ingestion of carotene causes\\ncarotenemia, not vitamin A toxicity. Carotenemia is usually asymptomatic but may lead to carotenodermia,\\nin which the skin becomes yellow. When taken as a supplement, β-carotene has been associated with'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 92, 'source_type': 'Authorotative', 'priority': '1'}, page_content='in which the skin becomes yellow. When taken as a supplement, β-carotene has been associated with\\nincreased cancer risk; risk does not seem to increase when carotenoids are consumed in fruits and\\nvegetables.\\nSymptoms and Signs\\nAlthough symptoms may vary, headache and rash usually develop during acute or chronic toxicity. Acute\\ntoxicity causes increased intracranial pressure. Drowsiness, irritability, abdominal pain, nausea, and\\nvomiting are common. Sometimes the skin subsequently peels.\\nEarly symptoms of chronic toxicity are sparsely distributed, coarse hair; alopecia of the eyebrows; dry,\\nrough skin; dry eyes; and cracked lips. Later, severe headache, pseudotumor cerebri, and generalized\\nweakness develop. Cortical hyperostosis of bone and arthralgia may occur, especially in children.\\nFractures may occur easily, especially in the elderly. In children, toxicity can cause pruritus, anorexia, and\\nfailure to thrive. Hepatomegaly and splenomegaly may occur.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 92, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Fractures may occur easily, especially in the elderly. In children, toxicity can cause pruritus, anorexia, and\\nfailure to thrive. Hepatomegaly and splenomegaly may occur.\\nIn carotenodermia, the skin (but not the sclera) becomes deep yellow, especially on the palms and soles.\\nDiagnosis\\n• Clinical evaluation\\nDiagnosis is clinical. Blood vitamin levels correlate poorly with toxicity. However, if clinical diagnosis is\\nequivocal, laboratory testing may help. In vitamin A toxicity, fasting serum retinol levels may increase from\\nnormal (28 to 86 μg/dL [1 to 3 μmol/L]) to > 100 μg/dL (> 3.49 μmol/L), sometimes to > 2000 μg/dL (> 69.8\\nμmol/L). Hypercalcemia is common.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n84'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 93, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Differentiating vitamin A toxicity from other disorders may be difficult. Carotenodermia may also occur in\\nsevere hypothyroidism and anorexia nervosa, possibly because carotene is converted to vitamin A more\\nslowly.\\nPrognosis\\nComplete recovery usually occurs if vitamin A ingestion stops. Symptoms and signs of chronic toxicity\\nusually disappear within 1 to 4 wk. However, birth defects in the fetus of a mother who has taken\\nmegadoses of vitamin A are not reversible.\\nTreatment\\nVitamin A is stopped.\\nVitamin B6\\nVitamin B6 includes a group of closely related compounds: pyridoxine, pyridoxal, and pyridoxamine. They\\nare metabolized in the body to pyridoxal phosphate, which acts as a coenzyme in many important\\nreactions in blood, CNS, and skin metabolism. Vitamin B6 is important in heme and nucleic acid\\nbiosynthesis and in lipid, carbohydrate, and amino acid metabolism.\\nVitamin B6 Deficiency and Dependency'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 93, 'source_type': 'Authorotative', 'priority': '1'}, page_content='reactions in blood, CNS, and skin metabolism. Vitamin B6 is important in heme and nucleic acid\\nbiosynthesis and in lipid, carbohydrate, and amino acid metabolism.\\nVitamin B6 Deficiency and Dependency\\nBecause vitamin B6 is present in most foods, dietary deficiency is rare. Secondary deficiency\\nmay result from various conditions. Symptoms can include peripheral neuropathy, a pellagra-\\nlike syndrome, anemia, and seizures, which, particularly in infants, may not resolve when\\ntreated with anticonvulsants. Impaired metabolism (dependency) is rare; it causes various\\nsymptoms, including seizures, intellectual disability, and anemia. Diagnosis is usually clinical;\\nno laboratory test readily assesses vitamin B6 status. Treatment consists of giving oral vitamin\\nB6 and, when possible, treating the cause.\\nDietary deficiency, though rare, can develop because extensive processing can deplete foods of vitamin'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 93, 'source_type': 'Authorotative', 'priority': '1'}, page_content='B6 and, when possible, treating the cause.\\nDietary deficiency, though rare, can develop because extensive processing can deplete foods of vitamin\\nB6. Secondary deficiency most often results from protein-energy undernutrition, malabsorption,\\nalcoholism, use of pyridoxine-inactivating drugs (eg, anticonvulsants, isoniazid, cycloserine, hydralazine,\\ncorticosteroids, penicillamine), or excessive loss. Rarely, it results from increased metabolic demand (eg,\\nin hyperthyroidism).\\nRare inborn errors of metabolism can affect pyridoxine metabolism.\\nThe role of vitamin B6 deficiency in increasing plasma homocysteine levels and in contributing to vascular\\ndisorders is under study.\\nSymptoms and Signs\\nDeficiency causes a pellagra-like syndrome, with seborrheic dermatitis, glossitis, and cheilosis, and, in\\nadults, can cause depression, confusion, EEG abnormalities, and seizures. Rarely, deficiency or'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 93, 'source_type': 'Authorotative', 'priority': '1'}, page_content='adults, can cause depression, confusion, EEG abnormalities, and seizures. Rarely, deficiency or\\ndependency causes seizures in infants. Seizures, particularly in infants, may be refractory to treatment\\nwith anticonvulsants. Normocytic, microcytic, or sideroblastic anemia can also develop.\\nDiagnosis\\n• Clinical evaluation\\nVitamin B6 deficiency should be considered in any infant who has seizures, any patient who has seizures\\nrefractory to treatment with anticonvulsants, and any patient with deficiencies of other B vitamins,\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n85'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 94, 'source_type': 'Authorotative', 'priority': '1'}, page_content='particularly in patients with alcoholism or protein-energy undernutrition. Diagnosis is usually clinical.\\nThere is no single accepted laboratory test of vitamin B6 status; measurement of serum pyridoxal\\nphosphate is most common.\\nTreatment\\n• Pyridoxine\\n• Elimination of risk factors when possible\\nFor secondary deficiency, causes (eg, use of pyridoxine-inactivating drugs, malabsorption) should be\\ncorrected if possible. Usually, pyridoxine 50 to 100 mg po once/day corrects the deficiency in adults. Most\\npeople taking isoniazid should also be given pyridoxine 30 to 50 mg/day. For deficiency due to increased\\nmetabolic demand, amounts larger than the daily recommended intake may be required. For most cases\\nof inborn errors of metabolism, high doses of pyridoxine may be effective.\\nVitamin B6 Toxicity\\nThe ingestion of megadoses (> 500 mg/day) of pyridoxine (eg, taken to treat carpal tunnel syndrome or'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 94, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"of inborn errors of metabolism, high doses of pyridoxine may be effective.\\nVitamin B6 Toxicity\\nThe ingestion of megadoses (> 500 mg/day) of pyridoxine (eg, taken to treat carpal tunnel syndrome or\\npremenstrual syndrome although efficacy is unproved) may cause peripheral neuropathy with deficits in a\\nstocking-glove distribution, including progressive sensory ataxia and severe impairment of position and\\nvibration senses. Senses of touch, temperature, and pain are less affected. Motor and central nervous\\nsystems are usually intact.\\nDiagnosis is clinical. Treatment is to stop taking vitamin B6. Recovery is slow and, for some patients,\\nincomplete.\\nVitamin B12\\nCobalamin is a general term for compounds with biologic vitamin B12 activity. These compounds are\\ninvolved in nucleic acid metabolism, methyl transfer, and myelin synthesis and repair. They are necessary\\nfor the formation of normal RBCs.\\nFood-bound vitamin B12 is released in the stomach's acid environment and is bound to R protein\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 94, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"for the formation of normal RBCs.\\nFood-bound vitamin B12 is released in the stomach's acid environment and is bound to R protein\\n(haptocorrin). Pancreatic enzymes cleave this B12 complex (B12-R protein) in the small intestine. After\\ncleavage, intrinsic factor, secreted by parietal cells in the gastric mucosa, binds with vitamin B12. Intrinsic\\nfactor is required for absorption of vitamin B12, which takes place in the terminal ileum.\\nVitamin B12 in plasma is bound to transcobalamins I and II. Transcobalamin II is responsible for delivering\\nvitamin B12 to tissues. The liver stores large amounts of vitamin B12. Enterohepatic reabsorption helps\\nretain vitamin B12. Liver vitamin B12 stores can normally sustain physiologic needs for 3 to 5 yr if B12\\nintake stops (eg, in people who become vegans) and for months to 1 yr if enterohepatic reabsorption\\ncapacity is absent.\\nLarge amounts of vitamin B12 seem to be nontoxic but are not recommended for regular use (ie, as a\\ngeneral tonic).\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 94, 'source_type': 'Authorotative', 'priority': '1'}, page_content='capacity is absent.\\nLarge amounts of vitamin B12 seem to be nontoxic but are not recommended for regular use (ie, as a\\ngeneral tonic).\\nVitamin B12 Deficiency\\nDietary vitamin B12 deficiency usually results from inadequate absorption, but deficiency can\\ndevelop in vegans who do not take vitamin supplements. Deficiency causes megaloblastic\\nanemia, damage to the white matter of the spinal cord and brain, and peripheral neuropathy.\\nDiagnosis is usually made by measuring serum vitamin B12 levels. The Schilling test helps\\ndetermine etiology. Treatment consists of oral or parenteral vitamin B12. Folate (folic acid)\\nshould not be used instead of vitamin B12 because folate may alleviate the anemia but allow\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n86'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 95, 'source_type': 'Authorotative', 'priority': '1'}, page_content='neurologic deficits to progress.\\nEtiology\\nInadequate vitamin B12 intake is possible in vegans but is otherwise unlikely. Breastfed babies of vegan\\nmothers may develop vitamin B12 deficiency by age 4 to 6 mo because their\\n[\\nTable 4-5. Causes of Vitamin B12 Deficiency]\\nliver stores (which are normally extensive) are limited and their rapid growth rate results in high demand.\\nVitamin B12 deficiency usually results from inadequate absorption (see Table 4-5 and p. 153), which, in\\nthe elderly, most commonly results from decreased acid secretion. In such cases, crystalline vitamin B12\\n(such as that available in vitamin supplements) can be absorbed, but food-bound vitamin B12 is not\\nliberated and absorbed normally. Inadequate absorption may occur in blind loop syndrome (with\\novergrowth of bacteria) or fish tapeworm infestation; in these cases, bacteria or parasites use ingested\\nvitamin B12 so that less is available for absorption. Vitamin B12 absorption may be inadequate if ileal'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 95, 'source_type': 'Authorotative', 'priority': '1'}, page_content='vitamin B12 so that less is available for absorption. Vitamin B12 absorption may be inadequate if ileal\\nabsorptive sites are destroyed by inflammatory bowel disease or are surgically removed. Less common\\ncauses of inadequate vitamin B12 absorption include chronic pancreatitis, gastric surgery, malabsorption\\nsyndromes, AIDS, use of certain drugs (eg, antacids, metformin), repeated exposure to nitrous oxide, and\\na genetic disorder causing malabsorption in the ileum (Imerslund-Graesbeck syndrome).\\nPernicious anemia is often used synonymously with vitamin B12 deficiency. However, pernicious\\nanemia specifically refers to anemia resulting from vitamin B12 deficiency caused by an autoimmune\\nmetaplastic atrophic gastritis with loss of intrinsic factor (see p. 133). Patients with classic pernicious\\nanemia, most commonly younger adults, are at increased risk of stomach and other GI cancers.\\nSubacute combined degeneration refers to degenerative changes in the nervous system due to'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 95, 'source_type': 'Authorotative', 'priority': '1'}, page_content='anemia, most commonly younger adults, are at increased risk of stomach and other GI cancers.\\nSubacute combined degeneration refers to degenerative changes in the nervous system due to\\nvitamin B12 deficiency; they affect mostly brain and spinal cord white matter. Demyelinating or axonal\\nperipheral neuropathies can occur.\\nSymptoms and Signs\\nAnemia usually develops insidiously. It is often more severe than its symptoms indicate because its slow\\nevolution allows physiologic adaptation. Occasionally, splenomegaly and hepatomegaly occur. Various GI\\nsymptoms, including weight loss and poorly localized abdominal pain, may occur. Glossitis, usually\\ndescribed as burning of the tongue, is uncommon.\\nNeurologic symptoms develop independently from and often without hematologic abnormalities. In early\\nstages, decreased position and vibratory sensation in the extremities is accompanied by mild to moderate'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 95, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"stages, decreased position and vibratory sensation in the extremities is accompanied by mild to moderate\\nweakness and hyporeflexia. In later stages, spasticity, extensor plantar responses, greater loss of position\\nand vibratory sensation in the lower extremities, and ataxia emerge. These deficits may develop in a\\nstocking-glove distribution. Tactile, pain, and temperature sensations are usually spared but may be\\ndifficult to assess in the elderly.\\nSome patients are also irritable and mildly depressed. Paranoia (megaloblastic madness), delirium,\\nconfusion, spastic ataxia, and, at times, postural hypotension may occur in advanced cases. The\\nconfusion may be difficult to differentiate from age-related dementias, such as Alzheimer's disease.\\nDiagnosis\\n• CBC and vitamin B12 and folate levels\\n• Sometimes methylmalonic acid levels or Schilling test\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n87\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 96, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Diagnosis is based on CBC and vitamin B12 and folate levels. It is important to remember that severe\\nneurologic disease may occur without anemia or macrocytosis.\\nCBC detects megaloblastic anemia. Tissue deficiency and macrocytic indexes may precede the\\ndevelopment of anemia. A vitamin B12 level < 200 pg/mL (< 145 pmol/L) indicates vitamin B12 deficiency.\\nThe folate level is measured because vitamin B12 deficiency must be differentiated from folate deficiency\\nas a cause of megaloblastic anemia; folate supplementation can mask vitamin B12 deficiency and may\\nalleviate megaloblastic anemia but allow the neurologic deficits to progress or even accelerate.\\nWhen clinical judgment suggests vitamin B12 deficiency but the vitamin B12 level is low-normal (200 to\\n350 pg/mL [145 to 260 pmol/L]) or hematologic indexes are normal, other tests can be done. Measuring\\nserum methylmalonic acid (MMA) levels may be useful. An elevated MMA level supports vitamin B12'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 96, 'source_type': 'Authorotative', 'priority': '1'}, page_content='350 pg/mL [145 to 260 pmol/L]) or hematologic indexes are normal, other tests can be done. Measuring\\nserum methylmalonic acid (MMA) levels may be useful. An elevated MMA level supports vitamin B12\\ndeficiency but may be due to renal failure. MMA levels can also be used to monitor the response to\\ntreatment. MMA levels remain normal in folate deficiency; homocysteine levels may be elevated with\\neither vitamin B12 or folate deficiency. Less commonly, holotranscobalamin II (transcobalamin II-B12\\ncomplex) content is measured; when holotranscobalamin II is < 40 pg/mL (< 30 pmol/L), vitamin B12 is\\ndeficient.\\nAfter deficiency is diagnosed, additional tests may be indicated for younger adults but usually not for the\\nelderly. Unless dietary vitamin B12 is obviously inadequate, measurement of serum gastrin levels or\\nautoantibodies to intrinsic factor may be done; sensitivity and specificity of these tests may be poor.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 96, 'source_type': 'Authorotative', 'priority': '1'}, page_content='autoantibodies to intrinsic factor may be done; sensitivity and specificity of these tests may be poor.\\nSchilling test: The Schilling test is useful only if diagnosing intrinsic factor deficiency is important, as in\\nclassic pernicious anemia. This test is not necessary for most elderly patients. The Schilling test\\nmeasures absorption of free radiolabeled vitamin B12. Radiolabeled vitamin B12 is given orally, followed\\nin 1 to 6 h by 1000 μg (1 mg) of parenteral vitamin B12, which reduces uptake of radiolabeled vitamin\\nB12 by the liver. Absorbed radiolabeled vitamin B12 is excreted in urine, which is collected for 24 h. The\\namount excreted is measured, and the percentage of total radiolabeled vitamin B12 is determined. If\\nabsorption is normal, ≥ 9% of the dose given appears in the urine. Reduced urinary excretion (< 5% if\\nkidney function is normal) indicates inadequate vitamin B12 absorption. Improved absorption with the'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 96, 'source_type': 'Authorotative', 'priority': '1'}, page_content='kidney function is normal) indicates inadequate vitamin B12 absorption. Improved absorption with the\\nsubsequent addition of intrinsic factor to radiolabeled vitamin B12 confirms the diagnosis of pernicious\\nanemia. The test is often difficult to do or interpret because of incomplete urine collection or renal\\ninsufficiency. In addition, because the Schilling test does not measure absorption of protein-bound vitamin\\nB12, the test does not detect defective liberation of vitamin B12 from foods, which is common among the\\nelderly. The Schilling test repletes vitamin B12 and can mask deficiency, so it should be done only after all\\nother diagnostic tests and therapeutic trials.\\nIf malabsorption is identified, the Schilling test can be repeated after a 2-wk trial of an oral antibiotic. If\\nantibiotic therapy corrects malabsorption, the likely cause is intestinal overgrowth of bacteria (eg, blind-\\nloop syndrome).\\nTreatment\\n• Supplemental vitamin B12'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 96, 'source_type': 'Authorotative', 'priority': '1'}, page_content='antibiotic therapy corrects malabsorption, the likely cause is intestinal overgrowth of bacteria (eg, blind-\\nloop syndrome).\\nTreatment\\n• Supplemental vitamin B12\\nVitamin B12 1000 to 2000 μg po can be given once/day to patients who do not have severe deficiency or\\nneurologic symptoms or signs. A nasal gel preparation of vitamin B12 is available at a higher price. Large\\noral doses can be absorbed by mass action, even when intrinsic factor is absent. If the MMA level\\n(sometimes used to monitor treatment) does not decrease, patients may not be taking vitamin B12. For\\nmore severe deficiency, vitamin B12 1 mg IM is usually given 1 to 4 times/wk for several weeks until\\nhematologic abnormalities are corrected; then it is given once/mo.\\nAlthough hematologic abnormalities are usually corrected within 6 wk (reticulocyte count should improve\\nwithin 1 wk), resolution of neurologic symptoms may take much longer. Neurologic symptoms that persist'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 96, 'source_type': 'Authorotative', 'priority': '1'}, page_content='within 1 wk), resolution of neurologic symptoms may take much longer. Neurologic symptoms that persist\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n88'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 97, 'source_type': 'Authorotative', 'priority': '1'}, page_content='for months or years become irreversible. In most elderly people with vitamin B12 deficiency and dementia,\\ncognition does not improve after treatment. Vitamin B12 treatment must be continued for life unless the\\npathophysiologic mechanism for the deficiency is corrected.\\nInfants of vegan mothers should receive supplemental vitamin B12 from birth.\\nVitamin C\\nVitamin C (ascorbic acid) plays a role in collagen, carnitine, hormone, and amino acid formation. It is\\nessential for wound healing and facilitates recovery from burns. Vitamin C is also an antioxidant, supports\\nimmune function, and facilitates the absorption of iron.\\nVitamin C Deficiency\\nIn developed countries, vitamin C deficiency can occur as part of general undernutrition, but\\nsevere deficiency (causing scurvy) is uncommon. Symptoms include fatigue, depression, and\\nconnective tissue defects (eg, gingivitis, petechiae, rash, internal bleeding, impaired wound'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 97, 'source_type': 'Authorotative', 'priority': '1'}, page_content='severe deficiency (causing scurvy) is uncommon. Symptoms include fatigue, depression, and\\nconnective tissue defects (eg, gingivitis, petechiae, rash, internal bleeding, impaired wound\\nhealing). In infants and children, bone growth may be impaired. Diagnosis is usually clinical.\\nTreatment consists of oral vitamin C.\\nSevere deficiency results in scurvy, a disorder characterized by hemorrhagic manifestations and abnormal\\nosteoid and dentin formation.\\nEtiology\\nIn adults, primary deficiency is usually due to inadequate diet. The need for dietary vitamin C is increased\\nby febrile illnesses, inflammatory disorders (particularly diarrheal disorders), achlorhydria, smoking,\\nthyrotoxicosis, iron deficiency, cold or heat stress, surgery, burns, and protein deficiency. Heat (eg,\\nsterilization of formulas, cooking) can destroy some of the vitamin C in food.\\nPathophysiology\\nFormation of intercellular cement substances in connective tissues, bones, and dentin is defective,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 97, 'source_type': 'Authorotative', 'priority': '1'}, page_content='sterilization of formulas, cooking) can destroy some of the vitamin C in food.\\nPathophysiology\\nFormation of intercellular cement substances in connective tissues, bones, and dentin is defective,\\nresulting in weakened capillaries with subsequent hemorrhage and defects in bone and related\\nstructures.\\nBone tissue formation becomes impaired, which, in children, causes bone lesions and poor bone growth.\\nFibrous tissue forms between the diaphysis and the epiphysis, and costochondral junctions enlarge.\\nDensely calcified fragments of cartilage are embedded in the fibrous tissue. Subperiosteal hemorrhages,\\nsometimes due to small fractures, may occur in children or adults.\\nSymptoms and Signs\\nIn adults, symptoms develop after weeks to months of vitamin C depletion. Lassitude, weakness,\\nirritability, weight loss, and vague myalgias and arthralgias may develop early.\\nLater, symptoms related to defects in connective tissues develop. Follicular hyperkeratosis, coiled hair,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 97, 'source_type': 'Authorotative', 'priority': '1'}, page_content='irritability, weight loss, and vague myalgias and arthralgias may develop early.\\nLater, symptoms related to defects in connective tissues develop. Follicular hyperkeratosis, coiled hair,\\nand perifollicular hemorrhages may develop. Gums may become swollen, purple, spongy, and friable; they\\nbleed easily in severe deficiency. Eventually, teeth become loose and avulsed. Secondary infections may\\ndevelop. Wounds heal poorly and tear easily, and spontaneous hemorrhages may occur, especially as\\necchymoses in the skin of the lower limbs or as bulbar conjunctival hemorrhage.\\nOther symptoms and signs include femoral neuropathy due to hemorrhage into femoral sheaths (which\\nmay mimic deep venous thrombosis), lower-extremity edema, and painful bleeding or effusions within\\njoints.\\nDiagnosis\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n89'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 98, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"• Usually, skin or gingival findings and risk factors\\nDiagnosis is usually made clinically in a patient who has skin or gingival signs and is at risk of vitamin C\\ndeficiency. Laboratory confirmation may be available. Anemia is common. Bleeding, coagulation, and PT\\nare normal.\\nSkeletal x-rays can help diagnose childhood (but not adult) scurvy. Changes are most evident at the ends\\nof long bones, particularly at the knee. Early changes resemble atrophy. Loss of trabeculae results in a\\nground-glass appearance. The cortex thins. A line of calcified, irregular cartilage (white line of Fraenkel)\\nmay be visible at the metaphysis. A zone of rarefaction or a linear fracture proximal and parallel to the\\nwhite line may be visible as only a triangular defect at the bone's lateral margin but is specific. The\\nepiphysis may be compressed. Healing subperiosteal hemorrhages may elevate and calcify the\\nperiosteum.\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 98, 'source_type': 'Authorotative', 'priority': '1'}, page_content='epiphysis may be compressed. Healing subperiosteal hemorrhages may elevate and calcify the\\nperiosteum.\\nLaboratory diagnosis, which requires measuring blood ascorbic acid, is sometimes done at academic\\ncenters. Levels of < 0.6 mg/dL (< 34 μmol/L) are considered marginal; levels of < 0.2 mg/dL (< 11 μmol/L)\\nindicate vitamin C deficiency. Measurement of ascorbic acid levels in the WBC-platelet layer of\\ncentrifuged blood is not widely available or standardized.\\nIn adults, scurvy must be differentiated from arthritis, hemorrhagic disorders, gingivitis, and protein-energy\\nundernutrition. Hyperkeratotic hair follicles with surrounding hyperemia or hemorrhage are almost\\npathognomonic. Bleeding gums, conjunctival hemorrhages, most petechiae, and ecchymoses are\\nnonspecific.\\nTreatment\\n• Nutritious diet with supplemental ascorbic acid\\nFor scurvy in adults, ascorbic acid 100 to 500 mg po tid is given for 1 to 2 wk, until signs disappear, and'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 98, 'source_type': 'Authorotative', 'priority': '1'}, page_content='nonspecific.\\nTreatment\\n• Nutritious diet with supplemental ascorbic acid\\nFor scurvy in adults, ascorbic acid 100 to 500 mg po tid is given for 1 to 2 wk, until signs disappear, and\\nfollowed by a nutritious diet supplying 1 to 2 times the daily recommended intake. In scurvy, therapeutic\\ndoses of ascorbic acid restore the functions of vitamin C in a few days. The symptoms and signs usually\\ndisappear over 1 to 2 wk. Chronic gingivitis with extensive subcutaneous hemorrhage persists longer.\\nPrevention\\nVitamin C 75 mg po once/day for women and 90 mg po once/day for men prevents deficiency. Smokers\\nshould consume an additional 35 mg/day. Five servings of most fruits and vegetables (recommended\\ndaily) provide > 200 mg of vitamin C.\\nVitamin C Toxicity\\nThe upper limit for vitamin C intake is 2000 mg/day. Up to 10 g/day of vitamin C are sometimes taken for\\nunproven health benefits, such as preventing or shortening the duration of viral infections or slowing or'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 98, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"unproven health benefits, such as preventing or shortening the duration of viral infections or slowing or\\nreversing the progression of cancer or atherosclerosis. Such doses may acidify the urine, cause nausea\\nand diarrhea, interfere with the healthy antioxidant-prooxidant balance in the body, and, in patients with\\nthalassemia or hemochromatosis, promote iron overload. Intake below the upper limit does not have toxic\\neffects in healthy adults.\\nVitamin D\\nVitamin D has 2 main forms: D2 (ergocalciferol) and D3 (cholecalciferol); the latter is the naturally\\noccurring form and the form used for low-dose supplementation. Vitamin D3 is synthesized in skin by\\nexposure to direct sunlight (ultraviolet B radiation) and obtained in the diet chiefly in fish liver oils and salt\\nwater fish. In some developed countries, milk and other foods are fortified with vitamin D. Human breast\\nmilk is low in vitamin D, containing an average of only 10% of the amount in fortified cow's milk.\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 98, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"milk is low in vitamin D, containing an average of only 10% of the amount in fortified cow's milk.\\nRequirements for vitamin D increase with age because skin synthesis declines. Sunscreen use and dark\\nskin pigmentation also reduce skin synthesis of vitamin D.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n90\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 99, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Vitamin D is a prohormone with several active metabolites that act as hormones. Vitamin D is metabolized\\nby the liver to 25(OH)D, which is then converted by the kidneys to 1,25(OH)2D (1,25-\\ndihydroxycholecalciferol, calcitriol, or active vitamin D hormone). 25(OH)D, the major circulating form, has\\nsome metabolic activity, but 1,25(OH)2D is the most metabolically active. The conversion to 1,25(OH)2D\\nis regulated by its own concentration, parathyroid hormone (PTH), and serum concentrations of Ca and\\nphosphate.\\n[\\nTable 4-6. Actions of Vitamin D and its Metabolites]\\nVitamin D affects many organ systems (see Table 4-6), but mainly it increases Ca and phosphate\\nabsorption from the intestine and promotes normal bone formation and mineralization. Vitamin D and\\nrelated analogs may be used to treat psoriasis, hypoparathyroidism, renal osteodystrophy, and possibly\\nleukemia and breast, prostate, and colon cancers; they may also be used for immunosuppression.\\nVitamin D Deficiency and Dependency'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 99, 'source_type': 'Authorotative', 'priority': '1'}, page_content='leukemia and breast, prostate, and colon cancers; they may also be used for immunosuppression.\\nVitamin D Deficiency and Dependency\\nInadequate exposure to sunlight predisposes to vitamin D deficiency. Deficiency impairs bone\\nmineralization, causing rickets in children and osteomalacia in adults and possibly contributing\\nto osteoporosis. Treatment usually consists of oral vitamin D; Ca and phosphate are\\nsupplemented as needed. Prevention is often possible. Rarely, hereditary disorders cause\\nimpaired metabolism of vitamin D (dependency).\\nVitamin D deficiency is a common cause of rickets and osteomalacia, but these disorders may also result\\nfrom other conditions, such as various renal tubular disorders, familial hypophosphatemic (vitamin D-\\nresistant) rickets (see p. 2991), chronic metabolic acidosis, hypoparathyroidism (which reduces vitamin D\\nabsorption), inadequate dietary Ca, and disorders or drugs that impair the mineralization of bone matrix.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 99, 'source_type': 'Authorotative', 'priority': '1'}, page_content='absorption), inadequate dietary Ca, and disorders or drugs that impair the mineralization of bone matrix.\\nVitamin D deficiency causes hypocalcemia, which stimulates production of PTH, causing\\nhyperparathyroidism. Hyperparathyroidism increases absorption, bone mobilization, and renal\\nconservation of Ca but increases excretion of phosphate. As a result, the serum level of Ca may be\\nnormal, but because of hypophosphatemia, bone mineralization is impaired.\\nEtiology\\nVitamin D deficiency may result from the following.\\nInadequate exposure or intake: Inadequate direct sunlight exposure (or sunscreen use) and\\ninadequate intake usually occur simultaneously to result in clinical deficiency. Susceptible people include\\nthe elderly (who are often undernourished and are not exposed to enough sunlight), and certain\\ncommunities (eg, women and children who are confined to the home or who wear clothing that covers the'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 99, 'source_type': 'Authorotative', 'priority': '1'}, page_content='the elderly (who are often undernourished and are not exposed to enough sunlight), and certain\\ncommunities (eg, women and children who are confined to the home or who wear clothing that covers the\\nentire body and face). Inadequate vitamin D stores are common among the elderly, particularly those who\\nare house-bound, institutionalized, or hospitalized or who have had a hip fracture. Recommended direct\\nsunlight exposure is 5 to 15 min (suberythemal dose) to arms and legs, or face, arms and hands, at least\\n3 times a week.\\nReduced absorption: Malabsorption can deprive the body of dietary vitamin D; only a small amount of\\n25(OH)D is recirculated enterohepatically.\\nAbnormal metabolism: Vitamin D deficiency may result from defects in the production of 25(OH)D or\\n1,25(OH)2D. People with a chronic renal disorder commonly develop rickets or osteomalacia because\\nrenal production of 1,25 (OH)2D is decreased and phosphate levels are elevated. Hepatic dysfunction'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 99, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1,25(OH)2D. People with a chronic renal disorder commonly develop rickets or osteomalacia because\\nrenal production of 1,25 (OH)2D is decreased and phosphate levels are elevated. Hepatic dysfunction\\ncan also interfere with production of active vitamin D metabolites.\\nType I hereditary vitamin D-dependent rickets is an autosomal recessive disorder characterized by absent\\nor defective conversion of 25(OH)D to 1,25(OH)2D in the kidneys. X-linked familial hypophosphatemia\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n91'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 100, 'source_type': 'Authorotative', 'priority': '1'}, page_content='reduces vitamin D synthesis in the kidneys. Many anticonvulsants and glucocorticoid use increase the\\nneed for vitamin D supplementation.\\nResistance to effects of vitamin D: Type II hereditary vitamin D-dependent rickets has several forms\\nand is due to mutations in the 1,25(OH)2D receptor. This receptor affects the metabolism of gut, kidney,\\nbone, and other cells. In this disorder, 1,25(OH)2D is abundant but ineffective because the receptor is not\\nfunctional.\\nSymptoms and Signs\\nVitamin D deficiency can cause muscle aches, muscle weakness, and bone pain at any age.\\nVitamin D deficiency in a pregnant woman causes deficiency in the fetus. Occasionally, deficiency severe\\nenough to cause maternal osteomalacia results in rickets with metaphyseal lesions in neonates. In young\\ninfants, rickets causes softening of the entire skull (craniotabes). When palpated, the occiput and\\nposterior parietal bones feel like a ping pong ball. In older infants with rickets, sitting and crawling are'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 100, 'source_type': 'Authorotative', 'priority': '1'}, page_content='posterior parietal bones feel like a ping pong ball. In older infants with rickets, sitting and crawling are\\ndelayed, as is fontanelle closure; there is bossing of the skull and costochondral thickening.\\nCostochondral thickening can look like beadlike prominences along the lateral chest wall (rachitic rosary).\\nIn children 1 to 4 yr, epiphyseal cartilage at the lower ends of the radius, ulna, tibia, and fibula enlarges;\\nkyphoscoliosis develops, and walking is delayed. In older children and adolescents, walking is painful; in\\nextreme cases, deformities such as bowlegs and knock-knees develop.\\nTetany is caused by hypocalcemia and may accompany infantile or adult vitamin D deficiency. Tetany may\\ncause paresthesias of the lips, tongue, and fingers; carpopedal and facial spasm; and, if very severe,\\nseizures. Maternal deficiency can cause tetany in neonates.\\nOsteomalacia predisposes to fractures. In the elderly, hip fractures may result from only minimal trauma.\\nDiagnosis'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 100, 'source_type': 'Authorotative', 'priority': '1'}, page_content='seizures. Maternal deficiency can cause tetany in neonates.\\nOsteomalacia predisposes to fractures. In the elderly, hip fractures may result from only minimal trauma.\\nDiagnosis\\n• Levels of 25(OH)D (D2+D3)\\nDiagnosis may be suspected based on any of the following:\\n• A history of inadequate sunlight exposure or dietary intake\\n• Symptoms and signs of rickets, osteomalacia, or neonatal tetany\\n• Characteristic bone changes seen on x-ray\\nX-rays of the radius and ulna plus serum levels of Ca, phosphate, alkaline phosphatase, PTH, and\\n25(OH)D are needed to differentiate vitamin D deficiency from other causes of bone demineralization.\\nAssessment of vitamin D status and serologic tests for syphilis can be considered for infants with\\ncraniotabes based on the history and physical, but most cases of craniotabes resolve spontaneously.\\nRickets can be distinguished from chondrodystrophy because the latter is characterized by a large head,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 100, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Rickets can be distinguished from chondrodystrophy because the latter is characterized by a large head,\\nshort extremities, thick bones, and normal serum Ca, phosphate, and alkaline phosphatase levels.\\nTetany due to infantile rickets may be clinically indistinguishable from seizures due to other causes. Blood\\ntests and clinical history may help distinguish them.\\nBone changes, seen on x-rays, precede clinical signs. In rickets, changes are most evident at the lower\\nends of the radius and ulna. The diaphyseal ends lose their sharp, clear outline; they are cup-shaped and\\nshow a spotty or fringy rarefaction. Later, because the ends of the radius and ulna have become\\nnoncalcified and radiolucent, the distance between them and the metacarpal bones appears increased.\\nThe bone matrix elsewhere also becomes more radiolucent. Characteristic deformities result from the\\nbones bending at the cartilage-shaft junction because the shaft is weak. As healing begins, a thin white'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 100, 'source_type': 'Authorotative', 'priority': '1'}, page_content='bones bending at the cartilage-shaft junction because the shaft is weak. As healing begins, a thin white\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n92'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 101, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"line of calcification appears at the epiphysis, becoming denser and thicker as calcification proceeds.\\nLater, the bone matrix becomes calcified and opacified at the subperiosteal level.\\nIn adults, bone demineralization, particularly in the spine, pelvis, and lower extremities, can be seen on x-\\nrays; the fibrous lamellae can also be seen, and incomplete ribbonlike areas of demineralization\\n(pseudofractures, Looser's lines, Milkman's syndrome) appear in the cortex.\\nBecause levels of serum 25(OH)D reflect body stores of vitamin D and correlate with symptoms and signs\\nof vitamin D deficiency better than levels of other vitamin D metabolites, 25(OH)D (D2+D3) measurement\\nis generally considered the best way to diagnose deficiency. Goal 25(OH)D levels are 30 to 40 ng/mL\\n(about 75 to 100 nmol/L); whether higher levels may be beneficial remains uncertain.\\nIf the diagnosis is unclear, serum levels of 1,25(OH)2D and urinary Ca concentration can be measured. In\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 101, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(about 75 to 100 nmol/L); whether higher levels may be beneficial remains uncertain.\\nIf the diagnosis is unclear, serum levels of 1,25(OH)2D and urinary Ca concentration can be measured. In\\nsevere deficiency, serum 1,25(OH)2D is abnormally low, usually undetectable. Urinary Ca is low in all\\nforms of the deficiency except those associated with acidosis.\\nIn vitamin D deficiency, serum Ca may be low or, because of secondary hyperparathyroidism, may be\\nnormal. Serum phosphate usually decreases, and serum alkaline phosphatase usually increases. Serum\\nPTH is elevated.\\nType I hereditary vitamin D-dependent rickets results in normal serum 25(OH)D, low serum 1,25(OH)2D\\nand Ca, and normal or low serum phosphate.\\nTreatment\\n• Correction of Ca and phosphate deficiencies\\n• Supplemental vitamin D\\nCa deficiency (which is common) and phosphate deficiency should be corrected. As long as Ca and\\nphosphate intake is adequate, adults with osteomalacia and children with uncomplicated rickets can be'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 101, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Ca deficiency (which is common) and phosphate deficiency should be corrected. As long as Ca and\\nphosphate intake is adequate, adults with osteomalacia and children with uncomplicated rickets can be\\ncured by giving vitamin D 40 μg (1600 IU) po once/day. Serum 25(OH)D and 1,25(OH)2D begin to\\nincrease within 1 or 2 days. Serum Ca and phosphate increase and serum alkaline phosphatase\\ndecreases within about 10 days. During the 3rd wk, enough Ca and phosphate are deposited in bones to\\nbe visible on x-rays. After about 1 mo, the dose can usually be reduced gradually to the usual\\nmaintenance level of 10 to 15 μg (400 to 600 IU) once/day. If tetany is present, vitamin D should be\\nsupplemented with IV Ca salts for up to 1 wk (see p. 841). Elderly patients may need 25 to ≥ 50 μg (1000\\nto ≥ 2000 IU) daily to maintain a 25(OH)D level > 30 ng/mL (> 75 nmol/L); this dose is higher than the\\nrecommended daily allowance (RDA) for people > 70 yr (600 IU) and may exceed the current upper limit'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 101, 'source_type': 'Authorotative', 'priority': '1'}, page_content='recommended daily allowance (RDA) for people > 70 yr (600 IU) and may exceed the current upper limit\\nof 2000 IU/day.\\nBecause rickets and osteomalacia due to defective production of vitamin D metabolites are vitamin D-\\nresistant, they do not respond to the doses usually effective for rickets due to inadequate intake.\\nEndocrinologic evaluation is required because treatment depends on the specific defect. When 25(OH)D\\nproduction is defective, vitamin D 50 μg (2000 IU) once/day increases serum levels and results in clinical\\nimprovement. Patients with kidney disorders often need 1,25(OH)2D supplementation.\\nType I hereditary vitamin D-dependent rickets responds to 1,25(OH)2D 1 to 2 μg po once/day. Some\\npatients with type II hereditary vitamin D-dependent rickets respond to very high doses (eg, 10 to 24\\nμg/day) of 1,25(OH)2D; others require long-term infusions of Ca.\\nPrevention\\nDietary counseling is particularly important in communities whose members are at risk of vitamin D'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 101, 'source_type': 'Authorotative', 'priority': '1'}, page_content='μg/day) of 1,25(OH)2D; others require long-term infusions of Ca.\\nPrevention\\nDietary counseling is particularly important in communities whose members are at risk of vitamin D\\ndeficiency. Fortifying unleavened chapati flour with vitamin D (125 μg/kg) has been effective among Indian\\nimmigrants in Britain. The benefits of sunlight exposure for vitamin D status must be weighed against the\\nincreased skin damage and skin cancer risks.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n93'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 102, 'source_type': 'Authorotative', 'priority': '1'}, page_content='g\\nAll breastfed infants should be given supplemental vitamin D 5 μg (200 IU) once/day from birth to 6 mo; at\\n6 mo, a more diversified diet is available. For adolescents at risk, a single IM dose of ergocalciferol 2.5\\nmg (100,000 IU) given in the fall can maintain adequate 25(OH)D levels throughout the winter. The\\nrecommended daily allowance (RDA) for vitamin D is 400 IU for people aged 51 to 70 and 600 IU for\\nthose >70; many consider this intake too low, and the 2005 Dietary Guidelines for Americans\\nrecommends that healthy older adults consume 1000 IU/day.\\nVitamin D Toxicity\\nUsually, vitamin D toxicity results from taking excessive amounts. Marked hypercalcemia\\ncommonly causes symptoms. Diagnosis is typically based on elevated blood levels of 25(OH)D.\\nTreatment consists of stopping vitamin D, restricting dietary Ca, restoring intravascular volume\\ndeficits, and, if toxicity is severe, giving corticosteroids or bisphosphonates.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 102, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Treatment consists of stopping vitamin D, restricting dietary Ca, restoring intravascular volume\\ndeficits, and, if toxicity is severe, giving corticosteroids or bisphosphonates.\\nBecause synthesis of 1,25(OH)2D (the most active metabolite of vitamin D) is tightly regulated, vitamin D\\ntoxicity usually occurs only if excessive doses (prescription or megavitamin) are taken. Vitamin D 1000 μg\\n(40,000 IU)/day causes toxicity within 1 to 4 mo in infants. In adults, taking 1250 μg (50,000 IU)/day for\\nseveral months can cause toxicity. Vitamin D toxicity can occur iatrogenically when hypoparathyroidism is\\ntreated too aggressively (see p.\\n844).\\nSymptoms and Signs\\nThe main symptoms result from hypercalcemia. Anorexia, nausea, and vomiting can develop, often\\nfollowed by polyuria, polydipsia, weakness, nervousness, pruritus, and eventually renal failure.\\nProteinuria, urinary casts, azotemia, and metastatic calcifications (particularly in the kidneys) can develop.\\nDiagnosis'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 102, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Proteinuria, urinary casts, azotemia, and metastatic calcifications (particularly in the kidneys) can develop.\\nDiagnosis\\n• Hypercalcemia plus risk factors or elevated serum 25(OH)D levels\\nA history of excessive vitamin D intake may be the only clue differentiating vitamin D toxicity from other\\ncauses of hypercalcemia. Elevated serum Ca levels of 12 to 16 mg/dL (3 to 4 mmol/L) are a constant\\nfinding when toxic symptoms occur. Serum 25(OH)D levels are usually elevated > 150 ng/mL (> 375\\nnmol/L). Levels of 1,25(OH)2D, which need not be measured to confirm the diagnosis, may be normal.\\nSerum Ca should be measured often (weekly at first, then monthly) in all patients receiving large doses of\\nvitamin D, particularly the potent 1,25(OH)2D.\\nTreatment\\n• IV hydration plus corticosteroids or bisphosphonates\\nAfter stopping vitamin D intake, hydration with IV normal saline and corticosteroids or bisphosphonates\\n(which inhibit bone resorption) are used to reduce blood Ca levels.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 102, 'source_type': 'Authorotative', 'priority': '1'}, page_content='After stopping vitamin D intake, hydration with IV normal saline and corticosteroids or bisphosphonates\\n(which inhibit bone resorption) are used to reduce blood Ca levels.\\nKidney damage or metastatic calcifications, if present, may be irreversible.\\nVitamin E\\nVitamin E is a group of compounds (including tocopherols and tocotrienols) that have similar biologic\\nactivities. The most biologically active is α-tocopherol, but β-, γ-, and δ-tocopherols, 4 tocotrienols, and\\nseveral stereoisomers may also have important biologic activity. These compounds act as antioxidants,\\nwhich prevent lipid peroxidation of polyunsaturated fatty acids in cellular membranes. Plasma tocopherol\\nlevels vary with total plasma lipid levels. Normally, the plasma α-tocopherol level is 5 to 20 μg/mL (11.6 to\\n46.4 μmol/L). High-dose vitamin E supplements do not protect against cardiovascular disorders;whether\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n94'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 103, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"supplements can protect against Alzheimer's disease, tardive dyskinesia, and prostate cancer among\\nsmokers is controversial.\\nAlthough the amount of vitamin E in many fortified foods and supplements is given in IU, current\\nrecommendations are to use mg.\\nVitamin E Deficiency\\nDietary vitamin E deficiency is common in developing countries; deficiency among adults in\\ndeveloped countries is uncommon and usually due to fat malabsorption. The main symptoms\\nare hemolytic anemia and neurologic deficits. Diagnosis is based on measuring the ratio of\\nplasma α-tocopherol to total plasma lipids; a low ratio suggests vitamin E deficiency. Treatment\\nconsists of oral vitamin E, given in high doses if there are neurologic deficits or if deficiency\\nresults from malabsorption.\\nVitamin E deficiency causes fragility of RBCs and degeneration of neurons, particularly peripheral axons\\nand posterior column neurons.\\nEtiology\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 103, 'source_type': 'Authorotative', 'priority': '1'}, page_content='results from malabsorption.\\nVitamin E deficiency causes fragility of RBCs and degeneration of neurons, particularly peripheral axons\\nand posterior column neurons.\\nEtiology\\nIn developing countries, the most common cause is inadequate intake of vitamin E. In developed\\ncountries, the most common causes are disorders that cause fat malabsorption, including\\nabetalipoproteinemia (Bassen-Kornzweig syndrome, due to genetic absence of apolipoprotein B), chronic\\ncholestatic hepatobiliary disease, pancreatitis, short bowel syndrome, and cystic fibrosis. A rare genetic\\nform of vitamin E deficiency without fat malabsorption results from defective liver metabolism.\\nSymptoms and Signs\\nThe main symptoms are mild hemolytic anemia and nonspecific neurologic deficits. Abetalipoproteinemia\\nresults in progressive neuropathy and retinopathy in the first 2 decades of life (see p. 904).\\nVitamin E deficiency may contribute to retinopathy of prematurity (also called retrolental fibroplasia) in'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 103, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Vitamin E deficiency may contribute to retinopathy of prematurity (also called retrolental fibroplasia) in\\npremature infants and to some cases of intraventricular and subependymal hemorrhage in neonates.\\nAffected premature neonates have muscle weakness.\\nIn children, chronic cholestatic hepatobiliary disease or cystic fibrosis causes neurologic deficits, including\\nspinocerebellar ataxia with loss of deep tendon reflexes, truncal and limb ataxia, loss of vibration and\\nposition senses, ophthalmoplegia, muscle weakness, ptosis, and dysarthria.\\nIn adults with malabsorption, vitamin E deficiency very rarely causes spinocerebellar ataxia because\\nadults have large vitamin E stores in adipose tissue.\\nDiagnosis\\n• Low α-tocopherol level or low ratio of serum α-tocopherol to serum lipids\\nWithout a history of inadequate intake or a predisposing condition, vitamin E deficiency is unlikely.\\nConfirmation usually requires measuring the vitamin level. Measuring RBC hemolysis in response to'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 103, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Without a history of inadequate intake or a predisposing condition, vitamin E deficiency is unlikely.\\nConfirmation usually requires measuring the vitamin level. Measuring RBC hemolysis in response to\\nperoxide can suggest the diagnosis but is nonspecific. Hemolysis increases as vitamin E deficiency\\nimpairs RBC stability.\\nMeasuring the serum α-tocopherol level is the most direct method of diagnosis. In adults, vitamin E\\ndeficiency is suggested if the α-tocopherol level is < 5 μg/mL (< 11.6 μmol/L). Because abnormal lipid\\nlevels can affect vitamin E status, a low ratio of serum α-tocopherol to lipids (< 0.8 mg/g total lipid) is the\\nmost accurate indicator in adults with hyperlipidemia.\\nIn children and adults with abetalipoproteinemia, serum α-tocopherol levels are usually undetectable.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n95'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 104, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Treatment\\n• Supplemental α-tocopherol\\nIf malabsorption causes clinically evident deficiency, α-tocopherol 15 to 25 mg/kg po once/day should be\\ngiven. However, larger doses given by injection are required to treat neuropathy during its early stages or\\nto overcome the defect of absorption and transport in abetalipoproteinemia.\\nPrevention\\nAlthough premature neonates may require supplementation, human milk and commercial formulas have\\nenough vitamin E for full-term neonates.\\nVitamin E Toxicity\\nMany adults take relatively large amounts of vitamin E (α-tocopherol 400 to 800 mg/day) for months to\\nyears without any apparent harm. Occasionally, muscle weakness, fatigue, nausea, and diarrhea occur.\\nThe most significant risk is bleeding. However, bleeding is uncommon unless the dose is > 1000 mg/day\\nor the patient takes oral coumarin or warfarin. Thus, the upper limit for adults aged ≥19 yr is 1000 mg for'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 104, 'source_type': 'Authorotative', 'priority': '1'}, page_content='or the patient takes oral coumarin or warfarin. Thus, the upper limit for adults aged ≥19 yr is 1000 mg for\\nany form of α-tocopherol. Recent analyses of previous studies report that high vitamin E intakes may\\nincrease the risk of hemorrhagic stroke and premature death.\\nVitamin K\\nVitamin K1 (phylloquinone) is dietary vitamin K. Dietary fat enhances its absorption. Infant formulas\\ncontain supplemental vitamin K. Vitamin K2 refers to a group of compounds (menaquinones) synthesized\\nby bacteria in the intestinal tract; the amount synthesized does not satisfy the vitamin K requirement.\\nVitamin K controls the formation of coagulation factors II (prothrombin), VII, IX, and X in the liver. Other\\ncoagulation factors dependent on vitamin K are protein C, protein S, and protein Z; proteins C and S are\\nanticoagulants. Metabolic pathways conserve vitamin K. Once vitamin K has participated in formation of'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 104, 'source_type': 'Authorotative', 'priority': '1'}, page_content='anticoagulants. Metabolic pathways conserve vitamin K. Once vitamin K has participated in formation of\\ncoagulation factors, the reaction product, vitamin K epoxide, is enzymatically converted to the active form,\\nvitamin K hydroquinone.\\nThe actions of vitamin K-dependent proteins require Ca. The vitamin K-dependent proteins, osteocalcin\\nand matrix γ-carboxy-glutamyl (Gla) protein, may have important roles in bone and other tissues. Forms of\\nvitamin K are common therapy for osteoporosis in Japan and other countries.\\nVitamin K Deficiency\\nVitamin K deficiency results from extremely inadequate intake, fat malabsorption, or use of\\ncoumarin anticoagulants. Deficiency is particularly common among breastfed infants. It impairs\\nclotting. Diagnosis is suspected based on routine coagulation study findings and confirmed by\\nresponse to vitamin K. Treatment consists of vitamin K given orally or, when fat malabsorption\\nis the cause or risk of bleeding is high, parenterally.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 104, 'source_type': 'Authorotative', 'priority': '1'}, page_content='response to vitamin K. Treatment consists of vitamin K given orally or, when fat malabsorption\\nis the cause or risk of bleeding is high, parenterally.\\nVitamin K deficiency decreases levels of prothrombin and other vitamin K-dependent coagulation factors,\\ncausing defective coagulation and, potentially, bleeding.\\nEtiology\\nWorldwide, vitamin K deficiency causes infant morbidity and mortality. Vitamin K deficiency causes\\nhemorrhagic disease of the newborn, which usually occurs 1 to 7 days postpartum. In affected neonates,\\nbirth trauma can cause intracranial hemorrhage. Neonates are prone to vitamin K deficiency because of\\nthe following:\\n• The placenta transmits lipids and vitamin K relatively poorly.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n96'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 105, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"• The neonatal liver is immature with respect to prothrombin synthesis.\\n• Breast milk is low in vitamin K, containing about 2.5 μg/L (cow's milk contains 5000 μg/L).\\n• The neonatal gut is sterile during the first few days of life.\\nLate hemorrhagic disease (occurring 3 to 8 wk postpartum) is usually associated with breastfeeding,\\nmalabsorption, or a liver disorder. If the mother has taken phenytoin anticonvulsants, coumarin\\nanticoagulants, or cephalosporin antibiotics, the risk of both types of hemorrhagic disease is increased.\\nIn healthy adults, dietary vitamin K deficiency is uncommon because vitamin K is widely distributed in\\ngreen vegetables and the bacteria of the normal gut synthesize menaquinones. However, biliary\\nobstruction, malabsorption, cystic fibrosis, and resection of the small intestine can contribute to vitamin K\\ndeficiency.\\nCoumarin anticoagulants interfere with the synthesis of vitamin K-dependent coagulation proteins (factors\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 105, 'source_type': 'Authorotative', 'priority': '1'}, page_content='deficiency.\\nCoumarin anticoagulants interfere with the synthesis of vitamin K-dependent coagulation proteins (factors\\nII, VII, IX, and X) in the liver. Certain antibiotics (particularly some cephalosporins and other broad-\\nspectrum antibiotics), salicylates, megadoses of vitamin E, and hepatic insufficiency increase risk of\\nbleeding in patients with vitamin K deficiency.\\nSymptoms and Signs\\nBleeding is the usual manifestation. Easy bruisability and mucosal bleeding (especially epistaxis, GI\\nhemorrhage, menorrhagia, and hematuria) can occur. Blood may ooze from puncture sites or incisions.\\nHemorrhagic disease of the newborn and late hemorrhagic disease in infants may cause cutaneous, GI,\\nintrathoracic, or, in the worst cases, intracranial bleeding. If obstructive jaundice develops, bleeding—if it\\noccurs—usually begins after the 4th or 5th day. It may begin as a slow ooze from a surgical incision, the\\ngums, the nose, or GI mucosa, or it may begin as massive bleeding into the GI tract.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 105, 'source_type': 'Authorotative', 'priority': '1'}, page_content='occurs—usually begins after the 4th or 5th day. It may begin as a slow ooze from a surgical incision, the\\ngums, the nose, or GI mucosa, or it may begin as massive bleeding into the GI tract.\\nDiagnosis\\n• Usually, prolonged PT that decreases after phytonadione\\nVitamin K deficiency or antagonism (due to coumarin anticoagulants) is suspected when abnormal\\nbleeding occurs in a patient at risk. Blood coagulation studies can preliminarily confirm the diagnosis. PT,\\nusually reported as the INR, is prolonged, but PTT, thrombin time, platelet count, bleeding time, and\\nlevels of fibrinogen, fibrin-split products, and D-dimer are normal. If phytonadione (USP generic name for\\nvitamin K1) 1 mg IV significantly decreases PT within 2 to 6 h, a liver disorder is not the likely cause, and\\nthe diagnosis of vitamin K deficiency is confirmed. Some centers can detect vitamin K deficiency more\\ndirectly by measuring the serum vitamin level. The serum level of vitamin K1 ranges from 0.2 to 1.0 ng/mL'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 105, 'source_type': 'Authorotative', 'priority': '1'}, page_content='directly by measuring the serum vitamin level. The serum level of vitamin K1 ranges from 0.2 to 1.0 ng/mL\\nin healthy people consuming adequate quantities of vitamin K1 (50 to 150 μg/day). Knowing vitamin K\\nintake can help interpret serum levels; recent intake affects levels in serum but not in tissues.\\nMore sensitive indicators of vitamin K status, such as PIVKA (Protein Induced in Vitamin K Absence or\\nAntagonism) and under-carboxylated osteocalcin, are under study.\\nTreatment\\n• Phytonadione\\nWhenever possible, phytonadione should be given po or sc. The usual adult dose is 5 to 20 mg. (Rarely,\\neven when phytonadione is correctly diluted and given slowly, IV replacement can result in anaphylaxis or\\nanaphylactoid reactions.) INR usually decreases within 6 to 12 h. The dose may be repeated in 6 to 8 h if\\nINR has not decreased satisfactorily. Phytonadione 2.5 to 10 mg po is indicated for nonemergency'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 105, 'source_type': 'Authorotative', 'priority': '1'}, page_content='INR has not decreased satisfactorily. Phytonadione 2.5 to 10 mg po is indicated for nonemergency\\ncorrection of a prolonged INR in patients taking anticoagulants. Correction usually occurs within 6 to 8 h.\\nWhen only partial correction of INR is desirable (eg, when INR should remain slightly elevated because of\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n97'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 106, 'source_type': 'Authorotative', 'priority': '1'}, page_content='a prosthetic heart valve), lower doses (eg, 1 to 2.5 mg) of phytonadione can be given.\\nIn infants, bleeding due to deficiency can be corrected by giving phytonadione 1 mg sc or IM once. The\\ndose is repeated if INR remains elevated. Higher doses may be necessary if the mother has been taking\\noral anticoagulants.\\nPrevention\\nPhytonadione 0.5 to 1 mg IM (or 0.3 mg/kg for preterm infants) is recommended for all neonates within 6 h\\nof birth to reduce the incidence of intracranial hemorrhage due to birth trauma and of classic hemorrhagic\\ndisease of the newborn (increased bleeding risks 1 to 7 days after birth). It is also used prophylactically\\nbefore surgery. Some clinicians recommend that pregnant women taking anticonvulsants receive\\nphytonadione 10 mg po once/day for the 1 mo or 20 mg po once/day for the 2 wk before delivery. The low\\nvitamin K1 content in breast milk can be increased by increasing maternal dietary intake of phylloquinone\\nto 5 mg/day.\\nVitamin K Toxicity'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 106, 'source_type': 'Authorotative', 'priority': '1'}, page_content='vitamin K1 content in breast milk can be increased by increasing maternal dietary intake of phylloquinone\\nto 5 mg/day.\\nVitamin K Toxicity\\nVitamin K1 (phylloquinone) is not toxic when consumed orally, even in large amounts. However,\\nmenadione (a synthetic, water-soluble vitamin K precursor) can cause toxicity and should not be used to\\ntreat vitamin K deficiency.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition Chapter 4. Vitamin Deficiency, Dependency & Toxicity\\n98'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 107, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chapter 5. Mineral Deficiency and Toxicity\\nIntroduction\\nSix macrominerals are required by people in gram amounts. Four (Na, K, Ca, and Mg) are cations; two (Cl\\nand P) are accompanying anions (see p. 820). Daily requirements range from 0.3 to 2.0 g. Bone, muscle,\\nheart, and brain function depend on these minerals.\\nNine trace minerals (microminerals) are required by people in minute amounts: chromium, copper, iodine,\\niron, fluorine, manganese, molybdenum, selenium, and zinc. (For sources, functions, effects of deficiency\\nand toxicity, and dietary requirements, see\\nTables 5-1 and\\n5-2.) All trace minerals are toxic at high levels; some minerals (arsenic, nickel, and chromium) may be\\ncarcinogens.\\nMineral deficiencies (except of iodine, iron, and zinc) do not often develop spontaneously in adults on\\nordinary diets; infants are more vulnerable because their growth is rapid and intake varies. Trace mineral'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 107, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"ordinary diets; infants are more vulnerable because their growth is rapid and intake varies. Trace mineral\\nimbalances can result from hereditary disorders (eg, hemochromatosis, Wilson's disease), kidney dialysis,\\nparenteral nutrition, or restrictive diets prescribed for people with inborn errors of metabolism.\\nChromium\\nOnly 1 to 3% of biologically active trivalent chromium (Cr) is absorbed. Normal plasma levels are 0.05 to\\n0.50 μg/L (1.0 to 9.6 nmol/L). Chromium potentiates insulin activity and increases the growth rate in\\nundernourished children. Supplements do not enhance muscle size or strength in men.\\nDeficiency: Four patients receiving long-term TPN developed possible chromium deficiency, with\\nglucose intolerance, weight loss, ataxia, and peripheral neuropathy. Symptoms resolved in 3 who were\\ngiven trivalent chromium 150 to 250 mg.\\nToxicity: High doses of trivalent chromium given parenterally cause skin irritation, but lower doses given\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 107, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"given trivalent chromium 150 to 250 mg.\\nToxicity: High doses of trivalent chromium given parenterally cause skin irritation, but lower doses given\\norally are not toxic. Exposure to hexavalent chromium (CrO3) in the workplace may irritate the skin, lungs,\\nand GI tract and may cause perforation of the nasal septum and lung carcinoma.\\nCopper\\nCopper is a component of many body proteins; almost all of the body's copper is bound to copper\\nproteins. Unbound (free) copper ions are toxic. Genetic mechanisms control the incorporation of copper\\ninto apoproteins and the processes that prevent toxic accumulation of copper in the body. Copper\\nabsorbed in excess of metabolic requirements is excreted through bile.\\n[Table 5-1. Trace Minerals]\\nAcquired Copper Deficiency\\nIf the genetic mechanisms controlling copper metabolism are normal, dietary deficiency rarely causes\\nclinically significant copper deficiency. The only reported causes are kwashiorkor, persistent infantile\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 107, 'source_type': 'Authorotative', 'priority': '1'}, page_content='clinically significant copper deficiency. The only reported causes are kwashiorkor, persistent infantile\\ndiarrhea (usually associated with a diet limited to milk), severe malabsorption (as in sprue), and excessive\\nzinc intake.\\nDeficiency may cause neutropenia, impaired bone calcification, and hypochromic anemia not responsive\\nto iron supplements.\\nDiagnosis is based on low serum levels of copper and ceruloplasmin, although these tests are not always\\nreliable. Treatment is directed at the cause, and copper 1.5 to 3 mg/day po (usually as copper sulfate) is\\ngiven.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 5. Mineral Deficiency & Toxicity\\n99'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 108, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Inherited Copper Deficiency\\n(Menkes Syndrome)\\nInherited copper deficiency occurs in male infants who inherit a mutant X-linked gene. Incidence is about\\n1 in 50,000 live births. Copper is deficient in the liver, serum, and essential copper proteins, including\\ncytochrome-c oxidase, ceruloplasmin, and lysyl oxidase.\\nSymptoms are severe intellectual disability, vomiting, diarrhea, protein-losing enteropathy,\\nhypopigmentation, bone changes, and arterial rupture; the hair is sparse, steely, or kinky.\\nDiagnosis\\n• Serum copper and ceruloplasmin levels\\n• Serum levels of dopamine, norepinephrine, dihydroxyphenylacetic acid, and dihydroxyphenylglycol in\\ninfants at risk\\nDiagnosis is based on low copper and ceruloplasmin levels in serum, although these tests are not always\\nreliable. Because early diagnosis and treatment seem to result in a better prognosis, the disorder is\\nideally detected before age 2 wk. However, diagnostic accuracy of these tests is limited. Thus, infants at'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 108, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ideally detected before age 2 wk. However, diagnostic accuracy of these tests is limited. Thus, infants at\\nrisk (eg, those with a family history) can be screened by measuring dopamine, norepinephrine,\\ndihydroxyphenylacetic acid, and dihydroxyphenylglycol in serum. A dihydroxyphenylacetic\\nacid:dihydroxyphenylglycol ratio of > 4 seems to indicate deficiency, and a dopamine:norepinephrine ratio\\nof > 0.2 seems to confirm it.\\nTreatment\\n• Copper histidine\\nParenteral copper is usually given as copper histidine 250 μg sc bid to age 1 yr, then 250 μg sc once/day\\nuntil age 3 yr; monitoring kidney function is essential during treatment. Despite early treatment, many\\nchildren have abnormal neurodevelopment.\\nAcquired Copper Toxicity\\nAcquired copper toxicity can result from ingesting or absorbing excess copper (eg, from ingesting an\\nacidic food or beverage that has had prolonged contact with a copper container). Self-limited\\ngastroenteritis with nausea, vomiting, and diarrhea may occur.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 108, 'source_type': 'Authorotative', 'priority': '1'}, page_content='acidic food or beverage that has had prolonged contact with a copper container). Self-limited\\ngastroenteritis with nausea, vomiting, and diarrhea may occur.\\n[Table 5-2. Guidelines for Daily Intake of Minerals]\\nMore severe toxicity results from ingestion (usually with suicidal intent) of gram quantities of a copper salt\\n(eg, copper sulfate) or from absorption of large amounts through the skin (eg, if compresses saturated\\nwith a solution of a copper salt are applied to large areas of burned skin). Hemolytic anemia and anuria\\ncan result and may be fatal.\\nIndian childhood cirrhosis, non-Indian childhood cirrhosis, and idiopathic copper toxicity are probably\\nidentical disorders in which excess copper causes cirrhosis. All seem to be caused by ingesting milk that\\nhas been boiled or stored in corroded copper or brass vessels. Recent studies suggest that idiopathic\\ncopper toxicity may develop only in infants with an unknown genetic defect.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 108, 'source_type': 'Authorotative', 'priority': '1'}, page_content='has been boiled or stored in corroded copper or brass vessels. Recent studies suggest that idiopathic\\ncopper toxicity may develop only in infants with an unknown genetic defect.\\nDiagnosis usually requires liver biopsy, which shows Mallory hyalin bodies.\\nTreatment\\n• Chelation\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 5. Mineral Deficiency & Toxicity\\n100'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 109, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"• Supportive measures\\nFor copper toxicity due to ingesting grams of copper, prompt gastric lavage is done. Copper toxicity that\\ncauses complications such as hemolytic anemia, anuria, or hepatotoxicity is also treated with either oral\\npenicillamine 250 mg q 6 h to 750 mg q 12 h (1000 to 1500 mg/day in 2 to 4 doses) or dimercaprol 3 to 5\\nmg/kg IM q 4 h for 2 days, then q 4 to 6 h (see also\\nTable 340-4 and copper salts in\\nTable 340-8). If used early, hemodialysis may be effective. Occasionally, copper toxicity is fatal despite\\ntreatment.\\nInherited Copper Toxicity\\n(Wilson's Disease)\\nInherited copper toxicity results in accumulation of copper in the liver and other organs. Hepatic\\nor neurologic symptoms develop. Diagnosis is based on a low serum ceruloplasmin level, high\\nurinary excretion of copper, and sometimes liver biopsy results. Treatment consists of a low-\\ncopper diet and chelation, usually with penicillamine or dimercaprol.\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 109, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"urinary excretion of copper, and sometimes liver biopsy results. Treatment consists of a low-\\ncopper diet and chelation, usually with penicillamine or dimercaprol.\\nWilson's disease is a progressive disorder of copper metabolism that affects 1 person in 30,000. Affected\\npeople are homozygous for the mutant recessive gene, located on chromosome 13. Heterozygous\\ncarriers, who constitute about 1.1% of the population, are asymptomatic.\\nPathophysiology\\nThe genetic defect impairs copper transport. The impaired transport decreases copper secretion into the\\nbile, thus causing the copper overload and resultant accumulation in the liver, which begins at birth. The\\nimpaired transport also interferes with incorporation of copper into the copper protein ceruloplasmin, thus\\ndecreasing serum levels of ceruloplasmin.\\nHepatic fibrosis develops, ultimately causing cirrhosis. Copper diffuses out of the liver into the blood, then\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 109, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"decreasing serum levels of ceruloplasmin.\\nHepatic fibrosis develops, ultimately causing cirrhosis. Copper diffuses out of the liver into the blood, then\\ninto other tissues. It is most destructive to the brain but also damages the kidneys and reproductive\\norgans and causes hemolytic anemia. Some copper is deposited in Descemet's membrane of the cornea,\\ncausing Kayser-Fleischer rings.\\nSymptoms and Signs\\nSymptoms usually develop between ages 5 and 40. In almost half of patients, particularly adolescents,\\nthe first symptom is hepatitis—acute, chronic active, or fulminant. But hepatitis may develop at any time.\\nIn about 40% of patients, particularly young adults, the first symptoms reflect CNS involvement. Motor\\ndeficits are common, including any combination of tremors, dystonia, dysarthria, dysphagia, chorea,\\ndrooling, and incoordination. Sometimes the first symptoms are cognitive or psychiatric abnormalities. In 5\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 109, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"drooling, and incoordination. Sometimes the first symptoms are cognitive or psychiatric abnormalities. In 5\\nto 10% of patients, the first symptom is incidentally noted gold or greenish gold Kayser-Fleischer rings or\\ncrescents (due to copper deposits in the cornea), amenorrhea or repeated miscarriages, or hematuria.\\nDiagnosis\\n• Slit-lamp examination for Kayser-Fleischer rings\\n• Serum ceruloplasmin and 24-h urinary copper excretion\\n• Sometimes confirmation by penicillamine provocation test or liver biopsy\\nWilson's disease should be suspected in people < 40 with any of the following:\\n• An unexplained hepatic, neurologic, or psychiatric disorder\\n• An unexplained persistent elevation in hepatic transaminases\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 5. Mineral Deficiency & Toxicity\\n101\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 110, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"• A sibling, parent, or cousin with Wilson's disease\\n• Fulminant hepatitis\\nIf Wilson's disease is suspected, slit-lamp examination for Kayser-Fleischer rings is required, and serum\\nceruloplasmin and copper levels and 24-h urinary copper excretion are measured. Transaminase levels\\nare also often measured; high levels are consistent with the diagnosis.\\nKayser-Fleischer rings: These rings plus typical motor neurologic abnormalities or a decrease in\\nceruloplasmin are nearly pathognomonic for Wilson's disease. Rarely, these rings occur in other liver\\ndisorders (eg, biliary atresia, primary biliary cirrhosis), but ceruloplasmin levels should be unaffected.\\nCeruloplasmin: Serum ceruloplasmin (normally 20 to 35 mg/dL) is usually low in Wilson's disease but\\ncan be normal. It can also be low in heterozygous carriers and those with other liver disorders (eg, viral\\nhepatitis, drug- or alcohol-induced liver disease). A low ceruloplasmin level in a patient with a Kayser-\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 110, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"hepatitis, drug- or alcohol-induced liver disease). A low ceruloplasmin level in a patient with a Kayser-\\nFleischer ring is diagnostic. Also, a level of < 5 mg/dL is highly suggestive regardless of clinical findings.\\nSerum copper: Despite the copper accumulation in the body, serum copper levels are decreased\\nbecause of the decreased ceruloplasmin levels.\\nUrinary copper excretion: In Wilson's disease, 24-h urinary copper excretion (normally, ≤ 30 μg/day) is\\nusually > 100 μg/day. If serum ceruloplasmin is low and urinary copper excretion is high, diagnosis is\\nclear. If levels are equivocal, measuring urinary copper excretion after penicillamine is given\\n(penicillamine provocation test) may confirm the diagnosis; this test is not usually done in adults because\\ncutoff values are not well-established.\\nLiver biopsy: In unclear cases (eg, elevated transaminases, no Kayser-Fleischer rings, indeterminate\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 110, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"cutoff values are not well-established.\\nLiver biopsy: In unclear cases (eg, elevated transaminases, no Kayser-Fleischer rings, indeterminate\\nvalues for ceruloplasmin and urinary copper), the diagnosis is made by doing a liver biopsy to measure\\nhepatic copper concentration. However, false-negative results may occur because of a sampling error\\n(due to large variations in copper concentrations in the liver) or fulminant hepatitis (causing necrosis that\\nreleases large amounts of copper).\\nScreening: Because early treatment is most effective, screening is indicated for anyone who has a\\nsibling, cousin, or parent with Wilson's disease. Screening consists of a slit-lamp examination and\\nmeasurement of transaminase levels, serum copper and ceruloplasmin, and 24-h urine copper excretion.\\nIf any results are abnormal, liver biopsy is done to measure hepatic copper concentration. Infants should\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 110, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"If any results are abnormal, liver biopsy is done to measure hepatic copper concentration. Infants should\\nnot be tested until after age 1 yr because ceruloplasmin levels are low during the first few months of life.\\nChildren < 6 yr with normal test results should be retested 5 to 10 yr later.\\nGenetic testing is under investigation.\\nPrognosis\\nPrognosis is usually good, unless disease is advanced before treatment begins. Untreated Wilson's\\ndisease is fatal, usually by age 30.\\nTreatment\\n• Penicillamine or another chelating drug if needed to remove accumulated copper\\n• Low-copper diet\\n• For maintenance, lifelong low-dose chelation therapy or oral zinc\\nContinual, lifelong treatment is mandatory regardless of whether symptoms are present. Accumulated\\ncopper should be removed with chelating drugs. A low-copper diet (eg, avoiding beef liver, cashews,\\nblack-eyed peas, vegetable juice, shellfish, mushrooms, and cocoa) and use of either low-dose chelation\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 110, 'source_type': 'Authorotative', 'priority': '1'}, page_content='black-eyed peas, vegetable juice, shellfish, mushrooms, and cocoa) and use of either low-dose chelation\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 5. Mineral Deficiency & Toxicity\\n102'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 111, 'source_type': 'Authorotative', 'priority': '1'}, page_content='therapy or oral zinc can prevent copper from accumulating.\\nPenicillamine is the most commonly used chelating drug but has considerable toxicity (eg, fever, rash,\\nneutropenia, thrombocytopenia, proteinuria). Cross-reactivity may occur in people with penicillin allergy.\\nPatients > 5 yr are given oral doses of 62.5 mg q 6 h to 250 mg q 12 h (250 to 500 mg/day in 2 to 4\\ndoses) and slowly increased to a maximum of 250 mg q 6 h to 750 mg q 12 h (1000 to 1500 mg/day in 2\\nto 4 doses). Younger children are given 10 mg/kg bid or 6.7 mg/kg tid (20 mg/kg/d) po. Pyridoxine 25 mg\\npo once/day is given with penicillamine. Occasionally, use of penicillamine is associated with worsening\\nneurologic symptoms.\\nTrientine hydrochloride is an alternative treatment to penicillamine. Doses are 375 to 750 mg po bid or\\n250 to 500 mg po tid (750 to 1500 mg/day).\\nZinc acetate 50 mg po tid can prevent reaccumulation of copper in patients who cannot tolerate'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 111, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"250 to 500 mg po tid (750 to 1500 mg/day).\\nZinc acetate 50 mg po tid can prevent reaccumulation of copper in patients who cannot tolerate\\npenicillamine or trientine or who have neurologic symptoms that do not respond to the other drugs.\\n(CAUTION: Penicillamine or trientine must not be given with zinc because either drug can bind zinc,\\nforming a compound with no therapeutic effect.)\\nPoor long-term adherence to drug therapy is common. After 1 to 5 yr of therapy, lower dose maintenance\\ndrug therapy can be considered. Regular follow-up care with an expert in liver disease is recommended.\\nLiver transplantation may be lifesaving for patients who have Wilson's disease and fulminant hepatic\\nfailure or severe hepatic insufficiency refractory to drugs.\\nFluorine\\nMost of the body's fluorine (F) is contained in bones and teeth. Fluoride (the ionic form of fluorine) is\\nwidely distributed in nature. The main source of fluoride is fluoridated drinking water.\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 111, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Most of the body's fluorine (F) is contained in bones and teeth. Fluoride (the ionic form of fluorine) is\\nwidely distributed in nature. The main source of fluoride is fluoridated drinking water.\\nDeficiency: Fluorine deficiency can lead to dental caries and possibly osteoporosis. Fluoridation of\\nwater that contains < 1 ppm (the ideal) reduces the incidence of dental caries. If a child's drinking water is\\nnot fluoridated, oral fluoride supplements can be prescribed.\\nToxicity: Excess fluorine can accumulate in teeth and bones, causing fluorosis. Drinking water\\ncontaining > 10 ppm is a common cause. Permanent teeth that develop during high fluoride intake are\\nmost likely to be affected. Exposure must be much greater to affect deciduous teeth.\\nThe earliest signs are chalky white, irregularly distributed patches on the surface of the enamel; these\\npatches become stained yellow or brown, producing a characteristic mottled appearance. Severe toxicity\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 111, 'source_type': 'Authorotative', 'priority': '1'}, page_content='patches become stained yellow or brown, producing a characteristic mottled appearance. Severe toxicity\\nweakens the enamel, pitting its surface. Bony changes, including osteosclerosis, exostoses of the spine,\\nand genu valgum, can develop but only in adults after prolonged high intake of fluoride.\\nNo tests to diagnose toxicity are available.\\nTreatment involves reducing fluoride intake; eg, in areas with high fluoride water levels, patients should\\nnot drink fluoridated water or take fluoride supplements. Children should always be told not to swallow\\nfluoridated toothpastes.\\nIodine\\nIn the body, iodine (I) is involved primarily in the synthesis of 2 thyroid hormones, thyroxine (T4) and\\ntriiodothyronine (T3). Iodine occurs in the environment and in the diet primarily as iodide. In adults, about\\n80% of the iodide absorbed is trapped by the thyroid gland. Most environmental iodine occurs in\\nseawater as iodide; a small amount enters the atmosphere and, through rain, enters ground water and'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 111, 'source_type': 'Authorotative', 'priority': '1'}, page_content='80% of the iodide absorbed is trapped by the thyroid gland. Most environmental iodine occurs in\\nseawater as iodide; a small amount enters the atmosphere and, through rain, enters ground water and\\nsoil near the sea. Thus, people living far from the sea and at higher altitudes are at particular risk of\\ndeficiency. Fortifying table salt with iodide (typically 70 μg/g) helps ensure adequate intake (150 μg/day).\\nRequirements are higher for pregnant (220 μg/day) and breastfeeding (290 μg/day) women.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 5. Mineral Deficiency & Toxicity\\n103'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 112, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Iodine Deficiency\\nDeficiency is rare in areas where iodized salt is used but common worldwide. Iodine deficiency develops\\nwhen iodide intake is < 20 μg/day. In mild or moderate deficiency, the thyroid gland, influenced by thyroid-\\nstimulating hormone (TSH), hypertrophies to concentrate iodide in itself, resulting in colloid goiter.\\nUsually, patients remain euthyroid; however, severe iodine deficiency in adults may cause hypothyroidism\\n(endemic myxedema). It can decrease fertility and increase risk of stillbirth, spontaneous abortion, and\\nprenatal and infant mortality. Severe maternal iodine deficiency retards fetal growth and brain\\ndevelopment, sometimes resulting in birth defects, and, in infants, causes cretinism, which may include\\nintellectual disability, deaf-mutism, difficulty walking, short stature, and sometimes hypothyroidism.\\nDiagnosis\\n• Assessment of thyroid structure and function'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 112, 'source_type': 'Authorotative', 'priority': '1'}, page_content='intellectual disability, deaf-mutism, difficulty walking, short stature, and sometimes hypothyroidism.\\nDiagnosis\\n• Assessment of thyroid structure and function\\nDiagnosis in adults and children is usually based on thyroid function, examination for goiter, and imaging\\ntests identifying abnormalities in thyroid function and structure (see p.\\n776). All neonates should be screened by measuring the TSH level.\\nTreatment\\n• Iodide with or without levothyroxine\\nInfants with iodine deficiency are given L-thyroxine 3 μg/kg po once/day for a week plus iodide 50 to 90\\nμg po once/day for several weeks to quickly restore a euthyroid state. Children are treated with iodide 90\\nto 120 μg once/day. Adults are given iodide 150 μg once/day. Iodine deficiency can also be treated by\\ngiving levothyroxine. Serum TSH levels are monitored in all patients until the levels are normal (ie, < 5\\nμIU/mL).\\nIodine Toxicity\\nChronic toxicity may develop when intake is > 1.1 mg/day. Most people who ingest excess amounts of'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 112, 'source_type': 'Authorotative', 'priority': '1'}, page_content='μIU/mL).\\nIodine Toxicity\\nChronic toxicity may develop when intake is > 1.1 mg/day. Most people who ingest excess amounts of\\niodine remain euthyroid. Some people who ingest excess amounts of iodine, particularly those who were\\npreviously deficient, develop hyperthyroidism (Jod-Basedow phenomenon). Paradoxically, excess uptake\\nof iodine by the thyroid may inhibit thyroid hormone synthesis (called Wolff-Chaikoff effect). Thus, iodine\\ntoxicity can eventually cause iodide goiter, hypothyroidism, or myxedema. Very large amounts of iodide\\nmay cause a brassy taste in the mouth, increased salivation, GI irritation, and acneiform skin lesions.\\nPatients exposed to frequent large amounts of radiographic contrast dyes or the drug amiodarone also\\nneed to have their thyroid function monitored.\\nDiagnosis is usually based on thyroid function and imaging test findings (see p. 776), which are\\ncorrelated with clinical data. Iodine excretion may be more specific but is not usually measured. Treatment'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 112, 'source_type': 'Authorotative', 'priority': '1'}, page_content='correlated with clinical data. Iodine excretion may be more specific but is not usually measured. Treatment\\nconsists of correcting thyroid abnormalities and, if intake is excessive, dietary modification.\\nIron\\nIron (Fe) is a component of hemoglobin, myoglobin, and many enzymes in the body. Heme iron, contained\\nmainly in animal products, is absorbed much better than nonheme iron (eg, in plants and grains), which\\naccounts for > 85% of iron in the average diet. However, absorption of nonheme iron is increased when it\\nis consumed with animal protein and vitamin C.\\nDeficiency: Iron deficiency is one of the most common mineral deficiencies in the world. It may result\\nfrom the following:\\n• Inadequate iron intake, common in infants, adolescent girls, and pregnant women\\n• Malabsorption (eg, celiac sprue)\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 5. Mineral Deficiency & Toxicity\\n104'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 113, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Chronic bleeding\\nChronic bleeding due to colon cancer is a serious cause in middle-aged people and the elderly.\\nWhen deficiency is advanced, microcytic anemia develops (see p. 924).\\nIn addition to anemia, iron deficiency may cause pica (a craving for nonfoods) and spoon nails and is\\nassociated with restless leg syndrome. Rarely, iron deficiency causes dysphagia due to postcricoid\\nesophageal web.\\nDiagnosis involves CBC, serum ferritin, and possibly measurement of transferrin saturation (iron\\ncapacity).\\nAll people with moderate or severe iron deficiency and some people with mild deficiency require iron\\nsupplementation.\\nToxicity: Iron may accumulate in the body because of\\n• Iron therapy given in excessive amounts or for too long\\n• Repeated blood transfusions\\n• Chronic alcoholism\\n• Overdose of iron\\nIron overload can also result from an inherited iron overload disease (hemochromatosis—see p. 1032), a'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 113, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Repeated blood transfusions\\n• Chronic alcoholism\\n• Overdose of iron\\nIron overload can also result from an inherited iron overload disease (hemochromatosis—see p. 1032), a\\npotentially fatal but easily treatable genetic disorder in which too much iron is absorbed.\\nHemochromatosis affects > 1 million Americans.\\nAn overdose of iron is toxic (see p. 3341), causing vomiting, diarrhea, and damage to the intestine and\\nother organs.\\nDiagnosis is similar to that for iron deficiency.\\nTreatment often involves deferoxamine, which binds with iron and is excreted in urine.\\nManganese\\nManganese (Mn), necessary for healthy bone structure, is a component of several enzyme systems,\\nincluding manganese-specific glycosyltransferases and phosphoenolpyruvate carboxykinase. Median\\nintake is between 1.6 and 2.3 mg/day; absorption is 5 to 10%.\\nDeficiency has not been conclusively documented, although one experimental case in a volunteer'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 113, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"intake is between 1.6 and 2.3 mg/day; absorption is 5 to 10%.\\nDeficiency has not been conclusively documented, although one experimental case in a volunteer\\nresulted in transient dermatitis, hypocholesterolemia, and increased alkaline phosphatase levels.\\nToxicity is usually limited to people who mine and refine ore; prolonged exposure causes neurologic\\nsymptoms resembling those of parkinsonism or Wilson's disease.\\nMolybdenum\\nMolybdenum (Mo) is a component of coenzymes necessary for the activity of xanthine oxidase, sulfite\\noxidase, and aldehyde oxidase.\\nGenetic and nutritional deficiencies of molybdenum have been reported but are rare. Genetic sulfite\\noxidase deficiency was described in 1967 in a child. It resulted from the inability to form the molybdenum\\ncoenzyme despite the presence of adequate molybdenum. The deficiency caused intellectual disability,\\nseizures, opisthotonus, and lens dislocation.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 113, 'source_type': 'Authorotative', 'priority': '1'}, page_content='seizures, opisthotonus, and lens dislocation.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 5. Mineral Deficiency & Toxicity\\n105'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 114, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Molybdenum deficiency resulting in sulfite toxicity occurred in a patient receiving long-term TPN.\\nSymptoms were tachycardia, tachypnea, headache, nausea, vomiting, and coma. Laboratory tests\\nshowed high levels of sulfite and xanthine and low levels of sulfate and uric acid in the blood and urine.\\nAmmonium molybdate 300 μg/day IV caused dramatic recovery.\\nA case of molybdenum toxicity may have occurred in 1961; it caused goutlike symptoms and\\nabnormalities of the GI tract, liver, and kidneys.\\nSelenium\\nSelenium (Se) is a part of the enzyme glutathione peroxidase, which metabolizes hydro-peroxides formed\\nfrom polyunsaturated fatty acids. Selenium is also a part of the enzymes that deiodinate thyroid\\nhormones. Generally, selenium acts as an antioxidant that works with vitamin E. Some epidemiologic\\nstudies associate low selenium levels with cancer. In children with Down syndrome, selenium\\nsupplements may help prevent bacterial infections. Plasma levels vary from 8 to 25 μg/dL, depending on'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 114, 'source_type': 'Authorotative', 'priority': '1'}, page_content='studies associate low selenium levels with cancer. In children with Down syndrome, selenium\\nsupplements may help prevent bacterial infections. Plasma levels vary from 8 to 25 μg/dL, depending on\\nselenium intake. Diagnosis is usually clinical; sometimes blood glutathione peroxidase is measured.\\nDeficiency: Deficiency is rare, even in New Zealand and Finland, where selenium intake is 30 to 50\\nμg/day, compared with 100 to 250 μg/day in the US and Canada. In certain areas of China, where intake\\naverages 10 to 15 μg/day, selenium deficiency predisposes patients to Keshan disease, an endemic viral\\ncardiomyopathy affecting primarily children and young women. This cardiomyopathy can be prevented\\nbut not cured by sodium selenite supplements of 50 μg/day po. Patients receiving long-term TPN have\\ndeveloped selenium deficiency with muscle pain and tenderness that responded to a selenomethionine\\nsupplement. In Siberian Russia and China, growing children with selenium deficiency may develop'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 114, 'source_type': 'Authorotative', 'priority': '1'}, page_content='developed selenium deficiency with muscle pain and tenderness that responded to a selenomethionine\\nsupplement. In Siberian Russia and China, growing children with selenium deficiency may develop\\nchronic osteoarthropathy (Kashin-Beck disease). Selenium deficiency may contribute synergistically with\\niodine deficiency to the development of goiter and hypothyroidism.\\nDiagnosis is made clinically or sometimes by measuring glutathione peroxidase activity or plasma\\nselenium, but neither of these tests is readily available. Treatment consists of sodium selenite 100 μg/day\\npo.\\nToxicity: At high doses (> 900 μg/day), selenium causes toxicity. Manifestations include hair loss,\\nabnormal nails, dermatitis, peripheral neuropathy, nausea, diarrhea, fatigue, irritability, and a garlic odor of\\nthe breath. Toxic levels of plasma selenium are not well defined.\\nZinc\\nZinc (Zn) is contained mainly in bones, teeth, hair, skin, liver, muscle, leukocytes, and testes. Zinc is a'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 114, 'source_type': 'Authorotative', 'priority': '1'}, page_content='the breath. Toxic levels of plasma selenium are not well defined.\\nZinc\\nZinc (Zn) is contained mainly in bones, teeth, hair, skin, liver, muscle, leukocytes, and testes. Zinc is a\\ncomponent of several hundred enzymes, including many nicotinamide adenine dinucleotide (NADH)\\ndehydrogenases, RNA and DNA polymerases, and DNA transcription factors as well as alkaline\\nphosphatase, superoxide dismutase, and carbonic anhydrase. A diet high in fiber and phytate (eg, in\\nwhole-grain bread) reduces zinc absorption.\\nDeficiency: Dietary deficiency is unlikely in healthy people. Secondary zinc deficiency can develop in the\\nfollowing:\\n• Some patients with hepatic insufficiency (because the ability to retain zinc is lost)\\n• Patients taking diuretics\\n• Patients with diabetes mellitus, sickle cell disease, chronic renal failure, or malabsorption\\n• Patients with stressful conditions (eg, sepsis, burns, head injury)\\n• Elderly institutionalized and homebound patients (common)'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 114, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Patients with stressful conditions (eg, sepsis, burns, head injury)\\n• Elderly institutionalized and homebound patients (common)\\nMaternal zinc deficiency may cause fetal malformations and low birth weight.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 5. Mineral Deficiency & Toxicity\\n106'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 115, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Zinc deficiency in children causes impaired growth and impaired taste (hypogeusia). Other symptoms and\\nsigns in children include delayed sexual maturation and hypogonadism. In children or adults, symptoms\\ninclude hypogonadism, alopecia, impaired immunity, anorexia, dermatitis, night blindness, anemia,\\nlethargy, and impaired wound healing.\\nZinc deficiency should be suspected in undernourished patients with typical symptoms or signs. However,\\nbecause many of the symptoms and signs are nonspecific, clinical diagnosis of mild zinc deficiency is\\ndifficult. Laboratory diagnosis is also difficult. Low albumin levels, common in zinc deficiency, make serum\\nzinc levels difficult to interpret; diagnosis usually requires the combination of low levels of zinc in serum\\nand increased urinary zinc excretion. If available, isotope studies can measure zinc status more\\naccurately.\\nTreatment consists of elemental zinc 15 to 120 mg/day po until symptoms and signs resolve.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 115, 'source_type': 'Authorotative', 'priority': '1'}, page_content='and increased urinary zinc excretion. If available, isotope studies can measure zinc status more\\naccurately.\\nTreatment consists of elemental zinc 15 to 120 mg/day po until symptoms and signs resolve.\\nAcrodermatitis enteropathica (a rare, once fatal autosomal recessive disorder) causes malabsorption\\nof zinc. Psoriasiform dermatitis develops around the eyes, nose, and mouth; on the buttocks; and in an\\nacral distribution. The disorder also causes hair loss, paronychia, impaired immunity, recurrent infection,\\nimpaired growth, and diarrhea. Symptoms and signs usually develop after infants are weaned from breast\\nmilk. In such cases, doctors suspect the diagnosis. If deficiency is diagnosed, zinc sulfate 30 to 150\\nmg/day po usually results in complete remission.\\nToxicity: The recommended upper limit for zinc intake is 40 mg/day. Toxicity is rare. Ingesting doses of\\nelemental zinc ranging from 100 to 150 mg/day for prolonged periods interferes with copper metabolism'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 115, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"elemental zinc ranging from 100 to 150 mg/day for prolonged periods interferes with copper metabolism\\nand causes low blood copper levels, RBC microcytosis, neutropenia, and impaired immunity; higher\\ndoses should be given only for short periods of time and the patient should be followed closely. Ingesting\\nlarger amounts (200 to 800 mg/day), usually by consuming acidic food or drink from a galvanized (zinc-\\ncoated) container, can cause anorexia, vomiting, and diarrhea. Metal fume fever, also called brass-\\nfounders' ague or zinc shakes, is caused by inhaling industrial zinc oxide fumes; it results in neurologic\\ndamage. Symptoms usually resolve after 12 to 24 h in a zinc-free environment.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 5. Mineral Deficiency & Toxicity\\n107\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 116, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chapter 6. Obesity and the Metabolic Syndrome\\nObesity\\nObesity is excess body fat; consequences depend not only on the absolute amount but also on\\nthe distribution of the fat. Complications include cardiovascular disorders, diabetes mellitus,\\nmany cancers, cholelithiasis, fatty liver and cirrhosis, osteoarthritis, reproductive disorders in\\nmen and women, psychologic disorders, and premature death. Diagnosis is based on body\\nmass index (BMI—calculated from height and weight) and waist circumference. BP, fasting\\nplasma glucose, and lipid levels should be measured. Treatment includes physical activity,\\ndietary and behavioral modification, and sometimes drugs or surgery.\\nPrevalence of obesity in the US is high and is increasing, particularly among children and adolescents\\n(see\\nTable 6-1).\\nPrevalence is more than twice as high at age 55 as at age 20. Obesity is twice as common among women\\nin a lower socioeconomic group as among those in a higher group. Prevalence among black and white'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 116, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Prevalence is more than twice as high at age 55 as at age 20. Obesity is twice as common among women\\nin a lower socioeconomic group as among those in a higher group. Prevalence among black and white\\nmen does not differ significantly, but it is higher among black women than white women. More than 50%\\nof black women ≥ 40 yr are obese; > 80% are overweight.\\nIn the US, obesity and its complications cause as many as 300,000 premature deaths each year, making\\nit second only to cigarette smoking as a preventable cause of death.\\n[Table 6-1. Changes in Prevalence of Obesity According to Nhanes]\\nEtiology\\nAlmost all cases of obesity result from a combination of genetic predisposition and a chronic imbalance\\nbetween energy intake, energy utilization for basic metabolic processes, and energy expenditure from\\nphysical activity.\\nGenetic factors: Heritability of BMI is about 66%. Genetic factors may affect the many signaling'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 116, 'source_type': 'Authorotative', 'priority': '1'}, page_content='physical activity.\\nGenetic factors: Heritability of BMI is about 66%. Genetic factors may affect the many signaling\\nmolecules and receptors used by parts of the hypothalamus and GI tract to regulate food intake (see\\nSidebar 6-1). Rarely, obesity results from abnormal levels of peptides that regulate food intake (eg, leptin)\\nor abnormalities in their receptors (eg, melanocortin-4 receptor).\\nGenetic factors also regulate energy expenditure, including BMR, diet-induced thermogenesis, and\\nnonvoluntary activity-associated thermogenesis. Genetic factors may have a greater effect on the\\ndistribution of body fat, particularly abdominal fat (see Metabolic Syndrome on p. 64), than on the amount\\nof body fat.\\nEnvironmental factors: Weight is gained when caloric intake exceeds energy needs. Important\\ndeterminants of energy intake include portion sizes and the energy density of the food. High-fat foods,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 116, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Environmental factors: Weight is gained when caloric intake exceeds energy needs. Important\\ndeterminants of energy intake include portion sizes and the energy density of the food. High-fat foods,\\nprocessed foods, and diets high in refined carbohydrates, soft drinks, fruit juices, and alcohol promote\\nweight gain. Diets high in fresh fruit and vegetables, fiber, and complex carbohydrates, with water as the\\nmain fluid consumed, minimize weight gain. A sedentary lifestyle promotes weight gain.\\nRegulatory factors: Prenatal maternal obesity, prenatal maternal smoking, intrauterine growth\\nrestriction, and insufficient sleep can disturb weight regulation. About 15% of women permanently gain ≥\\n20 lb with each pregnancy. Obesity that persists beyond early childhood makes weight loss in later life\\nmore difficult.\\nDrugs, including corticosteroids, lithium, traditional antidepressants (tricyclics, tetracyclics, and'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 116, 'source_type': 'Authorotative', 'priority': '1'}, page_content='more difficult.\\nDrugs, including corticosteroids, lithium, traditional antidepressants (tricyclics, tetracyclics, and\\nmonoamine oxidase inhibitors [MAOIs]), benzodiazepines, and antipsychotic drugs, often cause weight\\ngain.\\nUncommonly, weight gain is caused by one of the following disorders:\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 6. Obesity & the Metabolic Syndrome\\n108'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 117, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"• Brain damage caused by a tumor (especially a craniopharyngioma) or an infection (particularly those\\naffecting the hypothalamus), which can stimulate consumption of excess calories\\n• Hyperinsulinism due to pancreatic tumors\\n• Hypercortisolism due to Cushing's syndrome, which causes predominantly abdominal obesity\\n• Hypothyroidism (rarely a cause of substantial weight gain)\\nSidebar 6-1 Pathways Regulating Food Intake\\nPreabsorptive and postabsorptive signals from the GI tract and changes in plasma nutrient levels provide\\nshort-term feedback to regulate food intake:\\n• GI hormones (eg, glucagon-like peptide 1 [GLP-1], cholecystokinin [CCK]) reduce food intake.\\n• Ghrelin, secreted primarily by the stomach, increases food intake.\\n• Leptin, secreted from adipose tissue, informs the brain as to how much fat is stored; high leptin levels\\ncorrelate with increased body fat.\\nThe hypothalamus integrates various signals involved in the regulation of energy balance and then\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 117, 'source_type': 'Authorotative', 'priority': '1'}, page_content='correlate with increased body fat.\\nThe hypothalamus integrates various signals involved in the regulation of energy balance and then\\nactivates pathways that increase or decrease food intake:\\n• Neuropeptide Y (NPY), agouti-related peptide (ARP), α-melanocyte-stimulating hormone (α-MSH),\\ncocaine- and amphetamine-related transcript (CART), orexin, and melanin-concentrating hormone\\n(MCH) increase food intake.\\n• Corticotropic hormone (CRH) and urocortin decrease it.\\nEating disorders: At least 2 pathologic eating patterns may be associated with obesity:\\n• Binge eating disorder is consumption of large amounts of food quickly with a subjective sense of loss\\nof control during the binge and distress after it (see p. 1537). This disorder does not include\\ncompensatory behaviors, such as vomiting. Prevalence is 1 to 3% among both sexes and 10 to 20%\\namong people entering weight reduction programs. Obesity is usually severe, large amounts of weight'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 117, 'source_type': 'Authorotative', 'priority': '1'}, page_content='compensatory behaviors, such as vomiting. Prevalence is 1 to 3% among both sexes and 10 to 20%\\namong people entering weight reduction programs. Obesity is usually severe, large amounts of weight\\nare frequently gained or lost, and pronounced psychologic disturbances are present.\\n• Night-eating syndrome consists of morning anorexia, evening hyperphagia, and insomnia. At least 25\\nto 50% of daily intake occurs after the evening meal. About 10% of people seeking treatment for severe\\nobesity may have this disorder. Rarely, a similar disorder is induced by use of a hypnotic such as\\nzolpidem.\\nSimilar but less extreme patterns, classified as eating disorders not otherwise specified (EDNOS),\\nprobably contribute to excess weight gain in more people. For example, nocturnal eating contributes to\\nexcess weight gain in many people who do not have night-eating syndrome.\\nComplications\\nComplications of obesity include the following:\\n• Metabolic syndrome\\n• Diabetes mellitus'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 117, 'source_type': 'Authorotative', 'priority': '1'}, page_content='excess weight gain in many people who do not have night-eating syndrome.\\nComplications\\nComplications of obesity include the following:\\n• Metabolic syndrome\\n• Diabetes mellitus\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 6. Obesity & the Metabolic Syndrome\\n109'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 118, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Cardiovascular disease\\n• Nonalcoholic steatohepatitis (fatty liver)\\n• Gallbladder disease\\n• Gastroesophageal reflux\\n• Obstructive sleep apnea\\n• Reproductive system disorders\\n• Many cancers\\n• Osteoarthritis\\n• Social and psychologic problems\\nInsulin resistance, dyslipidemias, and hypertension (the metabolic syndrome) develop, often leading to\\ndiabetes mellitus and coronary artery disease (see p. 64). These complications are more likely in patients\\nwith fat that is concentrated abdominally, a high serum triglyceride level, a family history of type 2\\ndiabetes mellitus or premature cardiovascular disease, or a combination of these risk factors.\\nObesity is also a risk factor for nonalcoholic steatohepatitis (which may lead to cirrhosis) and for\\nreproductive system disorders, such as a low serum testosterone level in men and polycystic ovary\\nsyndrome in women.\\nObstructive sleep apnea can result if excess fat in the neck compresses the airway during sleep.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 118, 'source_type': 'Authorotative', 'priority': '1'}, page_content='syndrome in women.\\nObstructive sleep apnea can result if excess fat in the neck compresses the airway during sleep.\\nBreathing stops for moments, as often as hundreds of times a night (see p. 1903). This disorder, often\\nundiagnosed, can cause loud snoring and excessive daytime sleepiness and increases the risk of\\nhypertension, cardiac arrhythmias, and metabolic syndrome.\\nObesity may cause the obesity-hypoventilation syndrome (Pickwickian syndrome). Impaired breathing\\nleads to hypercapnia, reduced sensitivity to CO2 in stimulating respiration, hypoxia, cor pulmonale, and\\nrisk of premature death. This syndrome may occur alone or secondary to obstructive sleep apnea.\\nOsteoarthritis and tendon and fascial disorders may result from obesity. Skin disorders are common;\\nincreased sweat and skin secretions, trapped in thick folds of skin, are conducive to fungal and bacterial\\ngrowth, making intertriginous infections especially common. Being overweight probably predisposes to'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 118, 'source_type': 'Authorotative', 'priority': '1'}, page_content='growth, making intertriginous infections especially common. Being overweight probably predisposes to\\ncholelithiasis, gout, deep venous thrombosis and pulmonary embolism, and many cancers (especially\\ncolon and breast cancers).\\nObesity leads to social, economic, and psychologic problems as a result of prejudice, discrimination, poor\\nbody image, and low self-esteem. For example, people may be underemployed or unemployed.\\nDiagnosis\\n• BMI\\n• Waist circumference\\n• Sometimes body composition analysis\\nIn adults, BMI, defined as weight (kg) divided by the square of the height (m2), is used to screen for\\noverweight or obesity. BMI of 25 to 29.9 kg/m2 indicates overweight; BMI ≥ 30 kg/m2 indicates obesity\\n(see\\nTable 6-2). However, BMI is a crude screening tool and has limitations in many subpopulations. BMI is\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 6. Obesity & the Metabolic Syndrome\\n110'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 119, 'source_type': 'Authorotative', 'priority': '1'}, page_content='age- and race-specific; its use is limited in children and the elderly. In children and adolescents,\\noverweight is BMI at the ≥ 95th percentile based on age- and sex-specific Centers for Disease Control\\nand Prevention (CDC) growth charts at the CDC web site.\\nAsians, Japanese, and many aboriginal populations have a lower cut-off (23 kg/m2) for overweight. In\\naddition, BMI may be high in muscular athletes who lack excess body fat, and normal or low in formerly\\noverweight people who have lost muscle mass.\\nThe risk of metabolic and cardiovascular complications due to obesity is determined more accurately by\\nthe following:\\n• Other risk factors, particularly a family history of type 2 diabetes or premature cardiovascular disease\\n• Waist circumference\\n• Serum triglycerides\\nThe waist circumference that increases risk of complications due to obesity varies by ethnic group and\\nsex:\\n• White men: > 93 cm (> 36.6 in), particularly > 101 cm (> 39.8 in)'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 119, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Serum triglycerides\\nThe waist circumference that increases risk of complications due to obesity varies by ethnic group and\\nsex:\\n• White men: > 93 cm (> 36.6 in), particularly > 101 cm (> 39.8 in)\\n• White women: > 79 cm (> 31.1 in), particularly > 87 cm (> 34.2 in)\\n• Asian Indian men: > 78 cm (> 30.7 in), particularly > 90 cm (> 35.4 in)\\n• Asian Indian women: > 72 cm (> 28.3 in), particularly > 80 cm (> 31.5 in)\\nBody composition analysis: Body composition—the percentage of body fat and muscle—is also\\nconsidered when obesity is diagnosed. Although probably unnecessary in routine clinical practice, body\\ncomposition analysis can be helpful if clinicians question whether elevated BMI is due to muscle or\\nexcessive fat.\\nThe percentage of body fat can be estimated by measuring skinfold thickness (usually over the triceps) or\\ndetermining mid upper arm area (see p.\\n13).\\nBioelectrical impedance analysis (BIA) can estimate percentage of body fat simply and noninvasively. BIA'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 119, 'source_type': 'Authorotative', 'priority': '1'}, page_content='determining mid upper arm area (see p.\\n13).\\nBioelectrical impedance analysis (BIA) can estimate percentage of body fat simply and noninvasively. BIA\\nestimates percentage of total body water directly; percentage of body fat is derived indirectly. BIA is most\\nreliable in healthy people and in people with only a few chronic disorders that do not change the\\npercentage of total body water (eg, moderate obesity, diabetes mellitus). Whether measuring BIA poses\\nrisks in people with implanted defibrillators is unclear.\\nUnderwater (hydrostatic) weighing is the most accurate method for measuring percentage of body fat.\\nCostly and time-consuming, it is used more often in research than in clinical care. To be weighed\\naccurately while submerged, people must fully exhale beforehand.\\nImaging procedures, including CT, MRI, and dual-energy x-ray absorptiometry (DEXA), can also estimate\\nthe percentage and distribution of body fat but are usually used only for research.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 119, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Imaging procedures, including CT, MRI, and dual-energy x-ray absorptiometry (DEXA), can also estimate\\nthe percentage and distribution of body fat but are usually used only for research.\\nOther testing: Obese patients should be screened for obstructive sleep apnea with an instrument such\\nas the Epworth Sleepiness Scale and often the apnea-hypopnea index (total number of apnea or\\nhypopnea episodes occurring per hour of sleep—see p. 1904). This disorder is often underdiagnosed,\\nand obesity increases the risk.\\nFasting glucose and lipid levels should be measured routinely in patients with a large waist circumference\\nor a family history of type 2 diabetes mellitus or premature cardiovascular disease.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 6. Obesity & the Metabolic Syndrome\\n111'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 120, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Prognosis\\nUntreated, obesity tends to progress. The probability and severity of complications are proportional to the\\nabsolute amount of fat, the distribution of the fat, and absolute muscle mass. After weight loss, most\\npeople return to their pretreatment weight within 5 yr, and\\n[Table 6-2. Body Mass Index (BMI)]\\naccordingly, obesity requires a lifelong management program similar to that for any other chronic disorder.\\nTreatment\\n• Nutrition management\\n• Physical activity\\n• Behavioral therapy\\n• Drugs (eg, sibutramine, orlistat)\\n• Bariatric surgery\\nWeight loss of even 5 to 10% improves overall health and well-being and in particular helps reduce risk of\\ncardiovascular disorders and type 2 diabetes. Weight loss can lead to improvement in patients with\\nobstructive sleep apnea, but sometimes a lot of weight must be lost for the disorder to resolve.\\nSupport from health care practitioners, peers, and family members and various structured programs can'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 120, 'source_type': 'Authorotative', 'priority': '1'}, page_content='obstructive sleep apnea, but sometimes a lot of weight must be lost for the disorder to resolve.\\nSupport from health care practitioners, peers, and family members and various structured programs can\\nhelp with weight loss and weight maintenance.\\nNutrition: A normal eating pattern is important. People who miss breakfast tend to passively consume too\\nmany calories later in the day. Patients should eat small meals and avoid or carefully choose snacks.\\nLow-fat (particularly very low saturated fat), high-fiber diets with modest calorie restriction (by 600\\nkcal/day) and substitution of some protein for carbohydrate seem to have the best long-term outcome.\\nFresh fruits and vegetables and salads should be substituted for refined carbohydrates and processed\\nfood, and water for soft drinks or juices. Alcohol consumption should be limited to moderate levels. Foods\\nwith a low glycemic index (see'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 120, 'source_type': 'Authorotative', 'priority': '1'}, page_content='food, and water for soft drinks or juices. Alcohol consumption should be limited to moderate levels. Foods\\nwith a low glycemic index (see\\nTable 1-1 on p. 3) and marine fish oils or monounsaturated fats derived from plants (eg, olive oil) reduce\\nthe risk of cardiovascular disorders and diabetes. Low-fat dairy products are also part of a healthy diet.\\nPatients need an adequate amount of vitamin D, preferably obtained by exercising outdoors in the\\nsunshine.\\nUse of meal replacements has proven efficacy; use can be ongoing or intermittent. Diets that require\\nunusual eating habits should be avoided. They are unlikely to be maintained, and weight increases when\\npatients resume previous poor eating habits. Diets of < 1200 kcal/day cannot be sustained, but such diets\\nare sometimes needed to achieve rapid short-term weight loss (eg, to prepare for surgery, to lessen\\nobstructive sleep apnea). Diets of < 800 kcal/day do not produce greater weight loss and are less well\\ntolerated.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 120, 'source_type': 'Authorotative', 'priority': '1'}, page_content='obstructive sleep apnea). Diets of < 800 kcal/day do not produce greater weight loss and are less well\\ntolerated.\\nPhysical activity: Exercise increases energy expenditure, BMR, and diet-induced thermogenesis.\\nExercise also seems to regulate appetite to more closely match caloric needs. Other benefits include\\n• Increased insulin sensitivity\\n• Improved lipid profile\\n• Lower BP\\n• Better aerobic fitness\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 6. Obesity & the Metabolic Syndrome\\n112'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 121, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Improved psychologic well-being\\nStrengthening (resistance) exercises increase muscle mass. Because muscle tissue burns more calories\\nat rest than does fat tissue, increasing muscle mass produces lasting increases in BMR. Exercise that is\\ninteresting and enjoyable is more likely to be sustained. A combination of aerobic and resistance exercise\\nis better than either alone.\\nBehavioral therapy: Behavioral therapy aims to improve eating habits and physical activity level. Rigid\\ndieting is discouraged in favor of healthy eating. Common-sense measures include the following:\\n• Avoiding high-calorie snacks\\n• Choosing healthful foods when dining out\\n• Eating slowly\\n• Substituting a physically active hobby for a passive one\\nSocial support, cognitive therapy, and stress management may help, particularly during the lapses usually\\nexperienced during any long-term weight loss program. Self-monitoring is useful, and maintenance of a\\ndiet diary is particularly effective.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 121, 'source_type': 'Authorotative', 'priority': '1'}, page_content='experienced during any long-term weight loss program. Self-monitoring is useful, and maintenance of a\\ndiet diary is particularly effective.\\nDrugs: Drugs may be used if BMI is > 30 or if BMI is > 27 and patients have complications (eg,\\nhypertension, insulin resistance). Most weight loss due to drug treatment is modest (5 to 10%) at best and\\noccurs during the first 6 mo; not all patients benefit. Drugs are more useful for maintaining weight loss but\\nmust be continued indefinitely for weight loss to be maintained. Premenopausal women taking\\nsystemically acting drugs for weight control should use contraception.\\nSibutramine is a centrally acting appetite suppressant that produces dose-related weight loss. The usual\\nstarting dose is 10 mg po once/day; the dose can be decreased to 5 mg or increased to 15 mg. Common\\nadverse effects are headache, dry mouth, insomnia, and constipation; the most common serious one is'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 121, 'source_type': 'Authorotative', 'priority': '1'}, page_content='starting dose is 10 mg po once/day; the dose can be decreased to 5 mg or increased to 15 mg. Common\\nadverse effects are headache, dry mouth, insomnia, and constipation; the most common serious one is\\nhypertension. Cardiovascular disorders, particularly poorly controlled hypertension, are contraindications.\\nOrlistat inhibits intestinal lipase, decreasing fat absorption and improving serum glucose and lipids.\\nBecause orlistat is not absorbed, systemic effects are rare. Flatus, oily stools, and diarrhea are common\\nbut tend to resolve during the 2nd yr of treatment. A dose of 120 mg po tid should be taken with meals\\nthat include fat. A vitamin supplement should be taken at least 2 h before or after taking orlistat.\\nMalabsorption and cholestasis are contraindications; irritable bowel syndrome and other GI disorders may\\nmake orlistat difficult to tolerate. Orlistat is available OTC.\\nOther OTC weight-loss drugs are not recommended. Some (eg, caffeine, ephedrine, guarana,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 121, 'source_type': 'Authorotative', 'priority': '1'}, page_content='make orlistat difficult to tolerate. Orlistat is available OTC.\\nOther OTC weight-loss drugs are not recommended. Some (eg, caffeine, ephedrine, guarana,\\nphenylpropanolamine) may be marginally effective, but their adverse effects outweigh their advantages.\\nOthers (eg, brindleberry, L-carnitine, chitosan, pectin, grapeseed extract, horse chestnut, chromium\\npicolinate, fucus vesiculosus, ginkgo biloba) have not been shown to be effective and may have adverse\\neffects.\\nSurgery: Surgery is the most effective treatment for extremely obese patients (see p. 61).\\nSpecial Populations\\nObesity is a particular concern in children and the elderly.\\nChildren: Childhood obesity is even more worrisome than adult obesity. For obese children,\\ncomplications are more likely because children are obese longer. About 20 to 25% of children and\\nadolescents are overweight or obese. Risk factors for obesity in infants are low birth weight and maternal'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 121, 'source_type': 'Authorotative', 'priority': '1'}, page_content='adolescents are overweight or obese. Risk factors for obesity in infants are low birth weight and maternal\\nobesity, diabetes, and smoking. After puberty, food intake increases; in boys, the extra calories are used\\nto increase protein deposition, but in girls, fat storage is increased.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 6. Obesity & the Metabolic Syndrome\\n113'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 122, 'source_type': 'Authorotative', 'priority': '1'}, page_content='For obese children, psychologic complications (eg, poor self-esteem, social difficulties, depression) and\\nmusculoskeletal complications can develop early. Some musculoskeletal complications, such as slipped\\ncapital femoral epiphyses, occur only in children. Other early complications may include obstructive sleep\\napnea, insulin resistance, hyperlipidemia, and nonalcoholic steatohepatitis. Risk of cardiovascular,\\nrespiratory, metabolic, hepatic, and other obesity-related complications increases when these children\\nbecome adults.\\nRisk of obesity persisting into adulthood depends partly on when obesity first develops:\\n• During infancy: Low risk\\n• Between 6 mo and 5 yr: 25%\\n• After 6 yr: > 50%\\n• During adolescence if a parent is obese: > 80%\\nIn children, preventing further weight gain, rather than losing weight, is a reasonable goal. Diet should be\\nmodified, and physical activity increased. Increasing general activities and play is more likely to be'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 122, 'source_type': 'Authorotative', 'priority': '1'}, page_content='modified, and physical activity increased. Increasing general activities and play is more likely to be\\neffective than a structured exercise program. Participating in physical activities during childhood may\\npromote a lifelong physically active lifestyle. Drugs and surgery are avoided but, if complications of\\nobesity are life threatening, may be warranted.\\nMeasures that control weight and prevent obesity in children may benefit public health the most. Such\\nmeasures should be implemented in the family, schools, and primary care programs.\\nThe elderly: In the US, the percentage of obese elderly people has been increasing.\\nWith aging, body fat increases and is redistributed to the abdomen, and muscle mass is lost, largely\\nbecause of physical inactivity, but decreased androgens and growth hormone (which are anabolic) and\\ninflammatory cytokines produced in obesity may also play a role.\\nRisk of complications depends on'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 122, 'source_type': 'Authorotative', 'priority': '1'}, page_content='because of physical inactivity, but decreased androgens and growth hormone (which are anabolic) and\\ninflammatory cytokines produced in obesity may also play a role.\\nRisk of complications depends on\\n• Body fat distribution (increasing with a predominantly abdominal distribution)\\n• Duration and severity of obesity\\n• Associated sarcopenia\\nIncreased waist circumference, suggesting abdominal fat distribution, predicts morbidity (eg,\\nhypertension, diabetes mellitus, coronary artery disease) and mortality risk better in the elderly than does\\nBMI.\\nFor the elderly, increased physical activity is usually preferable to dietary restriction unless restricted\\nmobility prohibits activity; in such cases, caloric restriction may be needed to reduce weight enough to\\nrestore mobility. Physical activity also improves muscle strength, endurance, and overall well-being.\\nActivity should include strengthening and endurance exercises.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 122, 'source_type': 'Authorotative', 'priority': '1'}, page_content='restore mobility. Physical activity also improves muscle strength, endurance, and overall well-being.\\nActivity should include strengthening and endurance exercises.\\nRegardless of whether caloric restriction is considered necessary, nutrition should be optimized.\\nWeight-loss drugs such as sibutramine or fluoxetine are not recommended for the elderly because the\\npossible benefits do not outweigh the adverse effects. However, orlistat may be useful for obese elderly\\npatients, particularly those with diabetes mellitus or hypertension. Surgery is usually best avoided,\\nalthough it has proven efficacy and benefits outweigh risks in carefully selected patients.\\nPrevention\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 6. Obesity & the Metabolic Syndrome\\n114'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 123, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Regular physical activity and healthy eating improve general fitness, can control weight, and help prevent\\nobesity and diabetes mellitus. Even without weight loss, exercise decreases the risk of cardiovascular\\ndisorders. Dietary fiber decreases the risk of colon cancer and cardiovascular disorders. Sufficient and\\ngood-quality sleep, management of stress, and moderation of alcohol intake are also important.\\nBariatric Surgery\\nBariatric surgery is the surgical alteration of the stomach, intestine, or both to cause weight\\nloss.\\nIn the US, bariatric surgery is done over 200,000 times annually, accounting for almost two thirds of all\\nbariatric operations done worldwide. Development of safer laparoscopic approaches has made this\\nsurgery more popular.\\nIndications\\nTo qualify for bariatric surgery, patients should\\n• Have acceptable operative risk\\n• Be well-informed and motivated\\n• Have unsuccessfully tried all reasonable nonsurgical methods to lose weight and manage obesity-'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 123, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Have acceptable operative risk\\n• Be well-informed and motivated\\n• Have unsuccessfully tried all reasonable nonsurgical methods to lose weight and manage obesity-\\nassociated complications\\n• Have a BMI of > 40 kg/m2 or a BMI > 35 kg/m2 plus a serious complication (eg, diabetes, hypertension,\\nobstructive sleep apnea, high-risk lipid profile) that could be expected to be meaningfully reduced with a\\nweight loss of 5 to 10%\\nContraindications include uncontrolled major depression or psychosis, binge eating disorders, current\\ndrug or alcohol abuse, severe coagulopathy, and inability to comply with nutritional requirements,\\nincluding lifelong vitamin replacement (when indicated). Whether bariatric surgery is appropriate for\\npatients < 18 or > 65 yr is controversial.\\nProcedures\\n• Restrictive procedures (adjustable gastric banding, vertical banded gastroplasty)\\n• Malabsorptive procedures (Roux-en-Y gastric bypass)'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 123, 'source_type': 'Authorotative', 'priority': '1'}, page_content='patients < 18 or > 65 yr is controversial.\\nProcedures\\n• Restrictive procedures (adjustable gastric banding, vertical banded gastroplasty)\\n• Malabsorptive procedures (Roux-en-Y gastric bypass)\\nMost procedures can be done laparoscopically, but the approach depends on the type of procedure as\\nwell as patient weight. Morbidity and mortality tend to be lower with laparoscopic than with open surgery.\\nHowever, if patients weigh ≥ 180 kg, open surgery is more likely to be successful. In about 8% of cases\\noverall (fewer with experienced surgeons), surgery begun laparoscopically must be finished as open\\nsurgery.\\nProcedures can be restrictive, malabsorptive, or both.\\nRestrictive procedures: Restrictive procedures limit the volume of the stomach available for ingested\\nfood. This limited volume helps restrict food intake, probably because of earlier satiety. The effects can\\nbe partially defeated by patients who consume more high-calorie liquid foods (eg, milk shakes, alcohol),'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 123, 'source_type': 'Authorotative', 'priority': '1'}, page_content='be partially defeated by patients who consume more high-calorie liquid foods (eg, milk shakes, alcohol),\\nwhich pass through the restricted portion quicker.\\nPurely restrictive procedures include adjustable gastric banding and vertical banded gastroplasty.\\n[\\nFig. 6-1. Adjustable gastric banding.]\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 6. Obesity & the Metabolic Syndrome\\n115'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 124, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Adjustable gastric banding accounts for about 15% of bariatric procedures done in the US; it is much\\nmore common in Europe and is growing in popularity in the US. It is the 2nd most common bariatric\\nprocedure. A band is placed around the upper part of the stomach to divide the stomach into a small\\nupper pouch and a larger lower pouch. Saline can be injected into the band via a subcutaneous access\\nport. When saline is injected, the band expands, decreasing the size of the passageway through the\\nstomach. As a result, the upper pouch fills more quickly, sending a message to the brain that the stomach\\nis full; patients eat smaller meals and lose substantial amounts of weight over time. This procedure is\\nusually done laparoscopically. Saline can be removed to make the passageway larger. Even though\\nweight loss from gastric banding is slightly less than that from Roux-en-Y, morbidity and mortality are\\nmuch less and gastric banding can be reversed if necessary.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 124, 'source_type': 'Authorotative', 'priority': '1'}, page_content='weight loss from gastric banding is slightly less than that from Roux-en-Y, morbidity and mortality are\\nmuch less and gastric banding can be reversed if necessary.\\nVertical banded gastroplasty is no longer commonly done. A stapler is used to divide the stomach into\\na small upper pouch and a larger lower pouch. A nonexpandable plastic band is placed around the\\nopening where the upper pouch empties into the lower pouch.\\nMalabsorptive procedures: Malabsorptive procedures, such as biliopancreatic diversion with a\\nduodenal switch and Roux-en-Y gastric bypass, result in ingested food bypassing parts of the stomach\\nand small intestine, creating malabsorption, which leads to weight loss. These procedures are also\\nrestrictive.\\nRoux-en-Y gastric bypass surgery accounts for about 80% of bariatric procedures in the US. It can\\noften be done laparoscopically. A small part of the proximal stomach is detached from the rest, creating a'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 124, 'source_type': 'Authorotative', 'priority': '1'}, page_content='often be done laparoscopically. A small part of the proximal stomach is detached from the rest, creating a\\nstomach pouch of < 30 mL. Because stomach volume is smaller, satiety occurs earlier. Also, food\\nbypasses part of the stomach and small intestine, where it is normally absorbed, reducing the amount of\\nfood and calories absorbed. The pouch is connected to the proximal jejunum with a narrow opening,\\nproducing even more restriction. The segment of bypassed proximal small intestine (and thus the\\nbypassed stomach) is attached to the distal small intestine, enabling bile acids and pancreatic enzymes to\\nmix with GI contents; this mixing limits malabsorption and nutritional deficiencies. Because a\\ngastrojejunostomy is created, symptoms similar to the dumping-syndrome may occur after high glycemic\\nloads; symptoms (light-headedness, diaphoresis, nausea, abdominal pain, diarrhea) may inhibit the\\nconsumption of such foods by adverse conditioning.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 124, 'source_type': 'Authorotative', 'priority': '1'}, page_content='loads; symptoms (light-headedness, diaphoresis, nausea, abdominal pain, diarrhea) may inhibit the\\nconsumption of such foods by adverse conditioning.\\nBiliopancreatic diversion with a duodenal switch accounts for < 5% of bariatric procedures done in\\nthe US. Part of the stomach is removed, causing restriction. The remaining part empties into the\\nduodenum. The duodenum is cut\\n[\\nFig. 6-2. Roux-en-Y gastric bypass surgery.]\\nand attached to the ileum, bypassing much of the small intestine, including the sphincter of Oddi (where\\nbile acids and pancreatic enzymes enter); malabsorption results. This procedure is technically demanding\\nbut can sometimes be done laparoscopically. Malabsorption and nutritional deficiencies often develop.\\nPreoperative Evaluation\\nEvaluation should determine whether patients have a psychologic commitment to the lifestyle changes\\nand whether operative risks are acceptable. Sleep apnea testing is done.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 124, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Preoperative Evaluation\\nEvaluation should determine whether patients have a psychologic commitment to the lifestyle changes\\nand whether operative risks are acceptable. Sleep apnea testing is done.\\nExtensive preoperative evaluation is probably unnecessary. However, for certain morbidly obese patients\\n(BMI > 50 kg/m2), examining the cardiac, pulmonary, GI, metabolic, and psychologic systems helps\\nidentify patients with acceptable operative risk and helps select the appropriate procedure. For these\\npatients, routine preoperative tests may include\\n• Liver function tests: Increased liver enzymes, especially ALT, are common but do not contraindicate\\nsurgery.\\n• Kidney function tests: If renal blood flow and glomerular filtration rate are increased, proteinuria is\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 6. Obesity & the Metabolic Syndrome\\n116'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 125, 'source_type': 'Authorotative', 'priority': '1'}, page_content='more likely and renal clearance of drugs may be increased. Thus, drug dosages may need to be\\nadjusted.\\n• ECG and echocardiography: These tests are needed because identifying heart failure and pulmonary\\nhypertension clinically in morbidly obese patients is difficult. Signs of heart failure (eg, increased jugular\\nvenous pressure, hepatomegaly, pulmonary crackles) are hard to identify when body fat is excessive.\\nPulmonary hypertension is also difficult to identify because many patients cannot exercise to the point\\nwhere exertional dyspnea, fatigue, or syncope would result. Pulmonary hypertension is diagnosed if\\nechocardiography shows tricuspid regurgitation and ECG shows tall R waves, right axis deviation, and\\nright ventricular strain.\\n• Sleep study: Polysomnography (see p.\\n1706) can confirm obstructive sleep apnea, which is common, and determine its severity. An apnea-\\nhypopnea index of > 30 signals high risk of morbidity and premature death. Obstructive sleep apnea'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 125, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1706) can confirm obstructive sleep apnea, which is common, and determine its severity. An apnea-\\nhypopnea index of > 30 signals high risk of morbidity and premature death. Obstructive sleep apnea\\ndoes not contraindicate surgery but is done to help plan for use of continuous positive airway pressure\\n(CPAP) postoperatively.\\nRisks\\nThe most common perioperative complication is wound infection (in about 3%); the most common late\\ncomplication is anastomotic stomach stenosis (in about 5%).\\nOther early complications include wound infection, incisional hernia, small-bowel obstruction, GI bleeding,\\nventral hernia, deep venous thrombosis, and pneumonia. These complications can cause significant\\nmorbidity, prolong hospitalization, and increase costs.\\nThe most common cause of early (within about 6 wk) postoperative death (in up to 0.5%) is pulmonary\\nembolism, followed by anastomotic leak. Tachycardia may be the only early sign of anastomotic leak.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 125, 'source_type': 'Authorotative', 'priority': '1'}, page_content='The most common cause of early (within about 6 wk) postoperative death (in up to 0.5%) is pulmonary\\nembolism, followed by anastomotic leak. Tachycardia may be the only early sign of anastomotic leak.\\nLess common causes of early postoperative death are MI, pneumonia, and bowel obstruction.\\nLater problems may include prolonged nausea and vomiting secondary to small-bowel obstruction, and\\nanastomotic stenosis. Nutritional deficiencies (eg, protein-energy undernutrition, vitamin B12 deficiency)\\nmay result from inadequate intake, inadequate supplementation, or malabsorption. Malodorous flatulence,\\ndiarrhea, or both may develop, particularly after malabsorptive procedures. Ca and vitamin D absorption\\nmay be impaired, causing deficiencies and sometimes hypocalcemia and secondary hyperparathyroidism.\\nWith prolonged vomiting, thiamin deficiency may occur. After Roux-en-Y gastric bypass, iron deficiency'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 125, 'source_type': 'Authorotative', 'priority': '1'}, page_content='With prolonged vomiting, thiamin deficiency may occur. After Roux-en-Y gastric bypass, iron deficiency\\nmay result. Patients may have symptoms of reflux, especially after biliopancreatic diversion with a\\nduodenal switch. After rapid weight loss, cholelithiasis may develop.\\nEating habits may be disordered. Adjusting to new eating habits can be difficult.\\nPrognosis\\nOverall, 30-day postoperative risk of death is 0.2 to 1%. Risk is higher in elderly patients and in patients\\nwho have had an open procedure, who are extremely morbidly obese (> 50 kg), or who have established\\norgan failure. Risk of death may be lowest with laparoscopic adjustable gastric banding. Risk of death is\\nalmost 3 times higher in hospitals that do < 50 of these procedures/yr than in those that do >150\\nprocedures/yr. The American Society of Bariatric Surgery may designate hospitals with better results as a\\nCenter of Excellence, based on resources and excellent short- and long-term outcomes.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 125, 'source_type': 'Authorotative', 'priority': '1'}, page_content='procedures/yr. The American Society of Bariatric Surgery may designate hospitals with better results as a\\nCenter of Excellence, based on resources and excellent short- and long-term outcomes.\\nIn most patients, comorbidities (eg, insulin insensitivity, dyslipidemias, hypertension, obstructive sleep\\napnea, polycystic ovary syndrome, nonalcoholic steatohepatitis) tend to resolve.\\nAverage loss of excess weight (real weight minus ideal weight) is about 60%, or about 40 to 60 kg in most\\npatients. Depending on the procedure, excess weight loss can vary between 50% and 70%; loss tends to\\nbe lower with gastric banding and somewhat higher with Roux-en-Y gastric bypass. In many patients,\\nweight loss, although initially rapid, plateaus after about 2 yr; then patients may slowly regain weight.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 6. Obesity & the Metabolic Syndrome\\n117'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 126, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Mood and work and personal relationships usually improve.\\nLong-term follow-up data are not yet available because these procedures are relatively new.\\nFollow-up\\nPatients should be monitored every 4 to 6 wk while weight loss is rapid (usually about the first 6 mo after\\nsurgery), then every 6 to 12 mo. Weight and BP are checked, and eating habits are reviewed. Blood tests\\n(usually CBC, electrolytes, glucose, BUN, creatinine, albumin, and protein) and liver function tests are\\ndone at each visit. If alkaline phosphatase is increased, parathyroid hormone level is measured; if\\nparathyroid hormone level is abnormal, bone density is monitored. If weight loss exceeds about 9 kg (20\\nlb)/mo, visits should be scheduled at least monthly, and blood tests should include Mg, phosphorus,\\nvitamin B12, and iron levels. Nutritional supplementation is sometimes necessary.\\nMetabolic Syndrome\\nMetabolic syndrome (syndrome X, insulin resistance syndrome) is characterized by a clustering'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 126, 'source_type': 'Authorotative', 'priority': '1'}, page_content='vitamin B12, and iron levels. Nutritional supplementation is sometimes necessary.\\nMetabolic Syndrome\\nMetabolic syndrome (syndrome X, insulin resistance syndrome) is characterized by a clustering\\nof risk factors for cardiovascular disease and type 2 diabetes mellitus. They commonly include\\nexcess intra-abdominal fat, insulin resistance, and ≥ 1 of the following: elevated serum\\ntriglyceride levels, decreased high-density lipoprotein (HDL) cholesterol level, and\\nhypertension. Causes, complications, diagnosis, and treatment are similar to those of obesity.\\nIn developed countries, metabolic syndrome is a serious problem. It is very common; in the US, > 40% of\\npeople > 50 yr may have it. Children and adolescents can develop\\n[\\nTable 6-3. Criteria Often Used for Diagnosis of Metabolic Syndrome*]\\nmetabolic syndrome, but in these age groups, no definition is established.\\nDevelopment of metabolic syndrome depends on distribution as well as amount of fat. Excess fat in the'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 126, 'source_type': 'Authorotative', 'priority': '1'}, page_content='metabolic syndrome, but in these age groups, no definition is established.\\nDevelopment of metabolic syndrome depends on distribution as well as amount of fat. Excess fat in the\\nabdomen (called apple shape), particularly when it results in a high waist-to-hip ratio (reflecting a\\nrelatively low muscle-to-fat mass ratio), increases risk. The syndrome is less common among people who\\nhave excess subcutaneous fat around the hips (called pear shape) and a low waist-to-hip ratio (reflecting\\na higher muscle-to-fat mass ratio).\\nExcess abdominal fat leads to excess free fatty acids in the portal vein, increasing fat accumulation in the\\nliver. Fat also accumulates in muscle cells. Insulin resistance develops, with hyperinsulinemia. Glucose\\nmetabolism is impaired, and dyslipidemias and hypertension develop. Serum uric acid levels are typically\\nelevated, and a prothrombotic state (with increased levels of fibrinogen and plasminogen activator'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 126, 'source_type': 'Authorotative', 'priority': '1'}, page_content='elevated, and a prothrombotic state (with increased levels of fibrinogen and plasminogen activator\\ninhibitor I) and an inflammatory state develop. Patients have an increased risk of obstructive sleep apnea.\\nOther risks include nonalcoholic steatohepatitis, chronic kidney disease, polycystic ovary syndrome (for\\nwomen), and low serum testosterone, erectile dysfunction, or both (for men).\\nDiagnosis\\n• Waist circumference and BP\\n• Fasting plasma glucose and a lipid profile\\nScreening is important. A family history plus measurement of waist circumference and BP are part of\\nroutine care. If patients with a family history of type 2 diabetes mellitus, particularly those ≥ 40 yr, have a\\nwaist circumference greater than that recommended for race and sex, fasting plasma glucose and a lipid\\nprofile must be determined.\\nMetabolic syndrome has many different definitions, but it is most often diagnosed when ≥ 3 of the'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 126, 'source_type': 'Authorotative', 'priority': '1'}, page_content='profile must be determined.\\nMetabolic syndrome has many different definitions, but it is most often diagnosed when ≥ 3 of the\\nfollowing are present: excess abdominal fat, a high fasting plasma glucose level, hypertension, a high\\ntriglyceride level, and a low HDL cholesterol level (see Table 6-3).\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 6. Obesity & the Metabolic Syndrome\\n118'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 127, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Treatment\\n• Healthy diet and exercise\\n• Sometimes metformin\\n• Management of cardiovascular risk factors\\nOptimally, the management approach results in weight loss based on a healthy diet and regular physical\\nactivity, which includes a combination of aerobic activity and resistance training, reinforced with\\nbehavioral therapy. Metformin, an insulin sensitizer, may be useful. Weight loss of ≈ 7% may be sufficient\\nto reverse the syndrome, but if not, each feature of the syndrome should be managed to achieve\\nrecommended targets; available drug treatment is very effective.\\nOther cardiovascular risk factors (eg, smoking cessation) also need to be managed. Increased physical\\nactivity has cardiovascular benefits even if weight is not lost.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 6. Obesity & the Metabolic Syndrome\\n119'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 128, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2 - Gastrointestinal Disorders\\nChapter 7. Approach to the Patient With Upper GI Complaints\\nIntroduction\\nUpper GI complaints include chest pain (see p. 2025), chronic and recurrent abdominal pain, dyspepsia,\\nlump in the throat, halitosis (see p. 506), hiccups, nausea and vomiting, and rumination. Some upper GI\\ncomplaints represent functional illness (ie, no physiologic cause found after extensive evaluation).\\nHistory: Using open-ended, interview-style questions, the physician identifies the location and quality of\\nsymptoms and any aggravating and alleviating factors. Psychologic stress factors must be specifically\\nsought. Because a psychiatric disorder does not preclude physiologic disease, the significance of vague,\\ndramatic, or bizarre complaints should not be minimized.\\nPatients report symptoms differently depending on their personality, the impact of the illness on their life,\\nand sociocultural influences. For example, nausea and vomiting may be minimized or reported indirectly'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 128, 'source_type': 'Authorotative', 'priority': '1'}, page_content='and sociocultural influences. For example, nausea and vomiting may be minimized or reported indirectly\\nby a severely depressed patient but presented with dramatic urgency by a histrionic one.\\nPhysical examination: Inspection of the abdomen with the patient supine may show a convex\\nappearance when bowel obstruction, ascites, or, rarely, a large mass is present. Auscultation to assess\\nbowel sounds and determine presence of bruits should follow. Percussion elicits hyperresonance\\n(tympany) in the presence of bowel obstruction and dullness with ascites and can determine the span of\\nthe liver. Palpation proceeds systematically, beginning gently to identify areas of tenderness and, if\\ntolerated, palpating deeper to locate masses or organomegaly. Digital rectal examination with testing for\\noccult blood and (in women) pelvic examination complete the evaluation of the abdomen.\\nTesting: Patients with acute, nonspecific symptoms (eg, dyspepsia, nausea) and an unremarkable'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 128, 'source_type': 'Authorotative', 'priority': '1'}, page_content='occult blood and (in women) pelvic examination complete the evaluation of the abdomen.\\nTesting: Patients with acute, nonspecific symptoms (eg, dyspepsia, nausea) and an unremarkable\\nphysical examination rarely require testing. Findings suggesting significant disease (alarm symptoms)\\nshould prompt further evaluation:\\n• Anorexia\\n• Anemia\\n• Blood in stool (gross or occult)\\n• Dysphagia\\n• Fever\\n• Hepatomegaly\\n• Pain that awakens patient\\n• Persistent nausea and vomiting\\n• Weight loss\\nChronic or recurrent symptoms, even with an unremarkable examination, also warrant evaluation. Specific\\nGI tests are discussed in Ch. 9.\\nChronic and Recurrent Abdominal Pain\\nChronic abdominal pain (CAP) persists for more than 3 mo either continuously or intermittently.\\nIntermittent pain may be referred to as recurrent abdominal pain (RAP). Acute abdominal pain is\\ndiscussed on p. 105. CAP occurs any time after 5 yr of age. Up to 10% of children require evaluation for'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 128, 'source_type': 'Authorotative', 'priority': '1'}, page_content='discussed on p. 105. CAP occurs any time after 5 yr of age. Up to 10% of children require evaluation for\\nRAP. About 2% of adults, predominantly women, have CAP (a much higher percentage of adults have\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 7. Approach to the Patient With Upper GI Complaints\\n120'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 129, 'source_type': 'Authorotative', 'priority': '1'}, page_content='some type of chronic GI symptoms, including nonulcer dyspepsia and various bowel disturbances).\\nNearly all patients with CAP have had prior medical evaluation that did not yield a diagnosis after history,\\nphysical, and basic testing.\\nPathophysiology\\nFunctional abdominal pain syndrome (FAPS) is pain that persists > 6 mo without evidence of physiologic\\ndisease, shows no relationship to physiologic events (eg, meals, defecation, menses), and interferes with\\ndaily functioning. FAPS is poorly understood but seems to involve altered nociception. Sensory neurons\\nin the dorsal horn of the spinal cord may become abnormally excitable and hyperalgesic due to a\\ncombination of factors. Cognitive and psychologic factors (eg, depression, stress, culture, secondary\\ngain, coping and support mechanisms) may cause efferent stimulation that amplifies pain signals,\\nresulting in perception of pain with low level inputs and persistence of pain long after the stimulus has'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 129, 'source_type': 'Authorotative', 'priority': '1'}, page_content='resulting in perception of pain with low level inputs and persistence of pain long after the stimulus has\\nceased. Additionally, the pain itself may function as a stressor, perpetuating a positive feedback loop.\\nIn addition, menopause increases GI symptoms in several disorders including irritable bowel syndrome,\\ninflammatory bowel disease, endometriosis, and nonulcer dyspepsia.\\nEtiology\\nPerhaps 10% of patients have an occult physiologic illness (see\\nTable 7-1); the remainder have a functional process. However, determining whether a particular\\nabnormality (eg, adhesions, ovarian cyst, endometriosis) is the cause of CAP symptoms or an incidental\\nfinding can be difficult.\\nEvaluation\\nHistory: History of present illness should elicit pain location, quality, duration, timing and frequency of\\nrecurrence, and factors that worsen or relieve pain (particularly eating or moving bowels). A specific'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 129, 'source_type': 'Authorotative', 'priority': '1'}, page_content='recurrence, and factors that worsen or relieve pain (particularly eating or moving bowels). A specific\\ninquiry as to whether milk and milk products cause abdominal cramps, bloating, or distention is needed,\\nbecause lactose intolerance is common, especially among blacks.\\nReview of systems seeks concomitant GI symptoms such as gastroesophageal reflux, anorexia,\\nbloating or \"gas,\" nausea, vomiting, jaundice, melena, hematuria, hematemesis, weight loss, and mucus\\nor blood in the stool. Bowel symptoms, such as diarrhea, constipation, and changes in stool consistency,\\ncolor, or elimination pattern, are particularly important.\\nIn adolescents, a diet history is important because ingestion of large amounts of cola beverages and fruit\\njuices (which may contain significant quantities of fructose and sorbitol) can account for otherwise\\npuzzling abdominal pain.\\nPast medical history should include nature and timing of any abdominal surgery and the results of'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 129, 'source_type': 'Authorotative', 'priority': '1'}, page_content='puzzling abdominal pain.\\nPast medical history should include nature and timing of any abdominal surgery and the results of\\nprevious tests that have been done and treatments that have been tried. A drug history should include\\ndetails concerning prescription and illicit drug use as well as alcohol.\\nFamily history of RAP, fevers, or both should be ascertained, as well as known diagnoses of sickle cell\\ntrait or disease, familial Mediterranean fever, and porphyria.\\nPhysical examination: Review of vital signs should particularly note presence of fever or tachycardia.\\nGeneral examination should seek presence of jaundice, skin rash, and peripheral edema. Abdominal\\nexamination should note areas of tenderness, presence of peritoneal findings (eg, guarding, rigidity,\\nrebound), and any masses or organomegaly. Rectal examination and (in women) pelvic examination to\\nlocate tenderness, masses, and blood are essential.\\nRed flags: The following findings are of particular concern:'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 129, 'source_type': 'Authorotative', 'priority': '1'}, page_content='locate tenderness, masses, and blood are essential.\\nRed flags: The following findings are of particular concern:\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 7. Approach to the Patient With Upper GI Complaints\\n121'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 130, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Fever\\n• Anorexia, weight loss\\n• Pain that awakens patient\\n• Blood in stool or urine\\n• Jaundice\\n• Edema\\n• Abdominal mass or organomegaly\\nInterpretation of findings: Clinical examination alone infrequently provides a firm diagnosis.\\nDetermining whether CAP is physiologic or functional can be difficult. Although the presence of red flag\\nfindings indicates a high likelihood of a physiologic cause, their absence does not rule it out. Other hints\\nare that physiologic causes usually cause pain that is well localized, especially to areas other than the\\nperiumbilical region. Pain that wakes the patient is usually physiologic. Some findings suggestive of\\nspecific disorders are listed in Table 7-1.\\nFunctional CAP may result in pain similar to that of physiologic origin. However, there are no associated\\nred flag findings, and psychosocial features are often prominent. A history of physical or sexual abuse or'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 130, 'source_type': 'Authorotative', 'priority': '1'}, page_content='red flag findings, and psychosocial features are often prominent. A history of physical or sexual abuse or\\nan unresolved loss (eg, divorce, miscarriage, or death of a family member) may be a clue.\\nThe Rome criteria for diagnosis of irritable bowel syndrome are the presence of abdominal pain or\\ndiscomfort for at least 3 days/mo in the last 3 mo along with at least 2 of the following: (1) improvement\\nwith defecation; (2) onset (of each episode of discomfort) associated with a change in frequency of\\ndefecation; and (3) change in consistency of stool.\\nTesting: In general, simple tests (including urinalysis, CBC, liver tests, ESR, amylase, and lipase) should\\nbe done. Abnormalities in these tests, the presence of red flag findings, or specific clinical findings\\nmandate further testing, even if previous assessments have been negative. Specific tests depend on the\\nfindings (see Table 7-1) but typically include CT of the abdomen and pelvis with contrast, upper GI'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 130, 'source_type': 'Authorotative', 'priority': '1'}, page_content='findings (see Table 7-1) but typically include CT of the abdomen and pelvis with contrast, upper GI\\nendoscopy or colonoscopy, and perhaps small-bowel x-rays or stool testing.\\nThe benefits of testing patients with no red flag findings are unclear. Those > 50 should probably have a\\ncolonoscopy; those ≤ 50 can be observed or have CT of the abdomen and pelvis with contrast if an\\nimaging study is desired. Magnetic resonance cholangiopancreatography (MRCP), ERCP, and\\nlaparoscopy are rarely helpful in the absence of specific indications.\\nBetween the initial evaluation and the follow-up visit, the patient (or family, if the patient is a child) should\\nrecord any pain, including\\n[Table 7-1. Physiologic Causes of Chronic Abdominal Pain]\\nits nature, intensity, duration, and precipitating factors. Diet, defecation pattern, and any remedies tried\\n(and the results obtained) should also be recorded. This record may reveal inappropriate behavior'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 130, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(and the results obtained) should also be recorded. This record may reveal inappropriate behavior\\npatterns and exaggerated responses to pain or otherwise suggest a diagnosis.\\nTreatment\\nPhysiologic conditions are treated.\\nIf the diagnosis of functional CAP is made, frequent examinations and tests should be avoided because\\nthey may focus on or magnify the physical complaints or imply that the physician lacks confidence in the\\ndiagnosis.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 7. Approach to the Patient With Upper GI Complaints\\n122'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 131, 'source_type': 'Authorotative', 'priority': '1'}, page_content='There are no modalities to cure functional CAP; however, many helpful measures are available. These\\nmeasures rest on a foundation of a trusting, empathic relationship among the physician, patient, and\\nfamily. Patients should be reassured that they are not in danger; specific concerns should be sought and\\naddressed. The physician should explain the laboratory findings and the nature of the problem and\\ndescribe how the pain is generated and how the patient perceives it (ie, that there is a constitutional\\ntendency to feel pain at times of stress). It is important to avoid perpetuating the negative psychosocial\\nconsequences of chronic pain (eg, prolonged absences from school or work, withdrawal from social\\nactivities) and to promote independence, social participation, and self-reliance. These strategies help the\\npatient control or tolerate the symptoms while participating fully in everyday activities.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 131, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"activities) and to promote independence, social participation, and self-reliance. These strategies help the\\npatient control or tolerate the symptoms while participating fully in everyday activities.\\nDrugs such as aspirin, NSAIDs, H2 receptor blockers, proton pump inhibitors, and tricyclic\\nantidepressants can be effective. Opioids should be avoided because they invariably lead to dependency.\\nCognitive methods (eg, relaxation training, biofeedback, hypnosis) may help by contributing to the\\npatient's sense of well-being and control. Regular follow-up visits should be scheduled weekly, monthly, or\\nbimonthly, depending on the patient's needs, and should continue until well after the problem has\\nresolved. Psychiatric referral may be required if symptoms persist, especially if the patient is depressed\\nor there are significant psychologic difficulties in the family.\\nSchool personnel should become involved for children who have CAP. Children can rest briefly in the\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 131, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"or there are significant psychologic difficulties in the family.\\nSchool personnel should become involved for children who have CAP. Children can rest briefly in the\\nnurse's office during the school day, with the expectation that they return to class after 15 to 30 min. The\\nschool nurse can be authorized to dispense a mild analgesic (eg, acetaminophen). The nurse can\\nsometimes allow the child to call a parent, who should encourage the child to stay in school. However,\\nonce parents stop treating their child as special or ill, the symptoms may worsen before they abate.\\nKey Points\\n• Most cases represent a functional process.\\n• Red flag findings indicate a physiologic cause and need for further assessment.\\n• Testing is guided by clinical features.\\n• Repeated testing after physiologic causes are ruled out is usually counterproductive.\\nDyspepsia\\nDyspepsia is a sensation of pain or discomfort in the upper abdomen; it often is recurrent. It may be\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 131, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Repeated testing after physiologic causes are ruled out is usually counterproductive.\\nDyspepsia\\nDyspepsia is a sensation of pain or discomfort in the upper abdomen; it often is recurrent. It may be\\ndescribed as indigestion, gassiness, early satiety, postprandial fullness, gnawing, or burning.\\nEtiology\\nThere are several common causes of dyspepsia (see\\nTable 7-2).\\nMany patients have findings on testing (eg, duodenitis, pyloric dysfunction, motility disturbance,\\nHelicobacter pylori  gastritis, lactose deficiency, cholelithiasis) that correlate poorly with symptoms (ie,\\ncorrection of the condition does not alleviate dyspepsia).\\nNonulcer (functional) dyspepsia is defined as dyspeptic symptoms in a patient who has no\\nabnormalities on physical examination and upper GI endoscopy.\\nEvaluation\\nHistory: History of present illness should elicit a clear description of the symptoms, including whether'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 131, 'source_type': 'Authorotative', 'priority': '1'}, page_content='abnormalities on physical examination and upper GI endoscopy.\\nEvaluation\\nHistory: History of present illness should elicit a clear description of the symptoms, including whether\\nthey are acute or chronic and recurrent. Other elements include timing and frequency of recurrence, any\\ndifficulty swallowing, and relationship of symptoms to eating or taking drugs. Factors that worsen\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 7. Approach to the Patient With Upper GI Complaints\\n123'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 132, 'source_type': 'Authorotative', 'priority': '1'}, page_content='symptoms (particularly exertion, certain foods or alcohol) or relieve them (particularly eating or taking\\nantacids) are noted.\\nReview of systems seeks concomitant GI symptoms such as anorexia, nausea, vomiting, hematemesis,\\nweight loss, and bloody or black (melanotic) stools. Other symptoms include dyspnea and diaphoresis.\\nPast medical history should include known GI and cardiac diagnoses, cardiac risk factors (eg,\\nhypertension, hypercholesterolemia), and the results of previous tests that have been done and\\ntreatments that have been tried. Drug history should include prescription and illicit drug use as well as\\nalcohol.\\nPhysical examination: Review of vital signs should note presence of tachycardia or irregular pulse.\\nGeneral examination should note presence of pallor or diaphoresis, cachexia, or jaundice. Abdomen is\\npalpated for tenderness, masses, and organomegaly. Rectal examination is done to detect gross or occult\\nblood.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 132, 'source_type': 'Authorotative', 'priority': '1'}, page_content='palpated for tenderness, masses, and organomegaly. Rectal examination is done to detect gross or occult\\nblood.\\nRed flags: The following findings are of particular concern:\\n[Table 7-2. Some Causes of Dyspepsia]\\n• Acute episode with dyspnea, diaphoresis, or tachycardia\\n• Anorexia\\n• Nausea or vomiting\\n• Weight loss\\n• Blood in the stool\\n• Dysphagia or odynophagia\\n• Failure to respond to therapy with H2 blockers or proton pump inhibitors (PPIs)\\nInterpretation of findings: Some findings are helpful (see Table 7-2).\\nA patient presenting with a single, acute episode of dyspepsia is of concern, particularly if symptoms are\\naccompanied by dyspnea, diaphoresis, or tachycardia; such patients may have acute coronary ischemia.\\nChronic symptoms that occur with exertion and are relieved by rest may represent angina.\\nGI causes are most likely to manifest as chronic complaints. Symptoms are sometimes classified as ulcer-'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 132, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chronic symptoms that occur with exertion and are relieved by rest may represent angina.\\nGI causes are most likely to manifest as chronic complaints. Symptoms are sometimes classified as ulcer-\\nlike, dysmotility-like, or reflux-like; these classifications suggest but do not confirm an etiology. Ulcer-like\\nsymptoms consist of pain that is localized in the epigastrium, frequently occurs before meals, and is\\npartially relieved by food, antacids, or H2 blockers. Dysmotility-like symptoms consist of discomfort rather\\nthan pain, along with early satiety, postprandial fullness, nausea, vomiting, bloating, and symptoms that\\nare worsened by food. Reflux-like symptoms consist of heartburn or acid regurgitation. However,\\nsymptoms often overlap.\\nAlternating constipation and diarrhea with dyspepsia suggests irritable bowel syndrome or excessive use\\nof OTC laxatives or antidiarrheals.\\n[\\nTable 7-3. Some Oral Drugs for Dyspepsia]'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 132, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Alternating constipation and diarrhea with dyspepsia suggests irritable bowel syndrome or excessive use\\nof OTC laxatives or antidiarrheals.\\n[\\nTable 7-3. Some Oral Drugs for Dyspepsia]\\nTesting: Patients in whom symptoms suggest acute coronary ischemia, particularly those with risk\\nfactors, should be sent to the emergency department for urgent evaluation, including ECG and serum\\ncardiac markers.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 7. Approach to the Patient With Upper GI Complaints\\n124'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 133, 'source_type': 'Authorotative', 'priority': '1'}, page_content='For patients with chronic, nonspecific symptoms, routine tests include CBC (to exclude anemia caused by\\nGI blood loss) and routine blood chemistries. If results are abnormal, additional tests (eg, imaging studies,\\nendoscopy) should be considered. Because of the risk of cancer, patients > 45 and those with new-onset\\nred flag findings should undergo upper GI endoscopy. For patients < 45 with no red flag findings, some\\nauthorities recommend empiric therapy for 2 to 4 wk with antisecretory agents followed by endoscopy in\\ntreatment failures. Others recommend screening for H. pylori infection with a C14-urea breath test or\\nstool assay (see p. 129). However, caution is required in using H. pylori or any other nonspecific findings\\nto explain symptoms.\\nEsophageal manometry and pH studies are indicated if reflux symptoms persist after upper GI endoscopy\\nand a 2- to 4-wk trial with a PPI.\\nTreatment'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 133, 'source_type': 'Authorotative', 'priority': '1'}, page_content='to explain symptoms.\\nEsophageal manometry and pH studies are indicated if reflux symptoms persist after upper GI endoscopy\\nand a 2- to 4-wk trial with a PPI.\\nTreatment\\nSpecific conditions are treated. Patients without identifiable conditions are observed over time and\\nreassured. Symptoms are treated with PPIs, H2 blockers, or a cytoprotective agent (see Table 7-3).\\nProkinetic drugs (eg, metoclopramide, erythromycin) given as a liquid suspension also may be tried in\\npatients with dysmotility-like dyspepsia. However, there is no clear evidence that matching the drug class\\nto the specific symptoms (eg, reflux vs dysmotility) makes a difference. Misoprostol and anticholinergics\\nare not effective in functional dyspepsia. Drugs that alter sensory perception (eg, tricyclic\\nantidepressants) may be helpful.\\nKey Points\\n• Coronary ischemia is possible in a patient with acute \"gas.\"\\n• Endoscopy is indicated for those > 45 or with red flag findings.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 133, 'source_type': 'Authorotative', 'priority': '1'}, page_content='antidepressants) may be helpful.\\nKey Points\\n• Coronary ischemia is possible in a patient with acute \"gas.\"\\n• Endoscopy is indicated for those > 45 or with red flag findings.\\n• Empiric treatment with an acid blocker is reasonable for those < 45 without red flag findings. Those who\\ndo not respond in 2 to 4 wk require further evaluation.\\nHiccups\\nHiccups (hiccough, singultus) are repeated involuntary spasms of the diaphragm followed by sudden\\nclosure of the glottis, which checks the inflow of air and causes the characteristic sound. Transient\\nepisodes are very common. Persistent (> 2 days) and intractable (> 1 mo) hiccups are uncommon but\\nquite distressing.\\nEtiology\\nHiccups follow irritation of afferent or efferent diaphragmatic nerves or of medullary centers that control\\nthe respiratory muscles, particularly the diaphragm. Hiccups are more common among men.\\nCause is generally unknown, but transient hiccups are often caused by the following:\\n• Gastric distention\\n• Alcohol consumption'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 133, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Cause is generally unknown, but transient hiccups are often caused by the following:\\n• Gastric distention\\n• Alcohol consumption\\n• Swallowing hot or irritating substances\\nPersistent and intractable hiccups have myriad causes (see\\nTable 7-4).\\nEvaluation\\nHistory: History of present illness should note duration of hiccups, remedies tried, and relationship of\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 7. Approach to the Patient With Upper GI Complaints\\n125'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 134, 'source_type': 'Authorotative', 'priority': '1'}, page_content='onset to recent illness or surgery.\\nReview of systems seeks concomitant GI symptoms such as gastroesophageal reflux and swallowing\\ndifficulties; thoracic symptoms such as cough, fever, or chest pain; and any neurologic symptoms.\\nPast medical history should query known GI and neurologic disorders. A drug history should include\\ndetails concerning alcohol use.\\nPhysical examination: Examination is usually unrewarding but should seek signs of chronic disease\\n(eg, cachexia). A full neurologic examination is important.\\nRed flags: The following is of particular concern:\\n• Neurologic symptoms or signs\\nInterpretation of findings: Few findings are specific. Hiccups after alcohol consumption or surgery may\\nwell be related to those events. Other possible causes (see Table 7-4) are both numerous and rarely a\\ncause of hiccups.\\nTesting: No specific evaluation is required for acute hiccups if routine history and physical examination\\nare unremarkable; abnormalities are pursued with appropriate testing.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 134, 'source_type': 'Authorotative', 'priority': '1'}, page_content='cause of hiccups.\\nTesting: No specific evaluation is required for acute hiccups if routine history and physical examination\\nare unremarkable; abnormalities are pursued with appropriate testing.\\nPatients with hiccups of longer duration and no obvious cause should have testing, probably including\\nserum electrolytes, BUN and creatinine, chest x-ray, and ECG. Upper GI endoscopy and perhaps\\nesophageal pH monitoring should be considered. If these are unremarkable, brain MRI and chest CT may\\nbe done.\\n[Table 7-4. Some Causes of Intractable Hiccups]\\nTreatment\\nIdentified problems are treated (eg, proton pump inhibitors for gastroesophageal reflux disease, dilation\\nfor esophageal stricture).\\nFor symptom relief, many simple measures can be tried, although none are more than slightly effective:\\nPaCO2 can be increased and diaphragmatic activity can be inhibited by a series of deep breath-holds or\\nby breathing deeply in to and out of a paper bag. (CAUTION: Plastic bags can cling to the nostrils and'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 134, 'source_type': 'Authorotative', 'priority': '1'}, page_content='by breathing deeply in to and out of a paper bag. (CAUTION: Plastic bags can cling to the nostrils and\\nshould not be used.) Vagal stimulation by pharyngeal irritation (eg, swallowing dry bread, granulated\\nsugar, or crushed ice; applying traction on the tongue; stimulating gagging) may work. Numerous other\\nfolk remedies exist.\\nPersistent hiccups are often recalcitrant to treatment. Many drugs have been used in anecdotal series.\\nBaclofen, a γ-aminobutyric acid agonist (5 mg po q 6 h increasing to 20 mg/dose), may be effective. Other\\ndrugs include chlorpromazine 10 to 50 mg po tid as needed, metoclopramide 10 mg po bid to qid, and\\nvarious anticonvulsants (eg, gabapentin). Additionally, an empiric trial of proton pump inhibitors may be\\ngiven. For severe symptoms, chlorpromazine 25 to 50 mg IM or IV can be given. In intractable cases, the\\nphrenic nerve may be blocked by small amounts of 0.5% procaine solution, with caution being taken to'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 134, 'source_type': 'Authorotative', 'priority': '1'}, page_content='phrenic nerve may be blocked by small amounts of 0.5% procaine solution, with caution being taken to\\navoid respiratory depression and pneumothorax. Even bilateral phrenicotomy does not cure all cases.\\nKey Points\\n• The cause is usually unknown.\\n• Rarely, a serious disorder is present.\\n• Evaluation is typically unrewarding but should be pursued for hiccups of long duration.\\n• Numerous remedies exist, none with clear superiority (or perhaps even effectiveness).\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 7. Approach to the Patient With Upper GI Complaints\\n126'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 135, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Lump in Throat\\nLump in the throat (globus sensation, globus hystericus) is the sensation of a lump or mass in the throat,\\nunrelated to swallowing, when no mass is present. (If a mass is present, see p.\\n461.)\\nEtiology\\nNo specific etiology or physiologic mechanism has been established. Some studies suggest that elevated\\ncricopharyngeal (upper esophageal sphincter) pressure or abnormal hypopharyngeal motility occur during\\nthe time of symptoms. The sensation may also result from gastroesophageal reflux disease (GERD) or\\nfrom frequent swallowing and drying of the throat associated with anxiety or another emotional state.\\nAlthough not associated with stress factors or a specific psychiatric disorder, globus sensation may be a\\nsymptom of certain mood states (eg, grief, pride); some patients may have a predisposition to this\\nresponse.\\nDisorders that can be confused with globus sensation include cricopharyngeal (upper esophageal) webs,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 135, 'source_type': 'Authorotative', 'priority': '1'}, page_content='response.\\nDisorders that can be confused with globus sensation include cricopharyngeal (upper esophageal) webs,\\nsymptomatic diffuse esophageal spasm, GERD, skeletal muscle disorders (eg, myasthenia gravis,\\nmyotonia dystrophica, polymyositis), and mass lesions in the neck or mediastinum that cause esophageal\\ncompression.\\nEvaluation\\nThe main goal is to distinguish globus sensation from true dysphagia (see p. 120), which suggests a\\nstructural or motor disorder of the pharynx or esophagus.\\nHistory: History of present illness should elicit a clear description of the symptom, particularly as to\\nwhether there is any pain with swallowing, difficulty swallowing (including sensation of food sticking).\\nTiming of symptoms is important, particularly whether it occurs with eating or drinking or is independent of\\nthose activities; association with emotional events should be queried specifically.\\nReview of systems seeks weight loss (as evidence of a swallowing disorder) and symptoms of muscle'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 135, 'source_type': 'Authorotative', 'priority': '1'}, page_content='those activities; association with emotional events should be queried specifically.\\nReview of systems seeks weight loss (as evidence of a swallowing disorder) and symptoms of muscle\\nweakness.\\nPast medical history should include known neurologic diagnoses, particularly those causing weakness.\\nPhysical examination: The neck and floor of the mouth are palpated for masses. The oropharynx is\\ninspected (including by direct laryngoscopy). Swallowing (of water and a solid food such as crackers)\\nshould be observed. Neurologic examination with particular attention to motor function is important.\\nRed flags: The following findings are of particular concern:\\n• Neck or throat pain\\n• Weight loss\\n• Abrupt onset after age 50\\n• Pain, choking, or difficulty with swallowing\\n• Regurgitation of food\\n• Muscle weakness\\n• Palpable or visible mass\\n• Progressive worsening of symptoms\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 7. Approach to the Patient With Upper GI Complaints\\n127'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 136, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Interpretation of findings: Symptoms unrelated to swallowing, with no pain or difficulty with swallowing,\\nor sensation of food sticking in the throat in a patient with a normal examination imply globus sensation.\\nAny red flag findings or abnormal findings on examination suggest a mechanical or motor disorder of\\nswallowing. Chronic symptoms that occur during unresolved or pathologic grief and that may be relieved\\nby crying suggest globus sensation.\\nTesting: Those with findings typical of globus sensation need no testing. If the diagnosis is unclear or the\\nclinician cannot adequately visualize the pharynx, testing as for dysphagia is done. Typical tests include\\nplain or video esophagography, measurement of swallowing time, chest x-ray, and esophageal\\nmanometry.\\nTreatment\\nTreatment involves reassurance and sympathetic concern. No drug is of proven benefit. Underlying\\ndepression, anxiety, or other behavioral disturbances should be managed supportively, with psychiatric'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 136, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Treatment involves reassurance and sympathetic concern. No drug is of proven benefit. Underlying\\ndepression, anxiety, or other behavioral disturbances should be managed supportively, with psychiatric\\nreferral if necessary. At times, communicating to the patient the association between symptoms and mood\\nstate can be beneficial.\\nKey Points\\n• Globus symptoms are unrelated to swallowing.\\n• Tests are not needed unless symptoms are related to swallowing, examination is abnormal, or there are\\nred flag findings.\\nNausea and Vomiting\\n(For nausea and vomiting in infants and children, see p. 2746.)\\nNausea, the unpleasant feeling of needing to vomit, represents awareness of afferent stimuli (including\\nincreased parasympathetic tone) to the medullary vomiting center. Vomiting is the forceful expulsion of\\ngastric contents caused by involuntary contraction of the abdominal musculature when the gastric fundus\\nand lower esophageal sphincter are relaxed.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 136, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"gastric contents caused by involuntary contraction of the abdominal musculature when the gastric fundus\\nand lower esophageal sphincter are relaxed.\\nVomiting should be distinguished from regurgitation, the spitting up of gastric contents without associated\\nnausea or forceful abdominal muscular contractions. Patients with achalasia or a Zenker's diverticulum\\nmay regurgitate undigested food without nausea.\\nComplications: Severe vomiting can lead to symptomatic dehydration and electrolyte abnormalities\\n(typically a metabolic alkalosis with hypokalemia) or rarely to an esophageal tear, either partial (Mallory-\\nWeiss) or complete (Boerhaave's syndrome). Chronic vomiting can result in undernutrition, weight loss,\\nand metabolic abnormalities.\\nEtiology\\nNausea and vomiting occur in response to conditions that affect the vomiting center. Causes may\\noriginate in the GI tract or CNS or may result from a number of systemic conditions (see\\nTable 7-5).\\nThe most common causes are the following:\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 136, 'source_type': 'Authorotative', 'priority': '1'}, page_content='originate in the GI tract or CNS or may result from a number of systemic conditions (see\\nTable 7-5).\\nThe most common causes are the following:\\n• Gastroenteritis\\n• Drugs\\n• Toxins\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 7. Approach to the Patient With Upper GI Complaints\\n128'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 137, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Cyclic vomiting syndrome is an uncommon disorder characterized by severe, discrete attacks of vomiting\\nor sometimes only nausea that occur at varying intervals, with normal health between episodes. It is most\\ncommon in childhood (mean age of onset 5 yr) and tends to remit with adulthood. The condition may be\\nassociated with migraine headaches, possibly representing a migraine variant.\\nEvaluation\\nHistory: History of present illness should elicit frequency and duration of vomiting; its relation to\\npossible precipitants such as drug or toxin ingestion, head injury, and motion (eg, car, plane, boat,\\namusement rides); and whether vomitus contained bile (bitter, yellow-green) or blood (red or \"coffee\\nground\" material). Important associated symptoms include presence of abdominal pain and diarrhea; the\\nlast passage of stool and flatus; and presence of headache, vertigo, or both.\\nReview of systems seeks symptoms of causative disorders such as amenorrhea, breast swelling'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 137, 'source_type': 'Authorotative', 'priority': '1'}, page_content='last passage of stool and flatus; and presence of headache, vertigo, or both.\\nReview of systems seeks symptoms of causative disorders such as amenorrhea, breast swelling\\n(pregnancy); polyuria, polydipsia (diabetes); and hematuria, flank pain (kidney stones).\\nPast medical history should ascertain known causes such as pregnancy, diabetes, migraine, hepatic or\\nrenal disease, cancer (including timing of any chemotherapy or radiation therapy), and previous\\nabdominal surgery (which may cause bowel obstruction due to adhesions). All drugs and substances\\ningested recently should be ascertained; certain substances may not manifest toxicity until several days\\nafter ingestion (eg, acetaminophen, some mushrooms).\\nFamily history of recurrent vomiting should be noted.\\nPhysical examination: Vital signs should particularly note presence of fever and signs of hypovolemia\\n(eg, tachycardia, hypotension, or both).\\nGeneral examination should seek presence of jaundice and skin rash.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 137, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"(eg, tachycardia, hypotension, or both).\\nGeneral examination should seek presence of jaundice and skin rash.\\nOn abdominal examination, the clinician should look for distention and surgical scars; listen for presence\\nand quality of bowel sounds (eg, normal, high-pitched); percuss for tympany; and palpate for tenderness,\\nperitoneal findings (eg, guarding, rigidity, rebound), and any masses, organomegaly, or hernias. Rectal\\nexamination and (in women) pelvic examination to locate tenderness, masses, and blood are essential.\\nNeurologic examination should particularly note mental status, nystagmus, meningismus (eg, stiff neck,\\nKernig's or Brudzinski's signs), and ocular signs of increased intracranial pressure (eg, papilledema,\\nabsence of venous pulsations, 3rd cranial nerve palsy) or subarachnoid hemorrhage (retinal\\nhemorrhage).\\nRed flags: The following findings are of particular concern:\\n• Signs of hypovolemia\\n• Headache, stiff neck, or mental status change\\n• Peritoneal signs\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 137, 'source_type': 'Authorotative', 'priority': '1'}, page_content='hemorrhage).\\nRed flags: The following findings are of particular concern:\\n• Signs of hypovolemia\\n• Headache, stiff neck, or mental status change\\n• Peritoneal signs\\n• Distended, tympanitic abdomen\\nInterpretation of findings: Many findings are suggestive of a cause or group of causes (see Table 7-5).\\nVomiting occurring shortly after drug or toxin ingestion or exposure to motion in a patient with an\\nunremarkable neurologic and abdominal examination can confidently be ascribed to those causes, as\\nmay vomiting in a woman with a known pregnancy and a benign examination. Acute vomiting\\naccompanied by diarrhea in an otherwise\\n[Table 7-5. Some Causes of Nausea and Vomiting]\\nhealthy patient with a benign examination is highly likely to be infectious gastroenteritis; further\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 7. Approach to the Patient With Upper GI Complaints\\n129'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 138, 'source_type': 'Authorotative', 'priority': '1'}, page_content='assessment may be deferred.\\nVomiting that occurs at the thought of food or that is not temporally related to eating suggests a\\npsychogenic cause, as does personal or family history of functional nausea and vomiting. Patients should\\nbe questioned about the relationship between vomiting and stressful events because they may not\\nrecognize the association or even admit to feeling distress at those times.\\nTesting: All females of childbearing age should have a urine pregnancy test. Patients with severe\\nvomiting, vomiting lasting over 1 day, or signs of dehydration on examination should have other laboratory\\ntests (eg, electrolytes, BUN, creatinine, glucose, urinalysis, and sometimes liver tests). Patients with red\\nflag findings should have testing appropriate to the symptoms (see Table 7-5).\\nThe assessment of chronic vomiting usually includes the previously listed laboratory tests plus upper GI\\nendoscopy, small-bowel x-rays, and tests to assess gastric emptying and antral-duodenal motility.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 138, 'source_type': 'Authorotative', 'priority': '1'}, page_content='endoscopy, small-bowel x-rays, and tests to assess gastric emptying and antral-duodenal motility.\\nTreatment\\nSpecific conditions, including dehydration, are treated. Even without significant dehydration, IV fluid\\ntherapy (0.9% saline 1 L, or 20 mL/kg in children) often leads to reduction of symptoms. In adults, various\\nantiemetics are effective (see\\nTable 7-6). Choice of agent varies somewhat with the cause and severity of symptoms. Typical use is the\\nfollowing:\\n• Motion sickness: Antihistamines, scopolamine patches, or both\\n• Mild to moderate symptoms: Prochlorperazine or metoclopramide\\n• Severe or refractory vomiting and vomiting caused by chemotherapy: 5-HT3 antagonists\\nObviously, only parenteral agents should be used in actively vomiting patients.\\nFor psychogenic vomiting, reassurance indicates awareness of the patient\\'s discomfort and a desire to\\nwork toward relief of symptoms, regardless of cause. Comments such as \"nothing is wrong\" or \"the'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 138, 'source_type': 'Authorotative', 'priority': '1'}, page_content='For psychogenic vomiting, reassurance indicates awareness of the patient\\'s discomfort and a desire to\\nwork toward relief of symptoms, regardless of cause. Comments such as \"nothing is wrong\" or \"the\\nproblem is emotional\" should be avoided. Brief symptomatic treatment with antiemetics can be tried. If\\nlong-term management is necessary, supportive, regular office visits may help resolve the underlying\\nproblem.\\nKey Points\\n• Many episodes have an obvious cause and benign examination and require only symptomatic treatment.\\n• Physicians should be alert for signs of an acute abdomen or significant intracranial disorder.\\n• Pregnancy should always be considered in females of childbearing age.\\nRumination\\nRumination is the (usually involuntary) regurgitation of small amounts of food from the stomach (most\\noften 15 to 30 min after eating) that are rechewed and, in most cases, again swallowed. Patients do not\\ncomplain of nausea or abdominal pain.\\n[Table 7-6. Some Drugs for Vomiting]'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 138, 'source_type': 'Authorotative', 'priority': '1'}, page_content='often 15 to 30 min after eating) that are rechewed and, in most cases, again swallowed. Patients do not\\ncomplain of nausea or abdominal pain.\\n[Table 7-6. Some Drugs for Vomiting]\\nRumination is commonly observed in infants. The incidence in adults is unknown, because it is rarely\\nreported by patients themselves.\\nEtiology\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 7. Approach to the Patient With Upper GI Complaints\\n130'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 139, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Patients with achalasia or a Zenker's diverticulum may regurgitate undigested food without nausea. In the\\nmajority of patients who do not have these obstructive esophageal conditions, the pathophysiology is\\npoorly understood. The reverse peristalsis in ruminants has not been reported in humans. The disorder is\\nprobably a learned, maladaptive habit and may be part of an eating disorder. The person learns to open\\nthe lower esophageal sphincter and propel gastric contents into the esophagus and throat by increasing\\ngastric pressure via rhythmic contraction and relaxation of the diaphragm.\\nSymptoms\\nNausea, pain, and dysphagia do not occur. During periods of stress, the patient may be less careful\\nabout concealing rumination. Seeing the act for the first time, others may refer the patient to a physician.\\nRarely, patients regurgitate and expel enough food to lose weight.\\nDiagnosis\\n• Clinical evaluation\\n• Sometimes endoscopy, esophageal motility studies, or both\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 139, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Rarely, patients regurgitate and expel enough food to lose weight.\\nDiagnosis\\n• Clinical evaluation\\n• Sometimes endoscopy, esophageal motility studies, or both\\nRumination is usually diagnosed through observation. A psychosocial history may disclose underlying\\nemotional stress. Endoscopy or an upper GI series is necessary to exclude disorders causing mechanical\\nobstruction or Zenker's diverticulum. Esophageal manometry and tests to assess gastric emptying and\\nantral-duodenal motility may be used to identify a motility disturbance.\\nTreatment\\n• Behavioral techniques\\nTreatment is supportive. Drug therapy generally does not help. Motivated patients may respond to\\nbehavioral techniques (eg, relaxation, biofeedback, training in diaphragmatic breathing [using the\\ndiaphragm instead of chest muscles to breathe]). Psychiatric consultation may be helpful.\\nFunctional GI Illness\\nOften, no physiologic cause for GI complaints is found, even after extensive evaluation. Such patients are\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 139, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Functional GI Illness\\nOften, no physiologic cause for GI complaints is found, even after extensive evaluation. Such patients are\\nsaid to have functional illness, which accounts for 30 to 50% of referrals to gastroenterologists.\\nFunctional illness may manifest with upper and/or lower GI symptoms.\\nThe reasons for functional symptoms are not clear. Some evidence suggests that such patients have\\nvisceral hypersensitivity, a disturbance of nociception in which they experience discomfort caused by\\nsensations (eg, luminal distention, peristalsis) that other people do not find distressing. In some patients,\\npsychologic conditions such as anxiety (with or without aerophagia), conversion disorder, somatization in\\ndepression, or hypochondriasis are associated with GI symptoms. Psychologic theories hold that\\nfunctional symptoms may satisfy certain psychologic needs. For example, some patients with chronic'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 139, 'source_type': 'Authorotative', 'priority': '1'}, page_content='depression, or hypochondriasis are associated with GI symptoms. Psychologic theories hold that\\nfunctional symptoms may satisfy certain psychologic needs. For example, some patients with chronic\\nillness derive secondary benefits from being sick. For such patients, successful treatment of symptoms\\nmay lead to development of other symptoms.\\nMany referring physicians and GI specialists find functional GI complaints difficult to understand and treat,\\nand uncertainty may lead to frustration and judgmental attitudes. Physicians should avoid ordering\\nrepeated studies or multiple drug trials for the insistent patient with inexplicable complaints. When\\nsymptoms are not suggestive of serious illness, the physician should wait rather than embark on another\\ndiagnostic or therapeutic plan. In time, new information may direct evaluation and management.\\nFunctional complaints are sometimes present in patients with physiologic disease (eg, peptic ulcer,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 139, 'source_type': 'Authorotative', 'priority': '1'}, page_content='diagnostic or therapeutic plan. In time, new information may direct evaluation and management.\\nFunctional complaints are sometimes present in patients with physiologic disease (eg, peptic ulcer,\\nesophagitis); such symptoms may not remit even when a physiologic illness is addressed.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 7. Approach to the Patient With Upper GI Complaints\\n131'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 140, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chapter 8. Approach to the Patient With Lower GI Complaints\\nIntroduction\\nLower GI complaints include constipation, diarrhea, gas and bloating, abdominal pain (see also p. 105),\\nand rectal pain or bleeding (see Ch. 21). As with upper GI complaints, lower GI complaints result from\\nphysiologic illness or represent a functional disorder (ie, no radiologic, biochemical, or pathologic\\nabnormalities found even after extensive evaluation). The reasons for functional symptoms are not clear.\\nEvidence suggests that patients with functional symptoms may have disturbances of motility, nociception,\\nor both; ie, they perceive as uncomfortable certain sensations (eg, luminal distention, peristalsis) that\\nother people do not find distressing.\\nNo bodily function is more variable and subject to external influences than defecation. Bowel habits vary\\nconsiderably from person to person and are affected by age, physiology, diet, and social and cultural'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 140, 'source_type': 'Authorotative', 'priority': '1'}, page_content='considerably from person to person and are affected by age, physiology, diet, and social and cultural\\ninfluences. Some people have unwarranted preoccupation with bowel habits. In Western society, normal\\nstool frequency ranges from 2 to 3/day to 2 to 3/wk. Changes in stool frequency, consistency, volume, or\\ncomposition (ie, presence of blood, mucus, pus, or excess fatty material) may indicate disease.\\nConstipation\\nConstipation is difficult or infrequent passage of stool, hardness of stool, or a feeling of incomplete\\nevacuation.\\nMany people incorrectly believe that daily defecation is necessary and complain of constipation if stools\\noccur less frequently. Others are concerned with the appearance (size, shape, color) or consistency of\\nstools. Sometimes the major complaint is dissatisfaction with the act of defecation or the sense of\\nincomplete evacuation after defecation. Constipation is blamed for many complaints (abdominal pain,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 140, 'source_type': 'Authorotative', 'priority': '1'}, page_content='stools. Sometimes the major complaint is dissatisfaction with the act of defecation or the sense of\\nincomplete evacuation after defecation. Constipation is blamed for many complaints (abdominal pain,\\nnausea, fatigue, anorexia) that are actually symptoms of an underlying problem (eg, irritable bowel\\nsyndrome [IBS], depression). Patients should not expect all symptoms to be relieved by a daily bowel\\nmovement, and measures to aid bowel habits should be used judiciously.\\nObsessive-compulsive patients often feel the need to rid the body daily of \"unclean\" wastes. Such\\npatients often spend excessive time on the toilet or become chronic users of cathartics.\\nEtiology\\nAcute constipation suggests an organic cause, whereas chronic constipation may be organic or functional\\n(see\\nTable 8-1).\\nIn many patients, constipation is associated with sluggish movement of stool through the colon. This\\ndelay may be due to drugs, organic conditions, or a disorder of defecatory function (ie, pelvic floor'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 140, 'source_type': 'Authorotative', 'priority': '1'}, page_content='delay may be due to drugs, organic conditions, or a disorder of defecatory function (ie, pelvic floor\\ndysfunction). Patients with disordered defecation do not generate adequate rectal propulsive forces, do\\nnot relax the puborectalis and the external anal sphincter during defecation, or both. In IBS, patients have\\nsymptoms (eg, abdominal discomfort and altered bowel habits) but generally normal colonic transit and\\nanorectal functions. However, IBS-disordered defecation may coexist.\\nExcessive straining, perhaps secondary to pelvic floor dysfunctions, may contribute to anorectal\\npathology (eg, hemorrhoids, anal fissures, and rectal prolapse) and possibly even to syncope. Fecal\\nimpaction, which may cause or develop from constipation, is also common among elderly patients,\\nparticularly with prolonged bed rest or decreased physical activity. It is also common after barium has\\nbeen given by mouth or enema.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 140, 'source_type': 'Authorotative', 'priority': '1'}, page_content='particularly with prolonged bed rest or decreased physical activity. It is also common after barium has\\nbeen given by mouth or enema.\\nChanges with aging: Constipation is common among elderly people because of low-fiber diets, lack of\\nexercise, coexisting medical conditions, and use of constipating drugs. Many elderly people have\\nmisconceptions about normal bowel habits and use laxatives regularly. Other changes that predispose the\\nelderly to constipation include increased rectal compliance and impaired rectal sensation (such that larger\\nrectal volumes are needed to elicit the desire to defecate).\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 8. Approach to the Patient With Lower GI Complaints\\n132'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 141, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Evaluation\\nHistory: A lifetime history of the patient's stool frequency, consistency, need to strain or use perineal\\nmaneuvers (eg, pushing on the perineum, gluteal region, or recto-vaginal wall) during defecation, and\\nsatisfaction after defecation should be obtained, including frequency and duration of laxative or enema\\nuse. Some patients deny previous constipation\\n[Table 8-1. Causes of Constipation]\\nbut, when questioned specifically, admit to spending 15 to 20 min per bowel movement. The presence,\\namount, and duration of blood in the stool should also be elicited.\\nSymptoms of metabolic (eg, hypothyroidism, diabetes mellitus) and neurologic (eg, spinal cord injury)\\ndisorders and systemic symptoms (eg, weight loss) should also be sought. Prescription and\\nnonprescription drug use should be assessed, with specific questioning about anticholinergic and opioid\\ndrugs.\\nPhysical examination: A general examination is done to look for signs of systemic disease, including\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 141, 'source_type': 'Authorotative', 'priority': '1'}, page_content='drugs.\\nPhysical examination: A general examination is done to look for signs of systemic disease, including\\nfever and cachexia. Abdominal masses should be sought by palpation. A rectal examination should be\\ndone not only for fissures, strictures, blood, or masses (including fecal impaction) but also to evaluate\\nanal resting tone (the puborectalis \"lift\" when patients squeeze the anal sphincter), perineal descent\\nduring simulated evacuation, and rectal sensation. Patients with defecatory disorders may have increased\\nanal resting tone (or anismus), reduced (ie, < 2 cm) or increased (ie, > 4 cm) perineal descent, and/or\\nparadoxical contraction of the puborectalis during simulated evacuation.\\nRed flags: Certain findings raise suspicion of a more serious etiology of chronic constipation:\\n• Distended, tympanitic abdomen\\n• Vomiting\\n• Blood in stool\\n• Weight loss\\n• Severe constipation of recent onset/worsening in elderly patients'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 141, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Distended, tympanitic abdomen\\n• Vomiting\\n• Blood in stool\\n• Weight loss\\n• Severe constipation of recent onset/worsening in elderly patients\\nInterpretation of findings: Certain symptoms (eg, a sense of anorectal blockage, prolonged or difficult\\ndefecation), particularly when associated with abnormal (ie, increased or reduced) perineal motion during\\nsimulated evacuation, suggest a defecatory disorder. A tense, distended, tympanitic abdomen, particularly\\nwhen there is nausea and vomiting, suggests mechanical obstruction.\\nPatients with IBS typically have abdominal pain with disordered bowel habits (see p. 162). Chronic\\nconstipation with modest abdominal discomfort in a patient who has used laxatives for a long time\\nsuggests slow-transit constipation. Acute constipation coincident with the start of a constipating drug in\\npatients without red flag findings suggests the drug is the cause. New-onset constipation that persists for'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 141, 'source_type': 'Authorotative', 'priority': '1'}, page_content='patients without red flag findings suggests the drug is the cause. New-onset constipation that persists for\\nweeks or occurs intermittently with increasing frequency or severity, in the absence of a known cause,\\nsuggests colonic tumor or other causes of partial obstruction. Excessive straining or prolonged or\\nunsatisfactory defecation, with or without anal digitation, suggests a defecatory disorder. Patients with\\nfecal impaction may have cramps and may pass watery mucus or fecal material around the impacted\\nmass, mimicking diarrhea (paradoxic diarrhea).\\nTesting: Testing is guided by clinical presentation.\\nConstipation with a clear etiology (drugs, trauma, bed rest) may be treated symptomatically without further\\nstudy. Patients with symptoms of bowel obstruction require flat and upright abdominal x-rays, possibly a\\nwater-soluble contrast enema to evaluate for colonic obstruction, and possibly a CT scan or barium x-ray\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 141, 'source_type': 'Authorotative', 'priority': '1'}, page_content='water-soluble contrast enema to evaluate for colonic obstruction, and possibly a CT scan or barium x-ray\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 8. Approach to the Patient With Lower GI Complaints\\n133'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 142, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of the small intestine (see also p.\\n116). Most patients without a clear etiology should have sigmoidoscopy or colonoscopy and a laboratory\\nevaluation (CBC, thyroid-stimulating hormone, fasting glucose, electrolytes, and Ca).\\nFurther tests are usually reserved for patients with abnormal findings on the previously mentioned tests or\\nwho do not respond to symptomatic treatment. If the primary complaint is infrequent defecation, colonic\\ntransit times should be measured with radiopaque markers or scintigraphy. If the primary complaint is\\ndifficulty with defecation, anorectal manometry and rectal balloon expulsion should be assessed.\\nTreatment\\n• Possibly discontinuation of causative drugs (some may be necessary)\\n• Increase in dietary fiber\\n• Possibly trial with a brief course of osmotic laxatives\\nAny identified conditions should be treated.\\nAgents used to treat constipation are summarized in\\nTable 8-2. Laxatives should be used judiciously. Some (eg, phosphate, bran, cellulose) bind drugs and'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 142, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Any identified conditions should be treated.\\nAgents used to treat constipation are summarized in\\nTable 8-2. Laxatives should be used judiciously. Some (eg, phosphate, bran, cellulose) bind drugs and\\ninterfere with absorption. Rapid fecal transit may rush some drugs and nutrients beyond their optimal\\nabsorptive locus. Contraindications to laxative and cathartic use include acute abdominal pain of\\nunknown origin, inflammatory bowel disorders, intestinal obstruction, GI bleeding, and fecal impaction.\\nDiet and behavior: The diet should contain enough fiber (typically 15 to 20 g/day) to ensure adequate\\nstool bulk. Vegetable fiber, which is largely indigestible and unabsorbable, increases stool bulk. Certain\\ncomponents of fiber also absorb fluid, making stools softer and facilitating their passage. Fruits and\\nvegetables are recommended sources, as are cereals containing bran. Fiber supplementation is'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 142, 'source_type': 'Authorotative', 'priority': '1'}, page_content='components of fiber also absorb fluid, making stools softer and facilitating their passage. Fruits and\\nvegetables are recommended sources, as are cereals containing bran. Fiber supplementation is\\nparticularly effective in treating normal-transit constipation but is not very effective for slow-transit\\nconstipation or defecatory disorders.\\n[Table 8-2. Agents Used to Treat Constipation]\\nBehavioral changes may help. Patients should try to move their bowels at the same time daily, preferably\\n15 to 45 min after breakfast, because food ingestion stimulates colonic motility. Initial efforts at regular,\\nunhurried bowel movements may be aided by glycerin suppositories.\\nExplanation is important, but it is difficult to convince obsessive-compulsive patients that their attitude\\ntoward defecation is abnormal. Physicians must explain that daily bowel movements are not essential,\\nthat the bowel must be given a chance to function, and that frequent use of laxatives or enemas (> once/3'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 142, 'source_type': 'Authorotative', 'priority': '1'}, page_content='that the bowel must be given a chance to function, and that frequent use of laxatives or enemas (> once/3\\ndays) denies the bowel that chance.\\nTypes of laxatives: Bulking agents (eg, psyllium, Ca polycarbophil, methylcellulose) act slowly and\\ngently and are the safest agents for promoting elimination. Proper use involves gradually increasing the\\ndose—ideally taken tid or qid with sufficient liquid (eg, 500 mL/day of extra fluid) to prevent impaction\\n—until a softer, bulkier stool results. Bloating may be reduced by gradually titrating the dose of dietary\\nfiber to the recommended dose, or by switching to a synthetic fiber preparation such as methylcellulose.\\nOsmotic agents contain poorly absorbed polyvalent ions (eg, Mg, phosphate, sulfate), polymers (eg,\\npolyethylene glycol), or carbohydrates (eg, lactulose, sorbitol) that remain in the bowel, increasing\\nintraluminal osmotic pressure and thereby drawing water into the intestine. The increased volume'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 142, 'source_type': 'Authorotative', 'priority': '1'}, page_content='polyethylene glycol), or carbohydrates (eg, lactulose, sorbitol) that remain in the bowel, increasing\\nintraluminal osmotic pressure and thereby drawing water into the intestine. The increased volume\\nstimulates peristalsis. These agents usually work within 3 h.\\nIn general, osmotic laxatives are reasonably safe even when used regularly. However, Na phosphate\\nshould not be used for bowel cleansing because it may rarely cause acute renal failure even after a single\\nuse for bowel preparation. These events occurred primarily in elderly patients, those with preexisting\\nrenal disease, and those who were taking drugs that affect renal perfusion or function (eg, diuretics, ACE\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 8. Approach to the Patient With Lower GI Complaints\\n134'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 143, 'source_type': 'Authorotative', 'priority': '1'}, page_content='inhibitors, angiotensin II receptor blockers). Also, Mg and phosphate are partially absorbed and may be\\ndetrimental in some conditions (eg, renal insufficiency). Na (in some preparations) may exacerbate heart\\nfailure. In large or frequent doses, these drugs may upset fluid and electrolyte balance. Another approach\\nto cleansing the bowel for diagnostic tests or surgery or sometimes for chronic constipation uses large\\nvolumes of a balanced osmotic agent (eg, polyethylene glycol-electrolyte solution) given orally or via\\nNGT.\\nSecretory or stimulant cathartics (eg, phenolphthalein, bisacodyl, anthraquinones, castor oil,\\nanthraquinones) act by irritating the intestinal mucosa or by directly stimulating the submucosal and\\nmyenteric plexus. Although phenolphthalein was withdrawn from the US market after animal studies\\nsuggested the compound was carcinogenic, there is no epidemiologic evidence of this in humans.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 143, 'source_type': 'Authorotative', 'priority': '1'}, page_content='myenteric plexus. Although phenolphthalein was withdrawn from the US market after animal studies\\nsuggested the compound was carcinogenic, there is no epidemiologic evidence of this in humans.\\nBisacodyl is an effective rescue drug for chronic constipation. The anthraquinones senna, cascara\\nsagrada, aloe, and rhubarb are common constituents of herbal and OTC laxatives. They pass unchanged\\nto the colon where bacterial metabolism converts them to active forms. Adverse effects include allergic\\nreactions, electrolyte depletion, melanosis coli, and cathartic colon. Melanosis coli is a brownish black\\ncolorectal pigmentation of unknown composition. Cathartic colon refers to alterations in colonic anatomy\\nobserved on barium enema in patients with chronic stimulant laxative use. It is unclear whether cathartic\\ncolon, which has been attributed to destruction of myenteric plexus neurons by anthraquinones, is caused'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 143, 'source_type': 'Authorotative', 'priority': '1'}, page_content='colon, which has been attributed to destruction of myenteric plexus neurons by anthraquinones, is caused\\nby currently available agents or other neurotoxic agents (eg, podophyllin), which are no longer available.\\nThere does not seem to be an increased risk of colon cancer with long-term anthraquinone use.\\nEnemas can be used, including tap water and commercially prepared hypertonic solutions.\\nEmollient agents (eg, docusate, mineral oil) act slowly to soften stools, making them easier to pass.\\nHowever, they are not potent stimulators of defecation. Docusate is a surfactant, which allows water to\\nenter the fecal mass to soften and increase its bulk.\\nFecal impaction: Fecal impaction is treated initially with enemas of tap water followed by small enemas\\n(100 mL) of commercially prepared hypertonic solutions (eg, Na phosphate). If these do not work, manual\\nfragmentation and disimpaction of the mass is necessary. This procedure is painful, so perirectal and'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 143, 'source_type': 'Authorotative', 'priority': '1'}, page_content='fragmentation and disimpaction of the mass is necessary. This procedure is painful, so perirectal and\\nintrarectal application of local anesthetics (eg, lidocaine 5% ointment or dibucaine 1% ointment) is\\nrecommended. Some patients require sedation.\\nKey Points\\n• Drug causes are common (eg, chronic laxative abuse, use of anticholinergic or opioid drugs).\\n• Clinicians should be wary of bowel obstruction when constipation is acute and severe.\\n• Symptomatic treatment is reasonable in the absence of red flag findings and after excluding pelvic floor\\ndysfunction.\\nDyschezia\\n(Disordered Evacuation; Dysfunction of Pelvic Floor or Anal Sphincters; Functional Defecatory Disorders;\\nDyssynergia)\\nDyschezia is difficulty defecating. Patients sense the presence of stool and the need to\\ndefecate but are unable. It results from a lack of coordination of pelvic floor muscles and anal\\nsphincters. Diagnosis requires anorectal testing. Treatment is difficult, but biofeedback may be\\nof benefit.\\nEtiology'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 143, 'source_type': 'Authorotative', 'priority': '1'}, page_content='sphincters. Diagnosis requires anorectal testing. Treatment is difficult, but biofeedback may be\\nof benefit.\\nEtiology\\nNormally, when a person tries to defecate, rectal pressure rises in coordination with relaxation of the\\nexternal anal sphincter. This process may be affected by one or more dysfunctions (eg, impaired rectal\\ncontraction, excessive contraction of the abdominal wall, paradoxic anal contraction, failure of anal\\nrelaxation) of unclear etiology. Functional defecatory disorders may manifest at any age. In contrast,\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 8. Approach to the Patient With Lower GI Complaints\\n135'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 144, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Hirschsprung's disease, which is due to an absent recto-anal inhibitory reflex, is almost always diagnosed\\nin infancy or childhood.\\nSymptoms and Signs\\nThe patient may or may not sense that stool is present in the rectum. Despite prolonged straining,\\nevacuation is tedious or impossible, frequently even for soft stool or enemas. Patients may complain of\\nanal blockage and may digitally remove stool from their rectum or manually support their perineum or\\nsplint the vagina to evacuate. Actual stool frequency may or may not be decreased.\\nDiagnosis\\nRectal and pelvic examinations may reveal hypertonia of the pelvic floor muscles and anal sphincters.\\nWith bearing down, patients may not demonstrate the expected anal relaxation and perineal descent.\\nWith excessive straining, the anterior rectal wall prolapses into the vagina in patients with impaired anal\\nrelaxation; thus rectoceles are usually a secondary rather than a primary disturbance. Long-standing\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 144, 'source_type': 'Authorotative', 'priority': '1'}, page_content='relaxation; thus rectoceles are usually a secondary rather than a primary disturbance. Long-standing\\ndyschezia with chronic straining may cause a solitary rectal ulcer or varying degrees of rectal prolapse or\\nexcessive perineal descent or an enterocoele. Anorectal manometry and rectal balloon expulsion,\\noccasionally supplemented by defecatory or magnetic resonance proctography, are necessary to\\ndiagnose the condition.\\nTreatment\\nBecause treatment with laxatives is unsatisfactory, it is important to assess anorectal functions in patients\\nwith refractory constipation. Biofeedback therapy can improve coordination between abdominal\\ncontraction and pelvic floor relaxation during defecation, thereby alleviating symptoms. However, pelvic\\nfloor retraining for defecatory disorders is highly specialized and available at select centers only. A\\ncollaborative approach (physiotherapists, dietitians, behavior therapists, gastroenterologists) is\\nnecessary.\\nDiarrhea'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 144, 'source_type': 'Authorotative', 'priority': '1'}, page_content='collaborative approach (physiotherapists, dietitians, behavior therapists, gastroenterologists) is\\nnecessary.\\nDiarrhea\\n(See also Chs. 17 and 19. For diarrhea in children, see p. 2737.)\\nStool is 60 to 90% water. In Western society, stool amount is 100 to 200 g/day in healthy adults and 10\\ng/kg/day in infants, depending on the amount of unabsorbable dietary material (mainly carbohydrates).\\nDiarrhea is defined as stool weight > 200 g/day. However, many people consider any increased stool\\nfluidity to be diarrhea. Alternatively, many people who ingest fiber have bulkier but formed stools but do\\nnot consider themselves to have diarrhea.\\nComplications: Complications may result from diarrhea of any etiology. Fluid loss with consequent\\ndehydration, electrolyte loss (Na, K, Mg, Cl), and even vascular collapse sometimes occur. Collapse can\\ndevelop rapidly in patients who have severe diarrhea (eg, patients with cholera) or are very young, very'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 144, 'source_type': 'Authorotative', 'priority': '1'}, page_content='develop rapidly in patients who have severe diarrhea (eg, patients with cholera) or are very young, very\\nold, or debilitated. HCO3 loss can cause metabolic acidosis. Hypokalemia can occur when patients have\\nsevere or chronic diarrhea or if the stool contains excess mucus. Hypomagnesemia after prolonged\\ndiarrhea can cause tetany.\\nEtiology\\nNormally, the small intestine and colon absorb 99% of fluid resulting from oral intake and GI tract\\nsecretions—a total fluid load of about 9 of 10 L daily. Thus, even small reductions (ie, 1%) in intestinal\\nwater absorption or increases in secretion can increase water content enough to cause diarrhea.\\nThere are a number of causes of diarrhea (see\\nTable 8-3). Several basic mechanisms are responsible for most clinically significant diarrheas: increased\\nosmotic load, increased secretions, and decreased contact time/surface area. In many disorders, more\\nthan one mechanism is active. For example, diarrhea in inflammatory bowel disease results from mucosal'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 144, 'source_type': 'Authorotative', 'priority': '1'}, page_content='than one mechanism is active. For example, diarrhea in inflammatory bowel disease results from mucosal\\ndestruction, exudation into the lumen, and from multiple secretagogues and bacterial toxins that affect\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 8. Approach to the Patient With Lower GI Complaints\\n136'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 145, 'source_type': 'Authorotative', 'priority': '1'}, page_content='enterocyte function.\\n[Table 8-3. Some Causes of Diarrhea*]\\nOsmotic load: Diarrhea occurs when unabsorbable, water-soluble solutes remain in the bowel and\\nretain water. Such solutes include polyethylene glycol, Mg salts (hydroxide and sulfate), and Na\\nphosphate, which are used as laxatives. Osmotic diarrhea occurs with sugar intolerance (eg, lactose\\nintolerance caused by lactase deficiency). Ingesting large amounts of hexitols (eg, sorbitol, mannitol,\\nxylitol) or high fructose corn syrups, which are used as sugar substitutes in candy, gum, and fruit juices,\\ncauses osmotic diarrhea because hexitols are poorly absorbed. Lactulose, which is used as a laxative,\\ncauses diarrhea by a similar mechanism. Overingesting certain foodstuffs (see\\nTable 8-4) can cause osmotic diarrhea.\\nIncreased secretions: Diarrhea occurs when the bowels secrete more electrolytes and water than they\\nabsorb. Causes of increased secretions include infections, unabsorbed fats, certain drugs, and various'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 145, 'source_type': 'Authorotative', 'priority': '1'}, page_content='absorb. Causes of increased secretions include infections, unabsorbed fats, certain drugs, and various\\nintrinsic and extrinsic secretagogues.\\nInfections (eg, gastroenteritis; discussed in Ch. 16) are the most common causes of secretory diarrhea.\\nInfections combined with food poisoning are the most common causes of acute diarrhea (< 4 days in\\nduration). Most enterotoxins block Na+-H+ exchange, which is an important driving force for fluid\\nabsorption in the small bowel and colon.\\nUnabsorbed dietary fat and bile acids (as in malabsorption syndromes and after ileal resection) can\\nstimulate colonic secretion and cause diarrhea.\\nDrugs may stimulate intestinal secretions directly (eg, quinidine, quinine, colchicine, anthraquinone\\ncathartics, castor oil, prostaglandins) or indirectly by impairing fat absorption (eg, orlistat).\\nVarious endocrine tumors produce secretagogues, including vipomas (vasoactive intestinal peptide),'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 145, 'source_type': 'Authorotative', 'priority': '1'}, page_content='cathartics, castor oil, prostaglandins) or indirectly by impairing fat absorption (eg, orlistat).\\nVarious endocrine tumors produce secretagogues, including vipomas (vasoactive intestinal peptide),\\ngastrinomas (gastrin), mastocytosis (histamine), medullary carcinoma of the thyroid (calcitonin and\\nprostaglandins), and carcinoid tumors (histamine, serotonin, and polypeptides). Some of these mediators\\n(eg, prostaglandins, serotonin, related compounds) also accelerate intestinal transit, colonic transit, or\\nboth.\\nReduced contact time/surface area: Rapid intestinal transit and diminished surface area impair fluid\\nabsorption and cause diarrhea. Common causes include small-bowel or large-bowel resection or bypass,\\ngastric resection,\\n[Table 8-4. Dietary Factors that May Worsen Diarrhea]\\nand inflammatory bowel disease. Other causes include microscopic colitis (collagenous or lymphocytic\\ncolitis) and celiac sprue.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 145, 'source_type': 'Authorotative', 'priority': '1'}, page_content='[Table 8-4. Dietary Factors that May Worsen Diarrhea]\\nand inflammatory bowel disease. Other causes include microscopic colitis (collagenous or lymphocytic\\ncolitis) and celiac sprue.\\nStimulation of intestinal smooth muscle by drugs (eg, Mg-containing antacids, laxatives, cholinesterase\\ninhibitors, SSRIs) or humoral agents (eg, prostaglandins, serotonin) also can speed transit.\\nEvaluation\\nHistory: Duration and severity of diarrhea, circumstances of onset (including recent travel, food\\ningested, source of water), drug use (including any antibiotics within the previous 3 mo), abdominal pain\\nor vomiting, frequency and timing of bowel movements, changes in stool characteristics (eg, presence of\\nblood, pus, or mucus; changes in color or consistency; evidence of steatorrhea), associated changes in\\nweight or appetite, and rectal urgency or tenesmus should be noted. Simultaneous occurrence of\\ndiarrhea in close contacts should be ascertained.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 145, 'source_type': 'Authorotative', 'priority': '1'}, page_content='weight or appetite, and rectal urgency or tenesmus should be noted. Simultaneous occurrence of\\ndiarrhea in close contacts should be ascertained.\\nPhysical examination: Fluid and hydration status should be evaluated. A full examination with attention\\nto the abdomen and a digital rectal examination for sphincter competence and occult blood testing are\\nimportant.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 8. Approach to the Patient With Lower GI Complaints\\n137'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 146, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Red flags: Certain findings raise suspicion of an organic or more serious etiology of diarrhea:\\n• Blood or pus\\n• Fever\\n• Signs of dehydration\\n• Chronic diarrhea\\n• Weight loss\\nInterpretation of findings: Acute, watery diarrhea in an otherwise healthy person is likely to be of\\ninfectious etiology, particularly when travel, possibly tainted food, or an outbreak with a point-source is\\ninvolved. Acute bloody diarrhea with or without hemodynamic instability in an otherwise healthy person\\nsuggests an enteroinvasive infection. Diverticular bleeding and ischemic colitis also manifest with acute\\nbloody diarrhea. Recurrent bouts of bloody diarrhea in a younger person suggest inflammatory bowel\\ndisease. In the absence of laxative use, large-volume diarrhea (eg, daily stool volume > 1 L/day) strongly\\nsuggests an endocrine cause in patients with normal GI anatomy. A history of oil droplets in stool,\\nparticularly if associated with weight loss, suggests malabsorption.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 146, 'source_type': 'Authorotative', 'priority': '1'}, page_content='suggests an endocrine cause in patients with normal GI anatomy. A history of oil droplets in stool,\\nparticularly if associated with weight loss, suggests malabsorption.\\nDiarrhea that consistently follows ingestion of certain foods (eg, fats) suggests food intolerance. Recent\\nantibiotic use should raise suspicion for antibiotic-associated diarrhea, including Clostridium difficile\\ncolitis.\\nThe symptoms can help identify the affected part of the bowel. Generally, in small-bowel diseases, stools\\nare voluminous and watery or fatty. In colonic diseases, stools are frequent, sometimes small in volume,\\nand possibly accompanied by blood, mucus, pus, and abdominal discomfort. In irritable bowel syndrome\\n(IBS), abdominal discomfort is relieved by defecation, associated with more loose or frequent stools, or\\nboth. However, these symptoms alone do not discriminate IBS from other diseases (eg, inflammatory'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 146, 'source_type': 'Authorotative', 'priority': '1'}, page_content='both. However, these symptoms alone do not discriminate IBS from other diseases (eg, inflammatory\\nbowel disease). Patients with IBS or rectal mucosal involvement often have marked urgency, tenesmus,\\nand small, frequent stools (see p. 163).\\nExtra-abdominal findings that suggest an etiology include skin lesions or flushing (mastocytosis), thyroid\\nnodules (medullary carcinoma of the thyroid), right-sided heart murmur (carcinoid), lymphadenopathy\\n(lymphoma, AIDS), and arthritis (inflammatory bowel disease, celiac disease).\\nTesting: Acute diarrhea (< 4 days) typically does not require testing. Exceptions are patients with signs of\\ndehydration, bloody stool, fever, severe pain, hypotension, or toxic features—particularly those who are\\nvery young or very old. These patients should have a CBC and measurement of electrolytes, BUN, and\\ncreatinine. Stool samples should be collected for microscopy, culture, fecal leukocyte testing, and, if'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 146, 'source_type': 'Authorotative', 'priority': '1'}, page_content='creatinine. Stool samples should be collected for microscopy, culture, fecal leukocyte testing, and, if\\nantibiotics have been taken recently, C. difficile toxin assay.\\nChronic diarrhea (> 4 wk) requires evaluation, as does a shorter (1 to 3 wk) bout of diarrhea in\\nimmunocompromised patients or those who appear significantly ill. Initial stool testing should include\\nculture, fecal leukocytes (detected by smear or measurement of fecal lactoferrin), microscopic\\nexamination for ova and parasites, pH (bacterial fermentation of unabsorbed carbohydrate lowers stool\\npH < 6.0), fat (by Sudan stain), and electrolytes (Na and K). If no standard pathogens are found, specific\\ntests for Giardia antigen and Aeromonas, Plesiomonas, coccidia, and microsporidia should be requested.\\nSigmoidoscopy or colonoscopy with biopsies should follow to look for inflammatory causes.\\nIf no diagnosis is apparent and Sudan stain is positive for fat, fecal fat excretion should be measured,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 146, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Sigmoidoscopy or colonoscopy with biopsies should follow to look for inflammatory causes.\\nIf no diagnosis is apparent and Sudan stain is positive for fat, fecal fat excretion should be measured,\\nfollowed by small-bowel enteroclysis or CT enterography (structural disease) and endoscopic small-bowel\\nbiopsy (mucosal disease). If evaluation still yields negative findings, assessment of pancreatic structure\\nand function (see p. 142) should be considered for patients who have unexplained steatorrhea.\\nInfrequently, capsule endoscopy may uncover lesions, predominantly Crohn's disease or NSAID\\nenteropathy, not identified by other modalities.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 8. Approach to the Patient With Lower GI Complaints\\n138\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 147, 'source_type': 'Authorotative', 'priority': '1'}, page_content='The stool osmotic gap, which is calculated 290 - 2 × (stool Na + stool K), indicates whether diarrhea is\\nsecretory or osmotic. An osmotic gap < 50 mEq/L indicates secretory diarrhea; a larger gap suggests\\nosmotic diarrhea. Patients with osmotic diarrhea may have covert Mg laxative ingestion (detectable by\\nstool Mg levels) or carbohydrate malabsorption (diagnosed by hydrogen breath test, lactase assay, and\\ndietary review).\\nUndiagnosed secretory diarrhea requires testing (eg, plasma gastrin, calcitonin, vasoactive intestinal\\npeptide levels, histamine, urinary 5-hydroxyindole acetic acid [5-HIAA]) for endocrine-related causes. A\\nreview for symptoms and signs of thyroid disease and adrenal insufficiency should be done. Surreptitious\\nlaxative abuse must be considered; it can be ruled out by a fecal laxative assay.\\nTreatment\\n• Fluid and electrolytes for dehydration\\n• Possibly antidiarrheals for nonbloody diarrhea in patients without systemic toxicity'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 147, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Treatment\\n• Fluid and electrolytes for dehydration\\n• Possibly antidiarrheals for nonbloody diarrhea in patients without systemic toxicity\\nSevere diarrhea requires fluid and electrolyte replacement to correct dehydration, electrolyte imbalance,\\nand acidosis. Parenteral fluids containing NaCl, KCl, and glucose are generally required. Salts to\\ncounteract acidosis (Na lactate, acetate, HCO3) may be indicated if serum HCO3 is < 15 mEq/L. An oral\\nglucose-electrolyte solution can be given if diarrhea is not severe and nausea and vomiting are minimal\\n(see p.\\n2809). Oral and parenteral fluids are sometimes given simultaneously when water and electrolytes must\\nbe replaced in massive amounts (eg, in cholera).\\nDiarrhea is a symptom. When possible, the underlying disorder should be treated, but symptomatic\\ntreatment is often necessary. Diarrhea may be decreased by oral loperamide 2 to 4 mg tid or qid'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 147, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Diarrhea is a symptom. When possible, the underlying disorder should be treated, but symptomatic\\ntreatment is often necessary. Diarrhea may be decreased by oral loperamide 2 to 4 mg tid or qid\\n(preferably given 30 min before meals), diphenoxylate 2.5 to 5 mg (tablets or liquid) tid or qid, codeine\\nphosphate 15 to 30 mg bid or tid, or paregoric (camphorated opium tincture) 5 to 10 mL once/day to qid.\\nBecause antidiarrheals may exacerbate C. difficile colitis or increase the likelihood of hemolytic-uremic\\nsyndrome in Shiga toxin-producing Escherichia coli infection, they should not be used in bloody diarrhea\\nof unknown cause. Their use should be restricted to patients with watery diarrhea and no signs of\\nsystemic toxicity. However, there is little evidence to justify previous concerns about prolonging excretion\\nof possible bacterial pathogens with antidiarrheals.\\nPsyllium or methylcellulose compounds provide bulk. Although usually prescribed for constipation, bulking'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 147, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of possible bacterial pathogens with antidiarrheals.\\nPsyllium or methylcellulose compounds provide bulk. Although usually prescribed for constipation, bulking\\nagents given in small doses decrease the fluidity of liquid stools. Kaolin, pectin, and activated attapulgite\\nadsorb fluid. Osmotically active dietary substances (see Table 8-4) and stimulatory drugs should be\\navoided.\\nKey Points\\n• In patients with acute diarrhea, stool examination (cultures, ova and parasites, C. difficile cytotoxin) is\\nonly necessary for those who have prolonged symptoms (ie, > 1 wk) or red flag findings.\\n• Antidiarrheals should be used cautiously if there is a possibility of C. difficile, Salmonella, or shigellosis.\\nGas-Related Complaints\\nThe gut contains < 200 mL of gas, whereas daily gas expulsion averages 600 to 700 mL after consuming\\na standard diet plus 200 g of baked beans. About 75% of flatus is derived from colonic bacterial'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 147, 'source_type': 'Authorotative', 'priority': '1'}, page_content='The gut contains < 200 mL of gas, whereas daily gas expulsion averages 600 to 700 mL after consuming\\na standard diet plus 200 g of baked beans. About 75% of flatus is derived from colonic bacterial\\nfermentation of ingested nutrients and endogenous glycoproteins. Gases include hydrogen (H2),\\nmethane (CH4), and carbon dioxide (CO2). Flatus odor correlates with H2 sulphide concentrations.\\nSwallowed air (aerophagia) and diffusion from the blood into the lumen also contribute to intestinal gas.\\nGas diffuses between the lumen and the blood in a direction that depends on the difference in partial\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 8. Approach to the Patient With Lower GI Complaints\\n139'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 148, 'source_type': 'Authorotative', 'priority': '1'}, page_content='pressures. Thus, most nitrogen (N2) in the lumen originates from the bloodstream, and most H2 in the\\nbloodstream originates from the lumen.\\nEtiology\\nThere are 3 main gas-related complaints: excessive belching, distention (bloating), and excessive flatus,\\neach with a number of causes (see\\nTable 8-5). Infants 2 to 4 mo of age with recurrent crying spells often appear to observers to be in pain,\\nwhich in the past has been attributed to abdominal cramping or gas and termed colic. However, studies\\nshow no increase in H2 production or in mouth-to-cecum transit times in colicky infants. Hence, the cause\\nof infantile colic remains unclear (see p. 2725).\\nExcessive belching: Belching (eructation) results from swallowed air or from gas generated by\\ncarbonated beverages. Aerophagia occurs normally in small amounts during eating and drinking, but\\nsome people unconsciously swallow air repeatedly while eating or smoking and at other times, especially'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 148, 'source_type': 'Authorotative', 'priority': '1'}, page_content='some people unconsciously swallow air repeatedly while eating or smoking and at other times, especially\\nwhen anxious or in an attempt to induce belching. Excessive salivation increases aerophagia and may be\\nassociated with various GI disorders (eg, gastroesophageal reflux disease), ill-fitting dentures, certain\\ndrugs, gum chewing, or nausea of any cause.\\nMost swallowed air is eructated. Only a small amount of swallowed air passes into the small bowel; the\\namount is apparently influenced by position. In an upright person, air is readily belched; in a supine\\nperson, air trapped above the stomach fluid tends to be propelled into the duodenum. Excessive\\neructation may also be voluntary; patients who belch after taking antacids may attribute the relief of\\nsymptoms to belching rather than to antacids and may intentionally belch to relieve distress.\\nDistention (bloating): Abdominal bloating may occur in isolation or along with other GI symptoms in'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 148, 'source_type': 'Authorotative', 'priority': '1'}, page_content='symptoms to belching rather than to antacids and may intentionally belch to relieve distress.\\nDistention (bloating): Abdominal bloating may occur in isolation or along with other GI symptoms in\\npatients with functional disorders (eg, aerophagia, nonulcer dyspepsia, gastroparesis, irritable bowel\\nsyndrome) or organic disorders (eg, ovarian cancer, colon cancer). However, excessive intestinal gas is\\nnot clearly linked to these complaints. In most healthy people, 1 L/h of gas can be infused into the gut\\nwith minimal symptoms. It is likely that many symptoms are incorrectly attributed to \"too much gas.\"\\nOn the other hand, some patients with recurrent GI symptoms often cannot tolerate small quantities of\\ngas: Retrograde colonic distention by balloon inflation or air instillation during colonoscopy often elicits\\nsevere discomfort in some patients (eg, those with irritable bowel syndrome) but minimal symptoms in'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 148, 'source_type': 'Authorotative', 'priority': '1'}, page_content='severe discomfort in some patients (eg, those with irritable bowel syndrome) but minimal symptoms in\\nothers. Similarly, patients with eating disorders (eg, anorexia nervosa, bulimia) often misperceive and are\\nparticularly stressed by symptoms such as bloating. Thus, the basic abnormality in patients with gas-\\nrelated symptoms may be a hypersensitive intestine. Altered motility may contribute further to symptoms.\\nExcessive flatus: There is great variability in the quantity and frequency of rectal gas passage. As with\\nstool frequency, people who complain of flatulence often have a misconception of what is normal. The\\naverage number of gas passages is about 13 to 21/day. Objectively recording flatus frequency (using a\\ndiary kept by the patient) is a first step in evaluation.\\nFlatus is a metabolic byproduct of intestinal bacteria; almost none originates from swallowed air or back-\\ndiffusion of gases (primarily N2) from the bloodstream. Bacterial metabolism yields significant volumes of'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 148, 'source_type': 'Authorotative', 'priority': '1'}, page_content='diffusion of gases (primarily N2) from the bloodstream. Bacterial metabolism yields significant volumes of\\nH2, CH4, and CO2.\\nH2 is produced in large quantities in patients with malabsorption syndromes and after ingestion of certain\\nfruits and vegetables containing indigestible carbohydrates (eg, baked beans), sugars (eg, fructose), or\\nsugar alcohols (eg, sorbitol). In patients with disaccharidase deficiencies (most commonly lactase\\ndeficiency), large amounts of disaccharides pass into the colon and are fermented to H2. Celiac disease,\\ntropical sprue, pancreatic insufficiency, and other causes of carbohydrate malabsorption should also be\\nconsidered in cases of excess colonic gas.\\nCH4 is also produced by colonic bacterial metabolism of the same foods (eg, dietary fiber). However,\\nabout 10% of people have bacteria that produce CH4 but not H2.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 8. Approach to the Patient With Lower GI Complaints\\n140'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 149, 'source_type': 'Authorotative', 'priority': '1'}, page_content='CO2 is also produced by bacterial metabolism and generated in the reaction of HCO3- and H+. H+ may\\ncome from gastric HCl or from fatty acids released during digestion of fats—the latter sometimes\\nproduces several hundred mEq of H+. The acid products released by bacterial fermentation of\\nunabsorbed carbohydrates in the colon may also react with HCO3- to produce CO2. Although bloating\\nmay occasionally occur, the rapid diffusion of CO2 into the blood generally prevents distention.\\n[Table 8-5. Some Causes of Gas-Related Complaints]\\nDiet accounts for much of the variation in flatus production among individuals, but poorly understood\\nfactors (eg, differences in colonic flora and motility) may also play a role.\\nDespite the flammable nature of the H2 and CH4 in flatulence, working near open flames is not\\nhazardous. However, gas explosion, even with fatal outcome, has been reported during jejunal and\\ncolonic surgery and colonoscopy, when diathermy was used during procedures in patients with'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 149, 'source_type': 'Authorotative', 'priority': '1'}, page_content='hazardous. However, gas explosion, even with fatal outcome, has been reported during jejunal and\\ncolonic surgery and colonoscopy, when diathermy was used during procedures in patients with\\nincomplete bowel cleaning.\\nEvaluation\\nHistory: Patients with belching should have the history directed at finding the cause of aerophagia,\\nespecially dietary causes.\\nIn patients complaining of gas, bloating, or flatus, the relationship between symptoms and meals (both\\ntiming and type and amount of food), bowel movements, and exertion should be explored. Certain\\npatients, particularly in the acute setting, may use the term \"gas\" to describe their symptoms of coronary\\nischemia. Changes in frequency and color and consistency of stool are sought. History of weight loss is\\nnoted.\\nPhysical examination: The examination is generally normal, but in patients with bloating or flatus, signs\\nof an underlying organic disorder should be sought on abdominal, rectal, and (for women) pelvic\\nexamination.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 149, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of an underlying organic disorder should be sought on abdominal, rectal, and (for women) pelvic\\nexamination.\\nRed flags: The following findings are of concern:\\n• Weight loss\\n• Blood in stool (occult or gross)\\nInterpretation of findings: Chronic, recurrent bloating or distention relieved by defecation and\\nassociated with change in frequency or consistency of stool but without red flag findings suggests irritable\\nbowel syndrome.\\nLong-standing symptoms in an otherwise well young person who has not lost weight are unlikely to be\\ncaused by serious physiologic disease, although an eating disorder should be considered, particularly in\\nyoung women. Bloating accompanied by diarrhea, weight loss, or both (or only after ingestion of certain\\nfoods) suggests a malabsorption syndrome.\\nTesting: Testing is not indicated for belching unless other symptoms suggest a particular disorder.\\nTesting for carbohydrate intolerance (eg, lactose, fructose) with breath tests should be considered'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 149, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Testing: Testing is not indicated for belching unless other symptoms suggest a particular disorder.\\nTesting for carbohydrate intolerance (eg, lactose, fructose) with breath tests should be considered\\nparticularly when the history suggests significant consumption of these sugars. Testing for small-bowel\\nbacterial overgrowth should also be considered, particularly in patients who also have diarrhea, weight\\nloss, or both, preferably by aerobic and anaerobic culture of small-bowel aspirates obtained during upper\\nGI endoscopy. Testing for bacterial overgrowth with H2 breath tests, generally glucose-H2 breath tests, is\\nprone to false-positive (ie, with rapid transit) and false-negative (ie, when there are no H2-producing\\nbacteria) results. New, persistent bloating in middle-aged or older women (or those with an abnormal\\npelvic examination) should prompt pelvic ultrasonography to rule out ovarian cancer.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 149, 'source_type': 'Authorotative', 'priority': '1'}, page_content='pelvic examination) should prompt pelvic ultrasonography to rule out ovarian cancer.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 8. Approach to the Patient With Lower GI Complaints\\n141'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 150, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Treatment\\nBelching and bloating are difficult to relieve because they are usually caused by unconscious aerophagia\\nor increased sensitivity to normal amounts of gas. Aerophagia may be reduced by eliminating gum and\\ncarbonated beverages, cognitive behavioral techniques to prevent air swallowing, and management of\\nassociated upper GI diseases (eg, peptic ulcer). Foods containing unabsorbable carbohydrates should be\\navoided. Even lactose-intolerant patients generally tolerate up to 1 glass of milk drunk in small amounts\\nthroughout the day. The mechanism of repeated belching should be explained and demonstrated. When\\naerophagia is troublesome, behavioral therapy to encourage open-mouth, diaphragmatic breathing and\\nminimize swallowing may be effective.\\nSidebar 8-1 Essay on Flatulence\\n(First printed in the 14th Edition of The Merck Manual)\\nFlatulence, which can cause great psychosocial distress, is unofficially described according to its salient'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 150, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Sidebar 8-1 Essay on Flatulence\\n(First printed in the 14th Edition of The Merck Manual)\\nFlatulence, which can cause great psychosocial distress, is unofficially described according to its salient\\ncharacteristics: (1) the \"slider\" (crowded elevator type), which is released slowly and noiselessly,\\nsometimes with devastating effect; (2) the open sphincter, or \"pooh\" type, which is said to be of higher\\ntemperature and more aromatic; (3) the staccato or drumbeat type, pleasantly passed in privacy; and (4)\\nthe \"bark\" type (described in a personal communication) is characterized by a sharp exclamatory eruption\\nthat effectively interrupts (and often concludes) conversation. Aromaticity is not a prominent feature.\\nRarely, this usually distressing symptom has been turned to advantage, as with a Frenchman referred to\\nas \"Le Petomane,\" who became affluent as an effluent performer who played tunes with the gas from his\\nrectum on the Moulin Rouge stage.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 150, 'source_type': 'Authorotative', 'priority': '1'}, page_content='as \"Le Petomane,\" who became affluent as an effluent performer who played tunes with the gas from his\\nrectum on the Moulin Rouge stage.\\nDrugs provide little benefit. Results with simethicone, an agent that breaks up small gas bubbles, and\\nvarious anticholinergics are poor. Some patients with dyspepsia and postprandial upper abdominal\\nfullness benefit from antacids, a low dose of tricyclic antidepressants (eg, nortriptyline 10 to 50 mg po\\nonce/day), or both to reduce visceral hypersensitivity.\\nComplaints of excess flatus are treated with avoidance of triggering substances (see Table 8-5).\\nRoughage (eg, bran, psyllium seed) may be added to the diet to try to increase colonic transit; however,\\nin some patients, worsening of symptoms may result. Activated charcoal can sometimes help reduce gas\\nand unpleasant odor; however, it stains clothing and the oral mucosa. Charcoal-lined undergarments are'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 150, 'source_type': 'Authorotative', 'priority': '1'}, page_content='and unpleasant odor; however, it stains clothing and the oral mucosa. Charcoal-lined undergarments are\\navailable. Probiotics (eg, VSL#3) may also reduce bloating and flatulence by modulating intestinal\\nbacterial flora. Antibiotics are useful in patients with documented bacterial overgrowth.\\nFunctional bloating, distention, and flatus may run an intermittent, chronic course that is only partially\\nrelieved by therapy. When appropriate, reassurance that these problems are not detrimental to health is\\nimportant.\\nKey Points\\n• Testing should be guided by the clinical features.\\n• Clinicians should be wary of new-onset, persistent symptoms in older patients.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 8. Approach to the Patient With Lower GI Complaints\\n142'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 151, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chapter 9. Diagnostic and Therapeutic GI Procedures\\nIntroduction\\nDiagnostic tests and therapeutic procedures available for patients with GI disorders include acid-related\\ntests, endoscopy, laparoscopy, manometry, nuclear scans, x-ray contrast studies, nasogastric or intestinal\\nintubation, anoscopy and sigmoidoscopy, abdominal paracentesis, electrogastrography, and electrical\\nimpedance testing. CT, MRI, and ultrasonography are also commonly done for GI disorders, and\\nsometimes angiography is used. The selection of procedures is discussed in subsequent chapters.\\nERCP, percutaneous transhepatic cholangiography, and liver biopsy are discussed in Ch. 24.\\nAcid-Related Tests\\nAcid-related tests are used to ascertain the effectiveness of acid-blocking drugs. All require nasogastric or\\nnasoesophageal intubation. Complications are very rare. Patients must have nothing by mouth (npo) after\\nmidnight.\\nAmbulatory pH Monitoring'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 151, 'source_type': 'Authorotative', 'priority': '1'}, page_content='nasoesophageal intubation. Complications are very rare. Patients must have nothing by mouth (npo) after\\nmidnight.\\nAmbulatory pH Monitoring\\nAmbulatory 24-h esophageal pH monitoring is currently the best available test for quantifying esophageal\\nacid exposure. The principal indications are\\n• To document excessive acid exposure in patients without endoscopic evidence of esophagitis\\n• To evaluate the effectiveness of medical or surgical treatments\\nA thin tube containing a pH probe is positioned 5 cm above the lower esophageal sphincter. The patient\\nrecords symptoms, meals, and sleep for 24 h. Esophageal acid exposure is defined by the percentage of\\nthe 24-h recording time that the pH is < 4.0. Values > 3.5% are considered abnormal. However, symptoms\\nmay not correlate with acid exposure or the presence of esophagitis. This may be because symptoms\\nmay result from nonacidic as well as acidic refluxate. Multichannel intraluminal impedance testing allows'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 151, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"may result from nonacidic as well as acidic refluxate. Multichannel intraluminal impedance testing allows\\nfor recognition of major acid, minor acid, nonacid, and gas reflux, all of which can cause reflux symptoms.\\nGastric Analysis\\nSamples of stomach contents obtained via NGT are used to measure gastric acid output in a basal and\\nstimulated state. This information may be useful in a patient who develops a recurrent ulcer after surgical\\nvagotomy for peptic ulcer disease. In this case, a positive acid response to stimulation (sham feeding)\\nindicates an incomplete vagotomy. The test also is used to evaluate a patient with elevated serum gastrin\\nlevels. Hyperchlorhydria in the presence of elevated gastrin usually indicates Zollinger-Ellison syndrome.\\nHypochlorhydria in the presence of elevated gastrin indicates impairment of acid output, such as occurs\\nin pernicious anemia, atrophic gastritis, and Menetrier's disease and after inhibition of gastric acid\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 151, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"in pernicious anemia, atrophic gastritis, and Menetrier's disease and after inhibition of gastric acid\\nsecretion by potent antisecretory drugs.\\nTo do gastric analysis, an NGT is inserted and the gastric contents are aspirated and discarded. Gastric\\njuice is then collected for 1 h, divided into four 15-min samples. These samples represent basal acid\\noutput.\\nEndoscopy\\nFlexible endoscopes equipped with video cameras can be used to view the upper GI tract from pharynx to\\nupper duodenum and the lower GI tract from anus to cecum (and, sometimes, terminal ileum). Several\\nother diagnostic and therapeutic interventions also can be done endoscopically. The potential to combine\\ndiagnosis and therapy in one procedure gives endoscopy a significant advantage over procedures that\\nprovide only imaging (eg, x-ray contrast studies, CT, MRI) and often outweighs endoscopy's higher cost\\nand need for sedation.\\nDiagnostic procedures include the use of ultrasound-equipped endoscopes to evaluate blood flow or\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 151, 'source_type': 'Authorotative', 'priority': '1'}, page_content='and need for sedation.\\nDiagnostic procedures include the use of ultrasound-equipped endoscopes to evaluate blood flow or\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 9. Diagnostic & Therapeutic GI Procedures\\n143'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 152, 'source_type': 'Authorotative', 'priority': '1'}, page_content='provide imaging of lesions. Endoscopic ultrasound can provide information (eg, the depth and extent of\\nlesions) that is not available via conventional endoscopy. Other diagnostic procedures include cell and\\ntissue sample collection by brush or biopsy forceps.\\nScreening colonoscopy is recommended for patients at high risk of colon cancer and for everyone ≥ 50.\\nColonoscopy should be done every 10 yr for patients with no risk factors and with a normal initial\\ncolonoscopy. CT colonography (see p. 98) is an alternative to colonoscopy for screening for colonic\\ntumors.\\nTherapeutic endoscopic procedures include removal of foreign bodies; hemostasis by thermal\\ncoagulation, laser photocoagulation, variceal banding, or sclerotherapy; debulking of tumors by laser or\\nbipolar electrocoagulation; dilation of webs or strictures; stent placement; reduction of volvulus or\\nintussusception; and decompression of acute or subacute colonic dilatation.\\nAbsolute contraindications to endoscopy include\\n• Shock'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 152, 'source_type': 'Authorotative', 'priority': '1'}, page_content='intussusception; and decompression of acute or subacute colonic dilatation.\\nAbsolute contraindications to endoscopy include\\n• Shock\\n• Acute MI\\n• Peritonitis\\n• Acute perforation\\n• Fulminant colitis\\nRelative contraindications include poor patient cooperation, coma (unless the patient is intubated), and\\ncardiac arrhythmias or recent myocardial ischemia.\\nPatients taking anticoagulants or chronic NSAID therapy can safely undergo diagnostic endoscopy.\\nHowever, if there is a possibility that biopsy or photocoagulation will be done, these drugs should be\\nstopped for an appropriate interval before the procedure. Oral iron-containing drugs should be stopped 4\\nto 5 days before colonoscopy, because certain green vegetables interact with iron to form a sticky residue\\nthat is difficult to remove with a bowel preparation and interferes with visualization. The American Heart\\nAssociation no longer recommends endocarditis prophylaxis for patients having GI endoscopy.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 152, 'source_type': 'Authorotative', 'priority': '1'}, page_content='that is difficult to remove with a bowel preparation and interferes with visualization. The American Heart\\nAssociation no longer recommends endocarditis prophylaxis for patients having GI endoscopy.\\nRoutine preparations for endoscopy include no solids for 6 to 8 h and no liquids for 4 h before the\\nprocedure. Additionally, colonoscopy requires cleansing of the colon. A variety of regimens may be used,\\nbut all typically include a full or clear liquid diet for 24 to 48 h and some type of laxative, with or without an\\nenema. A common laxative preparation involves having the patient drink a high-volume (4 L) balanced\\nelectrolyte solution over a period of 3 to 4 h before the procedure. Patients who cannot tolerate this\\nsolution may be given Mg citrate, Na phosphate, lactulose, or other laxatives. Enemas can be done with\\neither Na phosphate or tap water. Phosphate preparations should not be used in patients with renal\\ninsufficiency.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 152, 'source_type': 'Authorotative', 'priority': '1'}, page_content='either Na phosphate or tap water. Phosphate preparations should not be used in patients with renal\\ninsufficiency.\\nEndoscopy generally requires IV sedation and, for upper endoscopy, topical anesthesia of the throat.\\nExceptions are anoscopy and sigmoidoscopy (see p. 98), which generally require nothing. The overall\\ncomplication rate of endoscopy is 0.1 to 0.2%; mortality is about 0.03%. Complications are usually drug\\nrelated (eg, respiratory depression); procedural complications (eg, aspiration, perforation, significant\\nbleeding) are less common.\\nVideo capsule endoscopy: In video capsule endoscopy (wireless video endoscopy), patients swallow a\\ncapsule containing a camera that transmits images to an external recorder. This noninvasive technology\\nprovides diagnostic imaging of the small bowel that is otherwise difficult to obtain. This procedure is\\nparticularly useful in patients with occult GI bleeding. Capsule endoscopy is more difficult in the colon;'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 152, 'source_type': 'Authorotative', 'priority': '1'}, page_content='particularly useful in patients with occult GI bleeding. Capsule endoscopy is more difficult in the colon;\\nproducts and procedures are under development.\\nLaparoscopy\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 9. Diagnostic & Therapeutic GI Procedures\\n144'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 153, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Diagnostic laparoscopy is a surgical procedure used to evaluate intra-abdominal or pelvic pathology (eg,\\ntumor, endometriosis) in patients with acute or chronic abdominal pain and operability in patients with\\ncancer. It also is used for lymphoma staging and liver biopsy.\\nAbsolute contraindications include\\n• A coagulation or bleeding disorder\\n• Poor patient cooperation\\n• Peritonitis\\n• Intestinal obstruction\\n• Infection of the abdominal wall\\nRelative contraindications include severe cardiac or pulmonary disease, large abdominal hernias, multiple\\nabdominal operations, and tense ascites.\\nCBC, coagulation studies, and type and Rh testing are done before laparoscopy. X-rays of the chest and\\nabdomen (kidneys, ureters, and bladder) are also taken. Laparoscopy is done with sterile technique in an\\noperating room or a well-equipped endoscopy suite. The patient is given local anesthesia plus IV sedation\\nand analgesia with an opioid and short-acting sedative (eg, midazolam, propofol).'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 153, 'source_type': 'Authorotative', 'priority': '1'}, page_content='operating room or a well-equipped endoscopy suite. The patient is given local anesthesia plus IV sedation\\nand analgesia with an opioid and short-acting sedative (eg, midazolam, propofol).\\nThe procedure involves insertion of a pneumoperitoneum needle into the peritoneal cavity and infusion of\\nnitrous oxide to distend the abdomen. After the opening is enlarged, a peritoneoscope is inserted into the\\nabdomen and the abdominal contents are examined. Surgical instruments for biopsy and other\\nprocedures are inserted through separate openings. When the procedure is completed, the nitrous oxide\\nis expelled by the patient with a Valsalva maneuver and the cannula is removed. Complications can\\ninclude bleeding, bacterial peritonitis, and perforation of a viscus.\\nManometry\\nManometry is measurement of pressure within various parts of the GI tract. It is done by passing a\\ncatheter containing solid-state or liquid-filled pressure transducers through the mouth or anus into the'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 153, 'source_type': 'Authorotative', 'priority': '1'}, page_content='catheter containing solid-state or liquid-filled pressure transducers through the mouth or anus into the\\nlumen of the organ to be studied. Manometry typically is done to evaluate motility disorders in patients in\\nwhom structural lesions have been ruled out by other studies. Manometry is used in the esophagus,\\nstomach and duodenum, sphincter of Oddi, and rectum. Aside from minor discomfort, complications are\\nvery rare. Patients must have nothing by mouth (npo) after midnight.\\nEsophageal manometry: This test is used to evaluate patients with dysphagia, heartburn, or chest\\npain. It measures the pressure in the upper and lower esophageal sphincters, determines the\\neffectiveness and coordination of propulsive movements, and detects abnormal contractions. Manometry\\nis used to diagnose achalasia, diffuse spasm, systemic sclerosis, and lower esophageal sphincter\\nhypotension and hypertension. It also is used to evaluate esophageal function before certain therapeutic'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 153, 'source_type': 'Authorotative', 'priority': '1'}, page_content='hypotension and hypertension. It also is used to evaluate esophageal function before certain therapeutic\\nprocedures (eg, antireflux surgery, pneumatic dilation for achalasia).\\nGastroduodenal manometry: In this test, transducers are placed in the gastric antrum, duodenum, and\\nproximal jejunum. Pressure is monitored for 5 to 24 h in both fasting and fed states. This test is used\\nmainly in patients who have symptoms suggestive of dysmotility but normal gastric emptying studies.\\nBarostat: This is a pressure-sensing device that is placed in the stomach to measure gastric\\naccommodation. The device consists of a plastic balloon and an electronic controller that varies the\\namount of air in the balloon to maintain constant pressure. This device is used mainly in research studies\\nassessing sensory threshold and altered visceral perception, particularly in functional GI disorders.\\nAnorectal manometry: This test evaluates the anorectal sphincter mechanism and rectal sensation in'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 153, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Anorectal manometry: This test evaluates the anorectal sphincter mechanism and rectal sensation in\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 9. Diagnostic & Therapeutic GI Procedures\\n145'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 154, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"patients with incontinence (and sometimes constipation) by means of a pressure transducer in the anus. It\\ncan help diagnose Hirschsprung's disease and provide biofeedback training for fecal incontinence.\\nNuclear Scans\\nGastric emptying can be measured by having the patient ingest a radiolabeled meal (solid or liquid) and\\nobserving its passage out of the stomach with a gamma camera. Because this test cannot differentiate\\nphysical obstruction from gastroparesis, further diagnostic studies typically are done if emptying is\\ndelayed. The test also is useful in monitoring response to promotility drugs (eg, metoclopramide,\\nerythromycin).\\nBleeding scans use 99mTc-labeled RBCs, or occasionally 99mTc-labeled colloid, to determine the origin\\nof lower GI hemorrhage before surgery or angiography. Active bleeding sites are identified by focal areas\\nof tracer that conform to bowel anatomy, increase with time, and move with peristalsis. Bleeding scans\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 154, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"of tracer that conform to bowel anatomy, increase with time, and move with peristalsis. Bleeding scans\\nare useful mainly for colonic bleeding in patients with significant hemorrhage and an unprepared bowel, in\\nwhom endoscopic visualization is difficult.\\nA Meckel scan identifies ectopic gastric mucosa (as in a Meckel's diverticulum) by using an injection of\\n99mTc pertechnetate, which is taken up by mucus-secreting cells of the gastric mucosa. Focal uptake\\noutside of the stomach and in the small bowel indicates a Meckel's diverticulum.\\nX-Ray and Other Imaging Contrast Studies\\nX-ray and other imaging contrast studies visualize the entire GI tract from pharynx to rectum and are most\\nuseful for detecting mass lesions and structural abnormalities (eg, tumors, strictures). Single-contrast\\nstudies fill the lumen with radiopaque material, outlining the structure. Better, more detailed images are\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 154, 'source_type': 'Authorotative', 'priority': '1'}, page_content='studies fill the lumen with radiopaque material, outlining the structure. Better, more detailed images are\\nobtained from double-contrast studies, in which a small amount of high-density barium coats the mucosal\\nsurface and gas distends the organ and enhances contrast. The gas is injected by the operator in double-\\ncontrast barium enema, whereas in other studies, intrinsic GI tract gas is adequate. In all cases, patients\\nturn themselves to properly distribute the gas and barium. Fluoroscopy can monitor the progress of the\\ncontrast material. Either video or plain films can be taken for documentation, but video is particularly\\nuseful when assessing motor disorders (eg, cricopharyngeal spasm, achalasia).\\nThe main contraindication to x-ray contrast studies is suspected perforation, because free barium is\\nhighly irritating to the mediastinum and peritoneum; water-soluble contrast is less irritating and may be'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 154, 'source_type': 'Authorotative', 'priority': '1'}, page_content='highly irritating to the mediastinum and peritoneum; water-soluble contrast is less irritating and may be\\nused if perforation is possible. Older patients may have difficulty turning themselves to properly distribute\\nthe barium and intraluminal gas.\\nPatients having upper GI x-ray contrast studies must have nothing by mouth (npo) after midnight. Patients\\nhaving barium enema follow a clear liquid diet the day before, take an oral Na phosphate laxative in the\\nafternoon, and take a bisacodyl suppository in the evening. Other laxative regimens are effective.\\nComplications are rare. Perforation can occur if barium enema is done in a patient with toxic megacolon.\\nBarium impaction may be prevented by postprocedure oral fluids and sometimes laxatives.\\nAn upper GI examination is best done as a biphasic study beginning with a double-contrast examination\\nof the esophagus, stomach, and duodenum, followed by a single-contrast study using low-density barium.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 154, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of the esophagus, stomach, and duodenum, followed by a single-contrast study using low-density barium.\\nGlucagon 0.5 mg IV can facilitate the examination by causing gastric hypotonia.\\nA small-bowel meal is done by using fluoroscopy and provides a more detailed evaluation of the small\\nbowel. Shortly before the examination, the patient is given metoclopramide 20 mg po to hasten transit of\\nthe contrast material.\\nEnteroclysis (small-bowel enema) provides still better visualization of the small bowel but requires\\nintubation of the duodenum with a flexible, balloon-tipped catheter. A barium suspension is injected,\\nfollowed by a solution of methylcellulose, which functions as a double-contrast agent that enhances\\nvisualization of the small-bowel mucosa.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 9. Diagnostic & Therapeutic GI Procedures\\n146'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 155, 'source_type': 'Authorotative', 'priority': '1'}, page_content='A barium enema can be done as a single-or double-contrast study. Single-contrast barium enemas are\\nused for potential obstruction, diverticulitis, fistulas, and megacolon. Double-contrast studies are\\npreferred for detection of tumors.\\nCT scanning of the abdomen: CT scanning using oral and IV contrast allows excellent visualization of\\nboth the small bowel and colon as well as of other intra-abdominal structures.\\nCT enterography provides optimal visualization of the small-bowel mucosa; it is preferably done by\\nusing a multidetector CT (MDCT) scanner. Patients are given a large volume (1350 mL) of 0.1% barium\\nsulfate before imaging. For certain indications (eg, obscure GI bleeding, small-bowel tumors, chronic\\nischemia), a biphasic contrast-enhanced MDCT study is done.\\nCT colonography (virtual colonoscopy) generates 3D and 2D images of the colon by using MDCT and a\\ncombination of oral contrast and gas distention of the colon. Viewing the high-resolution 3D images'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 155, 'source_type': 'Authorotative', 'priority': '1'}, page_content='CT colonography (virtual colonoscopy) generates 3D and 2D images of the colon by using MDCT and a\\ncombination of oral contrast and gas distention of the colon. Viewing the high-resolution 3D images\\nsomewhat simulates the appearance of optical endoscopy, hence the name. Optimal CT colonography\\ntechnique requires careful cleansing and distention of the colon. Residual stool causes problems similar\\nto those encountered with barium enema because it simulates polyps or masses. Three-dimensional\\nendoluminal images are useful to confirm the presence of a lesion and to improve diagnostic confidence.\\nCT enterography and CT colonoscopy have largely supplanted standard small-bowel series and barium\\nenema examinations.\\nGI Procedures for the Generalist\\nNasogastric or Intestinal Intubation\\nNasogastric or intestinal intubation is used to decompress the stomach. It is used to treat gastric atony,\\nileus, or obstruction; remove ingested toxins, give antidotes (eg, activated charcoal), or both; obtain a'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 155, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"ileus, or obstruction; remove ingested toxins, give antidotes (eg, activated charcoal), or both; obtain a\\nsample of gastric contents for analysis (volume, acid content, blood); and supply nutrients.\\nContraindications include\\n• Nasopharyngeal or esophageal obstruction\\n• Severe maxillofacial trauma\\n• Uncorrected coagulation abnormalities\\nEsophageal varices previously have been considered a contraindication, but evidence of adverse effects\\nis lacking.\\nSeveral types of tubes are available. A Levin or Salem sump tube is used for gastric decompression or\\nanalysis and rarely for short-term feeding. A variety of long, thin, intestinal tubes are used for long-term\\nenteral feeding (see p. 21).\\nFor intubation, the patient sits upright or, if unable, lies in the left lateral decubitus position. A topical\\nanesthetic sprayed in the nose and pharynx helps reduce discomfort. With the patient's head partially\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 155, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"anesthetic sprayed in the nose and pharynx helps reduce discomfort. With the patient's head partially\\nflexed, the lubricated tube is inserted through the nares and aimed back and then down to conform to the\\nnasopharynx. As the tip reaches the posterior pharyngeal wall, the patient should sip water through a\\nstraw. Violent coughing with flow of air through the tube during respiration indicates that the tube is\\nmisplaced in the trachea. Aspiration of gastric juice verifies entry into the stomach. The position of larger\\ntubes can be confirmed by instilling 20 to 30 mL of air and listening with the stethoscope under the left\\nsubcostal region for a rush of air.\\nSome smaller, more flexible intestinal feeding tubes require the use of stiffening wires or stylets. These\\ntubes usually require fluoroscopic or endoscopic assistance for passage through the pylorus.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 9. Diagnostic & Therapeutic GI Procedures\\n147\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 156, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Complications are rare and include nasopharyngeal trauma with or without hemorrhage, pulmonary\\naspiration, traumatic esophageal or gastric hemorrhage or perforation, and (very rarely) intracranial or\\nmediastinal penetration.\\nAnoscopy and Sigmoidoscopy\\nAnoscopy and sigmoidoscopy are used to evaluate symptoms referable to the rectum or anus (eg, bright\\nrectal bleeding, discharge, protrusions, pain). There are no absolute contraindications. Patients with\\ncardiac arrhythmias or recent myocardial ischemia should have the procedure postponed until the\\ncomorbid conditions improve; otherwise, patients will need cardiac monitoring. Per changes in American\\nHeart Association guidelines, these procedures no longer require endocarditis prophylaxis.\\nThe perianal area and distal rectum can be examined with a 7-cm anoscope, and the rectum and sigmoid\\nwith either a rigid 25-cm or a flexible 60-cm instrument. Flexible sigmoidoscopy is much more comfortable'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 156, 'source_type': 'Authorotative', 'priority': '1'}, page_content='with either a rigid 25-cm or a flexible 60-cm instrument. Flexible sigmoidoscopy is much more comfortable\\nfor the patient and readily permits photography and biopsy of tissue. Considerable skill is required to pass\\na rigid sigmoidoscope beyond the rectosigmoid junction (15 cm) without causing discomfort.\\nSigmoidoscopy is done after giving an enema to empty the rectum. IV drugs are usually not needed. The\\npatient is placed in the left lateral position. After external inspection and digital rectal examination, the\\nlubricated instrument is gently inserted 3 to 4 cm past the anal sphincter. At this point, the obturator of the\\nrigid sigmoidoscope is removed, and the instrument is inserted further under direct vision.\\nAnoscopy may be done without preparation. The anoscope is inserted its full length as described above\\nfor rigid sigmoidoscopy, usually with the patient in the left lateral position. Complications are exceedingly\\nrare when the procedure is done properly.\\nAbdominal Paracentesis'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 156, 'source_type': 'Authorotative', 'priority': '1'}, page_content='for rigid sigmoidoscopy, usually with the patient in the left lateral position. Complications are exceedingly\\nrare when the procedure is done properly.\\nAbdominal Paracentesis\\nAbdominal paracentesis is used to obtain ascitic fluid for testing. It also can be used to remove tense\\nascites causing respiratory difficulties or pain or as a treatment for chronic ascites.\\nAbsolute contraindications include\\n• Severe, uncorrectable disorders of blood coagulation\\n• Intestinal obstruction\\n• An infected abdominal wall\\nPoor patient cooperation, surgical scarring over the puncture area, and severe portal hypertension with\\nabdominal collateral circulation are relative contraindications.\\nCBC, platelet count, and coagulation studies are done before the procedure. After emptying the bladder,\\nthe patient sits in bed with the head elevated 45 to 90°. In patients with obvious and marked ascites, a\\npoint is located at the midline between the umbilicus and the pubic bone and is cleaned with an antiseptic'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 156, 'source_type': 'Authorotative', 'priority': '1'}, page_content='point is located at the midline between the umbilicus and the pubic bone and is cleaned with an antiseptic\\nsolution and alcohol. In patients with moderate ascites, precise location of ascitic fluid by abdominal\\nultrasound is indicated. Under sterile technique, the area is anesthetized to the peritoneum with lidocaine\\n1%. For diagnostic paracentesis, an 18-gauge needle attached to a 50-mL syringe is inserted through the\\nperitoneum (generally a popping sensation is noted). Fluid is gently aspirated and sent for cell count,\\nprotein or amylase content, cytology, or culture as needed. For therapeutic (large-volume) paracentesis, a\\n14-gauge cannula attached to a vacuum aspiration system is used to collect up to 8 L of ascitic fluid.\\nPostprocedure hypotension caused by fluid redistribution is rare as long as interstitial (leg) edema is\\npresent.\\nHemorrhage is the most common complication. Occasionally, with tense ascites, prolonged leakage of\\nascitic fluid occurs through the needle site.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 156, 'source_type': 'Authorotative', 'priority': '1'}, page_content='present.\\nHemorrhage is the most common complication. Occasionally, with tense ascites, prolonged leakage of\\nascitic fluid occurs through the needle site.\\nOther Testing Procedures\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 9. Diagnostic & Therapeutic GI Procedures\\n148'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 157, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Electrogastrography measures gastric electrical activity with adhesive cutaneous electrodes. This\\nprocedure is useful in patients with gastroparesis.\\nIn electrical impedance testing, an electrical sensor is placed in the distal esophagus to assess\\nnonacid reflux, which is common among patients receiving gastric antisecretory drugs and among infants\\nwith reflux disease.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 9. Diagnostic & Therapeutic GI Procedures\\n149'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 158, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chapter 10. GI Bleeding\\nIntroduction\\nGI bleeding can originate anywhere from the mouth to the anus and can be overt or occult. The\\nmanifestations depend on the location and rate of bleeding.\\nHematemesis is vomiting of red blood and indicates upper GI bleeding, usually from an arterial source or\\nvarix. Coffee-ground emesis is vomiting of dark brown, granular material that resembles coffee grounds. It\\nresults from upper GI bleeding that has slowed or stopped, with conversion of red Hb to brown hematin\\nby gastric acid.\\nHematochezia is the passage of gross blood from the rectum and usually indicates lower GI bleeding but\\nmay result from vigorous upper GI bleeding with rapid transit of blood through the intestines.\\nMelena is black, tarry stool and typically indicates upper GI bleeding, but bleeding from a source in the\\nsmall bowel or right colon may also be the cause. About 100 to 200 mL of blood in the upper GI tract is'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 158, 'source_type': 'Authorotative', 'priority': '1'}, page_content='small bowel or right colon may also be the cause. About 100 to 200 mL of blood in the upper GI tract is\\nrequired to cause melena, which may persist for several days after bleeding has ceased. Black stool that\\ndoes not contain occult blood may result from ingestion of iron, bismuth, or various foods and should not\\nbe mistaken for melena.\\nChronic occult bleeding can occur from anywhere in the GI tract and is detectable by chemical testing of a\\nstool specimen. Acute, severe bleeding also can occur from anywhere in the GI tract. Patients may\\npresent with signs of shock. Those with underlying ischemic heart disease may develop angina or MI\\nbecause of hypoperfusion.\\nGI bleeding may precipitate portal-systemic encephalopathy (see p. 220) or hepatorenal syndrome\\n(kidney failure secondary to liver failure—see p. 223).\\nEtiology\\nThere are many possible causes (see\\nTable 10-1), which are divided into upper GI (above the ligament of Treitz), lower GI, and small bowel.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 158, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Etiology\\nThere are many possible causes (see\\nTable 10-1), which are divided into upper GI (above the ligament of Treitz), lower GI, and small bowel.\\nBleeding of any cause is more likely, and potentially more severe, in patients with chronic liver disease\\n(eg, caused by alcohol abuse or chronic hepatitis), in those with hereditary coagulation disorders, or in\\nthose taking certain drugs. Drugs associated with GI bleeding include anticoagulants (eg, heparin,\\nwarfarin), those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and\\nthose affecting mucosal defenses (eg, NSAIDs).\\nEvaluation\\nStabilization with airway management, IV fluids, or transfusions is essential before and during diagnostic\\nevaluation.\\nHistory: History of present illness should attempt to ascertain quantity and frequency of blood\\npassage. However, quantity can be difficult to assess because even small amounts (5 to 10 mL) of blood'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 158, 'source_type': 'Authorotative', 'priority': '1'}, page_content='History: History of present illness should attempt to ascertain quantity and frequency of blood\\npassage. However, quantity can be difficult to assess because even small amounts (5 to 10 mL) of blood\\nturn water in a toilet bowl an opaque red, and modest amounts of vomited blood appear huge to an\\nanxious patient. However, most can distinguish among blood streaks, a few teaspoons, and clots.\\nPatients with hematemesis should be asked whether blood was passed with initial vomiting or only after\\nan initial (or several) nonbloody emesis.\\nPatients with rectal bleeding should be asked whether pure blood was passed; whether it was mixed with\\nstool, pus, or mucus; or whether blood simply coated the stool. Those with bloody diarrhea should be\\nasked about travel or other possible exposure to GI pathogens.\\n[Table 10-1. Common Causes of GI Bleeding]\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 10. GI Bleeding\\n150'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 159, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Review of symptoms should include presence of abdominal discomfort, weight loss, easy bleeding or\\nbruising, previous colonoscopy results, and symptoms of anemia (eg, weakness, easy fatigability,\\ndizziness).\\nPast medical history should inquire about previous GI bleeding (diagnosed or undiagnosed); known\\ninflammatory bowel disease, bleeding diatheses, and liver disease; and use of any drugs that increase\\nthe likelihood of bleeding or chronic liver disease (eg, alcohol).\\nPhysical examination: General examination focuses on vital signs and other indicators of shock or\\nhypovolemia (eg, tachycardia, tachypnea, pallor, diaphoresis, oliguria, confusion) and anemia (eg, pallor,\\ndiaphoresis). Patients with lesser degrees of bleeding may simply have mild tachycardia (heart rate >\\n100). Orthostatic changes in pulse (a change of > 10 beats/min) or BP (a drop of ≥ 10 mm Hg) often\\ndevelop after acute loss of ≥ 2 units of blood. However, orthostatic measurements are unwise in patients'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 159, 'source_type': 'Authorotative', 'priority': '1'}, page_content='develop after acute loss of ≥ 2 units of blood. However, orthostatic measurements are unwise in patients\\nwith severe bleeding (possibly causing syncope) and generally lack sensitivity and specificity as a\\nmeasure of intravascular volume, especially in elderly patients.\\nExternal stigmata of bleeding disorders (eg, petechiae, ecchymoses) are sought, as are signs of chronic\\nliver disease (eg, spider angiomas, ascites, palmar erythema) and portal hypertension (eg, splenomegaly,\\ndilated abdominal wall veins).\\nA digital rectal examination is necessary to search for stool color, masses, and fissures. Anoscopy is done\\nto diagnose hemorrhoids. Chemical testing of a stool specimen for occult blood completes the\\nexamination if gross blood is not present.\\nRed flags: Several findings suggest hypovolemia or hemorrhagic shock:\\n• Syncope\\n• Hypotension\\n• Pallor\\n• Diaphoresis\\n• Tachycardia\\nInterpretation of findings: The history and physical examination suggest a diagnosis in about 50% of'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 159, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Syncope\\n• Hypotension\\n• Pallor\\n• Diaphoresis\\n• Tachycardia\\nInterpretation of findings: The history and physical examination suggest a diagnosis in about 50% of\\npatients, but findings are rarely diagnostic and confirmatory testing is required.\\nEpigastric abdominal discomfort relieved by food or antacids suggests peptic ulcer disease. However,\\nmany patients with bleeding ulcers have no history of pain. Weight loss and anorexia, with or without a\\nchange in stool, suggest a GI cancer. A history of cirrhosis or chronic hepatitis suggests esophageal\\nvarices. Dysphagia suggests esophageal cancer or stricture. Vomiting and retching before the onset of\\nbleeding suggests a Mallory-Weiss tear of the esophagus, although about 50% of patients with Mallory-\\nWeiss tears do not have this history.\\nA history of bleeding (eg, purpura, ecchymosis, hematuria) may indicate a bleeding diathesis (eg,\\nhemophilia, hepatic failure). Bloody diarrhea, fever, and abdominal pain suggest ischemic colitis,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 159, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"A history of bleeding (eg, purpura, ecchymosis, hematuria) may indicate a bleeding diathesis (eg,\\nhemophilia, hepatic failure). Bloody diarrhea, fever, and abdominal pain suggest ischemic colitis,\\ninflammatory bowel disease (eg, ulcerative colitis, Crohn's disease), or an infectious colitis (eg, Shigella,\\nSalmonella, Campylobacter, amebiasis). Hematochezia suggests diverticulosis or angiodysplasia. Fresh\\nblood only on toilet paper or the surface of formed stools suggests internal hemorrhoids or fissures,\\nwhereas blood mixed with the stool indicates a more proximal source. Occult blood in the stool may be the\\nfirst sign of colon cancer or a polyp, particularly in patients > 45 yr.\\nBlood in the nose or trickling down the pharynx suggests the nasopharynx as the source. Spider\\nangiomas, hepatosplenomegaly, or ascites is consistent with chronic liver disease and hence possible\\nesophageal varices. Arteriovenous malformations, especially of the mucous membranes, suggest\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 159, 'source_type': 'Authorotative', 'priority': '1'}, page_content='angiomas, hepatosplenomegaly, or ascites is consistent with chronic liver disease and hence possible\\nesophageal varices. Arteriovenous malformations, especially of the mucous membranes, suggest\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 10. GI Bleeding\\n151'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 160, 'source_type': 'Authorotative', 'priority': '1'}, page_content='hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Cutaneous nail bed and GI\\ntelangiectasia may indicate systemic sclerosis or mixed connective tissue disease.\\nTesting: Several tests are done to help confirm the suspected diagnosis.\\n• CBC and often other laboratory studies\\n• NGT for all but those with minimal rectal bleeding\\n• Upper endoscopy for suspected upper GI bleeding\\n• Colonoscopy for lower GI bleeding (unless clearly caused by hemorrhoids)\\nCBC should be obtained in patients with occult blood loss. Those with more significant bleeding also\\nrequire coagulation studies (eg, platelet count, PT, PTT) and liver function tests (eg, bilirubin, alkaline\\nphosphatase, albumin, AST, ALT). Type and crossmatch are done if bleeding is ongoing. Hb and Hct may\\nbe repeated up to every 6 h in patients with severe bleeding. Additionally, one or more diagnostic\\nprocedures are typically required.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 160, 'source_type': 'Authorotative', 'priority': '1'}, page_content='be repeated up to every 6 h in patients with severe bleeding. Additionally, one or more diagnostic\\nprocedures are typically required.\\nNasogastric aspiration and lavage should be done in all patients with suspected upper GI bleeding (eg,\\nhematemesis, coffee-ground emesis, melena, massive rectal bleeding). Bloody nasogastric aspirate\\nindicates active upper GI bleeding, but about 10% of patients with upper GI bleeding have no blood in the\\nnasogastric aspirate. Coffee-ground material indicates bleeding that is slow or stopped. If there is no sign\\nof bleeding, and bile is returned, the NGT is removed; otherwise, it is left in place to monitor continuing or\\nrecurrent bleeding. Nonbloody, nonbilious return is considered a nondiagnostic aspirate.\\nUpper endoscopy (examination of the esophagus, stomach, and duodenum) should be done for upper GI\\nbleeding. Because endoscopy may be therapeutic as well as diagnostic, it should be done rapidly for'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 160, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Upper endoscopy (examination of the esophagus, stomach, and duodenum) should be done for upper GI\\nbleeding. Because endoscopy may be therapeutic as well as diagnostic, it should be done rapidly for\\nsignificant bleeding but may be deferred for 24 h if bleeding stops or is minimal. Upper GI barium x-rays\\nhave no role in acute bleeding, and the contrast used may obscure subsequent attempts at angiography.\\nAngiography is useful in the diagnosis of upper GI bleeding and permits certain therapeutic maneuvers\\n(eg, embolization, vasoconstrictor infusion).\\nFlexible sigmoidoscopy and anoscopy may be all that is required acutely for patients with symptoms\\ntypical of hemorrhoidal bleeding. All other patients with hematochezia should have colonoscopy, which\\ncan be done electively after routine preparation unless there is significant ongoing bleeding. In such\\npatients, a rapid prep (5 to 10 L of polyethylene glycol solution delivered via NGT or by mouth over 3 to 4'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 160, 'source_type': 'Authorotative', 'priority': '1'}, page_content='patients, a rapid prep (5 to 10 L of polyethylene glycol solution delivered via NGT or by mouth over 3 to 4\\nh) often allows adequate visualization. If colonoscopy cannot visualize the source and ongoing bleeding is\\nsufficiently rapid (> 0.5 to 1 mL/min), angiography may localize the source. Some angiographers first take\\na radionuclide scan to focus the examination, because angiography is less sensitive than the radionuclide\\nscan.\\nDiagnosis of occult bleeding can be difficult, because heme-positive stools may result from bleeding\\nanywhere in the GI tract. Endoscopy is the preferred method, with symptoms determining whether the\\nupper or lower GI tract is examined first. Double-contrast barium enema and sigmoidoscopy can be used\\nfor the lower tract when colonoscopy is unavailable or the patient refuses it. If the results of upper\\nendoscopy and colonoscopy are negative and occult blood persists in the stool, an upper GI series with'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 160, 'source_type': 'Authorotative', 'priority': '1'}, page_content='endoscopy and colonoscopy are negative and occult blood persists in the stool, an upper GI series with\\nsmall-bowel follow-through, small-bowel endoscopy (enteroscopy), capsule endoscopy, technetium-\\nlabeled colloid or RBC scan, and angiography should be considered.\\nTreatment\\n• Secure airway if needed\\n• IV fluid resuscitation\\n• Blood transfusion if needed\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 10. GI Bleeding\\n152'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 161, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• In some, angiographic or endoscopic hemostasis\\nHematemesis, hematochezia, or melena should be considered an emergency. Admission to an ICU, with\\nconsultation by both a gastroenterologist and a surgeon, is recommended for all patients with severe GI\\nbleeding. General treatment is directed at maintenance of the airway and restoration of circulating\\nvolume. Hemostasis and other treatment depend on the cause of the bleeding.\\nAirway: A major cause of morbidity and mortality in patients with active upper GI bleeding is aspiration of\\nblood with subsequent respiratory compromise. To prevent these problems, endotracheal intubation\\nshould be considered in patients who have inadequate gag reflexes or are obtunded or unconscious\\n—particularly if they will be undergoing upper endoscopy.\\nFluid resuscitation: IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see\\np. 2297): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 161, 'source_type': 'Authorotative', 'priority': '1'}, page_content='p. 2297): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia\\nremit—up to a maximum of 2 L (for children, 20 mL/kg, that may be repeated once). Patients requiring\\nfurther resuscitation should receive transfusion with packed RBCs. Transfusions continue until\\nintravascular volume is restored and then are given as needed to replace ongoing blood loss.\\nTransfusions in older patients or those with coronary artery disease may be stopped when Hct is stable at\\n30 unless the patient is symptomatic. Younger patients or those with chronic bleeding are usually not\\ntransfused unless Hct is < 23 or they have symptoms such as dyspnea or coronary ischemia.\\nPlatelet count should be monitored closely; platelet transfusion may be required with severe bleeding.\\nPatients who are taking antiplatelet drugs (eg, clopidogrel, aspirin) have platelet dysfunction, often'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 161, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Patients who are taking antiplatelet drugs (eg, clopidogrel, aspirin) have platelet dysfunction, often\\nresulting in increased bleeding. Platelet transfusion should be considered when patients taking these\\ndrugs have severe ongoing bleeding, although a residual circulating drug (particularly clopidogrel) may\\ninactivate transfused platelets. Fresh frozen plasma should be transfused after every 4 units of packed\\nRBCs.\\nHemostasis: GI bleeding stops spontaneously in about 80% of patients. The remaining patients require\\nsome type of intervention. Specific therapy depends on the bleeding site. Early intervention to control\\nbleeding is important to minimize mortality, particularly in elderly patients.\\nFor peptic ulcer, ongoing bleeding or rebleeding is treated with endoscopic coagulation (with bipolar\\nelectrocoagulation, injection sclerotherapy, heater probes, or laser). Non-bleeding vessels that are visible'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 161, 'source_type': 'Authorotative', 'priority': '1'}, page_content='electrocoagulation, injection sclerotherapy, heater probes, or laser). Non-bleeding vessels that are visible\\nwithin an ulcer crater are also treated. If endoscopy does not stop the bleeding, surgery is required to\\noversew the bleeding site. If medical management does not control gastric acid secretion, surgeons do\\nacid-reduction surgery (see p. 136) at the same time.\\nActive variceal bleeding can be treated with endoscopic banding, injection sclerotherapy, or a transjugular\\nintrahepatic portosystemic shunting (TIPS) procedure.\\nSevere, ongoing lower GI bleeding caused by diverticula or angiomas can sometimes be controlled\\ncolonoscopically by electrocautery, coagulation with a heater probe, or injection with dilute epinephrine.\\nPolyps can be removed by snare or cautery. If these methods are ineffective or unfeasible, angiography\\nwith embolization or vasopressin infusion may be successful. However, because collateral blood flow to'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 161, 'source_type': 'Authorotative', 'priority': '1'}, page_content='with embolization or vasopressin infusion may be successful. However, because collateral blood flow to\\nthe bowel is limited, angiographic techniques have a significant risk of bowel ischemia or infarction unless\\nsuper-selective catheterization techniques are used. In most series, the rate of ischemic complications is\\n< 5%. Vasopressin infusion has about an 80% success rate for stopping bleeding, but bleeding recurs in\\nabout 50% of patients. Also, there is a risk of hypertension and coronary ischemia. Furthermore,\\nangiography can be used to localize the source of bleeding more accurately. Surgery may be used in\\npatients with continued bleeding (requiring > 4 units transfusion/24 h), but localization of the bleeding site\\nis very important. Blind hemicolectomy (with no preoperative identification of the bleeding site) carries a\\nmuch higher mortality risk than does directed segmental resection. However, assessment must be\\nexpeditious so that surgery is not unnecessarily delayed.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 161, 'source_type': 'Authorotative', 'priority': '1'}, page_content='much higher mortality risk than does directed segmental resection. However, assessment must be\\nexpeditious so that surgery is not unnecessarily delayed.\\nAcute or chronic bleeding of internal hemorrhoids stops spontaneously in most cases. Patients with\\nrefractory bleeding are treated via anoscopy with rubber band ligation, injection, coagulation, or surgery.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 10. GI Bleeding\\n153'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 162, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Geriatrics Essentials\\nIn the elderly, hemorrhoids and colorectal cancer are the most common causes of minor bleeding. Peptic\\nulcer, diverticular disease, and angiodysplasia are the most common causes of major bleeding. Variceal\\nbleeding is less common than in younger patients.\\nMassive GI bleeding is tolerated poorly by elderly patients. Diagnosis must be made quickly, and\\ntreatment must be started sooner than in younger patients, who can better tolerate repeated episodes of\\nbleeding.\\nKey Points\\n• Rectal bleeding may result from upper or lower GI bleeding.\\n• Orthostatic changes in vital signs are unreliable markers for serious bleeding.\\n• About 80% of patients stop bleeding spontaneously; various endoscopic techniques are usually the first\\nchoice for the remainder.\\nVarices\\nVarices are dilated veins in the distal esophagus or proximal stomach caused by elevated\\npressure in the portal venous system, typically from cirrhosis. They may bleed massively but'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 162, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Varices\\nVarices are dilated veins in the distal esophagus or proximal stomach caused by elevated\\npressure in the portal venous system, typically from cirrhosis. They may bleed massively but\\ncause no other symptoms. Diagnosis is by upper endoscopy. Treatment is primarily with\\nendoscopic banding and IV octreotide. Sometimes a transjugular intrahepatic portosystemic\\nshunting procedure is needed.\\nPortal hypertension (see p. 218) results from a number of conditions, predominantly liver cirrhosis. If\\nportal pressure remains higher than inferior vena caval pressure for a significant period, venous\\ncollaterals develop. The most dangerous collaterals occur in the distal esophagus and gastric fundus,\\ncausing engorged, serpentine submucosal vessels known as varices. These varices partially decompress\\nportal hypertension but can rupture, causing massive GI bleeding. The trigger for variceal rupture is'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 162, 'source_type': 'Authorotative', 'priority': '1'}, page_content='portal hypertension but can rupture, causing massive GI bleeding. The trigger for variceal rupture is\\nunknown, but bleeding almost never occurs unless the portal/systemic pressure gradient is > 12 mm Hg.\\nCoagulopathies caused by liver disease may facilitate bleeding. NGT passage in a patient with varices\\nhas not been shown to trigger bleeding.\\nSymptoms and Signs\\nPatients typically present with sudden, painless, upper GI bleeding, often massive. Signs of shock may be\\npresent. Bleeding is usually from the distal esophagus, less often from the gastric fundus. Bleeding from\\ngastric varices also may be acute but is more often subacute or chronic.\\nBleeding into the GI tract may precipitate portal-systemic encephalopathy in patients with impaired\\nhepatic function.\\nDiagnosis\\n• Endoscopy\\n• Evaluation for coagulopathy\\nBoth esophageal and gastric varices are best diagnosed by endoscopy, which may also identify varices at'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 162, 'source_type': 'Authorotative', 'priority': '1'}, page_content='hepatic function.\\nDiagnosis\\n• Endoscopy\\n• Evaluation for coagulopathy\\nBoth esophageal and gastric varices are best diagnosed by endoscopy, which may also identify varices at\\nhigh risk of bleeding (eg, those with red markings). Endoscopy is also critical to exclude other causes of\\nacute bleeding (eg, peptic ulcer), even in patients known to have varices; perhaps as many as one third\\nof patients with known varices who have upper GI bleeding have a nonvariceal source.\\nBecause varices are typically associated with significant hepatic disease, evaluation for possible\\ncoagulopathy is important. Laboratory tests include CBC with platelets, PT, PTT, and liver function tests.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 10. GI Bleeding\\n154'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 163, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Bleeding patients should have type and crossmatch for 6 units of packed RBCs.\\nPrognosis\\nIn about 80% of patients, variceal bleeding stops spontaneously. Nevertheless, mortality is high, often >\\n50%. Mortality depends primarily on severity of the associated liver disease rather than on the bleeding\\nitself. Bleeding is often fatal in patients with severe hepatocellular impairment (eg, advanced cirrhosis),\\nwhereas patients with good hepatic reserve usually recover.\\nSurviving patients are at high risk of further variceal bleeding; typically, 50 to 75% have recurrence within\\n1 to 2 yr. Ongoing endoscopic or drug therapy significantly lowers this risk, but the overall effect on long-\\nterm mortality seems to be marginal, probably because of the underlying hepatic disease.\\nTreatment\\n• Fluid resuscitation\\n• Endoscopic banding (sclerotherapy second choice)\\n• IV octreotide\\n• Possibly a transjugular intrahepatic portosystemic shunting (TIPS) procedure'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 163, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Treatment\\n• Fluid resuscitation\\n• Endoscopic banding (sclerotherapy second choice)\\n• IV octreotide\\n• Possibly a transjugular intrahepatic portosystemic shunting (TIPS) procedure\\nManagement of hypovolemia and hemorrhagic shock is as described above and in Ch. 226. Patients with\\ncoagulation abnormalities (eg, elevated INR) should be given 1 to 2 units of fresh frozen plasma and 2.5\\nto 10 mg vitamin K IM (or IV if severe).\\nBecause varices are invariably diagnosed during endoscopy, primary treatment is endoscopic.\\nEndoscopic banding of varices is preferred over injection sclerotherapy. At the same time, IV octreotide (a\\nsynthetic analog of somatostatin, which may also be used) should be given. Octreotide increases\\nsplanchnic vascular resistance by inhibiting the release of splanchnic vasodilator hormones (eg,\\nglucagon, vasoactive intestinal peptide). The usual dose is a 50 μg IV bolus, followed by infusion of 50'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 163, 'source_type': 'Authorotative', 'priority': '1'}, page_content='glucagon, vasoactive intestinal peptide). The usual dose is a 50 μg IV bolus, followed by infusion of 50\\nμg/h. Octreotide is preferred over previously used agents such as vasopressin and terlipressin, because\\nit has fewer adverse effects.\\nIf bleeding continues or recurs despite these measures, emergency techniques to shunt blood from the\\nportal system to the vena cava can lower portal pressure and diminish bleeding. A TIPS procedure is the\\nemergency intervention of choice. TIPS is an invasive radiologic procedure in which a guidewire is\\npassed from the vena cava through the liver parenchyma into the portal circulation. The resultant\\npassage is dilated by a balloon catheter, and a metallic stent is inserted, creating a bypass between the\\nportal and hepatic venous circulations. Stent size is crucial. If the stent is too large, portal-systemic\\nencephalopathy results because of diversion of too much portal blood flow from the liver. If the stent is'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 163, 'source_type': 'Authorotative', 'priority': '1'}, page_content='encephalopathy results because of diversion of too much portal blood flow from the liver. If the stent is\\ntoo small, it is more likely to occlude. Surgical portacaval shunts, such as the distal spleno-renal shunt,\\nwork by a similar mechanism but are more invasive and have a higher immediate mortality.\\nMechanical compression of bleeding varices with a Sengstaken-Blakemore tube or one of its variants\\ncauses considerable morbidity and should not be used as primary management. However, such a tube\\nmay provide life-saving tamponade pending decompression with a TIPS or surgical procedure. The tube\\nis a flexible NGT with one gastric balloon and one esophageal balloon. After insertion, the gastric balloon\\nis inflated with a fixed volume of air, and traction is applied to the tube to pull the balloon snugly against\\nthe gastroesophageal junction. This balloon is often sufficient to control bleeding, but if not, the'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 163, 'source_type': 'Authorotative', 'priority': '1'}, page_content='the gastroesophageal junction. This balloon is often sufficient to control bleeding, but if not, the\\nesophageal balloon is inflated to a pressure of 25 mm Hg. The procedure is quite uncomfortable and may\\nresult in esophageal perforation and aspiration; thus, endotracheal intubation and IV sedation are often\\nrecommended.\\nLiver transplantation can also decompress the portal system but is a practical option only for patients\\nalready on a transplant list.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 10. GI Bleeding\\n155'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 164, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Long-term medical therapy of portal hypertension (with β-blockers and nitrates) is discussed elsewhere\\n(see p.\\n219). Treatment of portal-systemic encephalopathy may be needed (see p. 220).\\nVascular GI Lesions\\nSeveral distinct congenital or acquired syndromes involve abnormal mucosal or submucosal\\nblood vessels in the GI tract. These vessels may cause recurrent bleeding, which is rarely\\nmassive. Diagnosis is by endoscopy and sometimes angiography. Treatment is endoscopic\\nhemostasis; occasionally, angiographic embolization or surgical resection may be needed.\\nVascular ectasias (angiodysplasias, arteriovenous malformations) are dilated, tortuous vessels that\\ntypically develop in the cecum and ascending colon. They occur mainly in people > 60 and are the most\\ncommon cause of lower GI bleeding in that age group. They are thought to be degenerative and do not\\noccur in association with other vascular abnormalities. Most patients have 2 or 3 lesions, which are'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 164, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"occur in association with other vascular abnormalities. Most patients have 2 or 3 lesions, which are\\ntypically 0.5 to 1.0 cm, bright red, flat or slightly raised, and covered by very thin epithelium. Vascular\\nectasias also occur in association with a number of systemic diseases (eg, renal failure, cirrhosis, CREST\\nsyndrome [calcinosis cutis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly,\\ntelangiectasias]—see p. 310) and after radiation to the bowel.\\nGastric antral vascular ectasia (watermelon stomach) consists of large dilated veins running linearly\\nalong the stomach, creating a striped appearance suggestive of a watermelon. The condition occurs\\nmainly in older women and is of unknown etiology.\\nHereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome—see also p. 982) is an\\nautosomal dominant disorder that causes multiple vascular lesions in various parts of the body, including\\nthe entire GI tract. GI bleeding rarely occurs before age 40.\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 164, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"autosomal dominant disorder that causes multiple vascular lesions in various parts of the body, including\\nthe entire GI tract. GI bleeding rarely occurs before age 40.\\nDieulafoy's lesion is an abnormally large artery that penetrates the gut wall, occasionally eroding\\nthrough the mucosa and causing massive bleeding. It occurs mainly in the proximal stomach.\\nArteriovenous malformations and hemangiomas, both congenital disorders of blood vessels, can\\noccur in the GI tract but are rare.\\nSymptoms and Signs\\nVascular lesions are painless. Patients often present with heme-positive stools or modest amounts of\\nbright red blood from the rectum. Bleeding is often intermittent, sometimes with long periods between\\nepisodes. Patients with upper GI lesions may present with melena. Major bleeding is unusual.\\nDiagnosis\\n• Endoscopy\\nVascular lesions are most commonly diagnosed endoscopically. If routine endoscopy is nondiagnostic,\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 164, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Diagnosis\\n• Endoscopy\\nVascular lesions are most commonly diagnosed endoscopically. If routine endoscopy is nondiagnostic,\\nsmall-bowel endoscopy, capsule endoscopy, intraoperative endoscopy, or visceral angiography may be\\nrequired. 99mTc-labeled RBC scans are less specific but may help localize the lesion enough to facilitate\\nendoscopy or angiography.\\nTreatment\\n• Endoscopic coagulation\\nEndoscopic coagulation (with heater probe, laser, argon plasma, or bipolar electrocoagulation) is effective\\nfor many vascular lesions. Vascular ectasias often recur, although there is some evidence that oral\\nestrogen-progesterone combinations may limit recurrence.\\nMild recurrent bleeding can be treated simply with chronic iron therapy. More significant bleeding that is\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 10. GI Bleeding\\n156'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 165, 'source_type': 'Authorotative', 'priority': '1'}, page_content='unresponsive to endoscopic measures may require angiographic embolization or surgical resection.\\nHowever, rebleeding occurs in about 15 to 25% of surgically treated patients.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 10. GI Bleeding\\n157'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 166, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chapter 11. Acute Abdomen and Surgical Gastroenterology\\nIntroduction\\nAcute abdomen refers to abdominal symptoms and signs of such severity or concern that disorders\\nrequiring surgery should be considered. The primary symptom is acute abdominal pain. Chronic\\nabdominal pain is discussed in Ch. 7.\\nAcute Abdominal Pain\\nAbdominal pain is common and often inconsequential. Acute and severe abdominal pain, however, is\\nalmost always a symptom of intra-abdominal disease. It may be the sole indicator of the need for surgery\\nand must be attended to swiftly: Gangrene and perforation of the gut can occur < 6 h from onset of\\nsymptoms in certain conditions (eg, interruption of the intestinal blood supply caused by a strangulating\\nobstruction or an arterial embolus). Abdominal pain is of particular concern in patients who are very young\\nor very old and those who have HIV infection or are taking immunosuppressants.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 166, 'source_type': 'Authorotative', 'priority': '1'}, page_content='obstruction or an arterial embolus). Abdominal pain is of particular concern in patients who are very young\\nor very old and those who have HIV infection or are taking immunosuppressants.\\nTextbook descriptions of abdominal pain have limitations because people react to pain differently. Some,\\nparticularly elderly people, are stoic, whereas others exaggerate their symptoms. Infants, young children,\\nand some elderly people may have difficulty localizing the pain.\\nPathophysiology\\nVisceral pain comes from the abdominal viscera, which are innervated by autonomic nerve fibers and\\nrespond mainly to the sensations of distention and muscular contraction—not to cutting, tearing, or local\\nirritation. Visceral pain is typically vague, dull, and nauseating. It is poorly localized and tends to be\\nreferred to areas corresponding to the embryonic origin of the affected structure. Foregut structures\\n(stomach, duodenum, liver, and pancreas) cause upper abdominal pain. Midgut structures (small bowel,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 166, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(stomach, duodenum, liver, and pancreas) cause upper abdominal pain. Midgut structures (small bowel,\\nproximal colon, and appendix) cause periumbilical pain. Hindgut structures (distal colon and GU tract)\\ncause lower abdominal pain.\\nSomatic pain comes from the parietal peritoneum, which is innervated by somatic nerves, which respond\\nto irritation from infectious, chemical, or other inflammatory processes. Somatic pain is sharp and well\\nlocalized.\\nReferred pain is pain perceived distant from its source and results from convergence of nerve fibers at\\nthe spinal cord. Common examples of referred pain are scapular pain due to biliary colic, groin pain due\\nto renal colic, and shoulder pain due to blood or infection irritating the diaphragm.\\nPeritonitis: Peritonitis is inflammation of the peritoneal cavity. The most serious cause is perforation of\\nthe GI tract (see p. 111), which causes immediate chemical inflammation followed shortly by infection from'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 166, 'source_type': 'Authorotative', 'priority': '1'}, page_content='the GI tract (see p. 111), which causes immediate chemical inflammation followed shortly by infection from\\nintestinal organisms. Peritonitis can also result from any abdominal condition that causes marked\\ninflammation (eg, appendicitis, diverticulitis, strangulating intestinal obstruction, pancreatitis, pelvic\\ninflammatory disease, mesenteric ischemia). Intraperitoneal blood from any source (eg, ruptured\\naneurysm, trauma, surgery, ectopic pregnancy) is irritating and results in peritonitis. Barium causes\\nsevere peritonitis and should never be given to a patient with suspected GI tract perforation. Peritoneo-\\nsystemic shunts, drains, and dialysis catheters in the peritoneal cavity predispose a patient to infectious\\nperitonitis, as does ascitic fluid. Rarely, spontaneous bacterial peritonitis occurs, in which the peritoneal\\ncavity is infected by blood-borne bacteria.\\nPeritonitis causes fluid shift into the peritoneal cavity and bowel, leading to severe dehydration and'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 166, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"cavity is infected by blood-borne bacteria.\\nPeritonitis causes fluid shift into the peritoneal cavity and bowel, leading to severe dehydration and\\nelectrolyte disturbances. Adult respiratory distress syndrome can develop rapidly. Kidney failure, liver\\nfailure, and disseminated intravascular coagulation follow. The patient's face becomes drawn into the\\nmasklike appearance typical of hippocratic facies. Death occurs within days.\\nEtiology\\nMany intra-abdominal disorders cause abdominal pain (see\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 11. Acute Abdomen & Surgical Gastroenterology\\n158\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 167, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Fig. 11-1); some are trivial but some are immediately life threatening, requiring rapid diagnosis and\\nsurgery. These include ruptured abdominal aortic aneurysm (AAA), perforated viscus, mesenteric\\nischemia, and ruptured ectopic pregnancy. Others (eg, intestinal obstruction, appendicitis, severe acute\\npancreatitis) are also serious and nearly as urgent. Several extra-abdominal disorders also cause\\nabdominal pain (see\\nTable 11-1).\\nAbdominal pain in neonates, infants, and young children has numerous causes not encountered in adults,\\nincluding meconium peritonitis, pyloric stenosis, esophageal webs, volvulus of a gut with a common\\nmesentery, imperforate anus, intussusception, and intestinal obstruction caused by atresia.\\nEvaluation\\nEvaluation of mild and severe pain follows the same process, although with severe abdominal pain,\\ntherapy sometimes proceeds simultaneously and involves early consultation with a surgeon. History and'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 167, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Evaluation of mild and severe pain follows the same process, although with severe abdominal pain,\\ntherapy sometimes proceeds simultaneously and involves early consultation with a surgeon. History and\\nphysical examination usually exclude all but a few possible causes, with final diagnosis confirmed by\\njudicious use of laboratory and imaging tests. Life-threatening causes should always be ruled out before\\nfocusing on less serious diagnoses. In seriously ill patients with severe abdominal pain, the most\\nimportant diagnostic measure may be expeditious surgical exploration. In mildly ill patients, watchful\\nwaiting may be best.\\nHistory: A thorough history usually suggests the diagnosis (see\\nTable 11-2). Of particular importance are pain location (see Fig. 11-1) and characteristics, history of\\nsimilar symptoms, and associated symptoms. Concomitant symptoms such as gastroesophageal reflux,\\nnausea, vomiting, diarrhea, constipation, jaundice, melena, hematuria, hematemesis, weight loss, and'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 167, 'source_type': 'Authorotative', 'priority': '1'}, page_content='similar symptoms, and associated symptoms. Concomitant symptoms such as gastroesophageal reflux,\\nnausea, vomiting, diarrhea, constipation, jaundice, melena, hematuria, hematemesis, weight loss, and\\nmucus or blood in the stool help direct subsequent evaluation. A drug history should include details\\nconcerning prescription and illicit drug use as well as alcohol. Many drugs cause GI upset. Prednisone or\\nimmunosuppressants may inhibit the inflammatory response to perforation or peritonitis and result in less\\npain and leukocytosis than might otherwise be expected. Anticoagulants can increase the chances of\\nbleeding and hematoma formation. Alcohol predisposes to pancreatitis.\\nKnown medical conditions and previous abdominal surgeries are important to ascertain. Women should\\nbe asked whether they are pregnant.\\nPhysical examination: The general appearance is important. A happy, comfortable-appearing patient'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 167, 'source_type': 'Authorotative', 'priority': '1'}, page_content='be asked whether they are pregnant.\\nPhysical examination: The general appearance is important. A happy, comfortable-appearing patient\\nrarely has a serious problem, unlike one who is anxious, pale, diaphoretic, or in obvious pain. BP, pulse,\\nstate of consciousness, and other signs of peripheral perfusion must be evaluated. However, the focus\\n[Fig. 11-1. Location of abdominal pain and possible causes.]\\n[Table 11-1. Extra-Abdominal Causes of Abdominal Pain]\\nof the examination is the abdomen, beginning with inspection and auscultation, followed by palpation and\\npercussion. Rectal examination and pelvic examination (for women) to locate tenderness, masses, and\\nblood are essential.\\nPalpation begins gently, away from the area of greatest pain, detecting areas of particular tenderness, as\\nwell as the presence of guarding, rigidity, and rebound (all suggesting peritoneal irritation) and any\\nmasses. Guarding is an involuntary contraction of the abdominal muscles that is slightly slower and more'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 167, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"masses. Guarding is an involuntary contraction of the abdominal muscles that is slightly slower and more\\nsustained than the rapid, voluntary flinch exhibited by sensitive or anxious patients. Rebound is a distinct\\nflinch upon brisk withdrawal of the examiner's hand. The inguinal area and all surgical scars should be\\npalpated for hernias.\\nRed flags: Certain findings raise suspicion of a more serious etiology:\\n• Severe pain\\n• Signs of shock (eg, tachycardia, hypotension, diaphoresis, confusion)\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 11. Acute Abdomen & Surgical Gastroenterology\\n159\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 168, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"• Signs of peritonitis\\n• Abdominal distention\\nInterpretation of findings: Distention, especially when surgical scars, tympany to percussion, and high-\\npitched peristalsis or borborygmi in rushes are present, strongly suggests bowel obstruction. Severe pain\\nin a patient with a silent abdomen who is lying as still as possible suggests peritonitis; location of\\ntenderness suggests etiology (eg, right upper quadrant suggests cholecystitis, right lower quadrant\\nsuggests appendicitis) but may not be diagnostic. Back pain with shock suggests ruptured AAA,\\nparticularly if there is a tender, pulsatile mass. Shock and vaginal bleeding in a pregnant woman suggest\\nruptured ectopic pregnancy. Ecchymoses of the costovertebral angles (Grey Turner's sign) or around the\\numbilicus (Cullen's sign) suggest hemorrhagic pancreatitis but are not very sensitive for this disorder.\\nHistory is often suggestive (see Table 11-2). Mild to moderate pain in the presence of active peristalsis of\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 168, 'source_type': 'Authorotative', 'priority': '1'}, page_content='History is often suggestive (see Table 11-2). Mild to moderate pain in the presence of active peristalsis of\\nnormal pitch suggests a nonsurgical disease (eg, gastroenteritis) but may also be the early manifestations\\nof a more serious disorder. A patient who is writhing around trying to get comfortable is more likely to\\nhave an obstructive mechanism (eg, renal or biliary colic).\\nPrevious abdominal surgery makes obstruction from adhesions more likely. Generalized atherosclerosis\\nincreases the possibility of MI, AAA, and mesenteric ischemia. HIV infection makes infectious causes and\\ndrug adverse effects likely.\\nTesting: Tests are selected based on clinical suspicion.\\n• Urine pregnancy test for all women of childbearing age\\n• Selected imaging tests based on suspected diagnosis\\nStandard tests (eg, CBC, chemistries, urinalysis) are often done but are of little value due to poor\\nspecificity; patients with significant disease may have normal results. Abnormal results do not provide a'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 168, 'source_type': 'Authorotative', 'priority': '1'}, page_content='specificity; patients with significant disease may have normal results. Abnormal results do not provide a\\nspecific diagnosis (the urinalysis in particular may show pyuria or hematuria in a wide variety of\\nconditions), and they can also occur in the absence of significant disease. An exception is serum lipase,\\nwhich strongly suggests a diagnosis of acute pancreatitis. A bedside urine pregnancy test should be done\\nfor all women of childbearing age because a negative result effectively excludes ruptured ectopic\\npregnancy.\\nAn abdominal series, consisting of flat and upright abdominal x-rays and upright chest x-rays (left lateral\\nrecumbent abdomen and anteroposterior chest x-ray for patients unable to stand), should be done when\\nperforation or obstruction is suspected. However, these plain x-rays are seldom diagnostic for other\\nconditions and need not be automatically done. Ultrasound should be done for suspected biliary tract\\ndisease or ectopic pregnancy (transvaginal'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 168, 'source_type': 'Authorotative', 'priority': '1'}, page_content='conditions and need not be automatically done. Ultrasound should be done for suspected biliary tract\\ndisease or ectopic pregnancy (transvaginal\\n[Table 11-2. History in Patients with Acute Abdominal Pain]\\nprobe). Ultrasound can also detect AAA but cannot reliably identify rupture. Noncontrast helical CT is the\\nmodality of choice for suspected renal stones. CT with oral contrast is diagnostic in about 95% of patients\\nwith significant abdominal pain and has markedly lowered the negative laparotomy rate. However,\\nadvanced imaging must not be allowed to delay surgery in patients with definitive symptoms and signs.\\nTreatment\\nSome clinicians feel that providing pain relief before a diagnosis is made interferes with their ability to\\nevaluate. However, moderate doses of IV analgesics (eg, fentanyl 50 to 100 μg, morphine 4 to 6 mg) do\\nnot mask peritoneal signs and, by diminishing anxiety and discomfort, often make examination easier.\\nKey Points'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 168, 'source_type': 'Authorotative', 'priority': '1'}, page_content='not mask peritoneal signs and, by diminishing anxiety and discomfort, often make examination easier.\\nKey Points\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 11. Acute Abdomen & Surgical Gastroenterology\\n160'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 169, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Life-threatening causes should be looked for first.\\n• Pregnancy should be ruled out in women of childbearing age.\\n• Signs of peritonitis, shock, and obstruction should be sought.\\n• Blood tests are of minimal value.\\nAcute Mesenteric Ischemia\\nAcute mesenteric ischemia is interruption of intestinal blood flow by embolism, thrombosis, or\\na low-flow state. It leads to mediator release, inflammation, and ultimately infarction. Abdominal\\npain is out of proportion to physical findings. Early diagnosis is difficult, but angiography and\\nexploratory laparotomy have the most sensitivity; other imaging modalities often become\\npositive only late in the disease. Treatment is by embolectomy, revascularization of viable\\nsegments, or resection; sometimes vasodilator therapy is successful. Mortality is high.\\nPathophysiology\\nThe intestinal mucosa has a high metabolic rate and, accordingly, a high blood flow requirement (normally'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 169, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Pathophysiology\\nThe intestinal mucosa has a high metabolic rate and, accordingly, a high blood flow requirement (normally\\nreceiving 20 to 25% of cardiac output), making it very sensitive to the effects of decreased perfusion.\\nIschemia disrupts the mucosal barrier, allowing release of bacteria, toxins, and vasoactive mediators,\\nwhich in turn leads to myocardial depression, systemic inflammatory response syndrome (see p. 2299),\\nmultisystem organ failure, and death. Mediator release may occur even before complete infarction.\\nNecrosis can occur as soon as 10 to 12 h after the onset of symptoms.\\nThree major vessels serve the abdominal contents: the celiac trunk, the superior mesenteric artery\\n(SMA), and the inferior mesenteric artery (IMA). The celiac trunk supplies the esophagus, stomach,\\nproximal duodenum, liver, gallbladder, pancreas, and spleen. The SMA supplies the distal duodenum,\\njejunum, ileum, and colon to the splenic flexure. The IMA supplies the descending colon and sigmoid'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 169, 'source_type': 'Authorotative', 'priority': '1'}, page_content='proximal duodenum, liver, gallbladder, pancreas, and spleen. The SMA supplies the distal duodenum,\\njejunum, ileum, and colon to the splenic flexure. The IMA supplies the descending colon and sigmoid\\ncolon and the rectum. Collateral vessels are abundant in the stomach, duodenum, and rectum; these\\nareas rarely develop ischemia. The splenic flexure is a watershed between the SMA and IMA and is at\\nparticular risk of ischemia.\\nEtiology\\nMesenteric blood flow may be disrupted on either the venous or arterial sides. In general, patients > 50\\nare at greatest risk and have the types of occlusions and risk factors shown in\\nTable 11-3. However, many patients have no identifiable risk factors.\\nSymptoms and Signs\\nThe early hallmark of mesenteric ischemia is severe pain but minimal physical findings. The abdomen\\nremains soft, with little or no tenderness. Mild tachycardia may be present. Later, as necrosis develops,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 169, 'source_type': 'Authorotative', 'priority': '1'}, page_content='remains soft, with little or no tenderness. Mild tachycardia may be present. Later, as necrosis develops,\\nsigns of peritonitis appear, with marked abdominal tenderness, guarding, rigidity, and no bowel sounds.\\nThe stool may be heme-positive (increasingly likely as ischemia progresses). The usual signs of shock\\ndevelop and are frequently followed by death.\\nSudden onset of pain suggests but is not diagnostic of an arterial embolism, whereas a more gradual\\nonset is typical of venous thrombosis. Patients with a history of postprandial abdominal discomfort (which\\nsuggests intestinal angina) may have arterial thrombosis.\\n[Table 11-3. Causes of Acute Mesenteric Ischemia]\\nDiagnosis\\n• Clinical diagnosis more important than diagnostic tests\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 11. Acute Abdomen & Surgical Gastroenterology\\n161'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 170, 'source_type': 'Authorotative', 'priority': '1'}, page_content='• Mesenteric angiography if diagnosis unclear\\nEarly diagnosis is particularly important because mortality increases significantly once intestinal infarction\\nhas occurred. Mesenteric ischemia must be considered in any patient > 50 with known risk factors or\\npredisposing conditions who develops sudden, severe abdominal pain.\\nPatients with clear peritoneal signs should proceed directly to the operating room for both diagnosis and\\ntreatment. For others, selective mesenteric angiography is the diagnostic procedure of choice. Other\\nimaging studies and serum markers can show abnormalities but lack sensitivity and specificity early in the\\ncourse of the disease when diagnosis is most critical. Plain abdominal x-rays are useful mainly in ruling\\nout other causes of pain (eg, perforated viscus), although portal venous gas or pneumatosis intestinalis\\nmay be seen late in the disease. These findings also appear on CT, which may also directly visualize'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 170, 'source_type': 'Authorotative', 'priority': '1'}, page_content='may be seen late in the disease. These findings also appear on CT, which may also directly visualize\\nvascular occlusion—more accurately on the venous side. Doppler ultrasonography can sometimes\\nidentify arterial occlusion, but sensitivity is low. MRI is very accurate in proximal vascular occlusion, less\\nso in distal vascular occlusion. Serum markers (eg, creatine kinase, lactate) rise with necrosis but are\\nnonspecific findings that are seen later. Intestinal fatty acid binding protein in the urine may prove\\nvaluable in the future as an early marker.\\nPrognosis\\nIf diagnosis and treatment take place before infarction occurs, mortality is low; after intestinal infarction,\\nmortality approaches 70 to 90%. For this reason, clinical diagnosis of mesenteric ischemia should\\nsupersede diagnostic tests, which may delay treatment.\\nTreatment\\n• Surgical: Embolectomy, revascularization, or resection\\n• Angiographic: Vasodilators or thrombolysis\\n• Long-term anticoagulation or antiplatelet therapy'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 170, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Treatment\\n• Surgical: Embolectomy, revascularization, or resection\\n• Angiographic: Vasodilators or thrombolysis\\n• Long-term anticoagulation or antiplatelet therapy\\nIf diagnosis is made during exploratory laparotomy, options are surgical embolectomy, revascularization,\\nand resection. A \"second look\" laparotomy may be needed to reassess the viability of questionable areas\\nof bowel. If diagnosis is made by angiography, infusion of the vasodilator papaverine through the\\nangiography catheter may improve survival in both occlusive and nonocclusive ischemia. A 60-mg bolus is\\ngiven over 2 min, followed by an infusion of 30 to 60 mg/h. Papaverine is useful even when surgical\\nintervention is planned and is sometimes given during and after surgical intervention as well. In addition,\\nfor arterial occlusion, thrombolysis or surgical embolectomy may be done. The development of peritoneal\\nsigns at any time during the evaluation suggests the need for immediate surgery. Mesenteric venous'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 170, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"signs at any time during the evaluation suggests the need for immediate surgery. Mesenteric venous\\nthrombosis without signs of peritonitis can be treated with papaverine followed by anticoagulation with\\nheparin and then warfarin.\\nPatients with arterial embolism or venous thrombosis require long-term anticoagulation with warfarin.\\nPatients with nonocclusive ischemia may be treated with antiplatelet therapy.\\nAcute Perforation\\nAny part of the GI tract may become perforated, releasing gastric or intestinal contents into the\\nperitoneal space. Causes vary. Symptoms develop suddenly, with severe pain followed shortly\\nby signs of shock. Diagnosis is usually made by the presence of free air in the abdomen on\\nimaging studies. Treatment is with fluid resuscitation, antibiotics, and surgery. Mortality is high,\\nvarying with the underlying disorder and the patient's general health.\\nEtiology\\nBoth blunt and penetrating trauma can result in perforation of any part of the GI tract (see\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 170, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"varying with the underlying disorder and the patient's general health.\\nEtiology\\nBoth blunt and penetrating trauma can result in perforation of any part of the GI tract (see\\nTable 11-4). Swallowed foreign bodies, even sharp ones, rarely cause perforation unless they become\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 11. Acute Abdomen & Surgical Gastroenterology\\n162\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 171, 'source_type': 'Authorotative', 'priority': '1'}, page_content='impacted, causing ischemia and necrosis from local pressure. Foreign bodies inserted via the anus may\\nperforate the rectum.\\nSymptoms and Signs\\nEsophageal, gastric, and duodenal perforation tends to manifest suddenly and catastrophically, with\\nabrupt onset of acute abdomen with severe generalized abdominal pain, tenderness, and peritoneal\\nsigns. Pain may radiate to the shoulder.\\nPerforation at other GI sites often occurs in the setting of other painful, inflammatory conditions. Because\\nsuch perforations are often small initially and frequently walled off by the omentum, pain often develops\\ngradually and may be localized. Tenderness also is more focal. Such findings can make it difficult to\\ndistinguish perforation from worsening of the underlying disorder or lack of response to treatment.\\nIn all types of perforation, nausea, vomiting, and anorexia are common. Bowel sounds are quiet to absent.\\nDiagnosis\\n• Abdominal series\\n• If nondiagnostic, abdominal CT'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 171, 'source_type': 'Authorotative', 'priority': '1'}, page_content='In all types of perforation, nausea, vomiting, and anorexia are common. Bowel sounds are quiet to absent.\\nDiagnosis\\n• Abdominal series\\n• If nondiagnostic, abdominal CT\\nAn abdominal series (supine and upright abdominal x-rays and chest x-rays) may be diagnostic, showing\\nfree air under the diaphragm in 50 to 75% of cases. As time passes, this sign becomes more common. A\\nlateral chest x-ray is more sensitive for free air than a posteroanterior x-ray. If the abdominal series is\\nnondiagnostic, abdominal CT usually with oral and IV and/or rectal contrast may be helpful. Barium\\nshould not be used if perforation is suspected.\\nTreatment\\n• Surgery\\n• IV fluids and antibiotics\\n[Table 11-4. Some Causes of GI Tract Perforation]\\nIf a perforation is noted, immediate surgery is necessary because mortality caused by peritonitis\\nincreases rapidly the longer treatment is delayed. If an abscess or an inflammatory mass has formed, the\\nprocedure may be limited to drainage of the abscess.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 171, 'source_type': 'Authorotative', 'priority': '1'}, page_content='increases rapidly the longer treatment is delayed. If an abscess or an inflammatory mass has formed, the\\nprocedure may be limited to drainage of the abscess.\\nAn NGT is inserted before operation. Patients with signs of volume depletion should have urine output\\nmonitored with a catheter. Fluid status is maintained by adequate IV fluid and electrolyte replacement. IV\\nantibiotics effective against intestinal flora should be given (eg, cefotetan 1 to 2 g bid, or amikacin 5\\nmg/kg tid plus clindamycin 600 to 900 mg qid).\\nAppendicitis\\nAppendicitis is acute inflammation of the vermiform appendix, typically resulting in abdominal\\npain, anorexia, and abdominal tenderness. Diagnosis is clinical, often supplemented by CT or\\nultrasound. Treatment is surgical removal.\\nIn the US, acute appendicitis is the most common cause of acute abdominal pain requiring surgery. Over\\n5% of the population develops appendicitis at some point. It most commonly occurs in the teens and 20s\\nbut may occur at any age.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 171, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"5% of the population develops appendicitis at some point. It most commonly occurs in the teens and 20s\\nbut may occur at any age.\\nOther conditions affecting the appendix include carcinoids, cancer, villous adenomas, and diverticula. The\\nappendix may also be affected by Crohn's disease or ulcerative colitis with pancolitis.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 11. Acute Abdomen & Surgical Gastroenterology\\n163\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 172, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Etiology\\nAppendicitis is thought to result from obstruction of the appendiceal lumen, typically by lymphoid\\nhyperplasia, but occasionally by a fecalith, foreign body, or even worms. The obstruction leads to\\ndistention, bacterial overgrowth, ischemia, and inflammation. If untreated, necrosis, gangrene, and\\nperforation occur. If the perforation is contained by the omentum, an appendiceal abscess results.\\nSymptoms and Signs\\nThe classic symptoms of acute appendicitis are epigastric or periumbilical pain followed by brief nausea,\\nvomiting, and anorexia; after a few hours, the pain shifts to the right lower quadrant. Pain increases with\\ncough and motion. Classic signs are right lower quadrant direct and rebound tenderness located at\\nMcBurney's point (junction of the middle and outer thirds of the line joining the umbilicus to the anterior\\nsuperior spine). Additional signs are pain felt in the right lower quadrant with palpation of the left lower\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 172, 'source_type': 'Authorotative', 'priority': '1'}, page_content='superior spine). Additional signs are pain felt in the right lower quadrant with palpation of the left lower\\nquadrant (Rovsing sign), an increase in pain from passive extension of the right hip joint that stretches\\nthe iliopsoas muscle (psoas sign), or pain caused by passive internal rotation of the flexed thigh\\n(obturator sign). Low-grade fever (rectal temperature 37.7 to 38.3° C [100 to 101° F]) is common.\\nUnfortunately, these classic findings appear in < 50% of patients. Many variations of symptoms and signs\\noccur. Pain may not be localized, particularly in infants and children. Tenderness may be diffuse or, in rare\\ninstances, absent. Bowel movements are usually less frequent or absent; if diarrhea is a sign, a\\nretrocecal appendix should be suspected. RBCs or WBCs may be present in the urine. Atypical symptoms\\nare common among elderly patients and pregnant women; in particular, pain is less severe and local\\ntenderness is less marked.\\nDiagnosis\\n• Clinical evaluation'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 172, 'source_type': 'Authorotative', 'priority': '1'}, page_content='are common among elderly patients and pregnant women; in particular, pain is less severe and local\\ntenderness is less marked.\\nDiagnosis\\n• Clinical evaluation\\n• Abdominal CT if necessary\\n• Ultrasound an option to CT\\nWhen classic symptoms and signs are present, the diagnosis is clinical. In such patients, delaying\\nlaparotomy to do imaging tests only increases the likelihood of perforation and subsequent complications.\\nIn patients with atypical or equivocal findings, imaging studies should be done without delay. Contrast-\\nenhanced CT has reasonable accuracy in diagnosing appendicitis and can also reveal other causes of\\nan acute abdomen. Graded compression ultrasound can usually be done quickly and uses no radiation\\n(of particular concern in children); however, it is occasionally limited by the presence of bowel gas and is\\nless useful for recognizing nonappendiceal causes of pain. Appendicitis remains primarily a clinical'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 172, 'source_type': 'Authorotative', 'priority': '1'}, page_content='less useful for recognizing nonappendiceal causes of pain. Appendicitis remains primarily a clinical\\ndiagnosis. Selective and judicious use of radiographic studies may reduce the rate of negative\\nlaparotomy.\\nLaparoscopy can be used for diagnosis as well as definitive treatment; it may be especially helpful in\\nwomen with lower abdominal pain of unclear etiology. Laboratory studies typically show leukocytosis\\n(12,000 to 15,000/μL), but this finding is highly variable; a normal WBC count should not be used to\\nexclude appendicitis.\\nPrognosis\\nWithout surgery or antibiotics, mortality is > 50%.\\nWith early surgery, the mortality rate is < 1%, and convalescence is normally rapid and complete. With\\ncomplications (rupture and development of an abscess or peritonitis), the prognosis is worse: Repeat\\noperations and a long convalescence may follow.\\nTreatment\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 11. Acute Abdomen & Surgical Gastroenterology\\n164'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 173, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"• Surgical removal\\n• IV fluids and antibiotics\\nTreatment of acute appendicitis is open or laparoscopic appendectomy; because treatment delay\\nincreases mortality, a negative appendectomy rate of 15% is considered acceptable. The surgeon can\\nusually remove the appendix even if perforated. Occasionally, the appendix is difficult to locate: In these\\ncases, it usually lies behind the cecum or the ileum and mesentery of the right colon. A contraindication to\\nappendectomy is inflammatory bowel disease involving the cecum. However, in cases of terminal ileitis\\nand a normal cecum, the appendix should be removed.\\nAppendectomy should be preceded by IV antibiotics. Third-generation cephalosporins are preferred. For\\nnonperforated appendicitis, no further antibiotics are required. If the appendix is perforated, antibiotics\\nshould be continued until the patient's temperature and WBC count have normalized or continued for a\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 173, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"should be continued until the patient's temperature and WBC count have normalized or continued for a\\nfixed course, according to the surgeon's preference. If surgery is impossible, antibiotics—although not\\ncurative—markedly improve the survival rate. When a large inflammatory mass is found involving the\\nappendix, terminal ileum, and cecum, resection of the entire mass and ileocolostomy are preferable. In\\nlate cases in which a pericolic abscess has already formed, the abscess is drained either by an\\nultrasound-guided percutaneous catheter or by open operation (with appendectomy to follow at a later\\ndate). A Meckel's diverticulum in a patient under the age of 40 should be removed concomitantly with the\\nappendectomy unless extensive inflammation around the appendix prevents the procedure.\\nHernias of the Abdominal Wall\\nA hernia of the abdominal wall is a protrusion of the abdominal contents through an acquired or\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 173, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Hernias of the Abdominal Wall\\nA hernia of the abdominal wall is a protrusion of the abdominal contents through an acquired or\\ncongenital area of weakness or defect in the wall. Many hernias are asymptomatic, but some\\nbecome incarcerated or strangulated, causing pain and requiring immediate surgery. Diagnosis\\nis clinical. Treatment is elective surgical repair.\\nAbdominal hernias are extremely common, particularly among males, necessitating about 700,000\\noperations each year in the US.\\nClassification\\nAbdominal hernias are classified as either abdominal wall or groin hernias. Strangulated hernias are\\nischemic from physical constriction of their blood supply. Gangrene, perforation, and peritonitis may\\ndevelop. Incarcerated and strangulated hernias cannot be reduced manually.\\nAbdominal wall hernias include umbilical hernias, epigastric hernias, Spigelian hernias, and incisional\\n(ventral) hernias. Umbilical hernias (protrusions through the umbilical ring) are mostly congenital, but'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 173, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(ventral) hernias. Umbilical hernias (protrusions through the umbilical ring) are mostly congenital, but\\nsome are acquired in adulthood secondary to obesity, ascites, pregnancy, or chronic peritoneal dialysis.\\nEpigastric hernias occur through the linea alba. Spigelian hernias occur through defects in the\\ntransversus abdominis muscle lateral to the rectus sheath, usually below the level of the umbilicus.\\nIncisional hernias occur through an incision from previous abdominal surgery.\\nGroin hernias include inguinal hernias and femoral hernias. Inguinal hernias occur above the inguinal\\nligament. Indirect inguinal hernias traverse the internal inguinal ring into the inguinal canal, and direct\\ninguinal hernias extend directly forward and do not pass through the inguinal canal. Femoral hernias\\noccur below the inguinal ligament and go into the femoral canal.\\nAbout 75% of all abdominal hernias are inguinal. Incisional hernias comprise another 10 to 15%. Femoral'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 173, 'source_type': 'Authorotative', 'priority': '1'}, page_content='occur below the inguinal ligament and go into the femoral canal.\\nAbout 75% of all abdominal hernias are inguinal. Incisional hernias comprise another 10 to 15%. Femoral\\nand unusual hernias account for the remaining 10 to 15%.\\nSymptoms and Signs\\nMost patients complain only of a visible bulge, which may cause vague discomfort or be asymptomatic.\\nMost hernias, even large ones, can be manually reduced with persistent gentle pressure; placing the\\npatient in the Trendelenburg position may help. An incarcerated hernia cannot be reduced but has no\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 11. Acute Abdomen & Surgical Gastroenterology\\n165'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 174, 'source_type': 'Authorotative', 'priority': '1'}, page_content='additional symptoms. A strangulated hernia causes steady, gradually increasing pain, typically with\\nnausea and vomiting. The hernia itself is tender, and the overlying skin may be erythematous; peritonitis\\nmay develop depending on location, with diffuse tenderness, guarding, and rebound.\\nDiagnosis\\n• Clinical evaluation\\nThe diagnosis is clinical. Because the hernia may be apparent only when abdominal pressure is\\nincreased, the patient should be examined in a standing position. If no hernia is palpable, the patient\\nshould cough or perform a Valsalva maneuver as the examiner palpates the abdominal wall. Examination\\nfocuses on the umbilicus, the inguinal area (with a finger in the inguinal canal in males), the femoral\\ntriangle, and any incisions that are present.\\nInguinal masses that resemble hernias may be the result of adenopathy (infectious or malignant), an\\nectopic testis, or lipoma. These masses are solid and are not reducible. A scrotal mass may be a'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 174, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Inguinal masses that resemble hernias may be the result of adenopathy (infectious or malignant), an\\nectopic testis, or lipoma. These masses are solid and are not reducible. A scrotal mass may be a\\nvaricocele, hydrocele, or testicular tumor. Ultrasound may be done if physical examination is equivocal.\\nPrognosis\\nCongenital umbilical hernias rarely strangulate and are not treated; most resolve spontaneously within\\nseveral years. Very large defects may be repaired electively after age 2 yr. Umbilical hernias in adults\\ncause cosmetic concerns and can be electively repaired; strangulation and incarceration are unusual but,\\nif happen, usually contain omentum rather than intestine.\\nTreatment\\n• Surgical repair\\nGroin hernias should be repaired electively because of the risk of strangulation, which results in higher\\nmorbidity (and possible mortality in elderly patients). Repair may be through a standard incision or\\nlaparoscopically.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 174, 'source_type': 'Authorotative', 'priority': '1'}, page_content='morbidity (and possible mortality in elderly patients). Repair may be through a standard incision or\\nlaparoscopically.\\nAn incarcerated or strangulated hernia of any kind requires urgent surgical repair.\\nIleus\\n(Paralytic Ileus; Adynamic Ileus; Paresis)\\nIleus is a temporary arrest of intestinal peristalsis. It occurs most commonly after abdominal\\nsurgery, particularly when the intestines have been manipulated. Symptoms are nausea,\\nvomiting, and vague abdominal discomfort. Diagnosis is based on x-ray findings and clinical\\nimpression. Treatment is supportive, with nasogastric suction and IV fluids.\\nEtiology\\nIn addition to postoperative causes, ileus also results from intraperitoneal or retroperitoneal inflammation\\n(eg, appendicitis, diverticulitis, perforated duodenal ulcer), retroperitoneal or intra-abdominal hematomas\\n(eg, ruptured abdominal aortic aneurysm, lumbar compression fracture), metabolic disturbances (eg,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 174, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(eg, ruptured abdominal aortic aneurysm, lumbar compression fracture), metabolic disturbances (eg,\\nhypokalemia), or drugs (eg, opioids, anticholinergics, sometimes Ca channel blockers). Ileus sometimes\\noccurs in association with renal or thoracic disease (eg, lower rib fractures, lower lobe pneumonias, MI).\\nGastric and colonic motility disturbances after abdominal surgery are common. The small bowel is\\ntypically least affected, with motility and absorption returning to normal within hours after surgery.\\nStomach emptying is usually impaired for about 24 h or more. The colon is often most affected and may\\nremain inactive for 48 to 72 h or more.\\nSymptoms and Signs\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 11. Acute Abdomen & Surgical Gastroenterology\\n166'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 175, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Symptoms and signs include abdominal distention, vomiting, and vague discomfort. Pain rarely has the\\nclassic colicky pattern present in mechanical obstruction. There may be obstipation or passage of slight\\namounts of watery stool. Auscultation reveals a silent abdomen or minimal peristalsis. The abdomen is\\nnot tender unless the underlying cause is inflammatory.\\nDiagnosis\\n• Clinical evaluation\\n• Sometimes x-rays\\nThe most essential task is to distinguish ileus from intestinal obstruction. In both conditions, x-rays show\\ngaseous distention of isolated segments of intestine. In postoperative ileus, however, gas may\\naccumulate more in the colon than in the small bowel. Postoperative accumulation of gas in the small\\nbowel often implies development of a complication (eg, obstruction, peritonitis). In other types of ileus, x-\\nray findings are similar to obstruction; differentiation can be difficult unless clinical features clearly favor'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 175, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"ray findings are similar to obstruction; differentiation can be difficult unless clinical features clearly favor\\none or the other. Water-soluble contrast studies may help differentiate.\\nTreatment\\n• NGT\\n• IV fluids\\nTreatment involves continuous nasogastric suction, npo status, IV fluids and electrolytes, a minimal\\namount of sedatives, and avoidance of opioids and anticholinergic drugs. Maintaining an adequate serum\\nK level (> 4 mEq/L [> 4 mmol/L]) is especially important. Ileus persisting > 1 wk probably has a\\nmechanical obstructive cause, and laparotomy should be considered. Sometimes colonic ileus can be\\nrelieved by colonoscopic decompression; rarely, cecostomy is required. Colonoscopic decompression is\\nhelpful in treating pseudo-obstruction (Ogilvie's syndrome), which consists of apparent obstruction at the\\nsplenic flexure, although no cause can be found by contrast enema or colonoscopy for the failure of gas\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 175, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"splenic flexure, although no cause can be found by contrast enema or colonoscopy for the failure of gas\\nand feces to pass this point. Some clinicians use IV neostigmine (requires cardiac monitoring) to treat\\nOgilvie's syndrome.\\nIntestinal Obstruction\\nIntestinal obstruction is significant mechanical impairment or complete arrest of the passage of\\ncontents through the intestine. Symptoms include cramping pain, vomiting, obstipation, and\\nlack of flatus. Diagnosis is clinical, confirmed by abdominal x-rays. Treatment is fluid\\nresuscitation, nasogastric suction, and, in most cases of complete obstruction, surgery.\\nMechanical obstruction is divided into obstruction of the small bowel (including the duodenum) and\\nobstruction of the large bowel. Obstruction may be partial or complete. About 85% of partial small-bowel\\nobstructions resolve with nonoperative treatment, whereas about 85% of complete small-bowel\\nobstructions require operation.\\nEtiology\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 175, 'source_type': 'Authorotative', 'priority': '1'}, page_content='obstructions resolve with nonoperative treatment, whereas about 85% of complete small-bowel\\nobstructions require operation.\\nEtiology\\nOverall, the most common causes of mechanical obstruction are adhesions, hernias, and tumors. Other\\ngeneral causes are diverticulitis, foreign bodies (including gallstones), volvulus (twisting of bowel on its\\nmesentery), intussusception (telescoping of one segment of bowel into another—see p. 2801), and fecal\\nimpaction. Specific segments of the intestine are affected differently (see\\nTable 11-5).\\nPathophysiology\\nIn simple mechanical obstruction, blockage occurs without vascular compromise. Ingested fluid and food,\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 11. Acute Abdomen & Surgical Gastroenterology\\n167'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 176, 'source_type': 'Authorotative', 'priority': '1'}, page_content='digestive secretions, and gas accumulate above the obstruction. The proximal bowel distends, and the\\ndistal segment collapses. The normal secretory and absorptive functions of the mucosa are depressed,\\nand the bowel wall becomes edematous and congested. Severe intestinal distention is self-perpetuating\\nand progressive, intensifying\\n[Table 11-5. Causes of Intestinal Obstruction]\\nthe peristaltic and secretory derangements and increasing the risks of dehydration and progression to\\nstrangulating obstruction.\\nStrangulating obstruction is obstruction with compromised blood flow; it occurs in nearly 25% of patients\\nwith small-bowel obstruction. It is usually associated with hernia, volvulus, and intussusception.\\nStrangulating obstruction can progress to infarction and gangrene in as little as 6 h. Venous obstruction\\noccurs first, followed by arterial occlusion, resulting in rapid ischemia of the bowel wall. The ischemic'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 176, 'source_type': 'Authorotative', 'priority': '1'}, page_content='occurs first, followed by arterial occlusion, resulting in rapid ischemia of the bowel wall. The ischemic\\nbowel becomes edematous and infarcts, leading to gangrene and perforation. In large-bowel obstruction,\\nstrangulation is rare (except with volvulus).\\nPerforation may occur in an ischemic segment (typically small bowel) or when marked dilation occurs.\\nThe risk is high if the cecum is dilated to a diameter ≥ 13 cm. Perforation of a tumor or a diverticulum may\\nalso occur at the obstruction site.\\nSymptoms and Signs\\nObstruction of the small bowel causes symptoms shortly after onset: abdominal cramps centered\\naround the umbilicus or in the epigastrium, vomiting, and—in patients with complete obstruction\\n—obstipation. Patients with partial obstruction may develop diarrhea. Severe, steady pain suggests that\\nstrangulation has occurred. In the absence of strangulation, the abdomen is not tender. Hyperactive,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 176, 'source_type': 'Authorotative', 'priority': '1'}, page_content='strangulation has occurred. In the absence of strangulation, the abdomen is not tender. Hyperactive,\\nhigh-pitched peristalsis with rushes coinciding with cramps is typical. Sometimes, dilated loops of bowel\\nare palpable. With infarction, the abdomen becomes tender and auscultation reveals a silent abdomen or\\nminimal peristalsis. Shock and oliguria are serious signs that indicate either late simple obstruction or\\nstrangulation.\\nObstruction of the large bowel usually causes milder symptoms that develop more gradually than\\nthose caused by small-bowel obstruction. Increasing constipation leads to obstipation and abdominal\\ndistention. Vomiting may occur (usually several hours after onset of other symptoms) but is not common.\\nLower abdominal cramps unproductive of feces occur. Physical examination typically shows a distended\\nabdomen with loud borborygmi. There is no tenderness, and the rectum is usually empty. A mass'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 176, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Lower abdominal cramps unproductive of feces occur. Physical examination typically shows a distended\\nabdomen with loud borborygmi. There is no tenderness, and the rectum is usually empty. A mass\\ncorresponding to the site of an obstructing tumor may be palpable. Systemic symptoms are relatively mild,\\nand fluid and electrolyte deficits are uncommon.\\nVolvulus often has an abrupt onset. Pain is continuous, sometimes with superimposed waves of colicky\\npain.\\nDiagnosis\\n• Abdominal series\\nSupine and upright abdominal x-rays should be taken and are usually adequate to diagnose obstruction.\\nAlthough only laparotomy can definitively diagnose strangulation, careful serial clinical examination may\\nprovide early warning. Elevated WBCs and acidosis may indicate that strangulation has already occurred.\\nOn plain x-rays, a ladderlike series of distended small-bowel loops is typical of small-bowel obstruction'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 176, 'source_type': 'Authorotative', 'priority': '1'}, page_content='On plain x-rays, a ladderlike series of distended small-bowel loops is typical of small-bowel obstruction\\nbut may also occur with obstruction of the right colon. Fluid levels in the bowel can be seen in upright\\nviews. Similar, although perhaps less dramatic, x-ray findings and symptoms occur in ileus (paralysis of\\nthe intestine without obstruction—see p. 114); differentiation can be difficult. Distended loops and fluid\\nlevels may be absent with an obstruction of the upper jejunum or with closed-loop strangulating\\nobstructions (as may occur with volvulus). Infarcted bowel may produce a mass effect on x-ray. Gas in the\\nbowel wall (pneumatosis intestinalis) indicates gangrene.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 11. Acute Abdomen & Surgical Gastroenterology\\n168'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 177, 'source_type': 'Authorotative', 'priority': '1'}, page_content='In large-bowel obstruction, abdominal x-ray shows distention of the colon proximal to the obstruction. In\\ncecal volvulus, there may be a large gas bubble in the mid-abdomen or left upper quadrant. With both\\ncecal and sigmoidal volvulus, a contrast enema shows the site of obstruction by a typical \"bird-beak\"\\ndeformity at the site of the twist; the procedure may actually reduce a sigmoid volvulus. If contrast enema\\nis not done, colonoscopy can be used to decompress a sigmoid volvulus but rarely works with a cecal\\nvolvulus.\\nTreatment\\n• Nasogastric suction\\n• IV fluids\\n• IV antibiotics if bowel ischemia suspected\\nPatients with possible intestinal obstruction should be hospitalized. Treatment of acute intestinal\\nobstruction must proceed simultaneously with diagnosis. A surgeon should always be involved.\\nSupportive care is similar for small- and large-bowel obstruction: nasogastric suction, IV fluids (0.9%'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 177, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"obstruction must proceed simultaneously with diagnosis. A surgeon should always be involved.\\nSupportive care is similar for small- and large-bowel obstruction: nasogastric suction, IV fluids (0.9%\\nsaline or lactated Ringer's solution for intravascular volume repletion), and a urinary catheter to monitor\\nfluid output. Electrolyte replacement should be guided by test results, although in cases of repeated\\nvomiting serum Na and K are likely to be depleted. If bowel ischemia or infarction is suspected, antibiotics\\nshould be given (eg, a 3rd-generation cephalosporin, such as cefotetan 2 g IV) before laparotomy.\\nSpecific measures: Obstruction of the duodenum in adults is treated by resection or, if the lesion\\ncannot be removed, palliative gastrojejunostomy (for treatment in children, see p. 2978).\\nComplete obstruction of the small bowel is preferentially treated with early laparotomy, although surgery\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 177, 'source_type': 'Authorotative', 'priority': '1'}, page_content='cannot be removed, palliative gastrojejunostomy (for treatment in children, see p. 2978).\\nComplete obstruction of the small bowel is preferentially treated with early laparotomy, although surgery\\ncan be delayed 2 or 3 h to improve fluid status and urine output in a very ill, dehydrated patient. The\\noffending lesion is removed whenever possible. If a gallstone is the cause of obstruction, it is removed\\nthrough an enterotomy, and cholecystectomy need not be done. Procedures to prevent recurrence should\\nbe done, including repair of hernias, removal of foreign bodies, and lysis of the offending adhesions. In\\nsome patients with early postoperative obstruction or repeated obstruction caused by adhesions, simple\\nintubation with a long intestinal tube (many consider a standard NGT to be equally effective), rather than\\nsurgery, may be attempted in the absence of peritoneal signs.\\nDisseminated intraperitoneal cancer obstructing the small bowel is a major cause of death in adult'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 177, 'source_type': 'Authorotative', 'priority': '1'}, page_content='surgery, may be attempted in the absence of peritoneal signs.\\nDisseminated intraperitoneal cancer obstructing the small bowel is a major cause of death in adult\\npatients with GI tract cancer. Bypassing the obstruction, either surgically or with endoscopically placed\\nstents, may palliate symptoms briefly.\\nObstructing colon cancers can often be treated by a single-stage resection and anastomosis. Other\\noptions include a diverting ileostomy and distal anastomosis. Occasionally, a diverting colostomy with\\ndelayed resection is required.\\nWhen diverticulitis causes obstruction, perforation is often present. Removal of the involved area may be\\nvery difficult but is indicated if perforation and general peritonitis are present. Resection and colostomy\\nare done, and anastomosis is postponed.\\nFecal impaction usually occurs in the rectum and can be removed digitally and with enemas. However, a\\nfecal concretion alone or in a mixture (ie, with barium or antacids) that causes complete obstruction'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 177, 'source_type': 'Authorotative', 'priority': '1'}, page_content='fecal concretion alone or in a mixture (ie, with barium or antacids) that causes complete obstruction\\n(usually in the sigmoid) requires laparotomy.\\nTreatment of cecal volvulus consists of resection and anastomosis of the involved segment or fixation of\\nthe cecum in its normal position by cecostomy in the frail patient. In sigmoidal volvulus, an endoscope or a\\nlong rectal tube can often decompress the loop, and resection and anastomosis may be deferred for a\\nfew days. Without a resection, recurrence is almost inevitable.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 11. Acute Abdomen & Surgical Gastroenterology\\n169'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 178, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Intra-Abdominal Abscesses\\nAbscesses can occur anywhere in the abdomen and retroperitoneum. They mainly occur after\\nsurgery, trauma, or conditions involving abdominal infection and inflammation, particularly\\nwhen peritonitis or perforation occurs. Symptoms are malaise, fever, and abdominal pain.\\nDiagnosis is by CT. Treatment is with drainage, either surgical or percutaneous. Antibiotics are\\nancillary.\\nEtiology\\nIntra-abdominal abscesses are classified as intraperitoneal, retroperitoneal, or visceral (see\\nTable 11-6). Many intra-abdominal abscesses develop after perforation of a hollow viscus or colonic\\ncancer. Others develop by extension of infection or inflammation resulting from conditions such as\\nappendicitis, diverticulitis, Crohn's disease, pancreatitis, pelvic inflammatory disease, or indeed any\\ncondition causing generalized peritonitis. Abdominal surgery, particularly that involving the digestive or\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 178, 'source_type': 'Authorotative', 'priority': '1'}, page_content='condition causing generalized peritonitis. Abdominal surgery, particularly that involving the digestive or\\nbiliary tract, is another significant risk factor: The peritoneum may be contaminated during or after surgery\\nfrom such events as anastomotic leaks. Traumatic\\n[Table 11-6. Intra-Abdominal Abscesses]\\nabdominal injuries—particularly lacerations and hematomas of the liver, pancreas, spleen, and intestines\\n—may develop abscesses, whether treated operatively or not.\\nThe infecting organisms typically reflect normal bowel flora and are a complex mixture of anaerobic and\\naerobic bacteria. Most frequent isolates are aerobic gram-negative bacilli (eg, Escherichia coli and\\nKlebsiella) and anaerobes (especially Bacteroides fragilis).\\nUndrained abscesses may extend to contiguous structures, erode into adjacent vessels (causing\\nhemorrhage or thrombosis), rupture into the peritoneum or bowel, or form a cutaneous fistula.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 178, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Undrained abscesses may extend to contiguous structures, erode into adjacent vessels (causing\\nhemorrhage or thrombosis), rupture into the peritoneum or bowel, or form a cutaneous fistula.\\nSubdiaphragmatic abscesses may extend into the thoracic cavity, causing an empyema, lung abscess, or\\npneumonia. An abscess in the lower abdomen may track down into the thigh or perirectal fossa. Splenic\\nabscess is a rare cause of sustained bacteremia in endocarditis that persists despite appropriate\\nantimicrobial therapy.\\nSymptoms and Signs\\nAbscesses may form within 1 wk of perforation or significant peritonitis, whereas postoperative abscesses\\nmay not occur until 2 to 3 wk after operation and, rarely, not for several months. Although manifestations\\nvary, most abscesses cause fever and abdominal discomfort ranging from minimal to severe (usually near\\nthe abscess). Paralytic ileus, either generalized or localized, may develop. Nausea, anorexia, and weight\\nloss are common.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 178, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"the abscess). Paralytic ileus, either generalized or localized, may develop. Nausea, anorexia, and weight\\nloss are common.\\nAbscesses in Douglas' cul-de-sac, adjacent to the colon, may cause diarrhea. Contiguity to the bladder\\nmay result in urinary urgency and frequency and, if caused by diverticulitis, may create a colovesical\\nfistula.\\nSubphrenic abscesses may cause chest symptoms such as nonproductive cough, chest pain, dyspnea,\\nand shoulder pain. Rales, rhonchi, or a friction rub may be audible. Dullness to percussion and decreased\\nbreath sounds are typical when basilar atelectasis, pneumonia, or pleural effusion occurs.\\nGenerally, there is tenderness over the location of the abscess. Large abscesses may be palpable as a\\nmass.\\nDiagnosis\\n• Abdominal CT\\n• Rarely, radionuclide scanning\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 11. Acute Abdomen & Surgical Gastroenterology\\n170\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 179, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"CT of the abdomen and pelvis with oral contrast is the preferred diagnostic modality for suspected\\nabscess. Other imaging studies, if done, may show abnormalities; plain abdominal x-rays may reveal\\nextraintestinal gas in the abscess, displacement of adjacent organs, a soft-tissue density representing the\\nabscess, or loss of the psoas muscle shadow. Abscesses near the diaphragm may result in chest x-ray\\nabnormalities such as ipsilateral pleural effusion, elevated or immobile hemidiaphragm, lower lobe\\ninfiltrates, and atelectasis.\\nCBC and blood cultures should be done. Leukocytosis occurs in most patients, and anemia is common.\\nOccasionally, radionuclide scanning with indium111-labeled leukocytes may be helpful in identifying intra-\\nabdominal abscesses.\\nPrognosis\\nIntra-abdominal abscesses have a mortality rate of 10 to 40%. Outcome depends mainly on the patient's\\nprimary illness or injury and general medical condition rather than on the specific nature and location of\\nthe abscess.\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 179, 'source_type': 'Authorotative', 'priority': '1'}, page_content='primary illness or injury and general medical condition rather than on the specific nature and location of\\nthe abscess.\\nTreatment\\n• IV antibiotics\\n• Drainage: Percutaneous or surgical\\nAll intra-abdominal abscesses require drainage, either by percutaneous catheters or surgery. Drainage\\nthrough catheters (placed with CT or ultrasound guidance) may be appropriate given the following\\nconditions: Few abscess cavities are present; the drainage route does not traverse bowel or\\nuncontaminated organs, pleura, or peritoneum; the source of contamination is controlled; and the pus is\\nthin enough to pass through the catheter.\\nAntibiotics are not curative but may limit hematogenous spread and should be given before and after\\nintervention. Therapy requires drugs active against bowel flora, such as a combination of an\\naminoglycoside (eg, gentamicin 1.5 mg/kg q 8 h) and metronidazole 500 mg q 8 h. Single-agent therapy'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 179, 'source_type': 'Authorotative', 'priority': '1'}, page_content='intervention. Therapy requires drugs active against bowel flora, such as a combination of an\\naminoglycoside (eg, gentamicin 1.5 mg/kg q 8 h) and metronidazole 500 mg q 8 h. Single-agent therapy\\nwith cefotetan 2 g q 12 h is also reasonable. Patients previously given antibiotics or those who have\\nhospital-acquired infections should receive drugs active against resistant aerobic gram-negative bacilli\\n(eg, Pseudomonas) and anaerobes.\\nNutritional support is important, with the enteral route preferred. Parenteral nutrition should begin early if\\nthe enteral route is not feasible.\\nIschemic Colitis\\nIschemic colitis is a transient reduction in blood flow to the colon.\\nNecrosis may occur but is usually limited to the mucosa and submucosa, only occasionally causing full-\\nthickness necrosis necessitating surgery. It occurs mainly in older people (> 60) and is thought to be\\ncaused by small-vessel atherosclerosis.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 179, 'source_type': 'Authorotative', 'priority': '1'}, page_content='thickness necrosis necessitating surgery. It occurs mainly in older people (> 60) and is thought to be\\ncaused by small-vessel atherosclerosis.\\nSymptoms are milder and of slower onset than those of acute mesenteric ischemia and consist of left\\nlower quadrant pain followed by rectal bleeding. Diagnosis is made by colonoscopy; angiography or\\nmagnetic resonance angiography is not indicated. Treatment is supportive with IV fluids, bowel rest, and\\nantibiotics. Surgery is rarely required. About 5% of patients have a recurrence. Occasionally, strictures\\ndevelop at the site of the ischemia several weeks later, necessitating surgical resection.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 11. Acute Abdomen & Surgical Gastroenterology\\n171'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 180, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Chapter 12. Esophageal and Swallowing Disorders\\nIntroduction\\n(See also Esophageal Cancer on p. 186 and Esophageal Atresia on p. 2975.)\\nThe swallowing apparatus consists of the pharynx, upper esophageal (cricopharyngeal) sphincter, the\\nbody of the esophagus, and the lower esophageal sphincter (LES). The upper third of the esophagus\\nand the structures proximal to it are composed of skeletal muscle; the distal esophagus and LES are\\ncomposed of smooth muscle. These components work as an integrated system that transports material\\nfrom the mouth to the stomach and prevents its reflux into the esophagus. Physical obstruction or\\ndisorders that interfere with motor function (motility disorders) can affect the system.\\nThe patient's history suggests the diagnosis almost 80% of the time. The only physical findings in\\nesophageal disorders are cervical and supraclavicular lymphadenopathy caused by metastasis, swellings\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 180, 'source_type': 'Authorotative', 'priority': '1'}, page_content='esophageal disorders are cervical and supraclavicular lymphadenopathy caused by metastasis, swellings\\nin the neck caused by large pharyngeal diverticula or thyromegaly, and prolonged swallowing time (the\\ntime from the act of swallowing to the sound of the bolus of fluid and air entering the stomach—normally ≤\\n12 sec—heard by auscultation with the stethoscope over the epigastrium). Watching the patient swallow\\nmay help diagnose aspiration or nasal regurgitation. Most esophageal disorders require specific tests for\\ndiagnosis.\\nDysphagia\\nDysphagia is difficulty swallowing. The condition results from impeded transport of liquids, solids, or both\\nfrom the pharynx to the stomach. Dysphagia should not be confused with globus sensation (see p. 78), a\\nfeeling of having a lump in the throat, which is unrelated to swallowing and occurs without impaired\\ntransport.\\nComplications: Dysphagia can lead to tracheal aspiration of ingested material, oral secretions, or both.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 180, 'source_type': 'Authorotative', 'priority': '1'}, page_content='transport.\\nComplications: Dysphagia can lead to tracheal aspiration of ingested material, oral secretions, or both.\\nAspiration can cause acute pneumonia; recurrent aspiration may eventually lead to chronic lung disease.\\nProlonged dysphagia often leads to inadequate nutrition and weight loss.\\nEtiology\\nDysphagia is classified as oropharyngeal or esophageal, depending on where it occurs.\\nOropharyngeal dysphagia: Oropharyngeal dysphagia is difficulty emptying material from the\\noropharynx into the esophagus; it results from abnormal function proximal to the esophagus. Patients\\ncomplain of difficulty initiating swallowing, nasal regurgitation, and tracheal aspiration followed by\\ncoughing.\\nMost often, oropharyngeal dysphagia occurs in patients with neurologic conditions or muscular disorders\\nthat affect skeletal muscles (see\\nTable 12-1).\\nEsophageal dysphagia: Esophageal dysphagia is difficulty passing food down the esophagus. It results'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 180, 'source_type': 'Authorotative', 'priority': '1'}, page_content='that affect skeletal muscles (see\\nTable 12-1).\\nEsophageal dysphagia: Esophageal dysphagia is difficulty passing food down the esophagus. It results\\nfrom either a motility disorder or a mechanical obstruction (see\\nTable 12-2).\\nEvaluation\\nHistory: History of present illness begins with duration of symptoms and acuity of onset. Patients\\nshould describe what substances cause difficulty and where they feel the disturbance is located. Specific\\nconcerns include whether patients have difficulty swallowing solids, liquids, or both; whether food comes\\nout their nose; whether they drool or have food spill from their mouth; and whether they cough or choke\\nwhile eating.\\n[Table 12-1. Some Causes of Oropharyngeal Dysphagia]\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 12. Esophageal & Swallowing Disorders\\n172'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 181, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Review of symptoms should focus on symptoms suggestive of neuromuscular, GI, and connective\\ntissue disorders and on the presence of complications. Important neuromuscular symptoms include\\nweakness and easy fatigability, gait or balance disturbance, tremor, and difficulty speaking. Important GI\\nsymptoms include heartburn or other chest discomfort suggestive of reflux. Symptoms of connective\\ntissue disorders include muscle and joint pain, Raynaud's phenomenon, and skin changes (eg, rash,\\nswelling, thickening).\\nPast medical history should ascertain known diseases that may cause dysphagia (see Tables 12-1 and\\n12-2).\\nPhysical examination: Examination focuses on findings suggestive of neuromuscular, GI, and\\nconnective tissue disorders and on the presence of complications.\\nGeneral examination should evaluate nutritional status (including body weight). A complete neurologic\\nexamination is essential, with attention to any resting tremor, the cranial nerves (note the gag reflex may\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 181, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"examination is essential, with attention to any resting tremor, the cranial nerves (note the gag reflex may\\nnormally be absent; this absence is thus not a good marker of swallowing dysfunction), and muscle\\nstrength. Patients who describe easy fatigability should be observed performing a repetitive action (eg,\\nblinking, counting aloud) for a rapid decrement in performance.\\n[Table 12-2. Some Causes of Esophageal Dysphagia]\\nThe patient's gait should be observed, and balance should be tested. Skin is examined for rash and\\nthickening or texture changes, particularly on the fingertips. Muscles are inspected for wasting and\\nfasciculations and are palpated for tenderness. The neck is evaluated for thyromegaly or other mass.\\nRed flags: Any dysphagia is of concern, but certain findings are more urgent:\\n• Symptoms of complete obstruction (eg, drooling, inability to swallow anything)\\n• Dysphagia resulting in weight loss\\n• New focal neurologic deficit, particularly any objective weakness\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 181, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"• Symptoms of complete obstruction (eg, drooling, inability to swallow anything)\\n• Dysphagia resulting in weight loss\\n• New focal neurologic deficit, particularly any objective weakness\\nInterpretation of findings: Dysphagia that occurs in conjunction with an acute neurologic event is likely\\nthe result of that event; new dysphagia in a patient with a stable, long-standing neurologic disorder may\\nhave another etiology. Dysphagia for solids alone suggests mechanical obstruction; however, a problem\\nwith both solids and liquids is nonspecific. Drooling and spilling food from the mouth while eating or nasal\\nregurgitation suggests an oropharyngeal disorder. Regurgitation of a small amount of food on lateral\\ncompression of the neck is virtually diagnostic of pharyngeal diverticulum.\\nPatients who complain of difficulty getting food to leave the mouth or of food sticking in the lower\\nesophagus are usually correct about the condition's location; the sensation of dysphagia in the upper\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 181, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"esophagus are usually correct about the condition's location; the sensation of dysphagia in the upper\\nesophagus is less specific.\\nMany findings suggest specific disorders (see\\nTable 12-3) but are of varying sensitivity and specificity and thus do not rule in or out a given cause;\\nhowever, they can guide testing.\\nTesting: A barium swallow (with a solid bolus, usually a marshmallow or tablet) should be done. If this\\ntest shows obstruction, endoscopy (and possibly biopsy) should be done to rule out malignancy. If the\\nbarium swallow is negative or suggestive of a motility disorder, esophageal motility studies should be\\ndone. Other tests for specific causes are done as suggested by findings.\\nTreatment\\nTreatment is directed at the specific cause. If complete obstruction occurs, emergent upper endoscopy is\\nessential. If a stricture, ring, or web is found, careful endoscopic dilation is performed. Pending resolution,\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 181, 'source_type': 'Authorotative', 'priority': '1'}, page_content='essential. If a stricture, ring, or web is found, careful endoscopic dilation is performed. Pending resolution,\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 12. Esophageal & Swallowing Disorders\\n173'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 182, 'source_type': 'Authorotative', 'priority': '1'}, page_content='patients with oropharyngeal dysphagia may benefit\\n[Table 12-3. Some Helpful Findings in Dysphagia]\\nfrom evaluation by a rehabilitation specialist. Sometimes patients benefit from changing head position\\nwhile eating, retraining the swallowing muscles, doing exercises that improve the ability to accommodate\\na food bolus in the oral cavity, or doing strength and coordination exercises for the tongue. Patients with\\nsevere dysphagia and recurrent aspiration may require a gastrostomy tube.\\nGeriatrics Essentials\\nChewing, swallowing, tasting, and communicating require intact, coordinated neuromuscular function in\\nthe mouth, face, and neck. Oral motor function in particular declines measurably with aging, even in\\nhealthy people. Decline in function may have many manifestations:\\n• Reduction in masticatory muscle strength and coordination is common, especially among patients with\\npartial or complete dentures, and may lead to a tendency to swallow larger food particles, which can'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 182, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"partial or complete dentures, and may lead to a tendency to swallow larger food particles, which can\\nincrease the risk of choking or aspiration.\\n• Drooping of the lower face and lips caused by decreased circumoral muscle tone and, in edentulous\\npeople, reduced bone support, is an aesthetic concern and can lead to drooling, spilling of food and\\nliquids, and difficulty closing the lips while eating, sleeping, or resting. Sialorrhea (saliva leakage) is\\noften the first symptom.\\n• Swallowing difficulties increase. It takes longer to move food from mouth to oropharynx, which increases\\nthe likelihood of aspiration.\\nAfter age-related changes, the most common causes of oral motor disorders are neuromuscular disorders\\n(eg, cranial neuropathies caused by diabetes, stroke, Parkinson's disease, amyotrophic lateral sclerosis,\\nmultiple sclerosis). Iatrogenic causes also contribute. Drugs (eg, anticholinergics, diuretics), radiation\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 182, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"multiple sclerosis). Iatrogenic causes also contribute. Drugs (eg, anticholinergics, diuretics), radiation\\ntherapy to the head and neck, and chemotherapy can greatly impair saliva production. Hyposalivation is a\\nmajor cause of delayed and impaired swallowing.\\nOral motor dysfunction is best managed with a multidisciplinary approach. Coordinated referrals to\\nspecialists in prosthetic dentistry, rehabilitative medicine, speech pathology, otolaryngology, and\\ngastroenterology may be needed.\\nKey Points\\n• All patients complaining of esophageal dysphagia should undergo upper endoscopy to rule out cancer.\\n• If the upper endoscopy is normal, biopsies should be obtained to rule out eosinophilic esophagitis.\\n• Treatment is geared toward the cause.\\nCricopharyngeal Incoordination\\nIn cricopharyngeal incoordination, the cricopharyngeal muscle (the upper esophageal sphincter) is\\nuncoordinated. It can cause a Zenker's diverticulum (see p. 125). Repeated aspiration of material from the\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 182, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"uncoordinated. It can cause a Zenker's diverticulum (see p. 125). Repeated aspiration of material from the\\ndiverticulum can lead to chronic lung disease. The condition can be treated by surgical section of the\\ncricopharyngeal muscle.\\nObstructive Disorders\\n(See also Benign Esophageal Tumors and Esophageal Cancer on p. 186.)\\nLower Esophageal Ring\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 12. Esophageal & Swallowing Disorders\\n174\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 183, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"(Schatzki's Ring, B Ring)\\nA lower esophageal ring is a 2- to 4-mm mucosal stricture, probably congenital, causing a\\nringlike narrowing of the distal esophagus at the squamocolumnar junction.\\nThese rings cause intermittent dysphagia for solids. This symptom can begin at any age but usually does\\nnot begin until after age 25. The swallowing difficulty comes and goes and is especially aggravated by\\nmeat and dry bread. Symptoms usually occur only when the esophageal lumen is < 12 mm in diameter\\nand never when it is > 20 mm. If the distal esophagus is adequately distended, barium x-rays usually\\nshow the ring. Instructing the patient to chew food thoroughly is usually the only treatment required in\\nwider rings, but narrow-lumen rings require dilation by endoscopy or bougienage. Surgical resection is\\nrarely required.\\nEsophageal Web\\n(Plummer-Vinson Syndrome; Paterson-Kelly Syndrome; Sideropenic Dysphagia)\\nAn esophageal web is a thin mucosal membrane that grows across the lumen.\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 183, 'source_type': 'Authorotative', 'priority': '1'}, page_content='rarely required.\\nEsophageal Web\\n(Plummer-Vinson Syndrome; Paterson-Kelly Syndrome; Sideropenic Dysphagia)\\nAn esophageal web is a thin mucosal membrane that grows across the lumen.\\nRarely, webs develop in patients with untreated severe iron-deficiency anemia; they develop even more\\nrarely in patients without anemia. Webs usually occur in the upper esophagus, causing dysphagia for\\nsolids. They are best diagnosed by barium swallow. Webs resolve with treatment of the anemia but can\\nbe easily ruptured during esophagoscopy.\\nDysphagia Lusoria\\nDysphagia lusoria is caused by compression of the esophagus from any of several congenital\\nvascular abnormalities.\\nThe vascular abnormality is usually an aberrant right subclavian artery arising from the left side of the\\naortic arch, a double aortic arch, or a right aortic arch with left ligamentum arteriosum. The dysphagia\\nmay develop in childhood or later in life as a result of arteriosclerotic changes in the aberrant vessel.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 183, 'source_type': 'Authorotative', 'priority': '1'}, page_content='may develop in childhood or later in life as a result of arteriosclerotic changes in the aberrant vessel.\\nBarium swallow shows the extrinsic compression, but arteriography is necessary for absolute diagnosis.\\nMost patients require no treatment, but surgical repair is sometimes done.\\nMotility Disorders\\nAchalasia\\n(Cardiospasm; Esophageal Aperistalsis; Megaesophagus)\\nAchalasia is a neurogenic esophageal motility disorder characterized by impaired esophageal\\nperistalsis, a lack of lower esophageal sphincter relaxation during swallowing, and an elevation\\nof lower esophageal sphincter resting pressure. Symptoms are slowly progressive dysphagia,\\nusually to both liquids and solids, and regurgitation of undigested food. Evaluation typically\\nincludes barium swallow, endoscopy, and sometimes manometry. Treatments include dilation,\\nchemical denervation, and surgical myotomy.\\nAchalasia is thought to be caused by a loss of ganglion cells in the myenteric plexus of the esophagus,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 183, 'source_type': 'Authorotative', 'priority': '1'}, page_content='chemical denervation, and surgical myotomy.\\nAchalasia is thought to be caused by a loss of ganglion cells in the myenteric plexus of the esophagus,\\nresulting in denervation of esophageal muscle. Etiology of the denervation is unknown, although a viral\\ncause is suspected, and certain tumors may cause achalasia either by direct obstruction or as a\\nparaneoplastic process. Chagas disease, which causes destruction of autonomic ganglia, may result in\\nachalasia.\\nIncreased pressure at the lower esophageal sphincter (LES) causes obstruction with secondary dilation\\nof the esophagus. Esophageal retention of undigested food is common.\\nSymptoms and Signs\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 12. Esophageal & Swallowing Disorders\\n175'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 184, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Achalasia occurs at any age but usually begins between ages 20 and 60. Onset is insidious, and\\nprogression is gradual over months or years. Dysphagia for both solids and liquids is the major symptom.\\nNocturnal regurgitation of undigested food occurs in about 33% of patients and may cause cough and\\npulmonary aspiration. Chest pain is less common but may occur on swallowing or spontaneously. Mild to\\nmoderate weight loss occurs; when weight loss is pronounced, particularly in elderly patients whose\\nsymptoms of dysphagia developed rapidly, achalasia secondary to a tumor of the gastroesophageal\\njunction should be considered.\\nDiagnosis\\n• Barium swallow\\n• Esophageal manometry\\nThe preferred test is barium swallow, which shows absence of progressive peristaltic contractions during\\nswallowing. The esophagus is dilated, often enormously, but is narrowed and beaklike at the LES. If\\nesophagoscopy is done, there is dilation but no obstructing lesion. The esophagoscope usually passes'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 184, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"esophagoscopy is done, there is dilation but no obstructing lesion. The esophagoscope usually passes\\nreadily into the stomach; resistance raises the possibility of an inapparent cancer or stricture. To exclude\\ncancer, a retroflexed view of the gastric cardia, biopsies, and brushings for cytology should be obtained.\\nEsophageal manometry is usually done and typically shows aperistalsis, increased LES pressure, and\\nincomplete sphincteric relaxation during swallowing.\\nAchalasia must be differentiated from a distal stenosing carcinoma and a peptic stricture, particularly in\\npatients with systemic sclerosis (see p. 309), in whom esophageal manometry may also show\\naperistalsis. Systemic sclerosis is usually accompanied by a history of Raynaud's phenomenon and\\nsymptoms of gastroesophageal reflux disease (GERD), due to low or absent LES pressure.\\nAchalasia due to cancer at the gastroesophageal junction can be diagnosed by CT of the chest and\\nabdomen or by endoscopic ultrasound.\\nPrognosis\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 184, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Achalasia due to cancer at the gastroesophageal junction can be diagnosed by CT of the chest and\\nabdomen or by endoscopic ultrasound.\\nPrognosis\\nPulmonary aspiration and the presence of cancer are the determining prognostic factors. Nocturnal\\nregurgitation and coughing suggest aspiration. Pulmonary complications secondary to aspiration are\\ndifficult to manage. Incidence of esophageal cancer in patients with achalasia may be increased; this\\npoint is controversial.\\nTreatment\\n• Balloon dilation of the LES\\n• Alternatively, botulinum toxin injection or surgical myotomy\\nNo therapy restores peristalsis; treatment aims at reducing the pressure (and thus the obstruction) at the\\nLES. Pneumatic balloon dilation of the LES is indicated initially. Results are satisfactory in about 85% of\\npatients, but repeated dilations may be needed. Esophageal rupture and secondary mediastinitis\\nrequiring surgical repair occur in < 2% of patients. Nitrates (eg, isosorbide dinitrate 5 to 10 mg'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 184, 'source_type': 'Authorotative', 'priority': '1'}, page_content='patients, but repeated dilations may be needed. Esophageal rupture and secondary mediastinitis\\nrequiring surgical repair occur in < 2% of patients. Nitrates (eg, isosorbide dinitrate 5 to 10 mg\\nsublingually before meals) or Ca channel blockers (eg, nifedipine 10 mg po tid) are of limited\\neffectiveness but may reduce LES pressure enough to prolong the time between dilations.\\nAchalasia can also be treated by chemical denervation of cholinergic nerves in the distal esophagus by\\ndirect injection of botulinum toxin type A into the LES. Clinical improvement occurs in 70 to 80% of\\npatients, but results may last only 6 mo to 1 yr.\\nA Heller myotomy, in which the muscular fibers in the LES are cut, is usually reserved for patients who do\\nnot respond to dilation; its success rate is about 85%. It can be done via laparoscopy or thoracoscopy\\nand may be a viable alternative to dilation as primary therapy. Symptomatic GERD occurs after surgery in\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 184, 'source_type': 'Authorotative', 'priority': '1'}, page_content='and may be a viable alternative to dilation as primary therapy. Symptomatic GERD occurs after surgery in\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 12. Esophageal & Swallowing Disorders\\n176'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 185, 'source_type': 'Authorotative', 'priority': '1'}, page_content='about 15% of patients.\\nSymptomatic Diffuse Esophageal Spasm\\n(Spastic Pseudodiverticulosis; Rosary Bead or Corkscrew Esophagus)\\nSymptomatic diffuse esophageal spasm is part of a spectrum of motility disorders\\ncharacterized variously by nonpropulsive contractions, hyperdynamic contractions, or elevated\\nlower esophageal sphincter pressure. Symptoms are chest pain and sometimes dysphagia.\\nDiagnosis is by barium swallow or manometry. Treatment is difficult but includes nitrates, Ca\\nchannel blockers, botulinum toxin injection, and antireflux therapy.\\nAbnormalities in esophageal motility correlate poorly with patient symptoms; similar abnormalities may\\ncause different or no symptoms in different people. Furthermore, neither symptoms nor abnormal\\ncontractions are definitively associated with histopathologic abnormalities of the esophagus.\\nSymptoms and Signs\\nDiffuse esophageal spasm typically causes substernal chest pain with dysphagia for both liquids and'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 185, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Symptoms and Signs\\nDiffuse esophageal spasm typically causes substernal chest pain with dysphagia for both liquids and\\nsolids. The pain may waken the patient from sleep. Very hot or cold liquids may aggravate the pain. Over\\nmany years, this disorder may evolve into achalasia.\\nEsophageal spasms can cause severe pain without dysphagia. This pain is often described as a\\nsubsternal squeezing pain and may occur in association with exercise. Such pain may be\\nindistinguishable from angina pectoris.\\nSome patients have symptoms that combine those of achalasia and diffuse spasm. One such combination\\nhas been called vigorous achalasia because it features both the food retention and aspiration of\\nachalasia and the severe pain and spasm of diffuse spasm.\\nDiagnosis\\n• Barium swallow\\n• Esophageal manometry\\n• Possibly testing for coronary ischemia\\nAlternative diagnoses include coronary ischemia. Definitive confirmation of an esophageal origin for'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 185, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Diagnosis\\n• Barium swallow\\n• Esophageal manometry\\n• Possibly testing for coronary ischemia\\nAlternative diagnoses include coronary ischemia. Definitive confirmation of an esophageal origin for\\nsymptoms is difficult. Barium swallow may show poor progression of a bolus and disordered,\\nsimultaneous contractions or tertiary contractions. Severe spasms may mimic the radiographic\\nappearance of diverticula but vary in size and position. Esophageal manometry (see p. 96) provides the\\nmost specific description of the spasms. Contractions are usually simultaneous, prolonged or multiphasic,\\nand possibly of very high amplitude (\"nutcracker esophagus\"). However, spasms may not occur during\\ntesting. Lower esophageal sphincter (LES) pressure elevation or impaired relaxation is present in 30% of\\npatients. Esophageal scintigraphy and provocative tests with drugs (eg, edrophonium chloride 10 mg IV)\\nhave not proved helpful.\\nTreatment\\n• Ca channel blockers\\n• Botulinum toxin injection'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 185, 'source_type': 'Authorotative', 'priority': '1'}, page_content='patients. Esophageal scintigraphy and provocative tests with drugs (eg, edrophonium chloride 10 mg IV)\\nhave not proved helpful.\\nTreatment\\n• Ca channel blockers\\n• Botulinum toxin injection\\nEsophageal spasms are often difficult to treat, and controlled studies of treatment methods are lacking.\\nAnticholinergics, nitroglycerin, and long-acting nitrates have had limited success. Ca channel blockers\\ngiven orally (eg, verapamil 80 mg tid, nifedipine 10 mg tid) may be useful, as may injection of botulinum\\ntoxin type A into the LES.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 12. Esophageal & Swallowing Disorders\\n177'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 186, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Medical management is usually sufficient, but pneumatic dilation and bougienage, or even surgical\\nmyotomy along the full length of the esophagus, may be tried in intractable cases.\\nEsophageal Diverticula\\nAn esophageal diverticulum is an outpouching of mucosa through the muscular layer of the\\nesophagus. It can be asymptomatic or cause dysphagia and regurgitation. Diagnosis is made by\\nbarium swallow; surgical repair is rarely required.\\nThere are several types of esophageal diverticula, each of different origin.\\n• Zenker's (pharyngeal) diverticula are posterior outpouchings of mucosa and submucosa through the\\ncricopharyngeal muscle, probably resulting from an incoordination between pharyngeal propulsion and\\ncricopharyngeal relaxation.\\n• Midesophageal (traction) diverticula are caused by traction from mediastinal inflammatory lesions or,\\nsecondarily, by motility disorders.\\n• Epiphrenic diverticula occur just above the diaphragm and usually accompany a motility disorder\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 186, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"secondarily, by motility disorders.\\n• Epiphrenic diverticula occur just above the diaphragm and usually accompany a motility disorder\\n(achalasia, diffuse esophageal spasm).\\nSymptoms and Signs\\nA Zenker's diverticulum fills with food that might be regurgitated when the patient bends or lies down.\\nAspiration pneumonitis may result if regurgitation is nocturnal. Rarely, the pouch becomes large, causing\\ndysphagia and sometimes a palpable neck mass.\\nTraction and epiphrenic diverticula are rarely symptomatic, although their underlying cause may be.\\nDiagnosis\\nAll diverticula are diagnosed by videotaped barium swallow.\\nTreatment\\n• Usually none\\n• Sometimes surgical resection\\nSpecific treatment is usually not required, although resection is occasionally necessary for large or\\nsymptomatic diverticula. Diverticula associated with motility disorders require treatment of the primary\\ndisorder. For example, case reports suggest doing a cricopharyngeal myotomy when resecting a Zenker's\\ndiverticulum.\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 186, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"disorder. For example, case reports suggest doing a cricopharyngeal myotomy when resecting a Zenker's\\ndiverticulum.\\nGastroesophageal Reflux Disease\\nIncompetence of the lower esophageal sphincter allows reflux of gastric contents into the\\nesophagus, causing burning pain. Prolonged reflux may lead to esophagitis, stricture, and rarely\\nmetaplasia or cancer. Diagnosis is clinical, sometimes with endoscopy, with or without acid\\ntesting. Treatment involves lifestyle modification, acid suppression using proton pump\\ninhibitors, and sometimes surgical repair.\\nGastroesophageal reflux disease (GERD) is common, occurring in 30 to 40% of adults. It also occurs\\nfrequently in infants, typically beginning at birth.\\nEtiology\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 12. Esophageal & Swallowing Disorders\\n178\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 187, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"The presence of reflux implies lower esophageal sphincter (LES) incompetence, which may result from a\\ngeneralized loss of intrinsic sphincter tone or from recurrent inappropriate transient relaxations (ie,\\nunrelated to swallowing). Transient LES relaxations are triggered by gastric distention or subthreshold\\npharyngeal stimulation.\\nFactors that contribute to the competence of the gastroesophageal junction include the angle of the\\ncardioesophageal junction, the action of the diaphragm, and gravity (ie, an upright position). Factors\\ncontributing to reflux include weight gain, fatty foods, caffeinated or carbonated beverages, alcohol,\\ntobacco smoking, and drugs. Drugs that lower LES pressure include anticholinergics, antihistamines,\\ntricyclic antidepressants, Ca channel blockers, progesterone, and nitrates.\\nComplications: GERD may lead to esophagitis, peptic esophageal ulcer, esophageal stricture, Barrett's\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 187, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"tricyclic antidepressants, Ca channel blockers, progesterone, and nitrates.\\nComplications: GERD may lead to esophagitis, peptic esophageal ulcer, esophageal stricture, Barrett's\\nesophagus, and esophageal adenocarcinoma (see p. 186). Factors that contribute to the development of\\nesophagitis include the caustic nature of the refluxate, the inability to clear the refluxate from the\\nesophagus, the volume of gastric contents, and local mucosal protective functions. Some patients,\\nparticularly infants, aspirate the reflux material.\\nSymptoms and Signs\\nThe most prominent symptom of GERD is heartburn, with or without regurgitation of gastric contents into\\nthe mouth. Infants present with vomiting, irritability, anorexia, and sometimes symptoms of chronic\\naspiration. Both adults and infants with chronic aspiration may have cough, hoarseness, or wheezing.\\nEsophagitis may cause odynophagia and even esophageal hemorrhage, which is usually occult but can\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 187, 'source_type': 'Authorotative', 'priority': '1'}, page_content='aspiration. Both adults and infants with chronic aspiration may have cough, hoarseness, or wheezing.\\nEsophagitis may cause odynophagia and even esophageal hemorrhage, which is usually occult but can\\nbe massive. Peptic stricture causes a gradually progressive dysphagia for solid foods. Peptic esophageal\\nulcers cause the same type of pain as gastric or duodenal ulcers, but the pain is usually localized to the\\nxiphoid or high substernal region. Peptic esophageal ulcers heal slowly, tend to recur, and usually leave a\\nstricture on healing.\\nDiagnosis\\n• Clinical diagnosis\\n• Endoscopy for those not responding to empiric treatment\\n• 24-h pH testing for those with typical symptoms but normal endoscopy\\nA detailed history points to the diagnosis. Patients with typical symptoms of GERD may be given a trial of\\ntherapy. Patients who do not improve, or have long-standing symptoms or symptoms of complications,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 187, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"therapy. Patients who do not improve, or have long-standing symptoms or symptoms of complications,\\nshould be studied. Endoscopy, with cytologic washings and biopsy of abnormal areas, is the test of\\nchoice. Endoscopic biopsy is the only test that consistently detects the columnar mucosal changes of\\nBarrett's esophagus. Patients with unremarkable endoscopy findings who have typical symptoms despite\\ntreatment with proton pump inhibitors should undergo 24-h pH testing (see p. 95). Although barium\\nswallow readily shows esophageal ulcers and peptic strictures, it is less useful for mild to moderate reflux;\\nin addition, most patients with abnormalities require subsequent endoscopy. Esophageal manometry may\\nbe used to guide pH probe placement and to evaluate esophageal peristalsis before surgical treatment.\\nTreatment\\n• Head of bed elevated\\n• Coffee, alcohol, fats, and smoking avoided\\n• Proton pump inhibitors\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 187, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Treatment\\n• Head of bed elevated\\n• Coffee, alcohol, fats, and smoking avoided\\n• Proton pump inhibitors\\nManagement of uncomplicated GERD consists of elevating the head of the bed about 15 cm (6 in) and\\navoiding the following: eating within 2 to 3 h of bedtime, strong stimulants of acid secretion (eg, coffee,\\nalcohol), certain drugs (eg, anticholinergics), specific foods (eg, fats, chocolate), and smoking.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 12. Esophageal & Swallowing Disorders\\n179'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 188, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Drug therapy is with a proton pump inhibitor. For example, adults can be given omeprazole 20 mg,\\nlansoprazole 30 mg, or esomeprazole 40 mg 30 min before breakfast. In some cases, proton pump\\ninhibitors may be given bid. Infants and children may be given these drugs at an appropriate lower single\\ndaily dose (ie, omeprazole 20 mg in children > 3 yr, 10 mg in children < 3 yr; lansoprazole 15 mg in\\nchildren ≤ 30 kg, 30 mg in children > 30 kg). These drugs may be continued long-term, but the dose\\nshould be adjusted to the minimum required to prevent symptoms. H2 blockers (eg, ranitidine 150 mg at\\nbedtime) or promotility agents (eg, metoclopramide 10 mg po 30 min before meals and at bedtime) are\\nless effective.\\nAntireflux surgery (usually via laparoscopy) is done on patients with serious esophagitis, large hiatal\\nhernias, hemorrhage, stricture, or ulcers. Esophageal strictures are managed by repeated balloon\\ndilation.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 188, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"hernias, hemorrhage, stricture, or ulcers. Esophageal strictures are managed by repeated balloon\\ndilation.\\nBarrett's esophagus may or may not regress with medical or surgical therapy. Because Barrett's\\nesophagus is a precursor to adenocarcinoma, endoscopic surveillance for malignant transformation is\\nrecommended every 1 to 2 yr. Surveillance has uncertain cost-effectiveness in patients with low-grade\\ndysplasia but is important in high-grade dysplasia in patients who are unable to undergo surgical\\nresection. Alternatively, Barrett's esophagus may be treated with endoscopic mucosal resection,\\nphotodynamic therapy, cryotherapy, or laser ablation.\\nHiatus Hernia\\nHiatus hernia is a protrusion of the stomach through the diaphragmatic hiatus. Most hernias are\\nasymptomatic, but an increased incidence of acid reflux may lead to symptoms of\\ngastroesophageal reflux disease (GERD). Diagnosis is by barium swallow. Treatment is directed\\nat symptoms of GERD if present.\\nEtiology\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 188, 'source_type': 'Authorotative', 'priority': '1'}, page_content='gastroesophageal reflux disease (GERD). Diagnosis is by barium swallow. Treatment is directed\\nat symptoms of GERD if present.\\nEtiology\\nEtiology is usually unknown, but a hiatus hernia is thought to be acquired through stretching of the fascial\\nattachments between the esophagus and diaphragm at the hiatus (the opening through which the\\nesophagus traverses the diaphragm).\\nPathophysiology\\nIn a sliding hiatus hernia (the most common type), the gastroesophageal junction and a portion of the\\nstomach are above the diaphragm. In a paraesophageal hiatus hernia, the gastroesophageal junction is in\\nthe normal location, but a portion of the stomach is adjacent to the esophagus in the diaphragmatic\\nhiatus. Hernias may also occur through other parts of the diaphragm (see p. 2977).\\nA sliding hiatus hernia is common and is an incidental finding on x-ray in > 40% of the population;\\ntherefore, the relationship of hernia to symptoms is unclear. Although most patients with GERD have'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 188, 'source_type': 'Authorotative', 'priority': '1'}, page_content='A sliding hiatus hernia is common and is an incidental finding on x-ray in > 40% of the population;\\ntherefore, the relationship of hernia to symptoms is unclear. Although most patients with GERD have\\nsome degree of hiatus hernia, < 50% of patients with hiatus hernia have GERD.\\nSymptoms and Signs\\nMost patients with a sliding hiatus hernia are asymptomatic, but chest pain and other reflux symptoms can\\noccur. A paraesophageal hiatus hernia is generally asymptomatic but, unlike a sliding hiatus hernia, may\\nincarcerate and strangulate. Occult or massive GI hemorrhage may occur with either type.\\nDiagnosis\\n• Barium swallow\\nA large hiatus hernia is often discovered incidentally on chest x-ray. Smaller hernias are diagnosed with a\\nbarium swallow.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 12. Esophageal & Swallowing Disorders\\n180'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 189, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Treatment\\n• Sometimes a proton pump inhibitor\\nAn asymptomatic sliding hiatus hernia requires no specific therapy. Patients with accompanying GERD\\nshould be treated with a proton pump inhibitor. A paraesophageal hernia should be reduced surgically\\nbecause of the risk of strangulation.\\nInfectious Esophageal Disorders\\nEsophageal infection occurs mainly in patients with impaired host defenses. Primary agents\\ninclude Candida albicans, herpes simplex virus, and cytomegalovirus. Symptoms are\\nodynophagia and chest pain. Diagnosis is by endoscopic visualization and culture. Treatment is\\nwith antifungal or antiviral drugs.\\nEsophageal infection is rare in patients with normal host defenses. Primary esophageal defenses include\\nsaliva, esophageal motility, and cellular immunity. Thus, at-risk patients include those with AIDS, organ\\ntransplants, alcoholism, diabetes, undernutrition, cancer, and motility disorders. Candida infection may'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 189, 'source_type': 'Authorotative', 'priority': '1'}, page_content='transplants, alcoholism, diabetes, undernutrition, cancer, and motility disorders. Candida infection may\\noccur in any of these patients. Herpes simplex virus (HSV) and cytomegalovirus (CMV) infections occur\\nmainly in AIDS and transplant patients.\\nCandida: Patients with Candida esophagitis usually complain of odynophagia and, less commonly,\\ndysphagia. About two thirds of patients have signs of oral thrush (thus its absence does not exclude\\nesophageal involvement). Patients with odynophagia and typical thrush may be given empiric treatment,\\nbut if significant improvement does not occur in 5 to 7 days, endoscopic evaluation is required. Barium\\nswallow is less accurate.\\nTreatment is with fluconazole 200 mg po or IV for one dose, then 100 mg po or IV q 24 h for 14 to 21\\ndays. Alternatives include the azoles (eg, itraconazole, voriconazole, ketoconazole) or echinocandins (eg,\\ncaspofungin). Topical therapy has no role.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 189, 'source_type': 'Authorotative', 'priority': '1'}, page_content='days. Alternatives include the azoles (eg, itraconazole, voriconazole, ketoconazole) or echinocandins (eg,\\ncaspofungin). Topical therapy has no role.\\nHSV and CMV: These infections are equally likely in transplant patients, but HSV occurs early after\\ntransplantation (reactivation) and CMV occurs 2 to 6 mo after. Among AIDS patients, CMV is much more\\ncommon than HSV, and viral esophagitis occurs mainly when the CD4+ count is < 200/μL. Severe\\nodynophagia results from either infection.\\nEndoscopy, with cytology or biopsy, is usually necessary for diagnosis. HSV is treated with IV acyclovir 5\\nmg/kg q 8 h for 7 days or valacyclovir 1 g po tid. CMV is treated with ganciclovir 5 mg/kg IV q 12 h for 14\\nto 21 days with maintenance at 5 mg/kg IV 5 days/wk in immunocompromised patients. Alternatives\\ninclude foscarnet and cidofovir.\\nMallory-Weiss Syndrome\\nMallory-Weiss syndrome is a nonpenetrating mucosal laceration of the distal esophagus and'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 189, 'source_type': 'Authorotative', 'priority': '1'}, page_content='include foscarnet and cidofovir.\\nMallory-Weiss Syndrome\\nMallory-Weiss syndrome is a nonpenetrating mucosal laceration of the distal esophagus and\\nproximal stomach caused by vomiting, retching, or hiccuping.\\nInitially described in alcoholics, Mallory-Weiss syndrome can occur in any patient who vomits forcefully. It\\nis the cause of about 5% of episodes of upper GI hemorrhage. Most episodes of bleeding stop\\nspontaneously; severe bleeding occurs in about 10% of patients who require significant intervention,\\nsuch as transfusion or endoscopic hemostasis (by injection of ethanol, polidocanol, or epinephrine or by\\nelectrocautery). Intra-arterial infusion of pitressin or therapeutic embolization into the left gastric artery\\nduring angiography may also be used to control bleeding. Surgical repair is rarely required.\\nEsophageal Rupture\\nEsophageal rupture may be iatrogenic during endoscopic procedures or other instrumentation'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 189, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Esophageal Rupture\\nEsophageal rupture may be iatrogenic during endoscopic procedures or other instrumentation\\nor may be spontaneous (Boerhaave's syndrome). Patients are seriously ill, with symptoms of\\nmediastinitis. Diagnosis is by esophagography with a water-soluble contrast agent. Immediate\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 12. Esophageal & Swallowing Disorders\\n181\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 190, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"surgical repair and drainage are required.\\nEndoscopic procedures are the primary cause of esophageal rupture, but spontaneous rupture may\\noccur, typically related to vomiting, retching, or swallowing a large food bolus. The most common site of\\nrupture is the distal esophagus on the left side. Acid and other stomach contents cause a fulminant\\nmediastinitis and shock. Pneumomediastinum is common.\\nSymptoms and Signs\\nSymptoms include chest and abdominal pain, vomiting, hematemesis, and shock. Subcutaneous\\nemphysema is palpable in about 30% of patients. Mediastinal crunch (Hamman's sign), a crackling sound\\nsynchronous with the heartbeat, may be present.\\nDiagnosis\\n• Chest and abdominal x-rays\\n• Esophagography\\nChest and abdominal x-rays showing mediastinal air, pleural effusion, or mediastinal widening suggest the\\ndiagnosis. Diagnosis is confirmed by esophagography with a water-soluble contrast agent, which avoids\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 190, 'source_type': 'Authorotative', 'priority': '1'}, page_content='diagnosis. Diagnosis is confirmed by esophagography with a water-soluble contrast agent, which avoids\\npotential mediastinal irritation from barium. CT of the thorax detects mediastinal air and fluid but does not\\nlocalize the perforation well. Endoscopy may miss a small perforation.\\nTreatment\\n• Surgical repair\\nPending surgical repair, patients should receive broad-spectrum antibiotics (eg, gentamicin plus\\nmetronidazole or piperacillin/tazobactam) and fluid resuscitation as needed for shock. Even with\\ntreatment, mortality is high.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 12. Esophageal & Swallowing Disorders\\n182'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 191, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chapter 13. Gastritis and Peptic Ulcer Disease\\nIntroduction\\nAcid is secreted by parietal cells in the proximal two thirds (body) of the stomach. Gastric acid aids\\ndigestion by creating the optimal pH for pepsin and gastric lipase and by stimulating pancreatic\\nbicarbonate secretion. Acid secretion is initiated by food: the thought, smell, or taste of food effects vagal\\nstimulation of the gastrin-secreting G cells located in the distal one third (antrum) of the stomach. The\\narrival of protein to the stomach further stimulates gastrin output. Circulating gastrin triggers the release\\nof histamine from enterochromaffin-like cells in the body of the stomach. Histamine stimulates the parietal\\ncells via their H2 receptors. The parietal cells secrete acid, and the resulting drop in pH causes the antral\\nD cells to release somatostatin, which inhibits gastrin release (negative feedback control).'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 191, 'source_type': 'Authorotative', 'priority': '1'}, page_content='D cells to release somatostatin, which inhibits gastrin release (negative feedback control).\\nAcid secretion is present at birth and reaches adult levels (on a weight basis) by age 2. There is a decline\\nin acid output in elderly patients who develop chronic gastritis, but acid output is otherwise maintained\\nthroughout life.\\nNormally, the GI mucosa is protected by several distinct mechanisms: (1) Mucosal production of mucus\\nand HCO3 creates a pH gradient from the gastric lumen (low pH) to the mucosa (neutral pH). The mucus\\nserves as a barrier to the diffusion of acid and pepsin. (2) Epithelial cells remove excess hydrogen ions\\n(H+) via membrane transport systems and have tight junctions, which prevent back diffusion of H+ ions.\\n(3) Mucosal blood flow removes excess acid that has diffused across the epithelial layer. Several growth\\nfactors (eg, epidermal growth factor, insulin-like growth factor I) and prostaglandins have been linked to'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 191, 'source_type': 'Authorotative', 'priority': '1'}, page_content='factors (eg, epidermal growth factor, insulin-like growth factor I) and prostaglandins have been linked to\\nmucosal repair and maintenance of mucosal integrity.\\nFactors that interfere with these mucosal defenses (particularly NSAIDs and Helicobacter pylori\\ninfection) predispose to gastritis and peptic ulcer disease.\\nNSAIDs promote mucosal inflammation and ulcer formation (sometimes with GI bleeding) both topically\\nand systemically. By inhibiting prostaglandin production via blockage of the enzyme cyclooxygenase\\n(COX), NSAIDs reduce gastric blood flow, reduce mucus and HCO3 secretion, and decrease cell repair\\nand replication. Also, because NSAIDs are weak acids and are nonionized at gastric pH, they diffuse\\nfreely across the mucus barrier into gastric epithelial cells, where H+ ions are liberated, leading to cellular\\ndamage. Because gastric prostaglandin production involves the COX-1 isoform, NSAIDs that are selective'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 191, 'source_type': 'Authorotative', 'priority': '1'}, page_content='damage. Because gastric prostaglandin production involves the COX-1 isoform, NSAIDs that are selective\\nCOX-2 inhibitors have fewer adverse gastric effects than other NSAIDs.\\nHelicobacter pylori Infection\\nH. pylori is a common gastric pathogen that causes gastritis, peptic ulcer disease, gastric\\nadenocarcinoma, and low-grade gastric lymphoma. Infection may be asymptomatic or result in\\nvarying degrees of dyspepsia. Diagnosis is by urea breath test and testing of endoscopic\\nbiopsy samples. Treatment is with a proton pump inhibitor plus two antibiotics.\\nH. pylori is a spiral-shaped, gram-negative organism that has adapted to thrive in acid. In developing\\ncountries, it commonly causes chronic infections and is usually acquired during childhood. In the US,\\ninfection is less common among children but increases with age: by age 60, about 50% of people are\\ninfected. Infection is most common among blacks, Hispanics, and Asians.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 191, 'source_type': 'Authorotative', 'priority': '1'}, page_content='infection is less common among children but increases with age: by age 60, about 50% of people are\\ninfected. Infection is most common among blacks, Hispanics, and Asians.\\nThe organism has been cultured from stool, saliva, and dental plaque, which suggests oral-oral or fecal-\\noral transmission. Infections tend to cluster in families and in residents of custodial institutions. Nurses\\nand gastroenterologists seem to be at high risk because bacteria can be transmitted by improperly\\ndisinfected endoscopes.\\nPathophysiology\\nEffects of H. pylori infection vary depending on the location within the stomach. Antral-predominant\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 13. Gastritis & Peptic Ulcer Disease\\n183'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 192, 'source_type': 'Authorotative', 'priority': '1'}, page_content='infection results in increased gastrin production, probably via local impairment of somatostatin release.\\nResultant hypersecretion of acid predisposes to prepyloric and duodenal ulcer. Body-predominant\\ninfection leads to gastric atrophy and decreased acid production, possibly via increased local production\\nof IL-1β. Patients with body-predominant infection are predisposed to gastric ulcer and adenocarcinoma.\\nSome patients have mixed infection of both antrum and body with varying clinical effects. Many patients\\nwith H. pylori infection have no noticeable clinical effects.\\nAmmonia produced by H. pylori enables the organism to survive in the acidic environment of the stomach\\nand may erode the mucus barrier. Cytotoxins and mucolytic enzymes (eg, bacterial protease, lipase)\\nproduced by H. pylori may play a role in mucosal damage and subsequent ulcerogenesis.\\nInfected people are 3 to 6 times more likely to develop stomach cancer. H. pylori infection is associated'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 192, 'source_type': 'Authorotative', 'priority': '1'}, page_content='produced by H. pylori may play a role in mucosal damage and subsequent ulcerogenesis.\\nInfected people are 3 to 6 times more likely to develop stomach cancer. H. pylori infection is associated\\nwith intestinal-type adenocarcinoma of the gastric body and antrum but not cancer of the gastric cardia.\\nOther associated cancers include gastric lymphoma and mucosa-associated lymphoid tissue (MALT)\\nlymphoma, a monoclonally restricted B-cell tumor.\\nDiagnosis\\n• For initial diagnosis: Serologic tests\\n• For confirmation of cure: Urea breath test or stool antigen assay\\nScreening of asymptomatic patients is not warranted. Tests are done during evaluation for peptic ulcer\\nand gastritis. Posttreatment testing is typically done to confirm eradication of the organism. Different tests\\nare preferred for initial diagnosis and posttreatment.\\nNoninvasive tests: Laboratory and office-based serologic assays for antibodies to H. pylori have'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 192, 'source_type': 'Authorotative', 'priority': '1'}, page_content='are preferred for initial diagnosis and posttreatment.\\nNoninvasive tests: Laboratory and office-based serologic assays for antibodies to H. pylori have\\nsensitivity and specificity of > 85% and are considered the noninvasive tests of choice for initial\\ndocumentation of H. pylori infection. However, because qualitative assays remain positive for up to 3 yr\\nafter successful treatment and because quantitative antibody levels do not decline significantly for 6 to 12\\nmo after treatment, serologic assays are not usually used to assess cure.\\nUrea breath tests use an oral dose of 13C- or 14C-labeled urea. In an infected patient, the organism\\nmetabolizes the urea and liberates labeled CO2, which is exhaled and can be quantified in breath\\nsamples taken 20 to 30 min after ingestion of the urea. Sensitivity and specificity are > 90%. Urea breath\\ntests are well suited for confirming eradication of the organism after therapy. False-negative results are'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 192, 'source_type': 'Authorotative', 'priority': '1'}, page_content='tests are well suited for confirming eradication of the organism after therapy. False-negative results are\\npossible with recent antibiotic use or concomitant proton pump inhibitor therapy; therefore, follow-up\\ntesting should be delayed ≥ 4 wk after antibiotic therapy and 1 wk after proton pump inhibitor therapy. H2\\nblockers do not affect the test.\\nStool antigen assays seem to have a sensitivity and specificity near that of urea breath tests, particularly\\nfor initial diagnosis; an office-based test is under development.\\nInvasive tests: Endoscopy is used to obtain mucosal biopsy samples for a rapid urease test (RUT) or\\nhistologic staining. Bacterial culture is of limited use because of the fastidious nature of the organism.\\nEndoscopy is not recommended solely for diagnosis of H. pylori; noninvasive tests are preferred unless\\nendoscopy is indicated for other reasons.\\nThe RUT, in which presence of bacterial urease in the biopsy sample causes a color change on a special'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 192, 'source_type': 'Authorotative', 'priority': '1'}, page_content='endoscopy is indicated for other reasons.\\nThe RUT, in which presence of bacterial urease in the biopsy sample causes a color change on a special\\nmedium, is the diagnostic method of choice on tissue samples. Histologic staining of biopsy samples\\nshould be done for patients with negative RUT results but suspicious clinical findings, recent antibiotic\\nuse, or treatment with proton pump inhibitors. RUT and histologic staining each have a sensitivity and\\nspecificity of > 90%.\\nTreatment\\n• Antibiotics (various regimens) plus a proton pump inhibitor\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 13. Gastritis & Peptic Ulcer Disease\\n184'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 193, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Patients with complications (eg, gastritis, ulcer, cancer) should have the organism eradicated. Eradication\\nof H. pylori can even cure some cases of MALT lymphoma (but not other infection-related cancers).\\nTreatment of asymptomatic infection has been controversial, but the recognition of the role of H. pylori in\\ncancer has led to a recommendation for treatment. Vaccines, both preventive and therapeutic (ie, as an\\nadjunct to treatment of infected patients), are under development.\\nH. pylori eradication requires multidrug therapy, typically antibiotics plus acid suppressants. Proton pump\\ninhibitors suppress H. pylori, and the increased gastric pH accompanying their use can enhance tissue\\nconcentration and efficacy of antimicrobials, creating a hostile environment for H. pylori.\\nTriple therapy is recommended. Oral omeprazole 20 mg bid or lansoprazole 30 mg bid, plus clarithromycin\\n500 mg bid, plus amoxicillin 1 g bid (or, for penicillin-allergic patients, metronidazole 500 mg bid) for 14'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 193, 'source_type': 'Authorotative', 'priority': '1'}, page_content='500 mg bid, plus amoxicillin 1 g bid (or, for penicillin-allergic patients, metronidazole 500 mg bid) for 14\\ndays, cures infection in > 95% of cases. This regimen has excellent tolerability. Ranitidine bismuth citrate\\n400 mg po bid may be substituted for the proton pump inhibitor.\\nQuadruple therapy with a proton pump inhibitor bid, tetracycline 500 mg and bismuth subsalicylate or\\nsubcitrate 525 mg qid, and metronidazole 500 mg tid is also effective but more cumbersome.\\nInfected patients with duodenal or gastric ulcer require continuation of the acid suppression for at least 4\\nwk.\\nTreatment is repeated if H. pylori is not eradicated. If two courses are unsuccessful, some authorities\\nrecommend endoscopy to obtain cultures for sensitivity testing.\\nGastritis\\nGastritis is inflammation of the gastric mucosa caused by any of several conditions, including\\ninfection (Helicobacter pylori), drugs (NSAIDs, alcohol), stress, and autoimmune phenomena'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 193, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Gastritis\\nGastritis is inflammation of the gastric mucosa caused by any of several conditions, including\\ninfection (Helicobacter pylori), drugs (NSAIDs, alcohol), stress, and autoimmune phenomena\\n(atrophic gastritis). Many cases are asymptomatic, but dyspepsia and GI bleeding sometimes\\noccur. Diagnosis is by endoscopy. Treatment is directed at the cause but often includes acid\\nsuppression and, for H. pylori infection, antibiotics.\\nGastritis is classified as erosive or nonerosive based on the severity of mucosal injury. It is also classified\\naccording to the site of involvement (ie, cardia, body, antrum). Gastritis can be further classified\\nhistologically as acute or chronic based on the inflammatory cell type. No classification scheme matches\\nperfectly with the pathophysiology; a large degree of overlap exists. Some forms of gastritis involve acid-\\npeptic and H. pylori disease. Additionally, the term is often loosely applied to nonspecific (and often'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 193, 'source_type': 'Authorotative', 'priority': '1'}, page_content='peptic and H. pylori disease. Additionally, the term is often loosely applied to nonspecific (and often\\nundiagnosed) abdominal discomfort and gastroenteritis.\\nAcute gastritis is characterized by PMN infiltration of the mucosa of the antrum and body.\\nChronic gastritis implies some degree of atrophy (with loss of function of the mucosa) or metaplasia. It\\npredominantly involves the antrum (with subsequent loss of G cells and decreased gastrin secretion) or\\nthe corpus (with loss of oxyntic glands, leading to reduced acid, pepsin, and intrinsic factor).\\nErosive Gastritis\\nErosive gastritis is gastric mucosal erosion caused by damage to mucosal defenses. It is\\ntypically acute, manifesting with bleeding, but may be subacute or chronic with few or no\\nsymptoms. Diagnosis is by endoscopy. Treatment is supportive, with removal of the inciting\\ncause. Certain ICU patients (eg, ventilator-bound, head trauma, burn, multisystem trauma)\\nbenefit from prophylaxis with acid suppressants.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 193, 'source_type': 'Authorotative', 'priority': '1'}, page_content='cause. Certain ICU patients (eg, ventilator-bound, head trauma, burn, multisystem trauma)\\nbenefit from prophylaxis with acid suppressants.\\nCauses of erosive gastritis include NSAIDs, alcohol, stress, and less commonly radiation, viral infection\\n(eg, cytomegalovirus), vascular injury, and direct trauma (eg, nasogastric tubes).\\nSuperficial erosions and punctate mucosal lesions occur. These may develop as soon as 12 h after the\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 13. Gastritis & Peptic Ulcer Disease\\n185'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 194, 'source_type': 'Authorotative', 'priority': '1'}, page_content='initial insult. Deep erosions, ulcers, and sometimes perforation may occur in severe or untreated cases.\\nLesions typically occur in the body, but the antrum may also be involved.\\nAcute stress gastritis, a form of erosive gastritis, occurs in about 5% of critically ill patients. The\\nincidence increases with duration of ICU stay and length of time the patient is not receiving enteral\\nfeeding. Pathogenesis likely involves hypoperfusion of the GI mucosa, resulting in impaired mucosal\\ndefenses. Patients with head injury or burns may also have increased secretion of acid.\\nSymptoms and Signs\\nPatients with mild erosive gastritis are often asymptomatic, although some complain of dyspepsia,\\nnausea, or vomiting. Often, the first sign is hematemesis, melena, or blood in the nasogastric aspirate,\\nusually within 2 to 5 days of the inciting event. Bleeding is usually mild to moderate, although it can be'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 194, 'source_type': 'Authorotative', 'priority': '1'}, page_content='usually within 2 to 5 days of the inciting event. Bleeding is usually mild to moderate, although it can be\\nmassive if deep ulceration is present, particularly in acute stress gastritis. Acute and chronic erosive\\ngastritis are diagnosed endoscopically.\\nDiagnosis\\nAcute and chronic erosive gastritis are diagnosed endoscopically.\\nTreatment\\n• For bleeding: Endoscopic hemostasis\\n• For acid suppression: A proton pump inhibitor or H2 blocker\\nIn severe gastritis, bleeding is managed with IV fluids and blood transfusion as needed. Endoscopic\\nhemostasis should be attempted, with surgery (total gastrectomy) a fallback procedure. Angiography is\\nunlikely to stop severe gastric bleeding because of the many collateral vessels supplying the stomach.\\nAcid suppression should be started if the patient is not already receiving it.\\nFor milder gastritis, removing the offending agent and using drugs to reduce gastric acidity (see p. 136)\\nmay be all that is required.\\nPrevention'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 194, 'source_type': 'Authorotative', 'priority': '1'}, page_content='For milder gastritis, removing the offending agent and using drugs to reduce gastric acidity (see p. 136)\\nmay be all that is required.\\nPrevention\\nProphylaxis with acid-suppressive drugs can reduce the incidence of acute stress gastritis. However, it\\nmainly benefits certain high-risk ICU patients, including those with severe burns, CNS trauma,\\ncoagulopathy, sepsis, shock, multiple trauma, mechanical ventilation for > 48 h, hepatic or renal failure,\\nmultiorgan dysfunction, and history of peptic ulcer or GI bleeding.\\nProphylaxis consists of IV H2 blockers, proton pump inhibitors, or oral antacids to raise intragastric pH >\\n4.0. Repeated pH measurement and titration of therapy are not required. Early enteral feeding also can\\ndecrease the incidence of bleeding.\\nAcid suppression is not recommended for patients simply taking NSAIDs unless they have previously had\\nan ulcer.\\nNonerosive Gastritis\\nNonerosive gastritis refers to a variety of histologic abnormalities that are mainly the result of'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 194, 'source_type': 'Authorotative', 'priority': '1'}, page_content='an ulcer.\\nNonerosive Gastritis\\nNonerosive gastritis refers to a variety of histologic abnormalities that are mainly the result of\\nH. pylori infection. Most patients are asymptomatic. Diagnosis is by endoscopy. Treatment is\\neradication of H. pylori and sometimes acid suppression.\\nPathology\\nSuperficial gastritis: Lymphocytes and plasma cells mixed with neutrophils are the predominant\\ninfiltrating inflammatory cells. Inflammation is superficial and may involve the antrum, body, or both. It is\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 13. Gastritis & Peptic Ulcer Disease\\n186'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 195, 'source_type': 'Authorotative', 'priority': '1'}, page_content='usually not accompanied by atrophy or metaplasia. Prevalence increases with age.\\nDeep gastritis: Deep gastritis is more likely to be symptomatic (eg, vague dyspepsia). Mononuclear cells\\nand neutrophils infiltrate the entire mucosa to the level of the muscularis, but exudate or crypt abscesses\\nseldom result, as might be expected by such infiltration. Distribution may be patchy. Superficial gastritis\\nmay be present, as may partial gland atrophy and metaplasia.\\nGastric atrophy: Atrophy of gastric glands may follow in gastritis, most often longstanding antral\\n(sometimes referred to as type B) gastritis. Some patients with gastric atrophy have autoantibodies to\\nparietal cells, usually in association with corpus (type A) gastritis and pernicious anemia.\\nAtrophy may occur without specific symptoms. Endoscopically, the mucosa may appear normal until\\natrophy is advanced, when submucosal vascularity may be visible. As atrophy becomes complete,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 195, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Atrophy may occur without specific symptoms. Endoscopically, the mucosa may appear normal until\\natrophy is advanced, when submucosal vascularity may be visible. As atrophy becomes complete,\\nsecretion of acid and pepsin diminishes and intrinsic factor may be lost, resulting in vitamin B12\\nmalabsorption.\\nMetaplasia: Two types of metaplasia are common in chronic nonerosive gastritis: mucous gland and\\nintestinal.\\nMucous gland metaplasia (pseudopyloric metaplasia) occurs in the setting of severe atrophy of the\\ngastric glands, which are progressively replaced by mucous glands (antral mucosa), especially along the\\nlesser curve. Gastric ulcers may be present (typically at the junction of antral and corpus mucosa), but\\nwhether they are the cause or consequence of these metaplastic changes is not clear.\\nIntestinal metaplasia typically begins in the antrum in response to chronic mucosal injury and may extend'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 195, 'source_type': 'Authorotative', 'priority': '1'}, page_content='whether they are the cause or consequence of these metaplastic changes is not clear.\\nIntestinal metaplasia typically begins in the antrum in response to chronic mucosal injury and may extend\\nto the body. Gastric mucosa cells change to resemble intestinal mucosa—with goblet cells, endocrine\\n(enterochromaffin or enterochromaffin-like) cells, and rudimentary villi—and may even assume functional\\n(absorptive) characteristics. Intestinal metaplasia is classified histologically as complete (most common)\\nor incomplete. With complete metaplasia, gastric mucosa is completely transformed into small-bowel\\nmucosa, both histologically and functionally, with the ability to absorb nutrients and secrete peptides. In\\nincomplete metaplasia, the epithelium assumes a histologic appearance closer to that of the large\\nintestine and frequently exhibits dysplasia. Intestinal metaplasia may lead to stomach cancer.\\nSymptoms and Signs'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 195, 'source_type': 'Authorotative', 'priority': '1'}, page_content='intestine and frequently exhibits dysplasia. Intestinal metaplasia may lead to stomach cancer.\\nSymptoms and Signs\\nMost patients with H. pylori-associated gastritis are asymptomatic, although some have mild dyspepsia or\\nother vague symptoms.\\nDiagnosis\\n• Endoscopy\\nOften, the condition is discovered during endoscopy done for other purposes. Testing of asymptomatic\\npatients is not indicated. Once gastritis is identified, testing for H. pylori is appropriate.\\nTreatment\\n• Eradication of H. pylori\\n• Sometimes acid-suppressive drugs\\nTreatment of chronic nonerosive gastritis is H. pylori eradication (see p. 130). Treatment of asymptomatic\\npatients is somewhat controversial given the high prevalence of H. pylori-associated superficial gastritis\\nand the relatively low incidence of clinical sequelae (ie, peptic ulcer disease). However, H. pylori is a\\nclass J carcinogen; eradication removes the cancer risk. In H. pylori-negative patients, treatment is'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 195, 'source_type': 'Authorotative', 'priority': '1'}, page_content='class J carcinogen; eradication removes the cancer risk. In H. pylori-negative patients, treatment is\\ndirected at symptoms using acid-suppressive drugs (eg, H2 blockers, proton pump inhibitors) or antacids.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 13. Gastritis & Peptic Ulcer Disease\\n187'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 196, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Postgastrectomy Gastritis\\nPostgastrectomy gastritis is gastric atrophy developing after partial or subtotal gastrectomy\\n(except in cases of gastrinoma).\\nMetaplasia of the remaining corpus mucosa is common. The degree of gastritis is usually greatest at the\\nlines of anastomosis.\\nSeveral mechanisms are responsible: bile reflux, which is common after such surgery, damages the\\ngastric mucosa; loss of antral gastrin decreases stimulation of parietal and peptic cells, causing atrophy;\\nand vagotomy may result in a loss of vagal trophic action.\\nThere are no specific symptoms of gastritis. Postgastrectomy gastritis often progresses to severe atrophy\\nand achlorhydria. Production of intrinsic factor may cease with resultant vitamin B12 deficiency (which\\nmay be worsened by bacterial overgrowth in the afferent loop). The relative risk of gastric\\nadenocarcinoma seems to increase 15 to 20 yr after partial gastrectomy; however, given the low absolute'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 196, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"may be worsened by bacterial overgrowth in the afferent loop). The relative risk of gastric\\nadenocarcinoma seems to increase 15 to 20 yr after partial gastrectomy; however, given the low absolute\\nincidence of postgastrectomy cancer, routine endoscopic surveillance is probably not cost effective, but\\nupper GI symptoms or anemia in such patients should prompt endoscopy.\\nUncommon Gastritis Syndromes\\nMenetrier's disease: This rare idiopathic disorder affects adults aged 30 to 60 and is more common\\namong men. It manifests as a significant thickening of the gastric folds of the gastric body but not the\\nantrum. Gland atrophy and marked foveolar pit hyperplasia occur, often accompanied by mucous gland\\nmetaplasia and increased mucosal thickness with little inflammation. Hypoalbuminemia (the most\\nconsistent laboratory abnormality) caused by GI protein loss may be present (protein-losing gastropathy).\\nAs the disease progresses, the secretion of acid and pepsin decreases, causing hypochlorhydria.\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 196, 'source_type': 'Authorotative', 'priority': '1'}, page_content='As the disease progresses, the secretion of acid and pepsin decreases, causing hypochlorhydria.\\nSymptoms are nonspecific and commonly include epigastric pain, nausea, weight loss, edema, and\\ndiarrhea. Differential diagnosis includes (1) lymphoma, in which multiple gastric ulcers may occur; (2)\\nmucosa-associated lymphoid tissue (MALT) lymphoma, with extensive infiltration of monoclonal B\\nlymphocytes; (3) Zollinger-Ellison syndrome with associated gastric fold hypertrophy; and (4) Cronkhite-\\nCanada syndrome, a mucosal polypoid protein-losing syndrome associated with diarrhea. Diagnosis is\\nmade by endoscopy with deep mucosal biopsy or full-thickness laparoscopic gastric biopsy.\\nVarious treatments have been used, including anticholinergics, antisecretory drugs, and corticosteroids,\\nbut none have proved fully effective. Partial or complete gastric resection may be necessary in cases of\\nsevere hypoalbuminemia.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 196, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"but none have proved fully effective. Partial or complete gastric resection may be necessary in cases of\\nsevere hypoalbuminemia.\\nEosinophilic gastritis: Extensive infiltration of the mucosa, submucosa, and muscle layers with\\neosinophils often occurs in the antrum. It is usually idiopathic but may result from nematode infestation.\\nSymptoms include nausea, vomiting, and early satiety. Diagnosis is by endoscopic biopsy of involved\\nareas. Corticosteroids can be successful in idiopathic cases; however, if pyloric obstruction develops,\\nsurgery may be required.\\nMucosa-associated lymphoid tissue (MALT) lymphoma: This rare condition is characterized by\\nmassive lymphoid infiltration of the gastric mucosa, which can resemble Menetrier's disease.\\nGastritis caused by systemic disorders: Sarcoidosis, TB, amyloidosis, and other granulomatous\\ndiseases can cause gastritis, which is seldom of primary importance.\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 196, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Gastritis caused by systemic disorders: Sarcoidosis, TB, amyloidosis, and other granulomatous\\ndiseases can cause gastritis, which is seldom of primary importance.\\nGastritis caused by physical agents: Radiation and ingestion of corrosives (especially acidic\\ncompounds) can cause gastritis. Exposure to > 16 Gy of radiation causes marked deep gastritis, usually\\ninvolving the antrum more than the corpus. Pyloric stenosis and perforation are possible complications of\\nradiation-induced gastritis.\\nInfectious (septic) gastritis: Except for H. pylori infection, bacterial invasion of the stomach is rare and\\nmainly occurs after ischemia, ingestion of corrosives, or exposure to radiation. On x-ray, gas outlines the\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 13. Gastritis & Peptic Ulcer Disease\\n188'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 197, 'source_type': 'Authorotative', 'priority': '1'}, page_content='mucosa. The condition can manifest as an acute surgical abdomen and has a very high mortality rate.\\nSurgery is often necessary.\\nDebilitated or immunocompromised patients may develop viral or fungal gastritis with cytomegalovirus,\\nCandida, histoplasmosis, or mucormycosis; these diagnoses should be considered in patients with\\nexudative gastritis, esophagitis, or duodenitis.\\nAutoimmune Metaplastic Atrophic Gastritis\\nAutoimmune metaplastic atrophic gastritis (AMAG) is an inherited autoimmune disease that\\nattacks parietal cells, resulting in hypochlorhydria and decreased production of intrinsic factor.\\nConsequences include atrophic gastritis, B12 malabsorption, and, frequently, pernicious\\nanemia. Risk of gastric adenocarcinoma increases 3-fold. Diagnosis is by endoscopy. Treatment\\nis with parenteral vitamin B12.\\nPatients with AMAG have antibodies to parietal cells and their components (which include intrinsic factor'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 197, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"is with parenteral vitamin B12.\\nPatients with AMAG have antibodies to parietal cells and their components (which include intrinsic factor\\nand the proton pump H+,K+-ATPase). AMAG is inherited as an autosomal dominant trait. Some patients\\nalso develop Hashimoto's thyroiditis and 50% have thyroid antibodies; conversely, parietal cell antibodies\\nare found in 30% of patients with thyroiditis.\\nThe lack of intrinsic factor leads to vitamin B12 deficiency that can result in a megaloblastic anemia\\n(pernicious anemia—see p. 932) or neurologic symptoms (subacute combined degeneration—see p.\\n38).\\nHypochlorhydria leads to G-cell hyperplasia and elevated serum gastrin levels (often >1000 pg/mL).\\nElevated gastrin levels lead to enterochromaffin-like cell hyperplasia, which occasionally undergoes\\ntransformation to a carcinoid tumor.\\nIn some patients, AMAG may be associated with chronic Helicobacter pylori  infection, although the\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 197, 'source_type': 'Authorotative', 'priority': '1'}, page_content='transformation to a carcinoid tumor.\\nIn some patients, AMAG may be associated with chronic Helicobacter pylori  infection, although the\\nrelationship is not clear. Gastrectomy and chronic acid suppression with proton pump inhibitors cause\\nsimilar deficiencies of intrinsic factor secretion.\\nThe areas of atrophic gastritis in the body and fundus may manifest metaplasia. Patients with AMAG have\\na 3-fold increased relative risk of developing gastric adenocarcinoma.\\nDiagnosis is made by endoscopic biopsy. Serum B12 levels should be obtained. Parietal cell antibodies\\ncan be detected but are not measured routinely. The issue of surveillance endoscopy for cancer\\nscreening is unsettled; follow-up examinations are unnecessary unless histologic abnormalities (eg,\\ndysplasia) are present on initial biopsy or symptoms develop. No treatment is needed other than\\nparenteral replacement of vitamin B12.\\nPeptic Ulcer Disease'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 197, 'source_type': 'Authorotative', 'priority': '1'}, page_content='dysplasia) are present on initial biopsy or symptoms develop. No treatment is needed other than\\nparenteral replacement of vitamin B12.\\nPeptic Ulcer Disease\\nA peptic ulcer is an erosion in a segment of the GI mucosa, typically in the stomach (gastric\\nulcer) or the first few centimeters of the duodenum (duodenal ulcer), that penetrates through\\nthe muscularis mucosae. Nearly all ulcers are caused by Helicobacter pylori infection or NSAID\\nuse. Symptoms typically include burning epigastric pain that is often relieved by food.\\nDiagnosis is by endoscopy and testing for H. pylori. Treatment involves acid suppression,\\neradication of H. pylori (if present), and avoidance of NSAIDs.\\nUlcers may range in size from several millimeters to several centimeters. Ulcers are delineated from\\nerosions by the depth of penetration; erosions are more superficial and do not involve the muscularis\\nmucosae. Ulcers can occur at any age, including infancy and childhood, but are most common among'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 197, 'source_type': 'Authorotative', 'priority': '1'}, page_content='erosions by the depth of penetration; erosions are more superficial and do not involve the muscularis\\nmucosae. Ulcers can occur at any age, including infancy and childhood, but are most common among\\nmiddle-aged adults.\\nEtiology\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 13. Gastritis & Peptic Ulcer Disease\\n189'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 198, 'source_type': 'Authorotative', 'priority': '1'}, page_content='H. pylori and NSAIDs disrupt normal mucosal defense and repair, making the mucosa more susceptible to\\nacid. H. pylori infection is present in 50 to 70% of patients with duodenal ulcers and 30 to 50% of\\npatients with gastric ulcers. If H. pylori is eradicated, only 10% of patients have recurrence of peptic ulcer\\ndisease, compared with 70% recurrence in patients treated with acid suppression alone. NSAIDs now\\naccount for > 50% of peptic ulcers.\\nCigarette smoking is a risk factor for the development of ulcers and their complications. Also, smoking\\nimpairs ulcer healing and increases the incidence of recurrence. Risk correlates with the number of\\ncigarettes smoked per day. Although alcohol is a strong promoter of acid secretion, no definitive data link\\nmoderate amounts of alcohol to the development or delayed healing of ulcers. Very few patients have\\nhypersecretion of gastrin (Zollinger-Ellison syndrome—see p. 200).\\nA family history exists in 50 to 60% of children with duodenal ulcer.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 198, 'source_type': 'Authorotative', 'priority': '1'}, page_content='hypersecretion of gastrin (Zollinger-Ellison syndrome—see p. 200).\\nA family history exists in 50 to 60% of children with duodenal ulcer.\\nSymptoms and Signs\\nSymptoms depend on ulcer location and patient age; many patients, particularly elderly patients, have\\nfew or no symptoms. Pain is most common, often localized to the epigastrium and relieved by food or\\nantacids. The pain is described as burning or gnawing, or sometimes as a sensation of hunger. The\\ncourse is usually chronic and recurrent. Only about half of patients present with the characteristic pattern\\nof symptoms.\\nGastric ulcer symptoms often do not follow a consistent pattern (eg, eating sometimes exacerbates\\nrather than relieves pain). This is especially true for pyloric channel ulcers, which are often associated\\nwith symptoms of obstruction (eg, bloating, nausea, vomiting) caused by edema and scarring.\\nDuodenal ulcers tend to cause more consistent pain. Pain is absent when the patient awakens but'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 198, 'source_type': 'Authorotative', 'priority': '1'}, page_content='with symptoms of obstruction (eg, bloating, nausea, vomiting) caused by edema and scarring.\\nDuodenal ulcers tend to cause more consistent pain. Pain is absent when the patient awakens but\\nappears in mid-morning, is relieved by food, but recurs 2 to 3 h after a meal. Pain that awakens a patient\\nat night is common and is highly suggestive of duodenal ulcer. In neonates, perforation and hemorrhage\\nmay be the first manifestation of duodenal ulcer. Hemorrhage may also be the first recognized sign in later\\ninfancy and early childhood, although repeated vomiting or evidence of abdominal pain may be a clue.\\nDiagnosis\\n• Endoscopy\\n• Sometimes serum gastrin levels\\nDiagnosis of peptic ulcer is suggested by patient history and confirmed by endoscopy. Empiric therapy is\\noften begun without definitive diagnosis. However, endoscopy allows for biopsy or cytologic brushing of\\ngastric and esophageal lesions to distinguish between simple ulceration and ulcerating stomach cancer.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 198, 'source_type': 'Authorotative', 'priority': '1'}, page_content='gastric and esophageal lesions to distinguish between simple ulceration and ulcerating stomach cancer.\\nStomach cancer may manifest with similar manifestations and must be excluded, especially in patients\\nwho are > 45, have lost weight, or report severe or refractory symptoms. The incidence of malignant\\nduodenal ulcer is extremely low, so biopsies of lesions in that area are generally not warranted.\\nEndoscopy can also be used to definitively diagnose H. pylori infection, which should be sought when an\\nulcer is detected.\\nGastrin-secreting cancer and Zollinger-Ellison syndrome should be considered when there are multiple\\nulcers, when ulcers develop in atypical locations (eg, postbulbar) or are refractory to treatment, or when\\nthe patient has prominent diarrhea or weight loss. Serum gastrin levels should be measured in these\\npatients.\\nComplications\\nHemorrhage: Mild to severe hemorrhage is the most common complication of peptic ulcer disease.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 198, 'source_type': 'Authorotative', 'priority': '1'}, page_content='patients.\\nComplications\\nHemorrhage: Mild to severe hemorrhage is the most common complication of peptic ulcer disease.\\nSymptoms include hematemesis (vomiting of fresh blood or \"coffee ground\" material); passage of bloody\\nstools (hematochezia) or black tarry stools (melena); and weakness, orthostasis, syncope, thirst, and\\nsweating caused by blood loss.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 13. Gastritis & Peptic Ulcer Disease\\n190'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 199, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Penetration (confined perforation): A peptic ulcer may penetrate the wall of the stomach. If adhesions\\nprevent leakage into the peritoneal cavity, free penetration is avoided and confined perforation occurs.\\nStill, the ulcer may penetrate into the duodenum and enter the adjacent confined space (lesser sac) or\\nanother organ (eg, pancreas, liver). Pain may be intense, persistent, referred to sites other than the\\nabdomen (usually the back when caused by penetration of a posterior duodenal ulcer into the pancreas),\\nand modified by body position. CT or MRI is usually needed to confirm the diagnosis. When therapy does\\nnot result in healing, surgery is required.\\nFree perforation: Ulcers that perforate into the peritoneal cavity unchecked by adhesions are usually\\nlocated in the anterior wall of the duodenum or, less commonly, in the stomach. The patient presents with\\nan acute abdomen. There is sudden, intense, continuous epigastric pain that spreads rapidly throughout'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 199, 'source_type': 'Authorotative', 'priority': '1'}, page_content='an acute abdomen. There is sudden, intense, continuous epigastric pain that spreads rapidly throughout\\nthe abdomen, often becoming prominent in the right lower quadrant and at times referred to one or both\\nshoulders. The patient usually lies still because even deep breathing worsens the pain. Palpation of the\\nabdomen is painful, rebound tenderness is prominent, abdominal muscles are rigid (boardlike), and bowel\\nsounds are diminished or absent. Shock may ensue, heralded by increased pulse rate and decreased BP\\nand urine output. Symptoms may be less striking in elderly or moribund patients and those receiving\\ncorticosteroids or immunosuppressants.\\nDiagnosis is confirmed if an x-ray or CT shows free air under the diaphragm or in the peritoneal cavity.\\nUpright views of the chest and abdomen are preferred. The most sensitive view is the lateral x-ray of the\\nchest. Severely ill patients may be unable to sit upright and should have a lateral decubitus x-ray of the'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 199, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"chest. Severely ill patients may be unable to sit upright and should have a lateral decubitus x-ray of the\\nabdomen. Failure to detect free air does not exclude the diagnosis.\\nImmediate surgery is required. The longer the delay, the poorer is the prognosis. When surgery is\\ncontraindicated, the alternatives are continuous nasogastric suction and broad-spectrum antibiotics.\\nGastric outlet obstruction: Obstruction may be caused by scarring, spasm, or inflammation from an\\nulcer. Symptoms include recurrent, large-volume vomiting, occurring more frequently at the end of the day\\nand often as late as 6 h after the last meal. Loss of appetite with persistent bloating or fullness after\\neating also suggests gastric outlet obstruction. Prolonged vomiting may cause weight loss, dehydration,\\nand alkalosis.\\nIf the patient's history suggests obstruction, physical examination, gastric aspiration, or x-rays may\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 199, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"and alkalosis.\\nIf the patient's history suggests obstruction, physical examination, gastric aspiration, or x-rays may\\nprovide evidence of retained gastric contents. A succussion splash heard > 6 h after a meal or aspiration\\nof fluid or food residue > 200 mL after an overnight fast suggests gastric retention. If gastric aspiration\\nshows marked retention, the stomach should be emptied and endoscopy done or x-rays taken to\\ndetermine site, cause, and degree of obstruction.\\nEdema or spasm caused by an active pyloric channel ulcer is treated with gastric decompression by\\nnasogastric suction and acid suppression (eg, IV H2 blockers). Dehydration and electrolyte imbalances\\nresulting from protracted vomiting or continued nasogastric suctioning should be vigorously sought and\\ncorrected. Prokinetic agents are not indicated. Generally, obstruction resolves within 2 to 5 days of\\ntreatment. Prolonged obstruction may result from peptic scarring and may respond to endoscopic pyloric\"),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 199, 'source_type': 'Authorotative', 'priority': '1'}, page_content='treatment. Prolonged obstruction may result from peptic scarring and may respond to endoscopic pyloric\\nballoon dilation. Surgery is necessary to relieve obstruction in selected cases.\\nRecurrence: Factors that affect recurrence of ulcer include failure to eradicate H. pylori, continued\\nNSAID use, and smoking. Less commonly, a gastrinoma (Zollinger-Ellison syndrome) may be the cause.\\nThe 3-yr recurrence rate for gastric and duodenal ulcers is < 10% when H. pylori is successfully\\neradicated but > 50% when it is not. Thus, a patient with recurrent disease should be tested for H. pylori\\nand treated again if the tests are positive.\\nAlthough long-term treatment with H2 blockers, proton pump inhibitors, or misoprostol reduces the risk of\\nrecurrence, their routine use for this purpose is not recommended. However, patients who require NSAIDs\\nafter having had a peptic ulcer are candidates for long-term therapy, as are those with a marginal ulcer or\\nprior perforation or bleeding.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 199, 'source_type': 'Authorotative', 'priority': '1'}, page_content='after having had a peptic ulcer are candidates for long-term therapy, as are those with a marginal ulcer or\\nprior perforation or bleeding.\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 13. Gastritis & Peptic Ulcer Disease\\n191'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 200, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Stomach cancer: Patients with H. pylori-associated ulcers have a 3- to 6-fold increased risk of gastric\\ncancer later in life. There is no increased risk of cancer with ulcers of other etiology.\\nTreatment\\n• Eradication of H. pylori (when present)\\n• Acid-suppressive drugs\\nTreatment of gastric and duodenal ulcers requires eradication of H. pylori when present (see p. 130) and\\na reduction of gastric acidity. For duodenal ulcers, it is particularly important to suppress nocturnal acid\\nsecretion.\\nMethods of decreasing acidity include a number of drugs, all of which are effective but which vary in cost,\\nduration of therapy, and convenience of dosing. In addition, mucosal protective drugs (eg, sucralfate) and\\nacid-reducing surgical procedures may be used. Drug therapy is discussed on p. 136.\\nAdjuncts: Smoking should be stopped, and alcohol consumption stopped or limited to small amounts of\\ndilute alcohol. There is no evidence that changing the diet speeds ulcer healing or prevents recurrence.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 200, 'source_type': 'Authorotative', 'priority': '1'}, page_content='dilute alcohol. There is no evidence that changing the diet speeds ulcer healing or prevents recurrence.\\nThus, many physicians recommend eliminating only foods that cause distress.\\nSurgery: With current drug therapy, the number of patients requiring surgery has declined dramatically.\\nIndications include perforation, obstruction, uncontrolled or recurrent bleeding, and, although rare,\\nsymptoms that do not respond to drug therapy.\\nSurgery consists of a procedure to reduce acid secretion, often combined with a procedure to ensure\\ngastric drainage. The recommended operation for duodenal ulcer is highly selective, or parietal cell,\\nvagotomy (which is limited to nerves at the gastric body and spares antral innervation, thereby obviating\\nthe need for a drainage procedure). This procedure has a very low mortality rate and avoids the morbidity\\nassociated with resection and traditional vagotomy. Other acid-reducing surgical procedures include'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 200, 'source_type': 'Authorotative', 'priority': '1'}, page_content='associated with resection and traditional vagotomy. Other acid-reducing surgical procedures include\\nantrectomy, hemigastrectomy, partial gastrectomy, and subtotal gastrectomy (ie, resection of 30 to 90% of\\nthe distal stomach). These are typically combined with truncal vagotomy. Patients who undergo a\\nresective procedure or who have an obstruction require gastric drainage via a gastroduodenostomy\\n(Billroth I) or gastrojejunostomy (Billroth II).\\nThe incidence and type of postsurgical symptoms vary with the type of operation. After resective surgery,\\nup to 30% of patients have significant symptoms, including weight loss, maldigestion, anemia, dumping\\nsyndrome, reactive hypoglycemia, bilious vomiting, mechanical problems, and ulcer recurrence.\\nWeight loss is common after subtotal gastrectomy; the patient may limit food intake because of early\\nsatiety (because the residual gastric pouch is small) or to prevent dumping syndrome and other'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 200, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Weight loss is common after subtotal gastrectomy; the patient may limit food intake because of early\\nsatiety (because the residual gastric pouch is small) or to prevent dumping syndrome and other\\npostprandial syndromes. With a small gastric pouch, distention or discomfort may occur after a meal of\\neven moderate size; patients should be encouraged to eat smaller and more frequent meals.\\nMaldigestion and steatorrhea caused by pancreaticobiliary bypass, especially with Billroth II\\nanastomosis, may contribute to weight loss.\\nAnemia is common (usually from iron deficiency, but occasionally from vitamin B12 deficiency caused by\\nloss of intrinsic factor or bacterial overgrowth) in the afferent limb, and osteomalacia may occur. IM\\nvitamin B12 supplementation is recommended for all patients with total gastrectomy but may also be given\\nto patients with subtotal gastrectomy if deficiency is suspected.\\nDumping syndrome may follow gastric surgical procedures, particularly resections. Weakness,'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 200, 'source_type': 'Authorotative', 'priority': '1'}, page_content='to patients with subtotal gastrectomy if deficiency is suspected.\\nDumping syndrome may follow gastric surgical procedures, particularly resections. Weakness,\\ndizziness, sweating, nausea, vomiting, and palpitation occur soon after eating, especially hyperosmolar\\nfoods. This phenomenon is referred to as early dumping, the cause of which remains unclear but likely\\ninvolves autonomic reflexes, intravascular volume contraction, and release of vasoactive peptides from\\nthe small intestine. Dietary modifications, with smaller, more frequent meals and decreased carbohydrate\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 13. Gastritis & Peptic Ulcer Disease\\n192'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 201, 'source_type': 'Authorotative', 'priority': '1'}, page_content='intake, usually help.\\nReactive hypoglycemia or late dumping (another form of the syndrome) results from rapid emptying of\\ncarbohydrates from the gastric pouch. Early high peaks in blood glucose stimulate excess release of\\ninsulin, which leads to symptomatic hypoglycemia several hours after the meal. A high-protein, low-\\ncarbohydrate diet and adequate caloric intake (in frequent small feedings) are recommended.\\nMechanical problems (including gastroparesis and bezoar formation—see p. 138) may occur secondary\\nto a decrease in phase III gastric motor contractions, which are altered after antrectomy and vagotomy.\\nDiarrhea is especially common after vagotomy, even without a resection (pyloroplasty).\\nUlcer recurrence, according to older studies, occurs in 5 to 12% after highly selective vagotomy and in 2\\nto 5% after resective surgery. Recurrent ulcers are diagnosed by endoscopy and generally respond to'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 201, 'source_type': 'Authorotative', 'priority': '1'}, page_content='to 5% after resective surgery. Recurrent ulcers are diagnosed by endoscopy and generally respond to\\neither proton pump inhibitors or H2 blockers. For ulcers that continue to recur, the completeness of\\nvagotomy should be tested by gastric analysis, H. pylori eliminated if present, and Zollinger-Ellison\\nsyndrome ruled out by serum gastrin studies.\\nDrug Treatment of Gastric Acidity\\nDrugs for decreasing acidity are used for peptic ulcer, gastroesophageal reflux disease (GERD—see p.\\n125), and many forms of gastritis. Some drugs are used in regimens for treating H. pylori infection. Drugs\\ninclude proton pump inhibitors, H2 blockers, antacids, and prostaglandins.\\nProton pump inhibitors: These drugs are potent inhibitors of H+,K+-ATPase. This enzyme, located in\\nthe apical secretory membrane of the parietal cell, plays a key role in the secretion of H+ (protons).\\nThese drugs can completely inhibit acid secretion and have a long duration of action. They promote ulcer'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 201, 'source_type': 'Authorotative', 'priority': '1'}, page_content='These drugs can completely inhibit acid secretion and have a long duration of action. They promote ulcer\\nhealing and are also key components of H. pylori eradication regimens. Proton pump inhibitors have\\nreplaced H2 blockers in most clinical situations because of greater rapidity of action and efficacy.\\nProton pump inhibitors include esomeprazole, lansoprazole, and pantoprazole, all available orally and IV,\\nand omeprazole and rabeprazole, available only orally in the US (see\\nTable 13-1). Omeprazole is available without a prescription in the US. For uncomplicated duodenal ulcers,\\nomeprazole 20 mg po once/day or lansoprazole 30 mg po once/day is given for 4 wk. Complicated\\nduodenal ulcers (ie, multiple\\n[Table 13-1. Proton Pump Inhibitors]\\nulcers, bleeding ulcers, those > 1.5 cm, or those occurring in patients with serious underlying illness)\\nrespond better to higher doses (omeprazole 40 mg once/day, lansoprazole 60 mg once/day or 30 mg bid).'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 201, 'source_type': 'Authorotative', 'priority': '1'}, page_content='respond better to higher doses (omeprazole 40 mg once/day, lansoprazole 60 mg once/day or 30 mg bid).\\nGastric ulcers require treatment for 6 to 8 wk. Gastritis and GERD require 8 to 12 wk of therapy; GERD\\nadditionally requires long-term maintenance.\\nLong-term proton pump inhibitor therapy produces elevated gastrin levels, which lead to\\nenterochromaffin-like cell hyperplasia. However, there is no evidence of dysplasia or malignant\\ntransformation in patients receiving this treatment. Some may develop vitamin B12 malabsorption.\\nH2 blockers: These drugs (cimetidine, ranitidine, famotidine, available IV and orally; and nizatidine\\navailable orally) are competitive inhibitors of histamine at the H2 receptor, thus suppressing gastrin-\\nstimulated acid secretion and proportionately reducing gastric juice volume. Histamine-mediated pepsin\\nsecretion is also decreased.\\nH2 blockers are well absorbed from the GI tract, with onset of action 30 to 60 min after ingestion and'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 201, 'source_type': 'Authorotative', 'priority': '1'}, page_content='secretion is also decreased.\\nH2 blockers are well absorbed from the GI tract, with onset of action 30 to 60 min after ingestion and\\npeak effects at 1 to 2 h. IV administration produces a more rapid onset of action. Duration of action is\\nproportional to dose and ranges from 6 to 20 h. Doses should often be reduced in elderly patients.\\nFor duodenal ulcers, once daily oral administration of cimetidine 800 mg, ranitidine 300 mg, famotidine 40\\nThe Merck Manual of Diagnosis & Therapy, 19th Edition\\nChapter 13. Gastritis & Peptic Ulcer Disease\\n193'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 202, 'source_type': 'Authorotative', 'priority': '1'}, page_content='mg, or nizatidine 300 mg given at bedtime or after dinner for 6 to 8 wk is effective. Gastric ulcers may\\nrespond to the same regimen continued for 8 to 12 wk, but because nocturnal acid secretion is less\\nimportant, morning administration may be equally or more effective. Children ≥ 40 kg may receive adult\\ndoses. Below that weight, the oral dosage is ranitidine 2 mg/kg q 12 h and cimetidine 10 mg/kg q 12 h.\\nFor GERD, H2 blockers are now mostly used for pain management. Gastritis heals with famotidine or\\nranitidine given bid for 8 to 12 wk.\\nCimetidine has minor antiandrogen effects expressed as reversible gynecomastia and, less commonly,\\nerectile dysfunction with prolonged use. Mental status changes, diarrhea, rash, drug fever, myalgias,\\nthrombocytopenia, and sinus bradycardia and hypotension after rapid IV administration have been\\nreported with all H2 blockers, generally in < 1% of treated patients but more commonly in elderly patients.'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 202, 'source_type': 'Authorotative', 'priority': '1'}, page_content='reported with all H2 blockers, generally in < 1% of treated patients but more commonly in elderly patients.\\nCimetidine and, to a lesser extent, other H2 blockers interact with the P-450 microsomal enzyme system\\nand may delay metabolism of other drugs eliminated through this system (eg, phenytoin, warfarin,\\ntheophylline, diazepam, lidocaine).\\nAntacids: These agents neutralize gastric acid and reduce pepsin activity (which diminishes as gastric\\npH rises to > 4.0). In addition, some antacids adsorb pepsin. Antacids may interfere with the absorption of\\nother drugs (eg, tetracycline, digoxin, iron).\\nAntacids relieve symptoms, promote ulcer healing, and reduce recurrence. They are relatively\\ninexpensive but must be taken 5 to 7 times/day. The optimal antacid regimen for ulcer healing seems to\\nbe 15 to 30 mL of liquid or 2 to 4 tablets 1 h and 3 h after each meal and at bedtime. The total daily'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 202, 'source_type': 'Authorotative', 'priority': '1'}, page_content='be 15 to 30 mL of liquid or 2 to 4 tablets 1 h and 3 h after each meal and at bedtime. The total daily\\ndosage of antacids should provide 200 to 400 mEq neutralizing capacity. However, antacids have been\\nsuperseded by acid-suppressive therapy in the treatment of peptic ulcer and are used only for short-term\\nsymptom relief.\\nIn general, there are 2 types of antacids: absorbable and nonabsorbable. Absorbable antacids (eg, Na\\nbicarbonate, Ca carbonate) provide rapid, complete neutralization but may cause alkalosis and should be\\nused only briefly (1 or 2 days). Nonabsorbable antacids (eg, aluminum or Mg hydroxide) have fewer\\nsystemic adverse effects and are preferred.\\nAluminum hydroxide is a relatively safe, commonly used antacid. With chronic use, phosphate depletion\\noccasionally develops as a result of binding of phosphate by aluminum in the GI tract. The risk of\\nphosphate depletion increases in alcoholics, undernourished patients, and patients with renal disease'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 202, 'source_type': 'Authorotative', 'priority': '1'}, page_content='phosphate depletion increases in alcoholics, undernourished patients, and patients with renal disease\\n(including those receiving hemodialysis). Aluminum hydroxide causes constipation.\\nMg hydroxide is a more effective antacid than aluminum but may cause diarrhea. To limit diarrhea, many\\nproprietary antacids combine Mg and aluminum antacids. Because small amounts of Mg are absorbed,\\nMg preparations should be used with caution in patients with renal disease.\\nProstaglandins: Certain prostaglandins (especially misoprostol) inhibit acid secretion by decreasing the\\ngeneration of cyclic AMP that is triggered by histamine stimulation of the parietal cell, and enhance\\nmucosal defense. Synthetic prostaglandin derivatives are used predominantly to decrease the risk of\\nNSAID-induced mucosal injury. Patients at high risk of NSAID-induced ulcers (ie, elderly patients, those\\nwith a history of ulcer or ulcer complication, those also taking corticosteroids) are candidates to take'),\n",
       " Document(metadata={'producer': 'Atop CHM to PDF Converter', 'creator': 'Atop CHM to PDF Converter', 'creationdate': 'D:20120615054440', 'source': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'file_path': '../data/pdfs/The Merck Manual of Diagnos_ (Z-Library).pdf', 'total_pages': 4113, 'format': 'PDF 1.4', 'title': 'The Merck Manual of Diagnosis & Therapy, 19th Edition', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': 'D:20120615054440', 'page': 202, 'source_type': 'Authorotative', 'priority': '1'}, page_content='with a history of ulcer or ulcer complication, those also taking corticosteroids) are candidates to take\\nmisoprostol 200 μg po qid with food along with their NSAID. Common adverse effects of misoprostol are\\nabdominal cramping and diarrhea, which occur in 30% of patients. Misoprostol is a powerful abortifacient\\nand is absolutely contraindicated in women of childbearing age who are not using contraception.\\nSucralfate: This drug is a sucrose-aluminum complex that dissociates in stomach acid and forms a\\nphysical barrier over an inflamed area, protecting it from acid, pepsin, and bile salts. It also inhibits\\npepsin-substrate interaction, stimulates mucosal prostaglandin production, and binds bile salts. It has no\\neffect on acid output or gastrin secretion. Sucralfate seems to have trophic effects on the ulcerated\\nmucosa, possibly by binding growth factors and concentrating them at an ulcer site. Systemic absorption'),\n",
       " ...]"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chunks=split_documents(all_pdf_documents)\n",
    "chunks"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "83e0b65c",
   "metadata": {},
   "outputs": [
    {
     "ename": "ValidationError",
     "evalue": "5 validation errors for Settings\nclickhouse_host\n  Input should be a valid string [type=string_type, input_value=None, input_type=NoneType]\n    For further information visit https://errors.pydantic.dev/2.12/v/string_type\nclickhouse_port\n  Input should be a valid string [type=string_type, input_value=None, input_type=NoneType]\n    For further information visit https://errors.pydantic.dev/2.12/v/string_type\nchroma_server_host\n  Input should be a valid string [type=string_type, input_value=None, input_type=NoneType]\n    For further information visit https://errors.pydantic.dev/2.12/v/string_type\nchroma_server_http_port\n  Input should be a valid string [type=string_type, input_value=None, input_type=NoneType]\n    For further information visit https://errors.pydantic.dev/2.12/v/string_type\nchroma_server_grpc_port\n  Input should be a valid string [type=string_type, input_value=None, input_type=NoneType]\n    For further information visit https://errors.pydantic.dev/2.12/v/string_type",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mValidationError\u001b[39m                           Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[27]\u001b[39m\u001b[32m, line 9\u001b[39m\n\u001b[32m      5\u001b[39m \u001b[38;5;28;01mimport\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mpydantic\u001b[39;00m\n\u001b[32m      7\u001b[39m pydantic.BaseSettings = BaseSettings\n\u001b[32m----> \u001b[39m\u001b[32m9\u001b[39m \u001b[38;5;28;01mimport\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mchromadb\u001b[39;00m\n\u001b[32m     10\u001b[39m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mchromadb\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mconfig\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m Settings\n\u001b[32m     11\u001b[39m \u001b[38;5;28;01mimport\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01muuid\u001b[39;00m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~/Desktop/Arvia-Ai/Arvia/.venv/lib/python3.14/site-packages/chromadb/__init__.py:11\u001b[39m\n\u001b[32m      7\u001b[39m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mchromadb\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mapi\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m API\n\u001b[32m      9\u001b[39m logger = logging.getLogger(\u001b[34m__name__\u001b[39m)\n\u001b[32m---> \u001b[39m\u001b[32m11\u001b[39m __settings = \u001b[43mchromadb\u001b[49m\u001b[43m.\u001b[49m\u001b[43mconfig\u001b[49m\u001b[43m.\u001b[49m\u001b[43mSettings\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m     13\u001b[39m __version__ = \u001b[33m\"\u001b[39m\u001b[33m0.3.23\u001b[39m\u001b[33m\"\u001b[39m\n\u001b[32m     16\u001b[39m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34mconfigure\u001b[39m(**kwargs: Dict[Any, Any]) -> \u001b[38;5;28;01mNone\u001b[39;00m:\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~/Desktop/Arvia-Ai/Arvia/.venv/lib/python3.14/site-packages/pydantic_settings/main.py:194\u001b[39m, in \u001b[36mBaseSettings.__init__\u001b[39m\u001b[34m(__pydantic_self__, _case_sensitive, _nested_model_default_partial_update, _env_prefix, _env_file, _env_file_encoding, _env_ignore_empty, _env_nested_delimiter, _env_nested_max_split, _env_parse_none_str, _env_parse_enums, _cli_prog_name, _cli_parse_args, _cli_settings_source, _cli_parse_none_str, _cli_hide_none_type, _cli_avoid_json, _cli_enforce_required, _cli_use_class_docs_for_groups, _cli_exit_on_error, _cli_prefix, _cli_flag_prefix_char, _cli_implicit_flags, _cli_ignore_unknown_args, _cli_kebab_case, _cli_shortcuts, _secrets_dir, **values)\u001b[39m\n\u001b[32m    164\u001b[39m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34m__init__\u001b[39m(\n\u001b[32m    165\u001b[39m     __pydantic_self__,\n\u001b[32m    166\u001b[39m     _case_sensitive: \u001b[38;5;28mbool\u001b[39m | \u001b[38;5;28;01mNone\u001b[39;00m = \u001b[38;5;28;01mNone\u001b[39;00m,\n\u001b[32m   (...)\u001b[39m\u001b[32m    192\u001b[39m     **values: Any,\n\u001b[32m    193\u001b[39m ) -> \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[32m--> \u001b[39m\u001b[32m194\u001b[39m     \u001b[38;5;28;43msuper\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\u001b[43m.\u001b[49m\u001b[34;43m__init__\u001b[39;49m\u001b[43m(\u001b[49m\n\u001b[32m    195\u001b[39m \u001b[43m        \u001b[49m\u001b[43m*\u001b[49m\u001b[43m*\u001b[49m\u001b[43m__pydantic_self__\u001b[49m\u001b[43m.\u001b[49m\u001b[43m_settings_build_values\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m    196\u001b[39m \u001b[43m            \u001b[49m\u001b[43mvalues\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    197\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_case_sensitive\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_case_sensitive\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    198\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_nested_model_default_partial_update\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_nested_model_default_partial_update\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    199\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_env_prefix\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_env_prefix\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    200\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_env_file\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_env_file\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    201\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_env_file_encoding\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_env_file_encoding\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    202\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_env_ignore_empty\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_env_ignore_empty\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    203\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_env_nested_delimiter\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_env_nested_delimiter\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    204\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_env_nested_max_split\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_env_nested_max_split\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    205\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_env_parse_none_str\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_env_parse_none_str\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    206\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_env_parse_enums\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_env_parse_enums\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    207\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_prog_name\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_prog_name\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    208\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_parse_args\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_parse_args\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    209\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_settings_source\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_settings_source\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    210\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_parse_none_str\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_parse_none_str\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    211\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_hide_none_type\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_hide_none_type\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    212\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_avoid_json\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_avoid_json\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    213\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_enforce_required\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_enforce_required\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    214\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_use_class_docs_for_groups\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_use_class_docs_for_groups\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    215\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_exit_on_error\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_exit_on_error\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    216\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_prefix\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_prefix\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    217\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_flag_prefix_char\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_flag_prefix_char\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    218\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_implicit_flags\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_implicit_flags\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    219\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_ignore_unknown_args\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_ignore_unknown_args\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    220\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_kebab_case\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_kebab_case\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    221\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_cli_shortcuts\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_cli_shortcuts\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    222\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_secrets_dir\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_secrets_dir\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    223\u001b[39m \u001b[43m        \u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    224\u001b[39m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~/Desktop/Arvia-Ai/Arvia/.venv/lib/python3.14/site-packages/pydantic/main.py:250\u001b[39m, in \u001b[36mBaseModel.__init__\u001b[39m\u001b[34m(self, **data)\u001b[39m\n\u001b[32m    248\u001b[39m \u001b[38;5;66;03m# `__tracebackhide__` tells pytest and some other tools to omit this function from tracebacks\u001b[39;00m\n\u001b[32m    249\u001b[39m __tracebackhide__ = \u001b[38;5;28;01mTrue\u001b[39;00m\n\u001b[32m--> \u001b[39m\u001b[32m250\u001b[39m validated_self = \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m__pydantic_validator__\u001b[49m\u001b[43m.\u001b[49m\u001b[43mvalidate_python\u001b[49m\u001b[43m(\u001b[49m\u001b[43mdata\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mself_instance\u001b[49m\u001b[43m=\u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[43m)\u001b[49m\n\u001b[32m    251\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mself\u001b[39m \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m validated_self:\n\u001b[32m    252\u001b[39m     warnings.warn(\n\u001b[32m    253\u001b[39m         \u001b[33m'\u001b[39m\u001b[33mA custom validator is returning a value other than `self`.\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[33m'\u001b[39m\n\u001b[32m    254\u001b[39m         \u001b[33m\"\u001b[39m\u001b[33mReturning anything other than `self` from a top level model validator isn\u001b[39m\u001b[33m'\u001b[39m\u001b[33mt supported when validating via `__init__`.\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[33m\"\u001b[39m\n\u001b[32m    255\u001b[39m         \u001b[33m'\u001b[39m\u001b[33mSee the `model_validator` docs (https://docs.pydantic.dev/latest/concepts/validators/#model-validators) for more details.\u001b[39m\u001b[33m'\u001b[39m,\n\u001b[32m    256\u001b[39m         stacklevel=\u001b[32m2\u001b[39m,\n\u001b[32m    257\u001b[39m     )\n",
      "\u001b[31mValidationError\u001b[39m: 5 validation errors for Settings\nclickhouse_host\n  Input should be a valid string [type=string_type, input_value=None, input_type=NoneType]\n    For further information visit https://errors.pydantic.dev/2.12/v/string_type\nclickhouse_port\n  Input should be a valid string [type=string_type, input_value=None, input_type=NoneType]\n    For further information visit https://errors.pydantic.dev/2.12/v/string_type\nchroma_server_host\n  Input should be a valid string [type=string_type, input_value=None, input_type=NoneType]\n    For further information visit https://errors.pydantic.dev/2.12/v/string_type\nchroma_server_http_port\n  Input should be a valid string [type=string_type, input_value=None, input_type=NoneType]\n    For further information visit https://errors.pydantic.dev/2.12/v/string_type\nchroma_server_grpc_port\n  Input should be a valid string [type=string_type, input_value=None, input_type=NoneType]\n    For further information visit https://errors.pydantic.dev/2.12/v/string_type"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "from sentence_transformers import SentenceTransformer\n",
    "import sys\n",
    "from pydantic_settings import BaseSettings\n",
    "import pydantic\n",
    "\n",
    "pydantic.BaseSettings = BaseSettings\n",
    "\n",
    "import chromadb\n",
    "from chromadb.config import Settings\n",
    "import uuid\n",
    "from typing import List, Dict, Any, Tuple\n",
    "from sklearn.metrics.pairwise import cosine_similarity"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "5616ade9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading embedding model: all-MiniLM-L6-v2\n",
      "Error loading model all-MiniLM-L6-v2: name 'SentenceTransformer' is not defined\n"
     ]
    },
    {
     "ename": "NameError",
     "evalue": "name 'SentenceTransformer' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mNameError\u001b[39m                                 Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[23]\u001b[39m\u001b[32m, line 46\u001b[39m\n\u001b[32m     41\u001b[39m         \u001b[38;5;28;01mreturn\u001b[39;00m embeddings\n\u001b[32m     44\u001b[39m \u001b[38;5;66;03m## initialize the embedding manager\u001b[39;00m\n\u001b[32m---> \u001b[39m\u001b[32m46\u001b[39m embedding_manager=\u001b[43mEmbeddingManager\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m     47\u001b[39m embedding_manager\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[23]\u001b[39m\u001b[32m, line 13\u001b[39m, in \u001b[36mEmbeddingManager.__init__\u001b[39m\u001b[34m(self, model_name)\u001b[39m\n\u001b[32m     11\u001b[39m \u001b[38;5;28mself\u001b[39m.model_name = model_name\n\u001b[32m     12\u001b[39m \u001b[38;5;28mself\u001b[39m.model = \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[32m---> \u001b[39m\u001b[32m13\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m_load_model\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[23]\u001b[39m\u001b[32m, line 19\u001b[39m, in \u001b[36mEmbeddingManager._load_model\u001b[39m\u001b[34m(self)\u001b[39m\n\u001b[32m     17\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m     18\u001b[39m     \u001b[38;5;28mprint\u001b[39m(\u001b[33mf\u001b[39m\u001b[33m\"\u001b[39m\u001b[33mLoading embedding model: \u001b[39m\u001b[38;5;132;01m{\u001b[39;00m\u001b[38;5;28mself\u001b[39m.model_name\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m\"\u001b[39m)\n\u001b[32m---> \u001b[39m\u001b[32m19\u001b[39m     \u001b[38;5;28mself\u001b[39m.model = \u001b[43mSentenceTransformer\u001b[49m(\u001b[38;5;28mself\u001b[39m.model_name)\n\u001b[32m     20\u001b[39m     \u001b[38;5;28mprint\u001b[39m(\u001b[33mf\u001b[39m\u001b[33m\"\u001b[39m\u001b[33mModel loaded successfully. Embedding dimension: \u001b[39m\u001b[38;5;132;01m{\u001b[39;00m\u001b[38;5;28mself\u001b[39m.model.get_sentence_embedding_dimension()\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m\"\u001b[39m)\n\u001b[32m     21\u001b[39m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mException\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m e:\n",
      "\u001b[31mNameError\u001b[39m: name 'SentenceTransformer' is not defined"
     ]
    }
   ],
   "source": [
    "class EmbeddingManager:\n",
    "    \"\"\"Handles document embedding generation using SentenceTransformer\"\"\"\n",
    "    \n",
    "    def __init__(self, model_name: str = \"all-MiniLM-L6-v2\"):\n",
    "        \"\"\"\n",
    "        Initialize the embedding manager\n",
    "        \n",
    "        Args:\n",
    "            model_name: HuggingFace model name for sentence embeddings\n",
    "        \"\"\"\n",
    "        self.model_name = model_name\n",
    "        self.model = None\n",
    "        self._load_model()\n",
    "\n",
    "    def _load_model(self):\n",
    "        \"\"\"Load the SentenceTransformer model\"\"\"\n",
    "        try:\n",
    "            print(f\"Loading embedding model: {self.model_name}\")\n",
    "            self.model = SentenceTransformer(self.model_name)\n",
    "            print(f\"Model loaded successfully. Embedding dimension: {self.model.get_sentence_embedding_dimension()}\")\n",
    "        except Exception as e:\n",
    "            print(f\"Error loading model {self.model_name}: {e}\")\n",
    "            raise\n",
    "\n",
    "    def generate_embeddings(self, texts: List[str]) -> np.ndarray:\n",
    "        \"\"\"\n",
    "        Generate embeddings for a list of texts\n",
    "        \n",
    "        Args:\n",
    "            texts: List of text strings to embed\n",
    "            \n",
    "        Returns:\n",
    "            numpy array of embeddings with shape (len(texts), embedding_dim)\n",
    "        \"\"\"\n",
    "        if not self.model:\n",
    "            raise ValueError(\"Model not loaded\")\n",
    "        \n",
    "        print(f\"Generating embeddings for {len(texts)} texts...\")\n",
    "        embeddings = self.model.encode(texts, show_progress_bar=True)\n",
    "        print(f\"Generated embeddings with shape: {embeddings.shape}\")\n",
    "        return embeddings\n",
    "\n",
    "\n",
    "## initialize the embedding manager\n",
    "\n",
    "embedding_manager=EmbeddingManager()\n",
    "embedding_manager"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.14.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
